
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/15/2022</td><td class="leftalignment">TheScreener</td><td class="leftalignment">An unfavourable environment weighs on REGENERON PHARMA, which sees a downgrade to Slightly Negative</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : JPM22 Investor Event Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0028241000 / US0576652004 / US5324571083 / US7170811035 / US75886F1075 / US6402681083 / US7665596034 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US03209R1032 / US14167L1035 / US1488061029 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US45781M1018 / US44842L1035 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / CA05156X8843 / US7291391057 / US12233L1070 / US4131971040 / US04683R1068 / KYG7307E1070 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Abbott Laboratories / Balchem Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Catalent Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Innoviva Inc / HUTCHMED (China) Ltd / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Aurora Cannabis Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Qilian International Holding Group Ltd / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Crysvita 2022 Guidance and Recent Corporate Updates; Fireside Chat with the CEO on Thursday</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">90400D108 / REGN.OQ</td><td class="leftalignment">Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Edwin Zhang, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 11, 2022</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALV.N / AXP.N / BA.N / COF.N / CP.TO / DD.N / F.N / GE.N / GM.N / IP.N / KBH.N / NSC.N / PNN.L / STLA.PA / TOL.N / TTG.L / VC.N / WEIR.L / SSE.L / WY.N / CFP.TO / LPX.N / WLL.N / CNR.TO / WCC.N / IEX.N / ROP.N / CSX.N / UNP.N / MMM.N / UNM.N / EMR.N / MTG.N / RDN.N / LNC.N / AME.N / BMRN.O / REGN.O / PRU.N / FLS.CO / BLU.N / GGG.N / VSEC.OQ / DFS.N / CSGP.OQ / ADS.N / ACGL.O / RUS.TO / NVT.N / WEF.TO / DRX.L / TDG.N / HICL.L / MERC.O / SPR.N / DAIGn.DE / KTOS.OQ / NOG.A / 759351604 / PCH.O / CFX.TO / IFP.TO / XYL.N / SLM.OQ / RFP.N / ALLY.N / TSLA.N / ESNT.N / XNCR.OQ / ITCI.O / RYAM.N / SYF.N / HQY.OQ / NMIH.O / 03835T200 / VACN.S / ATKR.N / STLC.TO / AQUA.N / APTV.N / CDMO.OQ / GTES.N / VRCA.OQ / ALLO.OQ / EPAC.N / CARR.N / LUNE.ST / MOCORP.HE / WFG.N / AKRBP.OL / BHG.N / CNM.N / RIVN.OQ / DTGGe.DE</td><td class="leftalignment">Autoliv Inc / American Express Co / Boeing Co / Capital One Financial Corp / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / Ford Motor Co / General Electric Co / General Motors Co / International Paper Co / KB Home / Norfolk Southern Corp / Pennon Group PLC / Stellantis NV / Toll Brothers Inc / TT electronics PLC / Visteon Corp / Weir Group PLC / SSE PLC / Weyerhaeuser Co / Canfor Corp / Louisiana-Pacific Corp / Whiting Petroleum Corp / Canadian National Railway Co / Wesco International Inc / IDEX Corp / Roper Technologies Inc / CSX Corp / Union Pacific Corp / 3M Co / Unum Group / Emerson Electric Co / MGIC Investment Corp / Radian Group Inc / Lincoln National Corp / AMETEK Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Prudential Financial Inc / FLSmidth & Co A/S / BELLUS Health Inc / Graco Inc / VSE Corp / Discover Financial Services / CoStar Group Inc / Alliance Data Systems Corp / Arch Capital Group Ltd / Russel Metals Inc / nVent Electric PLC / Western Forest Products Inc / Drax Group PLC / TransDigm Group Inc / HICL Infrastructure PLC / Mercer International Inc / Spirit AeroSystems Holdings Inc / Daimler AG / Kratos Defense and Security Solutions Inc / Northern Oil and Gas Inc / Reinsurance Group of America Inc / Potlatchdeltic Corp / Canfor Pulp Products Inc / Interfor Corp / Xylem Inc / SLM Corp / Resolute Forest Products Inc / Ally Financial Inc / Tesla Inc / Essent Group Ltd / Xencor Inc / Intra-Cellular Therapies Inc / Rayonier Advanced Materials Inc / Synchrony Financial / Healthequity Inc / NMI Holdings Inc / Aptose Biosciences Inc / VAT Group AG / Atkore Inc / Stelco Holdings Inc / Evoqua Water Technologies Corp / Aptiv PLC / Avid Bioservices Inc / Gates Industrial Corporation PLC / Verrica Pharmaceuticals Inc / Allogene Therapeutics Inc / Enerpac Tool Group Corp / Carrier Global Corp / Lundin Energy AB / Metso Outotec Corp / West Fraser Timber Co Ltd / Aker BP ASA / Bright Health Group Inc / Core & Main Inc / Rivian Automotive Inc / Daimler Truck Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Finland / United Kingdom / Ireland / Netherlands / Norway / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 31, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Eylea/REGEN-COV preliminary Q4 sales beat Street as oncology grows in focus into 2022</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : Live from The J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ABT / AME / BAC / BSX / CP / IEX / IOT / MDT / NOC.N / NSC / PEN / PFE.N / PNC / ROP / TFC / USB / GILD.O / GD.N / EPC / REGN.O / VRTX.O / NDSN.O / BIIB.O / DXCM.O / TNDM.OQ / FIVE.O / MEIP.O / NVRO.K / SMAR.K / SWAV.O / LHX.N / BEAM.O</td><td class="leftalignment">Abbott Laboratories / AMETEK Inc / Bank of America Corp / Boston Scientific Corp / Canadian Pacific Railway Ltd / IDEX Corp / Samsara Inc / Medtronic PLC / Northrop Grumman Corp / Norfolk Southern Corp / Penumbra Inc / Pfizer Inc / PNC Financial Services Group Inc / Roper Technologies Inc / Truist Financial Corp / US Bancorp / Gilead Sciences Inc / General Dynamics Corp / Edgewell Personal Care Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nordson Corp / Biogen Inc / Dexcom Inc / Tandem Diabetes Care Inc / Five Below Inc / MEI Pharma Inc / Nevro Corp / Smartsheet Inc / Shockwave Medical Inc / L3harris Technologies Inc / Beam Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Eylea and REGEN-COV Annual Sales Beat Our Estimates; We Remain Bullish on Regeneron</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ / 02043Q107 / NTLA.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intellia Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Takeaways From Presentation; Encouraging 4Q21 Sales and Early Oncology Data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">REGN: Key New Items from the Call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 Preannounce: Eylea Continues To Perform; REGEN-COV Beats Due To Pull Forward</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Brittany Woods, Ph.D. / Tara Bancroft, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: ALNY/NVS Liver Collab; SGMO Regains SCD Rights</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">ALNY.OQ / SGMO.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Sangamo Therapeutics Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Another Quarter, Another US Eylea Beat</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / INTC=US / TWTR=US / ADI=US / AMD=US / AMZN=US / INCY=US / TXN=US / NVDA=US / MPWR=US / CRM=US / DIOD=US / XLNX=US / BYD=US / TTMI=US / MGM=US / MANH=US / PENN=US / APH=US / ARW=US / AVGO=US / AVT=US / BMRN=US / COLL=US / EXEL=US / MCHP=US / REGN=US / APPN=US / BDSI=US / TPX=US / CZR=US / APP=US / BDC=US / XM=US / TEL=US / PRPL=US / OLO=US / NXPI=US / QTWO=US / FIVN=US / COUP=US / HUBS=US / WK=US / ON=US / ARGX=US / SMAR=US / APLT=US / DKNG=US / BALY=US / USER=US</td><td class="leftalignment">Merck & Co Inc / Intel Corp / Twitter Inc / Analog Devices Inc / Advanced Micro Devices Inc / Amazon.com Inc / Incyte Corp / Texas Instruments Inc / NVIDIA Corp / Monolithic Power Systems Inc / Salesforce.Com Inc / Diodes Inc / Xilinx Inc / Boyd Gaming Corp / TTM Technologies Inc / MGM Resorts International / Manhattan Associates Inc / Penn National Gaming Inc / Amphenol Corp / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Biomarin Pharmaceutical Inc / Collegium Pharmaceutical Inc / Exelixis Inc / Microchip Technology Inc / Regeneron Pharmaceuticals Inc / Appian Corp / BioDelivery Sciences International Inc / Tempur Sealy International Inc / Caesars Entertainment Inc / Applovin Corp / Belden Inc / Qualtrics International Inc / TE Connectivity Ltd / Purple Innovation Inc / Olo Inc / NXP Semiconductors NV / Q2 Holdings Inc / Five9 Inc / Coupa Software Inc / HubSpot Inc / Workiva Inc / ON Semiconductor Corp / argenx SE / Smartsheet Inc / Applied Therapeutics Inc / DraftKings Inc / Bally's Corp / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FY2021 Eylea and REGEN-COV sales above consensus estimates</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0188021085 / US0236081024 / US0255371017 / US0311621009 / US1101221083 / US1258961002 / US1264081035 / US1270971039 / US1475281036 / US22160K1051 / US2333311072 / US25179M1036 / US25746U1097 / US26875P1012 / US29364G1031 / US30161N1019 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US4592001014 / US5010441013 / US5324571083 / US56418H1005 / US6267171022 / US64125C1099 / US65473P1057 / US6558441084 / US6745991058 / US7170811035 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US7703231032 / AN8068571086 / US8168511090 / US8425871071 / US8454671095 / US87612E1064 / US8851601018 / US9078181081 / US92276F1003 / US92532F1003 / US9746371007 / US98389B1008 / CA1363751027 / CA4530384086 / CA5649051078 / CA1363851017 / US1667641005 / US5658491064 / CA0636711016 / US0017441017 / US20825C1045 / US15189T1079 / US2274831047 / US09062X1037 / CA67072Q1046 / CA2265331074 / US6293775085 / US0534841012 / US1011211018 / US2644115055 / CA6993202069 / CA0906971035 / CA4495861060 / US42809H1077 / BMG383271050 / US4219461047 / US49427F1084 / US89785X1019 / US2120151012 / US38500T1016 / US26884L1098 / CA22576C1014 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / CA00829Q1019 / US26441C2044 / CA89156V1067 / US69327R1014 / US72919P2020 / CA4013393042 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA3565001086 / US70509V1008 / CA04682R1073 / US5764852050 / US29355A1079 / US25278X1090 / CA4882951060 / US71943U1043 / US60468T1051 / US03674X1063 / CA14150G4007 / CA7397211086 / US65341B1061 / US29444U7000 / US30040W1080 / US83417M1045 / US4278255009 / US92939U1060 / US86771W1053 / US0130911037 / US2057683029 / US13462K1097 / US15136A1025 / GB00BDSFG982 / CA46016U1084 / US92840M1027 / US05722G1004 / US12653C1080 / CA35905B1076 / US00191U1025 / US83200N1037 / US87484T1088 / US0937121079 / US08579X1019 / CA7241121077 / CA6744822033 / US86745K1043 / US69047Q1022 / CA4220961078 / CA84678A1021 / US5168062058 / US13123X5086 / CA89055A2039 / US0412421085 / US62955J1034 / US1651677353 / US03743Q1085 / CA00791P1071 / US1374041093</td><td class="leftalignment">Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Amgen Inc / Bristol-Myers Squibb Co / CMS Energy Corp / CSX Corp / Coterra Energy Inc / Caseys General Stores Inc / Costco Wholesale Corp / DTE Energy Co / Devon Energy Corp / Dominion Energy Inc / EOG Resources Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / International Business Machines Corp / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Murphy Oil Corp / Neurocrine Biosciences Inc / NiSource Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Schlumberger NV / Sempra Energy / Southern Co / Southwestern Energy Co / Target Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Xcel Energy Inc / Canadian National Railway Co / Imperial Oil Ltd / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Chevron Corp / Marathon Oil Corp / Bank of Montreal / AMN Healthcare Services Inc / Conocophillips / CenterPoint Energy Inc / Cross Country Healthcare Inc / Biogen Inc / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Avalonbay Communities Inc / Boston Properties Inc / Duke Realty Corp / Paramount Resources Ltd / Birchcliff Energy Ltd / IGM Financial Inc / Hess Corp / GeoPark Ltd / Healthcare Realty Trust Inc / Kilroy Realty Corp / TrueBlue Inc / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Crescent Point Energy Corp / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Africa Oil Corp / Duke Energy Corp / Tourmaline Oil Corp / PDC Energy Inc / Plug Power Inc / Guardian Capital Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Freehold Royalties Ltd / Pebblebrook Hotel Trust / Athabasca Oil Corp / Matador Resources Co / Enphase Energy Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Physicians Realty Trust / Mirati Therapeutics Inc / Antero Resources Corp / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Hersha Hospitality Trust / WEC Energy Group Inc / Sunrun Inc / Albertsons Companies Inc / Comstock Resources Inc / Camping World Holdings Inc / Centennial Resource Development Inc / TechnipFMC PLC / International Petroleum Corp / Vistra Corp / Baker Hughes Co / CNX Resources Corp / Frontera Energy Corp / ASGN Inc / Smartsheet Inc / Talos Energy Inc / Bloom Energy Corp / Berry Corporation (Bry) / Pipestone Energy Corp / Obsidian Energy Ltd / Sunnova Energy International Inc / Ovintiv Inc / Headwater Exploration Inc / Spartan Delta Corp / Laredo Petroleum Inc / Callon Petroleum Co / Topaz Energy Corp / Arko Corp. / Nov Inc / Chesapeake Energy Corp / APA Corp (US) / Advantage Energy Ltd / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AES.N / AIG.N / ALV.N / AU.N / BOX.N / CCI.N / CI.N / CL.N / CVS.N / EIX.N / F.N / FSR.N / GM.N / KBH.N / MAS.N / MO.N / NEM.N / OREP.PA / PHM.N / SO.N / T.N / TOL.N / VC.N / PG.N / HUM.N / FNV.N / CPB.N / TEN.N / CMCSA.O / AMGN.O / THC.N / UHS.N / AGI.N / UNH.N / BWA.N / LEA.N / PNM.N / DISH.O / LEN.N / VMC.N / PCG.N / AEM.N / AMT.N / KGC.N / WHR.N / NG.L / VZ.N / HCA.N / EXEL.O / CYH.N / XEL.N / DHI.N / CINF.O / APH.N / EXC.N / AXL.N / RPM.N / IRT.N / VTR.N / MRD.TO / BMRN.O / EXE.TO / REGN.O / ENR.N / MHK.N / CAR_u.TO / NCR.N / TEL.N / GFI.N / CPK.N / CHE.N / CDE.N / HL.N / ST.N / SKY.N / SWN.N / PLUG.OQ / SEM.N / GPN.N / RGLD.O / CASY.O / AMED.O / PAAS.O / EQIX.O / GOLD.N / SMU_U.TO / REI_u.TO / MRC.TO / MRT_u.TO / HR_u.TO / CUF_u.TO / HOT_u.TO / AP_u.TO / CSH_u.TO / D_u.TO / DPM.TO / CRT_u.TO / EDV.TO / BEI_u.TO / CG.TO / BECN.O / DLR.N / VIAC.O / IAG.N / 416515104 / GMS.N / LHCG.O / BKD.N / FIS.N / CRR_u.TO / MA.N / OC.N / EHTH.O / AUY.N / AX_u.TO / IIP_u.TO / ENSG.O / DAN.N / NGD.A / ADUS.OQ / EGO.N / AR.TO / SPB.N / NWH_u.TO / TXG.TO / NEE.N / MTOR.N / ATD.TO / FBHS.N / ACHC.O / MRG_u.TO / PANW.N / MDLZ.OQ / DIR_u.TO / GRT_u.TO / TPH.N / TSLA.N / BLDR.N / TMUS.N / TMHC.N / MR_u.TO / CHP_u.TO / BEP.N / 81762P102 / DOOR.N / PLZ_u.TO / IBP.N / 922475108 / BTG.N / NEP.N / ANTM.N / WBA.N / SUM.N / SIA.TO / PYPL.OQ / SRU_u.TO / RUN.O / SGRY.O / SQ.N / SITE.N / KMP_u.TO / APR_U.TO / TWLO.N / OR.N / ADNT.N / JELD.N / SAND.N / VST.N / WPM.N / SSRM.O / KL.N / APTV.N / EHC.N / EQX.TO / COLD.N / WELL.N / SMAR.N / VNE.N / MI_U.TO / HOMU.TO / CRWD.O / NOVA.N / GMAB.O / CRNC.OQ / PNTG.OQ / FCR_u.TO / AZEK.N / WTRG.N / SLQT.N / AHCO.O / WMG.OQ / NKLA.OQ / FOUR.N / ERE_u.TO / GOCO.O / DCT.O / AEP.OQ / GATO.N / RIDE.OQ / MAX.N / LSPD.N / PUBM.O / DFH.OQ / AFRM.O / CHK.OQ / COUR.N / TSP.OQ / AVAH.OQ / TFPM.TO / FLYW.O / BHG.N / TRMR.OQ / CNM.N / COOK.N / FLNC.OQ / RIVN.OQ / IOT.N</td><td class="leftalignment">AES Corp / American International Group Inc / Autoliv Inc / AngloGold Ashanti Ltd / Box Inc / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Edison International / Ford Motor Co / Fisker Inc / General Motors Co / KB Home / Masco Corp / Altria Group Inc / Newmont Corporation / L'Oreal SA / Pultegroup Inc / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Procter & Gamble Co / Humana Inc / Franco-Nevada Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Amgen Inc / Tenet Healthcare Corp / Universal Health Services Inc / Alamos Gold Inc / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / DISH Network Corp / Lennar Corp / Vulcan Materials Co / PG&E Corp / Agnico Eagle Mines Ltd / American Tower Corp / Kinross Gold Corp / Whirlpool Corp / National Grid PLC / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Xcel Energy Inc / D R Horton Inc / Cincinnati Financial Corp / Amphenol Corp / Exelon Corp / American Axle & Manufacturing Holdings Inc / RPM International Inc / Independence Realty Trust Inc / Ventas Inc / Melcor Developments Ltd / Biomarin Pharmaceutical Inc / Extendicare Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Mohawk Industries Inc / Canadian Apartment Properties Real Estate Investment Trust / NCR Corp / TE Connectivity Ltd / Gold Fields Ltd / Chesapeake Utilities Corp / Chemed Corp / Coeur Mining Inc / Hecla Mining Co / Sensata Technologies Holding PLC / Skyline Champion Corp / Southwestern Energy Co / Plug Power Inc / Select Medical Holdings Corp / Global Payments Inc / Royal Gold Inc / Caseys General Stores Inc / Amedisys Inc / Pan American Silver Corp / Equinix Inc / Barrick Gold Corp / Summit Industrial Income REIT / RioCan Real Estate Investment Trust / Morguard Corp / Morguard Real Estate Investment Trust / H&R Real Estate Investment Trust / Cominar Real Estate Investment Trust / American Hotel Income Properties REIT LP / Allied Properties Real Estate Investment Trust / Chartwell Retirement Residences / Dream Office Real Estate Investment Trust / Dundee Precious Metals Inc / CT Real Estate Investment Trust / Endeavour Mining PLC / Boardwalk Real Estate Investment Trust / Centerra Gold Inc / Beacon Roofing Supply Inc / Digital Realty Trust Inc / ViacomCBS Inc / IAMGOLD Corp / Hartford Financial Services Group Inc / GMS Inc / LHC Group Inc / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Crombie Real Estate Investment Trust / Mastercard Inc / Owens Corning / eHealth Inc / Yamana Gold Inc / Artis Real Estate Investment Trust / InterRent Real Estate Investment Trust / Ensign Group Inc / Dana Inc / New Gold Inc / Addus Homecare Corp / Eldorado Gold Corp / Argonaut Gold Inc / Spectrum Brands Holdings Inc / NorthWest Healthcare Properties REIT / Torex Gold Resources Inc / Nextera Energy Inc / Meritor Inc / Alimentation Couche-Tard Inc / Fortune Brands Home & Security Inc / Acadia Healthcare Company Inc / Morguard North American Residential Real Estate Investment Trust / Palo Alto Networks Inc / Mondelez International Inc / Dream Industrial Real Estate Investment Trust / Granite Real Estate Investment Trust / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Builders FirstSource Inc / T-Mobile US Inc / Taylor Morrison Home Corp / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Brookfield Renewable Partners LP / ServiceNow Inc / Masonite International Corp / Plaza Retail REIT / Installed Building Products Inc / Veeva Systems Inc / B2Gold Corp / Nextera Energy Partners LP / Anthem Inc / Walgreens Boots Alliance Inc / Summit Materials Inc / Sienna Senior Living Inc / PayPal Holdings Inc / SmartCentres Real Estate Investment Trust / Sunrun Inc / Surgery Partners Inc / Block Inc / SiteOne Landscape Supply Inc / Killam Apartment REIT / Automotive Properties Real Estate Investment Trust / Twilio Inc / Osisko Gold Royalties Ltd / Adient PLC / JELD-WEN Holding Inc / Sandstorm Gold Ltd / Vistra Corp / Wheaton Precious Metals Corp / SSR Mining Inc / Kirkland Lake Gold Ltd / Aptiv PLC / Encompass Health Corp / Equinox Gold Corp / Americold Realty Trust / Welltower Inc / Smartsheet Inc / Veoneer Inc / Minto Apartment Real Estate Investment Trust / BSR Real Estate Investment Trust / CrowdStrike Holdings Inc / Sunnova Energy International Inc / Genmab A/S / Cerence Inc / Pennant Group Inc / First Capital Real Estate Investment Trust / Azek Company Inc / Essential Utilities Inc / SelectQuote Inc / Adapthealth Corp / Warner Music Group Corp / Nikola Corp / Shift4 Payments Inc / European Residential REIT / Gohealth Inc / Duck Creek Technologies Inc / American Electric Power Company Inc / Gatos Silver Inc / Lordstown Motors Corp / Mediaalpha Inc / Lightspeed Commerce Inc / PubMatic Inc / Dream Finders Homes Inc / Affirm Holdings Inc / Chesapeake Energy Corp / Coursera Inc / TuSimple Holdings Inc / Aveanna Healthcare Holdings Inc / Triple Flag Precious Metals Corp / Flywire Corp / Bright Health Group Inc / Tremor International Ltd / Core & Main Inc / Traeger Inc / Fluence Energy Inc / Rivian Automotive Inc / Samsara Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/08/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMRN.O / REGN.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMPE-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMPE.K / ABT / JNJ / PFE / RIGL.O / REGN.O / ALIM.O / AERI.O</td><td class="leftalignment">Ampio Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Pfizer Inc / Rigel Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alimera Sciences Inc / Aerie Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALDX-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALDX.O / REGN.O / TENX.O / ANTH.PK</td><td class="leftalignment">Aldeyra Therapeutics Inc / Regeneron Pharmaceuticals Inc / Tenax Therapeutics Inc / Anthera Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Suspending Research Coverage</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">00287Y10 / 03116210 / 71708110 / 92532F10 / 37555810 / 75886F10 / 80105N10 / 40637H10 / 31572Q80 / 75046920 / G3910J11 / 61776010 / G8807B10 / 04539610 / 68386J20 / G7627910</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / Halozyme Therapeutics Inc / FibroGen Inc / Radius Health Inc / GlaxoSmithKline PLC / MorphoSys AG / Theravance Biopharma Inc / Assembly Biosciences Inc / Opthea Ltd / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Cayman Islands / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jim Kelly</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, REGN</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - CMS AD NCD & JPM Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 24, 2021 to January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8336351056 / US0091581068 / US0126531013 / US0234361089 / US0311621009 / US0536111091 / US1101221083 / US2017231034 / US2788651006 / US3755581036 / US3976241071 / US4128221086 / US4180561072 / US4282911084 / US4448591028 / US45337C1027 / US4601461035 / US5324571083 / US5463471053 / US56418H1005 / US5719032022 / US5770811025 / US64125C1099 / US6516391066 / US6703461052 / US6935061076 / US6951561090 / US7170811035 / US7310681025 / US7496851038 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / US8243481061 / US8581191009 / US9113121068 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA25822C2058 / CA1469001053 / CA0679011084 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US37940X1028 / US2274831047 / US09062X1037 / US46625H1005 / US0605051046 / US20451N1019 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2971781057 / US1331311027 / US1508701034 / US2538681030 / CA8911605092 / CA1360691010 / US1011211018 / US2644115055 / US9290421091 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / US57636Q1040 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US5021751020 / US63633D1046 / US5500211090 / US89785X1019 / CA3518581051 / US92826C8394 / US58502B1061 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / CA55903Q1046 / US76131N1019 / US70509V1008 / CA38045Y1025 / US16208T1025 / US78573L1061 / US74965L1017 / US23283R1005 / CA05577W2004 / US71943U1043 / US60468T1051 / US9660842041 / US02665T3068 / US45378A1060 / US11120U1051 / US02005N1000 / US1785871013 / CA45868C1095 / US14174T1079 / BMG0750C1082 / US8621211007 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US9741551033 / US1638511089 / US4278255009 / US96145D1054 / US70450Y1038 / CA8485101031 / US95040Q1040 / US8522341036 / 100607060 / US45688C1071 / US53223X1072 / US0441861046 / CA26829L1076 / US7005171050 / US43300A2033 / US46187W1071 / CA9628791027 / GB00BF3ZNS54 / US87105L1044 / CA53680Q2071 / US46590V1008 / CA2960061091 / US3610081057 / CA8585221051 / US29261A1007 / US00191U1025 / US83200N1037 / US48251W1045 / CA4039254079 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / US2605571031 / GB00BJT16S69 / US73757R1023 / US26614N1028 / US5012701026 / US42250P1030 / CA92625W5072 / US14316J1088 / US47012E4035 / US69526K1051 / CA67079A1021 / US15202L1070 / CA00076T1057 / US11135E2037 / US00848J1043 / BMG6964L1072 / US0708301041 / US71844V2016 / US27923Q1094 / AU0000193666 / US4576791085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Air Products and Chemicals Inc / Albemarle Corp / Amedisys Inc / Amgen Inc / Avery Dennison Corp / Bristol-Myers Squibb Co / Commercial Metals Co / Ecolab Inc / Gilead Sciences Inc / Greif Inc / Harley-Davidson Inc / Hasbro Inc / Hexcel Corp / Humana Inc / Incyte Corp / International Paper Co / Eli Lilly and Co / Louisiana-Pacific Corp / ManpowerGroup Inc / Marriott International Inc / Mattel Inc / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / PPG Industries Inc / Packaging Corp of America / Pfizer Inc / Polaris Inc / RPM International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Sherwin-Williams Co / Steel Dynamics Inc / United Parcel Service Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Dorel Industries Inc / Cascades Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Global Payments Inc / Cross Country Healthcare Inc / Biogen Inc / JPMorgan Chase & Co / Bank of America Corp / Compass Minerals International Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Celanese Corp / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Mastercard Inc / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Lululemon Athletica Inc / TrueBlue Inc / Franco-Nevada Corp / Visa Inc / MEDNAX Inc / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / MAG Silver Corp / Retail Opportunity Investments Corp / Pebblebrook Hotel Trust / GoGold Resources Inc / Chatham Lodging Trust / Sabra Health Care REIT Inc / RLJ Lodging Trust / CyrusOne Inc / BRP Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Whitestone REIT / American Homes 4 Rent / Independence Realty Trust Inc / Brixmor Property Group Inc / Ally Financial Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Axalta Coating Systems Ltd / STORE Capital Corp / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Wingstop Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / PayPal Holdings Inc / Spin Master Corp / Welltower Inc / Block Inc / First-Citizens Bank & Trust Co / Ingevity Corp / Life Storage Inc / Ashland Global Holdings Inc / ECN Capital Corp / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Invitation Homes Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Switch Inc / Lithium Americas Corp / JBG SMITH Properties / Ero Copper Corp / Funko Inc / Stelco Holdings Inc / Encompass Health Corp / ASGN Inc / Smartsheet Inc / KKR & Co Inc / H&R Real Estate Investment Trust / Livent Corp / Linde PLC / Calibre Mining Corp / Dow Inc / Tronox Holdings PLC / Postal Realty Trust Inc / Dupont De Nemours Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Carlyle Group Inc / JAKKS Pacific Inc / Pactiv Evergreen Inc / Nuvei Corp / Centerspace / Abc Technologies Holdings Inc / Broadstone Net Lease Inc / Agiliti Inc / Paysafe Ltd / Bath & Body Works Inc / Phillips Edison & Co Inc / Ecovyst Inc / Allkem Ltd / Innovid Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Chile / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 31, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">REGN Collab to Commercialize Evkeeza w/ Pot'l to Partner on FOP Prgm a Net Pos.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ / 90400D10 / RARE.OQ / 75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph P. Schwartz / Joori Park, Ph.D. / Will Soghikian / Beth Feindt-Scott</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / CARS / FISV=US / LLY=US / AMGN=US / BMY=US / TWTR=US / AMZN=US / EBAY=US / GILD=US / PEB=US / H=US / CRM=US / V=US / MTN=US / VRM=US / MAR=US / EXPE=US / TNL=US / HLT=US / HUM=US / CVS=US / W=US / STZ=US / DV=US / AIR=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CCK=US / CW=US / DRH=US / DCO=US / EEFT=US / HEI=US / HXL=US / TREE=US / MRCY=US / NRDS=US / REGN=US / ROLL=US / SHOP=US / SFT=US / SNAP=US / TRIP=US / TGI=US / TRUE=US / VSEC=US / VRTX=US / WIX=US / WEX=US / FOUR=US / GPN=US / PYPL=US / BKNG=US / PRI=US / FB=US / MTCH=US / SPR=US / EVOP=US / MQ / DKS=US / PTON=US / BIIB=US / FLT=US / MOG.A=US / APP=US / SHO=US / BLDR=US / FIS=US / TDG=US / HST=US / MA=US / WU=US / KTOS=US / WH=US / IAC=US / 45665G303 / HGV=US / GDOT=US / WWD=US / PCRX=US / RLJ=US / VAC=US / ANGI=US / RHP=US / SSTK=US / ABBV=US / GOOGL=US / BABA=US / AFMD=US / CMPR=US / BVH=US / WBA=US / GDDY=US / ETSY=US / AJRD=US / BWXT=US / ZG=US / SQ=US / IBEX=US / NTLA=US / TTD=US / CRSP=US / TRVG=US / PK=US / PLYA=US / AYX=US / CVNA=US / YEXT=US / RDFN=US / CARG=US / SFIX=US / ROOT=US / MAXR=US / GSKY=US / FTDR=US / EB=US / AXNX=US / LYFT=US / UBER=US / LSPD=US / APLT=US / LHX=US / RPAY=US / ONEW=US / SPCE=US / AZEK=US / TSHA / PAYA=US / ABNB=US / DASH=US / AFRM=US / VMEO=US / MNTV=US / SQSP=US / 00152K101</td><td class="leftalignment">Albany International Corp / Cars.com Inc / Fiserv Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Twitter Inc / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / CVS Health Corp / Wayfair Inc / Constellation Brands Inc / DoubleVerify Holdings Inc / AAR Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Euronet Worldwide Inc / HEICO Corp / Hexcel Corp / Lendingtree Inc / Mercury Systems Inc / Nerdwallet Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Shopify Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / TrueCar Inc / VSE Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / WEX Inc / Shift4 Payments Inc / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Primerica Inc / Meta Platforms Inc / Match Group Inc / Spirit AeroSystems Holdings Inc / EVO Payments Inc / Marqeta Inc / DICK'S Sporting Goods Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Moog Inc / Applovin Corp / Sunstone Hotel Investors Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Western Union Co / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / Green Dot Corp / Woodward Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Shutterstock Inc / Abbvie Inc / Alphabet Inc / Alibaba Group Holding Ltd / Affimed NV / Cimpress PLC / Bluegreen Vacations Holding Corp / Walgreens Boots Alliance Inc / GoDaddy Inc / ETSY Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Zillow Group Inc / Block Inc / Ibex Ltd / Intellia Therapeutics Inc / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Alteryx Inc / Carvana Co / Yext Inc / Redfin Corp / CarGurus Inc / Stitch Fix Inc / Root Inc / Maxar Technologies Inc / GreenSky Inc / Frontdoor Inc / Eventbrite Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Applied Therapeutics Inc / L3harris Technologies Inc / Repay Holdings Corp / OneWater Marine Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Taysha Gene Therapies Inc / Paya Holdings Inc / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Vimeo Inc / Momentive Global Inc / Squarespace Inc / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US8336351056 / US0126531013 / US0311621009 / US1101221083 / US3755581036 / US4448591028 / US45337C1027 / US5324571083 / US5463471053 / US5719032022 / US64125C1099 / US6516391066 / US7170811035 / US7549071030 / US75886F1075 / US7802871084 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA0679011084 / CA9528451052 / US09062X1037 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2538681030 / US1011211018 / US2644115055 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US63633D1046 / CA3518581051 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / US70509V1008 / US16208T1025 / US78573L1061 / US71943U1043 / US60468T1051 / CA45868C1095 / US14174T1079 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / CA9628791027 / US87105L1044 / CA53680Q2071 / CA2960061091 / US53814L1089 / CA13000C2058 / US2605571031 / US73757R1023 / US5012701026 / US42250P1030 / CA92625W5072 / US15202L1070 / US11135E2037 / US0708301041 / AU0000193666</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Albemarle Corp / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Humana Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Marriott International Inc / Neurocrine Biosciences Inc / Newmont Corporation / Pfizer Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Biogen Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Digital Realty Trust Inc / Boston Properties Inc / Duke Realty Corp / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / National Health Investors Inc / Franco-Nevada Corp / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Sabra Health Care REIT Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Interfor Corp / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Wheaton Precious Metals Corp / Switch Inc / Lithium Americas Corp / Ero Copper Corp / Livent Corp / Calibre Mining Corp / Dow Inc / Postal Realty Trust Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Centerspace / Broadstone Net Lease Inc / Bath & Body Works Inc / Allkem Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FY2022 Large-Cap Biotech Preview</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">AMGN=US / BIIB=US / LLY=US / BMY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / ABBV=US</td><td class="leftalignment">Amgen Inc / Biogen Inc / Eli Lilly and Co / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Navigating the Virtual Circus: Expectations and Mgmt Qs for Next Week's Conf.</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">NTLA 2022 Preview: Near Term ATTR Update And Broadening Of Clinical Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">45826J105 / 66987V10 / 75886F10</td><td class="leftalignment">Intellia Therapeutics Inc / Novartis AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Starting With a Bang: Fund Flows Positive Into 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAP / AR / AZO / BBY / BMY.N / BP.N / CHD / CL / CLR / CLX / CNX / COP / CPE / CVX / DVN / EL / EOG / EQT / FND / HD / HES / KMB / KO / LLY.N / LOW / MGY / MRK.N / MRO / MUR / OLN / OXY / PFE.N / PG / PXD / RH / RRC / SLB.N / SM / SPB / STZ / SWN / TAP.N / W / WLK / WLL / WSM / CNQ.TO / GILD.O / AMGN.O / HAL.N / EPC / MGM.N / SU.TO / BBBY.O / XOM / LBRT.N / PENN.O / LPI / REGN.O / VRTX.O / TSCO.O / COCO.O / SMG.N / WYNN.O / MNST.O / ORLY.O / WOOF.O / BIIB.O / NOV.N / RDSb / NOG.A / CZR.O / BKR.N / ESTE.K / MTDR.K / PDCE.O / AMBA.O / FANG.O / ABBV.N / GTLS.N / COTY.K / CIVI.K / TCON.O / CDEV.O / CVNA.K / IOVA.O / EYE.O / PEP.O / INSP.K / KDP.N / AVRO.O / BRY.O / NWL.O / FLTRF.L / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / GRWG.O / SFT.O / BALY.N / RSI.N / HYFM.O / CHK.O / JOAN.O / ZVIA.N / WEBR.N</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bristol-Myers Squibb Co / BP PLC / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Chevron Corp / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Home Depot Inc / Hess Corp / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Murphy Oil Corp / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Procter & Gamble Co / Pioneer Natural Resources Co / RH / Range Resources Corp / Schlumberger NV / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Wayfair Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Williams-Sonoma Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Halliburton Co / Edgewell Personal Care Co / MGM Resorts International / Suncor Energy Inc / Bed Bath & Beyond Inc / Exxon Mobil Corp / Liberty Oilfield Services Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Tractor Supply Co / Vita Coco Company Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / Monster Beverage Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Northern Oil and Gas Inc / Caesars Entertainment Inc / Baker Hughes Co / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / Abbvie Inc / Chart Industries Inc / Coty Inc / Civitas Resources Inc / TRACON Pharmaceuticals Inc / Centennial Resource Development Inc / Carvana Co / Iovance Biotherapeutics Inc / National Vision Holdings Inc / PepsiCo Inc / Inspire Medical Systems Inc / Keurig Dr Pepper Inc / AVROBIO Inc / Berry Corporation (Bry) / Newell Brands Inc / Flutter Entertainment PLC / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / GrowGeneration Corp / Shift Technologies Inc / Bally's Corp / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Joann Inc / Zevia PBC / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 5, 2022</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CAS.TO / CVS.N / F.N / FLS.N / GE.N / GM.N / RYN.N / WY.N / CFP.TO / LPX.N / AMGN.O / ETN.N / DHR.N / UNH.N / WCC.N / DOV.N / IEX.N / ROP.N / HON.N / MMM.N / EMR.N / ADCT.N / GWW.N / HCA.N / EXEL.O / CYH.N / JCI.N / ARNA.O / AME.N / BMRN.O / REGN.O / JHX.AX / GGG.N / PNR.N / TT.N / LNG.A / SGEN.OQ / IMGN.O / LIFE.O / NTR.N / NVT.N / WEF.TO / MWA.N / CLW.N / ADN.TO / PCH.O / CTT.N / IFP.TO / XYL.N / RFP.N / KPT.TO / PRTA.O / AGIO.O / CFF.TO / MESO.O / FTV.N / ATKR.N / UN01.DE / ATNX.O / AQUA.N / GTES.N / GMAB.O / EPAC.N / CARR.N / NRIX.OQ / NUVB.N / TTEF.PA</td><td class="leftalignment">Cascades Inc / CVS Health Corp / Ford Motor Co / Flowserve Corp / General Electric Co / General Motors Co / Rayonier Inc / Weyerhaeuser Co / Canfor Corp / Louisiana-Pacific Corp / Amgen Inc / Eaton Corporation PLC / Danaher Corp / UnitedHealth Group Inc / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Honeywell International Inc / 3M Co / Emerson Electric Co / ADC Therapeutics SA / W W Grainger Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Johnson Controls International PLC / Arena Pharmaceuticals Inc / AMETEK Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / James Hardie Industries PLC / Graco Inc / Pentair PLC / Trane Technologies PLC / Cheniere Energy Inc / Seagen Inc / ImmunoGen Inc / aTyr Pharma Inc / Nutrien Ltd / nVent Electric PLC / Western Forest Products Inc / Mueller Water Products Inc / Clearwater Paper Corp / Acadian Timber Corp / Potlatchdeltic Corp / CatchMark Timber Trust Inc / Interfor Corp / Xylem Inc / Resolute Forest Products Inc / KP Tissue Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Conifex Timber Inc / Mesoblast Ltd / Fortive Corp / Atkore Inc / Uniper SE / Athenex Inc / Evoqua Water Technologies Corp / Gates Industrial Corporation PLC / Genmab A/S / Enerpac Tool Group Corp / Carrier Global Corp / Nurix Therapeutics Inc / Nuvation Bio Inc / TotalEnergies SE</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: 1Q22 Prep Pack - key questions for mgmt teams across our coverage universe</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / LIFE.O / PRTA.O / AGIO.O / MESO.O / ATNX.O / GMAB.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / aTyr Pharma Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Biopharma—Feedback From our Recent Launch; Slides attached–CC TMRW (1/5) 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 78 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">HBAN.OQ / KOP.N / AAN.N / BBY.N / CL.N / COF.N / CVS.N / F.N / HLT.N / SLB.N / T.N / TMO.N / BEN.N / THC.N / GBX.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / TGT.N / XL.N / AMP.N / ARW.N / ATO.N / TWTR.N / HAE.N / STL.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / REGN.OQ / BBBY.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / BCO.N / CVGI.OQ / BBW.N / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / SCHW.N / EXPR.N / DDD.N / GRPN.OQ / FB.OQ / TROX.N / COTY.N / CTG.OQ / MGNX.OQ / LADR.N / TWOU.OQ / FGEN.OQ / ANTM.N / PFX.N / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Huntington Bancshares Inc / Koppers Holdings Inc / Aaron's Company Inc / Best Buy Co Inc / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Greenbrier Companies Inc / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Target Corp / XL Fleet Corp / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Haemonetics Corp / Sterling Bancorp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Regeneron Pharmaceuticals Inc / Bed Bath & Beyond Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Brinks Co / Commercial Vehicle Group Inc / Build-A-Bear Workshop Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / Charles Schwab Corp / Express Inc / 3D Systems Corp / Groupon Inc / Meta Platforms Inc / Tronox Holdings PLC / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Ladder Capital Corp / 2U Inc / FibroGen Inc / Anthem Inc / PhenixFIN Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">January "Monthly Controversies" report & '22 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GBT=US / GILD=US / H=US / CRM=US / MTN=US / HSII=US / MAR=US / TNL=US / KFRC=US / HLT=US / KFY=US / AMN=US / PATH=US / CHH=US / COLL=US / MAN=US / ASGN=US / RARE=US / REGN=US / RHI=US / VRTX=US / SAGE=US / CCRN=US / JAZZ=US / COP=US / APPN=US / INST=US / BDSI=US / MRNS=US / BIIB=US / RNG=US / APTX=US / XM=US / NSP=US / HST=US / CPRX=US / WH=US / HGV=US / VAC=US / RHP=US / FATE=US / CNCE=US / FIVN=US / AFMD=US / HUBS=US / BVH=US / WK=US / RLMD=US / VKTX=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / PK=US / ANAB=US / PLYA=US / VRNA=US / ARVN=US / CYCN=US / TSHA / COUR=US / UDMY=US / USER=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Gilead Sciences Inc / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Heidrick & Struggles International Inc / Marriott International Inc / Travel + Leisure Co / Kforce Inc / Hilton Worldwide Holdings Inc / Korn Ferry / AMN Healthcare Services Inc / UiPath Inc / Choice Hotels International Inc / Collegium Pharmaceutical Inc / ManpowerGroup Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Vertex Pharmaceuticals Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Jazz Pharmaceuticals PLC / Conocophillips / Appian Corp / Instructure Holdings Inc / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Biogen Inc / RingCentral Inc / Aptinyx Inc / Qualtrics International Inc / Insperity Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Five9 Inc / Affimed NV / HubSpot Inc / Bluegreen Vacations Holding Corp / Workiva Inc / Relmada Therapeutics Inc / Viking Therapeutics Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / Arvinas Inc / Cyclerion Therapeutics Inc / Taysha Gene Therapies Inc / Coursera Inc / Udemy Inc / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Previewing 2022 — We See Several Opportunities Within the Neurology and Immunology Therapeutics Categories</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">2713317 / BDRW1L7 / 2455965 / 2623911 / 2730190 / BQPVQZ6 / BP4GNK9 / BYZLV46 / BF4VBS8 / BJLKVS6 / BYZR4X4 / BZ05388 / BDVLM39 / BJMLSD2 / BYTJZL1 / BRJ3GY4 / BG0Q4Y1 / BK71LV3 / BF3N4P3 / BJRFSB7 / BN0XTW4 / BMZ9Z11 / BLR6S36 / BMHR7K6 / BFYVZ75 / BJLV8T9 / BMW5LX6 / BP96C52</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / AnaptysBio Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Horizon Therapeutics PLC / SAGE Therapeutics Inc / InflaRx NV / BioXcel Therapeutics Inc / Phathom Pharmaceuticals Inc / Axsome Therapeutics Inc / Global Blood Therapeutics Inc / argenx SE / Karuna Therapeutics Inc / Zogenix Inc / Xenon Pharmaceuticals Inc / Exicure Inc / Relmada Therapeutics Inc / Arena Pharmaceuticals Inc / Immunovant Inc / Orphazyme A/S / Prometheus Biosciences Inc / Longboard Pharmaceuticals Inc / Impel Neuropharma Inc / Seelos Therapeutics Inc / Celldex Therapeutics Inc / Eliem Therapeutics Inc / Surrozen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">1H22 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">375558103 / 031162100 / 766559603 / 09062X103 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G50871105 / 03835T200 / 78667J108 / 03209R103 / 16383L106 / 868459108 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 68404V100 / 98401F105 / 23284F105 / 03168L105 / 80706P103 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 87808K106 / 483347100 / 37890U108 / 29668H708 / 68906L105 / 04016X101 / 87184Q107 / 481116101 / 59935V107 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 05454B105 / 729139105 / 00972D105 / 760273102 / 00973J101 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 80810D103 / 92243A200 / 74366E102 / 00166B105 / 45790W108 / 04335A105 / 23257D103 / 76029N106 / 4525EP101 / 46565G104 / 52490G102 / 75382E109 / 38341P102 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 92556V106 / 03890D108 / 03835L207 / 413197104 / 002120202 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 00288U106 / 38406L103 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 75974E103 / 09077A106 / 75082Q105 / 23954D109 / 15673T100 / 61225M102 / 730541109 / 670703107 / 68217N105 / 87978U108 / 00032Q104</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Jazz Pharmaceuticals PLC / Aptose Biosciences Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Supernus Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Scholar Rock Holding Corp / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / ESSA Pharma Inc / Otonomy Inc / argenx SE / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Milestone Pharmaceuticals Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Axcella Health Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / Akouos Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Schrodinger Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Replimune Group Inc / Immunic Inc / Iteos Therapeutics Inc / Legend Biotech Corp / Rapt Therapeutics Inc / Gossamer Bio Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Viatris Inc / Aravive Inc / Aptevo Therapeutics Inc / Harmony Biosciences Holdings Inc / aTyr Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Abcellera Biologics Inc / Gracell Biotechnologies Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Reneo Pharmaceuticals Inc / Biomea Fusion Inc / Rain Therapeutics Inc / Day One Biopharmaceuticals Inc / Century Therapeutics Inc / Monte Rosa Therapeutics Inc / POINT Biopharma Global Inc / Nuvalent Inc / Omega Therapeutics Inc / Tempest Therapeutics Inc / Aadi Bioscience Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Mr. Do G. Kim / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Allison M. Bratzel, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Large Cap Biotech: Price Increases as of Jan 1, 2022 for BIIB, GILD, REGN and VRTX products</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ / BIIB.OQ / GILD.OQ / VRTX.OQ / GILD=US / REGN=US / VRTX=US / BIIB=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Biogen Inc / Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Eleven-bagger Regeneron jumps 31% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron climbs 11% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">64125C109 / 75886F107 / 640268108 / 45337C102 / 45773H201 / 462222100 / 92915B106 / 531229706 / 65343E108 / 79400X107 / 74275C205 / 809171101 / 02155X106 / 20454B104</td><td class="leftalignment">Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Incyte Corp / Inovio Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Voyager Therapeutics Inc / Liberty Media Corp / NextCure Inc / Salarius Pharmaceuticals Inc / Processa Pharmaceuticals Inc / Scopus Biopharma Inc / Alterity Therapeutics Ltd / Compass Therapeutics Inc.</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / United States</td><td class="leftalignment"></td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Matthew Harrigan / Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">2022 Expectations Across Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">64125C109 / 75886F107 / 640268108 / 45337C102 / 45773H201 / 462222100 / 92915B106 / 65343E108 / 79400X107 / 74275C205 / 809171101 / 02155X106 / 20454B104</td><td class="leftalignment">Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Incyte Corp / Inovio Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Voyager Therapeutics Inc / NextCure Inc / Salarius Pharmaceuticals Inc / Processa Pharmaceuticals Inc / Scopus Biopharma Inc / Alterity Therapeutics Ltd / Compass Therapeutics Inc.</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / United States</td><td class="leftalignment"></td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Ending the Year on a Positive Note - Biotech Inflows Close Out 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">302</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">COVID-19 Vaccine/Therapeutics Names: Expect Volatile 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.O / REGN.O / VRTX.O / MRNA.O / SRPT.O / INO.O</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc / Inovio Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">12/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Imitation Is the Sincerest Form of Flattery, Adbry Approved but Dupixent Reigns</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F10 / 04635310 / 80105N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / AstraZeneca PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: NVS Nets Gyroscope to GT Nest; PFE DMD Hold</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Race to the Bottom? Which Biopharma Has Most LOE Risk in 2025-30 Period?</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Nice Stocking Stuffer - Fund Flows Decidedly Positive This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">BioBeats- Keeping Up With Biotech - Slides Only</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">US00287Y1091 / US75886F1075 / US02043Q1076 / US09609G1004 / US90400D1081 / US5588681057 / US47103J1051</td><td class="leftalignment">Abbvie Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / bluebird bio Inc / Ultragenyx Pharmaceutical Inc / Madrigal Pharmaceuticals Inc / Janux Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US02553E1064 / US0311621009 / US0530151036 / US0584981064 / US0936711052 / US1101221083 / US2017231034 / US2371941053 / US3647601083 / US3703341046 / US3755581036 / US45337C1027 / US5324571083 / US5951121038 / US64125C1099 / US6541061031 / US6556641008 / US6703461052 / US7043261079 / US7170811035 / US75886F1075 / US7782961038 / US8000131040 / US8168511090 / US8270481091 / US8354951027 / US8581191009 / US8589121081 / US8725401090 / US9170471026 / US9182041080 / US92276F1003 / US92532F1003 / US9746371007 / CA1249003098 / CA8029121057 / CA30150P1099 / CA1469001053 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US2283681060 / US2274831047 / US09062X1037 / US0534841012 / US29476L1070 / US2971781057 / CA8911605092 / CA1360691010 / US74144T1088 / US1011211018 / US2644115055 / US9290421091 / CA6445351068 / US9043111072 / US7376301039 / CA1375761048 / US9026531049 / US25960P1093 / US49427F1084 / CA3499151080 / US5500211090 / US02913V1035 / US90384S3031 / US3886891015 / US58933Y1055 / US18538R1032 / US74340W1036 / US6936561009 / US7512121010 / CA07380N1042 / CA96145A2002 / US4440971095 / US78573L1061 / GB00B11DNM70 / US60468T1051 / US1220171060 / US2921041065 / US1785871013 / CA45868C1095 / US14174T1079 / US96145D1054 / US72703H1014 / US95040Q1040 / CA26829L1076 / US7495271071 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US03843E1047 / KYG370921069 / VGG1890L1076 / US73757R1023 / US76156B1070 / US88339P1012 / CA29446Y5020 / US70614W1009 / CA04302L1004 / US82575P1075 / US26484T1060 / US15202L1070 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027 / US1374041093</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Automatic Data Processing Inc / Ball Corp / H & R Block Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darden Restaurants Inc / Gap Inc / General Mills Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nordstrom Inc / Nucor Corp / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sanderson Farms Inc / Sempra Energy / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / Stericycle Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / CCL Industries Inc / Saputo Inc / Exco Technologies Ltd / Cascades Inc / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Crown Holdings Inc / Cross Country Healthcare Inc / Biogen Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / T Rowe Price Group Inc / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / New Gold Inc / Under Armour Inc / Potlatchdeltic Corp / Canfor Corp / UDR Inc / Douglas Emmett Inc / Kilroy Realty Corp / Fortuna Silver Mines Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Graphic Packaging Holding Co / Merck & Co Inc / Clearwater Paper Corp / Prologis Inc / PVH Corp / Ralph Lauren Corp / Bear Creek Mining Corp / Westshore Terminals Investment Corp / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Horizonte Minerals PLC / Mirati Therapeutics Inc / Burlington Stores Inc / Empire State Realty Trust Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Westrock Co / Planet Fitness Inc / Welltower Inc / ECN Capital Corp / REV Group Inc / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Aquestive Therapeutics Inc / Galaxy Digital Holdings Ltd / Capri Holdings Ltd / Postal Realty Trust Inc / Revolve Group Inc / RealReal Inc / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Sibanye Stillwater Ltd / Dun & Bradstreet Holdings Inc / Centerspace / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.O / BMRN.O / REGN.O / AGIO.O</td><td class="leftalignment">Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Agios Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">There’s No Biopharma Without M&A; Dip in Deals in 2021 Does Not Make a Trend</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - Model update post CMD. Major catalyst of COVID data due early 22. CSe 60% POS $1b , NPV SFr 6.5/shr</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MOLN.S / JNJ.N / LLY.N / PFE.N / AZN.L / ROG.S / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / ABBV.N / ARGX.OQ</td><td class="leftalignment">Molecular Partners AG / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / argenx SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">It's Not the End of the Road for Lirentelimab, In Our View; Maintain OW</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US01671P1003 / US75886F1075</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Brian Cheng / Ms. Alethia R. Young</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">ALNY-REGN Seek MHRA Approval in the UK to Initiate a Phase 1 Trial for ALNY-APP in AD and CAA; Reiterate Buy and $844 PT</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ / ALNY.OQ / 02043Q107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE0006969603 / US09061G1013 / US0311621009 / US0718131099 / US1101221083 / US1311931042 / US1985161066 / US2435371073 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US6541061031 / US66987V1098 / US75886F1075 / US7782961038 / US8006771062 / US8305661055 / US8725401090 / US87612E1064 / US9021041085 / US9139031002 / US9182041080 / US92532F1003 / US3448491049 / US6402681083 / US21036P1084 / US2533931026 / US09062X1037 / US0042251084 / US02043Q1076 / US9043111072 / BREMBRACNOR4 / US4103451021 / US03152W1099 / US5500211090 / US36315X1019 / US58933Y1055 / US46333X1081 / US13100M5094 / DE000A1EWWW0 / US29082A1079 / US40412C1018 / US6936561009 / US7512121010 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US1220171060 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US74967X1037 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US89610F1012 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US98585X1046 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US0843101017 / US75943R1023 / US02875D1090 / US07373B1098 / US56854Q2003 / US81181C1045 / US74006W1080 / US55406W1036 / US30260D1037 / US38870X1046 / KYG7614L1095 / US98422T1007 / US01675A1097</td><td class="leftalignment">Puma SE / Biomarin Pharmaceutical Inc / Amgen Inc / Baxter International Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Columbia Sportswear Co / Deckers Outdoor Corp / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Nike Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sangamo Therapeutics Inc / Skechers USA Inc / TJX Companies Inc / Target Corp / II-VI Inc / Universal Health Services Inc / VF Corp / Vertex Pharmaceuticals Inc / Foot Locker Inc / Nektar Therapeutics / Constellation Brands Inc / DICK'S Sporting Goods Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Embraer SA / HanesBrands Inc / Amicus Therapeutics Inc / Lululemon Athletica Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Adidas AG / Embraer SA / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / RH / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Tricida Inc / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Berkeley Lights Inc / Relay Therapeutics Inc / American Outdoor Brands Inc / Beam Global / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / MYT Netherlands Parent BV / Figs Inc / Graphite Bio Inc / Rockley Photonics Holdings Ltd / Xilio Therapeutics Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Brazil / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">Both Phase 3 Trials of Lirentelimab in EOE and EG/ED Crash and Burn</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">01671P100 / 75886F107</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Top 10 Potential Surprises Of 2022</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US09062X1037 / US89610F1012 / US09061G1013 / US0311621009 / US1101221083 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US66987V1098 / US75886F1075 / US8006771062 / US92532F1003 / US6402681083 / US21036P1084 / US0042251084 / US02043Q1076 / US03152W1099 / US36315X1019 / US58933Y1055 / US46333X1081 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US75943R1023 / US56854Q2003 / US81181C1045 / US74006W1080 / US38870X1046 / US98422T1007</td><td class="leftalignment">Biogen Inc / Tricida Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Constellation Brands Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Relay Therapeutics Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / Graphite Bio Inc / Xilio Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ADS / ALLO / DE / INTC.O / NKE / ROK / TRMB / WMT / GILD.O / BRZE.O / PLUG.O / REGN.O / VRTX.O / ITRI.O / SPWR.O / CSIQ.O / WPRT.O / GPRE.O / TSLA.O / PCYO.O / AMRS.O / ENPH.O / CNHI / FATE.O / ALDX.O / ETSY.O / SEDG.O / RUN.O / SPXC / AQMS.O / CLLS.O / 05464C101 / ONCT.O / FVRR.K / SHLS.O / VIRX.O / BLDE.OQ / TSP.O / ENVX.O / LILM.O</td><td class="leftalignment">Alliance Data Systems Corp / Allogene Therapeutics Inc / Deere & Co / Intel Corp / Nike Inc / Rockwell Automation Inc / Trimble Inc / Walmart Inc / Gilead Sciences Inc / Braze Inc / Plug Power Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Itron Inc / SunPower Corp / Canadian Solar Inc / Westport Fuel Systems Inc / Green Plains Inc / Tesla Inc / Pure Cycle Corp / Amyris Inc / Enphase Energy Inc / CNH Industrial NV / Fate Therapeutics Inc / Aldeyra Therapeutics Inc / ETSY Inc / Solaredge Technologies Inc / Sunrun Inc / SPX Corp / Aqua Metals Inc / Cellectis SA / Axon Enterprise Inc / Oncternal Therapeutics Inc / Fiverr International Ltd / Shoals Technologies Group Inc / Viracta Therapeutics Inc / Blade Air Mobility Inc / TuSimple Holdings Inc / Enovix Corp / Lilium NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Opinion Leader Feedback--ASH 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALLO / GILD.O / REGN.O / FATE.O / CLLS.O / ONCT.O / VIRX.O</td><td class="leftalignment">Allogene Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Fate Therapeutics Inc / Cellectis SA / Oncternal Therapeutics Inc / Viracta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">And Then There Was One; Potent Antiviral Sotrovimab to Soften Global Omicron Crisis; Upping PT to $300; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">92764N102 / REGN.OQ</td><td class="leftalignment">Vir Biotechnology Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Analyst Says Regeneron Could Be 'Biotech Champion'</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / SONN.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Sonnet Biotherapeutics Holdings Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CABA Cap'd at Low Doses? GBIO Monkeying Around</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">CABA.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Cabaletta Bio Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2022 Outlook: Massive Biopharma Cash Reserves to Address Future Growth Crisis</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2022 Outlook for Investing in Healthcare</td><td class="leftalignment">English</td><td class="rightalignment">155</td><td class="leftalignment">75991610 / 07181310 / 75886F10 / 04963C20 / 02311120 / G5087110 / 74051N10 / 09073M104 / 40412C10 / 40131M10 / 45773010 / 74939710 / 68071010 / 77313F10 / 51654410 / G3910J11 / 81181C10 / 92857F10 / 38341P10 / 46565G10 / 50127T10 / 60468T10 / 98943L10 / 69014510 / 49232710 / 59045L10 / 01671P10 / 75955J40 / 56854Q20 / 89422G10 / 26622P10 / 30315R10 / 01626L10 / 95075A10 / 60853G10 / 00949610 / 04335A10 / 98422E10 / 92731L10 / 74276R10 / 88369M10</td><td class="leftalignment">Repligen Corp / Baxter International Inc / Regeneron Pharmaceuticals Inc / AtriCure Inc / Amarin Corporation PLC / Jazz Pharmaceuticals PLC / Premier Inc / Bio-Techne Corp / HCA Healthcare Inc / Guardant Health Inc / Inspire Medical Systems Inc / R1 RCM Inc / Olink Holding AB (publ) / Rocket Pharmaceuticals Inc / Lantheus Holdings Inc / GlaxoSmithKline PLC / Seagen Inc / Vocera Communications Inc / Gossamer Bio Inc / Iteos Therapeutics Inc / Kura Oncology Inc / Mirati Therapeutics Inc / Zentalis Pharmaceuticals Inc / Outset Medical Inc / Keros Therapeutics Inc / Mersana Therapeutics Inc / Allakos Inc / Relmada Therapeutics Inc / Marinus Pharmaceuticals Inc / Travere Therapeutics Inc / Doximity Inc / F-Star Therapeutics Inc / Aligos Therapeutics Inc / Werewolf Therapeutics Inc / Molecular Partners AG / Airsculpt Technologies Inc / Arvinas Inc / Xeris Biopharma Holdings Inc / Vincerx Pharma Inc / Privia Health Group Inc / Theseus Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Germany / United Kingdom / Ireland / Luxembourg / Sweden / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Jim Kelly / SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CI.N / CL.N / CVS.N / DD.N / ECL.N / EIX.N / EL.N / F.N / FSR.N / GM.N / KO.N / MDT.N / MO.N / PNC.N / PPG.N / SLB.N / SO.N / T.N / USB.N / VC.N / PG.N / HUM.N / GILD.O / CPB.N / TEN.N / INCY.O / DUK.N / BWA.N / LEA.N / DRI.N / ADBE.O / IMO.TO / MCD.N / VLO.N / DV.N / PCG.N / MGA.N / AMT.N / JAZZ.O / SHW.N / VZ.N / EXEL.O / XEL.N / ARNA.O / AMP.N / LNC.N / APH.N / SRE.N / EXC.N / FISV.O / AXL.N / ACN.N / PLD.N / NBIX.O / AME.N / BC.N / AJG.N / BMRN.O / REGN.O / VRTX.O / PRU.N / NCR.N / TEL.N / COP.N / CPK.N / PII.N / ST.N / DFS.N / PLUG.OQ / SGEN.OQ / GPN.N / MNST.O / IMGN.O / ACGL.O / ICPT.O / EQIX.O / BIIB.O / TFC.N / ACAD.O / 416515104 / ALNY.O / BKD.N / MA.N / HOG.N / AON.N / DAN.N / MSCI.N / CVE.TO / SPB.N / NEE.N / MTOR.N / SRPT.O / FFHu.TO / MDLZ.OQ / TSLA.N / TMUS.N / BEP.N / AGIO.O / PTC.O / QTWO.N / NEP.N / GBT.OQ / MESO.O / SPGI.N / ADNT.N / ATNX.O / CNNE.N / APTV.N / ITRM.O / VNE.N / GMDA.OQ / GMAB.O / CRNC.OQ / WTRG.N / CARR.N / OTIS.N / NKLA.OQ / FOUR.N / NRIX.OQ / LUMN.N / AEP.OQ / RIDE.OQ / LSPD.N / NUVB.N / TSP.OQ / FLYW.O / DBRG.N / BHG.N / RYAN.N / BASE.OQ / FLNC.OQ / RIVN.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / Coca-Cola Co / Medtronic PLC / Altria Group Inc / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / Southern Co / AT&T Inc / US Bancorp / Visteon Corp / Procter & Gamble Co / Humana Inc / Gilead Sciences Inc / Campbell Soup Co / Tenneco Inc / Incyte Corp / Duke Energy Corp / Borgwarner Inc / Lear Corp / Darden Restaurants Inc / Adobe Inc / Imperial Oil Ltd / McDonald's Corp / Valero Energy Corp / DoubleVerify Holdings Inc / PG&E Corp / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Sherwin-Williams Co / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Lincoln National Corp / Amphenol Corp / Sempra Energy / Exelon Corp / Fiserv Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Prologis Inc / Neurocrine Biosciences Inc / AMETEK Inc / Brunswick Corp / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Conocophillips / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Discover Financial Services / Plug Power Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / ImmunoGen Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Alnylam Pharmaceuticals Inc / Brookdale Senior Living Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / Dana Inc / MSCI Inc / Cenovus Energy Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Sarepta Therapeutics Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / PTC Inc / Q2 Holdings Inc / Nextera Energy Partners LP / Global Blood Therapeutics Inc / Mesoblast Ltd / S&P Global Inc / Adient PLC / Athenex Inc / Cannae Holdings Inc / Aptiv PLC / Iterum Therapeutics PLC / Veoneer Inc / Gamida Cell Ltd / Genmab A/S / Cerence Inc / Essential Utilities Inc / Carrier Global Corp / Otis Worldwide Corp / Nikola Corp / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / American Electric Power Company Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Nuvation Bio Inc / TuSimple Holdings Inc / Flywire Corp / DigitalBridge Group Inc / Bright Health Group Inc / Ryan Specialty Group Holdings Inc / Couchbase Inc / Fluence Energy Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / AGIO.O / MESO.O / ATNX.O / GMAB.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Agios Pharmaceuticals Inc / Mesoblast Ltd / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - ASH & 2022 Outlook Edition</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ACA / ALLO / ATRC / GBT / INCY / INSP / MBIO / NBIX / RAD / SAGE / WMT / GILD.O / EW / ONEM.O / RMD / FMTX / ISRG / ALPN / SGEN / REGN.O / VRTX.O / SSNC.O / NKTR / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / LHCG.O / INFI.O / TMDI / TNDM.O / ENSG.O / 483548103 / MRNA.O / BLRX / ADUS.O / AGIO / FATE.O / 02005N100 / RXDX.O / VBLT.O / APTO.O / EVH / 100063846 / IONS.O / 04280A100 / EDIT / VRAY / CRSP / SRRA / ATNX.O / APLS.O / 720795103 / ELOX.OQ / ARVN / XFOR.O / TMDX / KRTX / PSNL.O / 50127T109 / 87164F105 / PNTG.O / GMDA / ZNTL.O / ORIC.O / SPRB.OQ / TARS.O / VOR.O / NKTX.O / BMEA.O / CLNN.O / RZLT.O / CRBU.O / MDNA.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / Allogene Therapeutics Inc / AtriCure Inc / Global Blood Therapeutics Inc / Incyte Corp / Inspire Medical Systems Inc / Mustang Bio Inc / Neurocrine Biosciences Inc / Rite Aid Corp / SAGE Therapeutics Inc / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Resmed Inc / Forma Therapeutics Holdings Inc / Intuitive Surgical Inc / Alpine Immune Sciences Inc / Seagen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Nektar Therapeutics / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Titan Medical Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / BioLine RX Ltd / Addus Homecare Corp / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Ally Financial Inc / Prometheus Biosciences Inc / Vascular Biogenics Ltd / Aptose Biosciences Inc / Evolent Health Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Editas Medicine Inc / ViewRay Inc / CRISPR Therapeutics AG / Sierra Oncology Inc / Athenex Inc / Apellis Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Eloxx Pharmaceuticals Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Personalis Inc / Kura Oncology Inc / Syndax Pharmaceuticals Inc / Pennant Group Inc / Gamida Cell Ltd / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Spruce Biosciences Inc / Tarsus Pharmaceuticals Inc / Vor Biopharma Inc / Nkarta Inc / Biomea Fusion Inc / Clene Inc. / Rezolute Inc / Caribou Biosciences Inc / Medicenna Therapeutics Corp / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Ladenburg Thalmann & Co. Inc.</td><td class="leftalignment">ASH 2021 Highlights</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GILD / JNJ / REGN / US23254L6039 / IMGO</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Regeneron Pharmaceuticals Inc / Cyclacel Pharmaceuticals Inc / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ahu Demir, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">IL0006290147 / US00724F1012 / US0311621009 / US0383361039 / US0584981064 / US1101221083 / US31428X1063 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US81211K1007 / US8581191009 / US92532F1003 / CA59162N1096 / CA5394811015 / CA2918434077 / US9129091081 / CA1349211054 / US7665596034 / US09062X1037 / US02043Q1076 / US3546131018 / US74144T1088 / US09247X1019 / US40637H1095 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / BMG491BT1088 / IE00B4BNMY34 / US58933Y1055 / CA0985461049 / JE00B4T3BW64 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09609G1004 / CA3874371147 / CA16141A1030 / IE00B4Q5ZN47 / CA8661201167 / CA38045Y1025 / CA6674951059 / US6951271005 / US45845P1084 / CA0266951064 / CA58546R1091 / CA17039A1066 / US60468T1051 / US45378A1060 / US31189P1021 / CA72820F1036 / IE00BJ3V9050 / US03820J1007 / CA26153P1045 / CA1264621006 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US4622221004 / CA49410M1023 / US5588681057 / US68404V1008 / US03753U1060 / CA46136U1030 / IL0011417206 / US92645B1035 / US03168L1052 / US2997341035 / CA05585D1033 / US80706P1030 / US03836N1037 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / CA4039254079 / US04335A1051 / US50015M1099 / US03990B1017 / CA2849025093 / US62921N1054 / CA7426943006 / US61775R1059 / US09260D1072 / US03768E1055 / US71722W1071 / CA92625W5072 / CA31890B1031 / US14316J1088 / US80810D1037 / US6544051096 / IL0011326795 / CA67079A1021 / US12529R1077 / US3773201062 / CA33843T1084 / US92556V1061 / CA00288U1066 / CA65342N3159 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Adobe Inc / Amgen Inc / Aptargroup Inc / Ball Corp / Bristol-Myers Squibb Co / FedEx Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Steel Dynamics Inc / Vertex Pharmaceuticals Inc / Metro Inc / Loblaw Companies Ltd / Empire Company Ltd / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Halozyme Therapeutics Inc / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Invesco Ltd / Accenture PLC / Merck & Co Inc / Bonterra Energy Corp / Glencore PLC / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / bluebird bio Inc / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Jazz Pharmaceuticals PLC / Summit Industrial Income REIT / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mirati Therapeutics Inc / Independence Realty Trust Inc / Fate Therapeutics Inc / Plaza Retail REIT / Endo International PLC / Applied Genetic Technologies Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Ionis Pharmaceuticals Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Invesque Inc / Sol Gel Technologies Ltd / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Scholar Rock Holding Corp / Aptinyx Inc / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Kodiak Sciences Inc / Ares Management Corp / Eldorado Gold Corp / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / Morphic Holding Inc / Blackstone Inc / Apollo Global Management Inc / Phathom Pharmaceuticals Inc / Victoria Gold Corp / First Capital Real Estate Investment Trust / Carlyle Group Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Flagship Communities Real Estate Investment Trust / Viatris Inc / Abcellera Biologics Inc / Nexus Real Estate Investment Trust / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma Growth Crisis? Lower & Slower Growth Ahead as Major LOEs Loom</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">92532F10 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2022 BioPharma Outlook: A Light at the End of the Tunnel as Sector Sentiment Likely to Improve</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">IL0006290147 / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US7665596034 / US09062X1037 / US02043Q1076 / US40637H1095 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US6951271005 / US45845P1084 / US60468T1051 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / US4622221004 / US5588681057 / US68404V1008 / US03753U1060 / IL0011417206 / US03168L1052 / US2997341035 / US80706P1030 / US03836N1037 / CA0717341071 / US76029N1063 / US03843E1047 / US04335A1051 / US50015M1099 / US62921N1054 / US61775R1059 / US71722W1071 / US80810D1037 / US6544051096 / IL0011326795 / US12529R1077 / US92556V1061 / CA00288U1066 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Sol Gel Technologies Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Aptinyx Inc / Bausch Health Companies Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Arvinas Inc / Kodiak Sciences Inc / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Phathom Pharmaceuticals Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / C4 Therapeutics Inc / Viatris Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Flip the Script - Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Regeneron’s Next-Gen SARS-CoV-2 Antibodies Active Against Omicron and Delta; Set for Clinic in 1Q22.</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">64125C109 / 75886F107 / 640268108 / 45337C102 / 45773H201 / 462222100 / 92915B106 / AU0000026122 / 65343E108 / 79400X107 / 683416101 / 74275C205 / 809171101 / 771049103 / 02155X106 / 20454B104 / 84677R106</td><td class="leftalignment">Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Incyte Corp / Inovio Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Voyager Therapeutics Inc / Coronado Global Resources Inc / NextCure Inc / Salarius Pharmaceuticals Inc / Ooma Inc / Processa Pharmaceuticals Inc / Scopus Biopharma Inc / Roblox Corp / Alterity Therapeutics Ltd / Compass Therapeutics Inc. / Spartan Acquisition III Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mike Hickey / Ms. Fawne Jiang / Long Lin / Mr. Subash Chandra, CFA / Mr. Nathan Martin / Mr. Matthew Harrigan / Mr. Aydin Huseynov, MD / David Williams / Mr. Michael P. Ward, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Updates Across Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">64125C109 / 75886F107 / 640268108 / 45337C102 / 45773H201 / 462222100 / 92915B106 / 65343E108 / 79400X107 / 74275C205 / 809171101 / 02155X106 / 20454B104</td><td class="leftalignment">Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Incyte Corp / Inovio Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Voyager Therapeutics Inc / NextCure Inc / Salarius Pharmaceuticals Inc / Processa Pharmaceuticals Inc / Scopus Biopharma Inc / Alterity Therapeutics Ltd / Compass Therapeutics Inc.</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / United States</td><td class="leftalignment"></td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ALLO / EA / EVER / GGG / IEX / INTC.O / LECO / LOW / MSFT / PNR / SAGE / SONY / TTWO / ATVI.O / NVDA.O / HEAR / NFLX / LFUS.O / REGN.O / BIIB / 36467W109 / ZNGA / SPLK.O / CG.O / FDEV.L / FATE.O / 82655M107 / CRSP / BILI.O / DDOG.O / GMDA / APPH / VOR.O / NKTX.O / HUYA.K / CRBU.O</td><td class="leftalignment">Allogene Therapeutics Inc / Electronic Arts Inc / EverQuote Inc / Graco Inc / IDEX Corp / Intel Corp / Lincoln Electric Holdings Inc / Lowe's Companies Inc / Microsoft Corp / Pentair PLC / SAGE Therapeutics Inc / Sony Group Corp / Take-Two Interactive Software Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Netflix Inc / Littelfuse Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / GameStop Corp / Zynga Inc / Splunk Inc / Carlyle Group Inc / Frontier Developments PLC / Fate Therapeutics Inc / Sify Technologies Ltd / CRISPR Therapeutics AG / Bilibili Inc / Datadog Inc / Gamida Cell Ltd / AppHarvest Inc / Vor Biopharma Inc / Nkarta Inc / HUYA Inc / Caribou Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">HEI.N / CH0012032048 / US17275R1023 / US2829141009 / US3695501086 / US4228061093 / US5949181045 / US75886F1075 / US7711951043 / US4198791018 / US64049M2098 / US79466L3024 / US8485741099 / US76680R2067 / US5253271028 / US64829B1008 / US07725L1026 / US30057T1051 / US05351X1019 / US98980G1022 / US9842411095 / US69553P1003 / US4833791035 / US92537N1081 / US05380C1027 / US8334451098 / US20451W1018 / US86646P1030 / US49926T1043 / IL0011762130 / US00109K1051 / US34631B1017 / 50066V107 / US7047231052</td><td class="leftalignment">HEICO Corp / Roche Holding AG / Cisco Systems Inc / 8x8 Inc / General Dynamics Corp / HEICO Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Roche Holding AG / Hawaiian Holdings Inc / Neogenomics Inc / Salesforce.Com Inc / Spirit AeroSystems Holdings Inc / RingCentral Inc / Leidos Holdings Inc / New Relic Inc / Beigene Ltd / Evoqua Water Technologies Corp / Avaya Holdings Corp / Zscaler Inc / Y-mAbs Therapeutics Inc / PagerDuty Inc / Kaleyra Inc / Vertiv Holdings Co / AVITA Medical Inc / Snowflake Inc. / Compass Pathways PLC / Sumo Logic Inc / Knowbe4 Inc / Monday.Com Ltd / AFC Gamma Inc / ForgeRock Inc / KORE Group Holdings Inc / Pear Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US0341641035 / US0351282068 / US0394831020 / US1101221083 / US1564311082 / US2017231034 / US2372661015 / US3755581036 / US38059T1060 / US4227041062 / US4404521001 / US5324571083 / US6516391066 / US6703461052 / US75886F1075 / US7802871084 / US8000131040 / US8581191009 / US9024941034 / US9746371007 / CA13321L1085 / CA6979001089 / CA8787422044 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / CA8765111064 / CA3359341052 / US35671D8570 / AU000000FMG4 / BMG169621056 / CA98462Y1007 / CA5503721063 / CA8911605092 / CA4436281022 / CA1360691010 / CA95083R1001 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA29258Y1034 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / US3932221043 / GB00B2QPKJ12 / GB0004300496 / US91912E1055 / US1921085049 / CA69946Q1046 / US72147K1088 / CA66510M2040 / JE00B4T3BW64 / CA54928Q1081 / US4571871023 / AU000000EVN4 / JE00B5TT1872 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0213611001 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA5054401073 / CA33812R1091 / CA46579R1047 / CA65340P1062 / CA7397211086 / CA68827L1013 / CA30606C1086 / CA5503711080 / CA74273V1067 / AU000000S320 / CA0115321089 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / CA2960061091 / CA8585221051 / US3843135084 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA57776F4050 / CA5625684025 / CA48086P1009 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA9004352071 / US3680361090 / CA64782A1075 / CA36261G1028 / CA65401N1078 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA65343M2094 / CA0156581070 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Andersons Inc / AngloGold Ashanti Ltd / Archer-Daniels-Midland Co / Bristol-Myers Squibb Co / Century Aluminum Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Hormel Foods Corp / Eli Lilly and Co / Newmont Corporation / Nucor Corp / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Sanderson Farms Inc / Steel Dynamics Inc / Tyson Foods Inc / Winnebago Industries Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Taseko Mines Ltd / First Quantum Minerals Ltd / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Bunge Ltd / Yamana Gold Inc / Lundin Mining Corp / Toronto-Dominion Bank / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Wesdome Gold Mines Ltd / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Endeavour Silver Corp / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Green Plains Inc / Fresnillo PLC / Pan African Resources PLC / Vale SA / Coeur Mining Inc / Parex Resources Inc / Pilgrims Pride Corp / Northern Dynasty Minerals Ltd / Glencore PLC / Lucara Diamond Corp / Ingredion Inc / Evolution Mining Ltd / Centamin PLC / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / AltaGas Ltd / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / Labrador Iron Ore Royalty Corp / Fission Uranium Corp / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Prairiesky Royalty Ltd / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Probe Metals Inc / South32 Ltd / Alamos Gold Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / GrafTech International Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / Maverix Metals Inc / Mandalay Resources Corp / Josemaria Resources Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / NextSource Materials Inc / Algoma Steel Group Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Feedback From Meeting with Management</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Is Agenus the Most Under the Radar Biotech in I/O? Initiate at Buy and $12 PT</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">00847G705 / REGN.OQ / 98419J206 / M96088105</td><td class="leftalignment">Agenus Inc / Regeneron Pharmaceuticals Inc / XOMA Corp / Urogen Pharma Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Omicron Appears To Get A Ronaprieve</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Brittany Woods, Ph.D. / Tara Bancroft, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Transcript: ASH Doctor Call</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US1101221083 / US3755581036 / US75886F1075</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAPL / ACA / AOS / APP / APPS / DCI / DE / DOV / EA / ECL / INTC.O / IS / MGRC / MSFT / NPO / QCOM.O / QUIK / RXN / SONY / SPB / T / TTWO / U / AMZN.O / ATVI.O / NVDA.O / HEAR / KLR / AMD.O / VZ / NFLX / SGEN / REGN.O / VRTX.O / MRVL.O / ORBI.TA / GOOG.O / PBH / 36467W109 / ZNGA / FB.O / TMUS / AGIO / FDEV.L / 82655M107 / RXDX.O / VBLT.O / TTD.O / CRSP / APLS.O / BILI.O / ARVN / HEXO / KRTX / CMBM / GMDA / ONDS.OQ / TARS.O / HUYA.K / CLNN.O / RZLT.O / MDNA.O</td><td class="leftalignment">Apple Inc / Arcosa Inc / A O Smith Corp / Applovin Corp / Digital Turbine Inc / Donaldson Company Inc / Deere & Co / Dover Corp / Electronic Arts Inc / Ecolab Inc / Intel Corp / Ironsource Ltd / McGrath RentCorp / Microsoft Corp / EnPro Industries Inc / Qualcomm Inc / QuickLogic Corp / Zurn Water Solutions Corp / Sony Group Corp / Spectrum Brands Holdings Inc / AT&T Inc / Take-Two Interactive Software Inc / Unity Software Inc / Amazon.com Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Kaleyra Inc / Advanced Micro Devices Inc / Verizon Communications Inc / Netflix Inc / Seagen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Orbit Technologies Ltd / Alphabet Inc / Prestige Consumer Healthcare Inc / GameStop Corp / Zynga Inc / Meta Platforms Inc / T-Mobile US Inc / Agios Pharmaceuticals Inc / Frontier Developments PLC / Sify Technologies Ltd / Prometheus Biosciences Inc / Vascular Biogenics Ltd / Trade Desk Inc / CRISPR Therapeutics AG / Apellis Pharmaceuticals Inc / Bilibili Inc / Arvinas Inc / Hexo Corp / Karuna Therapeutics Inc / Cambium Networks Corp / Gamida Cell Ltd / Ondas Holdings Inc / Tarsus Pharmaceuticals Inc / HUYA Inc / Clene Inc. / Rezolute Inc / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / HD=US / BXP=US / AMZN=US / BLD=US / RUN=US / NOVA=US / LOW=US / TTWO=US / LEG=US / VMC=US / MGM=US / MLM=US / AIR=US / SWIM=US / ATRO=US / B=US / CW=US / DCO=US / HEI=US / HXL=US / IBP=US / MAS=US / MHK=US / REGN=US / ROLL=US / SEE=US / SHOP=US / TGI=US / VSEC=US / CNM=US / SPR=US / NFLX=US / MGNI=US / ATRS=US / TPX=US / MOG.A=US / EXP=US / BECN=US / BLDR=US / GMS=US / SPWR=US / TDG=US / PGTI=US / AWI=US / OC=US / PRPL=US / JACK=US / TREX=US / INSE / WWD=US / FBHS=US / TILE=US / FATE=US / QTWO=US / OSH=US / WK=US / ETSY=US / MIME=US / 82982L103 / JELD=US / ALLO=US / HARP=US / FERG=US / GMAB=US / AZEK=US / AFRM=US / REPX=US / GAMB=US / SNPO=US / CYXT=US / ROIV=US</td><td class="leftalignment">Albany International Corp / Home Depot Inc / Boston Properties Inc / Amazon.com Inc / TopBuild Corp / Sunrun Inc / Sunnova Energy International Inc / Lowe's Companies Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Vulcan Materials Co / MGM Resorts International / Martin Marietta Materials Inc / AAR Corp / Latham Group Inc / Astronics Corp / Barnes Group Inc / Curtiss-Wright Corp / Ducommun Inc / HEICO Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Sealed Air Corp / Shopify Inc / Triumph Group Inc / VSE Corp / Core & Main Inc / Spirit AeroSystems Holdings Inc / Netflix Inc / Magnite Inc / Antares Pharma Inc / Tempur Sealy International Inc / Moog Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Builders FirstSource Inc / GMS Inc / SunPower Corp / TransDigm Group Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Inspired Entertainment Inc / Woodward Inc / Fortune Brands Home & Security Inc / Interface Inc / Fate Therapeutics Inc / Q2 Holdings Inc / Oak Street Health Inc / Workiva Inc / ETSY Inc / Mimecast Ltd / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Ferguson PLC / Genmab A/S / Azek Company Inc / Affirm Holdings Inc / Riley Exploration Permian Inc / Gambling.com Group Ltd / Snap One Holdings Corp / Cyxtera Technologies Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">US0236081024 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US5463471053 / US75886F1075 / US9621661043 / CA9528451052 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / CA8911605092 / CA1360691010 / US7376301039 / CA1375761048 / US00287Y1091 / US09739D1000 / CA0158571053 / CA04016A1012 / CA45868C1095 / US78667J1088 / US23355L1061 / CA7766521099 / US90364P1057 / CA50202P1053</td><td class="leftalignment">Ameren Corp / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Regeneron Pharmaceuticals Inc / Weyerhaeuser Co / West Fraser Timber Co Ltd / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Potlatchdeltic Corp / Canfor Corp / Abbvie Inc / Boise Cascade Co / Algonquin Power & Utilities Corp / Argonaut Gold Inc / Interfor Corp / SAGE Therapeutics Inc / DXC Technology Co / Roots Corp / UiPath Inc / Li-Cycle Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Restoration of Complement Factor H Regulation in AMD; Initiating With a Buy Rating and $20 PT</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">GMTX.OQ / REGN.OQ / CLSD.OQ / UBX.OQ / ISEE.OQ / ANNX.OQ / 53566P109</td><td class="leftalignment">Gemini Therapeutics Inc / Regeneron Pharmaceuticals Inc / Clearside Biomedical Inc / UNITY Biotechnology Inc / Iveric Bio Inc / Annexon Inc / Lineage Cell Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Matthew Caufield / Andrew S. Fein</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">0989529 / 0925288 / 2434209 / 2516152 / 2000019 / 2008154 / 2050832 / 2026242 / 2270726 / 2317087 / 2100920 / 2689560 / 2048804 / 2707677 / 2730190 / 2440637 / 4595739 / 2857817 / B3D7K31 / 2949758 / B7TL820 / BCZS820 / BFDV8K0 / BBGVT40 / BP4GNK9 / BFZ1K46 / BMYML02 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BYY88Y7 / BNTB3N8 / BM8NHS1</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Eli Lilly and Co / Amazon.com Inc / Adobe Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / FirstEnergy Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Genmab A/S / Netflix Inc / Discovery Inc / Nexstar Media Group Inc / Meta Platforms Inc / Fate Therapeutics Inc / MacroGenics Inc / News Corp / SAGE Therapeutics Inc / Spotify Technology SA / DraftKings Inc / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Alphabet Inc / Vizio Holding Corp / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / India / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Xencor is a Marvel in the Making, Reminiscent of Regeneron Ten Years Ago; Initiate at Buy and $61 PT</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">REGN.OQ / XNCR.OQ / 92764N102 / 617760202</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Xencor Inc / Vir Biotechnology Inc / MorphoSys AG</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New Surveys Indicate Rapidly Evolving I&I Landscape; Still See Rinvoq Upside</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">031162100 / 75886F107 / 00287Y109 / 00461U105</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Aclaris Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0311621009 / US75886F1075 / PAYO / US02043Q1076 / US37890U1088 / US0400476075</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Payoneer Global Inc / Alnylam Pharmaceuticals Inc / Global Blood Therapeutics Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Doc Call Follow-Up: Focus on CAR-T in DLBCL After Practice Changing Data</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US00287Y1091</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASH highlights & mgmt commentary: If their costim platform works, REGN may not need TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Regeneron Provides Post-ASH Clinical Development Strategy Update</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ / NTLA.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Intellia Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0116591092 / US3695501086 / US45337C1027 / US4581401001 / US6821891057 / US7170811035 / US75886F1075 / US8006771062 / US8447411088 / US8793601050 / US9029251066 / US6402681083 / US21036P1084 / US0003752047 / US8936411003 / US8485741099 / US55616P1049 / US7181721090 / US1940141062 / US26884L1098 / US9100471096 / JE00B783TY65 / US85916J4094 / KYG037AX1015 / US5253271028 / US31189P1021 / US0465131078 / US72703H1014 / US87164F1057 / US45073V1089 / US02081G2012 / US74967X1037 / US23753F1075 / US4990491049 / US29604W1080 / VGG312491084 / US88688T1007 / CA39342L1085 / US0197701065 / US89377M1099 / US75513E1010 / US9663875089 / US5504241051 / US55406W1036 / US7731221062 / US9778521024 / IL0011796625</td><td class="leftalignment">Alaska Air Group Inc / General Dynamics Corp / Incyte Corp / Intel Corp / ON Semiconductor Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Southwest Airlines Co / Teledyne Technologies Inc / USA Truck Inc / Nektar Therapeutics / Constellation Brands Inc / Abb Ltd / TransDigm Group Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Philip Morris International Inc / Colfax Corp / EQT Corp / United Airlines Holdings Inc / Aptiv PLC / Stereotaxis Inc / Ambarella Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Atara Biotherapeutics Inc / Planet Fitness Inc / Syndax Pharmaceuticals Inc / ITT Inc / Alphatec Holdings Inc / RH / Daseke Inc / Knight-Swift Transportation Holdings Inc / Erytech Pharma SA / Establishment Labs Holdings Inc / Tilray Brands Inc / Green Thumb Industries Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Raytheon Technologies Corp / Whiting Petroleum Corp / Luminar Technologies Inc / MYT Netherlands Parent BV / Rocket Lab USA Inc / Wolfspeed Inc / Arbe Robotics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Israel / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US1264081035 / US3755581036 / US45337C1027 / US5324571083 / US6745991058 / US7170811035 / US75886F1075 / US20825C1045 / CA56501R1064 / CA8667961053 / CA39138C1068 / US26884L1098 / US58933Y1055 / US69327R1014 / CA21750U1012 / US31189P1021 / US86771W1053 / US03753U1060 / US03843E1047 / CA45075E1043 / US86745K1043 / US30205M1018</td><td class="leftalignment">CSX Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Occidental Petroleum Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Conocophillips / Manulife Financial Corp / Sun Life Financial Inc / Great-West Lifeco Inc / EQT Corp / Merck & Co Inc / PDC Energy Inc / Copper Mountain Mining Corp / Fate Therapeutics Inc / Sunrun Inc / Apellis Pharmaceuticals Inc / Aquestive Therapeutics Inc / iA Financial Corporation Inc / Sunnova Energy International Inc / Exicure Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Toripalimab Shows Survival Benefit in NSCLC Phase 3 Prompting BLA Discussion Request With the FDA; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">19249H103 / REGN.OQ</td><td class="leftalignment">Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Douglas D. Tsao</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BA.N / CP.TO / DD.N / DFDS.CO / NSC.N / VIEV.VI / GILD.O / CNR.TO / CSX.N / UNP.N / STT.N / ARNA.O / REGN.O / VRTX.O / SRG.MI / DCO.N / 878742204 / ALNY.O / DRX.L / ARWR.O / CS.TO / HOG.N / SPR.N / GETP.PA / VRSK.O / FHZN.S / RXDX.OQ / BERY.N / MOLN.S / 03835T200 / GBT.OQ / MESO.O / UBSG.S / NTLA.O / ATNX.O / ALLO.OQ / MORF.OQ / GMAB.O / ETNB.O / PLRX.OQ / NRIX.OQ / CHK.OQ / ASCU.TO</td><td class="leftalignment">Boeing Co / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / DFDS AS / Norfolk Southern Corp / Flughafen Wien AG / Gilead Sciences Inc / Canadian National Railway Co / CSX Corp / Union Pacific Corp / State Street Corp / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Snam SpA / Ducommun Inc / Teck Resources Ltd / Alnylam Pharmaceuticals Inc / Drax Group PLC / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Harley-Davidson Inc / Spirit AeroSystems Holdings Inc / Getlink SE / Verisk Analytics Inc / Flughafen Zuerich AG / Prometheus Biosciences Inc / Berry Global Group Inc / Molecular Partners AG / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Mesoblast Ltd / UBS Group AG / Intellia Therapeutics Inc / Athenex Inc / Allogene Therapeutics Inc / Morphic Holding Inc / Genmab A/S / 89Bio Inc / Pliant Therapeutics Inc / Nurix Therapeutics Inc / Chesapeake Energy Corp / Arizona Sonoran Copper Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Austria / Canada / Switzerland / Denmark / France / United Kingdom / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Regeneron Pharmaceuticals Incorporated</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : BCMA Bispecific Update at ASH Shows Progress, but We Await More Meaningful Updates</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASH Investor Event Outlines An Ambitious, But Coordinated Heme/Onc Program</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Brittany Woods, Ph.D. / Tara Bancroft, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ASH investor call: REGN5458 safety a key incoming as REGN's bispecific & co-stims mature</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">We think investments into bispecifics are beginning to bear fruit, as early data look active and safer</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US75886F1075 / US02043Q1076</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 3: Wrap Up and Regeneron Investor Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US58933Y1055 / US31189P1021 / US03753U1060</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0576652004 / US45168D1046 / US5324571083 / US67018T1051 / US7170811035 / US75886F1075 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US14167L1035 / US1488061029 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US45781M1018 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US54142F1021 / US4158581094 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / US14147L1089 / US7291391057 / US12233L1070 / US04537Y1091 / US4131971040 / US04683R1068 / US66988N2053 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Balchem Corp / IDEXX Laboratories Inc / Eli Lilly and Co / NU Skin Enterprises Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / CareDx Inc / Catalent Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Innoviva Inc / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / LogicBio Therapeutics Inc / Harrow Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Cardiff Oncology Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Aspira Women's Health Inc / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Novan Inc / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Dec. 13, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">It's beginning to look a lot like M&A (we hope)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0400476075 / US0311621009 / US75886F1075</td><td class="leftalignment">Arena Pharmaceuticals Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 3, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">Move to Neutral: Pfizer to Acquire Arena for $6.7B in Cash</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">040047607 / 75886F107</td><td class="leftalignment">Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Intellia Therapeutics Announces Dosing of First Patient in Phase 1/2 Study of NTLA-2002 for the Treatment of HAE</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NTLA.OQ / REGN.OQ</td><td class="leftalignment">Intellia Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) AAV GT Data for MGTX (RIX) & QURE (HemB)</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">MGTX.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / 199800 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">MeiraGTx Holdings PLC / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / ToolGen Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE=US / BMY=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / PG=US / WEN=US / AMZN=US / DVN=US / EBAY=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / IGT=US / MGY=US / SWN=US / VRM=US / MUR=US / BYD=US / MAR=US / MRO=US / EXPE=US / TNL=US / MGM=US / HLT=US / PENN=US / NWL=US / W=US / FLO=US / STZ=US / BMRN=US / CBRL=US / CTRA=US / CHD=US / COLL=US / CNX=US / DRI=US / DRH=US / EPC=US / EQT=US / GFF=US / GPOR=US / TREE=US / NOW=US / TEAM=US / REGN=US / SGMO=US / SMG=US / SNAP=US / TRIP=US / WIX=US / CVX=US / POST=US / CGEN=US / SGMS=US / BKNG=US / CNC=US / SNV=US / FB=US / MTCH=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / BDSI=US / MNST=US / PTON=US / IGMS=US / NOMD=US / RNG=US / CZR=US / SHO=US / PLAY=US / FRPT=US / DENN=US / XM=US / THS=US / ESMT=US / CMG=US / ELF=US / TAST=US / CENTA=US / QSR=US / CLR=US / WH=US / NOG=US / IAC=US / JACK=US / AGS=US / RCUS=US / UTZ=US / 45665G303 / INSE / AR=US / OAS=US / HGV=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / SSTK=US / NCLH=US / NDLS=US / GLPI=US / GOOGL=US / VNOM=US / LOCO=US / BABA=US / CIVI=US / CMPR=US / BVH=US / SHAK=US / GDDY=US / ETSY=US / WING=US / ZG=US / EVRI=US / TTD=US / EVBG=US / CDEV=US / TRVG=US / PK=US / PLYA=US / CVNA=US / YEXT=US / SBOW=US / RDFN=US / PETQ=US / CARG=US / SFIX=US / KDP=US / FTDR=US / EB=US / ARVN=US / HARP=US / LYFT=US / UBER=US / FERG=US / BRBR=US / OVV=US / REYN=US / NGMS=US / HYFM=US / CELU=US / ROCC=US / REPX=US / 67421J108 / MNTV=US / DNUT=US / GAMB=US / EWCZ=US / USER=US</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Procter & Gamble Co / Wendys Co / Amazon.com Inc / Devon Energy Corp / eBay Inc / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Vroom Inc / Murphy Oil Corp / Boyd Gaming Corp / Marriott International Inc / Marathon Oil Corp / Expedia Group Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Newell Brands Inc / Wayfair Inc / Flowers Foods Inc / Constellation Brands Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Coterra Energy Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Darden Restaurants Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Gulfport Energy Corp / Lendingtree Inc / ServiceNow Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Post Holdings Inc / Compugen Ltd / Scientific Games Corp / Booking Holdings Inc / Centene Corp / Synovus Financial Corp / Meta Platforms Inc / Match Group Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Peloton Interactive Inc / IGM Biosciences Inc / Nomad Foods Ltd / RingCentral Inc / Caesars Entertainment Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Qualtrics International Inc / TreeHouse Foods Inc / EngageSmart Inc / Chipotle Mexican Grill Inc / elf Beauty Inc / Carrols Restaurant Group Inc / Central Garden & Pet Co / Restaurant Brands International Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / PlayAGS Inc / Arcus Biosciences Inc / UTZ Brands Inc / Infinity Pharmaceuticals Inc / Inspired Entertainment Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Shutterstock Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Gaming and Leisure Properties Inc / Alphabet Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Alibaba Group Holding Ltd / Civitas Resources Inc / Cimpress PLC / Bluegreen Vacations Holding Corp / Shake Shack Inc / GoDaddy Inc / ETSY Inc / Wingstop Inc / Zillow Group Inc / Everi Holdings Inc / Trade Desk Inc / Everbridge Inc / Centennial Resource Development Inc / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Yext Inc / SilverBow Resources Inc / Redfin Corp / PetIQ Inc / CarGurus Inc / Stitch Fix Inc / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arvinas Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Reynolds Consumer Products Inc / NeoGames SA / Hydrofarm Holdings Group Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc / Oatly Group AB / Momentive Global Inc / Krispy Kreme Inc / Gambling.com Group Ltd / European Wax Center Inc / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US0311621009 / US0394831020 / US0536111091 / US1101221083 / US1266501006 / US3755581036 / US3976241071 / US45337C1027 / US5324571083 / US5719032022 / US64125C1099 / US65473P1057 / US7170811035 / US7445731067 / US75886F1075 / US92276F1003 / US92532F1003 / US98389B1008 / CA51925D1069 / US09062X1037 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US44107P1049 / US74460D1090 / US9026531049 / US30225T1025 / US58933Y1055 / US65339F1012 / US2296631094 / US09609G1004 / US70509V1008 / US16208T1025 / US60468T1051 / US14174T1079 / US9840171030 / US30040W1080 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / US03753U1060 / US04335A1051 / US15202L1070 / US4718711033 / US1374041093 / CA24477T1003 / CA22289D1078</td><td class="leftalignment">Amgen Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Bristol-Myers Squibb Co / CVS Health Corp / Gilead Sciences Inc / Greif Inc / Incyte Corp / Eli Lilly and Co / Marriott International Inc / Neurocrine Biosciences Inc / NiSource Inc / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Laurentian Bank of Canada / Biogen Inc / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Host Hotels & Resorts Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Merck & Co Inc / Nextera Energy Inc / CubeSmart / bluebird bio Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Mirati Therapeutics Inc / CareTrust REIT Inc / Xenia Hotels & Resorts Inc / Eversource Energy / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Apellis Pharmaceuticals Inc / Arvinas Inc / Centerspace / Jasper Therapeutics Inc / Candel Therapeutics Inc / Definity Financial Corp / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">REGN ASH Data Shows Progress in BCMA bispecific and Pozelimab</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AJG / ALL / AM / AMT / AR / AXP / BA.N / BAX / BMY.N / CB / CCI / CLR / CNC.N / CNX / COO / CPE / CPK / CRM.N / CVS.N / D / DG / DGX / DK / DLR / DVN / DY / EOG / EQT / HD / HEP / HIG / IFF / KNX / LOW / MCHP.O / MGY / MMP / MRK.N / MRO / OKE / OLN / OXY / PFE.N / PGR / PNM / PXD / QCOM.O / RKT / RMBS.O / RNG / RRC / SJI / SLG / SM / SWN / T / TFX / TOL / USM / WES / WLK / WLL / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / IRM / MGM.N / ADBE.O / PAA.N / SBAC.O / MXL / ADI.O / VZ / NWN / ARNA.O / SMTC.O / SLAB.O / SNPS.O / DLTR.O / BYD.N / ARGX.O / PENN.O / ISRG.O / LPI / CHDN.O / REGN.O / VRTX.O / MRVL.O / SMG.N / WYNN.O / SIVB.O / DIOD.O / ACGL.O / EQIX.O / OMCL.O / SWKS.O / BIIB.O / DKL / LVS.N / CDNS.O / CNSL.O / CLMT.O / CCOI.O / NOG.A / WRB.N / TSLA.O / NXPI.O / CZR.O / HZNP.O / ESTE.K / MTDR.K / TRGP.K / PDCE.O / AMBA.O / FANG.O / MPLX.K / ABBV.N / PFSI.K / PSXP.K / LGIH.O / FIVN.O / RXDX.O / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / CYAD.O / GBT.O / TMUS.O / RRR.O / EVBG.O / UNIT.O / CLLS.O / CDEV.O / WDAY.O / HESM.K / RYTM.O / SWCH.K / APLS.O / EGHT.K / AUTL.O / BRY.O / KZR.O / AXNX.O / SWAV.O / ZM.O / FLTRF.L / RTLR.O / MORF.O / CABA.O / OAS.O / OVV.N / PGEN.O / BEAM.O / DKNG.O / ZI.O / CTRA.K / GRWG.O / 45258J102 / NWE.O / LUMN.K / BALY.N / ALGM.O / RSI.N / HYFM.O / GRCL.O / CHK.O / HMPT.O / DBRG.N / BLND.N / YOU.N / WKME.O / KLTR.O / WOLF.N / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / American Tower Corp / Antero Resources Corp / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Continental Resources Inc / Centene Corp / CNX Resources Corp / Cooper Companies Inc / Callon Petroleum Co / Chesapeake Utilities Corp / Salesforce.Com Inc / CVS Health Corp / Dominion Energy Inc / Dollar General Corp / Quest Diagnostics Inc / Delek US Holdings Inc / Digital Realty Trust Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / International Flavors & Fragrances Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Microchip Technology Inc / Magnolia Oil & Gas Corp / Magellan Midstream Partners LP / Merck & Co Inc / Marathon Oil Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / PNM Resources Inc / Pioneer Natural Resources Co / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / SM Energy Co / Southwestern Energy Co / AT&T Inc / Teleflex Inc / Toll Brothers Inc / United States Cellular Corp / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / MGM Resorts International / Adobe Inc / Plains All American Pipeline LP / SBA Communications Corp / Maxlinear Inc / Analog Devices Inc / Verizon Communications Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Dollar Tree Inc / Boyd Gaming Corp / argenx SE / Penn National Gaming Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Churchill Downs Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / SVB Financial Group / Diodes Inc / Arch Capital Group Ltd / Equinix Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / Las Vegas Sands Corp / Cadence Design Systems Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Horizon Therapeutics PLC / Earthstone Energy Inc / Matador Resources Co / Targa Resources Corp / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Abbvie Inc / PennyMac Financial Services Inc / Phillips 66 Partners LP / LGI Homes Inc / Five9 Inc / Prometheus Biosciences Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Celyad Oncology SA / Global Blood Therapeutics Inc / T-Mobile US Inc / Red Rock Resorts Inc / Everbridge Inc / Uniti Group Inc / Cellectis SA / Centennial Resource Development Inc / Workday Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Switch Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Flutter Entertainment PLC / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Precigen Inc / Beam Therapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / NorthWestern Corp / Lumen Technologies Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / DigitalBridge Group Inc / Blend Labs Inc / Clear Secure Inc / Walkme Ltd / Kaltura Inc / Wolfspeed Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Regeneron Presents Positive Results for Phase 1 Study of REGN5458 in Relapsed or Refractory Multiple Myeloma</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CL.N / CRM.N / CVS.N / EIX.N / F.N / FSR.N / GM.N / GOG.L / PD.N / SO.N / T.N / VC.N / GILD.O / TEN.N / CMCSA.O / INCY.O / RBA.N / DUK.N / DIS.N / BWA.N / LEA.N / DT.N / DISH.O / PCG.N / AMT.N / KGC.N / JAZZ.O / VZ.N / XEL.N / LNC.N / APH.N / AXL.N / ACN.N / AJG.N / NBR.N / REGN.O / PRU.N / NCR.N / TEL.N / CPK.N / ST.N / PLUG.OQ / SGEN.OQ / IMGN.O / CASY.O / ACGL.O / EQIX.O / BIIB.O / DLR.N / 416515104 / BKD.N / MA.N / AON.N / DAN.N / INPP.L / NEE.N / NXT.AX / PKI.TO / MSP.N / MTOR.N / FFHu.TO / TSLA.N / TMUS.N / BEP.N / AGIO.O / KPTI.O / XNCR.OQ / COUP.N / NEP.N / HUBS.N / 03835T200 / GBT.OQ / MESO.O / ADNT.N / GDS.O / ATUS.N / ATNX.O / APTV.N / VNE.N / FOCS.O / ESTC.N / GMDA.OQ / SG.N / CRWD.O / GMAB.O / APRE.OQ / CRNC.OQ / IGMS.O / WTRG.N / NKLA.OQ / NRIX.OQ / LUMN.N / AEP.OQ / SUMO.O / RIDE.OQ / NUVB.N / COUR.N / PATH.N / TSP.OQ / BHG.N / XMTR.OQ / RYAN.N / BASE.OQ / GTLB.OQ / ZD.OQ / FLNC.OQ / RIVN.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Edison International / Ford Motor Co / Fisker Inc / General Motors Co / Go-Ahead Group PLC / PagerDuty Inc / Southern Co / AT&T Inc / Visteon Corp / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Incyte Corp / Ritchie Bros Auctioneers Inc / Duke Energy Corp / Walt Disney Co / Borgwarner Inc / Lear Corp / Dynatrace Inc / DISH Network Corp / PG&E Corp / American Tower Corp / Kinross Gold Corp / Jazz Pharmaceuticals PLC / Verizon Communications Inc / Xcel Energy Inc / Lincoln National Corp / Amphenol Corp / American Axle & Manufacturing Holdings Inc / Accenture PLC / Arthur J Gallagher & Co / Nabors Industries Ltd / Regeneron Pharmaceuticals Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Plug Power Inc / Seagen Inc / ImmunoGen Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Equinix Inc / Biogen Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Brookdale Senior Living Inc / Mastercard Inc / Aon PLC / Dana Inc / International Public Partnerships Ltd / Nextera Energy Inc / NEXTDC Ltd / Parkland Corp / Datto Holding Corp / Meritor Inc / Fairfax Financial Holdings Ltd / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Coupa Software Inc / Nextera Energy Partners LP / HubSpot Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Mesoblast Ltd / Adient PLC / GDS Holdings Ltd / Altice USA Inc / Athenex Inc / Aptiv PLC / Veoneer Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Sweetgreen Inc / CrowdStrike Holdings Inc / Genmab A/S / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Essential Utilities Inc / Nikola Corp / Nurix Therapeutics Inc / Lumen Technologies Inc / American Electric Power Company Inc / Sumo Logic Inc / Lordstown Motors Corp / Nuvation Bio Inc / Coursera Inc / UiPath Inc / TuSimple Holdings Inc / Bright Health Group Inc / Xometry Inc / Ryan Specialty Group Holdings Inc / Couchbase Inc / GitLab Inc / Ziff Davis Inc / Fluence Energy Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">REGN5458 Data Demonstrates Improvement At Higher Doses; Pozelimab Is Active</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Brittany Woods, Ph.D. / Tara Bancroft, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 2: More Data Updates With GILD's Yescarta/ZUMA-7 in the Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GILD.OQ / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US75886F1075 / US09609G1004 / US03753U1060 / US4718711033</td><td class="leftalignment">Gilead Sciences Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Apellis Pharmaceuticals Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASH Day 1: Some Encouraging Updates, but We Expect Limited Impact to Shares</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US75886F1075 / US58933Y1055 / US09609G1004 / US03753U1060</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Merck & Co Inc / bluebird bio Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ASH 2021 update: REGN5458 & REGN's CD3 bispecifics in focus as C5 portfolio suggests upside</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASH Updates (Part 2): REGN</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">12/11/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates:  More Is Always Better, Right?</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US00287Y1091 / US64125C1099 / US75886F1075 / US02043Q1076 / US4277461020 / US2681582019 / US4622221004 / KYG596651029 / US04335A1051 / US20451W1018 / US81181C1045 / US2300311063 / US92765F1084 / US45114M1099 / US87410C1045 / US92332V1070</td><td class="leftalignment">Abbvie Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Heron Therapeutics Inc / Dynavax Technologies Corp / Ionis Pharmaceuticals Inc / MeiraGTx Holdings PLC / Arvinas Inc / Compass Pathways PLC / Seagen Inc / Cullinan Oncology Inc / Viracta Therapeutics Inc / Icosavax Inc / Talaris Therapeutics Inc / Ventyx Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Bahrain / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">12/11/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: 3 directors</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US3755581036 / US75886F1075 / CA68620P1018 / CA1380351009 / US62818Q1040 / US01671P1003 / US88688T1007 / CA39342L1085 / CA58507M1077 / CA22587M1068 / CA89788C1041 / US12482W1018 / CA16106R1091 / CA23126M1023 / US1266541028 / CA05156X8843 / CA4283043079 / CA00489Y6001</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / OrganiGram Holdings Inc / Canopy Growth Corp / Mustang Bio Inc / Allakos Inc / Tilray Brands Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Cresco Labs Inc / Trulieve Cannabis Corp / cbdMD Inc / Charlotte's Web Holdings Inc / Curaleaf Holdings Inc / CV Sciences Inc / Aurora Cannabis Inc / Hexo Corp / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O / SGEN.OQ / MESO.O / ATNX.O / NUVB.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Seagen Inc / Mesoblast Ltd / Athenex Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Highlights—December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AJG / ALL / AM / AR / BA.N / BAX / BMY.N / CB / CLR / CNX / COO / CPK / CRM.N / D / DG / DK / DVN / EOG / EQT / HD / HEP / HIG / LOW / MMP / MRK.N / OKE / OLN / OXY / PFE.N / PGR / RRC / SJI / SLG / SWN / WES / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / PAA.N / ADI.O / NWN / ARNA.O / ARGX.O / ISRG.O / REGN.O / VRTX.O / SMG.N / SIVB.O / ACGL.O / OMCL.O / BIIB.O / DKL / CLMT.O / WRB.N / TSLA.O / HZNP.O / TRGP.K / FANG.O / MPLX.K / ABBV.N / PSXP.K / LGIH.O / RXDX.O / SHLX.K / NVRO.K / CIVI.K / PBFX.K / CDEV.O / HESM.K / RYTM.O / APLS.O / BRY.O / KZR.O / AXNX.O / SWAV.O / RTLR.O / MORF.O / CABA.O / CTRA.K / GRWG.O / 45258J102 / HYFM.O / CHK.O / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / Antero Resources Corp / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / CNX Resources Corp / Cooper Companies Inc / Chesapeake Utilities Corp / Salesforce.Com Inc / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / Lowe's Companies Inc / Magellan Midstream Partners LP / Merck & Co Inc / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / Southwestern Energy Co / Western Midstream Partners LP / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Plains All American Pipeline LP / Analog Devices Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / argenx SE / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Scotts Miracle-Gro Co / SVB Financial Group / Arch Capital Group Ltd / Omnicell Inc / Biogen Inc / Delek Logistics Partners LP / Calumet Specialty Products Partners LP / W R Berkley Corp / Tesla Inc / Horizon Therapeutics PLC / Targa Resources Corp / Diamondback Energy Inc / MPLX LP / Abbvie Inc / Phillips 66 Partners LP / LGI Homes Inc / Prometheus Biosciences Inc / Shell Midstream Partners LP / Nevro Corp / Civitas Resources Inc / PBF Logistics LP / Centennial Resource Development Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT / ACI / AIG / AJG / ALC / ALL / AM / AMAT.O / AMT / AON / AR / ARW / BA.N / BAX / BDX / BEP / BK / BMY.N / BP.N / BSX / CB / CLR / CMA / CNX / COO / COP / COST.O / CPK / CRM.N / CVX / D / DG / DK / DVN / EOG / EQT / F.N / FITB.O / GM.N / HD / HEP / HES / HFC / HIG / INTC.O / JNJ / KLAC.O / KR / LNC / LOW / LRCX.O / MCHP.O / MDT / MET / MMC / MMP / MPC / MRK.N / MUR / NTRS.O / OGE / OKE / OLN / OXY / PEN / PFE.N / PGR / PNC / PRU / PSX / QCOM.O / RE / RKT / RMBS.O / RNG / RNR / RRC / SJI / SLB.N / SLG / STT / SWN / SYK / TFC / TFX / TRV / VLO / WES / WMB / WMT / XLNX.O / ASND.O / AMZN.O / CNQ.TO / GILD.O / ET / AMGN.O / EW / BRO / AAPL.O / CSCO.O / HAL.N / NVDA.O / SU.TO / XOM / PAA.N / PBF / MXL / LBRT.N / IART.O / AMD.O / ADI.O / NWN / NTAP.O / ARNA.O / BJ.N / SMTC.O / SLAB.O / SNPS.O / ARGX.O / AXS / ISRG.O / REGN.O / VRTX.O / MU.O / MRVL.O / HPQ / HPE / AVGO.O / BE.N / SMG.N / FCEL.OQ / PLUG.OQ / SIVB.O / BLUE.O / DIOD.O / MMSI.O / ACGL.O / MKSI.O / OMCL.O / SWKS.O / BIIB.O / DKL / VIAC.O / NOV.N / BLDP.OQ / RDSb / DXCM.O / CDNS.O / STX.O / CLMT.O / CVLT.O / PODD.O / TNDM.OQ / WRB.N / JNPR.K / TSLA.O / NXPI.O / LUNG.O / BKR.N / HZNP.O / WDC.O / TRGP.K / AMBA.O / FANG.O / MPLX.K / UIHC.O / ABBV.N / GTLS.N / VOYA.K / PFSI.K / RNA.O / PSXP.K / FATE.O / LGIH.O / RXDX.O / ANET.K / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / GKOS.K / ZBH / CYAD.O / PSTG.K / NVCR.O / IONS.O / WLTW.O / EDIT.O / NTLA.O / NTNX.O / CLLS.O / CDEV.O / BHF.O / IOVA.O / HESM.K / RYTM.O / APLS.O / EQH / AVT.O / INSP.K / AUTL.O / BRY.O / KZR.O / STRO.O / AXNX.O / DELL.K / SWAV.O / RTLR.O / MORF.O / CHWY.K / BRP.O / CABA.O / PGEN.O / NARI.O / AVNT.K / CTRA.K / BEPC.K / GRWG.O / 45258J102 / ASO.O / EAR.O / ROOT.O / ALGM.O / HYFM.O / GRCL.O / CHK.O / HMPT.O / NPCE.O / RYAN.N / RXST.O / WOLF.N / ARBE.O / RIVN.O</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / American International Group Inc / Arthur J Gallagher & Co / Alcon AG / Allstate Corp / Antero Midstream Corp / Applied Materials Inc / American Tower Corp / Aon PLC / Antero Resources Corp / Arrow Electronics Inc / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / BP PLC / Boston Scientific Corp / Chubb Ltd / Continental Resources Inc / Comerica Inc / CNX Resources Corp / Cooper Companies Inc / Conocophillips / Costco Wholesale Corp / Chesapeake Utilities Corp / Salesforce.Com Inc / Chevron Corp / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Ford Motor Co / Fifth Third Bancorp / General Motors Co / Home Depot Inc / Holly Energy Partners LP / Hess Corp / HollyFrontier Corp / Hartford Financial Services Group Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kroger Co / Lincoln National Corp / Lowe's Companies Inc / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / MetLife Inc / Marsh & McLennan Companies Inc / Magellan Midstream Partners LP / Marathon Petroleum Corp / Merck & Co Inc / Murphy Oil Corp / Northern Trust Corp / OGE Energy Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Penumbra Inc / Pfizer Inc / Progressive Corp / PNC Financial Services Group Inc / Prudential Financial Inc / Phillips 66 / Qualcomm Inc / Everest Re Group Ltd / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Renaissancere Holdings Ltd / Range Resources Corp / South Jersey Industries Inc / Schlumberger NV / SL Green Realty Corp / State Street Corp / Southwestern Energy Co / Stryker Corp / Truist Financial Corp / Teleflex Inc / Travelers Companies Inc / Valero Energy Corp / Western Midstream Partners LP / Williams Companies Inc / Walmart Inc / Xilinx Inc / Ascendis Pharma A/S / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Halliburton Co / NVIDIA Corp / Suncor Energy Inc / Exxon Mobil Corp / Plains All American Pipeline LP / PBF Energy Inc / Maxlinear Inc / Liberty Oilfield Services Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Northwest Natural Holding Co / NetApp Inc / Arena Pharmaceuticals Inc / BJ's Wholesale Club Holdings Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / argenx SE / AXIS Capital Holdings Ltd / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Bloom Energy Corp / Scotts Miracle-Gro Co / Fuelcell Energy Inc / Plug Power Inc / SVB Financial Group / bluebird bio Inc / Diodes Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / MKS Instruments Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / ViacomCBS Inc / Nov Inc / Ballard Power Systems Inc / Royal Dutch Shell PLC / Dexcom Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Calumet Specialty Products Partners LP / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / W R Berkley Corp / Juniper Networks Inc / Tesla Inc / NXP Semiconductors NV / Pulmonx Corp / Baker Hughes Co / Horizon Therapeutics PLC / Western Digital Corp / Targa Resources Corp / Ambarella Inc / Diamondback Energy Inc / MPLX LP / United Insurance Holdings Corp / Abbvie Inc / Chart Industries Inc / Voya Financial Inc / PennyMac Financial Services Inc / Avidity Biosciences Inc / Phillips 66 Partners LP / Fate Therapeutics Inc / LGI Homes Inc / Prometheus Biosciences Inc / Arista Networks Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Pure Storage Inc / Novocure Ltd / Ionis Pharmaceuticals Inc / Willis Towers Watson PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / Cellectis SA / Centennial Resource Development Inc / Brighthouse Financial Inc / Iovance Biotherapeutics Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Equitable Holdings Inc / Avnet Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Sutro Biopharma Inc / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Chewy Inc / BRP Group Inc / Cabaletta Bio Inc / Precigen Inc / Inari Medical Inc / Avient Corp / Coterra Energy Inc / Brookfield Renewable Corp / GrowGeneration Corp / Immunovant Inc / Academy Sports and Outdoors Inc / Eargo Inc / Root Inc / Allegro Microsystems Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / Neuropace Inc / Ryan Specialty Group Holdings Inc / Rxsight Inc / Wolfspeed Inc / Arbe Robotics Ltd / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">KOL calls on BCMA and CD19 Therapies @ ASH on Dec 13 and 14</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">15117K103 / 75886F107 / 31189P102 / H17182108 / 74019P108 / 65487U108 / 52490G102</td><td class="leftalignment">Cellectis SA / Regeneron Pharmaceuticals Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Precision BioSciences Inc / Nkarta Inc / Legend Biotech Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David Dai</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video Link - ASH & Launch Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">ACA / BAX / DNLI / EBS / ICPT / INMD / NBIX / OM / PRGO / RAD / SAGE / SVA / WMT / GILD.O / EW / ONEM.O / ALKS.O / OPNT.O / REGN.O / SSNC.O / MRNS / NKTR / NOVN.O / CCRN.O / BCRX.O / AMED.O / EXAS.O / ANGN.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / CMMB / FREQ / ACAD.O / ALNY.O / DXCM.O / LHCG.O / MBRX.O / CBAY / CYCC.O / INFI.O / HUMA / 02043Q107 / TNDM.O / ENSG.O / 483548103 / MRNA.O / VERO / 771195104 / ADUS.O / GLAXOSM.LG / SPRO.O / 695127100 / SRPT.O / AERI.O / MDWD.O / 02005N100 / RXDX.O / INO.O / VBLT.O / NVRO / AUPH.O / GLPG.O / EVH / NVCR.O / 100063846 / IONS.O / CLRB.O / VRAY / NTLA / FLGT.O / IOVA / MTEM.O / ATNX.O / PTGX.O / 720795103 / ORTX.O / BNGO.O / IMUX.O / ZM.O / TMDX / IDYA.O / PSNL.O / DMTK.O / XAIR / PNTG.O / BCYC / NMTR.O / ORIC.O / PHGE.K / PLRX.O / NNOX / HGEN.O / TSHA.O / FSTX.O / PRTG.O / SNSE.O / IMCR.O / PHVS.O / 03823M100 / 390320109 / EVAX.O / RZLT.O / SERA.OQ / CGTX.OQ / ATXS.O</td><td class="leftalignment">Arcosa Inc / Baxter International Inc / Denali Therapeutics Inc / Emergent BioSolutions Inc / Intercept Pharmaceuticals Inc / Inmode Ltd / Neurocrine Biosciences Inc / Outset Medical Inc / Perrigo Company PLC / Rite Aid Corp / SAGE Therapeutics Inc / Sinovac Biotech Ltd / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Alkermes Plc / Opiant Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Marinus Pharmaceuticals Inc / Nektar Therapeutics / Novan Inc / Cross Country Healthcare Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Exact Sciences Corp / Angion Biomedica Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Cymabay Therapeutics Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Humacyte Inc / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Venus Concept Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Spero Therapeutics Inc / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / Ally Financial Inc / Prometheus Biosciences Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Aurinia Pharmaceuticals Inc / Galapagos NV / Evolent Health Inc / Novocure Ltd / Truist Financial Corp / Ionis Pharmaceuticals Inc / Cellectar Biosciences Inc / ViewRay Inc / Intellia Therapeutics Inc / Fulgent Genetics Inc / Iovance Biotherapeutics Inc / Molecular Templates Inc / Athenex Inc / Protagonist Therapeutics Inc / Pieris Pharmaceuticals Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Immunic Inc / Zoom Video Communications Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / Personalis Inc / DermTech Inc / Beyond Air Inc / Pennant Group Inc / Bicycle Therapeutics PLC / 9 Meters Biopharma Inc / Oric Pharmaceuticals Inc / Biomx Inc / Pliant Therapeutics Inc / Nano-X Imaging Ltd / Humanigen Inc / Taysha Gene Therapies Inc / F-Star Therapeutics Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Immunocore Holdings PLC / Pharvaris NV / Applied Minerals Inc / Great Elm Capital Corp / Evaxion Biotech A/S / Rezolute Inc / Sera Prognostics Inc / Cognition Therapeutics Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Belgium / Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Nigeria / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 71708110 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Charts of the Day: PRFT, ARLO, HOV, VNCE, HRL, TR, LEE, MCK, HBP, BXC, MSI, EXTR, TRNS, PI, AUID, QCOM, CIEN, OCN, CPSS, BSIG, MRBK, ACAD, OPNT, REGN, ABBV, AA, BLDR, LITE, CVS, CTG, and DHX</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">REGN.OQ / ABBV.N / AUID.OQ / BLDR.N / BSIG.N / BXC.N / CPSS.OQ / CVS.N / DHX.N / EXTR.OQ / HOV.N / HRL.N / LITE.OQ / MCK.N / MRBK.OQ / OPNT.OQ / PRFT.OQ / QCOM.OQ / TR.N / TRNS.OQ / VNCE.N / OCN.N / MSI.N / CTG.OQ / HBP.OQ / PI.OQ / ARLO.N / LEE.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Abbvie Inc / Ipsidy Inc / Builders FirstSource Inc / Brightsphere Investment Group Inc / Bluelinx Holdings Inc / Consumer Portfolio Services Inc / CVS Health Corp / DHI Group Inc / Extreme Networks Inc / Hovnanian Enterprises Inc / Hormel Foods Corp / Lumentum Holdings Inc / Mckesson Corp / Meridian Corp / Opiant Pharmaceuticals Inc / Perficient Inc / Qualcomm Inc / Tootsie Roll Industries Inc / Transcat Inc / Vince Holding Corp / Ocwen Financial Corp / Motorola Solutions Inc / Computer Task Group Inc / Huttig Building Products Inc / Impinj Inc / Arlo Technologies Inc / Lee Enterprises Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AAPL / ACA / AMT / APP / APPS / BBY / C.N / CCI / CHTR / CME / COST / DISH / DLR / EA / FOCS / GLW / GS / ICE / ICPT / INTC.O / IS / MCD / MCO / MS / MSFT / NET / NKE / ORCL / QCOM.O / QUIK / RAD / RH / RNG / RXT / SAP / SEIC / SONY / SPOT / T / TTWO / U / UPS / V / WMT / AMZN.O / GILD.O / CMCSA.O / NICE / CSCO.O / ATVI.O / ONEM.O / TRIT / NVDA.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / CSGS.O / SBAC.O / VG / AMD.O / ADI.O / EQIX / VZ / NFLX / CEVA / CRNT.O / LUMN / SMTC.O / FDS.N / TXN.O / DOX.O / REGN.O / MRVL.O / VRNT / SSNC.O / AVGO.O / NDAQ / XLNX.OQ / NOVN.O / CCRN.O / BCRX.O / AMED.O / EXAS.O / SWKS.O / ANGN.O / BIIB / 00846U101 / 868168105 / GOOG.O / CMMB / FREQ / SPGI / DXCM.O / LHCG.O / MBRX.O / 36467W109 / CBAY / CCOI / CYCC.O / INFI.O / COIN / IVZ / 02043Q107 / ENSG.O / 483548103 / 00826A109 / 771195104 / ADUS.O / GLAXOSM.LG / TSLA.O / NXPI.O / SPRO.O / ZNGA / FB.O / WDAY / TMUS / FDEV.L / WIX.O / ARMK / FIVN.O / 82655M107 / MDWD.O / VBLT.O / QRVO.O / CXDO / AUPH.O / GLPG.O / EVH / NVCR.O / 100063846 / IONS.O / CLRB.O / NTLA / TTD.O / FLGT.O / OKTA.O / MTEM.O / ATNX.O / ROKU.O / MDB.O / EGHT.K / PTGX.O / 720795103 / BILI.O / ORTX.O / BNGO.O / IMUX.O / ZM.O / IDYA.O / FSLY / PSNL.O / DMTK.O / CMBM / PNTG.O / BCYC / DKNG / NMTR.O / ORIC.O / PHGE.K / PLRX.O / FUBO / HGEN.O / TSHA.O / TEUM.PK / ONDS.OQ / PRTG.O / SNSE.O / PHVS.O / DOCN / HUYA.K / EVAX.O / RZLT.O / 975657107 / SERA.OQ / MNDY.O / ATXS.O / NN.O</td><td class="leftalignment">Apple Inc / Arcosa Inc / American Tower Corp / Applovin Corp / Digital Turbine Inc / Best Buy Co Inc / Citigroup Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / Costco Wholesale Corp / DISH Network Corp / Digital Realty Trust Inc / Electronic Arts Inc / Focus Financial Partners Inc / Corning Inc / Goldman Sachs Group Inc / Intercontinental Exchange Inc / Intercept Pharmaceuticals Inc / Intel Corp / Ironsource Ltd / McDonald's Corp / Moody's Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Oracle Corp / Qualcomm Inc / QuickLogic Corp / Rite Aid Corp / RH / RingCentral Inc / Rackspace Technology Inc / SAP SE / SEI Investments Co / Sony Group Corp / Spotify Technology SA / AT&T Inc / Take-Two Interactive Software Inc / Unity Software Inc / United Parcel Service Inc / Visa Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Nice Ltd / Cisco Systems Inc / Activision Blizzard Inc / 1Life Healthcare Inc / Triterras Inc / NVIDIA Corp / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / CSG Systems International Inc / SBA Communications Corp / Vonage Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / CEVA Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Semtech Corp / Factset Research Systems Inc / Texas Instruments Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Marvell Technology Inc / Verint Systems Inc / SS&C Technologies Holdings Inc / Broadcom Inc / Nasdaq Inc / Xilinx Inc / Novan Inc / Cross Country Healthcare Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Exact Sciences Corp / Skyworks Solutions Inc / Angion Biomedica Corp / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / S&P Global Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / GameStop Corp / Cymabay Therapeutics Inc / Cogent Communications Holdings Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Coinbase Global Inc / Invesco Ltd / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Affymax Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / NXP Semiconductors NV / Spero Therapeutics Inc / Zynga Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Wix.Com Ltd / Aramark / Five9 Inc / Sify Technologies Ltd / Mediwound Ltd / Vascular Biogenics Ltd / Qorvo Inc / Crexendo Inc / Aurinia Pharmaceuticals Inc / Galapagos NV / Evolent Health Inc / Novocure Ltd / Truist Financial Corp / Ionis Pharmaceuticals Inc / Cellectar Biosciences Inc / Intellia Therapeutics Inc / Trade Desk Inc / Fulgent Genetics Inc / Okta Inc / Molecular Templates Inc / Athenex Inc / Roku Inc / MongoDB Inc / 8x8 Inc / Protagonist Therapeutics Inc / Pieris Pharmaceuticals Inc / Bilibili Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Immunic Inc / Zoom Video Communications Inc / IDEAYA Biosciences Inc / Fastly Inc / Personalis Inc / DermTech Inc / Cambium Networks Corp / Pennant Group Inc / Bicycle Therapeutics PLC / DraftKings Inc / 9 Meters Biopharma Inc / Oric Pharmaceuticals Inc / Biomx Inc / Pliant Therapeutics Inc / Fubotv Inc / Humanigen Inc / Taysha Gene Therapies Inc / Pareteum Corp / Ondas Holdings Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Pharvaris NV / DigitalOcean Holdings Inc / HUYA Inc / Evaxion Biotech A/S / Rezolute Inc / Winston Pharmaceuticals Inc / Sera Prognostics Inc / Monday.Com Ltd / Astria Therapeutics Inc / NextNav Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / India / Israel / Japan / Luxembourg / Nigeria / Netherlands / United States / Virgin Islands, British / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let it Bleed; Four Straight Weeks of Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Institutional ownership of REGN at Sep 30: 199 (22%) exits from Regeneron</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / LH / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / AFMD.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Affimed NV / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Chapter 2: A Well-Designed CAR-T Portfolio that Could Further Drive Mustang’s Valuation</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">US62818Q1040 / US3755581036 / US75886F1075</td><td class="leftalignment">Mustang Bio Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Rare Bolt-on Opportunity with Platform Upside; Initiating at OP and $16 PT</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">BCRX.O / REGN.O / 771195104 / IONS.O / NTLA / PHVS.O / ATXS.O</td><td class="leftalignment">BioCryst Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Ionis Pharmaceuticals Inc / Intellia Therapeutics Inc / Pharvaris NV / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Justin A. Kim / Mr. Hartaj K. Singh</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">AU000000CIA2 / US0383361039 / US1264081035 / US1475281036 / US25179M1036 / US31428X1063 / US38059T1060 / US4433201062 / US4456581077 / US56418H1005 / US5770811025 / US5951121038 / US5962781010 / US6558441084 / US7010941042 / US7170811035 / US75886F1075 / US8552441094 / US8851601018 / US9078181081 / US9113121068 / US9311421039 / CA53278L1076 / CA1363751027 / CA0977512007 / CA90457D1006 / CA8787422044 / CA1247651088 / CA0679011084 / CA9528451052 / CA87971M1032 / CA13645T1003 / CA8676EP1086 / US14040H1059 / CA2265331074 / CA56501R1064 / US15135B1017 / US12541W2098 / CA1125851040 / CA95083R1001 / US57636Q1040 / CA30041N1078 / US63633D1046 / CA2945051027 / CA14068G1046 / US3932221043 / CA6252841045 / CA25675T1075 / CA15135U1093 / US65339F1012 / US74340W1036 / US30303M1027 / US4571871023 / CA7063271034 / US6092071058 / JE00B5TT1872 / CA0213611001 / CA3565001086 / CA74061A1084 / CA96145A2002 / CA81373C1023 / US78573L1061 / US6974351057 / CA46579R1047 / US02005N1000 / US14174T1079 / IE00BQPVQZ61 / CA0089118776 / BMG0750C1082 / CA8310211005 / US1638511089 / US95040Q1040 / AU000000NST8 / CA17040T3001 / BMG162341090 / CA87241L1094 / CA6632782083 / CA7847301032 / US87105L1044 / US04335A1051 / VGG1890L1076 / CA14179V5036 / US22052L1044 / US86745K1043 / US03768E1055 / US42250P1030 / CA31890B1031 / MHY0436Q1098 / CA4220961078 / US03940R1077 / US05478C1053 / CA67079A1021 / CA33843T1084 / US86333M1080 / US90364P1057 / CA5362211040 / CA65532M6062 / CA24874B1085 / CA03253E1079 / CA53229C1077 / US98955K1043</td><td class="leftalignment">Champion Iron Ltd / Aptargroup Inc / CSX Corp / Caseys General Stores Inc / Devon Energy Corp / FedEx Corp / Gold Fields Ltd / Hub Group Inc / J B Hunt Transport Services Inc / ManpowerGroup Inc / Mattel Inc / Micron Technology Inc / Middleby Corp / Norfolk Southern Corp / Parker-Hannifin Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Thor Industries Inc / Union Pacific Corp / United Parcel Service Inc / Walmart Inc / Linamar Corp / Canadian National Railway Co / Bombardier Inc / Uni-Select Inc / Teck Resources Ltd / CAE Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Telus Corp / Canadian Pacific Railway Ltd / Sunopta Inc / Capital One Financial Corp / Crew Energy Inc / Manulife Financial Corp / Centene Corp / CH Robinson Worldwide Inc / Brookfield Asset Management Inc / Wesdome Gold Mines Ltd / Mastercard Inc / Evertz Technologies Ltd / National Health Investors Inc / Equitable Group Inc / Capstone Mining Corp / Green Plains Inc / Mullen Group Ltd / Dollarama Inc / Cenovus Energy Inc / Nextera Energy Inc / Prologis Inc / Meta Platforms Inc / Ingredion Inc / Pembina Pipeline Corp / Mondelez International Inc / Centamin PLC / AltaGas Ltd / Freehold Royalties Ltd / Premium Brands Holdings Corp / Westshore Terminals Investment Corp / Secure Energy Services Inc / Sabra Health Care REIT Inc / Palo Alto Networks Inc / Ivanhoe Mines Ltd / Ally Financial Inc / CareTrust REIT Inc / Horizon Therapeutics PLC / Air Canada / Axalta Coating Systems Ltd / Slate Office REIT / Chemours Co / Welltower Inc / Northern Star Resources Ltd / Chorus Aviation Inc / Brookfield Business Partners LP / TFI International Inc / North West Company Inc / SSR Mining Inc / Switch Inc / Arvinas Inc / Capri Holdings Ltd / Cargojet Inc / Corteva Inc / Sunnova Energy International Inc / Apollo Global Management Inc / Healthpeak Properties Inc / First Capital Real Estate Investment Trust / Atlas Corp / Headwater Exploration Inc / Arch Resources Inc / Azek Company Inc / Nuvei Corp / Flagship Communities Real Estate Investment Trust / Stride Inc / UiPath Inc / Lion Electric Co / Nomad Royalty Company Ltd / dentalcorp Holdings Ltd / Anaergia Inc / Lightspeed Commerce Inc / Zevia PBC</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Ireland / United States / Virgin Islands, British / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">REGN: Key Takeaways from Our Biopharma Spotlight: Global Large Cap Event</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Best of BMO Q4/21</td><td class="leftalignment">English</td><td class="rightalignment">77</td><td class="leftalignment">AU000000CIA2 / US0383361039 / US25179M1036 / US38059T1060 / US56418H1005 / US5770811025 / US5951121038 / US7010941042 / US7170811035 / US75886F1075 / US8552441094 / US9311421039 / CA53278L1076 / CA90457D1006 / CA8787422044 / CA1247651088 / CA0679011084 / CA9528451052 / CA87971M1032 / US14040H1059 / CA2265331074 / CA56501R1064 / US15135B1017 / CA1125851040 / CA95083R1001 / US57636Q1040 / CA2945051027 / CA14068G1046 / CA15135U1093 / US65339F1012 / US74340W1036 / US30303M1027 / US4571871023 / CA0213611001 / CA81373C1023 / US6974351057 / US02005N1000 / IE00BQPVQZ61 / BMG0750C1082 / US95040Q1040 / AU000000NST8 / BMG162341090 / CA7847301032 / US87105L1044 / US04335A1051 / VGG1890L1076 / US22052L1044 / US86745K1043 / US03768E1055 / CA31890B1031 / CA4220961078 / US03940R1077 / US05478C1053 / CA33843T1084 / US86333M1080 / CA24874B1085 / CA03253E1079 / CA53229C1077</td><td class="leftalignment">Champion Iron Ltd / Aptargroup Inc / Devon Energy Corp / Gold Fields Ltd / ManpowerGroup Inc / Mattel Inc / Micron Technology Inc / Parker-Hannifin Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Walmart Inc / Linamar Corp / Uni-Select Inc / Teck Resources Ltd / CAE Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Telus Corp / Capital One Financial Corp / Crew Energy Inc / Manulife Financial Corp / Centene Corp / Brookfield Asset Management Inc / Wesdome Gold Mines Ltd / Mastercard Inc / Equitable Group Inc / Capstone Mining Corp / Cenovus Energy Inc / Nextera Energy Inc / Prologis Inc / Meta Platforms Inc / Ingredion Inc / AltaGas Ltd / Secure Energy Services Inc / Palo Alto Networks Inc / Ally Financial Inc / Horizon Therapeutics PLC / Axalta Coating Systems Ltd / Welltower Inc / Northern Star Resources Ltd / Brookfield Business Partners LP / SSR Mining Inc / Switch Inc / Arvinas Inc / Capri Holdings Ltd / Corteva Inc / Sunnova Energy International Inc / Apollo Global Management Inc / First Capital Real Estate Investment Trust / Headwater Exploration Inc / Arch Resources Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Stride Inc / dentalcorp Holdings Ltd / Anaergia Inc / Lightspeed Commerce Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Ireland / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Bert X. Powell, CFA / Mr. Ketan Mamtora / Mr. Sohrab Movahedi / Mr. Devin Dodge / Fadi Chamoun / Mr. Alexander Pearce / Matt Borsch / Mr. Simeon A. Siegel / Mike Murphy / Rene Cartier / Joel Jackson, CFA / Mr. Ben Pham, CFA / Mr. Randy Ollenberger / Mr. Stephen MacLeod, CFA / Mr. Phillip J. Jungwirth, CFA / Daniel Salmon / Jenny Ma / Mr. Raj Ray / Ms. Jackie Przybylowski / Mr. Ray Kwan / Mr. Gary Nachman / Mr. Kenneth B. Zaslow, CFA / Mr. James Fotheringham / Mr. Peter Sklar, CPA / Mr. Jeffrey M. Silber / Gerrick L. Johnson / Tom MacKinnon, FSA / Joanne Chen / Mr. Ambrish Srivastava, PHD / Mr. James M. Thalacker / Mr. Ameet I. Thakkar / Mr. Brian Quast / Keith F. Bachman, CFA / Mr. John Gibson / Mr. Evan D. Seigerman / Mr. Joel G. Tiss / Mr. John P. Kim / Mr. Ryan Thompson / Ari Klein / Tim J. Casey, CFA / Mr. Andrew Mikitchook, CFA / Mr. Juan C. Sanabria / Ms. Kelly A. Bania / Doug Morrow / Mr. Rufus Hone / Jin Li / Mr. Brian G. Belski / Colin Hamilton / David Gagliano / Matthew Luchini / Mr. Mark W. Wilde, PHD / John McNulty</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AJG / BMY.N / EMN / H / KO / LLY.N / MRK.N / OLN / PFE.N / PK / RKT / S.N / SWK / ASND.O / AMZN.O / HT / GILD.O / AMGN.O / EW / ARNA.O / CHH.N / GSK.N / ARGX.O / BMRN.O / REGN.O / VRTX.O / DOL.TO / SIVB.O / BIIB.O / SHO.N / HST.N / HZNP.O / SRPT.O / RHP.N / ABBV.N / PFSI.K / QURE.O / RXDX.O / XHR.N / APLE.N / RYTM.O / SFIX.O / APLS.O / KZR.O / MORF.O / CABA.O / 45258J102 / HMPT.O</td><td class="leftalignment">Arthur J Gallagher & Co / Bristol-Myers Squibb Co / Eastman Chemical Co / Hyatt Hotels Corp / Coca-Cola Co / Eli Lilly and Co / Merck & Co Inc / Olin Corp / Pfizer Inc / Park Hotels & Resorts Inc / Rocket Companies Inc / SentinelOne Inc / Stanley Black & Decker Inc / Ascendis Pharma A/S / Amazon.com Inc / Hersha Hospitality Trust / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Arena Pharmaceuticals Inc / Choice Hotels International Inc / GlaxoSmithKline PLC / argenx SE / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Dollarama Inc / SVB Financial Group / Biogen Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Horizon Therapeutics PLC / Sarepta Therapeutics Inc / Ryman Hospitality Properties Inc / Abbvie Inc / PennyMac Financial Services Inc / Uniqure NV / Prometheus Biosciences Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Rhythm Pharmaceuticals Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / Kezar Life Sciences Inc / Morphic Holding Inc / Cabaletta Bio Inc / Immunovant Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">The Skies Are Clearing but Stock Selection Still Important</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: The COVID Play with Near-Term Upside & Durable COVID Business; Initiate at Overweight</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N / MRK.N / ASND.O / GSK.N / BMRN.O / REGN.O / SRPT.O / ABBV.N / QURE.O</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc / Ascendis Pharma A/S / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">REGN: High Dose Eylea Provides Upside Vision—Initiating at Overweight</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0576652004 / US45168D1046 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US1488061029 / CA68620P1018 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US4622221004 / US45781M1018 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US54142F1021 / US4158581094 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / US14147L1089 / CA05156X8843 / US7291391057 / US12233L1070 / US04537Y1091 / US4131971040 / US04683R1068 / US66988N2053 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Balchem Corp / IDEXX Laboratories Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Catalent Inc / OrganiGram Holdings Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Innoviva Inc / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / LogicBio Therapeutics Inc / Harrow Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Cardiff Oncology Inc / Aurora Cannabis Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Aspira Women's Health Inc / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Novan Inc / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">NICE Backs Dupixent as Add-On Therapy Option for Severe Asthma in Patients Ages 12+; Reiterate Buy and $844 PT</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">December 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CSL / EA / MA / MSFT / NBIX / SONY / T / TTWO / V / MSCI / ATVI.O / NVDA.O / HEAR / SQ / CONN / AMD.O / VZ / NFLX / REGN.O / PYPL / AMED.O / CARG / ALNY.O / DXCM.O / LHCG.O / 36467W109 / ENSG.O / ADUS.O / NXPI.O / ZNGA / FDEV.L / 82655M107 / RXDX.O / IONS.O / NTLA / BILI.O / HUYA.K / BASE.O / CGTX.OQ</td><td class="leftalignment">Carlisle Companies Inc / Electronic Arts Inc / Mastercard Inc / Microsoft Corp / Neurocrine Biosciences Inc / Sony Group Corp / AT&T Inc / Take-Two Interactive Software Inc / Visa Inc / MSCI Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Block Inc / Conn's Inc / Advanced Micro Devices Inc / Verizon Communications Inc / Netflix Inc / Regeneron Pharmaceuticals Inc / PayPal Holdings Inc / Amedisys Inc / CarGurus Inc / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / GameStop Corp / Ensign Group Inc / Addus Homecare Corp / NXP Semiconductors NV / Zynga Inc / Frontier Developments PLC / Sify Technologies Ltd / Prometheus Biosciences Inc / Ionis Pharmaceuticals Inc / Intellia Therapeutics Inc / Bilibili Inc / HUYA Inc / Couchbase Inc / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">US0091581068 / US0311621009 / US1101221083 / US2017231034 / US2372661015 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US8718291078 / US8851601018 / US9078181081 / US9111631035 / US92532F1003 / US9746371007 / CA29250N1050 / CA1247651088 / CA2918434077 / US09062X1037 / BMG169621056 / US6293775085 / US12008R1077 / US1252691001 / CA6179141065 / US58933Y1055 / US65339F1012 / CA04364G1063 / CA0805581091 / CA38045Y1025 / US85208M1027 / US60468T1051 / US2383371091 / US1638511089 / US4622221004 / US13462K1097 / US8608971078 / US80810D1037 / US92719V1008 / US1374041093</td><td class="leftalignment">Air Products and Chemicals Inc / Amgen Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sysco Corp / Thor Industries Inc / Union Pacific Corp / United Natural Foods Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Enbridge Inc / CAE Inc / Empire Company Ltd / Biogen Inc / Bunge Ltd / NRG Energy Inc / Builders FirstSource Inc / CF Industries Holdings Inc / Morguard Real Estate Investment Trust / Merck & Co Inc / Nextera Energy Inc / Ascot Resources Ltd / Belo Sun Mining Corp / GoGold Resources Inc / Sprouts Farmers Market Inc / Mirati Therapeutics Inc / Dave & Buster's Entertainment Inc / Chemours Co / Ionis Pharmaceuticals Inc / Camping World Holdings Inc / Stitch Fix Inc / Schrodinger Inc / Vimeo Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Sotrovimab Leads Race to Treat High-Risk SARS-CoV-2 Patients With Positive Preclinical Omicron Results; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">92764N102 / REGN.OQ</td><td class="leftalignment">Vir Biotechnology Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Highlights from Our Prostate Cancer KOL Call on the Shifting Landscape and Opportunity for Emerging Therapeutics</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">5671735 / 0989529 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Early studies confirming vaccine induced immunity against Omicron is dropping, but conflicting data on by how much</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / GSK.L / PFIZ.NS / REGN.OQ</td><td class="leftalignment">Eli Lilly and Co / GlaxoSmithKline PLC / Pfizer Ltd / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / India / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Feedback From Our Launch: PFE’s Longer-Term COVID Benefit Clearer w/ Omicron</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">TTR Deal Clarifies In-House Strategic Priorities; HAE Emerging as a Primary Avenue for Value Creation</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">IONS.O / REGN.O / ALNY.O / NTLA</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intellia Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">ASH Preview #2: CD19 CAR-T and Novel Therapies in B-cell Malignancies</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">H17182108 / 75886F107 / 31189P102 / 74019P108</td><td class="leftalignment">CRISPR Therapeutics AG / Regeneron Pharmaceuticals Inc / Fate Therapeutics Inc / Precision BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David Dai</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">ASH Preview #1: BCMA CAR-T and Bispecifics Landscape</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">52490G102 / 75886F107</td><td class="leftalignment">Legend Biotech Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David Dai</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ASH Annual Meeting 2021 Planner and Preview</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">71708110 / 37555810 / 75886F10 / 478160104 / 640268108 / 80105N10 / 771195104 / 00287Y10 / 28106W10 / 98401F10 / 41358P10 / 01981810 / 09609G10 / 45826J10 / 77313F10 / 55609910 / N0104510 / 31189P10 / 07725L10 / 00847X10 / 37890U10 / 04685N10 / 34633R10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 03969F10 / 98887Q10 / 92765F10 / 37230320 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 92731L10 / 07373V10 / H1718210</td><td class="leftalignment">Pfizer Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Nektar Therapeutics / Sanofi SA / Roche Holding AG / Abbvie Inc / Editas Medicine Inc / Xencor Inc / Harpoon Therapeutics Inc / Allovir Inc / bluebird bio Inc / Intellia Therapeutics Inc / Rocket Pharmaceuticals Inc / MacroGenics Inc / Affimed NV / Fate Therapeutics Inc / Beigene Ltd / Agios Pharmaceuticals Inc / Global Blood Therapeutics Inc / Athenex Inc / Forma Therapeutics Holdings Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Arcus Biosciences Inc / Zai Lab Ltd / Viracta Therapeutics Inc / Genmab A/S / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Vincerx Pharma Inc / Beam Therapeutics Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Netherlands / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Daniel Tarjan, Ph.D. / Na Sun / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid / Nick Huang / Greco Song, Ph.D. / Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA / Mani Foroohar, M.D. / Christopher Liu, Pharm.D. / Mr. Rick Bienkowski, Ph.D. / Ken Shields / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AAPL / APPS / ARCC / CCI / CHTR / COST / CSL / DISH / EA / GBDC / INTC.O / JACK / MSFT / QUIK / SCM.N / SONY / SUNS / SVA / T / TTWO / VGR / WEN / AMZN.O / CMCSA.O / ORCC / ATVI.O / NVDA.O / HEAR / KLR / CSGS.O / VECO.O / VZ / NFLX / CRNT.O / LUMN / DOX.O / REGN.O / GLAD / WHF / MRNS / NKTR / 478160104 / 459200101 / GOOG.O / ACAD.O / MRCC / 36467W109 / PNNT / TNDM.O / MRNA.O / 092533108 / SLRC / HRZN / NMFC / PFLT / FDUS / ZNGA / TCPC / FB.O / TMUS / FDEV.L / TSLX / 563771203 / 82655M107 / 02005N100 / INO.O / RESN.O / COUP.O / AKTS.O / HLNE.O / IOVA / OCSL / MDB.O / BILI.O / CMBM / FCRD / STEP.O / ONDS.OQ / HUYA.K / 03823M100 / 390320109 / CCSI.OQ</td><td class="leftalignment">Apple Inc / Digital Turbine Inc / Ares Capital Corp / Crown Castle International Corp / Charter Communications Inc / Costco Wholesale Corp / Carlisle Companies Inc / DISH Network Corp / Electronic Arts Inc / Golub Capital Bdc Inc / Intel Corp / Jack in the Box Inc / Microsoft Corp / QuickLogic Corp / Stellus Capital Investment Corp / Sony Group Corp / SLR Senior Investment Corp / Sinovac Biotech Ltd / AT&T Inc / Take-Two Interactive Software Inc / Vector Group Ltd / Wendys Co / Amazon.com Inc / Comcast Corp / Owl Rock Capital Corp / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Kaleyra Inc / CSG Systems International Inc / Veeco Instruments Inc / Verizon Communications Inc / Netflix Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Gladstone Capital Corp / WhiteHorse Finance Inc / Marinus Pharmaceuticals Inc / Nektar Therapeutics / Johnson & Johnson / International Business Machines Corp / Alphabet Inc / ACADIA Pharmaceuticals Inc / Monroe Capital Corp / GameStop Corp / Pennantpark Investment Corp / Tandem Diabetes Care Inc / Moderna Inc / BlackRock Capital Investment Corp / SLR Investment Corp / Horizon Technology Finance Corp / New Mountain Finance Corp / PennantPark Floating Rate Capital Ltd / Fidus Investment Corp / Zynga Inc / BlackRock TCP Capital Corp / Meta Platforms Inc / T-Mobile US Inc / Frontier Developments PLC / Sixth Street Specialty Lending Inc / Mannatech Inc / Sify Technologies Ltd / Ally Financial Inc / Inovio Pharmaceuticals Inc / Resonant Inc / Coupa Software Inc / Akoustis Technologies Inc / Hamilton Lane Inc / Iovance Biotherapeutics Inc / Oaktree Specialty Lending Corp / MongoDB Inc / Bilibili Inc / Cambium Networks Corp / First Eagle Alternative Capital BDC Inc / StepStone Group Inc / Ondas Holdings Inc / HUYA Inc / Applied Minerals Inc / Great Elm Capital Corp / Consensus Cloud Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Cayman Islands / United Kingdom / India / Israel / Japan / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 07 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">DE0006969603 / US0028241000 / US0079031078 / US0116591092 / US0231351067 / US0320951017 / US0378331005 / US1924221039 / US1985161066 / US2435371073 / US28176E1082 / US3695501086 / US4448591028 / US4581401001 / US5184151042 / US5719032022 / US5949181045 / US5951121038 / US6541061031 / US67066G1040 / US75886F1075 / US7782961038 / US8305661055 / US8447411088 / US8636671013 / US8725401090 / US87612E1064 / US91347P1057 / US9182041080 / US92343V1044 / US9581021055 / US9839191015 / US3448491049 / US20030N1019 / US2533931026 / US00206R1023 / US9043111072 / US82706C1080 / US4103451021 / US8485741099 / US5500211090 / US25470M1099 / US64110D1046 / IE00B4BNMY34 / US9100471096 / DE000A1EWWW0 / US40412C1018 / US6936561009 / US7512121010 / US29414B1044 / US81762P1021 / US8725901040 / US55405Y1001 / US8086251076 / US5253271028 / US31189P1021 / US1220171060 / JE00BLG2ZQ72 / US0367521038 / US22822V1017 / US29444U7000 / US12685J1051 / US02079K1079 / US16119P1084 / US90138F1021 / CH0334081137 / US74967X1037 / US23355L1061 / US02156K1034 / US8753722037 / US74766Q1013 / US4622601007 / US09857L1089 / US98980G1022 / VGG312491084 / US04335A1051 / US0197701065 / US98585X1046 / US60770K1079 / US90041T1088 / US89377M1099 / US02875D1090 / US8334451098 / US86646P1030 / US56854Q2003 / US68062P1066 / US0090661010 / US55406W1036 / US15961R1059 / US90364P1057 / US5738741041 / IE00BKVD2N49 / US30260D1037 / US20717M1036 / US10920V1070 / US13781Y1038 / US30052F1003 / US88546E1055 / US8852601090 / US37637K1088 / US01675A1097 / US92561V1098</td><td class="leftalignment">Puma SE / Abbott Laboratories / Advanced Micro Devices Inc / Alaska Air Group Inc / Amazon.com Inc / Amphenol Corp / Apple Inc / Cognex Corp / Columbia Sportswear Co / Deckers Outdoor Corp / Edwards Lifesciences Corp / General Dynamics Corp / Humana Inc / Intel Corp / Lattice Semiconductor Corp / Marriott International Inc / Microsoft Corp / Micron Technology Inc / Nike Inc / NVIDIA Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Skechers USA Inc / Southwest Airlines Co / Stryker Corp / TJX Companies Inc / Target Corp / Universal Display Corp / VF Corp / Verizon Communications Inc / Western Digital Corp / Xilinx Inc / Foot Locker Inc / Comcast Corp / DICK'S Sporting Goods Inc / AT&T Inc / Under Armour Inc / Silicon Motion Technology Corp / HanesBrands Inc / Spirit AeroSystems Holdings Inc / Lululemon Athletica Inc / DISH Network Corp / NetApp Inc / Accenture PLC / United Airlines Holdings Inc / Adidas AG / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / Epam Systems Inc / ServiceNow Inc / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / Science Applications International Corp / Leidos Holdings Inc / Fate Therapeutics Inc / Burlington Stores Inc / Quotient Ltd / Anthem Inc / Crown Castle International Corp / Equinix Inc / Cable One Inc / Alphabet Inc / Charter Communications Inc / Twilio Inc / CRISPR Therapeutics AG / RH / DXC Technology Co / Altice USA Inc / Tandem Diabetes Care Inc / Quanterix Corp / Iovance Biotherapeutics Inc / Booking Holdings Inc / Zscaler Inc / Establishment Labs Holdings Inc / Arvinas Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Moderna Inc / Turning Point Therapeutics Inc / Transmedics Group Inc / American Outdoor Brands Inc / Snowflake Inc. / Sumo Logic Inc / Marinus Pharmaceuticals Inc / Olema Pharmaceuticals Inc / Airbnb Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc / UiPath Inc / Marvell Technology Inc / Seagate Technology Holdings PLC / Figs Inc / Confluent Inc / Bright Health Group Inc / Cano Health Inc / EVgo Inc / Thoughtworks Holding Inc / Thorne Healthtech Inc / GitLab Inc / Allbirds Inc / Vicarious Surgical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Ireland / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / AMD=US / IP=US / WEN=US / BLD=US / KMI=US / PEB=US / SLG=US / H=US / MTN=US / LOW=US / IGT=US / BYD=US / MAR=US / LEG=US / TNL=US / VMC=US / MGM=US / HLT=US / PENN=US / RCL=US / MLM=US / UNH=US / AMED=US / SWIM=US / CBRL=US / ELY=US / CCL=US / FUN=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / WGO=US / SGMS=US / SIVB=US / CNM=US / NLS=US / COP=US / AUTL=US / VICI=US / DIN=US / MGP=US / OGN / BCO=US / MRNS=US / RRR=US / PRG=US / TPX=US / EXP=US / CZR=US / BECN=US / TXRH=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / PGTI=US / AWI=US / OC=US / SAIC=US / AMRX=US / TAST=US / QSR=US / WRK=US / PRPL=US / WH=US / JACK=US / AGS=US / TREX=US / HGV=US / LPLA=US / VAC=US / FBHS=US / RHP=US / FANG=US / TILE=US / NCLH=US / NDLS=US / FOXF=US / FATE=US / GLPI=US / COUP=US / LOCO=US / AFMD=US / BVH=US / SHAK=US / WING=US / EVRI=US / 82982L103 / 50189K103 / JELD=US / IOVA=US / ALLO=US / HARP=US / FERG=US / GMAB=US / ONEW=US / DKNG=US / AZEK=US / BALY=US / VTRS=US / CELU=US / ROCC=US / SNPO=US / HLLY=US / PKG=U / GTLB=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / International Paper Co / Wendys Co / TopBuild Corp / Kinder Morgan Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Royal Caribbean Cruises Ltd / Martin Marietta Materials Inc / UnitedHealth Group Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Carnival Corp / Cedar Fair LP / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Winnebago Industries Inc / Scientific Games Corp / SVB Financial Group / Core & Main Inc / Nautilus Inc / Conocophillips / Autolus Therapeutics PLC / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / Organon & Co / Brinks Co / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / PROG Holdings Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Science Applications International Corp / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Westrock Co / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / PlayAGS Inc / Trex Company Inc / Hilton Grand Vacations Inc / LPL Financial Holdings Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Fox Factory Holding Corp / Fate Therapeutics Inc / Gaming and Leisure Properties Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / LCI Industries / JELD-WEN Holding Inc / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Ferguson PLC / Genmab A/S / OneWater Marine Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Celularity Inc / Ranger Oil Corp / Snap One Holdings Corp / Holley Inc / Packaging Corp of America / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Liberia / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">COVID-19 Experts - Call Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SVA / REGN.O / 478160104 / MRNA.O / 02005N100 / INO.O / 03823M100 / 390320109</td><td class="leftalignment">Sinovac Biotech Ltd / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Moderna Inc / Ally Financial Inc / Inovio Pharmaceuticals Inc / Applied Minerals Inc / Great Elm Capital Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US02553E1064 / US1101221083 / US2017231034 / US3647601083 / US3755581036 / US45337C1027 / US5324571083 / US6541061031 / US6556641008 / US6703461052 / US6819191064 / US68389X1054 / US7170811035 / US75886F1075 / US7782961038 / US8581191009 / US8725401090 / US8851601018 / US9170471026 / US9182041080 / CA8787422044 / CA87971M1032 / US9129091081 / US02043Q1076 / US9043111072 / US5500211090 / US90384S3031 / CA22576C1014 / US58933Y1055 / US6936561009 / US7512121010 / US98986T1088 / US00287Y1091 / US09609G1004 / CA1348082035 / CA96467A2002 / IE00B4Q5ZN47 / CA3748252069 / US31189P1021 / US1220171060 / US14174T1079 / US72703H1014 / US8760301072 / US8608971078 / US03753U1060 / US63845R1077 / CA8585221051 / US76029N1063 / VGG1890L1076 / US76156B1070 / US88339P1012 / US70614W1009 / US80810D1037 / CA2674881040 / US78440X8048 / US44891N2080 / CA00791P1071 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US4718711033 / US53190C1027 / CA0156581070</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Gap Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Nucor Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Steel Dynamics Inc / TJX Companies Inc / Thor Industries Inc / Urban Outfitters Inc / VF Corp / Teck Resources Ltd / Telus Corp / United States Steel Corp / Alnylam Pharmaceuticals Inc / Under Armour Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Crescent Point Energy Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Zynga Inc / Abbvie Inc / bluebird bio Inc / Canacol Energy Ltd / Whitecap Resources Inc / Jazz Pharmaceuticals PLC / Gibson Energy Inc / Fate Therapeutics Inc / Burlington Stores Inc / CareTrust REIT Inc / Planet Fitness Inc / Tapestry Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / National Vision Holdings Inc / Stelco Holdings Inc / Replimune Group Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Peloton Interactive Inc / Schrodinger Inc / Dye & Durham Ltd / SL Green Realty Corp / IAC/Interactivecorp / Advantage Energy Ltd / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Jasper Therapeutics Inc / Life Time Group Holdings Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Transfer: Core Business To Remain Stable As The Oncology Pipeline Emerges</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tyler M. Van Buren / Brittany Woods, Ph.D. / Tara Bancroft, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">STARTING IN 30 MINUTES: KOL Call on Prostate Cancer Landscape and Emerging Therapeutics</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: KRYS PIII Win in DEB; ABUS LNP Patent Upheld</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">ABUS.OQ / KRYS.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Arbutus Biopharma Corp / Krystal Biotech Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">441</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2021 ASH Preview and Itinerary Planner</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US31189P1021 / US03753U1060 / US80810D1037 / US4718711033</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc / Schrodinger Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Georgia / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini / Evan Hua</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2000019 / 2023607 / 2486813 / 2778844 / 2065159 / 2270726 / 2542049 / 2317087 / 2632003 / 2657802 / 2689560 / 2684703 / 2048804 / 2730190 / 2440637 / 2829601 / 7103065 / 2857817 / B02R1L6 / B5B1S13 / B7TL820 / B7VD3F2 / B7JYSG3 / BBGVT40 / BDZCRX3 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BD8DJ71 / BJ2Z0H2 / BZ8FPH3 / BYZM6C2 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BYY88Y7 / BRJ3GY4 / BMDCDP2 / BN7K304 / BNTB3N8 / BKPGJQ1 / BNKGXX2 / BMDW0R3 / BYQBFJ8</td><td class="leftalignment">Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Autodesk Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / New York Times Co / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Netflix Inc / ALLETE Inc / Dollar General Corp / Meta Platforms Inc / Duke Energy Corp / Guidewire Software Inc / News Corp / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Shopify Inc / Snap Inc / Pinterest Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Bigcommerce Holdings Inc / Academy Sports and Outdoors Inc / Vizio Holding Corp / Squarespace Inc / Verve Therapeutics Inc / Weave Communications Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / BMO.TO / BOX.N / CB.N / CL.N / CRM.N / EIX.N / F.N / FITB.O / FSR.N / GM.N / NA / PD.N / RYN.N / SO.N / T.N / VC.N / BFb.N / WY.N / TEN.N / CMCSA.O / AMGN.O / DIS.N / BWA.N / LEA.N / PNM.N / DT.N / DV.N / ENEI.MI / EPC.N / AMT.N / CONE.O / VZ.N / XEL.N / LNC.N / APH.N / FISV.O / V.N / AXL.N / ACN.N / JKHY.O / AJG.N / BMRN.O / REGN.O / SRG.MI / PRU.N / NCR.N / TEL.N / CPK.N / ST.N / SR.N / O.N / PLUG.OQ / GPN.N / IMGN.O / LIFE.O / CASY.O / ACGL.O / EQIX.O / ATDb.TO / DLR.N / 416515104 / FIS.N / MA.N / WU.N / AON.N / GETP.PA / DAN.N / ENV.N / NEE.N / NXT.AX / PCH.O / PKI.TO / CTT.N / MTOR.N / SPLK.OQ / FFHu.TO / INFA.N / TSLA.N / TMUS.N / BEP.N / AGIO.O / 81762P102 / 922475108 / NEP.N / HUBS.N / SQ.N / SCWX.O / ADNT.N / GDS.O / OKTA.OQ / OVID.O / WOW.N / ATNX.O / APTV.N / ZS.OQ / SMAR.N / VNE.N / FOCS.O / ESTC.N / CRWD.O / CRNC.OQ / WTRG.N / AHCO.O / VMD.OQ / NKLA.OQ / FOUR.N / IBEX.O / LUMN.N / AEP.OQ / RIDE.OQ / LSPD.N / AFRM.O / OLO.N / NAPA.N / COUR.N / PATH.N / TSP.OQ / FLYW.O / TASK.O / TRMR.OQ / RYAN.N / BASE.OQ / RIVN.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Bank of Montreal / Box Inc / Chubb Ltd / Colgate-Palmolive Co / Salesforce.Com Inc / Edison International / Ford Motor Co / Fifth Third Bancorp / Fisker Inc / General Motors Co / National Bank of Canada / PagerDuty Inc / Rayonier Inc / Southern Co / AT&T Inc / Visteon Corp / Brown-Forman Corp / Weyerhaeuser Co / Tenneco Inc / Comcast Corp / Amgen Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / PNM Resources Inc / Dynatrace Inc / DoubleVerify Holdings Inc / Enel SpA / Edgewell Personal Care Co / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / Xcel Energy Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Jack Henry & Associates Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Snam SpA / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Spire Inc / Realty Income Corp / Plug Power Inc / Global Payments Inc / ImmunoGen Inc / aTyr Pharma Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Equinix Inc / Alimentation Couche-Tard Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Fidelity National Information Services Inc / Mastercard Inc / Western Union Co / Aon PLC / Getlink SE / Dana Inc / Envestnet Inc / Nextera Energy Inc / NEXTDC Ltd / Potlatchdeltic Corp / Parkland Corp / CatchMark Timber Trust Inc / Meritor Inc / Splunk Inc / Fairfax Financial Holdings Ltd / Informatica Inc / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / ServiceNow Inc / Veeva Systems Inc / Nextera Energy Partners LP / HubSpot Inc / Block Inc / SecureWorks Corp / Adient PLC / GDS Holdings Ltd / Okta Inc / Ovid Therapeutics Inc / WideOpenWest Inc / Athenex Inc / Aptiv PLC / Zscaler Inc / Smartsheet Inc / Veoneer Inc / Focus Financial Partners Inc / Elastic NV / CrowdStrike Holdings Inc / Cerence Inc / Essential Utilities Inc / Adapthealth Corp / Viemed Healthcare Inc / Nikola Corp / Shift4 Payments Inc / Ibex Ltd / Lumen Technologies Inc / American Electric Power Company Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Affirm Holdings Inc / Olo Inc / Duckhorn Portfolio Inc / Coursera Inc / UiPath Inc / TuSimple Holdings Inc / Flywire Corp / Taskus Inc / Tremor International Ltd / Ryan Specialty Group Holdings Inc / Couchbase Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Powerful Reset in Execution Mode; Inflammation's New Enemies; Assuming Coverage at Buy and $7 PT</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">REGN.OQ / 88322Q108 / 03835T200 / 040047607 / 04522R101 / 34633R104 / 82640U404</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / TG Therapeutics Inc / Aptose Biosciences Inc / Arena Pharmaceuticals Inc / Aslan Pharmaceuticals Ltd / Forma Therapeutics Holdings Inc / Sierra Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical Sector: COVID-19 update: Omicron variant still something of a mystery, but looks to be highly transmissible</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">4507.T / 4519.T / PFE.N / ROG.S / GSK.L / REGN.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品・医療機器セクター: COVID-19に関するアップデート :変異株オミクロンに関しての詳細は依然不透明だが、高い感染性が示唆される</td><td class="leftalignment">Japanese</td><td class="rightalignment">5</td><td class="leftalignment">4507.T / 4519.T / PFE.N / ROG.S / GSK.L / REGN.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates COVID, NRDLs, Key News Items</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00287Y1091 / US09058V1035 / US75886F1075 / US6402681083 / US88322Q1085 / US29251M1062 / US4277461020 / CH0334081137 / US5011471027 / US20451W1018 / US16961L1061 / US1920101060 / US45114M1099 / US23345J1043</td><td class="leftalignment">Abbvie Inc / BioCryst Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / TG Therapeutics Inc / Enanta Pharmaceuticals Inc / Heron Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Compass Pathways PLC / Chinook Therapeutics Inc / Codiak BioSciences, Inc. / Icosavax Inc / Dice Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">12/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O / BMRN.O / REGN.O / IMGN.O / LIFE.O / AGIO.O / ATNX.O</td><td class="leftalignment">Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / ImmunoGen Inc / aTyr Pharma Inc / Agios Pharmaceuticals Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 26 to December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0002810146 / IL0006290147 / US0091581068 / US02553E1064 / US0383361039 / US0536111091 / US0584981064 / US1264081035 / US2017231034 / US2441991054 / US25179M1036 / US2788651006 / US30231G1022 / US31428X1063 / US3154051003 / US3647601083 / US4180561072 / US4282911084 / US4433201062 / US4456581077 / US4523081093 / US5010441013 / US5324571083 / US56418H1005 / US5770811025 / US5949181045 / US64125C1099 / US6516391066 / US6541061031 / US6556641008 / US6558441084 / US6703461052 / US6935061076 / US7170811035 / US7496851038 / US75886F1075 / US7703231032 / US7782961038 / US7802871084 / US81211K1007 / US8243481061 / US8581191009 / US8725401090 / US9078181081 / US9113121068 / US91324P1021 / US9170471026 / US9182041080 / US92532F1003 / CA53278L1076 / CA1363751027 / CA59162N1096 / CA29250N1050 / CA5394811015 / CA0977512007 / CA30150P1099 / CA1247651088 / CA2908761018 / CA5592224011 / CA0084741085 / CA0679011084 / CA1363851017 / CA2499061083 / US1667641005 / CA13645T1003 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US20825C1045 / US2274831047 / CA5734591046 / US09062X1037 / NO0010208051 / US49446R1095 / CA98462Y1007 / US79466L3024 / US9604131022 / CA5503721063 / US29476L1070 / US7588491032 / US1508701034 / CA8911605092 / CA1360691010 / CA8935781044 / US8288061091 / US44107P1049 / US12541W2098 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / CA32076V1031 / GB00B1FW5029 / US5021751020 / US63633D1046 / CA14068G1046 / US5500211090 / US89785X1019 / US90384S3031 / CA3518581051 / US91912E1055 / CA8672241079 / US58933Y1055 / CA25675T1075 / CA15135U1093 / US2566771059 / CA14042M1023 / NL0009434992 / CA9237251058 / CA07317Q1054 / US18538R1032 / CA00208D4084 / CA2927661025 / US61945C1036 / JE00B4T3BW64 / US6936561009 / US7512121010 / US71922G2093 / CA7063271034 / CA4932711001 / CA89156V1067 / CA55903Q1046 / CA96145A2002 / US70509V1008 / CA04682R1073 / US78573L1061 / US8486371045 / CA87262K1057 / US08579W1036 / US23283R1005 / CA05577W2004 / US1220171060 / US11120U1051 / CA68827L1013 / US78667J1088 / CA0089118776 / BMG0750C1082 / US1638511089 / US92939U1060 / CA8485101031 / US86771W1053 / US72703H1014 / US4622221004 / US45688C1071 / US0441861046 / US7005171050 / CA87241L1094 / US6792951054 / CA9628791027 / GB00BF3ZNS54 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / CA67077M1086 / US98980G1022 / US00191U1025 / US83200N1037 / IE00BZ12WP82 / VGG1890L1076 / US28618M1062 / US2605571031 / GB00BJT16S69 / CA87807B1076 / CA14179V5036 / US26614N1028 / US76156B1070 / JE00BJ1F3079 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / MHY0436Q1098 / US03750L1098 / JE00BMVMZ478 / US1651677353 / US24343R1068 / CA00076T1057 / US90364P1057 / US11135E2037 / US5738741041 / US60646V1052 / US0708301041 / US9264001028 / US27923Q1094 / US89269P1030 / US94770D1028 / US53190C1027 / US04302A1043</td><td class="leftalignment">Icl Group Ltd / Teva Pharmaceutical Industries Ltd / Air Products and Chemicals Inc / American Eagle Outfitters Inc / Aptargroup Inc / Avery Dennison Corp / Ball Corp / CSX Corp / Commercial Metals Co / Deere & Co / Devon Energy Corp / Ecolab Inc / Exxon Mobil Corp / FedEx Corp / Ferro Corp / Gap Inc / Hasbro Inc / Hexcel Corp / Hub Group Inc / J B Hunt Transport Services Inc / Illinois Tool Works Inc / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Mattel Inc / Microsoft Corp / Neurocrine Biosciences Inc / Newmont Corporation / Nike Inc / Nordstrom Inc / Norfolk Southern Corp / Nucor Corp / PPG Industries Inc / Pfizer Inc / RPM International Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Ross Stores Inc / Royal Gold Inc / Sealed Air Corp / Sherwin-Williams Co / Steel Dynamics Inc / TJX Companies Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Urban Outfitters Inc / VF Corp / Vertex Pharmaceuticals Inc / Linamar Corp / Canadian National Railway Co / Metro Inc / Enbridge Inc / Loblaw Companies Ltd / Bombardier Inc / Exco Technologies Ltd / CAE Inc / Emera Inc / Magna International Inc / Agnico Eagle Mines Ltd / Barrick Gold Corp / Canadian Natural Resources Ltd / Descartes Systems Group Inc / Chevron Corp / Canadian Pacific Railway Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Martinrea International Inc / Biogen Inc / Yara International ASA / Kimco Realty Corp / Yamana Gold Inc / Salesforce.Com Inc / Westlake Chemical Corp / Lundin Mining Corp / Equity Residential / Regency Centers Corp / Celanese Corp / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Transcontinental Inc / Simon Property Group Inc / Host Hotels & Resorts Inc / CH Robinson Worldwide Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / First Majestic Silver Corp / Hochschild Mining PLC / LTC Properties Inc / National Health Investors Inc / Capstone Mining Corp / Lululemon Athletica Inc / TrueBlue Inc / Ulta Beauty Inc / Franco-Nevada Corp / Vale SA / Suncor Energy Inc / Merck & Co Inc / Dollarama Inc / Cenovus Energy Inc / Dollar General Corp / Capital Power Corp / LyondellBasell Industries NV / Vermilion Energy Inc / Baytex Energy Corp / Clearwater Paper Corp / ARC Resources Ltd / Enerplus Corp / Mosaic Co / Glencore PLC / PVH Corp / Ralph Lauren Corp / PhosAgro PAO / Pembina Pipeline Corp / Keyera Corp / Tourmaline Oil Corp / MAG Silver Corp / Westshore Terminals Investment Corp / Pebblebrook Hotel Trust / Athabasca Oil Corp / Sabra Health Care REIT Inc / Splunk Inc / TMX Group Ltd / Berry Global Group Inc / CyrusOne Inc / BRP Inc / Burlington Stores Inc / Brixmor Property Group Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Air Canada / Axalta Coating Systems Ltd / Chemours Co / WEC Energy Group Inc / Spin Master Corp / Sunrun Inc / Planet Fitness Inc / Ionis Pharmaceuticals Inc / Ingevity Corp / Ashland Global Holdings Inc / Park Hotels & Resorts Inc / TFI International Inc / Okta Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Nutrien Ltd / Zscaler Inc / ASGN Inc / Smartsheet Inc / Linde PLC / Capri Holdings Ltd / Element Solutions Inc / Dow Inc / Tronox Holdings PLC / TC Energy Corp / Cargojet Inc / Dupont De Nemours Inc / Revolve Group Inc / Amcor PLC / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Atlas Corp / Apartment Income REIT Corp / Atotech Ltd / Chesapeake Energy Corp / Decibel Therapeutics Inc / Abc Technologies Holdings Inc / UiPath Inc / Broadstone Net Lease Inc / Marvell Technology Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Ecovyst Inc / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Arteris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / United Kingdom / Ireland / Israel / Netherlands / Norway / Russian Federation / United States / Virgin Islands, British / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 11012210 / 71708110 / 00846U10 / 88162420 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 80105N10 / NOVO B / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Sanofi SA / Novo Nordisk A/S / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / ALLO / MBIO / RAD / WMT / GILD.O / EW / ONEM.O / ISRG / BMRN.O / REGN.O / VRTX.O / CYAD / SSNC.O / CCRN.O / CSTL.O / AMED.O / EXAS.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / ALNY.O / LHCG.O / TMDI / ENSG.O / 483548103 / MRNA.O / ADUS.O / GLAXOSM.LG / FATE.O / VBIV.O / INO.O / EVH / 100063846 / NVTA.K / 04280A100 / CRSP / CLLS.O / MTEM.O / VERU.O / 720795103 / MOTS.O / TMDX / DMTK.O / PNTG.O / HRMY.O / HGEN.O / VOR.O / 03823M100 / CRBU.O / ATXS.O</td><td class="leftalignment">Arcosa Inc / Allogene Therapeutics Inc / Mustang Bio Inc / Rite Aid Corp / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Intuitive Surgical Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Celyad Oncology SA / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Castle Biosciences Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Alnylam Pharmaceuticals Inc / LHC Group Inc / Titan Medical Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Fate Therapeutics Inc / VBI Vaccines Inc / Inovio Pharmaceuticals Inc / Evolent Health Inc / Truist Financial Corp / Invitae Corp / Arrowhead Pharmaceuticals Inc / CRISPR Therapeutics AG / Cellectis SA / Molecular Templates Inc / Veru Inc / Pieris Pharmaceuticals Inc / Motus GI Holdings Inc / Transmedics Group Inc / DermTech Inc / Pennant Group Inc / Harmony Biosciences Holdings Inc / Humanigen Inc / Vor Biopharma Inc / Applied Minerals Inc / Caribou Biosciences Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">KOL Call Starting in 30 Mins, We're Talking Lipids and Blockbuster Opportunity for New Lipids Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REMINDER: KOL Call on Prostate Cancer Landscape and Emerging Therapeutics at 10:00 AM ET on December 6th, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / AN=US / CACI=US / AMZN=US / T=US / BLD=US / PEB=US / H=US / CRM=US / V=US / MTN=US / HSII=US / VRM=US / EWBC=US / UMPQ=US / EXPE=US / LEG=US / LSTR=US / TNL=US / KFRC=US / VMC=US / CMCSA=US / W=US / DV=US / AIR=US / ARCC=US / AMN=US / SWIM=US / ATRO=US / BLL=US / B=US / CHH=US / CPRT=US / CW=US / DRH=US / DCO=US / EXPO=US / FCN=US / HEI=US / HXL=US / IBP=US / MAIN=US / MAS=US / MRCY=US / MHK=US / ASGN=US / ORCC=US / OI=US / PACW=US / REGN=US / SEE=US / SHOP=US / SFT=US / STRA=US / SNAP=US / TRIP=US / TGI=US / VSEC=US / WIX=US / MANT=US / BKNG=US / FB=US / MTCH=US / SPR=US / CATY=US / REG=US / AUTL=US / BCO=US / PTON=US / PRG=US / MOG.A=US / EXP=US / KAR=US / APP=US / AINV=US / HURN=US / SHO=US / BAH=US / AAWW=US / GMS=US / KBR=US / HST=US / MA=US / XPO=US / PGTI=US / SAIA=US / PAG=US / ICFI=US / SAIC=US / PNNT=US / IAA=US / WH=US / ATSG=US / PSN=US / TREX=US / HGV=US / WWD=US / RLJ=US / VAC=US / ANGI=US / LKQ=US / RHP=US / BERY=US / TILE=US / LDOS=US / FATE=US / NMIH=US / GOOGL=US / TSLX=US / ARCB=US / 70806A106 / BABA=US / AFMD=US / CMPR=US / BVH=US / GDDY=US / GSBD=US / BWXT=US / ZG=US / SQ=US / 82982L103 / GXO=US / PK=US / JELD=US / PLYA=US / CVNA=US / YEXT=US / SFIX=US / MAXR=US / SMAR=US / FTDR=US / ALLO=US / FSK=US / HARP=US / LYFT=US / UBER=US / GMAB=US / SPCE=US / BIGC=US / ABNB=US / CELU=US / VMEO=US / MNTV=US / SQSP=US / SNPO=US / 00152K101</td><td class="leftalignment">Albany International Corp / AutoNation Inc / CACI International Inc / Amazon.com Inc / AT&T Inc / TopBuild Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Heidrick & Struggles International Inc / Vroom Inc / East West Bancorp Inc / Umpqua Holdings Corp / Expedia Group Inc / Leggett & Platt Inc / Landstar System Inc / Travel + Leisure Co / Kforce Inc / Vulcan Materials Co / Comcast Corp / Wayfair Inc / DoubleVerify Holdings Inc / AAR Corp / Ares Capital Corp / AMN Healthcare Services Inc / Latham Group Inc / Astronics Corp / Ball Corp / Barnes Group Inc / Choice Hotels International Inc / Copart Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Exponent Inc / FTI Consulting Inc / HEICO Corp / Hexcel Corp / Installed Building Products Inc / Main Street Capital Corp / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / ASGN Inc / Owl Rock Capital Corp / O-I Glass Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Shopify Inc / Shift Technologies Inc / Strategic Education Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / VSE Corp / Wix.Com Ltd / ManTech International Corp / Booking Holdings Inc / Meta Platforms Inc / Match Group Inc / Spirit AeroSystems Holdings Inc / Cathay General Bancorp / Regency Centers Corp / Autolus Therapeutics PLC / Brinks Co / Peloton Interactive Inc / PROG Holdings Inc / Moog Inc / Eagle Materials Inc / KAR Auction Services Inc / Applovin Corp / Apollo Investment Corp / Huron Consulting Group Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Atlas Air Worldwide Holdings Inc / GMS Inc / KBR Inc / Host Hotels & Resorts Inc / Mastercard Inc / XPO Logistics Inc / PGT Innovations Inc / Saia Inc / Penske Automotive Group Inc / ICF International Inc / Science Applications International Corp / Pennantpark Investment Corp / IAA Inc / Wyndham Hotels & Resorts Inc / Air Transport Services Group Inc / Parsons Corp / Trex Company Inc / Hilton Grand Vacations Inc / Woodward Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / LKQ Corp / Ryman Hospitality Properties Inc / Berry Global Group Inc / Interface Inc / Leidos Holdings Inc / Fate Therapeutics Inc / NMI Holdings Inc / Alphabet Inc / Sixth Street Specialty Lending Inc / ArcBest Corp / PennantPark Floating Rate Capital Ltd / Alibaba Group Holding Ltd / Affimed NV / Cimpress PLC / Bluegreen Vacations Holding Corp / GoDaddy Inc / Goldman Sachs BDC Inc / BWX Technologies Inc / Zillow Group Inc / Block Inc / SiteOne Landscape Supply Inc / GXO Logistics Inc / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Carvana Co / Yext Inc / Stitch Fix Inc / Maxar Technologies Inc / Smartsheet Inc / Frontdoor Inc / Allogene Therapeutics Inc / FS KKR Capital Corp / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / Genmab A/S / Virgin Galactic Holdings Inc / Bigcommerce Holdings Inc / Airbnb Inc / Celularity Inc / Vimeo Inc / Momentive Global Inc / Squarespace Inc / Snap One Holdings Corp / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19 Omicron variant - First data from South Africa suggests immune escape likely</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / ROG.S / GSK.L / REGN.OQ / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Live@PSC: Recaps of Fireside Chats with ABBV, AMGN, BMRN and REGN</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ / ABBV.N / AMGN.OQ / BMRN.OQ / 031162100 / 09061G101 / 75886F107 / 00287Y109</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Abbvie Inc / Amgen Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Bleeding Continues - Third Straight Week of Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / BMY=US / IP=US / GILD=US / PEB=US / H=US / CRM=US / MTN=US / MAR=US / TNL=US / HLT=US / AKR=US / APH=US / CHH=US / CSTR=US / DRH=US / REGN=US / ROLL=US / VRTX=US / CVX=US / PSA=US / SPG=US / SNOW=US / SGMS=US / FBK=US / MTCH=US / SRC=US / AUTL=US / BRX=US / PNFP=US / IGMS=US / STRO=US / BIIB=US / EXR=US / BECN=US / SHO=US / PLAY=US / HST=US / WH=US / IAC=US / EPRT=US / HGV=US / RLJ=US / VAC=US / CUBE=US / SPLK=US / RHP=US / ABBV=US / FATE=US / 00770K202 / AFMD=US / BVH=US / NSA=US / EDIT=US / NTLA=US / PK=US / PLYA=US / OKTA=US / ALLO=US / ESTC=US / HARP=US / CRWD=US / GMAB=US / NCNO=US / CELU=US / DHT.UN=CA / REPX=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Bristol-Myers Squibb Co / International Paper Co / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Amphenol Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Public Storage / Simon Property Group Inc / Snowflake Inc. / Scientific Games Corp / FB Financial Corp / Match Group Inc / Spirit Realty Capital Inc / Autolus Therapeutics PLC / Brixmor Property Group Inc / Pinnacle Financial Partners Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Splunk Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Fate Therapeutics Inc / Aemetis Inc / Affimed NV / Bluegreen Vacations Holding Corp / National Storage Affiliates Trust / Editas Medicine Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / nCino Inc / Celularity Inc / Dri Healthcare Trust / Riley Exploration Permian Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: ASH Planner Highlights 200+ Datapoints Not To Be Missed + Late Breakers</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GILD=US / REGN=US / AUTL=US / IGMS=US / STRO=US / ABBV=US / FATE=US / AFMD=US / EDIT=US / NTLA=US / ALLO=US / HARP=US / GMAB=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Autolus Therapeutics PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Abbvie Inc / Fate Therapeutics Inc / Affimed NV / Editas Medicine Inc / Intellia Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Regeneron Pharmaceuticals Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 77 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / CVS.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / TGT.N / XL.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / HAE.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / REGN.OQ / BBBY.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / SCHW.N / EXPR.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / MGNX.OQ / BRX.N / LADR.N / TWOU.OQ / FGEN.OQ / ANTM.N / PFX.N / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Target Corp / XL Fleet Corp / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Haemonetics Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / Regeneron Pharmaceuticals Inc / Bed Bath & Beyond Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Charles Schwab Corp / Express Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Brixmor Property Group Inc / Ladder Capital Corp / 2U Inc / FibroGen Inc / Anthem Inc / PhenixFIN Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Sign Up for Hearty Fridays - KOL Call Series: 12/3 at 11:30am ET, We're Talking Lipids and Blockbuster Opportunity for New Lipids Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Dec. 01, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Big Biopharma Will Have $500Bn in Gross Cash to Deploy YE22 - Get Set for M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AZN / 71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron climbs 18.1% from 6 week low</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Oh My Oh My Omicron: Does the Latest Variant Spell the End of REGEN-COV?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / 09075V102 / 92764N102</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / BioNTech SE / Vir Biotechnology Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">64125C109 / 958102105 / 75886F107 / 640268108 / 30063P105 / 45337C102 / 45773H201 / 462222100 / 71639T106 / 92915B106 / 65343E108 / 84918M106</td><td class="leftalignment">Neurocrine Biosciences Inc / Western Digital Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Exact Sciences Corp / Incyte Corp / Inovio Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / PetIQ Inc / Voyager Therapeutics Inc / NextCure Inc / Sports Entertainment Acquisition Corp.</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Mark Miller / Mr. Bruce D. Jackson / Mike Hickey / Mr. John Lawrence / Mr. Michael P. Ward, CFA / Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Commentary Across Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">64125C109 / 75886F107 / 640268108 / 45337C102 / 45773H201 / 462222100 / 92915B106 / 65343E108</td><td class="leftalignment">Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Incyte Corp / Inovio Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Voyager Therapeutics Inc / NextCure Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Nov. 30, 2021 / 9:15AM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">REGN Confirms COVID Ab Cocktail May Be Less Effective Against Omicron</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ / US5324571083 / US7170811035 / US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EA / INTC.O / MSFT / QCOM.O / SONY / TTWO / GILD.O / ATVI.O / NVDA.O / HEAR / NFLX / REGN.O / AMED.O / SWKS.O / LHCG.O / 36467W109 / ENSG.O / MRNA.O / ZNGA / FDEV.L / 82655M107 / INO.O / QRVO.O / BILI.O / HUYA.K / 03823M100 / MYPS</td><td class="leftalignment">Electronic Arts Inc / Intel Corp / Microsoft Corp / Qualcomm Inc / Sony Group Corp / Take-Two Interactive Software Inc / Gilead Sciences Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Netflix Inc / Regeneron Pharmaceuticals Inc / Amedisys Inc / Skyworks Solutions Inc / LHC Group Inc / GameStop Corp / Ensign Group Inc / Moderna Inc / Zynga Inc / Frontier Developments PLC / Sify Technologies Ltd / Inovio Pharmaceuticals Inc / Qorvo Inc / Bilibili Inc / HUYA Inc / Applied Minerals Inc / Playstudios Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / United Kingdom / India / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Omicron COVID-19 Strain Adds Uncertainty Into Year-end</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / REGN.O / MRNA.O / INO.O / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Well-Positioned for Robust Prophylaxis and Post-Infection COVID-19 Antiviral Market; Upping PT to $200; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">92764N102 / REGN.OQ</td><td class="leftalignment">Vir Biotechnology Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - Key Questions for management ahead of R&D day</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NOVN.S / BMY.N / LLY.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / REGN.OQ / GILD.OQ / BAYGN.DE / MOLN.S</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Bayer AG / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">207940.KS: Samsung Biologics Co., Ltd. - A focused large-scale biologics specialist</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">207940.KS / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / 1177.HK / TEVA.TA / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / 005930.KS / 000100.KS / 008930.KS / SFZN.S / BIIB.OQ / 006280.KS / TEVA.N / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / 032830.KS / 128940.KS / ABBV.N / CTLT.N / 196170.KQ / 028260.KS / 2269.HK / 091990.KQ / 302440.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Sino Biopharmaceutical Ltd / Teva Pharmaceutical Industries Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Samsung Electronics Co Ltd / Yuhan Corp / Hanmi Science Co Ltd / Siegfried Holding AG / Biogen Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Samsung Life Insurance Co Ltd / Hanmi Pharm Co Ltd / Abbvie Inc / Catalent Inc / Alteogen Inc / Samsung C&T Corp / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Israel / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: GSK Aims for NASH; Baidu Buddies with Sanofi</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GSK.L / SASY.PA / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">US02553E1064 / US2441991054 / US25179M1036 / US3647601083 / US5324571083 / US6541061031 / US6556641008 / US7170811035 / US75886F1075 / US7782961038 / US8725401090 / US9170471026 / US9182041080 / CA1363851017 / US20825C1045 / US49446R1095 / US29476L1070 / US7588491032 / US8288061091 / US44107P1049 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / US63633D1046 / US5500211090 / US90384S3031 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA00208D4084 / CA2927661025 / US6936561009 / US7512121010 / CA89156V1067 / US70509V1008 / US78573L1061 / US23283R1005 / CA0266951064 / US1220171060 / US86771W1053 / US72703H1014 / US7005171050 / US8760301072 / US8608971078 / US63845R1077 / VGG1890L1076 / US76156B1070 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / US03750L1098 / US1651677353 / US24343R1068 / US11135E2037 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027</td><td class="leftalignment">American Eagle Outfitters Inc / Deere & Co / Devon Energy Corp / Gap Inc / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Canadian Natural Resources Ltd / Conocophillips / Kimco Realty Corp / Equity Residential / Regency Centers Corp / Simon Property Group Inc / Host Hotels & Resorts Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / National Health Investors Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / ARC Resources Ltd / Enerplus Corp / PVH Corp / Ralph Lauren Corp / Tourmaline Oil Corp / Pebblebrook Hotel Trust / Sabra Health Care REIT Inc / CyrusOne Inc / American Hotel Income Properties REIT LP / Burlington Stores Inc / Sunrun Inc / Planet Fitness Inc / Park Hotels & Resorts Inc / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Apartment Income REIT Corp / Chesapeake Energy Corp / Decibel Therapeutics Inc / Broadstone Net Lease Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AES.N / CVS.N / EIX.N / NEM.N / RTO.L / SO.N / T.N / TMX.N / AMGN.O / DUK.N / AGI.N / ENB.TO / SU.TO / PCG.N / AMT.N / CONE.O / NG.L / VZ.N / EXEL.O / XEL.N / DSGX.O / ADSK.O / REGN.O / SRG.MI / CPK.N / ROL.N / SGEN.OQ / RGLD.O / EQIX.O / DLR.N / VMW.N / AR.TO / NEE.N / NXT.AX / INFA.N / TMUS.N / BEP.N / AGIO.O / NEP.N / WBA.N / MESO.O / TWLO.N / NTNX.O / GDS.O / SAND.N / OKTA.OQ / WPM.N / ZS.OQ / ESTC.N / ZM.O / CRWD.O / GMAB.O / WTRG.N / LUMN.N / AEP.OQ / FLNC.OQ</td><td class="leftalignment">AES Corp / CVS Health Corp / Edison International / Newmont Corporation / Rentokil Initial PLC / Southern Co / AT&T Inc / Terminix Global Holdings Inc / Amgen Inc / Duke Energy Corp / Alamos Gold Inc / Enbridge Inc / Suncor Energy Inc / PG&E Corp / American Tower Corp / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Descartes Systems Group Inc / Autodesk Inc / Regeneron Pharmaceuticals Inc / Snam SpA / Chesapeake Utilities Corp / Rollins Inc / Seagen Inc / Royal Gold Inc / Equinix Inc / Digital Realty Trust Inc / VMware Inc / Argonaut Gold Inc / Nextera Energy Inc / NEXTDC Ltd / Informatica Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Nextera Energy Partners LP / Walgreens Boots Alliance Inc / Mesoblast Ltd / Twilio Inc / Nutanix Inc / GDS Holdings Ltd / Sandstorm Gold Ltd / Okta Inc / Wheaton Precious Metals Corp / Zscaler Inc / Elastic NV / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Essential Utilities Inc / Lumen Technologies Inc / American Electric Power Company Inc / Fluence Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Second Straight Week of Negative Biotech Fund Flows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/27/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates - Around the Horn</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US00287Y1091 / US64125C1099 / US75886F1075 / US09609G1004 / US45826J1051 / CH0334081137 / BMG637AM1024 / US45720L1070 / US20451W1018</td><td class="leftalignment">Abbvie Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Inhibrx Inc / Compass Pathways PLC</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/27/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/27/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">REGN: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O / SGEN.OQ / AGIO.O / MESO.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Agios Pharmaceuticals Inc / Mesoblast Ltd / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Omicron Variant: What We Know, What We Don’t, and the Impact on Our Coverage</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US5324571083 / US7170811035 / US75886F1075 / US58933Y1055</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Not to be Alarmist but Nu is Alarming – and Good for PFE and Other Incumbents</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">PFE.N / 71708110 / 75886F10 / 58933Y10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">Hong Kong / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALLO / AMGN / C.N / DE / ICE / INCY / NBIX / NKE / QCOM.O / RARE / SEIC / VCTR / GILD.O / TRIT / ALKS.O / SQ / ARNA.O / FDS.N / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NDAQ / NKTR / LIFE.O / MSTR.O / PHAR.O / BIIB / MNKD.O / SPGI / ACAD.O / ALNY.O / COIN / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / CBOE.K / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Citigroup Inc / Deere & Co / Intercontinental Exchange Inc / Incyte Corp / Neurocrine Biosciences Inc / Nike Inc / Qualcomm Inc / Ultragenyx Pharmaceutical Inc / SEI Investments Co / Victory Capital Holdings Inc / Gilead Sciences Inc / Triterras Inc / Alkermes Plc / Block Inc / Arena Pharmaceuticals Inc / Factset Research Systems Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nasdaq Inc / Nektar Therapeutics / aTyr Pharma Inc / Microstrategy Inc / Pharming Group NV / Biogen Inc / MannKind Corp / S&P Global Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Coinbase Global Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Cboe Global Markets Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Cayman Islands / France / Ireland / Netherlands / El Salvador / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-3Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ALLO / AMGN / INCY / NBIX / RARE / GILD.O / ALKS.O / ARNA.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NKTR / LIFE.O / PHAR.O / BIIB / MNKD.O / ACAD.O / ALNY.O / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / Gilead Sciences Inc / Alkermes Plc / Arena Pharmaceuticals Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / aTyr Pharma Inc / Pharming Group NV / Biogen Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: Initial thoughts on new variant B.1.1.529; Delta displacement concerning</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / ROG.S / GSK.L / REGN.OQ</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AU.N / AXP.N / BAC.N / BB.N / BCE.TO / BK.N / C.N / COF.N / CVS.N / ELE.MC / FITB.O / JPM.N / KEY.N / NEM.N / NTRS.O / PB.N / PNC.N / T.TO / USB.N / WFC.N / ZION.O / CMA.N / GILD.O / FNV.N / INCY.O / CLS.N / AGI.N / DIS.N / HBAN.O / DT.N / GS.N / AEM.N / ENEI.MI / ADCT.N / KGC.N / JAZZ.O / SGMO.O / STT.N / AKAM.O / PACW.O / DSGX.O / EFX.N / FISV.O / ADSK.O / ACN.N / EXPE.O / WSP.TO / MTB.N / OTEX.O / REGN.O / CVX.N / MCO.N / NCR.N / NET.N / GFI.N / RF.N / CFR.N / CDE.N / FRC.N / HL.N / DFS.N / ADS.N / SGEN.OQ / GPN.N / FFBC.O / IMGN.O / RGLD.O / SIVB.O / BLUE.O / BPOP.O / BOKF.O / COLB.O / WTFC.O / PAAS.O / TCBI.O / STN.TO / GOLD.N / SNC.TO / TFC.N / DPM.TO / FHN.N / EDV.TO / CG.TO / IAU.TO / DLR.N / EDR.N / IAG.N / WAL.N / ALNY.O / MS.N / FIS.N / HICL.L / AUY.N / VMW.N / OSK.TO / NGD.A / HOMB.O / EGO.N / SBB.TO / FTNT.O / AR.TO / TXG.TO / SIL.TO / MOZ.TO / ANGI.OQ / SLM.OQ / PANW.N / ALLY.N / TMUS.N / PRTA.O / DOC.N / AGIO.O / ONB.OQ / 81762P102 / WIX.O / KPTI.O / XNCR.OQ / BTG.N / SYF.N / KXS.TO / CFG.N / GWB.N / ASB.N / WBA.N / 03835T200 / GBT.OQ / MESO.O / EDIT.O / SPGI.N / NTLA.O / OR.N / NTNX.O / SAND.N / CVNA.N / WPM.N / SSRM.O / KL.N / ATNX.O / CARG.O / BKNG.O / DBX.O / ALLO.OQ / GMDA.OQ / LYFT.O / UBER.N / FSLY.N / FVRR.N / GMAB.O / DDOG.O / APRE.OQ / CRNC.OQ / IGMS.O / NLOK.O / EGLX.TO / BEAM.O / PLRX.OQ / FOUR.N / NRIX.OQ / JAMF.O / GATO.N / ABNB.OQ / DASH.N / LSPD.N / CLVT.N / BMBL.OQ / AFRM.O / COUR.N / MAGT.TO / SQSP.N / TFPM.TO / FLYW.O / FA.OQ / TRMR.OQ / ZD.OQ / 12740C103</td><td class="leftalignment">AngloGold Ashanti Ltd / American Express Co / Bank of America Corp / BlackBerry Ltd / BCE Inc / Bank of New York Mellon Corp / Citigroup Inc / Capital One Financial Corp / CVS Health Corp / Endesa SA / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Newmont Corporation / Northern Trust Corp / Prosperity Bancshares Inc / PNC Financial Services Group Inc / Telus Corp / US Bancorp / Wells Fargo & Co / Zions Bancorporation NA / Comerica Inc / Gilead Sciences Inc / Franco-Nevada Corp / Incyte Corp / Celestica Inc / Alamos Gold Inc / Walt Disney Co / Huntington Bancshares Inc / Dynatrace Inc / Goldman Sachs Group Inc / Agnico Eagle Mines Ltd / Enel SpA / ADC Therapeutics SA / Kinross Gold Corp / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / State Street Corp / Akamai Technologies Inc / PacWest Bancorp / Descartes Systems Group Inc / Equifax Inc / Fiserv Inc / Autodesk Inc / Accenture PLC / Expedia Group Inc / WSP Global Inc / M&T Bank Corp / Open Text Corp / Regeneron Pharmaceuticals Inc / Chevron Corp / Moody's Corp / NCR Corp / Cloudflare Inc / Gold Fields Ltd / Regions Financial Corp / Cullen/Frost Bankers Inc / Coeur Mining Inc / First Republic Bank / Hecla Mining Co / Discover Financial Services / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / First Financial Bancorp / ImmunoGen Inc / Royal Gold Inc / SVB Financial Group / bluebird bio Inc / Popular Inc / BOK Financial Corp / Columbia Banking System Inc / Wintrust Financial Corp / Pan American Silver Corp / Texas Capital Bancshares Inc / Stantec Inc / Barrick Gold Corp / SNC-Lavalin Group Inc / Truist Financial Corp / Dundee Precious Metals Inc / First Horizon Corp / Endeavour Mining PLC / Centerra Gold Inc / I-80 Gold Corp / Digital Realty Trust Inc / Endeavor Group Holdings Inc / IAMGOLD Corp / Western Alliance Bancorp / Alnylam Pharmaceuticals Inc / Morgan Stanley / Fidelity National Information Services Inc / HICL Infrastructure PLC / Yamana Gold Inc / VMware Inc / Osisko Mining Inc / New Gold Inc / Home BancShares Inc / Eldorado Gold Corp / Sabina Gold & Silver Corp / Fortinet Inc / Argonaut Gold Inc / Torex Gold Resources Inc / Silvercrest Metals Inc / Marathon Gold Corp / Angi Inc / SLM Corp / Palo Alto Networks Inc / Ally Financial Inc / T-Mobile US Inc / Prothena Corporation PLC / Physicians Realty Trust / Agios Pharmaceuticals Inc / Old National Bancorp / ServiceNow Inc / Wix.Com Ltd / Karyopharm Therapeutics Inc / Xencor Inc / B2Gold Corp / Synchrony Financial / Kinaxis Inc / Citizens Financial Group Inc / Great Western Bancorp Inc / Associated Banc-Corp / Walgreens Boots Alliance Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Mesoblast Ltd / Editas Medicine Inc / S&P Global Inc / Intellia Therapeutics Inc / Osisko Gold Royalties Ltd / Nutanix Inc / Sandstorm Gold Ltd / Carvana Co / Wheaton Precious Metals Corp / SSR Mining Inc / Kirkland Lake Gold Ltd / Athenex Inc / CarGurus Inc / Booking Holdings Inc / Dropbox Inc / Allogene Therapeutics Inc / Gamida Cell Ltd / Lyft Inc / Uber Technologies Inc / Fastly Inc / Fiverr International Ltd / Genmab A/S / Datadog Inc / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / NortonLifeLock Inc / Enthusiast Gaming Holdings Inc / Beam Therapeutics Inc / Pliant Therapeutics Inc / Shift4 Payments Inc / Nurix Therapeutics Inc / Jamf Holding Corp / Gatos Silver Inc / Airbnb Inc / DoorDash Inc / Lightspeed Commerce Inc / CLARIVATE PLC / Bumble Inc / Affirm Holdings Inc / Coursera Inc / Magnet Forensics Inc / Squarespace Inc / Triple Flag Precious Metals Corp / Flywire Corp / First Advantage Corp / Tremor International Ltd / Ziff Davis Inc / Cadence Bank</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Puerto Rico / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Recent Developments Reaffirm Our Enthusiasm for Regeneron; Reiterate Buy Rating and $844 PT</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / 02043Q107 / 04280A100 / DBTX.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Decibel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Germany / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Kuwait / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Poland / Russian Federation / Saudi Arabia / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / Vietnam / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: ASH 2021 Planner</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GILD.O / INCY.O / ADCT.N / JAZZ.O / SGMO.O / REGN.O / SGEN.OQ / IMGN.O / BLUE.O / ALNY.O / PRTA.O / AGIO.O / KPTI.O / XNCR.OQ / 03835T200 / GBT.OQ / EDIT.O / NTLA.O / ATNX.O / ALLO.OQ / GMDA.OQ / GMAB.O / APRE.OQ / IGMS.O / BEAM.O / NRIX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / ADC Therapeutics SA / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / bluebird bio Inc / Alnylam Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Athenex Inc / Allogene Therapeutics Inc / Gamida Cell Ltd / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / Beam Therapeutics Inc / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Germany / Denmark / Spain / United Kingdom / Georgia / India / Ireland / Israel / Italy / Lao People's Democratic Republic / Malaysia / Nigeria / Poland / Russian Federation / Turkey / United States / Vietnam / Serbia</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Gregory J. Renza, MD / Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Luca Issi, PHD / Yinglu Zhang / Leonid Timashev / Stephen Mallon / Jackie Yan / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ASH 2021 Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">375558103 / 031162100 / 75886F107 / 02043Q107 / 45253H101 / 00287Y109 / 03835T200 / 31189P102 / 09627Y109 / 462260100 / 98401F105 / 41358P106 / 37890U108 / 04016X101 / 87184Q107 / 869367102 / 44975P103 / 64049K104 / 65343E108 / 492327101 / 359616109 / 80810D103 / 74366E102 / 00166B105 / 04335A105 / 46565G104 / 501575104 / 14147L108 / 67080M103 / 73730P108 / 81181C104 / 019818103 / 50107A104 / M47364100 / 03835L207 / 19240Q201 / 38406L103 / 45256X103 / 75082Q105 / 15673T100</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / ImmunoGen Inc / Abbvie Inc / Aptose Biosciences Inc / Fate Therapeutics Inc / Blueprint Medicines Corp / Iovance Biotherapeutics Inc / Xencor Inc / Harpoon Therapeutics Inc / Global Blood Therapeutics Inc / argenx SE / Syros Pharmaceuticals Inc / Sutro Biopharma Inc / I-Mab / Neoleukin Therapeutics Inc / NextCure Inc / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Schrodinger Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Arvinas Inc / Iteos Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Seagen Inc / Allovir Inc / Kronos Bio Inc / Gamida Cell Ltd / Aptevo Therapeutics Inc / Cogent Biosciences Inc / Gracell Biotechnologies Inc / Immunitybio Inc / Rain Therapeutics Inc / Century Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Cayman Islands / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Do G. Kim / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZIVO-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ZIVO.O / REGN.O / BRLI.O / PRPH.O / IAGX.PK</td><td class="leftalignment">Zivo Bioscience Inc / Regeneron Pharmaceuticals Inc / Brilliant Acquisition Corp / Prophase Labs Inc / Imagenetix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Phase I Study for NTLA-2001 Expands to Include ATTR Amyloidosis With Cardiomyopathy (ATTR-CM) Patients</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NTLA.OQ / REGN.OQ</td><td class="leftalignment">Intellia Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Strategic Collaboration Continues to Strengthen Gene Therapy Pipeline Ahead of DB-OTO's IND</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">DBTX.OQ / REGN.OQ</td><td class="leftalignment">Decibel Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Emanuela Branchetti, Ph.D., PHD / Joseph Pantginis, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Novo Nordisk Nabs DRNA; Danon Data from RCKT</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">RCKT.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Rocket Pharmaceuticals Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">R&D Day Reveal; Alnylam-Regeneron Partner in ALS and Glaucoma; Reiterate Buy and $844 PT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.OQ / 02043Q107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / CB.N / CL.N / CVS.N / EIX.N / F.N / FMS.N / FSR.N / GM.N / SO.N / T.N / VC.N / TCN.N / WY.N / CFP.TO / TEN.N / DUK.N / BWA.N / LEA.N / D.N / PNM.N / DT.N / DISH.O / PCG.N / ENEI.MI / EPC.N / AMT.N / CONE.O / VZ.N / CYH.N / XEL.N / ARNA.O / STZ.N / LNC.N / APH.N / DVA.N / ADSK.O / V.N / AXL.N / AJG.N / BMRN.O / REGN.O / PRU.N / NCR.N / TEL.N / GFI.N / CPK.N / ST.N / AMH.N / PLUG.OQ / GPN.N / MNST.O / IMGN.O / ACGL.O / PAAS.O / EQIX.O / DPM.TO / EDV.TO / DLR.N / 416515104 / WEF.TO / WAL.N / ALNY.O / FIS.N / MA.N / 443628102 / AON.N / VMW.N / DAN.N / NEE.N / NXT.AX / PCH.O / MTOR.N / SPLK.OQ / RFP.N / PANW.N / FFHu.TO / BERY.N / INFA.N / TSLA.N / TMUS.N / BEP.N / AGIO.O / CFF.TO / XNCR.OQ / NEP.N / MESO.O / ADNT.N / GDS.O / INVH.N / ORSTED.CO / APTV.N / VNE.N / NTGY.MC / GMAB.O / DDOG.O / CRNC.OQ / WTRG.N / NKLA.OQ / FOUR.N / NRIX.OQ / LUMN.N / BSY.O / GATO.N / RIDE.OQ / MAX.N / LSPD.N / WFG.N / AFRM.O / TSP.OQ / AVAH.OQ / TFPM.TO / FLYW.O / RYAN.N / FLNC.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Colgate-Palmolive Co / CVS Health Corp / Edison International / Ford Motor Co / Fresenius Medical Care AG & Co KGaA / Fisker Inc / General Motors Co / Southern Co / AT&T Inc / Visteon Corp / Tricon Residential Inc / Weyerhaeuser Co / Canfor Corp / Tenneco Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Dominion Energy Inc / PNM Resources Inc / Dynatrace Inc / DISH Network Corp / PG&E Corp / Enel SpA / Edgewell Personal Care Co / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / Community Health Systems Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / DaVita Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Gold Fields Ltd / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / American Homes 4 Rent / Plug Power Inc / Global Payments Inc / Monster Beverage Corp / ImmunoGen Inc / Arch Capital Group Ltd / Pan American Silver Corp / Equinix Inc / Dundee Precious Metals Inc / Endeavour Mining PLC / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Western Forest Products Inc / Western Alliance Bancorp / Alnylam Pharmaceuticals Inc / Fidelity National Information Services Inc / Mastercard Inc / Hudbay Minerals Inc / Aon PLC / VMware Inc / Dana Inc / Nextera Energy Inc / NEXTDC Ltd / Potlatchdeltic Corp / Meritor Inc / Splunk Inc / Resolute Forest Products Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Berry Global Group Inc / Informatica Inc / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Conifex Timber Inc / Xencor Inc / Nextera Energy Partners LP / Mesoblast Ltd / Adient PLC / GDS Holdings Ltd / Invitation Homes Inc / Orsted A/S / Aptiv PLC / Veoneer Inc / Naturgy Energy Group SA / Genmab A/S / Datadog Inc / Cerence Inc / Essential Utilities Inc / Nikola Corp / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / Bentley Systems Inc / Gatos Silver Inc / Lordstown Motors Corp / Mediaalpha Inc / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / TuSimple Holdings Inc / Aveanna Healthcare Holdings Inc / Triple Flag Precious Metals Corp / Flywire Corp / Ryan Specialty Group Holdings Inc / Fluence Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Italy / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Nov 12: Focus on Tagrisso</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/20/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates - Around the Horn</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US00287Y1091 / US09061G1013 / US75886F1075 / US02043Q1076 / US4277461020 / US23257D1037 / US04351P1012 / US24823R1059 / US5011471027 / US6047491013 / US20451W1018 / US81181C1045 / US92790C1045 / US45114M1099 / US23345J1043</td><td class="leftalignment">Abbvie Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Heron Therapeutics Inc / Cymabay Therapeutics Inc / Ascendis Pharma A/S / Denali Therapeutics Inc / Krystal Biotech Inc / Mirum Pharmaceuticals Inc / Compass Pathways PLC / Seagen Inc / Viridian Therapeutics Inc / Icosavax Inc / Dice Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARNA.O / BMRN.O / REGN.O / IMGN.O / AGIO.O / MESO.O / GMAB.O / NRIX.OQ</td><td class="leftalignment">Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / ImmunoGen Inc / Agios Pharmaceuticals Inc / Mesoblast Ltd / Genmab A/S / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 12 to 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / US8336351056 / GB0000456144 / US0311621009 / US0341641035 / US0351282068 / US0383361039 / US0394831020 / US0530151036 / US1101221083 / US1564311082 / US1924461023 / US2017231034 / US2310211063 / US3755581036 / US38059T1060 / US4227041062 / US45337C1027 / US4891701009 / US5324571083 / US64125C1099 / US6516391066 / US6703461052 / US67066G1040 / US7170811035 / US75886F1075 / US7782961038 / US7802871084 / US8581191009 / US87612E1064 / US9024941034 / US92532F1003 / US9311421039 / CA13321L1085 / CA59162N1096 / CA5394811015 / CA4296951094 / CA9611485090 / CA85472N1096 / CA90457D1006 / CA4609191032 / CA5649051078 / CA6979001089 / CA78460T1057 / CA8787422044 / CA0679011084 / US9129091081 / CA3039011026 / CA1349211054 / CA8765111064 / US0017441017 / CA3359341052 / CA09950M3003 / CA00762V1094 / US2274831047 / US35671D8570 / AU000000FMG4 / US09062X1037 / BMG169621056 / US20451N1019 / CA98462Y1007 / CA56501R1064 / CA4969024047 / CA5503721063 / CA4436281022 / US1011211018 / CA6445351068 / CA95083R1001 / CA0906971035 / US8666741041 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA0966311064 / CA29258Y1034 / CA4369131079 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / BMG162521014 / US00507V1098 / GB00B2QPKJ12 / CA86828P1036 / US91912E1055 / US1921085049 / IE00B4BNMY34 / US58933Y1055 / CA07317Q1054 / CA00208D4084 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US74340W1036 / US95058W1009 / CA54928Q1081 / CA00829Q1019 / AU000000EVN4 / JE00B5TT1872 / US09609G1004 / US98138H1014 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA6674951059 / CA04682R1073 / US16208T1025 / CA89531J1093 / GB00B11DNM70 / US29355A1079 / US8486371045 / US6974351057 / US08579W1036 / CA5054401073 / US23283R1005 / CA33812R1091 / US60468T1051 / CA46579R1047 / CA65340P1062 / US31189P1021 / US03674X1063 / US11120U1051 / CA92938W2022 / CA68827L1013 / CA30606C1086 / CA5503711080 / US29444U7000 / CA74273V1067 / CA82621K1021 / AU000000S320 / CA0115321089 / CA83179X1087 / CA83125J1049 / CA05329M1041 / US72703H1014 / CA8283631015 / CY0106002112 / CA19239C1068 / AU000000NST8 / CA17040T3001 / CA4991131083 / CA6882811046 / CA8910546032 / US5588681057 / CA31730E1016 / CA89621C1059 / US0441861046 / US15136A1025 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA75601Y1007 / CA9628791027 / CY0103562118 / CA7847301032 / CA15713J1049 / CA53680Q2071 / US68404V1008 / LU1701428291 / CA2960061091 / CA8585221051 / CA46136U1030 / US00191U1025 / US3843135084 / US76029N1063 / US08579X1019 / KYG370921069 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA7426943006 / CA33767E2024 / CA57776F4050 / US26614N1028 / CA5625684025 / CA48086P1009 / US2681501092 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / MHY0436Q1098 / CA4220961078 / CA3901437093 / CA36352H1001 / US6544051096 / US03940R1077 / CA70137W1086 / US44862P1093 / US05478C1053 / US7501021056 / CA33843T1084 / CA9004352071 / US3680361090 / CA64782A1075 / US87969B1017 / US03750L1098 / CA36261G1028 / CA65401N1078 / US11135E2037 / CA55292X1087 / AU0000143729 / US00848J1043 / US05356F1057 / CA53227W1059 / CA65532M6062 / CA00791P1071 / CA24874B1085 / GB00BL6K5J42 / CA66979W8429 / US45828L1089 / US0708301041 / US9264001028 / US98955K1043 / US89269P1030 / US9778521024 / US4718711033 / US1374041093 / 116833187</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Sociedad Quimica y Minera de Chile SA / Antofagasta PLC / Amgen Inc / Andersons Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Bristol-Myers Squibb Co / Century Aluminum Co / Cognizant Technology Solutions Corp / Commercial Metals Co / Cummins Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Incyte Corp / Kennametal Inc / Eli Lilly and Co / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / NVIDIA Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / Target Corp / Tyson Foods Inc / Vertex Pharmaceuticals Inc / Walmart Inc / Cameco Corp / Metro Inc / Loblaw Companies Ltd / High Liner Foods Inc / George Weston Ltd / Stantec Inc / Uni-Select Inc / Intertape Polymer Group Inc / Maple Leaf Foods Inc / Pan American Silver Corp / SNC-Lavalin Group Inc / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Canadian Apartment Properties Real Estate Investment Trust / Taseko Mines Ltd / AMN Healthcare Services Inc / First Quantum Minerals Ltd / Boralex Inc / Aecon Group Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Bunge Ltd / Compass Minerals International Inc / Yamana Gold Inc / Manulife Financial Corp / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / Boston Properties Inc / New Gold Inc / Wesdome Gold Mines Ltd / Birchcliff Energy Ltd / Sun Communities Inc / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Home Capital Group Inc / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Brookfield Infrastructure Partners LP / Activision Blizzard Inc / Fresnillo PLC / Superior Plus Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Merck & Co Inc / Baytex Energy Corp / ARC Resources Ltd / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / Prologis Inc / Wendys Co / Lucara Diamond Corp / Africa Oil Corp / Evolution Mining Ltd / Centamin PLC / bluebird bio Inc / Workday Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Athabasca Oil Corp / Chatham Lodging Trust / Trevali Mining Corp / Horizonte Minerals PLC / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / CyrusOne Inc / Fission Uranium Corp / Mirati Therapeutics Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Fate Therapeutics Inc / Antero Resources Corp / Brixmor Property Group Inc / WSP Global Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Equinix Inc / Probe Metals Inc / Sienna Senior Living Inc / South32 Ltd / Alamos Gold Inc / SmartCentres Real Estate Investment Trust / Sleep Country Canada Holdings Inc / Automotive Properties Real Estate Investment Trust / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Cogeco Communications Inc / Northern Star Resources Ltd / Chorus Aviation Inc / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Filo Mining Corp / Trilogy Metals Inc / Ashland Global Holdings Inc / Centennial Resource Development Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Real Matters Inc / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / CES Energy Solutions Corp / Lithium Americas Corp / OptiNose Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / Invesque Inc / ASGN Inc / GrafTech International Ltd / Replimune Group Inc / Berry Corporation (Bry) / Galaxy Digital Holdings Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / FirstService Corp / Maverix Metals Inc / Dupont De Nemours Inc / Mandalay Resources Corp / Josemaria Resources Inc / Dynatrace Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Atlas Corp / Headwater Exploration Inc / Great Bear Resources Ltd / Galiano Gold Inc / 9 Meters Biopharma Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Azek Company Inc / Rackspace Technology Inc / Flagship Communities Real Estate Investment Trust / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Telos Corp / Apartment Income REIT Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Broadstone Net Lease Inc / MDA Ltd / Sunrise Energy Metals Ltd / Agiliti Inc / Aveanna Healthcare Holdings Inc / LifeWorks Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Endeavour Mining PLC / Nouveau Monde Graphite Inc / Integral Ad Science Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co / Zevia PBC / Traeger Inc / Wolfspeed Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc / NextSource Materials Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Chile / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">406216101 / 806857108 / 75886F107 / 78709Y105 / 404251100 / 600544100 / 858155203 / 192005106 / 01609W102 / 530307107 / 92763W103 / 47215P106 / 05722G100 / 09075G105 / G48833118</td><td class="leftalignment">Halliburton Co / Schlumberger NV / Regeneron Pharmaceuticals Inc / Saia Inc / HNI Corp / MillerKnoll Inc / Steelcase Inc / Codexis Inc / Alibaba Group Holding Ltd / Liberty Broadband Corp / Vipshop Holdings Ltd / JD.Com Inc / Baker Hughes Co / Biofrontera AG / Weatherford International PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ms. Fawne Jiang / Long Lin / Mr. Aydin Huseynov, MD / Mr. Douglas L. Becker / Mr. Matthew Harrigan / Mr. Christopher Kuhn / Mr. Robert M. Wasserman / Mr. Bruce D. Jackson / Mr. Reuben Garner</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Share Buyback Seems To Be A Chess Deflection Game; M&A Is A More Viable Value Creation</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US8336351056 / US0311621009 / US0383361039 / US1101221083 / US1270971039 / US1924461023 / US25179M1036 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US5324571083 / US64125C1099 / US6745991058 / US7170811035 / US7237871071 / US75281A1097 / US75886F1075 / US7782961038 / AN8068571086 / US81211K1007 / US89531P1057 / US92532F1003 / CA9611485090 / US1667641005 / US5658491064 / US20825C1045 / US09062X1037 / US42809H1077 / US58933Y1055 / US09609G1004 / US98138H1014 / US34964C1062 / US6974351057 / US08579W1036 / US60468T1051 / US03674X1063 / US2057683029 / GB00BDSFG982 / US87484T1088 / US26614N1028 / US69047Q1022 / US05478C1053 / CA33843T1084 / US62955J1034 / US1651677353 / US45828L1089 / US1374041093</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / Coterra Energy Inc / Cognizant Technology Solutions Corp / Devon Energy Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Schlumberger NV / Sealed Air Corp / Trex Company Inc / Vertex Pharmaceuticals Inc / George Weston Ltd / Chevron Corp / Marathon Oil Corp / Conocophillips / Biogen Inc / Hess Corp / Merck & Co Inc / bluebird bio Inc / Workday Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Berry Global Group Inc / Mirati Therapeutics Inc / Antero Resources Corp / Comstock Resources Inc / TechnipFMC PLC / Talos Energy Inc / Dupont De Nemours Inc / Ovintiv Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Nov Inc / Chesapeake Energy Corp / Integral Ad Science Holding Corp / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">A Swing and a Miss - Biotech Fund Flows Turn Negative</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Bullish on BioPharma as We Emerge From COVID-19: Finding Alpha in the Sector That Saved the World</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, November 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US75886F1075 / 640268108 / 125919308 / 453204109 / 23256X100 / 888787108 / 54948X109</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Nektar Therapeutics / CPI Aerostructures Inc / Impinj Inc / Cybin Inc / Toast Inc / Lucid Diagnostics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">ASH preview: REGN5468 high dose cohorts response rate interesting</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Next-Gen Interleukin Primer - Cranking Up the Thermostat as Winter Weather Approaches</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2457864 / 2471950 / 2730190 / 7103065 / 2982924 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BMC5RV6 / BF3NP05 / BMDJ397 / BN2RM92 / BLF0CW7 / BP7KZP7 / BMW5084 / BNLYJ60 / BNLYBF3 / BMVBZF5 / BP2P6L0 / BMV6Y64</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Spectrum Pharmaceuticals Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / PMV Pharmaceuticals Inc / Imago BioSciences Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - COVID DARPin shows no benefit in hospitalised patients. Ambulatory data due 1Q22</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MOLN.S / AMGN.OQ / REGN.OQ</td><td class="leftalignment">Molecular Partners AG / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 5, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: AAVIATE Safety OK, Waiting for Liftoff</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">OXY=US / RRC=US / GBT=US / WEN=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / MRO=US / TTWO=US / SEIC=US / ATVI=US / FLO=US / AMN=US / PATH=US / ARRY=US / CTRA=US / COLL=US / CNX=US / EQT=US / GPOR=US / REGN=US / ROLL=US / SSNC=US / WGO=US / CVX=US / CGEN=US / BKNG=US / COP=US / BDSI=US / IGMS=US / JRVR=US / CLR=US / NOG=US / OLO=US / AR=US / OAS=US / ESTE=US / ZNGA=US / EA=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / VNOM=US / AFMD=US / CIVI=US / WBA=US / GDDY=US / EVBG=US / CDEV=US / SBOW=US / IOVA=US / SMAR=US / CYCN=US / NXTC=US / GMAB=US / OVV=US / ROCC=US / RBLX=US / REPX=US / EWCZ=US</td><td class="leftalignment">Occidental Petroleum Corp / Range Resources Corp / Global Blood Therapeutics Inc / Wendys Co / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Take-Two Interactive Software Inc / SEI Investments Co / Activision Blizzard Inc / Flowers Foods Inc / AMN Healthcare Services Inc / UiPath Inc / Array Technologies Inc / Coterra Energy Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / EQT Corp / Gulfport Energy Corp / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / SS&C Technologies Holdings Inc / Winnebago Industries Inc / Chevron Corp / Compugen Ltd / Booking Holdings Inc / Conocophillips / BioDelivery Sciences International Inc / IGM Biosciences Inc / James River Group Holdings Ltd / Continental Resources Inc / Northern Oil and Gas Inc / Olo Inc / Antero Resources Corp / Oasis Petroleum Inc / Earthstone Energy Inc / Zynga Inc / Electronic Arts Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Viper Energy Partners LP / Affimed NV / Civitas Resources Inc / Walgreens Boots Alliance Inc / GoDaddy Inc / Everbridge Inc / Centennial Resource Development Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Smartsheet Inc / Cyclerion Therapeutics Inc / NextCure Inc / Genmab A/S / Ovintiv Inc / Ranger Oil Corp / Roblox Corp / Riley Exploration Permian Inc / European Wax Center Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CD28 Costims Highlighted at SITC – REGN Leading the Charge and Hedging on 4-1BB</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">75886F10 / 98401F10 / F5548N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Xencor Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">0989529 / 2681511 / 2000019 / 2045623 / 2065159 / 2113434 / 2270726 / 2317087 / 2471950 / 2684703 / 2048804 / 2730190 / 2181334 / 2857817 / B125XQ6 / B02R1L6 / B5B2106 / B7TL820 / B4MG4Z6 / B7VD3F2 / B95N910 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BK1KWF7 / BD9GVY0 / BDHF4K6 / BHC8X90 / BKS3SM8 / BZ00V34 / BGCYWN8 / BWFKZT2 / BFZ1K46 / BLGJ610 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BD6D4Y5 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BWY4XV3 / BDD1B07 / BMDCDP2 / BMPRZV5 / BMC5RV6 / BLBLMD5 / BMDJ397 / BMZ9Z11 / BNTB3N8 / BKPGJQ1 / BMW5084 / BM8NHS1 / BNV0RN1 / BMHRMK1</td><td class="leftalignment">AstraZeneca PLC / PepsiCo Inc / Amazon.com Inc / ANSYS Inc / Autodesk Inc / Boston Scientific Corp / Walt Disney Co / Entergy Corp / Incyte Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Check Point Software Technologies Ltd / Netflix Inc / Portland General Electric Co / ALLETE Inc / Fortinet Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / PTC Inc / Twitter Inc / Wix.Com Ltd / Shopify Inc / Grocery Outlet Holding Corp / Zai Lab Ltd / CRISPR Therapeutics AG / Novo Nordisk A/S / IGM Biosciences Inc / Zscaler Inc / Xencor Inc / Cellectis SA / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Spire Inc / ViacomCBS Inc / Altair Engineering Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / Adaptimmune Therapeutics PLC / Rubius Therapeutics Inc / Bigcommerce Holdings Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Array Technologies Inc / Bolt Biotherapeutics Inc / Prometheus Biosciences Inc / Vizio Holding Corp / Squarespace Inc / PMV Pharmaceuticals Inc / Adagio Therapeutics Inc / Portillos Inc / Vita Coco Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">3Q21 Results; Late Stage Clinical Trial Data on Track for 4Q21 or 1Q22; Pipeline Expansion on Track for 4Q21</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALLK.OQ / REGN.OQ</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CL.N / CP.TO / EDP.LS / EOG.N / F.N / FSR.N / GM.N / MSFT.O / NA / NSC.N / PFE.N / T.N / VC.N / PXD.N / GILD.O / TEN.N / WLL.N / AMGN.O / INCY.O / THC.N / FER.MC / CNR.TO / DUK.N / BWA.N / LEA.N / FE.N / DISH.O / CSX.N / UNP.N / NICE.O / DV.N / MRO.N / PCG.N / PAA.N / DVN.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / MTG.N / RDN.N / VZ.N / LNC.N / APH.N / RRC.N / EQT.N / V.N / OKE.N / AXL.N / AWK.N / IG.MI / EPAY.O / AJG.N / REGN.O / VRTX.O / SRG.MI / PRU.N / SM.N / TEL.N / GFI.N / COP.N / CPE.N / ST.N / SWN.N / SR.N / CRC.N / PEGA.OQ / PLUG.OQ / GPN.N / LIFE.O / CASY.O / ACGL.O / PAAS.O / EQIX.O / ATDb.TO / BIIB.O / DPM.TO / EDV.TO / TRN.MI / DLR.N / ACAD.O / 416515104 / FIS.N / CCOI.O / MA.N / EHTH.O / AON.N / CLR.N / DAN.N / NOG.A / EDPR.LS / PHR.N / PKI.TO / MSP.N / MTOR.N / MTDR.N / SRPT.O / PANW.N / FFHu.TO / FANG.O / ABBV.N / KPT.TO / TSLA.N / TMUS.N / PTCT.O / 81762P102 / ESNT.N / XNCR.OQ / ITCI.O / SAGE.OQ / HQY.OQ / NMIH.O / NEWR.N / GLPG.O / TDOC.N / PYPL.OQ / RGNX.O / SPGI.N / TTD.O / ADNT.N / AQN.N / UNIT.O / CDEV.O / ESTE.N / WOW.N / ATNX.O / SAIL.N / APTV.N / SMAR.N / VRCA.OQ / ITRM.O / OPRX.OQ / VNE.N / HCAT.OQ / GMAB.O / CRNC.OQ / PNTG.OQ / IGMS.O / OAS.OQ / NKLA.OQ / APA.OQ / FOUR.N / NRIX.OQ / RXT.OQ / GOCO.O / IBEX.O / PLTR.N / AEP.OQ / SPRB.OQ / BSY.O / GATO.N / GDRX.O / MCFE.OQ / RIDE.OQ / MAX.N / TLMD.OQ / LSPD.N / PUBM.O / TIXT.TO / AFRM.O / NUVB.N / CHK.OQ / OLO.N / PATH.N / PSFE.N / TSP.OQ / TFPM.TO / FLYW.O / BHG.N / XMTR.OQ / TASK.O / TRMR.OQ / EVCM.O / NABL.N / RYAN.N / TWKS.OQ / GTLB.OQ / ROCC.O</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / EOG Resources Inc / Ford Motor Co / Fisker Inc / General Motors Co / Microsoft Corp / National Bank of Canada / Norfolk Southern Corp / Pfizer Inc / AT&T Inc / Visteon Corp / Pioneer Natural Resources Co / Gilead Sciences Inc / Tenneco Inc / Whiting Petroleum Corp / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Ferrovial SA / Canadian National Railway Co / Duke Energy Corp / Borgwarner Inc / Lear Corp / FirstEnergy Corp / DISH Network Corp / CSX Corp / Union Pacific Corp / Nice Ltd / DoubleVerify Holdings Inc / Marathon Oil Corp / PG&E Corp / Plains All American Pipeline LP / Devon Energy Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / MGIC Investment Corp / Radian Group Inc / Verizon Communications Inc / Lincoln National Corp / Amphenol Corp / Range Resources Corp / EQT Corp / Visa Inc / ONEOK Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Italgas SpA / Bottomline Technologies Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Snam SpA / Prudential Financial Inc / SM Energy Co / TE Connectivity Ltd / Gold Fields Ltd / Conocophillips / Callon Petroleum Co / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / California Resources Corp / Pegasystems Inc / Plug Power Inc / Global Payments Inc / aTyr Pharma Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Pan American Silver Corp / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Dundee Precious Metals Inc / Endeavour Mining PLC / Terna Rete Elettrica Nazionale SpA / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mastercard Inc / eHealth Inc / Aon PLC / Continental Resources Inc / Dana Inc / Northern Oil and Gas Inc / EDP Renovaveis SA / Phreesia Inc / Parkland Corp / Datto Holding Corp / Meritor Inc / Matador Resources Co / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / T-Mobile US Inc / PTC Therapeutics Inc / ServiceNow Inc / Essent Group Ltd / Xencor Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Healthequity Inc / NMI Holdings Inc / New Relic Inc / Galapagos NV / Teladoc Health Inc / PayPal Holdings Inc / Regenxbio Inc / S&P Global Inc / Trade Desk Inc / Adient PLC / Algonquin Power & Utilities Corp / Uniti Group Inc / Centennial Resource Development Inc / Earthstone Energy Inc / WideOpenWest Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Veoneer Inc / Health Catalyst Inc / Genmab A/S / Cerence Inc / Pennant Group Inc / IGM Biosciences Inc / Oasis Petroleum Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Nurix Therapeutics Inc / Rackspace Technology Inc / Gohealth Inc / Ibex Ltd / Palantir Technologies Inc / American Electric Power Company Inc / Spruce Biosciences Inc / Bentley Systems Inc / Gatos Silver Inc / Goodrx Holdings Inc / Mcafee Corp / Lordstown Motors Corp / Mediaalpha Inc / Soc Telemed Inc / Lightspeed Commerce Inc / PubMatic Inc / Telus International Cda Inc / Affirm Holdings Inc / Nuvation Bio Inc / Chesapeake Energy Corp / Olo Inc / UiPath Inc / Paysafe Ltd / TuSimple Holdings Inc / Triple Flag Precious Metals Corp / Flywire Corp / Bright Health Group Inc / Xometry Inc / Taskus Inc / Tremor International Ltd / EverCommerce Inc / N-Able Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc / GitLab Inc / Ranger Oil Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Comprehensive Approach to Hearing and Balance Disorders; Initiating at Buy and $23 PT</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">DBTX.OQ / REGN.OQ / 91307C102 / 90400D108 / 68906L105 / AKUS.OQ / 31447P100 / 03820J100</td><td class="leftalignment">Decibel Therapeutics Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Ultragenyx Pharmaceutical Inc / Otonomy Inc / Akouos Inc / Fennec Pharmaceuticals Inc / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Emanuela Branchetti, Ph.D., PHD / Joseph Pantginis, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/13/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075 / US92532F1003 / US29251M1062 / US04351P1012 / US37890U1088 / US28106W1036 / US5588681057 / CH0334081137 / US45781K1051 / US20451W1018 / US59101E1038 / US16961L1061 / US81181C1045 / US1920101060 / US95075A1079 / US6036931029</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Ascendis Pharma A/S / Global Blood Therapeutics Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Innate Pharma SA / Compass Pathways PLC / Metacrine Inc / Chinook Therapeutics Inc / Seagen Inc / Codiak BioSciences, Inc. / Werewolf Therapeutics Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">11/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / REGN.O / LIFE.O / ATNX.O / GMAB.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / aTyr Pharma Inc / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">Sector Commentary: Several Areas Left Behind in Current Rally</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RBLX=US / TWTR=US / DT=US / U=US / 7974=JP / AI=US / BYND=US / ISEE=US / REGN=US / RYAN=US / SHOP=US / NET=US / CNM=US / UPST=US / PTON=US / DVAX=US / MRNA=US / CPRX=US / COIN=US / AVXL=US / CLDX=US / RCUS=US / TSLA=US / CERE=US / PRLB=US / PRTA=US / BILL=US / NTLA=US / CRSP=US / ROKU=US / CDMO=US / GH=US / STNE=US / PINS=US / ZM=US / CRWD=US / FVRR=US / DDOG=US / OCGN=US / DKNG=US / PLTR=US / ASAN=US / TVTX=US / ABNB=US / AFRM=US / WISH=US / HAYW=US / CFLT=US / MNDY=US</td><td class="leftalignment">Roblox Corp / Twitter Inc / Dynatrace Inc / Unity Software Inc / Nintendo Co Ltd / C3.ai Inc / Beyond Meat Inc / Iveric Bio Inc / Regeneron Pharmaceuticals Inc / Ryan Specialty Group Holdings Inc / Shopify Inc / Cloudflare Inc / Core & Main Inc / Upstart Holdings Inc / Peloton Interactive Inc / Dynavax Technologies Corp / Moderna Inc / Catalyst Pharmaceuticals Inc / Coinbase Global Inc / Anavex Life Sciences Corp / Celldex Therapeutics Inc / Arcus Biosciences Inc / Tesla Inc / Cerevel Therapeutics Holdings Inc / Proto Labs Inc / Prothena Corporation PLC / Bill.com Holdings Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Roku Inc / Avid Bioservices Inc / Guardant Health Inc / StoneCo Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Fiverr International Ltd / Datadog Inc / Ocugen Inc / DraftKings Inc / Palantir Technologies Inc / Asana Inc / Travere Therapeutics Inc / Airbnb Inc / Affirm Holdings Inc / ContextLogic Inc / Hayward Holdings Inc / Confluent Inc / Monday.Com Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Ireland / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kenley Scott</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">SITC 2021 update: CD28-costim bispecific REGN7075 could have first human data in 2022</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Starting in 30 MINS: 10:00 am ET, We're Talking PAH Market, Merck/Acceleron, and $5B+ Opportunity for New Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Merck & Co Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Healthy Biotech Inflows Continue for a Third Straight Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Novartis, Roche, Regeneron: Survey* on usage of biosimilar Lucentis (& eventually Eylea)</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US75886F1075 / CH0012005267 / CH0012032048</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Novartis AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MEDACorp Derm Survey Shows Large Unmet Need & Opportunity for Novel Topicals</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">45337C10 / 03116210 / 75886F10 / F5548N10 / 00461U10 / ROIV</td><td class="leftalignment">Incyte Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / Aclaris Therapeutics Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Andrew Berens, M.D. / Mr. Thomas J. Smith / Anna Baran, CFA / Christopher Liu, Pharm.D. / Mike Kratky, CFA</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US00846U1016 / US4448591028 / US75886F1075 / US02043Q1076 / US03152W1099 / US88322Q1085 / US46116X1019 / US03820J1007 / US45773H2013 / CA68620P1018 / US0367521038 / US8162121045 / US03836N1037 / US88688T1007 / CA39342L1085 / CA58507M1077 / CA22587M1068 / US15117B2025 / CA89788C1041 / US12482W1018 / CA16106R1091 / CA23126M1023 / US42225T1079 / US1266541028 / CA05156X8843 / US38046W1053 / CA4283043079 / CA00489Y6001</td><td class="leftalignment">Agilent Technologies Inc / Humana Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / TG Therapeutics Inc / Intra-Cellular Therapies Inc / Applied Genetic Technologies Corp / Inovio Pharmaceuticals Inc / OrganiGram Holdings Inc / Anthem Inc / Selecta Biosciences Inc / Aptinyx Inc / Tilray Brands Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Cresco Labs Inc / Celldex Therapeutics Inc / Trulieve Cannabis Corp / cbdMD Inc / Charlotte's Web Holdings Inc / Curaleaf Holdings Inc / Health Catalyst Inc / CV Sciences Inc / Aurora Cannabis Inc / Gohealth Inc / Hexo Corp / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">3Q21 Financial Results Reported; Reiterate Neutral</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Raghuram Selvaraju, Ph.D. / Yi Chen, Ph.D. CFA</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Come On In, The Water’s Fine!</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">375558103 / 031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 00166B105 / 46565G104 / 49705R105 / 670703107</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q21 Take: Execution on pipeline continues with solid long-term growth prospects; increasing PT to $760</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US75886F1075 / US02043Q1076</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">3Q: Lead Asset IND Submission On Track for 4Q</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">87583X10 / 71708110 / 03116210 / 75886F10 / 00287Y10</td><td class="leftalignment">Tango Therapeutics Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">75886F107 / 55306N104 / 68213N109 / 89531P105 / 98986T108 / 575385109 / 75134P303 / 16842Q100 / 873379101 / AU0000026122 / 46185L103 / 81577F10 / 96758W101 / 771049103 / 307359109</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / MKS Instruments Inc / Omnicell Inc / Trex Company Inc / Zynga Inc / Masonite International Corp / Ramaco Resources Inc / Chicken Soup for The Soul Entertainment Inc / Tabula Rasa HealthCare Inc / Coronado Global Resources Inc / Invitae Corp / Seelos Therapeutics Inc / WideOpenWest Inc / Roblox Corp / Faraday Future Intelligent Electric Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mike Hickey / Mr. Reuben Garner / Mr. Mark Miller / Mr. Bruce D. Jackson / Mr. Michael P. Ward, CFA / Mr. Nathan Martin / Mr. Matthew Harrigan / Mr. Bill Sutherland / Mr. Daniel L. Kurnos, CFA</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">REGN Is Planning A Large Acquisition? Signs Are There</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron down 2.9% from 2 week high</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Sign Up for Hearty Fridays - KOL Call Series: 11/12 at 10:00 am ET, We're Talking PAH Market, Merck/Acceleron, and $5B+ Opportunity for New Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 5671735 / 0989529 / 2023607 / 2778844 / 2730190 / 7103065 / BHC8X90 / BNKGXX2</td><td class="leftalignment">Merck & Co Inc / Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Novo Nordisk A/S / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">VNiGM: In Hind(SIGHT) Don't Change the Filter! MRNA's Modality Moves</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">MRNA.OQ / SIGHT.PA / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Moderna Inc / Gensight Biologics SA / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">3Q21 results and model update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">FISV=US / BSX=US / PFE=US / OXY=US / GBT=US / IP=US / MDT=US / PD=US / AMZN=US / RUN=US / CMA=US / EOG=US / PB=US / DIOD=US / VRM=US / MUR=US / EWBC=US / UMPQ=US / EXPE=US / ATVI=US / VMC=US / UNM=US / CVS=US / CI=US / W=US / MLM=US / ARCC=US / PATH=US / COLL=US / MAIN=US / DOC=US / ORCC=US / PACW=US / REGN=US / SGMO=US / SNAP=US / TRGP=US / TRIP=US / VRTX=US / WAL=US / WIX=US / CVX=US / GPN=US / FNF=US / BKNG=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / CNM=US / FB=US / KIM=US / MKL=US / MTCH=US / SSB=US / RF=US / CATY=US / SBSI=US / BE=US / APPN=US / PNFP=US / BDSI=US / PTON=US / BIIB=US / TCBI=US / MOG.A=US / FNB=US / EXP=US / FHN=US / APP=US / AINV=US / XM=US / FIS=US / GPRE=US / CADE=US / WRK=US / PNNT=US / NOG=US / ATSG=US / IAC=US / HTA=US / OLO=US / OAS=US / BLND=US / ESTE=US / ANGI=US / ZNGA=US / PDCE=US / TILE=US / VOYA=US / CEQP=US / AERI=US / GOOGL=US / QTWO=US / TSLX=US / 70806A106 / BABA=US / CIVI=US / CMPR=US / RLMD=US / GDDY=US / GSBD=US / CHCT=US / LOB=US / PEN=US / SQ=US / ADVM=US / CDEV=US / ANAB=US / CVNA=US / SBOW=US / RDFN=US / SWCH=US / DCPH=US / MBIN=US / SFIX=US / HWC=US / OZK=US / FOCS=US / FTDR=US / FSK=US / LYFT=US / UBER=US / FERG=US / RPAY=US / AHCO=US / ONEM=US / DKNG=US / NCNO=US / PAYA=US / ABNB=US / RBLX=US / COUR=US / VMEO=US / MNTV=US / DNUT=US / PKG=U / 00152K101 / GTLB=US</td><td class="leftalignment">Fiserv Inc / Boston Scientific Corp / Pfizer Inc / Occidental Petroleum Corp / Global Blood Therapeutics Inc / International Paper Co / Medtronic PLC / PagerDuty Inc / Amazon.com Inc / Sunrun Inc / Comerica Inc / EOG Resources Inc / Prosperity Bancshares Inc / Diodes Inc / Vroom Inc / Murphy Oil Corp / East West Bancorp Inc / Umpqua Holdings Corp / Expedia Group Inc / Activision Blizzard Inc / Vulcan Materials Co / Unum Group / CVS Health Corp / Cigna Corp / Wayfair Inc / Martin Marietta Materials Inc / Ares Capital Corp / UiPath Inc / Collegium Pharmaceutical Inc / Main Street Capital Corp / Physicians Realty Trust / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Snap Inc / Targa Resources Corp / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Global Payments Inc / Fidelity National Financial Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Core & Main Inc / Meta Platforms Inc / Kimco Realty Corp / Markel Corp / Match Group Inc / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / Southside Bancshares Inc / Bloom Energy Corp / Appian Corp / Pinnacle Financial Partners Inc / BioDelivery Sciences International Inc / Peloton Interactive Inc / Biogen Inc / Texas Capital Bancshares Inc / Moog Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Applovin Corp / Apollo Investment Corp / Qualtrics International Inc / Fidelity National Information Services Inc / Green Plains Inc / Cadence Bank / Westrock Co / Pennantpark Investment Corp / Northern Oil and Gas Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Healthcare Trust Of America Inc / Olo Inc / Oasis Petroleum Inc / Blend Labs Inc / Earthstone Energy Inc / Angi Inc / Zynga Inc / PDC Energy Inc / Interface Inc / Voya Financial Inc / Crestwood Equity Partners LP / Aerie Pharmaceuticals Inc / Alphabet Inc / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Alibaba Group Holding Ltd / Civitas Resources Inc / Cimpress PLC / Relmada Therapeutics Inc / GoDaddy Inc / Goldman Sachs BDC Inc / Community Healthcare Trust Inc / Live Oak Bancshares Inc / Penumbra Inc / Block Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / AnaptysBio Inc / Carvana Co / SilverBow Resources Inc / Redfin Corp / Switch Inc / Deciphera Pharmaceuticals Inc / Merchants Bancorp / Stitch Fix Inc / Hancock Whitney Corp / Bank Ozk / Focus Financial Partners Inc / Frontdoor Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Repay Holdings Corp / Adapthealth Corp / 1Life Healthcare Inc / DraftKings Inc / nCino Inc / Paya Holdings Inc / Airbnb Inc / Roblox Corp / Coursera Inc / Vimeo Inc / Momentive Global Inc / Krispy Kreme Inc / Packaging Corp of America / AKA Brands Holding Corp / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AES.N / AFL.N / AIG.N / AXP.N / BAC.N / BK.N / C.N / CB.N / CC.N / CI.N / CL.N / COF.N / CVS.N / EIX.N / FITB.O / FMS.N / JPM.N / KEY.N / MSFT.O / NTRS.O / PNC.N / PNW.N / SO.N / T.N / T.TO / USB.N / WFC.N / FR.N / HUM.N / TEN.N / CHKP.O / AMGN.O / RBA.N / DUK.N / PNM.N / ENB.TO / TRP.TO / DISH.O / GS.N / DV.N / PCG.N / EPC.N / ADCT.N / SBAC.O / AMT.N / CONE.O / VZ.N / STT.N / EXEL.O / JCI.N / XEL.N / ARNA.O / LNC.N / EXC.N / V.N / AXL.N / EGP.N / PLD.N / EPAY.O / WSP.TO / MTB.N / JKHY.O / AJG.N / REGN.O / PRU.N / NET.N / SSNC.O / RF.N / CPK.N / LTC.N / AMH.N / SEM.N / SGEN.OQ / GPN.N / BLUE.O / CASY.O / ACGL.O / AMED.O / EQIX.O / STN.TO / ATDb.TO / SNC.TO / TFC.N / DLR.N / 416515104 / LHCG.O / IHS.N / BKD.N / MS.N / FIS.N / CCOI.O / MA.N / AON.N / BGS.N / PPL.TO / VMW.N / NOG.A / SII.TO / 759351604 / JACK.OQ / SWI.N / ADUS.OQ / FTNT.O / ENV.N / NEE.N / ERF.TO / PKI.TO / STAG.N / ANGI.OQ / SPLK.OQ / PANW.N / QLYS.O / FFHu.TO / ALLY.N / TMUS.N / PRTA.O / BEP.N / AGIO.O / ESNT.N / XNCR.OQ / VRNS.O / QTWO.N / NEP.N / CFG.N / GLPG.O / PYPL.OQ / RPD.O / SGRY.O / SQ.N / MIME.OQ / IONS.O / TRHC.OQ / SCWX.O / BBU.N / TTD.O / GDS.O / UNIT.O / OKTA.OQ / WOW.N / BHF.O / ATNX.O / SAIL.N / ZS.OQ / ESTC.N / CRWD.O / GMAB.O / PING.N / DDOG.O / PNTG.OQ / NLOK.O / WTRG.N / SLQT.N / AHCO.O / VMD.OQ / APA.OQ / FOUR.N / JAMF.O / LUMN.N / PLTR.N / AEP.OQ / MCFE.OQ / LSPD.N / PUBM.O / TIXT.TO / AFRM.O / OLO.N / PSFE.N / FLYW.O / TASK.O / TRMR.OQ / RYAN.N / GTLB.OQ / ROCC.O</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Chubb Ltd / Chemours Co / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Edison International / Fifth Third Bancorp / Fresenius Medical Care AG & Co KGaA / JPMorgan Chase & Co / KeyCorp / Microsoft Corp / Northern Trust Corp / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Southern Co / AT&T Inc / Telus Corp / US Bancorp / Wells Fargo & Co / First Industrial Realty Trust Inc / Humana Inc / Tenneco Inc / Check Point Software Technologies Ltd / Amgen Inc / Ritchie Bros Auctioneers Inc / Duke Energy Corp / PNM Resources Inc / Enbridge Inc / TC Energy Corp / DISH Network Corp / Goldman Sachs Group Inc / DoubleVerify Holdings Inc / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Johnson Controls International PLC / Xcel Energy Inc / Arena Pharmaceuticals Inc / Lincoln National Corp / Exelon Corp / Visa Inc / American Axle & Manufacturing Holdings Inc / Eastgroup Properties Inc / Prologis Inc / Bottomline Technologies Inc / WSP Global Inc / M&T Bank Corp / Jack Henry & Associates Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Prudential Financial Inc / Cloudflare Inc / SS&C Technologies Holdings Inc / Regions Financial Corp / Chesapeake Utilities Corp / LTC Properties Inc / American Homes 4 Rent / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / bluebird bio Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Amedisys Inc / Equinix Inc / Stantec Inc / Alimentation Couche-Tard Inc / SNC-Lavalin Group Inc / Truist Financial Corp / Digital Realty Trust Inc / Hartford Financial Services Group Inc / LHC Group Inc / IHS Holding Ltd / Brookdale Senior Living Inc / Morgan Stanley / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mastercard Inc / Aon PLC / B&G Foods Inc / Pembina Pipeline Corp / VMware Inc / Northern Oil and Gas Inc / Sprott Inc / Reinsurance Group of America Inc / Jack in the Box Inc / SolarWinds Corp / Addus Homecare Corp / Fortinet Inc / Envestnet Inc / Nextera Energy Inc / Enerplus Corp / Parkland Corp / STAG Industrial Inc / Angi Inc / Splunk Inc / Palo Alto Networks Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Ally Financial Inc / T-Mobile US Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Essent Group Ltd / Xencor Inc / Varonis Systems Inc / Q2 Holdings Inc / Nextera Energy Partners LP / Citizens Financial Group Inc / Galapagos NV / PayPal Holdings Inc / Rapid7 Inc / Surgery Partners Inc / Block Inc / Mimecast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / SecureWorks Corp / Brookfield Business Partners LP / Trade Desk Inc / GDS Holdings Ltd / Uniti Group Inc / Okta Inc / WideOpenWest Inc / Brighthouse Financial Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Zscaler Inc / Elastic NV / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Datadog Inc / Pennant Group Inc / NortonLifeLock Inc / Essential Utilities Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / APA Corp (US) / Shift4 Payments Inc / Jamf Holding Corp / Lumen Technologies Inc / Palantir Technologies Inc / American Electric Power Company Inc / Mcafee Corp / Lightspeed Commerce Inc / PubMatic Inc / Telus International Cda Inc / Affirm Holdings Inc / Olo Inc / Paysafe Ltd / Flywire Corp / Taskus Inc / Tremor International Ltd / Ryan Specialty Group Holdings Inc / GitLab Inc / Ranger Oil Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Ireland / Israel / Mauritius / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Compelling Buying Opportunity Amid CEO Transition; Reiterate Buy Ahead of November 19 R&D Day</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">02043Q107 / REGN.OQ</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BAYGn.DE: Bayer - 3Q21 Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BAYGN.DE / REGN.OQ / CTVA.N</td><td class="leftalignment">Bayer AG / Regeneron Pharmaceuticals Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Green Cross Corp: Readacross from Pfizer's oral COVID Ph-2/3 data; Green Cross. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">006280.KS / PFE.N / MRK.N / REGN.OQ / 068270.KS</td><td class="leftalignment">Green Cross Corp / Pfizer Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Celltrion Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Inc: Readacross from Pfizer's oral COVID Ph-2/3 data (Celltrion Inc). Maintain UNDERPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">068270.KS / PFE.N / MRK.N / REGN.OQ</td><td class="leftalignment">Celltrion Inc / Pfizer Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Healthcare Co Ltd: Readacross from Pfizer's oral COVID Ph-2/3 data (Celltrion Healthcare). Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">091990.KQ / PFE.N / MRK.N / REGN.OQ</td><td class="leftalignment">Celltrion Healthcare Co Ltd / Pfizer Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Readacross from Pfizer's oral COVID Ph-2/3 data; what additional data should we expect in near future</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">068270.KS / 091990.KQ / PFE.N / LLY.N / MRK.N / GSK.L / REGN.OQ / 006280.KS</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Pfizer Inc / Eli Lilly and Co / Merck & Co Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Green Cross Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/06/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US35104E1001 / US09061G1013 / US09058V1035 / US45337C1027 / US75886F1075 / US00287Y1091 / US29251M1062 / US02155H2004 / US04965G1094 / US6047491013 / CA07987C2040 / US05370A1088 / US45720L1070 / US20451W1018 / US59101E1038 / US16961L1061 / US81181C1045 / US92337R1014</td><td class="leftalignment">4D Molecular Therapeutics Inc / Biomarin Pharmaceutical Inc / BioCryst Pharmaceuticals Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Altimmune Inc / Atreca Inc / Mirum Pharmaceuticals Inc / BELLUS Health Inc / Avidity Biosciences Inc / Inhibrx Inc / Compass Pathways PLC / Metacrine Inc / Chinook Therapeutics Inc / Seagen Inc / Vera Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / REGN.O / SGEN.OQ / PRTA.O / AGIO.O / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / CGC / CHTR / CRY / MSFT / RAD / T / VCTR / WMT / WW / GILD.O / CMCSA.O / ONEM.O / XRAY.O / VZ / DOX.O / REGN.O / VRTX.O / SSNC.O / CCRN.O / AMED.O / BIIB / 459200101 / 00846U101 / 868168105 / GOOG.O / LHCG.O / PODD.O / MASI.O / ENSG.O / 483548103 / MRNA.O / STX.OQ / 771195104 / ADUS.O / TMUS / EVH / 100063846 / 720795103 / PNTG.O / FCRD / KDNY.O / LTH.N</td><td class="leftalignment">Arcosa Inc / Canopy Growth Corp / Charter Communications Inc / CryoLife Inc / Microsoft Corp / Rite Aid Corp / AT&T Inc / Victory Capital Holdings Inc / Walmart Inc / WW International Inc / Gilead Sciences Inc / Comcast Corp / 1Life Healthcare Inc / DENTSPLY SIRONA Inc / Verizon Communications Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Insulet Corp / Masimo Corp / Ensign Group Inc / Kaman Corp / Moderna Inc / Seagate Technology Holdings PLC / Roche Holding AG / Addus Homecare Corp / T-Mobile US Inc / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / First Eagle Alternative Capital BDC Inc / Chinook Therapeutics Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Ireland / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 1 to 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">CA4509131088 / IL0002810146 / US0126531013 / US0234361089 / US0236081024 / US0341641035 / US0383361039 / US0536111091 / US0584981064 / US0936711052 / US1096411004 / US1170431092 / US1266501006 / US1564311082 / US1844961078 / US2855121099 / US29364G1031 / US30161N1019 / US30231G1022 / US3024913036 / US3666511072 / US4062161017 / US4448591028 / US4606901001 / US4878361082 / US5463471053 / US5719032022 / US65473P1057 / US6819191064 / US6821891057 / US6988131024 / US7237871071 / US7445731067 / US75281A1097 / US7549071030 / US75886F1075 / AN8068571086 / US81211K1007 / US8589121081 / US8740541094 / US9621661043 / CA13321L1085 / CA53278L1076 / CA0977512007 / CA30150P1099 / CA85472N1096 / CA4530384086 / CA5649051078 / CA78460T1057 / CA6837151068 / CA3495531079 / CA3759161035 / CA82028K2002 / CA7029251088 / US1667641005 / US9129091081 / CA3039011026 / CA7481932084 / CA8765111064 / US0017441017 / US37940X1028 / CA3359341052 / CA00762V1094 / US2274831047 / US7665596034 / US60855R1005 / CA5734591046 / CA2265331074 / US9604131022 / CA56501R1064 / CA8667961053 / CA39138C1068 / CA4436281022 / US3546131018 / CA6993202069 / US1252691001 / US40637H1095 / US42809H1077 / CA21037X1006 / CA32076V1031 / US9026531049 / US2253101016 / US30225T1025 / US5021751020 / US63633D1046 / CA2945051027 / CA4369131079 / US05508R1068 / US3932221043 / BMG162521014 / US2120151012 / US00507V1098 / US38500T1016 / US4778391049 / US58502B1061 / US26884L1098 / US91912E1055 / US92345Y1064 / CA15135U1093 / CA69946Q1046 / US78454L1008 / NL0009538784 / NL0009434992 / CA07317Q1054 / US18538R1032 / CA2927661025 / US61945C1036 / US7512121010 / CA54928Q1081 / US9858171054 / US4571871023 / US26441C2044 / CA7063271034 / CA4932711001 / US6092071058 / US00287Y1091 / CA89156V1067 / JE00B8KF9B49 / US09739D1000 / US1091941005 / CA1348082035 / CA3874371147 / CA69338U1012 / CA74061A1084 / CA9307831052 / CA09202D2077 / CA21750U1012 / CA80013R2063 / US76131N1019 / CA11777Q2099 / US0067391062 / CA81373C1023 / CA04682R1073 / US6951271005 / CA2861812014 / CA3748252069 / US00404A1097 / US5764852050 / US75902K1060 / US0942351083 / US45845P1084 / CA17039A1066 / US85208M1027 / US03674X1063 / US2267181046 / US1630921096 / CA14150G4007 / US56117J1007 / US78667J1088 / IE00BQPVQZ61 / US4435731009 / CA0089118776 / US92686J1060 / US74736K1016 / US29444U7000 / US30040W1080 / US83417M1045 / CA1946931070 / US9741551033 / CA8485101031 / CA3803551074 / US8522341036 / GB00BYT5JK65 / US4622221004 / US45688C1071 / CA8910546032 / CA26829L1076 / US13462K1097 / CA87241L1094 / GB00BDSFG982 / US75134P3038 / US9490901041 / US23355L1061 / US93627C1018 / CA46016U1084 / CA85859H1055 / US00737L1035 / US05722G1004 / GB00BF3ZNS54 / CA7847301032 / US00183L1026 / US12653C1080 / CA53680Q2071 / LU1701428291 / CA35905B1076 / CA67077M1086 / US29261A1007 / US15677J1088 / US03168L1052 / CA75622P1045 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / US34417P1003 / KYG370921069 / US86272C1036 / US46005L1017 / US04335A1051 / US2936141033 / US53815P1084 / US53814L1089 / IE00BZ12WP82 / CA38119T8077 / CA13000C2058 / CA8849037095 / US1255231003 / CA2849025093 / US57778K1051 / VGG1890L1076 / CA45075E1043 / US85789A1051 / US63253R2013 / US35137L1052 / CA14179V5036 / US22052L1044 / US26614N1028 / US76156B1070 / CA6744822033 / JE00BJ1F3079 / CA29446Y5020 / US03768E1055 / CA1033101082 / CA31890B1031 / IE00BK9ZQ967 / CA36168Q1046 / CA70137W1086 / US5168062058 / US57667L1070 / US26484T1060 / US46121Y2019 / US69526K1051 / US3773201062 / CA89055A2039 / CA9004352071 / US62955J1034 / CA1295844056 / US03743Q1085 / CA00076T1057 / US44891N2080 / US92719V1008 / CA65532M6062 / CA21766N1096 / US53190C1027</td><td class="leftalignment">IAMGOLD Corp / Icl Group Ltd / Albemarle Corp / Amedisys Inc / Ameren Corp / Andersons Inc / Aptargroup Inc / Avery Dennison Corp / Ball Corp / H & R Block Inc / Brinker International Inc / Brunswick Corp / CVS Health Corp / Century Aluminum Co / Clean Harbors Inc / Electronic Arts Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / FMC Corp / Gartner Inc / Halliburton Co / Humana Inc / Interpublic Group of Companies Inc / Kellogg Co / Louisiana-Pacific Corp / Marriott International Inc / NiSource Inc / Omnicom Group Inc / ON Semiconductor Corp / Papa John's International Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Rayonier Inc / Regeneron Pharmaceuticals Inc / Schlumberger NV / Sealed Air Corp / Stericycle Inc / Take-Two Interactive Software Inc / Weyerhaeuser Co / Cameco Corp / Linamar Corp / Bombardier Inc / Exco Technologies Ltd / Stantec Inc / Imperial Oil Ltd / Maple Leaf Foods Inc / SNC-Lavalin Group Inc / Open Text Corp / Fortis Inc / Gildan Activewear Inc / Shaw Communications Inc / Pason Systems Inc / Chevron Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Quebecor Inc / Taseko Mines Ltd / AMN Healthcare Services Inc / Global Payments Inc / First Quantum Minerals Ltd / Aecon Group Inc / Cross Country Healthcare Inc / Rigel Pharmaceuticals Inc / Molina Healthcare Inc / Martinrea International Inc / Crew Energy Inc / Westlake Chemical Corp / Manulife Financial Corp / Sun Life Financial Inc / Great-West Lifeco Inc / Hudbay Minerals Inc / Franklin Resources Inc / Paramount Resources Ltd / CF Industries Holdings Inc / Halozyme Therapeutics Inc / Hess Corp / Constellation Software Inc / First Majestic Silver Corp / UDR Inc / Credit Acceptance Corp / Extra Space Storage Inc / LTC Properties Inc / National Health Investors Inc / Equitable Group Inc / Home Capital Group Inc / B&G Foods Inc / Green Plains Inc / Brookfield Infrastructure Partners LP / Continental Resources Inc / Activision Blizzard Inc / Gran Tierra Energy Inc / John Bean Technologies Corp / MEDNAX Inc / EQT Corp / Vale SA / Verisk Analytics Inc / Cenovus Energy Inc / Parex Resources Inc / SM Energy Co / NXP Semiconductors NV / LyondellBasell Industries NV / Baytex Energy Corp / Clearwater Paper Corp / Enerplus Corp / Mosaic Co / Ralph Lauren Corp / Lucara Diamond Corp / Yelp Inc / Ingredion Inc / Duke Energy Corp / Pembina Pipeline Corp / Keyera Corp / Mondelez International Inc / Abbvie Inc / Tourmaline Oil Corp / WPP PLC / Boise Cascade Co / Bright Horizons Family Solutions Inc / Canacol Energy Ltd / Granite Real Estate Investment Trust / PHX Energy Services Corp / Premium Brands Holdings Corp / Wajax Corp / Black Diamond Group Ltd / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Retail Opportunity Investments Corp / B2Gold Corp / Addus Homecare Corp / Secure Energy Services Inc / Athabasca Oil Corp / Pacira Biosciences Inc / Element Fleet Management Corp / Gibson Energy Inc / Acadia Healthcare Company Inc / Matador Resources Co / Regional Management Corp / Bloomin' Brands Inc / Intercept Pharmaceuticals Inc / Choice Properties Real Estate Investment Trust / Sprouts Farmers Market Inc / Antero Resources Corp / Criteo SA / Chegg Inc / Cardinal Energy Ltd (Alberta) / Malibu Boats Inc / SAGE Therapeutics Inc / Horizon Therapeutics PLC / HubSpot Inc / Air Canada / Viking Therapeutics Inc / Qorvo Inc / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Colliers International Group Inc / Wingstop Inc / Spin Master Corp / goeasy Ltd / Block Inc / Mimecast Ltd / Ionis Pharmaceuticals Inc / Ingevity Corp / Torex Gold Resources Inc / ECN Capital Corp / Camping World Holdings Inc / TFI International Inc / TechnipFMC PLC / Ramaco Resources Inc / Welbilt Inc / DXC Technology Co / Warrior Met Coal Inc / International Petroleum Corp / Step Energy Services Ltd / Adtalem Global Education Inc / Baker Hughes Co / Venator Materials PLC / SSR Mining Inc / Angi Inc / CNX Resources Corp / Lithium Americas Corp / Nexa Resources SA / Frontera Energy Corp / Nutrien Ltd / Encompass Health Corp / Ceridian HCM Holding Inc / Amneal Pharmaceuticals Inc / Recipe Unlimited Corp / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / Focus Financial Partners Inc / Galaxy Digital Holdings Ltd / Strategic Education Inc / International Money Express Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Liveramp Holdings Inc / Livent Corp / Linde PLC / Golden Star Resources Ltd / Calibre Mining Corp / Thomson Reuters Corp / Cigna Corp / Eldorado Gold Corp / Maxar Technologies Inc / Capri Holdings Ltd / iA Financial Corporation Inc / Stealth BioTherapeutics Corp / NAK Kazatomprom AO / Fox Corp / Cargojet Inc / Corteva Inc / Dupont De Nemours Inc / Revolve Group Inc / Obsidian Energy Ltd / Amcor PLC / Equinox Gold Corp / Apollo Global Management Inc / Boyd Group Services Inc / First Capital Real Estate Investment Trust / Trane Technologies PLC / GFL Environmental Inc / Parkland Corp / Laredo Petroleum Inc / Match Group Inc / Dun & Bradstreet Holdings Inc / Intrepid Potash Inc / Pactiv Evergreen Inc / Glatfelter Corp / Topaz Energy Corp / Turquoise Hill Resources Ltd / Nov Inc / Calfrac Well Services Ltd / APA Corp (US) / Abc Technologies Holdings Inc / IAC/Interactivecorp / Vimeo Inc / Nomad Royalty Company Ltd / Copperleaf Technologies Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Kazakhstan / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Nov. 05, 2021</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">AAPL / ALLO / AMGN / ATRC / CRY / CSII / EXEL / GBT / ICPT / INCY / INSP / IRTC / NBIX / OM / RARE / SAGE / ASND.O / GILD.O / EW / IART.O / SGEN / UTHR.O / PCSA.O / BMRN.O / DRRX.O / REGN.O / VRTX.O / NKTR / CCRN.O / STAA.O / AMED.O / EXAS.O / BIIB / 478160104 / MNKD.O / CMMB / ALNY.O / DXCM.O / LHCG.O / INFI.O / PODD.O / TNDM.O / MRNA.O / 771195104 / ADUS.O / SWAV / SRPT.O / AGIO / FATE.O / AERI.O / 02005N100 / AGRX.O / RXDX.O / APTO.O / AUPH.O / CFMS.O / VKTX / IONS.O / 04280A100 / MDGL / VRAY / NTLA / CRSP / IOVA / ATNX.O / 720795103 / PRVB.O / ORTX.O / BNGO.O / ARVN / XFOR.O / TMDX / PSNL.O / BCYC / ORIC.O / HGEN.O / 03823M100 / CLNN.O / CGTX.OQ</td><td class="leftalignment">Apple Inc / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / CryoLife Inc / Cardiovascular Systems Inc / Exelixis Inc / Global Blood Therapeutics Inc / Intercept Pharmaceuticals Inc / Incyte Corp / Inspire Medical Systems Inc / iRhythm Technologies Inc / Neurocrine Biosciences Inc / Outset Medical Inc / Ultragenyx Pharmaceutical Inc / SAGE Therapeutics Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Seagen Inc / United Therapeutics Corp / Processa Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / DURECT Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Cross Country Healthcare Inc / STAAR Surgical Co / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / MannKind Corp / Chemomab Therapeutics Ltd / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / Roche Holding AG / Addus Homecare Corp / Shockwave Medical Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Ally Financial Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Aptose Biosciences Inc / Aurinia Pharmaceuticals Inc / Conformis Inc / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / ViewRay Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Personalis Inc / Bicycle Therapeutics PLC / Oric Pharmaceuticals Inc / Humanigen Inc / Applied Minerals Inc / Clene Inc. / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">11012210 / 71708110 / 00846U10 / 88162420 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US0017441017 / US2274831047 / 26875P101 / 83088M102 / 75886F107 / 98156Q108 / 389375106 / 25470M109 / 12008R107 / 404251100 / 600544100 / 64049M209 / 858155203 / US30212P3038 / US0952291005 / US1635722093 / M7516K103 / G6331P104 / 87901J105 / 535919401 / 531229409 / 14575E105 / 89785L107 / US65487K1007 / 873379101 / 054540208 / 68619K20 / 683344105 / 92556H206 / 683373104 / 09624H208 / 62011B102 / 43538H103</td><td class="leftalignment">AMN Healthcare Services Inc / Cross Country Healthcare Inc / EOG Resources Inc / Skyworks Solutions Inc / Regeneron Pharmaceuticals Inc / World Wrestling Entertainment Inc / Gray Television Inc / DISH Network Corp / Builders FirstSource Inc / HNI Corp / MillerKnoll Inc / Neogenomics Inc / Steelcase Inc / Expedia Group Inc / Blucora Inc / Chembio Diagnostics Inc / Nova Ltd / Alpha and Omega Semiconductor Ltd / Tegna Inc / Lions Gate Entertainment Corp / Liberty Media Corp / Cars.com Inc / TrueCar Inc / nLIGHT Inc / Tabula Rasa HealthCare Inc / Axcelis Technologies Inc / Orgenesis Inc / Onto Innovation Inc / ViacomCBS Inc / Ontrak Inc / Bluelinx Holdings Inc / Motorsport Games Inc / Holley Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Brazil / Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Subash Chandra, CFA / David Williams / Mr. Cody Acree / Mr. Daniel L. Kurnos, CFA / Mr. Matthew Harrigan / Mr. Reuben Garner / Mr. Bill Sutherland / Mike Hickey / Mr. Bruce D. Jackson / Mr. John Lawrence / Mr. Mark Miller</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">3Q21: Elephant In The Room; Downgrade To Hold</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">3Q21 Results; Cosibelimab Top-Line Data Imminent; BLA Submission Within Spitting Distance</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">162828107 / REGN.OQ</td><td class="leftalignment">Checkpoint Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q21 Review: Moving from Strength to Strength</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">REGN.O / GILD.O / 771195104</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">PFE's COVID anti-viral could be a hard pill to swallow for competitors</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE=US / REGN=US</td><td class="leftalignment">Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Nov 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US0126531013 / US01988P1084 / US0231351067 / US0382221051 / US0758871091 / US1265011056 / US1266501006 / US16411R2085 / US1924221039 / US22284P1057 / US2358511028 / US2480191012 / US3021301094 / US3755581036 / US4234521015 / US4433201062 / US4448591028 / US4456581077 / US4523271090 / US45253H1014 / US45337C1027 / US4581401001 / US4657411066 / US4824801009 / US5128071082 / US5150981018 / US5184151042 / US5370081045 / US55306N1046 / US5763231090 / US58155Q1031 / US5950171042 / US5951121038 / US67066G1040 / US6745991058 / US6795801009 / US6821891057 / US7392761034 / US7475251036 / US75886F1075 / US8006771062 / US8168501018 / US8610121027 / US8835561023 / US9029251066 / US91347P1057 / US9282981086 / US9507551086 / US9581021055 / US9839191015 / US03073E1055 / US87157D1090 / AU000000LYC6 / US83088M1027 / LU0156801721 / US6402681083 / US88031M1099 / US02043Q1076 / US6098391054 / US6866881021 / US19239V3024 / US50187A1079 / US12541W2098 / US82706C1080 / US57636Q1040 / US78709Y1055 / US75025X1000 / US29089Q1058 / US45784P1012 / US53261M1045 / US88076W1036 / US25470M1099 / US34959E1091 / US1920051067 / US39304D1028 / NL0009538784 / US40412C1018 / JE00B783TY65 / US30212P3038 / US9837931008 / US00912X3026 / US55405Y1001 / US74587V1070 / US41068X1000 / US29428V1044 / US00847X1046 / US00771V1089 / US70438V1061 / US03937C1053 / US69888T2078 / US94419L1017 / US0465131078 / US0994061002 / US2681582019 / US0367521038 / US23283X2062 / US74736K1016 / US9283771007 / US8190471016 / US12685J1051 / US6323071042 / US72703H1014 / US37890U1088 / US74624M1027 / US50127T1097 / US8522341036 / US28106W1036 / US87164F1057 / US00773U1088 / US02081G2012 / US98419J2069 / US01345P1066 / US2067871036 / CA87241L1094 / NL0012169213 / US91325V1089 / US23753F1075 / US80689H1023 / US1468691027 / US03782L1017 / US24665A1034 / US02156K1034 / US4990491049 / US74766Q1013 / US4622601007 / US5011471027 / US03753U1060 / US57777K1060 / US05351X1019 / US05455M1009 / US55910K1088 / US0937121079 / US0197701065 / US53814L1089 / US68570P1012 / US1255231003 / US0144421072 / US98420X1037 / US62921N1054 / US90353T1007 / US70202L1026 / US05352A1007 / US18915M1071 / US85205L1070 / US70614W1009 / US92764N1028 / CA74319B5027 / US69242L1061 / US03969K1088 / US92537N1081 / US7027121000 / US39813G1094 / US4432011082 / CH0499880968 / US57667L1070 / US6833731044 / US65487U1088 / US0843101017 / US12769G1004 / US5015751044 / US20451W1018 / US69353Y1038 / US81181C1045 / US05875B1061 / US5533681012 / US0090661010 / US65443P1021 / US01625V1044 / US5738741041 / US92719V1008 / US25401T1088 / US20717M1036 / US45250K1079 / US00109K1051 / US74276L1052 / 50066V107</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Albemarle Corp / Allscripts Healthcare Solutions Inc / Amazon.com Inc / Applied Materials Inc / Becton Dickinson and Co / CTS Corp / CVS Health Corp / Cheniere Energy Inc / Cognex Corp / Covenant Logistics Group Inc / Danaher Corp / Deluxe Corp / Expeditors International of Washington Inc / Gilead Sciences Inc / Helmerich and Payne Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / Illumina Inc / ImmunoGen Inc / Incyte Corp / Intel Corp / Itron Inc / KLA Corp / Lam Research Corp / Landstar System Inc / Lattice Semiconductor Corp / Littelfuse Inc / MKS Instruments Inc / MasTec Inc / Mckesson Corp / Microchip Technology Inc / Micron Technology Inc / NVIDIA Corp / Occidental Petroleum Corp / Old Dominion Freight Line Inc / ON Semiconductor Corp / Power Integrations Inc / Qualcomm Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Semtech Corp / STMicroelectronics NV / Thermo Fisher Scientific Inc / USA Truck Inc / Universal Display Corp / Vishay Intertechnology Inc / Werner Enterprises Inc / Western Digital Corp / Xilinx Inc / Amerisourcebergen Corp / Synaptics Inc / Lynas Rare Earths Ltd / Skyworks Solutions Inc / Tenaris SA / Nektar Therapeutics / Tenaris SA / Alnylam Pharmaceuticals Inc / Monolithic Power Systems Inc / Ormat Technologies Inc / Cogent Communications Holdings Inc / LHC Group Inc / CH Robinson Worldwide Inc / Silicon Motion Technology Corp / Mastercard Inc / Saia Inc / Radiant Logistics Inc / Emergent BioSolutions Inc / Insulet Corp / Limelight Networks Inc / Teradata Corp / DISH Network Corp / Fortinet Inc / Codexis Inc / Green Dot Corp / NXP Semiconductors NV / HCA Healthcare Inc / Aptiv PLC / Expedia Group Inc / XPO Logistics Inc / Air Lease Corp / MACOM Technology Solutions Holdings Inc / Puma Biotechnology Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Epizyme Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Paylocity Holding Corp / ArcBest Corp / Par Pacific Holdings Inc / Wayfair Inc / Atara Biotherapeutics Inc / Boot Barn Holdings Inc / Dynavax Technologies Corp / Anthem Inc / Cytosorbents Corp / Qorvo Inc / Vista Outdoor Inc / Shake Shack Inc / Cable One Inc / Natera Inc / Planet Fitness Inc / Global Blood Therapeutics Inc / Pure Storage Inc / Kura Oncology Inc / Block Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Alphatec Holdings Inc / XOMA Corp / Albireo Pharma Inc / Conduent Inc / TFI International Inc / Qiagen NV / Uniti Group Inc / Daseke Inc / Schneider National Inc / Carvana Co / Appian Corp / Delek US Holdings Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Quanterix Corp / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / MaxCyte Inc / Avaya Holdings Corp / AVROBIO Inc / Magenta Therapeutics Inc / Bloom Energy Corp / Allogene Therapeutics Inc / Livent Corp / Orchard Therapeutics PLC / Cigna Corp / Alector Inc / X4 Pharmaceuticals Inc / NGM Biopharmaceuticals Inc / Uber Technologies Inc / Parsons Corp / Avantor Inc / Cloudflare Inc / SpringWorks Therapeutics Inc / Peloton Interactive Inc / Vir Biotechnology Inc / Profound Medical Corp / Oyster Point Pharma Inc / Arcutis Biotherapeutics Inc / Vertiv Holdings Co / Passage Bio Inc / Grid Dynamics Holdings Inc / Howmet Aerospace Inc / ADC Therapeutics SA / Match Group Inc / Ontrak Inc / Nkarta Inc / Berkeley Lights Inc / Caesars Entertainment Inc / Kymera Therapeutics Inc / Compass Pathways PLC / PMV Pharmaceuticals Inc / Seagen Inc / Bally's Corp / Mp Materials Corp / Airbnb Inc / 908 Devices Inc. / Alignment Healthcare Inc / Marvell Technology Inc / Vimeo Inc / DigitalBridge Group Inc / Confluent Inc / Imago BioSciences Inc / AFC Gamma Inc / Procept Biorobotics Corp / KORE Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CARS / DNB / FISV=US / OXY=US / TWTR=US / ADI=US / T=US / RUN=US / GILD=US / CPE=US / EOG=US / TRU=US / WLL=US / PXD=US / PAA=US / SWN=US / MUR=US / MRO=US / EXPE=US / VMC=US / PENN=US / BKI=US / CI=US / W=US / MLM=US / DISH=US / AMN=US / ARW=US / AVT=US / BLL=US / BL=US / KIDS=US / CHH=US / COLL=US / CSGP=US / CW=US / DRH=US / IBP=US / MCHP=US / ORCC=US / OI=US / PCTY=US / RARE=US / REGN=US / SGMO=US / STOR=US / STRA=US / TRGP=US / WW=US / GOLF=US / CVX=US / NET=US / GPN=US / CCRN=US / MANT=US / FNF=US / FRT=US / OHI=US / REG=US / APPN=US / DIN=US / MGNI=US / ATRS=US / MNST=US / PTON=US / IGMS=US / NOMD=US / SHO=US / DENN=US / LHCG=US / BLDR=US / SPWR=US / FIS=US / CCOI=US / GPRE=US / CLR=US / LLNW=US / PAGP=US / ATSG=US / IAC=US / PSN=US / AGS=US / GDOT=US / RLJ=US / CUBE=US / ANGI=US / MEIP=US / GMED=US / FOXF=US / LDOS=US / FATE=US / MBUU=US / QTWO=US / LOCO=US / AFMD=US / CIVI=US / SHAK=US / ZBH=US / CABO=US / SQ=US / NTLA=US / VVV=US / IRTC=US / LGF.B=US / CVNA=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / FNKO=US / LAZY=US / EQH=US / FOCS=US / ALLO=US / AXNX=US / UBER=US / LSPD=US / PLMR=US / XAIR=US / DDOG=US / AHCO=US / OPCH=US / REYN=US / BIGC=US / BALY=US / DASH=US / ROCC=US / VMEO=US / DBRG=US / SNPO=US / EWCZ=US / MNDT=US / CRXT=US</td><td class="leftalignment">Cars.com Inc / Dun & Bradstreet Holdings Inc / Fiserv Inc / Occidental Petroleum Corp / Twitter Inc / Analog Devices Inc / AT&T Inc / Sunrun Inc / Gilead Sciences Inc / Callon Petroleum Co / EOG Resources Inc / TransUnion / Whiting Petroleum Corp / Pioneer Natural Resources Co / Plains All American Pipeline LP / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Vulcan Materials Co / Penn National Gaming Inc / Black Knight Inc / Cigna Corp / Wayfair Inc / Martin Marietta Materials Inc / DISH Network Corp / AMN Healthcare Services Inc / Arrow Electronics Inc / Avnet Inc / Ball Corp / Blackline Inc / OrthoPediatrics Corp / Choice Hotels International Inc / Collegium Pharmaceutical Inc / CoStar Group Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Installed Building Products Inc / Microchip Technology Inc / Owl Rock Capital Corp / O-I Glass Inc / Paylocity Holding Corp / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / STORE Capital Corp / Strategic Education Inc / Targa Resources Corp / WW International Inc / Acushnet Holdings Corp / Chevron Corp / Cloudflare Inc / Global Payments Inc / Cross Country Healthcare Inc / ManTech International Corp / Fidelity National Financial Inc / Federal Realty Investment Trust / Omega Healthcare Investors Inc / Regency Centers Corp / Appian Corp / Dine Brands Global Inc / Magnite Inc / Antares Pharma Inc / Monster Beverage Corp / Peloton Interactive Inc / IGM Biosciences Inc / Nomad Foods Ltd / Sunstone Hotel Investors Inc / Denny's Corp / LHC Group Inc / Builders FirstSource Inc / SunPower Corp / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Green Plains Inc / Continental Resources Inc / Limelight Networks Inc / Plains GP Holdings LP / Air Transport Services Group Inc / IAC/Interactivecorp / Parsons Corp / PlayAGS Inc / Green Dot Corp / RLJ Lodging Trust / CubeSmart / Angi Inc / MEI Pharma Inc / Globus Medical Inc / Fox Factory Holding Corp / Leidos Holdings Inc / Fate Therapeutics Inc / Malibu Boats Inc / Q2 Holdings Inc / El Pollo Loco Holdings Inc / Affimed NV / Civitas Resources Inc / Shake Shack Inc / Zimmer Biomet Holdings Inc / Cable One Inc / Block Inc / Intellia Therapeutics Inc / Valvoline Inc / iRhythm Technologies Inc / Lions Gate Entertainment Corp / Carvana Co / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Funko Inc / Lazydays Holdings Inc / Equitable Holdings Inc / Focus Financial Partners Inc / Allogene Therapeutics Inc / Axonics Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Palomar Holdings Inc / Beyond Air Inc / Datadog Inc / Adapthealth Corp / Option Care Health Inc / Reynolds Consumer Products Inc / Bigcommerce Holdings Inc / Bally's Corp / DoorDash Inc / Ranger Oil Corp / Vimeo Inc / DigitalBridge Group Inc / Snap One Holdings Corp / European Wax Center Inc / Mandiant Inc / Clarus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Strong Quarter for Core and COVID – Raising Estimates, PT to $850</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">75886F10 / F5548N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">NTLA Reports 3Q21; Announces Upcoming Catalysts, Forms Strategic Partnerships and Advances New Development Candidates</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NTLA.OQ / REGN.OQ</td><td class="leftalignment">Intellia Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">204</td><td class="leftalignment">IL0002810146 / GB0000456144 / US0091581068 / US0126531013 / US0236081024 / US0351282068 / US0584981064 / US4227041062 / US4878361082 / US5950171042 / US6516391066 / US6988131024 / US7549071030 / US75886F1075 / US7802871084 / US8425871071 / CA1367178326 / CA29250N1050 / CA8029121057 / CA85472N1096 / CA5649051078 / CA8787422044 / CA0679011084 / CA1363851017 / CA6837151068 / CA3759161035 / CA0099051009 / CA3039011026 / CA7481932084 / US87157D1090 / US83088M1027 / US15189T1079 / US2274831047 / CA2265331074 / CA56501R1064 / CA8667961053 / CA39138C1068 / US12008R1077 / CA6993202069 / US1252691001 / CA21037X1006 / CA05534B7604 / CA32076V1031 / CA3518581051 / US3932221043 / US91912E1055 / US34959E1091 / CA07317Q1054 / US18538R1032 / CA00208D4084 / CA2927661025 / JE00B4T3BW64 / US9858171054 / US26441C2044 / CA7063271034 / CA4932711001 / CA1348082035 / CA3874371147 / CA0158571053 / CA6665111002 / CA74061A1084 / US6951271005 / CA29269R1055 / CA3748252069 / US1716041017 / CA58546R1091 / CA17039A1066 / US85208M1027 / US2267181046 / CA14150G4007 / US78667J1088 / US1638511089 / CA8485101031 / US86771W1053 / US72703H1014 / CA3803551074 / US13462K1097 / CA9628791027 / US00737L1035 / US00183L1026 / CA4707481046 / US03753U1060 / US03168L1052 / CA75622P1045 / US76029N1063 / US34417P1003 / US46005L1017 / US53814L1089 / CA13000C2058 / US62921N1054 / CA87807B1076 / US22052L1044 / US61775R1059 / CA29446Y5020 / US03768E1055 / US70614W1009 / CA36168Q1046 / US69526K1051 / US3773201062 / CA89055A2039 / CA83615X4075 / US44891N2080 / US92719V1008 / CA65532M6062 / CA53229C1077</td><td class="leftalignment">Icl Group Ltd / Antofagasta PLC / Air Products and Chemicals Inc / Albemarle Corp / Ameren Corp / AngloGold Ashanti Ltd / Ball Corp / Hecla Mining Co / Kellogg Co / Microchip Technology Inc / Newmont Corporation / Papa John's International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Southern Co / Canadian Utilities Ltd / Enbridge Inc / Saputo Inc / Stantec Inc / Maple Leaf Foods Inc / Teck Resources Ltd / Barrick Gold Corp / Canadian Natural Resources Ltd / Open Text Corp / Gildan Activewear Inc / AKITA Drilling Ltd / Fairfax Financial Holdings Ltd / Quebecor Inc / Synaptics Inc / Skyworks Solutions Inc / CenterPoint Energy Inc / Cross Country Healthcare Inc / Crew Energy Inc / Manulife Financial Corp / Sun Life Financial Inc / Great-West Lifeco Inc / Builders FirstSource Inc / Paramount Resources Ltd / CF Industries Holdings Inc / Constellation Software Inc / BCE Inc / First Majestic Silver Corp / Franco-Nevada Corp / Green Plains Inc / Vale SA / Fortinet Inc / Baytex Energy Corp / Clearwater Paper Corp / ARC Resources Ltd / Enerplus Corp / Glencore PLC / Yelp Inc / Duke Energy Corp / Pembina Pipeline Corp / Keyera Corp / Canacol Energy Ltd / Granite Real Estate Investment Trust / Algonquin Power & Utilities Corp / Northland Power Inc / Premium Brands Holdings Corp / Pacira Biosciences Inc / Enerflex Ltd / Gibson Energy Inc / Chuy's Holdings Inc / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Sprouts Farmers Market Inc / Criteo SA / Cardinal Energy Ltd (Alberta) / SAGE Therapeutics Inc / Chemours Co / Spin Master Corp / Sunrun Inc / Planet Fitness Inc / goeasy Ltd / Camping World Holdings Inc / Wheaton Precious Metals Corp / Adtalem Global Education Inc / Angi Inc / Jamieson Wellness Inc / Apellis Pharmaceuticals Inc / Amneal Pharmaceuticals Inc / Recipe Unlimited Corp / Replimune Group Inc / Focus Financial Partners Inc / International Money Express Inc / Livent Corp / Calibre Mining Corp / NGM Biopharmaceuticals Inc / TC Energy Corp / Corteva Inc / Morphic Holding Inc / Equinox Gold Corp / Apollo Global Management Inc / Peloton Interactive Inc / GFL Environmental Inc / Pactiv Evergreen Inc / Glatfelter Corp / Topaz Energy Corp / Source Energy Services Ltd / IAC/Interactivecorp / Vimeo Inc / Nomad Royalty Company Ltd / Lightspeed Commerce Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / France / United Kingdom / Israel / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">0925288 / 2486813 / 2778844 / 2050832 / 2045623 / 2942605 / 2111955 / 2219224 / 2206657 / 2216850 / 2222631 / 2317087 / 2670519 / 2613990 / 2471950 / 2632003 / 2645409 / 2657802 / 2680905 / 2730190 / 2440637 / 2799351 / 2825933 / 2829601 / 2980906 / 2503529 / 2783815 / B1HMF22 / 2212922 / 2857817 / B02R1L6 / B2R3PV1 / B3D7K31 / 2598246 / 2390817 / B44C366 / B783TY6 / B7VD3F2 / BCZS820 / B95N910 / B95WG16 / BZ07BW4 / BVVN4Q8 / BFZNYB7 / BKS3SM8 / BJ1FD74 / BKTHM05 / BR4T3B3 / BJ2Z0H2 / BYZM6C2 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BFXC911 / BKTNTR9 / BZ05388 / BJVR9Y9 / BYYWPW6 / BHZSB82 / BD6D4Y5 / BJ9NFQ3 / BZ1LFG7 / BGT3960 / BYY88Y7 / BYSGPK2 / BKX9VD3 / BZ0P3Z5 / BJMLSD2 / BYSFJV8 / BYTJZL1 / BWY4XV3 / BJTJGC4 / BDRW1L7 / BF3N4P3 / BQXZP64 / BMDCDP2 / BYXB1Y8 / BGDQ8B3 / BD8QGD5 / BD72R64 / BLR6S36 / BN2S6Y8 / BKVK9N4</td><td class="leftalignment">GlaxoSmithKline PLC / Kellogg Co / Merck & Co Inc / Ameren Corp / ANSYS Inc / Avista Corp / Borgwarner Inc / CMS Energy Corp / Coca-Cola Co / Consolidated Edison Inc / Cooper Companies Inc / Entergy Corp / Exelon Corp / Illumina Inc / Incyte Corp / New York Times Co / NiSource Inc / OGE Energy Corp / PPL Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Southern Co / Foot Locker Inc / World Wrestling Entertainment Inc / Zimmer Biomet Holdings Inc / First Solar Inc / NRG Energy Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Neogenomics Inc / Gray Television Inc / Heska Corp / Aptiv PLC / Duke Energy Corp / Fate Therapeutics Inc / PTC Inc / Zoetis Inc / Monster Beverage Corp / Eversource Energy / Allogene Therapeutics Inc / IGM Biosciences Inc / Revolve Group Inc / Passage Bio Inc / HubSpot Inc / Pinterest Inc / Intellia Therapeutics Inc / Evergy Inc / Fox Corp / Vistra Corp / Guardant Health Inc / ViacomCBS Inc / Global Blood Therapeutics Inc / iHeartMedia Inc / Beigene Ltd / Covetrus Inc / Altair Engineering Inc / Neoleukin Therapeutics Inc / Roku Inc / Orchard Therapeutics PLC / Alphabet Inc / ViewRay Inc / Arcutis Biotherapeutics Inc / Tegna Inc / Karuna Therapeutics Inc / Planet Fitness Inc / Zogenix Inc / Adaptimmune Therapeutics PLC / Kontoor Brands Inc / AnaptysBio Inc / Arena Pharmaceuticals Inc / Wayfair Inc / Bigcommerce Holdings Inc / Sunrun Inc / Axonics Inc / Liberty Media Corp / Liberty Media Corp / Longboard Pharmaceuticals Inc / Talaris Therapeutics Inc / European Wax Center Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">US4523271090 / US75886F1075 / US98956P1021 / INSG.OQ / ATEC.OQ / US45784P1012 / 004498101 / 008073108 / US3795772082 / US74736L1098 / BCBVTX1 / 94419L101 / 852234103 / 70975L107 / 632307104 / 046513107 / 13173L107 / 89853L104 / 450056106 / 019770106 / 37890U108 / 89377M109 / 90353T100 / 05338G106 / 73931J109 / 70614W100 / 090043100 / 683373104 / 00653Q102 / 34380C102 / 08975P108 / 009066101 / 62011B102 / 67577R102 / 25402D102 / 74275K108 / 126638105 / 92561V109 / 75724T103</td><td class="leftalignment">Illumina Inc / Regeneron Pharmaceuticals Inc / Zimmer Biomet Holdings Inc / Inseego Corp / Alphatec Holdings Inc / Insulet Corp / ACI Worldwide Inc / AeroVironment Inc / Globus Medical Inc / Q2 Holdings Inc / Agios Pharmaceuticals Inc / Wayfair Inc / Block Inc / Penumbra Inc / Natera Inc / Atara Biotherapeutics Inc / Calyxt Inc / T2 Biosystems Inc / iRhythm Technologies Inc / Allogene Therapeutics Inc / Global Blood Therapeutics Inc / Transmedics Group Inc / Uber Technologies Inc / Avalara Inc / PowerFleet Inc / Peloton Interactive Inc / Bill.com Holdings Inc / Ontrak Inc / Adapthealth Corp / Fluent Inc / Bigcommerce Holdings Inc / Airbnb Inc / Motorsport Games Inc / Ocuphire Pharma Inc / DigitalOcean Holdings Inc / Procore Technologies Inc / CVRx Inc / Vicarious Surgical Inc / Redbox Entertainment Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">The Triumvirate of Dupixent, Eylea and REGEN-COV Drive 3Q2021 Revenue and EPS Beat; Reiterate Buy; Raise PT to $844</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.OQ / ACET.OQ / 02043Q107 / NTLA.OQ / 09075V102 / 76029N106 / 24343R106</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Adicet Bio Inc / Alnylam Pharmaceuticals Inc / Intellia Therapeutics Inc / BioNTech SE / Replimune Group Inc / Decibel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CD20xCD3 Field Continues to Rumble Onwards at ASH</td><td class="leftalignment">English</td><td class="rightalignment">56</td><td class="leftalignment">75886F10 / 478160104 / 00287Y10 / 98401F10 / 98887Q10 / 37230320</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Abbvie Inc / Xencor Inc / Zai Lab Ltd / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Geoffrey Porges, MBBS / Faisal Khurshid / Nick Huang</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">ALTR.O / ANA.MC / BCE.TO / CF.N / CI.N / CSGN.S / ECL.N / EDP.LS / FMC.N / RYN.N / TMX.N / CNQ.TO / GILD.O / INCY.O / RBA.N / MET.N / WCC.N / K.N / CTXS.O / MFC.TO / MRO.N / VMC.N / JAZZ.O / RKT.N / SGMO.O / MTG.N / MDRX.O / ARNA.O / LNC.N / CTAS.O / FDS.N / EXPE.O / DNB.N / OTEX.O / GIL.N / REGN.O / VRTX.O / MCO.N / NET.N / SLF.TO / HCC.N / TRU.N / NTCT.OQ / SEM.N / MNST.O / ANSS.O / VIAC.O / LHCG.O / BKD.N / FIS.N / 443628102 / CLR.N / PPL.TO / TDC.N / MSCI.N / VRSK.O / FTNT.O / CTT.N / RFP.N / FFHu.TO / ORCC.N / PRMW.N / KPTI.O / XNCR.OQ / IBP.N / QTWO.N / CIA.TO / 03835T200 / SUM.N / EVA.N / GBT.OQ / RUN.O / SQ.N / SPGI.N / ADVM.OQ / NTLA.O / UN01.DE / LGFB.N / SAND.N / CVNA.N / WPM.N / ATUS.N / RDFN.O / ATNX.O / APTV.N / DBX.O / EQH.N / PRVB.O / FOCS.O / GMDA.OQ / PINS.N / UBER.N / CTVA.N / MORF.OQ / GMAB.O / DDOG.O / APRE.OQ / IGMS.O / NLOK.O / REYN.O / SLQT.N / NKLA.OQ / OTRK.OQ / PTVE.O / ABNB.OQ / LSPD.N / ANE.MC / ZD.OQ / 120681711</td><td class="leftalignment">Altair Engineering Inc / Acciona SA / BCE Inc / CF Industries Holdings Inc / Cigna Corp / Credit Suisse Group AG / Ecolab Inc / EDP Energias de Portugal SA / FMC Corp / Rayonier Inc / Terminix Global Holdings Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Incyte Corp / Ritchie Bros Auctioneers Inc / MetLife Inc / Wesco International Inc / Kellogg Co / Citrix Systems Inc / Manulife Financial Corp / Marathon Oil Corp / Vulcan Materials Co / Jazz Pharmaceuticals PLC / Rocket Companies Inc / Sangamo Therapeutics Inc / MGIC Investment Corp / Allscripts Healthcare Solutions Inc / Arena Pharmaceuticals Inc / Lincoln National Corp / Cintas Corp / Factset Research Systems Inc / Expedia Group Inc / Dun & Bradstreet Holdings Inc / Open Text Corp / Gildan Activewear Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moody's Corp / Cloudflare Inc / Sun Life Financial Inc / Warrior Met Coal Inc / TransUnion / Netscout Systems Inc / Select Medical Holdings Corp / Monster Beverage Corp / ANSYS Inc / ViacomCBS Inc / LHC Group Inc / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Hudbay Minerals Inc / Continental Resources Inc / Pembina Pipeline Corp / Teradata Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / CatchMark Timber Trust Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Owl Rock Capital Corp / Primo Water Corp / Karyopharm Therapeutics Inc / Xencor Inc / Installed Building Products Inc / Q2 Holdings Inc / Champion Iron Ltd / Aptose Biosciences Inc / Summit Materials Inc / Enviva Inc / Global Blood Therapeutics Inc / Sunrun Inc / Block Inc / S&P Global Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / Uniper SE / Lions Gate Entertainment Corp / Sandstorm Gold Ltd / Carvana Co / Wheaton Precious Metals Corp / Altice USA Inc / Redfin Corp / Athenex Inc / Aptiv PLC / Dropbox Inc / Equitable Holdings Inc / Provention Bio Inc / Focus Financial Partners Inc / Gamida Cell Ltd / Pinterest Inc / Uber Technologies Inc / Corteva Inc / Morphic Holding Inc / Genmab A/S / Datadog Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / NortonLifeLock Inc / Reynolds Consumer Products Inc / SelectQuote Inc / Nikola Corp / Ontrak Inc / Pactiv Evergreen Inc / Airbnb Inc / Lightspeed Commerce Inc / Corporacion Acciona Energias Renovables SA / Ziff Davis Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / Spain / Ireland / Israel / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Regeneron Pharmaceuticals Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare - 30th Annual Credit Suisse Healthcare Conference in HOLT</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">ABT.N / TMO.N / BMY.N / BSX.N / CVS.N / SYK.N / RMD.N / HCA.N / REGN.OQ / OMCL.OQ / VRTX.OQ / NUVA.OQ / ICLR.OQ / ADUS.OQ / HZNP.OQ / GMED.N / ANTM.N / MEDP.OQ</td><td class="leftalignment">Abbott Laboratories / Thermo Fisher Scientific Inc / Bristol-Myers Squibb Co / Boston Scientific Corp / CVS Health Corp / Stryker Corp / Resmed Inc / HCA Healthcare Inc / Regeneron Pharmaceuticals Inc / Omnicell Inc / Vertex Pharmaceuticals Inc / NuVasive Inc / ICON PLC / Addus Homecare Corp / Horizon Therapeutics PLC / Globus Medical Inc / Anthem Inc / Medpace Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steven Bock / HOLT Americas</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">3Q21 Update - Cardiomyopathy Patients Now Eligible For Lead Asset NTLA-2001</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">45826J105 / 75886F10</td><td class="leftalignment">Intellia Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Silvan Tuerkcan</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">REGN - REGN 3Q21 Postview:  REGEN-COV drives another beat as investors await clarity on the pipeline</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Q3:21 post-call: Q3 sees solid beat as SITC & ASH come into focus</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : 3Q Snapshot - Big COVID Beat on Top of Solid Base Business Execution</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Regeneron Pharmaceuticals</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASH 2021 spotlight on REGN, GILD, MEIP, ATNX, SGMO and Aruvant</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN=US / ATNX.OQ / GILD=US / MEIP.OQ / SGMO.OQ / SGMO=US / MEIP=US / ATNX=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Athenex Inc / Gilead Sciences Inc / MEI Pharma Inc / Sangamo Therapeutics Inc / Sangamo Therapeutics Inc / MEI Pharma Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Strong Underlying Q3 and Sustained COVID Ab Revenue while Waiting for Co-Stims</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let the Good Times Roll - Another Week of Biotech Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Quick Thoughts On Key Moving Parts</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Solid Q3 Beat Driven By Strong Eylea/Dupixent/REGEN-COV Sales</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US75886F1075 / US85205L1070 / US65487U1088 / US69353Y1038</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / SpringWorks Therapeutics Inc / Nkarta Inc / PMV Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">3Q21: Results Ahead of Expectations</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Eylea continues to see growth; additional REGEN-COV agreement reached with U.S government</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Post-3Q21 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">REGN - REGN 3Q21 – They said what?! Highlights from the conf call…and our perspective</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Not Just About REGEN-COV; Business is Hitting On All Cylinders</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : First Look at 3Q Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Wake Up and Get a $35M Check; 3Q21 Results Continue to Show Partners' Progress</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">98419J206 / REGN.OQ / RZLT.OQ / VIRX.OQ</td><td class="leftalignment">XOMA Corp / Regeneron Pharmaceuticals Inc / Rezolute Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on November 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PINS.N / AES.N / AIG.N / APD.N / BDX.N / BP.L / EOG.N / IBM.N / OXY.N / SLB.N / SO.N / HAL.N / DUK.N / PH.N / K.N / VMC.N / XOM.N / MTD.N / BLL.N / NRG.N / PWR.N / HWM.N / ABC.N / IRM.N / NET.N / CNP.N / AAPL.OQ / MSFT.OQ / REGN.OQ / SBUX.OQ / AAON.OQ / MCHP.OQ / XRAY.OQ / PENN.OQ / DISH.OQ / CTXS.OQ / AMZN.OQ / ILMN.OQ / SWKS.OQ / MNST.OQ / 0700.HK / VIAC.OQ / RDSa.L / LYV.N / FIS.N / HBI.N / 9999.HK / MRNA.OQ / NWSA.OQ / FTNT.OQ / MSI.N / HII.N / BKR.N / EPAM.N / ZTS.N / GOGO.OQ / ZBH.N / FND.N / APTV.N / WELL.N / REG.OQ / LNT.OQ / LYFT.OQ / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pinterest Inc / AES Corp / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / BP PLC / EOG Resources Inc / International Business Machines Corp / Occidental Petroleum Corp / Schlumberger NV / Southern Co / Halliburton Co / Duke Energy Corp / Parker-Hannifin Corp / Kellogg Co / Vulcan Materials Co / Exxon Mobil Corp / Mettler-Toledo International Inc / Ball Corp / NRG Energy Inc / Quanta Services Inc / Howmet Aerospace Inc / Amerisourcebergen Corp / Iron Mountain Inc / Cloudflare Inc / CenterPoint Energy Inc / Apple Inc / Microsoft Corp / Regeneron Pharmaceuticals Inc / Starbucks Corp / Aaon Inc / Microchip Technology Inc / DENTSPLY SIRONA Inc / Penn National Gaming Inc / DISH Network Corp / Citrix Systems Inc / Amazon.com Inc / Illumina Inc / Skyworks Solutions Inc / Monster Beverage Corp / Tencent Holdings Ltd / ViacomCBS Inc / Royal Dutch Shell PLC / Live Nation Entertainment Inc / Fidelity National Information Services Inc / HanesBrands Inc / NetEase Inc / Moderna Inc / News Corp / Fortinet Inc / Motorola Solutions Inc / Huntington Ingalls Industries Inc / Baker Hughes Co / Epam Systems Inc / Zoetis Inc / Gogo Inc / Zimmer Biomet Holdings Inc / Floor & Decor Holdings Inc / Aptiv PLC / Welltower Inc / Regency Centers Corp / Alliant Energy Corp / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / United States / Jersey / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">3Q21 Quick Take: 3Q21 driven by REGEN-COV beat and FY2021 driven by higher Dupi sales</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Brief of Regeneron Pharmaceuticals Inc conference call, Nov. 04, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Nov. 04, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - 3Q21 - Another Solid Quarter, Topline Beat Driven By REGEN-COV; Dupixent Continues to Outperform High Expectations</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q321 First Look: Solid Quarter Across the Board</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Q3:21 at first blush: top-/bottom-line beat driven by core product outperformance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: November 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / EOG.N / PNW.N / SO.N / WMT.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / HD.N / LOW.N / TGT.N / JCI.N / DHI.N / SRE.N / ATO.N / VTR.N / CSCO.OQ / JKHY.OQ / REGN.OQ / QCOM.OQ / MCHP.OQ / TPR.N / NVDA.OQ / ILMN.OQ / FIS.N / TDG.N / MRNA.OQ / FTNT.OQ / MSI.N / ZTS.N / PYPL.OQ / WRK.N / APTV.N / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / EOG Resources Inc / Pinnacle West Capital Corp / Southern Co / Walmart Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Lowe's Companies Inc / Target Corp / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Atmos Energy Corp / Ventas Inc / Cisco Systems Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Qualcomm Inc / Microchip Technology Inc / Tapestry Inc / NVIDIA Corp / Illumina Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Moderna Inc / Fortinet Inc / Motorola Solutions Inc / Zoetis Inc / PayPal Holdings Inc / Westrock Co / Aptiv PLC / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for REGN</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">OPK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPK.O / ABT / BMY / JNJ / LH / REGN.O / ALNY.O / ARDX.O / TEVA.K</td><td class="leftalignment">OPKO Health Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ardelyx Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AAPL / AMGN / AOS / APP / APPS / CSWC / DISH / ECL / HRB / INCY / INSP / INTC.O / IRTC / IS / KLAC.O / MSFT / PNR / RNG / ROK / RSI / RXN / SAGE / T / U / WMT / WTS / MWA / ATVI.O / AKAM / VECO.O / IART.O / VZ / AQUA / GPN / REGN.O / VRTX.O / FRSH.OQ / AMED.O / EXAS.O / BIIB / 478160104 / DENN.O / LHCG.O / XPO / INFI.O / Z.O / 88162G103 / MRNA.O / ADUS.O / XYL / TMUS / AGRX.O / RXDX.O / SEDG.O / VRAY / TTD.O / UAA / EGHT.K / 83417M104 / FRG.O / DKNG / CGTX.OQ</td><td class="leftalignment">Apple Inc / Amgen Inc / A O Smith Corp / Applovin Corp / Digital Turbine Inc / Capital Southwest Corp / DISH Network Corp / Ecolab Inc / H & R Block Inc / Incyte Corp / Inspire Medical Systems Inc / Intel Corp / iRhythm Technologies Inc / Ironsource Ltd / KLA Corp / Microsoft Corp / Pentair PLC / RingCentral Inc / Rockwell Automation Inc / Rush Street Interactive Inc / Zurn Water Solutions Corp / SAGE Therapeutics Inc / AT&T Inc / Unity Software Inc / Walmart Inc / Watts Water Technologies Inc / Mueller Water Products Inc / Activision Blizzard Inc / Akamai Technologies Inc / Veeco Instruments Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Evoqua Water Technologies Corp / Global Payments Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Freshworks Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Denny's Corp / LHC Group Inc / XPO Logistics Inc / Infinity Pharmaceuticals Inc / Zillow Group Inc / Tetra Tech Inc / Moderna Inc / Addus Homecare Corp / Xylem Inc / T-Mobile US Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Solaredge Technologies Inc / ViewRay Inc / Trade Desk Inc / Under Armour Inc / 8x8 Inc / Solaredge Technologies Inc / Franchise Group Inc / DraftKings Inc / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Pulse Call Takeaways: Co-Stims Are Coming & Could Even Get Crowded</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">45337C10 / 03116210 / 75886F10 / 478160104 / 98401F10 / 09075V10 / N5749R10 / 30315R10 / 37230320 / 60853G10</td><td class="leftalignment">Incyte Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Xencor Inc / BioNTech SE / Merus NV / F-Star Therapeutics Inc / Genmab A/S / Molecular Partners AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Hong Kong / Israel / Japan / Netherlands / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Our Outlook for Regeneron’s Upcoming 3Q21 Earnings Report</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / 02043Q107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AXP.N / CNA.L / COF.N / DD.N / EL.N / F.N / GM.N / NA / SRCL.O / TMX.N / WMB.N / ZION.O / CMA.N / TRI.N / GILD.O / LPX.N / AMGN.O / ETN.N / HBAN.O / LEA.N / ADCT.N / SHW.N / OI.N / EXEL.O / AKAM.O / PACW.O / NNN.N / MRCY.O / EPD.N / AME.N / REGN.O / VRTX.O / COP.N / DCO.N / MKL.N / DFS.N / HCC.N / ADC.N / O.N / ADS.N / GPN.N / SIVB.O / COLB.O / AMED.O / WTFC.O / NTR.N / MOS.N / HUN.N / WAL.N / WU.N / PRTS.OQ / VMW.N / CLW.N / ADUS.OQ / VRSK.O / LYB.N / XYL.N / SLM.OQ / MDLZ.OQ / ALLY.N / MPLX.N / USAC.N / PRMW.N / BTG.N / RYAM.N / SAGE.OQ / SYF.N / CTLT.N / NMIH.O / CIGI.O / ZG.O / SGRY.O / RGNX.O / AROC.N / MIME.OQ / ORSTED.CO / BHC.N / LYFT.O / REYN.O / VMD.OQ / PLTR.N / 900435207 / CHK.OQ / COUR.N / ACCA.OL / 120681711</td><td class="leftalignment">American Express Co / Centrica PLC / Capital One Financial Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / National Bank of Canada / Stericycle Inc / Terminix Global Holdings Inc / Williams Companies Inc / Zions Bancorporation NA / Comerica Inc / Thomson Reuters Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Amgen Inc / Eaton Corporation PLC / Huntington Bancshares Inc / Lear Corp / ADC Therapeutics SA / Sherwin-Williams Co / O-I Glass Inc / Exelixis Inc / Akamai Technologies Inc / PacWest Bancorp / National Retail Properties Inc / Mercury Systems Inc / Enterprise Products Partners LP / AMETEK Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Conocophillips / Ducommun Inc / Markel Corp / Discover Financial Services / Warrior Met Coal Inc / Agree Realty Corp / Realty Income Corp / Alliance Data Systems Corp / Global Payments Inc / SVB Financial Group / Columbia Banking System Inc / Amedisys Inc / Wintrust Financial Corp / Nutrien Ltd / Mosaic Co / Huntsman Corp / Western Alliance Bancorp / Western Union Co / Carparts.Com Inc / VMware Inc / Clearwater Paper Corp / Addus Homecare Corp / Verisk Analytics Inc / LyondellBasell Industries NV / Xylem Inc / SLM Corp / Mondelez International Inc / Ally Financial Inc / MPLX LP / USA Compression Partners LP / Primo Water Corp / B2Gold Corp / Rayonier Advanced Materials Inc / SAGE Therapeutics Inc / Synchrony Financial / Catalent Inc / NMI Holdings Inc / Colliers International Group Inc / Zillow Group Inc / Surgery Partners Inc / Regenxbio Inc / Archrock Inc / Mimecast Ltd / Orsted A/S / Bausch Health Companies Inc / Lyft Inc / Reynolds Consumer Products Inc / Viemed Healthcare Inc / Palantir Technologies Inc / Turquoise Hill Resources Ltd / Chesapeake Energy Corp / Coursera Inc / Aker Carbon Capture ASA / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Netherlands / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: November 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / ALL.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / EOG.N / PFE.N / PNW.N / SO.N / WMT.N / PXD.N / HUM.N / MET.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / HD.N / EMR.N / JCI.N / DHI.N / SRE.N / ATO.N / VTR.N / COP.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / MCHP.OQ / TPR.N / ANSS.OQ / ILMN.OQ / EQIX.OQ / FIS.N / TDG.N / MRNA.OQ / FTNT.OQ / MSI.N / EA.OQ / ZTS.N / MAR.OQ / PYPL.OQ / WRK.N / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Allstate Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / EOG Resources Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Walmart Inc / Pioneer Natural Resources Co / Humana Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Emerson Electric Co / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Atmos Energy Corp / Ventas Inc / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Microchip Technology Inc / Tapestry Inc / ANSYS Inc / Illumina Inc / Equinix Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Moderna Inc / Fortinet Inc / Motorola Solutions Inc / Electronic Arts Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / Westrock Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q Update Validates New Launch Cycles</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN / REGN.O / 478160104</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 73 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / PLUG.OQ / CHTR.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / EXPR.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / MGNX.OQ / BRX.N / LADR.N / TWOU.OQ / ANTM.N / PFX.N / MFIN.OQ / HOPE.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Plug Power Inc / Charter Communications Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Express Inc / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / MacroGenics Inc / Brixmor Property Group Inc / Ladder Capital Corp / 2U Inc / Anthem Inc / PhenixFIN Corp / Medallion Financial Corp / Hope Bancorp Inc / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">3Q21 Earnings Preview - Eyes on the Future</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">3Q21 Results; Pipeline Forges Ahead; Key Inflection Points Anticipated in Upcoming Year</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">720795103 / REGN.OQ</td><td class="leftalignment">Pieris Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 SITC Late-Breakers Added – Updated Planner</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">45337C10 / 75886F10 / 640268108 / 58933Y10 / 98401F10 / 58949210 / 09075V10 / 60770K10 / 55609910 / 98887Q10 / N4444510 / 30315R10 / 37230320 / 95075A10</td><td class="leftalignment">Incyte Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Merck & Co Inc / Xencor Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / MacroGenics Inc / Zai Lab Ltd / Immatics NV / F-Star Therapeutics Inc / Genmab A/S / Werewolf Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Anna Baran, CFA / Jonathan Chang, Ph.D., CFA / Geoffrey Porges, MBBS / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid / Nick Huang / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Remedying Retinal Diseases the Non-VEGF Way; Initiating at Buy and €5 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">OXUR.BR / REGN.OQ / 00771V108 / UBX.OQ / 483497103 / 088786108 / 617760202 / RZLT.OQ / 69012T107 / MOLN.OQ</td><td class="leftalignment">Oxurion NV / Regeneron Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / UNITY Biotechnology Inc / Kalvista Pharmaceuticals Inc / Bicycle Therapeutics PLC / MorphoSys AG / Rezolute Inc / Outlook Therapeutics Inc / Molecular Partners AG</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Yi Chen, Ph.D. CFA / Raghuram Selvaraju, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: November 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / ALL.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / DD.N / EL.N / EOG.N / PFE.N / PNW.N / SO.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / EMR.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / VTR.N / PRU.N / COP.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / DISH.OQ / TPR.N / ANSS.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / FIS.N / MRNA.OQ / FTNT.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / ZTS.N / MAR.OQ / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Allstate Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Ventas Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / DISH Network Corp / Tapestry Inc / ANSYS Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Fidelity National Information Services Inc / Moderna Inc / Fortinet Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Regeneron lifts 11% in past quarter; Chevy Chase Trust Holdings, Inc. lifts 22.2%</td><td class="leftalignment">English</td><td class="rightalignment">85</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">KOL Seminar Series Update: GI Doc Call on ALLK Phase 3 EOE and EG/ED Trials</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">01671P100 / 75886F107 / 04744L106 / 040047607 / 98420N105 / 501147102 / G5966510</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc / Athersys Inc / Arena Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Krystal Biotech Inc / MeiraGTx Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. David T. Hoang, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for REGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Bespoke GT Consortium; Mammoth/VRTX Deal</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">VRTX.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SCM.N / HD.N / LOW.N / NKE.N / VZ.N / BJ.N / KMX.N / AMGN.OQ / AAPL.OQ / ASTE.OQ / DIOD.OQ / CRVL.OQ / REGN.OQ / TRMB.OQ / QDEL.OQ / MNRO.OQ / AMSC.OQ / ORLY.OQ / GILD.OQ / VRTS.OQ / FCEL.OQ / ITRI.OQ / INCY.OQ / NATI.OQ / POOL.OQ / NBIX.OQ / CALM.OQ / EEFT.OQ / AMZN.OQ / MKTW.OQ / EXTR.OQ / UTHR.OQ / BMRN.OQ / PLUG.OQ / CHTR.OQ / MTCH.OQ / EXEL.OQ / MRVL.OQ / ARRY.OQ / SGEN.OQ / OSUR.OQ / VRTX.OQ / NFLX.OQ / CMCSA.OQ / PEB.NZ / ALNY.OQ / MPWR.OQ / LHCG.OQ / ATRC.OQ / SPWR.OQ / IOSP.OQ / ATNI.OQ / BIG.N / EHTH.OQ / CSIQ.OQ / FSLR.OQ / FRPT.OQ / LULU.OQ / AGCO.N / CODI.N / XPO.N / DOX.OQ / SAGE.OQ / WW.OQ / FND.N / FOCS.OQ / A71.F / ZWS.N</td><td class="leftalignment">Stellus Capital Investment Corp / Home Depot Inc / Lowe's Companies Inc / Nike Inc / Verizon Communications Inc / BJ's Wholesale Club Holdings Inc / Carmax Inc / Amgen Inc / Apple Inc / Astec Industries Inc / Diodes Inc / CorVel Corp / Regeneron Pharmaceuticals Inc / Trimble Inc / Quidel Corp / Monro Inc / American Superconductor Corp / O'Reilly Automotive Inc / Gilead Sciences Inc / Virtus Investment Partners Inc / Fuelcell Energy Inc / Itron Inc / Incyte Corp / National Instruments Corp / Pool Corp / Neurocrine Biosciences Inc / Cal-Maine Foods Inc / Euronet Worldwide Inc / Amazon.com Inc / MarketWise Inc / Extreme Networks Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Plug Power Inc / Charter Communications Inc / Match Group Inc / Exelixis Inc / Marvell Technology Inc / Array Technologies Inc / Seagen Inc / OraSure Technologies Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Comcast Corp / Pacific Edge Ltd / Alnylam Pharmaceuticals Inc / Monolithic Power Systems Inc / LHC Group Inc / AtriCure Inc / SunPower Corp / Innospec Inc / ATN International Inc / Big Lots Inc / eHealth Inc / Canadian Solar Inc / First Solar Inc / Freshpet Inc / Lululemon Athletica Inc / AGCO Corp / Compass Diversified Holdings / XPO Logistics Inc / Amdocs Ltd / SAGE Therapeutics Inc / WW International Inc / Floor & Decor Holdings Inc / Focus Financial Partners Inc / Ascendis Pharma A/S / Zurn Water Solutions Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Denmark / Ireland / Israel / Luxembourg / Netherlands / New Zealand / United States / Guernsey</td><td class="leftalignment">Automotive / Biotechnology / Broadcasting & Cable / Consumer / Financial Services / Healthcare / Info. Tech./Peripheral / Leisure & Entertainment / Machinery / Retailing</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CD28 Co-Stims – The Big Event for REGN in 2022 and Why They Should Work</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">AES.N / ALV.N / BATS.L / BOX.N / CB.N / CCO.TO / CL.N / EIX.N / EL.N / ENI.MI / F.N / FSR.N / GM.N / KO.N / NA / NEM.N / PERP.PA / PNN.L / PNW.N / SO.N / STO.AX / SVT.L / T.N / UU.L / VC.N / CERN.O / TRI.N / WY.N / CNQ.TO / TEN.N / CMCSA.O / SJRb.TO / RCIb.TO / ETR.N / UHS.N / AGI.N / BWA.N / LEA.N / K.N / DISH.O / IMO.TO / CLX.N / BEIG.DE / PCG.N / AEM.N / EPC.N / ADCT.N / AMT.N / CONE.O / GWW.N / VZ.N / CYH.N / ALA.TO / XEL.N / STZ.N / LNC.N / APH.N / DVA.N / EXC.N / RRC.N / FISV.O / EQT.N / V.N / EPD.N / CPT.N / CHTR.O / AXL.N / CHD.N / NWN.N / GIL.N / AJG.N / BMRN.O / REGN.O / ENR.N / PRU.N / MHK.N / TEL.N / COP.N / CPK.N / CHE.N / ST.N / CRC.N / LNG.A / WPC.N / PLUG.OQ / SGEN.OQ / GPN.N / PFS.N / IMGN.O / CASY.O / EQIX.O / ATDb.TO / GOLD.N / DLR.N / HUN.N / NESTE.HE / 416515104 / RDSb.L / DRX.L / FIS.N / SES.TO / CTCa.TO / MA.N / MERC.O / AUY.N / AON.N / BGS.N / DAIGn.DE / INO.OQ / ENSG.O / DAN.N / PBF.N / AGNC.O / ARX.TO / CLW.N / AAV.TO / EGO.N / CVE.TO / SPB.N / NEE.N / TOU.TO / NXT.AX / MTOR.N / TVE.TO / ACHC.O / HTGC.N / FFHu.TO / MDLZ.OQ / TSLA.N / TMUS.N / PRTA.O / ITCI.O / PLC.TO / 922475108 / RYAM.N / NEP.N / HUBS.N / FEVR.L / 03835T200 / CLNX.MC / WRK.N / RPD.O / SQ.N / MIME.OQ / GYM.L / MESO.O / BFIT.AS / TWLO.N / AZRE.N / ADNT.N / AQN.N / CARG.O / APTV.N / BSIG.N / VNE.N / NTGY.MC / NWL.O / FSLY.N / NOVA.N / DOCU.N / PING.N / DDOG.O / CRNC.OQ / WTRG.N / TFII.N / NKLA.OQ / FOUR.N / ZI.O / MGNI.OQ / NRIX.OQ / LUMN.N / AEP.OQ / RIDE.OQ / LSPD.N / NUVB.N / NAPA.N / COUR.N / TSP.OQ / AKRBP.OL / OTLY.O / RYAN.N / LTH US</td><td class="leftalignment">AES Corp / Autoliv Inc / British American Tobacco PLC / Box Inc / Chubb Ltd / Cameco Corp / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / Fisker Inc / General Motors Co / Coca-Cola Co / National Bank of Canada / Newmont Corporation / Pernod Ricard SA / Pennon Group PLC / Pinnacle West Capital Corp / Southern Co / Santos Ltd / Severn Trent PLC / AT&T Inc / United Utilities Group PLC / Visteon Corp / Cerner Corp / Thomson Reuters Corp / Weyerhaeuser Co / Canadian Natural Resources Ltd / Tenneco Inc / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Entergy Corp / Universal Health Services Inc / Alamos Gold Inc / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Imperial Oil Ltd / Clorox Co / Beiersdorf AG / PG&E Corp / Agnico Eagle Mines Ltd / Edgewell Personal Care Co / ADC Therapeutics SA / American Tower Corp / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Community Health Systems Inc / AltaGas Ltd / Xcel Energy Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / DaVita Inc / Exelon Corp / Range Resources Corp / Fiserv Inc / EQT Corp / Visa Inc / Enterprise Products Partners LP / Camden Property Trust / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Gildan Activewear Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / Mohawk Industries Inc / TE Connectivity Ltd / Conocophillips / Chesapeake Utilities Corp / Chemed Corp / Sensata Technologies Holding PLC / California Resources Corp / Cheniere Energy Inc / WP Carey Inc / Plug Power Inc / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / ImmunoGen Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Barrick Gold Corp / Digital Realty Trust Inc / Huntsman Corp / Neste Oyj / Hartford Financial Services Group Inc / Royal Dutch Shell PLC / Drax Group PLC / Fidelity National Information Services Inc / Secure Energy Services Inc / Canadian Tire Corporation Ltd / Mastercard Inc / Mercer International Inc / Yamana Gold Inc / Aon PLC / B&G Foods Inc / Daimler AG / Inovio Pharmaceuticals Inc / Ensign Group Inc / Dana Inc / PBF Energy Inc / AGNC Investment Corp / ARC Resources Ltd / Clearwater Paper Corp / Advantage Energy Ltd / Eldorado Gold Corp / Cenovus Energy Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Meritor Inc / Tamarack Valley Energy Ltd / Acadia Healthcare Company Inc / Hercules Capital Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Tesla Inc / T-Mobile US Inc / Prothena Corporation PLC / Intra-Cellular Therapies Inc / Park Lawn Corp / Veeva Systems Inc / Rayonier Advanced Materials Inc / Nextera Energy Partners LP / HubSpot Inc / Fevertree Drinks PLC / Aptose Biosciences Inc / Cellnex Telecom SA / Westrock Co / Rapid7 Inc / Block Inc / Mimecast Ltd / GYM Group PLC / Mesoblast Ltd / Basic Fit NV / Twilio Inc / Azure Power Global Ltd / Adient PLC / Algonquin Power & Utilities Corp / CarGurus Inc / Aptiv PLC / Brightsphere Investment Group Inc / Veoneer Inc / Naturgy Energy Group SA / Newell Brands Inc / Fastly Inc / Sunnova Energy International Inc / DocuSign Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Essential Utilities Inc / TFI International Inc / Nikola Corp / Shift4 Payments Inc / ZoomInfo Technologies Inc / Magnite Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / American Electric Power Company Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Nuvation Bio Inc / Duckhorn Portfolio Inc / Coursera Inc / TuSimple Holdings Inc / Aker BP ASA / Oatly Group AB / Ryan Specialty Group Holdings Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Spain / Finland / France / United Kingdom / Ireland / Italy / Mauritius / Netherlands / Norway / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Upgrading to Outperform, $200 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALNY.O / AMGN / EXEL / INCY / NBIX / ASND.O / GILD.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / BIIB / MRNA.O / SRPT.O / 04280A100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Amgen Inc / Exelixis Inc / Incyte Corp / Neurocrine Biosciences Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / Sarepta Therapeutics Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Trevor Allred</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 22</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: November 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CVS.N / DD.N / EL.N / EOG.N / FLT.N / MCK.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / KIM.N / CLX.N / SYY.N / IFF.N / VNO.N / EMR.N / WEC.N / XOM.N / MTD.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / AWK.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / O.N / DISH.OQ / TPR.N / ANSS.OQ / SBAC.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / MOS.N / FIS.N / ES.N / MRNA.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / FANG.OQ / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Fleetcor Technologies Inc / Mckesson Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Kimco Realty Corp / Clorox Co / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Mettler-Toledo International Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / American Water Works Company Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / Tapestry Inc / ANSYS Inc / SBA Communications Corp / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Mosaic Co / Fidelity National Information Services Inc / Eversource Energy / Moderna Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Diamondback Energy Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/31/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">BioBeats Podcast, Catalysts & More</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US00287Y1091 / US75886F1075 / US92532F1003 / US09609G1004 / US5011471027 / US84833T1034 / US20451W1018 / US31773D1019 / US29479A1088 / US23345J1043</td><td class="leftalignment">Abbvie Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / bluebird bio Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Compass Pathways PLC / Finch Therapeutics Group Inc / Erasca Inc / Dice Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">10/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADCT.N / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / PRTA.O / MESO.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">ADC Therapeutics SA / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Prothena Corporation PLC / Mesoblast Ltd / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 3Q Earnings Season: What's on Tap for the Week Ahead</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AMGN.O / MRNA.O / INCY.O / REGN.O / VRTX.O / RARE.O / CLVS.O / SAGE.O / PBYI.O / JNCE.O / ALLO.O</td><td class="leftalignment">Amgen Inc / Moderna Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for REGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Primer Ahead Of Today's KOL Call On Discounted Pricing Strategies For Anti-PD-(L)1s; What To Know</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY / MRK / CKPT / US3755581036 / US45337C1027 / US75886F1075 / US88322Q1085 / US03969F1093</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Checkpoint Therapeutics Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / TG Therapeutics Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Jennifer M. Kim / Louise Chen / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / CACI=US / LLY=US / PFE=US / ADI=US / AMD=US / IP=US / AGL=US / AMZN=US / INCY=US / TXN=US / GILD=US / AMT=US / PEB=US / BC=US / MPWR=US / CONE=US / V=US / NOVA=US / CHKP=US / IART=US / XLNX=US / TRMK=US / TNL=US / CMCSA=US / CI=US / W=US / WTFC=US / APH=US / AVT=US / CNX=US / CPRT=US / DVA=US / EQT=US / EXPO=US / FCN=US / AJG=US / LH=US / TREE=US / MHK=US / TEAM=US / NTST=US / ASGN=US / REGN=US / SLGN=US / VSEC=US / WEX=US / FOUR=US / CFR=US / CPT=US / OFC=US / CUZ=US / MAA=US / WRE=US / AMSF=US / VICI=US / ACVA=US / MD=US / MOH=US / FLT=US / TPX=US / KAR=US / TXRH=US / BAH=US / MPW=US / KBR=US / MA=US / SAIA=US / PAG=US / TEL=US / TAST=US / EIG=US / PRPL=US / EHC=US / IAA=US / WH=US / RCUS=US / KNSL=US / AR=US / NXPI=US / NLSN=US / LKQ=US / PTCT=US / 00770K202 / CMPR=US / GDDY=US / ETSY=US / SPNE=US / ARGX=US / NVCR=US / WLTW=US / KDP=US / FTDR=US / EB=US / ARQT=US / AIRC=US / HYFM=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Eli Lilly and Co / Pfizer Inc / Analog Devices Inc / Advanced Micro Devices Inc / International Paper Co / agilon health Inc / Amazon.com Inc / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / Monolithic Power Systems Inc / CyrusOne Inc / Visa Inc / Sunnova Energy International Inc / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Xilinx Inc / Trustmark Corp / Travel + Leisure Co / Comcast Corp / Cigna Corp / Wayfair Inc / Wintrust Financial Corp / Amphenol Corp / Avnet Inc / CNX Resources Corp / Copart Inc / DaVita Inc / EQT Corp / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Laboratory Corporation of America Holdings / Lendingtree Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / ASGN Inc / Regeneron Pharmaceuticals Inc / Silgan Holdings Inc / VSE Corp / WEX Inc / Shift4 Payments Inc / Cullen/Frost Bankers Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Mid-America Apartment Communities Inc / Washington Real Estate Investment Trust / Amerisafe Inc / VICI Properties Inc / ACV Auctions Inc / MEDNAX Inc / Molina Healthcare Inc / Fleetcor Technologies Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Texas Roadhouse Inc / Booz Allen Hamilton Holding Corp / Medical Properties Trust Inc / KBR Inc / Mastercard Inc / Saia Inc / Penske Automotive Group Inc / TE Connectivity Ltd / Carrols Restaurant Group Inc / Employers Holdings Inc / Purple Innovation Inc / Encompass Health Corp / IAA Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Antero Resources Corp / NXP Semiconductors NV / Nielsen Holdings PLC / LKQ Corp / PTC Therapeutics Inc / Aemetis Inc / Cimpress PLC / GoDaddy Inc / ETSY Inc / SeaSpine Holdings Corp / argenx SE / Novocure Ltd / Willis Towers Watson PLC / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arcutis Biotherapeutics Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">5671735 / 2516152 / 2681511 / 2000019 / 2550707 / 2778844 / 2002305 / 2003698 / 2026242 / 2219224 / 2206657 / 2229126 / 2270726 / 2317087 / 2328915 / 2345022 / 2048804 / 2730190 / 2440637 / 2829601 / 2842255 / 2853688 / 2098876 / 2503529 / 2181334 / 2971029 / B00FWN1 / B067BM3 / 2212922 / 2216991 / 2857817 / B3P93Y7 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BFLR866 / BFH3N85 / BVVN4Q8 / BD3W133 / BXDZ9Z0 / BJLT387 / BD8DJ71 / BJ2Z0H2 / BFZ1K46 / BMYML02 / BJJMGL2 / BYXJQG9 / BWY52P3 / BYY88Y7 / BMH0MR7 / BDVLM39 / BMG75B4 / BQXZP64 / BJRFSB7 / BD5GSZ4 / BNGJQZ8 / BJ9N563</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / McDonald's Corp / Merck & Co Inc / Abbott Laboratories / ABIOMED Inc / American Electric Power Company Inc / CMS Energy Corp / Coca-Cola Co / Columbia Sportswear Co / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Macy's Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Starbucks Corp / Stryker Corp / Yum! Brands Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / LKQ Corp / Alnylam Pharmaceuticals Inc / Molson Coors Beverage Co / NRG Energy Inc / Tempur Sealy International Inc / Netflix Inc / Anheuser Busch Inbev SA / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Twitter Inc / Veeva Systems Inc / Eversource Energy / Keurig Dr Pepper Inc / Shopify Inc / Avantor Inc / Snap Inc / Pinterest Inc / Spotify Technology SA / DraftKings Inc / Fox Corp / Spire Inc / Blueprint Medicines Corp / Alphabet Inc / Zendesk Inc / argenx SE / Inventiva SA / Wayfair Inc / Immunovant Inc / Infrastructure and Energy Alternatives Inc / Porch Group Inc / Sunnova Energy International Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / France / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Biologics Sector - Latest development of COVID oral treatment options; investor feedback and our thoughts on Celltrion stocks and Green Cross</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">006280.KS / 068270.KS / 091990.KQ / JNJ.N / ROG.S / GSK.L / REGN.OQ / ATEA.OL</td><td class="leftalignment">Green Cross Corp / Celltrion Inc / Celltrion Healthcare Co Ltd / Johnson & Johnson / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Atea ASA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Korea, Republic of / Norway / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / MCK.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / KIM.N / RCL.N / CLX.N / SYY.N / IFF.N / VNO.N / EMR.N / XOM.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / O.N / DISH.OQ / TPR.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / CMCSA.OQ / MOS.N / FIS.N / AON.N / ES.N / MRNA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Mckesson Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / Exxon Mobil Corp / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / Tapestry Inc / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mosaic Co / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SASY.PA / AZN.L / ROG.S / NOVOB.CO / NOVN.S / GSK.L / REGN.OQ / BAYGN.DE</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back on Track - Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMPE-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMPE.K / ABT / JNJ / PFE / RIGL.O / REGN.O / ALIM.O / AERI.O / FLXN.O</td><td class="leftalignment">Ampio Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Pfizer Inc / Rigel Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alimera Sciences Inc / Aerie Pharmaceuticals Inc / Pacira Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALDX-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALDX.O / REGN.O / TENX.O / ANTH.PK</td><td class="leftalignment">Aldeyra Therapeutics Inc / Regeneron Pharmaceuticals Inc / Tenax Therapeutics Inc / Anthera Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Readthrough from Sanofi 3Q21 Results; Dupixent Continues to Defy High Expectations; Kevzara Had a Strong Quarter</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190 / SASY.PA / 5671735</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sanofi SA / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">SNY EPS Color:Co. continues to be bullish on "Mega Brand" Dupi; expect updated LT guidance</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Dupixent posts another strong quarter with indication expansion</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q321 Sanofi Read-Through: Another Nice Dupixent Beat</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AIN / FISV=US / BSX=US / CACI=US / AMGN=US / BMY=US / HD=US / KO=US / MCD=US / AMD=US / RRC=US / IP=US / AVB=US / DT=US / EBAY=US / PEB=US / H=US / CONE=US / NOVA=US / MTN=US / CRK=US / CHKP=US / PB=US / VRM=US / XLNX=US / BYD=US / MAR=US / SPOT=US / TTMI=US / TNL=US / MGM=US / HLT=US / PENN=US / EQR=US / CI=US / AIR=US / APH=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CYH=US / CCK=US / CW=US / DRH=US / DCO=US / EQT=US / HEI=US / HXL=US / NOW=US / MAS=US / MCRI=US / MNRO=US / ASGN=US / PDM=US / REGN=US / ROLL=US / SLGN=US / SFT=US / VSEC=US / SGMS=US / R=US / MAA=US / SSB=US / SPR=US / DRE=US / ENSG=US / AMSF=US / BCO=US / MOH=US / MOG.A=US / CZR=US / EXR=US / SHO=US / FIS=US / HST=US / SIX=US / PAG=US / TEL=US / OC=US / EHC=US / WH=US / 45665G303 / INSE / AR=US / HGV=US / NXPI=US / WWD=US / RLJ=US / VAC=US / MTDR=US / RHP=US / ABBV=US / NDLS=US / LDOS=US / NEWR=US / BVH=US / LOB=US / EVRI=US / EVBG=US / PK=US / PLYA=US / CVNA=US / GSHD=US / FTDR=US / HARP=US / DDOG=US / TSHA / NGMS=US</td><td class="leftalignment">Albany International Corp / Fiserv Inc / Boston Scientific Corp / CACI International Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / International Paper Co / Avalonbay Communities Inc / Dynatrace Inc / eBay Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / CyrusOne Inc / Sunnova Energy International Inc / Vail Resorts Inc / Comstock Resources Inc / Check Point Software Technologies Ltd / Prosperity Bancshares Inc / Vroom Inc / Xilinx Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / TTM Technologies Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Equity Residential / Cigna Corp / AAR Corp / Amphenol Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Community Health Systems Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / EQT Corp / HEICO Corp / Hexcel Corp / ServiceNow Inc / Masco Corp / Monarch Casino & Resort Inc / Monro Inc / ASGN Inc / Piedmont Office Realty Trust Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Silgan Holdings Inc / Shift Technologies Inc / VSE Corp / Scientific Games Corp / Ryder System Inc / Mid-America Apartment Communities Inc / SouthState Corp / Spirit AeroSystems Holdings Inc / Duke Realty Corp / Ensign Group Inc / Amerisafe Inc / Brinks Co / Molina Healthcare Inc / Moog Inc / Caesars Entertainment Inc / Extra Space Storage Inc / Sunstone Hotel Investors Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Six Flags Entertainment Corp / Penske Automotive Group Inc / TE Connectivity Ltd / Owens Corning / Encompass Health Corp / Wyndham Hotels & Resorts Inc / Infinity Pharmaceuticals Inc / Inspired Entertainment Inc / Antero Resources Corp / Hilton Grand Vacations Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Matador Resources Co / Ryman Hospitality Properties Inc / Abbvie Inc / Noodles & Co / Leidos Holdings Inc / New Relic Inc / Bluegreen Vacations Holding Corp / Live Oak Bancshares Inc / Everi Holdings Inc / Everbridge Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Goosehead Insurance Inc / Frontdoor Inc / Harpoon Therapeutics Inc / Datadog Inc / Taysha Gene Therapies Inc / NeoGames SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AAP.N / AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / KO.N / MCK.N / MO.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / AON.N / ES.N / MRNA.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Hitting The Reset Button On Our PT (Now $17/Sh) As We Think Through Catalysts & Competition</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HARP=US / AMGN=US / REGN=US / ABBV=US</td><td class="leftalignment">Harpoon Therapeutics Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BEN.AX / BMY.N / BSX.N / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / F.N / GM.N / KO.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JKHY.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Motors Co / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Jack Henry & Associates Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / France / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0311621009 / US75886F1075 / US02043Q1076 / US45845P1084 / IL0011313900</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Galmed Pharmaceuticals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">ACG 2021 Update Overshadowed by Another Positive Dupixent Phase 3 EOE Trial</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">01671P100 / 75886F107</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Dupixent Keeps Going with PN and EoE; Positive Pivotals Increasing TAM</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">75886F10 / F5548N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / SHW.N / GWW.N / JCI.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / PYPL.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / W W Grainger Inc / Johnson Controls International PLC / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">A Target That May Check Off All the Boxes; Upcoming Histology Data is Key Inflection Point</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">ETNB / US0311621009 / US75886F1075 / US02043Q1076 / US45845P1084 / IL0011313900</td><td class="leftalignment">89Bio Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Galmed Pharmaceuticals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Positive Ph3 Readouts With Dupi In PN And EoE Support FY22 Filings</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Dupixent Receives Second Positive Phase 3 Results for Eosinophilic Esophagitis; Reiterate Buy, Maintain PT at $842</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: ESGCT Data; BIIB PIII Miss in ALS</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Phytochemical Approach for Conditions With Unmet Need; Initiating at Buy and $15 PT</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">BPTS.OQ / REGN.OQ</td><td class="leftalignment">Biophytis SA / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ALV.N / AXP.N / BAC.N / BK.N / C.N / CB.N / CCI.N / CL.N / COF.N / EL.N / F.N / FITB.O / FOUG.PA / FSR.N / GM.N / JPM.N / KEY.N / KMB.N / KO.N / MO.N / NTRS.O / PNC.N / PNW.N / SGEF.PA / SLB.N / T.N / USB.N / VC.N / WFC.N / PEP.N / BFb.N / PG.N / CNQ.TO / TEN.N / CMCSA.O / RCIb.TO / CHKP.O / AMGN.O / ETR.N / THC.N / BWA.N / LEA.N / ROP.N / K.N / DT.N / DISH.O / EPR.N / GS.N / CLX.N / CAG.N / HON.N / VLO.N / GIS.N / HSY.N / EPC.N / AMT.N / WHR.N / CONE.O / OLN.N / VZ.N / STT.N / HCA.N / STZ.N / AMP.N / LNC.N / APH.N / FISV.O / V.N / AXL.N / CHD.N / MTB.N / VTR.N / SAM.N / CTSH.O / AJG.N / BMRN.O / REGN.O / ENR.N / PRU.N / NCR.N / TEL.N / SSNC.O / RF.N / ST.N / CRC.N / PLUG.OQ / GPN.N / FFBC.O / CASY.O / EQIX.O / ATDb.TO / TFC.N / 416515104 / WAL.N / LHCG.O / DRX.L / MS.N / FIS.N / MA.N / AON.N / IVZ.N / BGS.N / DAN.N / AAV.TO / SPB.N / WCP.TO / FHI.N / MTOR.N / BKR.N / SPLK.OQ / FFHu.TO / MDLZ.OQ / ALLY.N / APAM.N / TSLA.N / TMUS.N / COTY.N / 81762P102 / QURE.O / VRNS.O / ARES.N / CFG.N / ANTM.N / PYPL.OQ / SQ.N / RMR.OQ / MP1.AX / TWLO.N / UN01.DE / ADNT.N / ATUS.N / ATNX.O / APTV.N / COLD.N / WELL.N / VCTR.N / BSIG.N / VNE.N / KDP.N / BHC.N / NWL.O / PINS.N / GMAB.O / CRNC.OQ / OAS.OQ / VMD.OQ / NKLA.OQ / FOUR.N / JAMF.O / RIDE.OQ / LSPD.N / NAPA.N / OSO.N / TSP.OQ / OTLY.O / TRMR.OQ / RYAN.N / COOK.N / BASE.OQ / CWAN.N</td><td class="leftalignment">Autoliv Inc / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Estee Lauder Companies Inc / Ford Motor Co / Fifth Third Bancorp / Eiffage SA / Fisker Inc / General Motors Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Northern Trust Corp / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canadian Natural Resources Ltd / Tenneco Inc / Comcast Corp / Rogers Communications Inc / Check Point Software Technologies Ltd / Amgen Inc / Entergy Corp / Tenet Healthcare Corp / Borgwarner Inc / Lear Corp / Roper Technologies Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / EPR Properties / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Valero Energy Corp / General Mills Inc / Hershey Co / Edgewell Personal Care Co / American Tower Corp / Whirlpool Corp / CyrusOne Inc / Olin Corp / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Constellation Brands Inc / Ameriprise Financial Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / M&T Bank Corp / Ventas Inc / Boston Beer Company Inc / Cognizant Technology Solutions Corp / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Regions Financial Corp / Sensata Technologies Holding PLC / California Resources Corp / Plug Power Inc / Global Payments Inc / First Financial Bancorp / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / Hartford Financial Services Group Inc / Western Alliance Bancorp / LHC Group Inc / Drax Group PLC / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Aon PLC / Invesco Ltd / B&G Foods Inc / Dana Inc / Advantage Energy Ltd / Spectrum Brands Holdings Inc / Whitecap Resources Inc / Federated Hermes Inc / Meritor Inc / Baker Hughes Co / Splunk Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Ally Financial Inc / Artisan Partners Asset Management Inc / Tesla Inc / T-Mobile US Inc / Coty Inc / ServiceNow Inc / Uniqure NV / Varonis Systems Inc / Ares Management Corp / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / Block Inc / RMR Group Inc / Megaport Ltd / Twilio Inc / Uniper SE / Adient PLC / Altice USA Inc / Athenex Inc / Aptiv PLC / Americold Realty Trust / Welltower Inc / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Veoneer Inc / Keurig Dr Pepper Inc / Bausch Health Companies Inc / Newell Brands Inc / Pinterest Inc / Genmab A/S / Cerence Inc / Oasis Petroleum Inc / Viemed Healthcare Inc / Nikola Corp / Shift4 Payments Inc / Jamf Holding Corp / Lordstown Motors Corp / Lightspeed Commerce Inc / Duckhorn Portfolio Inc / Olo Inc / TuSimple Holdings Inc / Oatly Group AB / Tremor International Ltd / Ryan Specialty Group Holdings Inc / Traeger Inc / Couchbase Inc / Clearwater Analytics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NEM.N / NSC.N / PFE.N / PNW.N / SO.N / TEL.PS / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / MTD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / APH.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / CHD.N / TWTR.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / ORLY.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / SWKS.O / CMCSA.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / MSCI.N / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / PLDT Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Mettler-Toledo International Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Amphenol Corp / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Twitter Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Skyworks Solutions Inc / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: China PD-(L)1 on the move: Picking long-term winners in a competitive race</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">BGNE.OQ / 1877.HK / BMY.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / INCY.OQ / AGEN.OQ / 600276.SS / 0950.HK / 002437.SZ / 300003.SZ / MRTX.OQ / ZLAB.OQ / 6160.HK / 1801.HK</td><td class="leftalignment">Beigene Ltd / Shanghai Junshi Biosciences Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Incyte Corp / Agenus Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Lee's Pharmaceutical Holdings Ltd / Harbin Gloria Pharmaceuticals Co Ltd / Lepu Medical Technology Beijing Co Ltd / Mirati Therapeutics Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">10/23/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">BioBeats Podcast, 3Q Catalyst Performance, Coverage Updates</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US00287Y1091 / US75886F1075 / US92532F1003 / US09609G1004 / US88322Q1085 / US29251M1062 / US90400D1081 / US4622221004 / US00773J1034 / US45826J1051 / BMG637AM1024 / KYG108301006 / US5011471027 / US84833T1034 / US77313F1066 / BMG5269C1010 / KYG596651029 / US04335A1051 / US04965G1094 / US45781K1051 / US20451W1018 / US59101E1038 / US16961L1061 / US89422G1076 / US2300311063 / US92337R1014</td><td class="leftalignment">Abbvie Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / bluebird bio Inc / TG Therapeutics Inc / Enanta Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Ionis Pharmaceuticals Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / Myovant Sciences Ltd / Beyondspring Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Rocket Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / MeiraGTx Holdings PLC / Arvinas Inc / Atreca Inc / Innate Pharma SA / Compass Pathways PLC / Metacrine Inc / Chinook Therapeutics Inc / Travere Therapeutics Inc / Cullinan Oncology Inc / Vera Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">10/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMRN.O / REGN.O / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Dupixent Recieves Positive Phase 3 Results for Prurigo Nodularis; Reiterate Buy and Increase PT to $842</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Regeneron Pharmaceuticals Incorporated</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / SLB.N / SO.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / ROP.N / CAT.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / HCA.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / FIS.N / STX.AX / ADP.PA / AON.N / MRNA.OQ / CME.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Southern Co / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / HCA Healthcare Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back to the Hurt Locker: Biotech Outflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">Eosinophil Depletion May Be Insufficient to Consistently Improve EGID Symptoms</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">01671P100 / 75886F107</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Asthmatic Children Will Now Breathe Better After Dupixent’s FDA Label Expansion; Reiterate Buy and $831 PT</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SE0000108656 / US09061G1013 / US00971T1016 / US0311621009 / US1924461023 / US2786421030 / US30161Q1040 / US3755581036 / US4062161017 / US4282911084 / US4433201062 / US45253H1014 / US45337C1027 / US4567881085 / US4781601046 / US64125C1099 / US75886F1075 / US91307C1027 / US92343V1044 / US92532F1003 / CA1363751027 / US64110L1061 / US2948216088 / US20030N1019 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US00206R1023 / US3020811044 / US29089Q1058 / US92932M1018 / NL0000687663 / US87874R1005 / US53261M1045 / US03152W1099 / BMG3922B1072 / US90384S3031 / US25470M1099 / IE00B4BNMY34 / US46333X1081 / US9100471096 / US29414B1044 / NL0010273215 / US8725901040 / US09609G1004 / US8036071004 / US4576693075 / US6951271005 / US00912X3026 / US74587V1070 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / US0994061002 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US12685J1051 / US37890U1088 / US4622221004 / US07725L1026 / US16119P1084 / US36165L1089 / US2067871036 / US23355L1061 / IL0011407140 / US02156K1034 / US87105L1044 / US76243J1051 / US5011471027 / US77313F1066 / US89854H1023 / US09354A1007 / US05455M1009 / US29260V1052 / US0197701065 / US61775R1059 / US85205L1070 / US39813G1094 / US4432011082 / US65487U1088 / US07373B1098 / US20451W1018 / US69353Y1038 / US81181C1045 / US50107A1043 / KYG3902L1095 / US74767V1098 / US7761531083 / US15961R1059 / US25401T1088 / US30052F1003 / US88546E1055</td><td class="leftalignment">Telefonaktiebolaget LM Ericsson / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Amgen Inc / Cognizant Technology Solutions Corp / eBay Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Hexcel Corp / Hub Group Inc / ImmunoGen Inc / Incyte Corp / Infosys Ltd / Johnson & Johnson / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Verizon Communications Inc / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Telefonaktiebolaget LM Ericsson / Comcast Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / AT&T Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / AerCap Holdings NV / TechTarget Inc / Limelight Networks Inc / Amicus Therapeutics Inc / Genpact Ltd / Ulta Beauty Inc / DISH Network Corp / Accenture PLC / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Epam Systems Inc / ASML Holding NV / T-Mobile US Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Air Lease Corp / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Cable One Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Charter Communications Inc / GDS Holdings Ltd / Conduent Inc / DXC Technology Co / Urogen Pharma Ltd / Altice USA Inc / Switch Inc / Rhythm Pharmaceuticals Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / TTEC Holdings Inc / Blink Charging Co / AVROBIO Inc / Endava PLC / Allogene Therapeutics Inc / Morphic Holding Inc / SpringWorks Therapeutics Inc / Grid Dynamics Holdings Inc / Howmet Aerospace Inc / Nkarta Inc / Beam Global / Compass Pathways PLC / PMV Pharmaceuticals Inc / Seagen Inc / Kronos Bio Inc / GDS Holdings Ltd / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc / DigitalBridge Group Inc / EVgo Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">This Company Has Its Compass Pointed in the Right Direction; Initiating Coverage With a Buy Rating and $11 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">CMPX.PK / REGN.OQ / 00847G705 / AGIO.OQ / 60468T105 / 032724106 / 41358P106 / 481116101 / 86877M209 / IMAB.OQ / 10806X102 / ALXO.OQ / 05465V108 / 449585108 / FSTX.OQ / 45249V107</td><td class="leftalignment">Compass Therapeutics Inc. / Regeneron Pharmaceuticals Inc / Agenus Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / AnaptysBio Inc / Harpoon Therapeutics Inc / Jounce Therapeutics Inc / Surface Oncology Inc / I-Mab / BridgeBio Pharma Inc / ALX Oncology Holdings Inc / Ayala Pharmaceuticals Inc / IGM Biosciences Inc / F-Star Therapeutics Inc / Imara Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Earnings Preview: Wishing For A Biotech Rally To End 2021</td><td class="leftalignment">English</td><td class="rightalignment">285</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">3Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CRSP CTX110 Data Doubts; FIXX PKU Ups & Downs</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">CRSP.BN / FIXX.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132 / TNYA.O</td><td class="leftalignment">CRISPR Therapeutics AG / Homology Medicines Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / BCE.TO / CB.N / CMS.N / ECL.N / EIX.N / EL.N / IBE.MC / KO.N / MAS.N / PNC.N / PNW.N / RIO.L / SO.N / T.N / T.TO / TOTF.PA / CMCSA.O / SJRb.TO / RCIb.TO / AMGN.O / AAL.L / DUK.N / QBRb.TO / UNH.N / CCA.TO / K.N / DISH.O / GS.N / CLX.N / VMC.N / PCG.N / EPC.N / ADCT.N / WHR.N / CONE.O / NG.L / VZ.N / EXEL.O / AKAM.O / XEL.N / STZ.N / LNC.N / V.N / NWN.N / UDR.N / DB1Gn.DE / AJG.N / BMRN.O / REGN.O / ENR.N / PRU.N / MHK.N / CEY.L / NCR.N / GFI.N / CNP.N / BLU.N / CPK.N / SKY.N / SGEN.OQ / GPN.N / LIFE.O / EQIX.O / BIIB.O / TFC.N / EDV.TO / BECN.O / DLR.N / 416515104 / GMS.N / BLDR.O / FIS.N / MA.N / OC.N / AON.N / ATL.MI / BGS.N / PPL.TO / HOCM.L / FRES.L / EDPR.LS / SPB.N / NEE.N / NXT.AX / PCRX.O / CTT.N / GLEN.L / TRL.TO / FBHS.N / POLYP.L / FFHu.TO / TMUS.N / UKWG.L / PRTA.O / BEP.N / DOOR.N / IBP.N / HUBS.N / NEWR.N / WBA.N / SUM.N / EVA.N / PYPL.OQ / SQ.N / SITE.N / IONS.O / JELD.N / ATNX.O / GMAB.O / AZEK.N / WTRG.N / FOUR.N / NRIX.OQ / DCT.O / LSPD.N / NAPA.N / OTLY.O / RYAN.N / CNM.N / TWKS.OQ / THRN.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / BCE Inc / Chubb Ltd / CMS Energy Corp / Ecolab Inc / Edison International / Estee Lauder Companies Inc / Iberdrola SA / Coca-Cola Co / Masco Corp / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Rio Tinto PLC / Southern Co / AT&T Inc / Telus Corp / TotalEnergies SE / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Amgen Inc / Anglo American PLC / Duke Energy Corp / Quebecor Inc / UnitedHealth Group Inc / Cogeco Communications Inc / Kellogg Co / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Vulcan Materials Co / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / Whirlpool Corp / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Akamai Technologies Inc / Xcel Energy Inc / Constellation Brands Inc / Lincoln National Corp / Visa Inc / Northwest Natural Holding Co / UDR Inc / Deutsche Boerse AG / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / Mohawk Industries Inc / Centamin PLC / NCR Corp / Gold Fields Ltd / CenterPoint Energy Inc / BELLUS Health Inc / Chesapeake Utilities Corp / Skyline Champion Corp / Seagen Inc / Global Payments Inc / aTyr Pharma Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / Endeavour Mining PLC / Beacon Roofing Supply Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / GMS Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / Mastercard Inc / Owens Corning / Aon PLC / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / Fresnillo PLC / EDP Renovaveis SA / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Glencore PLC / Trilogy International Partners Inc / Fortune Brands Home & Security Inc / Polymetal International PLC / Fairfax Financial Holdings Ltd / T-Mobile US Inc / Greencoat UK Wind PLC / Prothena Corporation PLC / Brookfield Renewable Partners LP / Masonite International Corp / Installed Building Products Inc / HubSpot Inc / New Relic Inc / Walgreens Boots Alliance Inc / Summit Materials Inc / Enviva Inc / PayPal Holdings Inc / Block Inc / SiteOne Landscape Supply Inc / Ionis Pharmaceuticals Inc / JELD-WEN Holding Inc / Athenex Inc / Genmab A/S / Azek Company Inc / Essential Utilities Inc / Shift4 Payments Inc / Nurix Therapeutics Inc / Duck Creek Technologies Inc / Lightspeed Commerce Inc / Duckhorn Portfolio Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc / Core & Main Inc / Thoughtworks Holding Inc / Thorne Healthtech Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / China / Germany / Denmark / Spain / United Kingdom / Ireland / Italy / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - 3Q sales preview</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ROG.S / REGN.OQ</td><td class="leftalignment">Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: In Vivo Gene Therapy—Company Feedback</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">66987V10 / NVAX.O / G3910J112 / 92532F100 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 75915K200 / TNYA.O</td><td class="leftalignment">Novartis AG / Novavax Inc / GlaxoSmithKline PLC / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Regulus Therapeutics Inc / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Interchangeable Humira, BioBeats #2, Catalysts Ahead, Etc</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US00287Y1091 / US75886F1075 / US8036071004 / US88322Q1085 / US04351P1012 / US45826J1051 / CH0334081137 / BMG637AM1024 / US38341P1021 / US12674W1099 / US20451W1018 / US81181C1045 / US89422G1076</td><td class="leftalignment">Abbvie Inc / Regeneron Pharmaceuticals Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Ascendis Pharma A/S / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Gossamer Bio Inc / Cabaletta Bio Inc / Compass Pathways PLC / Seagen Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">10/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / LIFE.O / PRTA.O / ATNX.O / GMAB.O / NRIX.OQ</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / aTyr Pharma Inc / Prothena Corporation PLC / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--October15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">A.N / AXP.N / CRY.N / JNJ.N / WMT.N / SUP.N / ABMD.OQ / AMGN.OQ / REGN.OQ / STAA.OQ / ICUI.OQ / IDXX.OQ / MMSI.OQ / GILD.OQ / ANIK.OQ / XRAY.OQ / INCY.OQ / IART.OQ / INMD.OQ / AMED.OQ / SSNC.OQ / CERS.OQ / SRDX.OQ / UTHR.OQ / BMRN.OQ / ISRG.OQ / ALGN.OQ / SGEN.OQ / OSUR.OQ / CCRN.OQ / VRTX.OQ / NUVA.OQ / ANGO.OQ / MNKD.OQ / DXCM.OQ / LHCG.OQ / ATRC.OQ / LMAT.OQ / ARAY.OQ / BLRX.TA / PODD.OQ / MASI.OQ / KIDS.OQ / ENSG.OQ / ADUS.OQ / PCRX.OQ / KAMN.N / TMD.TO / SRPT.OQ / ALLY.N / AXGN.OQ / FATE.OQ / FLXN.OQ / BLFS.OQ / GOOGL.OQ / XENT.OQ / SIEN.OQ / VCEL.OQ / EVH.N / SPNE.OQ / CYRX.OQ / IRTC.OQ / ALLO.OQ / SWAV.OQ / BEAM.OQ / VERO.OQ / ONEM.OQ / HUMA.OQ</td><td class="leftalignment">Agilent Technologies Inc / American Express Co / CryoLife Inc / Johnson & Johnson / Walmart Inc / Superior Industries International Inc / ABIOMED Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / STAAR Surgical Co / ICU Medical Inc / IDEXX Laboratories Inc / Merit Medical Systems Inc / Gilead Sciences Inc / Anika Therapeutics Inc / DENTSPLY SIRONA Inc / Incyte Corp / Integra Lifesciences Holdings Corp / Inmode Ltd / Amedisys Inc / SS&C Technologies Holdings Inc / Cerus Corp / Surmodics Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / Align Technology Inc / Seagen Inc / OraSure Technologies Inc / Cross Country Healthcare Inc / Vertex Pharmaceuticals Inc / NuVasive Inc / AngioDynamics Inc / MannKind Corp / Dexcom Inc / LHC Group Inc / AtriCure Inc / LeMaitre Vascular Inc / Accuray Inc / BioLine RX Ltd / Insulet Corp / Masimo Corp / OrthoPediatrics Corp / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Kaman Corp / Titan Medical Inc / Sarepta Therapeutics Inc / Ally Financial Inc / AxoGen Inc / Fate Therapeutics Inc / Pacira Biosciences Inc / BioLife Solutions Inc / Alphabet Inc / Intersect Ent Inc / Sientra Inc / Vericel Corp / Evolent Health Inc / SeaSpine Holdings Corp / Cryoport Inc / iRhythm Technologies Inc / Allogene Therapeutics Inc / Shockwave Medical Inc / Beam Therapeutics Inc / Venus Concept Inc / 1Life Healthcare Inc / Humacyte Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Israel / United States</td><td class="leftalignment">Biotechnology / Consumer / Engineering & Construction / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">75886F107 / 497498105 / 530307107 / 18563410</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Kirkland's Inc / Liberty Broadband Corp / Clene Inc.</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Matthew Harrigan / Ms. Fawne Jiang / Long Lin / Mr. Bruce D. Jackson / Mr. John Lawrence</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">There Will Likely Be Another Government Contract</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0311621009 / US2666051048 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US88322Q1085 / IL0011313900</td><td class="leftalignment">Amgen Inc / DURECT Corp / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / TG Therapeutics Inc / Galmed Pharmaceuticals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID mAbs Still Have Billions in Sales Ahead Despite Orals</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AZN / 04635310 / 75886F10 / 2137 / 58933Y10 / G3910J11</td><td class="leftalignment">AstraZeneca PLC / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Brii Biosciences Ltd / Merck & Co Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2437071 / 2280220 / 2270726 / 2317087 / 2576941 / 2455965 / 2471950 / 2623911 / 2632003 / 2048804 / 2730190 / 2825933 / 2931034 / 4595739 / B00FWN1 / B1F76F9 / B19FQ48 / 2713317 / B01SD70 / 2857817 / B3D7K31 / B7TL820 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BXDZ9Z0 / BZ1LFB2 / BD8DJ71 / BMQ5T49 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BZ05388 / BDFZSP1 / BK6N347 / BFWK4R7 / BYYWPW6 / BWY52P3 / BYY88Y7 / BDZ30Q0 / BYTJZL1 / BNRQM83 / BJ62Z18</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / New York Times Co / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Vertex Pharmaceuticals Inc / Genmab A/S / Alnylam Pharmaceuticals Inc / Western Union Co / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Domino's Pizza Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Shopify Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / Okta Inc / Uber Technologies Inc / PagSeguro Digital Ltd / Beigene Ltd / Blueprint Medicines Corp / Alphabet Inc / Arvinas Inc / Zogenix Inc / Petco Health and Wellness Company Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Guggenheim Biotech 3Q 2021 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">4595739 / 2471950 / 2023607 / 2437071 / 2576941 / 2455965 / 2623911 / 2730190 / 2931034 / B00FWN1 / B19FQ48 / 2713317 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BZ1LFB2 / BZ05388 / BYYWPW6 / BWY52P3 / BYTJZL1 / BJ62Z18</td><td class="leftalignment">Genmab A/S / Incyte Corp / Amgen Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Global Blood Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Zogenix Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Guggenheim Biot Research / Mr. Charles Zhu, Ph.D., III / Debjit Chattopadhyay, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Mr. Yatin Suneja / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q Large Cap Preview: New World Order is Navigating Consistent COVID-19 Trends to the Base Business</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US09062X1037 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003</td><td class="leftalignment">Amgen Inc / Biogen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Biotech Q3:21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / PBYI.OQ / GMAB.O</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Puma Biotechnology Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">SITC 2021 Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107 / 31189P102 / 462260100 / 98401F105 / H17182108 / 41358P106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 00166B105 / 67080M103 / 73730P108 / 81181C104 / 68236R103 / 03890D108 / 002120202 / 81728A108 / 00449L102 / 87978U108</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Fate Therapeutics Inc / Iovance Biotherapeutics Inc / Xencor Inc / CRISPR Therapeutics AG / Harpoon Therapeutics Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / ALX Oncology Holdings Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Seagen Inc / Oncorus Inc / Aravive Inc / aTyr Pharma Inc / Sensei Biotherapeutics Inc / Achilles Therapeutics PLC / Tempest Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Here Comes The Sun: Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">FDA Accepts REGEN-COV BLA for Priority Review; We See No Barriers to Approval</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ / 02043Q107 / NTLA.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intellia Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: Cell tx, I/O, & CDMO—Company Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">66987V10 / NVAX.O / G3910J112 / 92532F100 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / N71542109 / 03820J100 / 75915K200</td><td class="leftalignment">Novartis AG / Novavax Inc / GlaxoSmithKline PLC / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Regulus Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 01</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 1, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Genetic Medicines Conference: Gene Editing—Company Feedback</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NVAX.O / 92532F100 / 75886F107 / 02043Q107 / 339 / 800677106 / MRNA.O / 00289Y107 / ABUS.O / 75901B107 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / XCUR.O / PASG.O / IMTX.O / N90064101 / 83422E105 / N71542109 / 03820J100 / 75915K200 / TNYA.O</td><td class="leftalignment">Novavax Inc / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Sangamo Therapeutics Inc / Moderna Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Solid Biosciences Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Regulus Therapeutics Inc / Tenaya Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Hold on Tight! Soft Biopharma Q3 Coming as Pandemic Pressures Persist, FX Fades</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">00287Y10 / 03116210 / 71708110 / 92532F10 / 37555810 / 75886F10 / 75046920 / G3910J11 / 61776010 / F5548N10</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Radius Health Inc / GlaxoSmithKline PLC / MorphoSys AG / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Regeneron climbs 13% in 2021, outperforming Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">81</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAPL / ACI / AGCO / ALLO / AMGN / ATRC / AXP / AZO / CSL / DE / DG / EA / EL / FDX / FOCS / FTR / ICE / INCY / LOW / NET / NKE / NOW / RSI / SBUX / SONY / TRMB / UPS / V / WH / AMZN.O / GXO / GNSS / GILD.O / EW / MSCI / CBOE / GENI / NVDA.O / ADBE.O / RMD / SQ / MPWR.O / VG / IART.O / ADI.O / NFLX / PLUG.O / ADSK.O / SGEN / UTHR.O / ARRY.O / FCEL.O / TXN.O / EXPD.O / BMRN.O / AMSC.O / REGN.O / VRTX.O / MRVL.O / AVGO.O / NDAQ / TEAM.O / ITRI.O / BIIB / DPZ / MNKD.O / SPGI / DXCM.O / SPWR.O / XPO / CSIQ.O / FSLR.O / LULU / ULTA / WPRT.O / TWIN.O / TSLA.O / PCYO.O / NXPI.O / AMRS.O / ENPH.O / FB.O / CG.O / WDAY / CNHI / FATE.O / XENT / QRVO.O / SEDG.O / RUN.O / WKHS.O / AQMS.O / FLGT.O / CRSP / AQB / ROKU.O / MDB.O / LOVE / TPTX.O / CRWD.O / DKNG / 02081G201 / VLDR.O / SHLS.O / APPH / NKTX.O / TSP.O / ENVX.O / LILM.O / MDNA.O</td><td class="leftalignment">Apple Inc / Albertsons Companies Inc / AGCO Corp / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / American Express Co / Autozone Inc / Carlisle Companies Inc / Deere & Co / Dollar General Corp / Electronic Arts Inc / Estee Lauder Companies Inc / FedEx Corp / Focus Financial Partners Inc / Frontier Communications Parent Inc / Intercontinental Exchange Inc / Incyte Corp / Lowe's Companies Inc / Cloudflare Inc / Nike Inc / ServiceNow Inc / Rush Street Interactive Inc / Starbucks Corp / Sony Group Corp / Trimble Inc / United Parcel Service Inc / Visa Inc / Wyndham Hotels & Resorts Inc / Amazon.com Inc / GXO Logistics Inc / Genasys Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / MSCI Inc / Cboe Global Markets Inc / Genius Sports Ltd / NVIDIA Corp / Adobe Inc / Resmed Inc / Block Inc / Monolithic Power Systems Inc / Vonage Holdings Corp / Integra Lifesciences Holdings Corp / Analog Devices Inc / Netflix Inc / Plug Power Inc / Autodesk Inc / Seagen Inc / United Therapeutics Corp / Array Technologies Inc / Fuelcell Energy Inc / Texas Instruments Inc / Expeditors International of Washington Inc / Biomarin Pharmaceutical Inc / American Superconductor Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Broadcom Inc / Nasdaq Inc / Atlassian Corporation PLC / Itron Inc / Biogen Inc / Domino's Pizza Inc / MannKind Corp / S&P Global Inc / Dexcom Inc / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Westport Fuel Systems Inc / Twin Disc Inc / Tesla Inc / Pure Cycle Corp / NXP Semiconductors NV / Amyris Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Workday Inc / CNH Industrial NV / Fate Therapeutics Inc / Intersect Ent Inc / Qorvo Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Aqua Metals Inc / Fulgent Genetics Inc / CRISPR Therapeutics AG / AquaBounty Technologies Inc / Roku Inc / MongoDB Inc / Lovesac Co / Turning Point Therapeutics Inc / CrowdStrike Holdings Inc / DraftKings Inc / Alphatec Holdings Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / AppHarvest Inc / Nkarta Inc / TuSimple Holdings Inc / Enovix Corp / Lilium NV / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Japan / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Large Cap Medtech</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN / INCY / SYK / GILD.O / EW / RMD / SGEN / BMRN.O / REGN.O / VRTX.O / BIIB / XENT</td><td class="leftalignment">Amgen Inc / Incyte Corp / Stryker Corp / Gilead Sciences Inc / Edwards Lifesciences Corp / Resmed Inc / Seagen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Intersect Ent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steven M. Lichtman / David Kuang</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALV.N / CAS.TO / CB.N / EL.N / ELE.MC / F.N / FSR.N / GM.N / IBE.MC / KBH.N / KO.N / MSFT.O / NA / PHM.N / RYN.N / T.N / TOL.N / VC.N / WY.N / CFP.TO / GILD.O / TEN.N / CMCSA.O / AMGN.O / INCY.O / FER.MC / BWA.N / LEA.N / K.N / DISH.O / LEN.N / CLX.N / EPC.N / AMT.N / SIRI.O / CONE.O / VZ.N / EXEL.O / DHI.N / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / CHTR.O / AXL.N / BC.N / AJG.N / REGN.O / ENR.N / VRTX.O / JHX.AX / PRU.N / NCR.N / TEL.N / SSNC.O / CHE.N / PII.N / ST.N / SWN.N / PLUG.OQ / GPN.N / AMED.O / BIIB.O / DPM.TO / DLR.N / 416515104 / LHCG.O / BKD.N / FIS.N / HOG.N / MERC.O / AON.N / BGS.N / DAN.N / NOG.A / CLW.N / ADUS.OQ / SPB.N / TXG.TO / PCH.O / CFX.TO / CTT.N / MTOR.N / RFP.N / SRPT.O / PANW.N / FFHu.TO / KPT.TO / TPH.N / TSLA.N / ENTA.O / TMUS.N / TMHC.N / PTCT.O / PRTA.O / 81762P102 / QTWO.N / 922475108 / RYAM.N / RGNX.O / SQ.N / MESO.O / RACE.MI / ADVM.OQ / ADNT.N / ESTE.N / WOW.N / ATUS.N / ORSTED.CO / APTV.N / VNE.N / FOCS.O / ZM.O / FSLY.N / CRWD.O / GMAB.O / DOCU.N / CRNC.OQ / PNTG.OQ / ETNB.O / AHCO.O / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / RIDE.OQ / LSPD.N / DFH.OQ / AFRM.O / PSFE.N / TSP.OQ / OTLY.O / FLYW.O / TASK.O / RYAN.N / TWKS.OQ</td><td class="leftalignment">Autoliv Inc / Cascades Inc / Chubb Ltd / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fisker Inc / General Motors Co / Iberdrola SA / KB Home / Coca-Cola Co / Microsoft Corp / National Bank of Canada / Pultegroup Inc / Rayonier Inc / AT&T Inc / Toll Brothers Inc / Visteon Corp / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Ferrovial SA / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Lennar Corp / Clorox Co / Edgewell Personal Care Co / American Tower Corp / Sirius XM Holdings Inc / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Chemed Corp / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Plug Power Inc / Global Payments Inc / Amedisys Inc / Biogen Inc / Dundee Precious Metals Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / LHC Group Inc / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Harley-Davidson Inc / Mercer International Inc / Aon PLC / B&G Foods Inc / Dana Inc / Northern Oil and Gas Inc / Clearwater Paper Corp / Addus Homecare Corp / Spectrum Brands Holdings Inc / Torex Gold Resources Inc / Potlatchdeltic Corp / Canfor Pulp Products Inc / CatchMark Timber Trust Inc / Meritor Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Taylor Morrison Home Corp / PTC Therapeutics Inc / Prothena Corporation PLC / ServiceNow Inc / Q2 Holdings Inc / Veeva Systems Inc / Rayonier Advanced Materials Inc / Regenxbio Inc / Block Inc / Mesoblast Ltd / Ferrari NV / Adverum Biotechnologies Inc / Adient PLC / Earthstone Energy Inc / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Aptiv PLC / Veoneer Inc / Focus Financial Partners Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Cerence Inc / Pennant Group Inc / 89Bio Inc / Adapthealth Corp / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Dream Finders Homes Inc / Affirm Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Oatly Group AB / Flywire Corp / Taskus Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: VYGR Voyage Continues w/ PFE; ALLO's On Hold</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/09/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Weekend Updates: Cell Therapy Takes a Hit, Biobeats Podcast & More</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US35104E1001 / US75886F1075 / US00287Y1091 / US09609G1004 / US8036071004 / US29251M1062 / US28106W1036 / CH0334081137 / US02155H2004 / US38341P1021 / US20451W1018 / US1920101060 / US0080641071 / US45114M1099</td><td class="leftalignment">4D Molecular Therapeutics Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Editas Medicine Inc / CRISPR Therapeutics AG / Altimmune Inc / Gossamer Bio Inc / Compass Pathways PLC / Codiak BioSciences, Inc. / Aerovate Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">10/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / REGN.O / PRTA.O / MESO.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Mesoblast Ltd / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">October 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / BMY=US / BXP=US / AMZN=US / GL=US / SLG=US / BC=US / CRK=US / HSII=US / VRM=US / MAR=US / EXPE=US / TTWO=US / ATVI=US / CLI=US / CI=US / KFY=US / AIZ=US / EXEL=US / HZO=US / PDM=US / RARE=US / HOOK=US / REGN=US / SGMO=US / SHOP=US / STRA=US / SNAP=US / TRIP=US / VRTX=US / WIX=US / CGEN=US / HIW=US / BKNG=US / BDN=US / OFC=US / CUZ=US / EPR=US / FB=US / MTCH=US / PRA=US / VNO=US / WRE=US / AMSF=US / AUTL=US / MRNS=US / PTON=US / IGMS=US / JRVR=US / STRO=US / MOH=US / APP=US / EIG=US / APEI=US / TIL=US / NOG=US / KNSL=US / RLJ=US / ANGI=US / EA=US / ABBV=US / MBUU=US / GOOGL=US / BABA=US / CMPR=US / DEA=US / GDDY=US / MCFT=US / LOB=US / PEN=US / SQ=US / CVNA=US / IOVA=US / SFIX=US / FTDR=US / ALLO=US / ESTC=US / HARP=US / LYFT=US / UBER=US / TCRR=US / LSPD=US / PLMR=US / NXTC=US / GMAB=US / ONEW=US / VMEO=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Bristol-Myers Squibb Co / Boston Properties Inc / Amazon.com Inc / Globe Life Inc / SL Green Realty Corp / Brunswick Corp / Comstock Resources Inc / Heidrick & Struggles International Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / Veris Residential Inc / Cigna Corp / Korn Ferry / Assurant Inc / Exelixis Inc / MarineMax Inc / Piedmont Office Realty Trust Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Shopify Inc / Strategic Education Inc / Snap Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Compugen Ltd / Highwoods Properties Inc / Booking Holdings Inc / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / EPR Properties / Meta Platforms Inc / Match Group Inc / ProAssurance Corp / Vornado Realty Trust / Washington Real Estate Investment Trust / Amerisafe Inc / Autolus Therapeutics PLC / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / IGM Biosciences Inc / James River Group Holdings Ltd / Sutro Biopharma Inc / Molina Healthcare Inc / Applovin Corp / Employers Holdings Inc / American Public Education Inc / Instil Bio Inc / Northern Oil and Gas Inc / Kinsale Capital Group Inc / RLJ Lodging Trust / Angi Inc / Electronic Arts Inc / Abbvie Inc / Malibu Boats Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Easterly Government Properties Inc / GoDaddy Inc / Mastercraft Boat Holdings Inc / Live Oak Bancshares Inc / Penumbra Inc / Block Inc / Carvana Co / Iovance Biotherapeutics Inc / Stitch Fix Inc / Frontdoor Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Palomar Holdings Inc / NextCure Inc / Genmab A/S / OneWater Marine Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Nice New Clarity and a Likely Accelerated Revenue Stream; Price Target Increased to $69</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">98419J206 / REGN.OQ / RZLT.OQ / VIRX.OQ</td><td class="leftalignment">XOMA Corp / Regeneron Pharmaceuticals Inc / Rezolute Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Hot or Not? Checking The Temperature of SMID Oncology Subgroups</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / BMY=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / AUTL=US / IGMS=US / STRO=US / TIL=US / IOVA=US / ALLO=US / HARP=US / TCRR=US / NXTC=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Autolus Therapeutics PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">When It Rains, It Pours: Another Week of Big Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">Launching Coverage on Cancer Cell Therapy - ALLO, CRSP, CLLS, DTIL, FATE and LEGN</td><td class="leftalignment">English</td><td class="rightalignment">377</td><td class="leftalignment">H17182108 / DTIL.OQ / FATE.OQ / LEGN.OQ / 75886F107 / 15117K103 / 31189P102 / 74019P108 / 52490G102</td><td class="leftalignment">CRISPR Therapeutics AG / Precision BioSciences Inc / Fate Therapeutics Inc / Legend Biotech Corp / Regeneron Pharmaceuticals Inc / Cellectis SA / Fate Therapeutics Inc / Precision BioSciences Inc / Legend Biotech Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David Dai</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2026242 / 2732635 / 2222631 / 2270726 / 2542049 / 2317087 / 2121352 / 2415204 / 2515030 / 2684703 / 2048804 / 2730190 / 2825933 / 2943523 / 2503529 / 2181334 / 2170473 / B00FWN1 / 2769796 / 2857817 / B5B2106 / B7TL820 / B7VD3F2 / B8DPDT7 / BVVN4Q8 / BYW36M8 / BFZNYB7 / BD8DJ71 / BQT3XY6 / BZ1HM42 / BNFWR44 / BR4T3B3 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BKC9SX3 / BZ0P3Z5 / BNTB3N8 / BMGGJK8 / BM8NHS1</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / AutoNation Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Group 1 Automotive Inc / Hawaiian Electric Industries Inc / Lithia Motors Inc / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Penske Automotive Group Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Constellation Brands Inc / Alnylam Pharmaceuticals Inc / Fidelity National Information Services Inc / Netflix Inc / Fortinet Inc / Meta Platforms Inc / Duke Energy Corp / Sarepta Therapeutics Inc / Eversource Energy / PayPal Holdings Inc / Allogene Therapeutics Inc / Snap Inc / Cyberark Software Ltd / Adyen NV / Worldline SA / HubSpot Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Vizio Holding Corp / Valneva SE / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Initiating At Neutral: Current Asset Mix Gives Us Pause</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">68622V106 / 717081103 / 031162100 / 09062X103 / 881624209 / 75886F107 / 216648402 / 58933Y105 / 00287Y109 / G30401106 / G97822103 / 03168L105 / 071734107 / 30048L104 / 92556V106</td><td class="leftalignment">Organon & Co / Pfizer Inc / Amgen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Regeneron Pharmaceuticals Inc / Cooper Companies Inc / Merck & Co Inc / Abbvie Inc / Endo International PLC / Perrigo Company PLC / Amneal Pharmaceuticals Inc / Bausch Health Companies Inc / Evofem Biosciences Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">10/06/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Intellia Receives Authorization to Begin Phase 1/2 trial of NTLA-2002 for Treatment of Hereditary Angioedema (HAE)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NTLA.OQ / REGN.OQ</td><td class="leftalignment">Intellia Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107 / 55306N104</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / MKS Instruments Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Mark Miller / Mr. Josh W. Sullivan</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Market Sentiments Have Changed; Our Sales Projections Have Not</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2280220 / 2270726 / 2542049 / 2317087 / 2630085 / 2657802 / 2684703 / 2048804 / 2730190 / 7103065 / B121557 / 2857817 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / B7577T2 / BFLR866 / BVVN4Q8 / BD8DJ71 / BJ2Z0H2 / BGCYWN8 / BYZM6C2 / BJJMGL2 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BD72R64 / BNTB3N8 / BMW5LX6</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Neogen Corp / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Mastercard Inc / Netflix Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Snap Inc / Pinterest Inc / Xencor Inc / Intellia Therapeutics Inc / Fox Corp / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Liberty Media Corp / Vizio Holding Corp / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Key takeaways from Amgen's Immunology call and Sanofi's OX-40 data at EADV</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SASY.PA / AZN.L / 4151.T / REGN.OQ</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Kyowa Kirin Co Ltd / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Merck's molnupiravir data and read-across to Celltrion stocks</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">068270.KS / 091990.KQ / MRCG.DE / LLY.N / PFE.N / ROG.S / GSK.L / REGN.OQ / NVAX.OQ / INO.OQ / MRNA.OQ / CVAC.OQ / ABCL.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Merck KGaA / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Novavax Inc / Inovio Pharmaceuticals Inc / Moderna Inc / CureVac NV / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - COVID-Related Revenue Tailwinds Are Abating, But We Expect Core Programs to Continue to Outperform; Recent Sell-Off Is a Bit Overdone</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AGCO / ATRC / CSII / DE / FDX / IRTC / KMX / QCOM.O / TRMB / UPS / V / WMT / AMZN.O / EBAY.O / EW / NFLX / PLUG.O / ARRY.O / GPN / FCEL.O / AMSC.O / REGN.O / OSTK / XLNX.OQ / SIVB.O / ITRI.O / FLWS.O / PETS.O / 316773100 / SPWR.O / CSIQ.O / FSLR.O / WPRT.O / TWIN.O / CDXC / TSLA.O / SWAV / PCYO.O / AMRS.O / ANGI.O / ENPH.O / FB.O / 83416M105 / CNHI / TBK.O / ETSY.O / SEDG.O / RUN.O / WKHS.O / AQMS.O / AQB / ROKU.O / 83417M104 / TMDX / 02081G201 / VLDR.O / WISH.O / SHLS.O / APPH / TSP.O / 62957N102 / ENVX.O / LILM.O</td><td class="leftalignment">AGCO Corp / AtriCure Inc / Cardiovascular Systems Inc / Deere & Co / FedEx Corp / iRhythm Technologies Inc / Carmax Inc / Qualcomm Inc / Trimble Inc / United Parcel Service Inc / Visa Inc / Walmart Inc / Amazon.com Inc / eBay Inc / Edwards Lifesciences Corp / Netflix Inc / Plug Power Inc / Array Technologies Inc / Global Payments Inc / Fuelcell Energy Inc / American Superconductor Corp / Regeneron Pharmaceuticals Inc / Overstock.com Inc / Xilinx Inc / SVB Financial Group / Itron Inc / 1-800-Flowers.Com Inc / Petmed Express Inc / Fifth Third Bancorp / SunPower Corp / Canadian Solar Inc / First Solar Inc / Westport Fuel Systems Inc / Twin Disc Inc / Chromadex Corp / Tesla Inc / Shockwave Medical Inc / Pure Cycle Corp / Amyris Inc / Angi Inc / Enphase Energy Inc / Meta Platforms Inc / SLR Senior Investment Corp / CNH Industrial NV / Triumph Bancorp Inc / ETSY Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Aqua Metals Inc / AquaBounty Technologies Inc / Roku Inc / Solaredge Technologies Inc / Transmedics Group Inc / Alphatec Holdings Inc / Velodyne Lidar Inc / ContextLogic Inc / Shoals Technologies Group Inc / AppHarvest Inc / TuSimple Holdings Inc / Nacel Energy Corp / Enovix Corp / Lilium NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / China / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: EDITing Effect Elusive; PFE Fine-Tunes PIII</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Over or Underreaction? SVBL Analysts on Molnupiravir and Its Impact</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">91390310 / 75991610 / 91324P10 / 71708110 / 44485910 / 88355610 / 94184810 / 04635310 / 75886F10 / 53245710 / 02343610 / 50187A10 / 58933Y10 / 88033G40 / 87918A10 / 03675210 / 40412C10 / 67181A10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / G3910J11 / 05370A10 / F5548N10 / 00288U10 / 00404A10 / 12552310 / 04683R10</td><td class="leftalignment">Universal Health Services Inc / Repligen Corp / UnitedHealth Group Inc / Pfizer Inc / Humana Inc / Thermo Fisher Scientific Inc / Waters Corp / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Amedisys Inc / LHC Group Inc / Merck & Co Inc / Tenet Healthcare Corp / Teladoc Health Inc / Anthem Inc / HCA Healthcare Inc / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC / Avidity Biosciences Inc / Sanofi SA / Abcellera Biologics Inc / Acadia Healthcare Company Inc / Cigna Corp / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mr. Whit Mayo / Stephanie Davis, CFA / Mr. Puneet Souda / Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Sell-Off on Bout of COVID-opia Provides Entry Point for REGN Shares; Reiterate Buy and $831 PT</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / AIG.N / ALV.N / BAC.N / BATS.L / BK.N / C.N / CAS.TO / CB.N / CCI.N / CL.N / EIX.N / EL.N / F.N / FGP.L / FITB.O / FSR.N / GM.N / IBE.MC / JPM.N / KEY.N / KMB.N / KO.N / MO.N / NTRS.O / PEG.N / PERP.PA / PNC.N / RWEG.DE / SO.N / T.N / USB.N / VC.N / WFC.N / PEP.N / PG.N / LPX.N / TEN.N / AMGN.O / INCY.O / DUK.N / BWA.N / LEA.N / K.N / DISH.O / SU.TO / GS.N / CLX.N / CAG.N / BEIG.DE / PCG.N / HSY.N / EPC.N / ADCT.N / SBAC.O / AMT.N / GIBa.TO / CONE.O / VZ.N / STT.N / EXEL.O / XEL.N / ARNA.O / STZ.N / LNC.N / APH.N / AXL.N / CHD.N / NWN.N / MTB.N / BC.N / GIL.N / SAM.N / AJG.N / REGN.O / ENR.N / PRU.N / TEL.N / RF.N / CPK.N / PII.N / ST.N / CRC.N / PLUG.OQ / SGEN.OQ / MNST.O / BPOP.O / ACGL.O / EQIX.O / ATDb.TO / TFC.N / DLR.N / 416515104 / SJW.N / DRX.L / MS.N / HOG.N / AON.N / BGS.N / DAN.N / CLW.N / SPB.N / NEE.N / MTOR.N / RFP.N / FFHu.TO / MDLZ.OQ / KPT.TO / TSLA.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / PLC.TO / CFG.N / FEVR.L / ZG.O / RGNX.O / RACE.MI / ADVM.OQ / ADNT.N / UNIT.O / VST.N / ATNX.O / APTV.N / VNE.N / KDP.N / NWL.O / GMAB.O / CRNC.OQ / OAS.OQ / WTRG.N / REYN.O / NKLA.OQ / NRIX.OQ / LUMN.N / RIDE.OQ / WFG.N / TSP.OQ / OTLY.O / RYAN.N / COOK.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American International Group Inc / Autoliv Inc / Bank of America Corp / British American Tobacco PLC / Bank of New York Mellon Corp / Citigroup Inc / Cascades Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Ford Motor Co / FirstGroup PLC / Fifth Third Bancorp / Fisker Inc / General Motors Co / Iberdrola SA / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Northern Trust Corp / Public Service Enterprise Group Inc / Pernod Ricard SA / PNC Financial Services Group Inc / Rwe AG / Southern Co / AT&T Inc / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Procter & Gamble Co / Louisiana-Pacific Corp / Tenneco Inc / Amgen Inc / Incyte Corp / Duke Energy Corp / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Suncor Energy Inc / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / Beiersdorf AG / PG&E Corp / Hershey Co / Edgewell Personal Care Co / ADC Therapeutics SA / SBA Communications Corp / American Tower Corp / CGI Inc / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Brunswick Corp / Gildan Activewear Inc / Boston Beer Company Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / TE Connectivity Ltd / Regions Financial Corp / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / California Resources Corp / Plug Power Inc / Seagen Inc / Monster Beverage Corp / Popular Inc / Arch Capital Group Ltd / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / Digital Realty Trust Inc / Hartford Financial Services Group Inc / SJW Group / Drax Group PLC / Morgan Stanley / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Dana Inc / Clearwater Paper Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / KP Tissue Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Park Lawn Corp / Citizens Financial Group Inc / Fevertree Drinks PLC / Zillow Group Inc / Regenxbio Inc / Ferrari NV / Adverum Biotechnologies Inc / Adient PLC / Uniti Group Inc / Vistra Corp / Athenex Inc / Aptiv PLC / Veoneer Inc / Keurig Dr Pepper Inc / Newell Brands Inc / Genmab A/S / Cerence Inc / Oasis Petroleum Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Nurix Therapeutics Inc / Lumen Technologies Inc / Lordstown Motors Corp / West Fraser Timber Co Ltd / TuSimple Holdings Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc / Traeger Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Netherlands / Puerto Rico / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Impact of Merck's COVID small molecule drug molnupiravir on China healthcare</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / GSK.L / REGN.OQ / 2269.HK</td><td class="leftalignment">Merck & Co Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">Top Questions for Management Teams in Our Biotech Coverage Universe</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">004225108 / 01671P100 / 75886F107 / 04744L106 / 040047607 / 98420N105 / 24823R105 / 501147102 / 68570P101 / 77313F106 / 05464T104 / 74374N102 / 757468103 / G5966510 / 38341P102</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Allakos Inc / Regeneron Pharmaceuticals Inc / Athersys Inc / Arena Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Denali Therapeutics Inc / Krystal Biotech Inc / Orchard Therapeutics PLC / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Provention Bio Inc / Redhill Biopharma Ltd / MeiraGTx Holdings PLC / Gossamer Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David T. Hoang, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Sep 24</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 10.3.21</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 01988P10 / 00282410 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 44485910 / 45253H10 / 07181310 / 10113710 / 04635310 / 43644010 / 64125C10 / 37555810 / 15678210 / 03116210 / 75886F10 / 46120E60 / 11679410 / M2572210 / 45232710 / 02343610 / 09062X10 / 01625510 / 30063P10 / 478160104 / 640268108 / 075887109 / 00422510 / 02043Q10 / 67070410 / 40637H10 / 207410101 / 205306103 / 45784P10 / 25213110 / 50187A10 / 58502B10 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 02311120 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 05463X10 / 45780L10 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 03675210 / 75046920 / 00287Y10 / 40412C10 / G5960L10 / 46222210 / 18946410 / 04004760 / 21232630 / 04280A10 / 05337M104 / 23283X20 / 40131M10 / 604749101 / 63230710 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 67181A10 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 58949210 / 09627Y10 / 68071010 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 04685N10 / 13089P10 / 34633R10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 45332Y10 / 80405P10 / N4482110 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / 16961L10 / 65443P10 / 82939910 / 87410C10 / 19240Q20 / 00288U10 / 36870G10 / 64128810 / 00404A10 / N6960510 / 28036F10 / 51506910 / N5749R10 / 24343R10 / 75629V10 / 26622P10 / 52634L10 / 23003110 / 49705R10 / 38246G10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / N5151710 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 75382E10 / 29251M10 / 81064810 / G637AM10 / 15117B20 / 00038020 / 82489T10 / 00653Q10 / 12552310 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 87427V10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Abbott Laboratories / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / ImmunoGen Inc / Baxter International Inc / Boston Scientific Corp / AstraZeneca PLC / Hologic Inc / Neurocrine Biosciences Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Bruker Corp / Compugen Ltd / Illumina Inc / Amedisys Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Becton Dickinson and Co / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / NuVasive Inc / Halozyme Therapeutics Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / LHC Group Inc / MEDNAX Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Amarin Corporation PLC / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / AxoGen Inc / Inogen Inc / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Anthem Inc / Radius Health Inc / Abbvie Inc / HCA Healthcare Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Arrowhead Pharmaceuticals Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Mirum Pharmaceuticals Inc / Natera Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Olink Holding AB (publ) / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Inari Medical Inc / Satsuma Pharmaceuticals Inc / InflaRx NV / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / Chinook Therapeutics Inc / 908 Devices Inc. / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Cogent Biosciences Inc / Abcellera Biologics Inc / Gemini Therapeutics Inc / Neuropace Inc / Acadia Healthcare Company Inc / Pharvaris NV / Edgewise Therapeutics Inc / Landos Biopharma Inc / Merus NV / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc / Doximity Inc / LENSAR Inc / Cullinan Oncology Inc / Kinnate Biopharma Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / LAVA Therapeutics NV / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Rapt Therapeutics Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Celldex Therapeutics Inc / Abcam PLC / Shockwave Medical Inc / Adapthealth Corp / Cigna Corp / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Talkspace Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">10/02/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US35104E1001 / US45337C1027 / US75886F1075 / US00287Y1091 / US8036071004 / US88322Q1085 / US29251M1062 / US23257D1037 / CH0334081137 / US24823R1059 / US5011471027 / US84833T1034 / US02155H2004 / US65487U1088 / US68236R1032 / US81181C1045</td><td class="leftalignment">4D Molecular Therapeutics Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abbvie Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Enanta Pharmaceuticals Inc / Cymabay Therapeutics Inc / CRISPR Therapeutics AG / Denali Therapeutics Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Altimmune Inc / Nkarta Inc / Oncorus Inc / Seagen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">10/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / REGN.O / SGEN.OQ / PRTA.O / ATNX.O / GMAB.O / NRIX.OQ</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 75 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAN.N / T.N / AEP.N / CL.N / COF.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / BRX.N / TWOU.OQ / ANTM.N / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Colgate-Palmolive Co / Capital One Financial Corp / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Brixmor Property Group Inc / 2U Inc / Anthem Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / RAD / WMT / WW / ONEM.O / REGN.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / ANGO.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / WW International Inc / 1Life Healthcare Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / AngioDynamics Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary --Oct .01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / BAX / CSII / GBT / INCY / OM / PRTA / RAD / WMT / EW / ONEM.O / XRAY.O / UTHR.O / ALGN.O / REGN.O / SSNC.O / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / MNKD.O / ANGO.O / LHCG.O / 02043Q107 / ENSG.O / 483548103 / MRNA.O / BBI.O / 771195104 / ADUS.O / GLAXOSM.LG / SWAV / SPRO.O / TRVN / 02005N100 / VBIV.O / AUPH.O / 189464100 / EVH / 100063846 / EDIT / VRAY / FLGT.O / GTHX / ATNX.O / NCNA.O / APLS.O / 720795103 / ARVN / DMAC.O / TMDX / PNTG.O / ZNTL.O / ABST.TO / 03823M100 / CLNN.O</td><td class="leftalignment">Arcosa Inc / Baxter International Inc / Cardiovascular Systems Inc / Global Blood Therapeutics Inc / Incyte Corp / Outset Medical Inc / Prothena Corporation PLC / Rite Aid Corp / Walmart Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / DENTSPLY SIRONA Inc / United Therapeutics Corp / Align Technology Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / MannKind Corp / AngioDynamics Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Brickell Biotech Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Shockwave Medical Inc / Spero Therapeutics Inc / Trevena Inc / Ally Financial Inc / VBI Vaccines Inc / Aurinia Pharmaceuticals Inc / Clovis Oncology Inc / Evolent Health Inc / Truist Financial Corp / Editas Medicine Inc / ViewRay Inc / Fulgent Genetics Inc / G1 Therapeutics Inc / Athenex Inc / NuCana PLC / Apellis Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Arvinas Inc / DiaMedica Therapeutics Inc / Transmedics Group Inc / Pennant Group Inc / Zentalis Pharmaceuticals Inc / Absolute Software Corp / Applied Minerals Inc / Clene Inc.</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Molnupiravir Looks Like a Game Changer; REGEN-COV Outlook Less Certain Now</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Feedback From a KOL on Asthma/COPD & Potential of Dupixent in These Diseases</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084 / US92556V1061</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CCO.TO / DGE.L / NA / PD.N / SGEF.PA / STO.AX / AMZN.O / CNQ.TO / GILD.O / AMGN.O / AAL.L / ADCT.N / KGC.N / EXEL.O / ALA.TO / ARNA.O / RRC.N / KMX.N / ADSK.O / EPD.N / BMRN.O / REGN.O / VRTX.O / MCO.N / CEY.L / COP.N / SWN.N / CRC.N / LNG.A / SGEN.OQ / IMGN.O / RGLD.O / CASY.O / ATDb.TO / BIIB.O / FM.TO / NST.AX / 878742204 / EDV.TO / NTR.N / MOS.N / NESTE.HE / RDSb.L / DRX.L / SES.TO / CS.TO / 443628102 / HOCM.L / SLR.AX / OSK.TO / INO.OQ / ARX.TO / VALE.N / CVE.TO / BHPB.L / NEE.N / TOU.TO / GLEN.L / XYL.N / TVE.TO / FB.O / PANW.N / ENTA.O / PTCT.O / PRTA.O / AGIO.O / 46579R104 / GOOGL.O / CIA.TO / S32.AX / MESO.O / SPGI.N / AZRE.N / AKERBP.OL / PBYI.OQ / AQN.N / SNAP.N / SSRM.O / KL.N / ATNX.O / ZS.OQ / VRCA.OQ / PINS.N / ZM.O / CRWD.O / GMAB.O / ADT1.L / MGNI.OQ / NRIX.OQ / MTCR.O / NUVB.N / PATH.N / TSP.OQ / ANE.MC</td><td class="leftalignment">Cameco Corp / Diageo PLC / National Bank of Canada / PagerDuty Inc / Vinci SA / Santos Ltd / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Anglo American PLC / ADC Therapeutics SA / Kinross Gold Corp / Exelixis Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Range Resources Corp / Carmax Inc / Autodesk Inc / Enterprise Products Partners LP / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moody's Corp / Centamin PLC / Conocophillips / Southwestern Energy Co / California Resources Corp / Cheniere Energy Inc / Seagen Inc / ImmunoGen Inc / Royal Gold Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Biogen Inc / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Nutrien Ltd / Mosaic Co / Neste Oyj / Royal Dutch Shell PLC / Drax Group PLC / Secure Energy Services Inc / Capstone Mining Corp / Hudbay Minerals Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Osisko Mining Inc / Inovio Pharmaceuticals Inc / ARC Resources Ltd / Vale SA / Cenovus Energy Inc / BHP Group PLC / Nextera Energy Inc / Tourmaline Oil Corp / Glencore PLC / Xylem Inc / Tamarack Valley Energy Ltd / Meta Platforms Inc / Palo Alto Networks Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Ivanhoe Mines Ltd / Alphabet Inc / Champion Iron Ltd / South32 Ltd / Mesoblast Ltd / S&P Global Inc / Azure Power Global Ltd / Aker BP ASA / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Snap Inc / SSR Mining Inc / Kirkland Lake Gold Ltd / Athenex Inc / Zscaler Inc / Verrica Pharmaceuticals Inc / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Adriatic Metals PLC / Magnite Inc / Nurix Therapeutics Inc / Metacrine Inc / Nuvation Bio Inc / UiPath Inc / TuSimple Holdings Inc / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Denmark / Spain / Finland / France / United Kingdom / Ireland / Mauritius / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Revisiting remaining catalysts for Biotech in Q4:21 and year-end</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / PRTA.O / AGIO.O / MESO.O / PBYI.OQ / ATNX.O / GMAB.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Puma Biotechnology Inc / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - Merck molnupiravir data highlights $1bn+ Roche opportunity for AT-527</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ROG.S / AZN.L / GSK.L / REGN.OQ / 068270.KS / 091990.KQ</td><td class="leftalignment">Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Celltrion Inc / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">4Q21 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CBIO.OQ / 031162100 / 64125C109 / 766559603 / 09062X103 / 09061G101 / 75886F107 / AADI / 02043Q107 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 00287Y109 / 29251M106 / 023111206 / 45773H201 / 03835T200 / 189464100 / 78667J108 / 03209R103 / 16383L106 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 00771V108 / 01345P106 / 52187K101 / G11196105 / 462260100 / 558868105 / 98401F105 / 23284F105 / 29014R103 / 039697107 / H17182108 / 67576A100 / 761330109 / 41358P106 / 483347100 / 37890U108 / 269796108 / 088786108 / G46188101 / 29668H708 / 68906L105 / 04016X101 / 62921N105 / 87184Q107 / 481116101 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 729139105 / 00972D105 / 760273102 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 604749101 / 92243A200 / 00166B105 / 576810105 / 45790W108 / 04335A105 / 23257D103 / 4525EP101 / 46565G104 / 501575104 / 14147L108 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 03890D108 / 55028X109 / 03835L207 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 38406L103 / 81728A108 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 09077A106 / 75082Q105 / 15673T100 / 670703107 / 87990A106 / 87978U108</td><td class="leftalignment">Catalyst Biosciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Aadi Bioscience Inc / Alnylam Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Amarin Corporation PLC / Inovio Pharmaceuticals Inc / Aptose Biosciences Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Aerie Pharmaceuticals Inc / Albireo Pharma Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / Xencor Inc / CytomX Therapeutics Inc / Eloxx Pharmaceuticals Inc / Ardelyx Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / Eagle Pharmaceuticals Inc / Bicycle Therapeutics PLC / Horizon Therapeutics PLC / ESSA Pharma Inc / Otonomy Inc / argenx SE / NGM Biopharmaceuticals Inc / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Vaxart Inc / ALX Oncology Holdings Inc / Matinas BioPharma Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Immunic Inc / Iteos Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Aravive Inc / Lumos Pharma Inc / Aptevo Therapeutics Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Biomea Fusion Inc / Rain Therapeutics Inc / Century Therapeutics Inc / Nuvalent Inc / Tenaya Therapeutics Inc / Tempest Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Reversal of Fortune - Biotech Fund Flows Turn Negative</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron climbs 8.4% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Competition in Atopic Dermatitis Heating Up, but Nothing Challenges Dupi</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">71708110 / 03116210 / 75886F10 / 00287Y10 / F5548N10</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker - Wegovy launch insights: For The Week Ended Sep 17</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Regeneron Pharmaceuticals, Inc. SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc. (REGN) - A diversified growth story</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">09/29/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ / AMGN.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / BMRN.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / ALNY.OQ / SRPT.OQ / ABBV.N / MRTX.OQ / FATE.OQ / NVTA.N / NTRA.OQ / NTLA.OQ / 6160.HK / BBIO.OQ / 22UAy.DE</td><td class="leftalignment">Moderna Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Biomarin Pharmaceutical Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Invitae Corp / Natera Inc / Intellia Therapeutics Inc / Beigene Ltd / BridgeBio Pharma Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 09 28</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">ARMK.N / FEYE.OQ / CAH.N / HLT.N / ETN.N / BWA.N / GLW.N / ENR.N / REGN.OQ / TPR.N / SWKS.OQ / LAUR.OQ / MPWR.OQ / VMW.N / XYL.N / ADI.OQ / LKQ.OQ / PANW.N / PINC.OQ / ANET.N / TTD.OQ</td><td class="leftalignment">Aramark / Mandiant Inc / Cardinal Health Inc / Hilton Worldwide Holdings Inc / Eaton Corporation PLC / Borgwarner Inc / Corning Inc / Energizer Holdings Inc / Regeneron Pharmaceuticals Inc / Tapestry Inc / Skyworks Solutions Inc / Laureate Education Inc / Monolithic Power Systems Inc / VMware Inc / Xylem Inc / Analog Devices Inc / LKQ Corp / Palo Alto Networks Inc / Premier Inc / Arista Networks Inc / Trade Desk Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Apparel & Textiles / Automotive / Biotechnology / Education / Electrical / Electronics / Healthcare / Household Products / Info. Tech./Software / Lodging & Restaurants / Machinery / Semiconductors / Telecommunications / Wholesale</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2094670 / 2778844 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2657802 / 2689560 / 2684703 / 2707677 / 2730190 / 2862532 / 2138158 / 2799351 / 2829601 / 7103065 / 2857817 / 2390817 / B7TL820 / B7JYSG3 / B8L2798 / B7577T2 / B8DPDT7 / BFLR866 / BVVN4Q8 / BK0VHF6 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BP84RX0 / BGKG6M3 / BF3N4P3 / BMV31Q4 / BNNTQY0 / BJ62Z18</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Best Buy Co Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / Novartis AG / Netflix Inc / Gray Television Inc / Meta Platforms Inc / Guidewire Software Inc / Hemisphere Media Group Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Twitter Inc / Eversource Energy / IDEAYA Biosciences Inc / Snap Inc / Xencor Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Tegna Inc / Townsquare Media Inc / StoneCo Ltd / Arena Pharmaceuticals Inc / Audacy Inc / Oatly Group AB / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3956</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Sep. 27, 2021 / 9:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / ALV.N / CAS.TO / CB.N / CNA.L / CRM.N / EIX.N / EL.N / F.N / FSR.N / GM.N / KO.N / PD.N / RWEG.DE / SO.N / T.N / VC.N / SSE.L / TEN.N / CMCSA.O / AMGN.O / DUK.N / BWA.N / LEA.N / REE.MC / K.N / DISH.O / ADBE.O / NICE.O / CLX.N / PCG.N / EPC.N / AMT.N / VZ.N / HCA.N / XEL.N / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / AXL.N / ACN.N / NWN.N / BC.N / AJG.N / REGN.O / ENR.N / PRU.N / NCR.N / TEL.N / ENAG.MC / CNP.N / CPK.N / PII.N / ST.N / PLUG.OQ / SGEN.OQ / GPN.N / IMGN.O / CASY.O / EQIX.O / ATDb.TO / DLR.N / 416515104 / SJW.N / FIS.N / HOG.N / EHTH.O / AON.N / BGS.N / DAN.N / SPB.N / NEE.N / MTOR.N / IFP.TO / XYL.N / FFHu.TO / TSLA.N / TMUS.N / BEP.N / PYPL.OQ / RACE.MI / MP1.AX / TWLO.N / ADNT.N / UNIT.O / APTV.N / VNE.N / ESTC.N / FSK.N / ZM.O / FSLY.N / GMAB.O / DOCU.N / CRNC.OQ / OAS.OQ / WTRG.N / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / RIDE.OQ / LSPD.N / WFG.N / TSP.OQ / OTLY.O / RYAN.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Cascades Inc / Chubb Ltd / Centrica PLC / Salesforce.Com Inc / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / Coca-Cola Co / PagerDuty Inc / Rwe AG / Southern Co / AT&T Inc / Visteon Corp / SSE PLC / Tenneco Inc / Comcast Corp / Amgen Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Red Electrica Corporacion SA / Kellogg Co / DISH Network Corp / Adobe Inc / Nice Ltd / Clorox Co / PG&E Corp / Edgewell Personal Care Co / American Tower Corp / Verizon Communications Inc / HCA Healthcare Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Northwest Natural Holding Co / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Enagas SA / CenterPoint Energy Inc / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Plug Power Inc / Seagen Inc / Global Payments Inc / ImmunoGen Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / SJW Group / Fidelity National Information Services Inc / Harley-Davidson Inc / eHealth Inc / Aon PLC / B&G Foods Inc / Dana Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Interfor Corp / Xylem Inc / Fairfax Financial Holdings Ltd / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / PayPal Holdings Inc / Ferrari NV / Megaport Ltd / Twilio Inc / Adient PLC / Uniti Group Inc / Aptiv PLC / Veoneer Inc / Elastic NV / FS KKR Capital Corp / Zoom Video Communications Inc / Fastly Inc / Genmab A/S / DocuSign Inc / Cerence Inc / Oasis Petroleum Inc / Essential Utilities Inc / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / TuSimple Holdings Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">09/26/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Novartis Nabs Arctos; AGTC Safety in Focus</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">AGTC.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Applied Genetic Technologies Corp / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/25/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Humana's Lawsuit, Poss Big M&A Deal, Catalyst Preview & More</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US35104E1001 / US45337C1027 / US75886F1075 / US6402681083 / US00287Y1091 / US09609G1004 / US88322Q1085 / US04351P1012 / US84833T1034 / KYG596651029 / US38341P1021 / US6047491013 / CA07987C2040 / US20451W1018 / US81181C1045 / US29479A1088</td><td class="leftalignment">4D Molecular Therapeutics Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Abbvie Inc / bluebird bio Inc / TG Therapeutics Inc / Ascendis Pharma A/S / Spero Therapeutics Inc / MeiraGTx Holdings PLC / Gossamer Bio Inc / Mirum Pharmaceuticals Inc / BELLUS Health Inc / Compass Pathways PLC / Seagen Inc / Erasca Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">09/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ARNA.O / REGN.O / SGEN.OQ / IMGN.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - September 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US8336351056 / IL0002810146 / US00724F1012 / US0231351067 / US0255371017 / US1270971039 / US1423391002 / US22160K1051 / US2371941053 / US25179M1036 / US2546871060 / US25746U1097 / US26875P1012 / US2788651006 / US29364G1031 / US30231G1022 / US3024913036 / US31428X1063 / US3377381088 / US3703341046 / US5719032022 / US5951121038 / US6267171022 / US6516391066 / US6541061031 / US6745991058 / US6935061076 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US8270481091 / US8454671095 / US8552441094 / US8851601018 / US9078181081 / US92276F1003 / US9621661043 / CA53278L1076 / CA1363751027 / CA1367178326 / CA1249003098 / CA29250N1050 / CA0467894006 / CA8029121057 / CA30150P1099 / CA4609191032 / CA8787422044 / CA89346D1078 / CA97535P1045 / CA2908761018 / CA5592224011 / CA1469001053 / CA0084741085 / CA0679011084 / CA15101Q1081 / CA3495531079 / US1667641005 / US5658491064 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US37940X1028 / CA3359341052 / CA09950M3003 / US20825C1045 / US60855R1005 / CA5734591046 / US14040H1059 / US46625H1005 / US6174464486 / US0605051046 / US38141G1040 / NO0010208051 / US49446R1095 / US20451N1019 / US79466L3024 / CA5503721063 / US2971781057 / US2538681030 / CA8911605092 / CA4436281022 / CA1360691010 / US44107P1049 / US1252691001 / CA1125851040 / US3137472060 / US31620M1062 / CA0010921058 / US42809H1077 / US57636Q1040 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US25960P1093 / US30225T1025 / US4219461047 / US49427F1084 / US5021751020 / US63633D1046 / BMG491BT1088 / US02913V1035 / CA45790B1040 / BMG162521014 / US2120151012 / US92826C8394 / GB0004300496 / US38526M1062 / US26884L1098 / IE00B4BNMY34 / DE000BAY0017 / CA14042M1023 / US78454L1008 / US1729674242 / US61945C1036 / DE000KSAG888 / US2296631094 / US30303M1027 / US71922G2093 / CA7063271034 / CA4932711001 / CA89156V1067 / US1091941005 / JE00B5TT1872 / BMG162581083 / US69327R1014 / CA0158571053 / CA0213611001 / CA3565001086 / CA6665111002 / CA96145A2002 / CA8661201167 / US70509V1008 / US78573L1061 / CA3748252069 / US5764852050 / US25278X1090 / US71943U1043 / US2921041065 / US03674X1063 / US90184L1026 / US2267181046 / US11120U1051 / US1630921096 / US44157R1095 / US02005N1000 / US90214J1016 / US03820J1007 / US14174T1079 / US2383371091 / BMG0750C1082 / US42225P5017 / US29444U7000 / US9840171030 / US4278255009 / US70450Y1038 / US95040Q1040 / US02079K3059 / CA4488112083 / US8522341036 / US37954A2042 / US2057683029 / BMG162341090 / US53223X1072 / US15136A1025 / US7005171050 / US5186132032 / CA75601Y1007 / CA9628791027 / US00737L1035 / US12653C1080 / US46590V1008 / CA2960061091 / US12634H2004 / CA67077M1086 / US87484T1088 / US08579X1019 / US86272C1036 / US46005L1017 / CA4039254079 / CA12532H1047 / US35137L1052 / CA87807B1076 / CA14179V5036 / CA33767E2024 / US22052L1044 / US26614N1028 / CA60800C1095 / CA29446Y5020 / US42250P1030 / US69047Q1022 / US5168062058 / US13123X5086 / US46121Y2019 / CA67079A1021 / CA89055A2039 / CA00288U1066 / US86333M1080 / US15202L1070 / US1651677353 / US03743Q1085 / CA00076T1057 / CA5362211040 / BMG6964L1072 / GB00BNDRMJ14 / CA03253E1079 / US71844V2016</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Icl Group Ltd / Adobe Inc / Amazon.com Inc / American Electric Power Company Inc / Coterra Energy Inc / Carlisle Companies Inc / Costco Wholesale Corp / Darden Restaurants Inc / Devon Energy Corp / Walt Disney Co / Dominion Energy Inc / EOG Resources Inc / Ecolab Inc / Entergy Corp / Exxon Mobil Corp / FMC Corp / FedEx Corp / Fiserv Inc / General Mills Inc / Marriott International Inc / Micron Technology Inc / Murphy Oil Corp / Newmont Corporation / Nike Inc / Occidental Petroleum Corp / PPG Industries Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Silgan Holdings Inc / Southwestern Energy Co / Starbucks Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Weyerhaeuser Co / Linamar Corp / Canadian National Railway Co / Canadian Utilities Ltd / CCL Industries Inc / Enbridge Inc / Atco Ltd / Saputo Inc / Exco Technologies Ltd / Intertape Polymer Group Inc / Teck Resources Ltd / TransAlta Corp / Winpak Ltd / Emera Inc / Magna International Inc / Cascades Inc / Agnico Eagle Mines Ltd / Barrick Gold Corp / Celestica Inc / Fortis Inc / Chevron Corp / Marathon Oil Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Global Payments Inc / First Quantum Minerals Ltd / Boralex Inc / Conocophillips / Molina Healthcare Inc / Martinrea International Inc / Capital One Financial Corp / JPMorgan Chase & Co / Morgan Stanley / Bank of America Corp / Goldman Sachs Group Inc / Yara International ASA / Kimco Realty Corp / Compass Minerals International Inc / Salesforce.Com Inc / Lundin Mining Corp / Essex Property Trust Inc / Digital Realty Trust Inc / Toronto-Dominion Bank / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Host Hotels & Resorts Inc / CF Industries Holdings Inc / Brookfield Asset Management Inc / Federal Realty Investment Trust / Fidelity National Information Services Inc / AGF Management Ltd / Hess Corp / Mastercard Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Douglas Emmett Inc / Extra Space Storage Inc / Healthcare Realty Trust Inc / Kilroy Realty Corp / LTC Properties Inc / National Health Investors Inc / Invesco Ltd / American Public Education Inc / Innergex Renewable Energy Inc / Brookfield Infrastructure Partners LP / Continental Resources Inc / Visa Inc / Pan African Resources PLC / Grand Canyon Education Inc / EQT Corp / Accenture PLC / Bayer AG / Capital Power Corp / SM Energy Co / Citigroup Inc / Mosaic Co / K&S AG / CubeSmart / Meta Platforms Inc / PhosAgro PAO / Pembina Pipeline Corp / Keyera Corp / Tourmaline Oil Corp / Bright Horizons Family Solutions Inc / Centamin PLC / Brookfield Renewable Partners LP / PDC Energy Inc / Algonquin Power & Utilities Corp / AltaGas Ltd / Freehold Royalties Ltd / Northland Power Inc / Westshore Terminals Investment Corp / Summit Industrial Income REIT / Pebblebrook Hotel Trust / Sabra Health Care REIT Inc / Gibson Energy Inc / Matador Resources Co / Diamondback Energy Inc / Physicians Realty Trust / Empire State Realty Trust Inc / Antero Resources Corp / Twitter Inc / Criteo SA / Brixmor Property Group Inc / Chegg Inc / Houghton Mifflin Harcourt Co / Ally Financial Inc / 2U Inc / Applied Genetic Technologies Corp / CareTrust REIT Inc / Dave & Buster's Entertainment Inc / Axalta Coating Systems Ltd / Healthcare Trust Of America Inc / Equinix Inc / Xenia Hotels & Resorts Inc / Hersha Hospitality Trust / PayPal Holdings Inc / Welltower Inc / Alphabet Inc / Hydro One Ltd / Block Inc / Global Medical REIT Inc / Comstock Resources Inc / Brookfield Business Partners LP / Life Storage Inc / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Laureate Education Inc / Real Matters Inc / Wheaton Precious Metals Corp / Adtalem Global Education Inc / CNX Resources Corp / JBG SMITH Properties / Ero Copper Corp / CPI Card Group Inc / Nutrien Ltd / Talos Energy Inc / Berry Corporation (Bry) / Strategic Education Inc / International Money Express Inc / H&R Real Estate Investment Trust / CGI Inc / Fox Corp / TC Energy Corp / Cargojet Inc / FirstService Corp / Corteva Inc / Dupont De Nemours Inc / Mogo Inc / Equinox Gold Corp / Healthpeak Properties Inc / Ovintiv Inc / Laredo Petroleum Inc / Callon Petroleum Co / Intrepid Potash Inc / Nuvei Corp / Topaz Energy Corp / Abcellera Biologics Inc / Stride Inc / Centerspace / Chesapeake Energy Corp / APA Corp (US) / Abc Technologies Holdings Inc / Lion Electric Co / Paysafe Ltd / Alphawave IP Group PLC / Anaergia Inc / Phillips Edison & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Chile / Germany / France / United Kingdom / Ireland / Israel / Norway / Russian Federation / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084 / US92556V1061</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">In The Relentless Pursuit Of Innovation</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">REGN - Embedded Expectations Analysis - 2021 09 23</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">They May Be Small, But Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - Updated numbers post ESMO/pharma day</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ROG.S / 4503.T / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / REGN.OQ / BAYGN.DE</td><td class="leftalignment">Roche Holding AG / Astellas Pharma Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / MRK=US / HD=US / MCD=US / ADI=US / WEN=US / BXP=US / BLD=US / TXN=US / GILD=US / PEB=US / SLG=US / H=US / MTN=US / LOW=US / IGT=US / BYD=US / MAR=US / LEG=US / TNL=US / VMC=US / MGM=US / HLT=US / PENN=US / MLM=US / AMN=US / SWIM=US / ARW=US / AVT=US / CBRL=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MCHP=US / MHK=US / MCRI=US / PACW=US / REGN=US / REGI=US / SLGN=US / SGMS=US / CCRN=US / CNM=US / COP=US / DIN=US / MRNS=US / RRR=US / TPX=US / EXP=US / CZR=US / KAR=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / WH=US / JACK=US / TREX=US / HGV=US / RLJ=US / VAC=US / FBHS=US / RHP=US / TILE=US / NDLS=US / 00770K202 / LOCO=US / SHAK=US / WING=US / EDIT=US / 82982L103 / PK=US / JELD=US / PLYA=US / ROKU=US / DCPH=US / KOD=US / FERG=US / DKNG=US / AZEK=US / BALY=US / SNPO=US</td><td class="leftalignment">Cars.com Inc / Merck & Co Inc / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Boston Properties Inc / TopBuild Corp / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Martin Marietta Materials Inc / AMN Healthcare Services Inc / Latham Group Inc / Arrow Electronics Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Silgan Holdings Inc / Scientific Games Corp / Cross Country Healthcare Inc / Core & Main Inc / Conocophillips / Dine Brands Global Inc / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / KAR Auction Services Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Roku Inc / Deciphera Pharmaceuticals Inc / Kodiak Sciences Inc / Ferguson PLC / DraftKings Inc / Azek Company Inc / Bally's Corp / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - September 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US25746U1097 / US6516391066 / US75886F1075 / US8552441094 / CA8029121057 / CA8787422044 / CA0084741085 / CA0679011084 / CA3359341052 / US49446R1095 / CA5503721063 / CA4436281022 / CA1125851040 / CA96145A2002 / BMG0750C1082 / CA2960061091 / CA33767E2024 / CA29446Y5020</td><td class="leftalignment">Dominion Energy Inc / Newmont Corporation / Regeneron Pharmaceuticals Inc / Starbucks Corp / Saputo Inc / Teck Resources Ltd / Agnico Eagle Mines Ltd / Barrick Gold Corp / First Quantum Minerals Ltd / Kimco Realty Corp / Lundin Mining Corp / Hudbay Minerals Inc / Brookfield Asset Management Inc / Westshore Terminals Investment Corp / Axalta Coating Systems Ltd / Ero Copper Corp / FirstService Corp / Equinox Gold Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2100920 / 2689560 / 2684703 / 2730190 / 2842255 / 2098876 / 7103065 / B121557 / 2769796 / 2857817 / B7TL820 / B4MG4Z6 / BBPK0J0 / B7577T2 / B8DPDT7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BHC8X90 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Yum! Brands Inc / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Mirati Therapeutics Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Novo Nordisk A/S / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ANA.MC / CB.N / CCI.N / CI.N / CNA.L / DD.N / ECL.N / EL.N / GM.N / KO.N / PNC.N / PPG.N / SLB.N / TOTF.PA / USB.N / VC.N / HUM.N / AMGN.O / WCC.N / MCD.N / VLO.N / GIS.N / AMT.N / CONE.O / SHW.N / HCA.N / MDRX.O / ARNA.O / AMP.N / SRE.N / EXC.N / FISV.O / PLD.N / AME.N / REGN.O / VRNT.O / COP.N / BKH.N / DFS.N / SEM.N / GPN.N / MNST.O / JCOM.O / EQIX.O / BIIB.O / TFC.N / DLR.N / GMS.N / BAM.N / ARWR.O / 025676206 / ISBC.O / SLRS.MC / ENSG.O / DAN.N / BIP.N / JACK.OQ / MSCI.N / ADUS.OQ / NXT.AX / BKU.N / PCRX.O / MTOR.N / STAG.N / MTDR.N / MDLZ.OQ / APAM.N / BEP.N / DOOR.N / ESNT.N / IBP.N / VRNS.O / QTWO.N / NMIH.O / AXTA.N / RPD.O / MIME.OQ / MP1.AX / SPGI.N / ATKR.N / KNSL.OQ / BBU.N / UN01.DE / GDS.O / GREG.MC / RCM.OQ / ORSTED.CO / AQUA.N / APTV.N / CDMO.OQ / EAF.N / VRCA.OQ / FOCS.O / HCAT.OQ / APRE.OQ / CARR.N / OTIS.N / ANE.MC</td><td class="leftalignment">Acciona SA / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Centrica PLC / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / TotalEnergies SE / US Bancorp / Visteon Corp / Humana Inc / Amgen Inc / Wesco International Inc / McDonald's Corp / Valero Energy Corp / General Mills Inc / American Tower Corp / CyrusOne Inc / Sherwin-Williams Co / HCA Healthcare Inc / Allscripts Healthcare Solutions Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Sempra Energy / Exelon Corp / Fiserv Inc / Prologis Inc / AMETEK Inc / Regeneron Pharmaceuticals Inc / Verint Systems Inc / Conocophillips / Black Hills Corp / Discover Financial Services / Select Medical Holdings Corp / Global Payments Inc / Monster Beverage Corp / Ziff Davis Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / Digital Realty Trust Inc / GMS Inc / Brookfield Asset Management Inc / Arrowhead Pharmaceuticals Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Solaria Energia y Medio Ambiente SA / Ensign Group Inc / Dana Inc / Brookfield Infrastructure Partners LP / Jack in the Box Inc / MSCI Inc / Addus Homecare Corp / NEXTDC Ltd / BankUnited Inc / Pacira Biosciences Inc / Meritor Inc / STAG Industrial Inc / Matador Resources Co / Mondelez International Inc / Artisan Partners Asset Management Inc / Brookfield Renewable Partners LP / Masonite International Corp / Essent Group Ltd / Installed Building Products Inc / Varonis Systems Inc / Q2 Holdings Inc / NMI Holdings Inc / Axalta Coating Systems Ltd / Rapid7 Inc / Mimecast Ltd / Megaport Ltd / S&P Global Inc / Atkore Inc / Kinsale Capital Group Inc / Brookfield Business Partners LP / Uniper SE / GDS Holdings Ltd / Grenergy Renovables SA / R1 RCM Inc / Orsted A/S / Evoqua Water Technologies Corp / Aptiv PLC / Avid Bioservices Inc / GrafTech International Ltd / Verrica Pharmaceuticals Inc / Focus Financial Partners Inc / Health Catalyst Inc / Aprea Therapeutics Inc / Carrier Global Corp / Otis Worldwide Corp / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GB0009895292 / US75886F1075 / US0042251084 / US40637H1095 / US00287Y1091 / US23282W6057 / US46116X1019 / US0327973006 / US75615P1030 / US24823R1059 / US22663K1079 / US6700024010</td><td class="leftalignment">AstraZeneca PLC / Regeneron Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Abbvie Inc / Cytokinetics Inc / Intra-Cellular Therapies Inc / Anavex Life Sciences Corp / Reata Pharmaceuticals Inc / Denali Therapeutics Inc / Crinetics Pharmaceuticals Inc / Novavax Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Libtayo + chemo combo data looks competitive for 1L NSCLC, and we think supportive of approval</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Broad combo platform anchored by Libtayo; awaiting more combos</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESMO event takeaways maintain focus on pipeline bispecifics turbocharging Libtayo</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech - Key takeaways from our KOL call on wAMD landscape</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US / KOD=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Kodiak Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Mali / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Libtayo Chemo Combo Data Solidly Competitive And Supports Approval In 1L NSCLC</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Full Chemo-Combo Data Supports Libtayo Opportunity in NSCLC</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Late-Breaking Data at ESMO Show Libtayo + Chemo Significantly Increases Survival vs. Chemo Alone in NSCLC Patients</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Sep. 20, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">344</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FISV=US / PEP=US / AMGN=US / CAG=US / KO=US / OXY=US / RRC=US / EFX=US / CL=US / PG=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / H=US / TRU=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / HLT=US / MANH=US / NWL=US / CI=US / FLO=US / MAC=US / STZ=US / CHD=US / COLL=US / CNX=US / EPC=US / EQT=US / EXEL=US / GPOR=US / HAIN=US / PCTY=US / REGN=US / SMG=US / CVX=US / POST=US / OPT=US / SGMS=US / GPN=US / CFR=US / EGP=US / FRT=US / INTA=US / KIM=US / EVOP=US / COP=US / BRX=US / INST=US / MGPI=US / BDSI=US / MQ / MNST=US / NOMD=US / MOH=US / FLT=US / FRPT=US / THS=US / MPW=US / FIS=US / HST=US / ELF=US / CENTA=US / CLR=US / NOG=US / RCUS=US / AAN=US / UTZ=US / OLO=US / AR=US / OAS=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / MODN=US / FIVN=US / VNOM=US / HUBS=US / MCFT=US / SQ=US / EDIT=US / ADVM=US / CDEV=US / PK=US / PVAC=US / SBOW=US / PETQ=US / SFIX=US / KDP=US / KOD=US / TCRR=US / LSPD=US / RPAY=US / BRBR=US / GMAB=US / OVV=US / REYN=US / PAYA=US / HYFM=US / AFRM=US / REPX=US / 67421J108 / DNUT=US / PYCR=US / EWCZ=US</td><td class="leftalignment">Fiserv Inc / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / Occidental Petroleum Corp / Range Resources Corp / Equifax Inc / Colgate-Palmolive Co / Procter & Gamble Co / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / TransUnion / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Newell Brands Inc / Cigna Corp / Flowers Foods Inc / Macerich Co / Constellation Brands Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Edgewell Personal Care Co / EQT Corp / Exelixis Inc / Gulfport Energy Corp / Hain Celestial Group Inc / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Chevron Corp / Post Holdings Inc / Opthea Ltd / Scientific Games Corp / Global Payments Inc / Cullen/Frost Bankers Inc / Eastgroup Properties Inc / Federal Realty Investment Trust / Intapp Inc / Kimco Realty Corp / EVO Payments Inc / Conocophillips / Brixmor Property Group Inc / Instructure Holdings Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Marqeta Inc / Monster Beverage Corp / Nomad Foods Ltd / Molina Healthcare Inc / Fleetcor Technologies Inc / Freshpet Inc / TreeHouse Foods Inc / Medical Properties Trust Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / elf Beauty Inc / Central Garden & Pet Co / Continental Resources Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / Antero Resources Corp / Oasis Petroleum Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Model N Inc / Five9 Inc / Viper Energy Partners LP / HubSpot Inc / Mastercraft Boat Holdings Inc / Block Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / SilverBow Resources Inc / PetIQ Inc / Stitch Fix Inc / Keurig Dr Pepper Inc / Kodiak Sciences Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Genmab A/S / Ovintiv Inc / Reynolds Consumer Products Inc / Paya Holdings Inc / Hydrofarm Holdings Group Inc / Affirm Holdings Inc / Riley Exploration Permian Inc / Oatly Group AB / Krispy Kreme Inc / Paycor HCM Inc / European Wax Center Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Denmark / Luxembourg / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Encouraging Libtayo NSCLC Chemo Combo; Can it Catch Keytruda?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">75886F10 / 58933Y10 / F5548N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Merck & Co Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Astellas AAV on Hold; ABBV Grabs Hold of '314</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Another Libtayo Phase 3 Win in NSCLC-EMPOWER-Lung 3 Stopped Early, Hits in 1L in Chemo Combo; Reiterate Buy and $831 PT</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AEP.N / AES.N / ALV.N / CAS.TO / CB.N / CNA.L / EIX.N / EL.N / F.N / FSR.N / GM.N / KBH.N / KO.N / SO.N / T.N / VC.N / SSE.L / PXD.N / HUM.N / TEN.N / CMCSA.O / AMGN.O / ETR.N / RBA.N / CNR.TO / BWA.N / LEA.N / K.N / DISH.O / LEN.N / CLX.N / PCG.N / EPC.N / ADCT.N / AMT.N / NG.L / VZ.N / EXEL.O / XEL.N / ARNA.O / STZ.N / LNC.N / APH.N / EXC.N / FISV.O / V.N / AXL.N / ACN.N / NWN.N / BC.N / AJG.N / REGN.O / ENR.N / SRG.MI / PRU.N / NCR.N / TEL.N / CPK.N / GTY.N / PII.N / ST.N / AMH.N / PLUG.OQ / SGEN.OQ / GPN.N / CASY.O / JCOM.O / EQIX.O / ATDb.TO / DLR.N / 416515104 / SJW.N / FIS.N / MA.N / HOG.N / AON.N / BGS.N / DAN.N / EONGn.DE / NGD.A / SPB.N / NEE.N / MTOR.N / IFP.TO / PANW.N / FFHu.TO / TSLA.N / TMUS.N / RNW.TO / RACE.MI / TRHC.OQ / MP1.AX / ADNT.N / INVH.N / UNIT.O / ATNX.O / APTV.N / EQX.TO / VNE.N / NTGY.MC / ZM.O / GMAB.O / CRNC.OQ / WTRG.N / NKLA.OQ / FOUR.N / MGNI.OQ / RXT.OQ / IBEX.O / LUMN.N / RIDE.OQ / LSPD.N / PUBM.O / WFG.N / NUVB.N / PSFE.N / TSP.OQ / OTLY.O / RYAN.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Cascades Inc / Chubb Ltd / Centrica PLC / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / KB Home / Coca-Cola Co / Southern Co / AT&T Inc / Visteon Corp / SSE PLC / Pioneer Natural Resources Co / Humana Inc / Tenneco Inc / Comcast Corp / Amgen Inc / Entergy Corp / Ritchie Bros Auctioneers Inc / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Lennar Corp / Clorox Co / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / American Tower Corp / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Exelon Corp / Fiserv Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Northwest Natural Holding Co / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Snam SpA / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Getty Realty Corp / Polaris Inc / Sensata Technologies Holding PLC / American Homes 4 Rent / Plug Power Inc / Seagen Inc / Global Payments Inc / Caseys General Stores Inc / Ziff Davis Inc / Equinix Inc / Alimentation Couche-Tard Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Dana Inc / E.ON SE / New Gold Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Interfor Corp / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Tesla Inc / T-Mobile US Inc / TransAlta Renewables Inc / Ferrari NV / Tabula Rasa HealthCare Inc / Megaport Ltd / Adient PLC / Invitation Homes Inc / Uniti Group Inc / Athenex Inc / Aptiv PLC / Equinox Gold Corp / Veoneer Inc / Naturgy Energy Group SA / Zoom Video Communications Inc / Genmab A/S / Cerence Inc / Essential Utilities Inc / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / PubMatic Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Paysafe Ltd / TuSimple Holdings Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: EUA of Lilly/Junshi's COVID-19 NAb expanded to include prophylaxis use. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / REGN.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Libtayo/chemo combo late-breaker at ESMO 2021 opens potential for broad 1L NSCLC label</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">09/18/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Drama: Ad Comms, Drug Pricing, Data & More</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075 / US37890U1088 / US45826J1051 / BMG637AM1024 / KYG108301006 / US77313F1066 / US20451W1018 / US81181C1045 / US31773D1019</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Global Blood Therapeutics Inc / Intellia Therapeutics Inc / Myovant Sciences Ltd / Beyondspring Inc / Rocket Pharmaceuticals Inc / Compass Pathways PLC / Seagen Inc / Finch Therapeutics Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / REGN.O / SGEN.OQ / ATNX.O / GMAB.O / NUVB.N</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Athenex Inc / Genmab A/S / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084 / US92556V1061</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 2516152 / 2681511 / 2000019 / 2023607 / 2008154 / 2497406 / 2778844 / 2216850 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2689560 / 2707677 / 2730190 / 2212922 / 2857817 / B3D7K31 / B5B2106 / B7TL820 / BBPK0J0 / B87ZMX0 / B7577T2 / B424494 / BFLR866 / BVVN4Q8 / BYW36M8 / BF4VBS8 / BXDZ9Z0 / BF5L3T2 / BYNZGK1 / BZ00V34 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BM8NHS1</td><td class="leftalignment">Visa Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Adobe Inc / Kroger Co / Merck & Co Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / PG&E Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / NRG Energy Inc / Netflix Inc / Discovery Inc / Fortinet Inc / Meta Platforms Inc / Mirati Therapeutics Inc / Palo Alto Networks Inc / Renewable Energy Group Inc / Splunk Inc / Twitter Inc / Eversource Energy / PayPal Holdings Inc / BioXcel Therapeutics Inc / Shopify Inc / Elanco Animal Health Inc / Block Inc / Zscaler Inc / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AHT.L / BMY.N / CSL.AX / ELE.MC / HSX.L / IBE.MC / JD.L / JNJ.N / KOMN.S / KSP.I / PRTP.PA / SAN.MC / SAPJ.J / STM.PA / AZN.L / AAL.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / BAMI.MI / NOVN.S / FMEG.DE / ENEI.MI / MRCG.DE / BBVA.MC / BANB.S / GSK.L / ITX.MC / FLS.CO / PFIZ.NS / REGN.OQ / GILD.OQ / MAERSKB.CO / IFCN.S / BIIB.OQ / LXSG.DE / DRX.L / ISP.MI / ALM.MC / FXPO.L / SOON.S / GRLS.MC / SABE.MC / BAYGN.DE / 0486.HK / PHNX.L / OCDO.L / CABK.MC / CDR.WA / ABBV.N / OCI.AS / ELIOR.PA / SKIN.S / G24N.DE / LANDI.S / KAPQ.L / MOVE.S / GMAB.CO / JETJ.L / PPGN.S</td><td class="leftalignment">Ashtead Group PLC / Bristol-Myers Squibb Co / CSL Ltd / Endesa SA / Hiscox Ltd / Iberdrola SA / JD Sports Fashion PLC / Johnson & Johnson / Komax Holding AG / Kingspan Group PLC / Kering SA / Banco Santander SA / Sappi Ltd / STMicroelectronics NV / AstraZeneca PLC / Anglo American PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Banco BPM SpA / Novartis AG / Fresenius Medical Care AG & Co KGaA / Enel SpA / Merck KGaA / Banco Bilbao Vizcaya Argentaria SA / Bachem Holding AG / GlaxoSmithKline PLC / Industria de Diseno Textil SA / FLSmidth & Co A/S / Pfizer Ltd / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / AP Moeller - Maersk A/S / Inficon Holding AG / Biogen Inc / Lanxess AG / Drax Group PLC / Intesa Sanpaolo SpA / Almirall SA / Ferrexpo PLC / Sonova Holding AG / Grifols SA / Banco de Sabadell SA / Bayer AG / OK Rusal MKPAO / Phoenix Group Holdings PLC / Ocado Group PLC / Caixabank SA / CD Projekt SA / Abbvie Inc / OCI NV / Elior Group SA / Cassiopea SpA / Scout24 SE / Landis+Gyr Group AG / NAK Kazatomprom AO / Medacta Group SA / Genmab A/S / Just Eat Takeaway.com NV / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / India / Ireland / Italy / Kazakhstan / Netherlands / Norway / Poland / Russian Federation / Sweden / Turkey / United States / South Africa</td><td class="leftalignment">Apparel & Textiles / Banks / Biotechnology / Building & Building Materials / Chemicals / Consumer / Electronics / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Retailing / Semiconductors / Shipping & Shipbuilding / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Another Week of Moderate Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">285512109 / 958102105 / 75886F107 / 30063P105 / G9001E102</td><td class="leftalignment">Electronic Arts Inc / Western Digital Corp / Regeneron Pharmaceuticals Inc / Exact Sciences Corp / Liberty Latin America Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Bruce D. Jackson / Mr. Matthew Harrigan / Mike Hickey / Mr. Mark Miller</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Government Contract For 1.4M Doses Signed. Hoarding Is Yet To Come.</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / AMGN=US / BMY=US / HD=US / MDT=US / GILD=US / PEB=US / H=US / MTN=US / LOW=US / IGT=US / MAR=US / ADS=US / TTWO=US / TNL=US / ATVI=US / HLT=US / CLI=US / CHH=US / DRH=US / EXEL=US / MHK=US / HOOK=US / REGN=US / SGMO=US / TRIP=US / SGMS=US / CNM=US / MTCH=US / IGMS=US / STRO=US / APP=US / SHO=US / HST=US / WH=US / TIL=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / RHP=US / TILE=US / AERI=US / BWXT=US / PEN=US / IBEX=US / TTD=US / PK=US / PLYA=US / CVNA=US / NCNA=US / DCPH=US / GSKY=US / BTAI=US / TCRR=US / GMAB=US / RBLX=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Medtronic PLC / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Activision Blizzard Inc / Hilton Worldwide Holdings Inc / Veris Residential Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Exelixis Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Scientific Games Corp / Core & Main Inc / Match Group Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Aerie Pharmaceuticals Inc / BWX Technologies Inc / Penumbra Inc / Ibex Ltd / Trade Desk Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Deciphera Pharmaceuticals Inc / GreenSky Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S / Roblox Corp / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: New US government order for COVID NAb is a positive surprise. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / GSK.L / REGN.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US45337C1027 / US75886F1075 / ORTX / CA05156V1022 / US0400476075 / US01671P1003</td><td class="leftalignment">Incyte Corp / Regeneron Pharmaceuticals Inc / Orchard Therapeutics PLC / Aurinia Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Allakos Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ESMO Planner Highlights 130+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / LLY=US / AMGN=US / BMY=US / GILD=US / EXEL=US / HOOK=US / REGN=US / IGMS=US / STRO=US / TIL=US / NCNA=US / DCPH=US / BTAI=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Instil Bio Inc / NuCana PLC / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Billal Jahangiri / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Another Big REGEN-COV Contract; More Cash Now, More Contracts to Come?</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">The Tail Grows Longer; REGEN-COV Lands HHS Repeat Order for 1.4M Doses Totaling $2.9B; Reit Buy, Raise PT to $831</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MUTUAL FUNDS / TRUSTS RESEARCH</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">New REGEN-COV contract adds to backbone of growing base business</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Add'l REGEN-COV Purchase Well Telegraphed, But Still Impactful to 2021 Numbers</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US healthcare reform back in focus: Build Back Better includes direct negotiation</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / CSL.AX / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 03, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Sep. 13, 2021 / 8:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / 199800 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / ToolGen Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: PKU Trial Put on Hold; ProQR Partners w/ Lilly</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / 199800 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / ToolGen Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Key Takeaways from Fireside Chat with Genome Editing Powerhouse Intellia; Poised to Round off Catalyst Rich Year</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">NTLA.OQ / REGN.OQ</td><td class="leftalignment">Intellia Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US7055731035 / US0017441017 / US2274831047 / 40049J206 / 922417100 / 75886F107 / 96758W101 / 733245104 / 233278100</td><td class="leftalignment">Pegasystems Inc / AMN Healthcare Services Inc / Cross Country Healthcare Inc / Grupo Televisa SAB / Veeco Instruments Inc / Regeneron Pharmaceuticals Inc / WideOpenWest Inc / Porch Group Inc / IONQ Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Mexico / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Daniel L. Kurnos, CFA / Mr. Aydin Huseynov, MD / Mr. Mark W. Schappel / Mr. Matthew Harrigan / Mr. Mark Miller / Mr. Michael P. Ward, CFA / Mr. Bill Sutherland</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">US Government Continues Efforts To Procure Additional Monoclonal Antibodies</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084 / US92556V1061</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small, Hopefully Brief Pause in the Action; Modest Biotech Outflows This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: World Lung (WCLC) & ESMO cancer conference preview</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / JNJ.N / AZN.L / SASY.PA / ROG.S / NOVN.S / MRCG.DE / REGN.OQ / SGEN.OQ / 4568.T / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Regeneron Pharmaceuticals Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">HD=US / MCD=US / WEN=US / BLD=US / LOW=US / LEG=US / VMC=US / MLM=US / SWIM=US / BMRN=US / BL=US / CBRL=US / ELY=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / PLAN=US / RARE=US / REGN=US / REGI=US / THO=US / VSEC=US / CNM=US / NFLX=US / DIN=US / RNG=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / ENPH=US / SSTK=US / TILE=US / NDLS=US / QURE=US / 00770K202 / COUP=US / LOCO=US / WK=US / SHAK=US / SEDG=US / WING=US / EDIT=US / NTLA=US / ADVM=US / 82982L103 / CRSP=US / JELD=US / SBOW=US / GSHD=US / SMAR=US / LYFT=US / FERG=US / AZEK=US / TSHA / ABNB=US / COUR=US / SNPO=US</td><td class="leftalignment">Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Lowe's Companies Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Biomarin Pharmaceutical Inc / Blackline Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Anaplan Inc / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Thor Industries Inc / VSE Corp / Core & Main Inc / Netflix Inc / Dine Brands Global Inc / RingCentral Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Enphase Energy Inc / Shutterstock Inc / Interface Inc / Noodles & Co / Uniqure NV / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Workiva Inc / Shake Shack Inc / Solaredge Technologies Inc / Wingstop Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / SilverBow Resources Inc / Goosehead Insurance Inc / Smartsheet Inc / Lyft Inc / Ferguson PLC / Azek Company Inc / Taysha Gene Therapies Inc / Airbnb Inc / Coursera Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">FDA’s JAK Warnings Create Opportunity for Novel Drugs in 2nd Line Atopic Derm</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">45337C10 / 71708110 / 03116210 / 75886F10 / CNTB / 00287Y10 / 04004760 / 00461U10 / 51506910 / 75382E10</td><td class="leftalignment">Incyte Corp / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Connect Biopharma Holdings Ltd / Abbvie Inc / Arena Pharmaceuticals Inc / Aclaris Therapeutics Inc / Landos Biopharma Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Mr. Thomas J. Smith / Anna Baran, CFA / Na Sun / Mike Kratky, CFA / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Using ROIC to Find the Best & Worst Stocks in the S&P 500</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">ACCOUNTING / CORPORATE FINANCE / EARNINGS/FINANCIAL STATEMENTS / TAX ISSUES/ACCOUNTING</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Takeaways From The Two Day AAV AdCom And Read Throughs To Our Covered Genetic Medicine Companies</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BMRN=US / RARE=US / REGN=US / QURE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / TSHA</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Uniqure NV / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Taysha Gene Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 27, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US3755581036 / US75886F1075 / US00287Y1091 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AC.TO / AEP.N / AES.N / ALV.N / CCK.N / CF.N / CI.N / CP.TO / DCC.L / DFDS.CO / ECM.L / EIX.N / F.N / FLS.N / FMC.N / FSR.N / GM.N / MAS.N / PD.N / PHM.N / PPG.N / RWEG.DE / SCHN.PA / SO.N / T.N / TOL.N / VC.N / WEIR.L / CONG.DE / CFP.TO / GILD.O / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / ETR.N / THC.N / CNR.TO / BWA.N / LEA.N / WLK.N / WCC.N / DOV.N / IEX.N / ROP.N / DISH.O / ITP.TO / UNP.N / SIEGn.DE / DV.N / MMM.N / VMC.N / ADCT.N / MGA.N / CONE.O / OLN.N / SHW.N / VZ.N / JCI.N / XEL.N / ARNA.O / APH.N / FISV.O / ADSK.O / V.N / AXL.N / IG.MI / RSG.N / NBIX.O / NWN.N / BC.N / FTS.TO / BMRN.O / REGN.O / VRTX.O / EMA.TO / NCR.N / TEL.N / GPK.N / ALFA.ST / CNP.N / WCN.N / BLU.N / CPK.N / GGG.N / PNR.N / PII.N / ST.N / SKY.N / PLUG.OQ / SGEN.OQ / GPN.N / COA.L / SGSN.S / CCLb.TO / BCRX.O / AMED.O / ICPT.O / EQIX.O / SCHN.S / BIIB.O / NTR.N / NVT.N / MOS.N / BECN.O / DLR.N / ACAD.O / GMS.N / BUCN.S / BLDR.O / LHCG.O / SJW.N / FIS.N / MA.N / MWA.N / HOG.N / H.TO / DAIGn.DE / GETP.PA / DAN.N / TXG.TO / NEE.N / CJT.TO / MTOR.N / XYL.N / EFN.TO / SRPT.O / BERY.N / TPH.N / TSLA.N / ENTA.O / TMUS.N / PTCT.O / DOOR.N / IBP.N / ITCI.O / VRNS.O / 922475108 / SAGE.OQ / AXTA.N / GLPG.O / GBT.OQ / SITE.N / MESO.O / RACE.MI / SCWX.O / ATKR.N / AZRE.N / BBU.N / NTNX.O / ADNT.N / AQN.N / OKTA.OQ / WOW.N / VNTR.N / RHIM.L / ORSTED.CO / AQUA.N / APTV.N / GTES.N / ZS.OQ / SMAR.N / DBX.O / EAF.N / ITRM.O / VNE.N / PRVB.O / ZM.O / MORF.OQ / CRWD.O / DOCU.N / APRE.OQ / CRNC.OQ / EPAC.N / WTRG.N / TFII.N / GFL.N / CARR.N / NKLA.OQ / FOUR.N / MOCORP.HE / ASAN.N / MTCR.O / RIDE.OQ / LSPD.N / DFH.OQ / WFG.N / AFRM.O / PATH.N / TSP.OQ / 9VC.F / PWSC.N / BASE.OQ</td><td class="leftalignment">Air Canada / American Electric Power Company Inc / AES Corp / Autoliv Inc / Crown Holdings Inc / CF Industries Holdings Inc / Cigna Corp / Canadian Pacific Railway Ltd / DCC PLC / DFDS AS / Electrocomponents PLC / Edison International / Ford Motor Co / Flowserve Corp / FMC Corp / Fisker Inc / General Motors Co / Masco Corp / PagerDuty Inc / Pultegroup Inc / PPG Industries Inc / Rwe AG / Schneider Electric SE / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Weir Group PLC / Continental AG / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Entergy Corp / Tenet Healthcare Corp / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Westlake Chemical Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / DISH Network Corp / Intertape Polymer Group Inc / Union Pacific Corp / Siemens AG / DoubleVerify Holdings Inc / 3M Co / Vulcan Materials Co / ADC Therapeutics SA / Magna International Inc / CyrusOne Inc / Olin Corp / Sherwin-Williams Co / Verizon Communications Inc / Johnson Controls International PLC / Xcel Energy Inc / Arena Pharmaceuticals Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Italgas SpA / Republic Services Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Brunswick Corp / Fortis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Emera Inc / NCR Corp / TE Connectivity Ltd / Graphic Packaging Holding Co / Alfa Laval AB / CenterPoint Energy Inc / Waste Connections Inc / BELLUS Health Inc / Chesapeake Utilities Corp / Graco Inc / Pentair PLC / Polaris Inc / Sensata Technologies Holding PLC / Skyline Champion Corp / Plug Power Inc / Seagen Inc / Global Payments Inc / Coats Group PLC / SGS SA / CCL Industries Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Schindler Holding AG / Biogen Inc / Nutrien Ltd / nVent Electric PLC / Mosaic Co / Beacon Roofing Supply Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / GMS Inc / Bucher Industries AG / Builders FirstSource Inc / LHC Group Inc / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Hydro One Ltd / Daimler AG / Getlink SE / Dana Inc / Torex Gold Resources Inc / Nextera Energy Inc / Cargojet Inc / Meritor Inc / Xylem Inc / Element Fleet Management Corp / Sarepta Therapeutics Inc / Berry Global Group Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Masonite International Corp / Installed Building Products Inc / Intra-Cellular Therapies Inc / Varonis Systems Inc / Veeva Systems Inc / SAGE Therapeutics Inc / Axalta Coating Systems Ltd / Galapagos NV / Global Blood Therapeutics Inc / SiteOne Landscape Supply Inc / Mesoblast Ltd / Ferrari NV / SecureWorks Corp / Atkore Inc / Azure Power Global Ltd / Brookfield Business Partners LP / Nutanix Inc / Adient PLC / Algonquin Power & Utilities Corp / Okta Inc / WideOpenWest Inc / Venator Materials PLC / RHI Magnesita NV / Orsted A/S / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Zscaler Inc / Smartsheet Inc / Dropbox Inc / GrafTech International Ltd / Iterum Therapeutics PLC / Veoneer Inc / Provention Bio Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / DocuSign Inc / Aprea Therapeutics Inc / Cerence Inc / Enerpac Tool Group Corp / Essential Utilities Inc / TFI International Inc / GFL Environmental Inc / Carrier Global Corp / Nikola Corp / Shift4 Payments Inc / Metso Outotec Corp / Asana Inc / Metacrine Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Dream Finders Homes Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / UiPath Inc / TuSimple Holdings Inc / ATAI Life Sciences NV / PowerSchool Holdings Inc / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Italy / Mauritius / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - Balance of pipeline optionality & investment in R&D/commercial</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">GMAB.CO / JNJ.N / RECI.MI / SASY.PA / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / REGN.OQ / SGEN.OQ / IPN.PA / ORNBV.HE / HALO.OQ / ALM.MC / GRLS.MC / HZNP.OQ / ABBV.N / CTLT.N / VIFN.S</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Recordati Industria Chimica e Farmaceutica SpA / Sanofi SA / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Regeneron Pharmaceuticals Inc / Seagen Inc / Ipsen SA / Orion Oyj / Halozyme Therapeutics Inc / Almirall SA / Grifols SA / Horizon Therapeutics PLC / Abbvie Inc / Catalent Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Ireland / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ESMO Congress 2021 Planner</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100 / 75886F107 / 30161Q104 / 00287Y109 / 189464100 / 52187K101 / 87184Q107 / 24344T101 / 00166B105 / 81181C104</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Abbvie Inc / Clovis Oncology Inc / Leap Therapeutics Inc / Syros Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: GT Safety in Focus; New Roadblock for Astellas</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Another AML Failure, NVS/NHS Leqvio Deal, Webinars Ahead & More</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US00287Y1091 / US75886F1075 / US88322Q1085 / KYG108301006 / US77313F1066 / US45114M1099</td><td class="leftalignment">Abbvie Inc / Regeneron Pharmaceuticals Inc / TG Therapeutics Inc / Beyondspring Inc / Rocket Pharmaceuticals Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">09/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADCT.N / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / MESO.O</td><td class="leftalignment">ADC Therapeutics SA / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Mesoblast Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: September 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIRP.PA / ALB.N / AXP.N / BA.N / BAC.N / BAX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / IBM.N / JNJ.N / JPM.N / LLY.N / LMT.N / MDT.N / OXY.N / PFE.N / PM.N / PPCJ.J / RHI.N / SC.N / SLB.N / T.N / TMO.N / U.N / WAT.N / WFC.N / WMT.N / ACI.N / SPG.N / PG.N / HUM.N / NUE.N / CPB.N / HAL.N / DHR.N / UNH.N / IPG.N / SPOT.N / GS.N / CLX.N / VLO.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / KR.N / PCG.N / XOM.N / DVN.N / AMT.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / JCI.N / ORCL.N / VFC.N / V.N / ACN.N / WSM.N / PLD.N / JLL.N / HAE.N / SAM.N / BLK.N / CRL.N / CVX.N / IRM.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / REGN.OQ / RGEN.OQ / QDEL.OQ / SNPS.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / STLD.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / ERIE.OQ / NVDA.OQ / PLUG.OQ / MTCH.OQ / ISRG.OQ / BLUE.OQ / GRMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / SBNY.OQ / ACAD.OQ / EXR.N / MKTX.OQ / MPWR.OQ / LVS.N / NOV.N / DXCM.OQ / MS.N / CMG.N / FIS.N / STX.AX / HES.N / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / JAZZ.OQ / TDC.N / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / EPAM.N / PSX.N / NOW.N / SRPT.OQ / FANG.OQ / ABBV.N / BLDR.N / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / ARES.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / NVCR.OQ / PSTG.N / IONS.OQ / TWLO.N / COUP.OQ / LW.N / AYX.N / IOVA.OQ / ROKU.OQ / ZS.OQ / FB.PS / STNE.OQ / NFE.OQ / LYFT.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / MRVI.OQ / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Humana Inc / Nucor Corp / Campbell Soup Co / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / Kroger Co / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Johnson Controls International PLC / Oracle Corp / VF Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Prologis Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Iron Mountain Inc / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Repligen Corp / Quidel Corp / Synopsys Inc / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / Erie Indemnity Co / NVIDIA Corp / Plug Power Inc / Match Group Inc / Intuitive Surgical Inc / bluebird bio Inc / Garmin Ltd / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Nov Inc / Dexcom Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Hess Corp / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Jazz Pharmaceuticals PLC / Teradata Corp / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Epam Systems Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / Builders FirstSource Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / Ares Management Corp / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Novocure Ltd / Pure Storage Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Roku Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / New Fortress Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Maravai LifeSciences Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Keep on Rollin'</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 78 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AAN.N / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / COLL.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / SEIC.OQ / GILD.OQ / COST.OQ / NKTR.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / SPWR.OQ / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / BRX.N / TWOU.OQ / ANTM.N / NTRA.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / ALLO.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Aaron's Company Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Collegium Pharmaceutical Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / SEI Investments Co / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / SunPower Corp / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Brixmor Property Group Inc / 2U Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Allogene Therapeutics Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 2126335 / 2516152 / 2000019 / 2065159 / 2270726 / 2317087 / 2670519 / 2328915 / 2471950 / 2689560 / 2684703 / 2048804 / 2730190 / 7103065 / 2857817 / B0T7YX2 / B7VD3F2 / B85KFY9 / BFH3N85 / BVVN4Q8 / BZ1HM42 / BNFWR44 / BLGJ610 / BJJMGL2 / BKTNTR9 / BDFZSP1</td><td class="leftalignment">Sanofi SA / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Autodesk Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Incyte Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Netflix Inc / Live Nation Entertainment Inc / Duke Energy Corp / Five Below Inc / Veeva Systems Inc / Eversource Energy / Adyen NV / Worldline SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Okta Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Regeneron Pharmaceuticals Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron climbs 18.1% from 4 week low</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">958102105 / 75886F107 / 928661107 / 33938J106 / KYG596691041 / 68619K20 / 44148G10 / 98980L101 / 51818V106 / 90466Y10 / 44486Q10</td><td class="leftalignment">Western Digital Corp / Regeneron Pharmaceuticals Inc / VolitionRX Ltd / Pacira Biosciences Inc / Meituan / Orgenesis Inc / Hoth Therapeutics Inc / Zoom Video Communications Inc / Latch Inc / Unicycive Therapeutics Inc / Humacyte Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Fawne Jiang / Long Lin / Mr. Matthew Harrigan / Mr. Aydin Huseynov, MD / Mr. Mark W. Schappel / Mr. Bruce D. Jackson / Mr. Mark Miller</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Dupixent May Become The World's Top Selling Drug By 2030</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Regeneron Pharmaceuticals Incorporated</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Dupixent Scores Another Win, This One in Atopic Dermatitis (LIBERTY AD PRESCHOOL); Reiterate Buy and Maintain PT of $787</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 20, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / OCGN / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Ocugen Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / ALV.N / CMS.N / CRM.N / EIX.N / EL.N / F.N / FSR.N / GM.N / KO.N / PD.N / SO.N / VC.N / TEN.N / AMGN.O / DUK.N / BWA.N / LEA.N / K.N / CLX.N / PCG.N / EPC.N / ADCT.N / CONE.O / EXEL.O / XEL.N / ARNA.O / STZ.N / CINF.O / APH.N / FISV.O / ADSK.O / AXL.N / NWN.N / BC.N / BMRN.O / REGN.O / ENR.N / FTT.TO / NCR.N / TEL.N / CPK.N / MKL.N / PII.N / RLI.N / ST.N / PLUG.OQ / GPN.N / CASY.O / ATDb.TO / TIH.TO / DLR.N / WAL.N / SJW.N / FIS.N / HOG.N / BGS.N / DAN.N / WRB.N / SPB.N / NEE.N / NXT.AX / MTOR.N / FFHu.TO / TSLA.N / COTY.N / BEP.N / AGIO.O / RACE.MI / ADNT.N / OKTA.OQ / AY.O / APTV.N / VNE.N / ZM.O / CRWD.O / CRNC.OQ / WTRG.N / NKLA.OQ / FOUR.N / MGNI.OQ / RIDE.OQ / LSPD.N / AFRM.O / TSP.OQ / OTLY.O / RYAN.N / PWSC.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / CMS Energy Corp / Salesforce.Com Inc / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / Coca-Cola Co / PagerDuty Inc / Southern Co / Visteon Corp / Tenneco Inc / Amgen Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Kellogg Co / Clorox Co / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / CyrusOne Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Cincinnati Financial Corp / Amphenol Corp / Fiserv Inc / Autodesk Inc / American Axle & Manufacturing Holdings Inc / Northwest Natural Holding Co / Brunswick Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Finning International Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Markel Corp / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Plug Power Inc / Global Payments Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Toromont Industries Ltd / Digital Realty Trust Inc / Western Alliance Bancorp / SJW Group / Fidelity National Information Services Inc / Harley-Davidson Inc / B&G Foods Inc / Dana Inc / W R Berkley Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Meritor Inc / Fairfax Financial Holdings Ltd / Tesla Inc / Coty Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Ferrari NV / Adient PLC / Okta Inc / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Veoneer Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Cerence Inc / Essential Utilities Inc / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Affirm Holdings Inc / TuSimple Holdings Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc / PowerSchool Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Chardan Initiates TNYA; Roche Gets in Shape</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / ABUS.O / 75901B107 / M96883109 / 04280A100 / ADVM.O / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / OCGN / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Ocugen Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/28/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">REGN's High Dose Eylea, BYSI's Big Deal, Porous Patents, & More</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.OQ / US00287Y1091 / US09061G1013 / US45337C1027 / US75886F1075 / ABBV.N / US24823R1059 / CA07987C2040</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Abbvie Inc / Biomarin Pharmaceutical Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abbvie Inc / Denali Therapeutics Inc / BELLUS Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">08/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ADCT.N / EXEL.O / ARNA.O / REGN.O / AGIO.O</td><td class="leftalignment">Amgen Inc / ADC Therapeutics SA / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Agios Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: Novartis: CANOPY-1 P3 topline readout in 1L NSCLC expected in late 3Q/early 4Q21</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NOVN.S / BMY.N / MRK.N / SASY.PA / ROG.S / REGN.OQ</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Merck & Co Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Come Roaring Back</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Aug 13</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LXRX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LXRX.O / TMO / BTX / ILMN.O / BMRN.O / REGN.O / LGND.O / RARE.O / ESPR.O / AERI.O</td><td class="leftalignment">Lexicon Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Brooklyn Immunotherapeutics Inc / Illumina Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Ligand Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Esperion Therapeutics Inc / Aerie Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Regeneron Pharmaceuticals</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZIVO-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ZIVO.O / REGN.O / BRLI.O / PRPH.O / IAGX.PK</td><td class="leftalignment">Zivo Bioscience Inc / Regeneron Pharmaceuticals Inc / Brilliant Acquisition Corp / Prophase Labs Inc / Imagenetix Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Encouraging Phase 2 Top-line Results for High-Dose Eylea in Wet AMD Bolsters Bullish Outlook For Ongoing Phase 3 Studies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">High-dose Eylea Ph 2 Results Bode Well for Ph 3 Results in 2H22</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">So Far So Good For High-Dose Format of Aflibercept</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 13, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, REGN</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107 / 416906105 / 021369103 / 09075G105</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Harvard Bioscience Inc / Altair Engineering Inc / Biofrontera AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Mark W. Schappel / Mike Hickey / Mr. Bruce D. Jackson / Benchmark Research</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">REGN's Message To The US Government: Order More, We Are Running Out Of Stock Soon</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Rocket Hold Lifts; the Broad Is SEND(ing) It!</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">RCKT.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Rocket Pharmaceuticals Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / ALV.N / ANTO.L / CAS.TO / CL.N / EIX.N / EL.N / F.N / FSR.N / GM.N / IP.N / KMB.N / KO.N / MO.N / MSFT.O / RWEG.DE / RYN.N / SO.N / T.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / LPX.N / TEN.N / CMCSA.O / BWA.N / LEA.N / K.N / DISH.O / CLX.N / CAG.N / GIS.N / HSY.N / EPC.N / SBAC.O / AMT.N / CONE.O / VZ.N / EXEL.O / XEL.N / STZ.N / APH.N / ADSK.O / AXL.N / CHD.N / NWN.N / BC.N / SAM.N / REGN.O / ENR.N / JHX.AX / TEL.N / CPK.N / PII.N / ST.N / PLUG.OQ / MNST.O / CASY.O / ATDb.TO / DLR.N / WEF.TO / SJW.N / HOG.N / MERC.O / 3IN.L / BGS.N / DAN.N / EONGn.DE / CLW.N / ADN.TO / SPB.N / NEE.N / NXT.AX / CIO.N / PCH.O / CFX.TO / CTT.N / MTOR.N / IFP.TO / SPLK.OQ / RFP.N / PANW.N / MDLZ.OQ / KPT.TO / TSLA.N / PRMW.N / TMUS.N / COTY.N / AGIO.O / CFF.TO / COUP.N / RYAM.N / WRK.N / RACE.MI / UN01.DE / ADNT.N / GDS.O / ORSTED.CO / APTV.N / VNE.N / KDP.N / ESTC.N / NWL.O / CRNC.OQ / WTRG.N / REYN.O / NKLA.OQ / LUMN.N / ASAN.N / RIDE.OQ / WFG.N / NAPA.N / TSP.OQ / OTLY.O / TRMR.OQ / PWSC.N / COOK.N / BASE.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Antofagasta PLC / Cascades Inc / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Microsoft Corp / Rwe AG / Rayonier Inc / Southern Co / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Hershey Co / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Constellation Brands Inc / Amphenol Corp / Autodesk Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / James Hardie Industries PLC / TE Connectivity Ltd / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Plug Power Inc / Monster Beverage Corp / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Digital Realty Trust Inc / Western Forest Products Inc / SJW Group / Harley-Davidson Inc / Mercer International Inc / 3I Infrastructure PLC / B&G Foods Inc / Dana Inc / E.ON SE / Clearwater Paper Corp / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / City Office REIT Inc / Potlatchdeltic Corp / Canfor Pulp Products Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Splunk Inc / Resolute Forest Products Inc / Palo Alto Networks Inc / Mondelez International Inc / KP Tissue Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Agios Pharmaceuticals Inc / Conifex Timber Inc / Coupa Software Inc / Rayonier Advanced Materials Inc / Westrock Co / Ferrari NV / Uniper SE / Adient PLC / GDS Holdings Ltd / Orsted A/S / Aptiv PLC / Veoneer Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Lumen Technologies Inc / Asana Inc / Lordstown Motors Corp / West Fraser Timber Co Ltd / Duckhorn Portfolio Inc / TuSimple Holdings Inc / Oatly Group AB / Tremor International Ltd / PowerSchool Holdings Inc / Traeger Inc / Couchbase Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/21/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">COVID Webinar, NK Cells Rising, Catalyst Tracker, Stop Hitting Yourself & More</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075 / US02043Q1076 / US29251M1062 / US77313F1066 / US12674W1099 / US65487U1088 / US16961L1061 / US95075A1079</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Cabaletta Bio Inc / Nkarta Inc / Chinook Therapeutics Inc / Werewolf Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">08/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">EXEL.O / REGN.O / AGIO.O</td><td class="leftalignment">Exelixis Inc / Regeneron Pharmaceuticals Inc / Agios Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Vital Signs - Charts of the Day: CRAI, VERV, TNET, NSP, LRN, ROL, FN, MPWR, WRLD, INDT, HTA, CSR, DLR, AMT, LABP, REGN, MYGN, INMD, AXNX, CLDX, COO, A, AMCR, ASPN, BURL, BJ, INOV, VRSK, CSCO, NFLX, XAIR, ALTR, SNPS, CDNS, ADSK, and MSFT.</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MSFT.OQ / A.N / F.N / MO.N / CSR.N / COO.N / BJ.N / NSP.N / ADSK.OQ / CSCO.OQ / REGN.OQ / ROL.N / SNPS.OQ / WRLD.OQ / MYGN.OQ / INMD.OQ / CRAI.OQ / NFLX.OQ / MPWR.OQ / CDNS.OQ / LRN.N / CLDX.OQ / VRSK.OQ / ASPN.N / HTA.N / TNET.N / AXNX.OQ / XAIR.OQ / INDT.OQ / LABP.OQ / VERV.OQ</td><td class="leftalignment">Microsoft Corp / Agilent Technologies Inc / Ford Motor Co / Altria Group Inc / Centerspace / Cooper Companies Inc / BJ's Wholesale Club Holdings Inc / Insperity Inc / Autodesk Inc / Cisco Systems Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / Synopsys Inc / World Acceptance Corp / Myriad Genetics Inc / Inmode Ltd / CRA International Inc / Netflix Inc / Monolithic Power Systems Inc / Cadence Design Systems Inc / Stride Inc / Celldex Therapeutics Inc / Verisk Analytics Inc / Aspen Aerogels Inc / Healthcare Trust Of America Inc / TriNet Group Inc / Axonics Inc / Beyond Air Inc / Indus Realty Trust Inc / Landos Biopharma Inc / Verve Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">REGEN-COV Gains UK Conditional Marketing Approval; BLA Filed; Bullish Signs Abound for Prolonged Market Presence</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Nick Lenard / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Another Week, Another Outflow - Fund Flow Stays Negative This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">FINAM</td><td class="leftalignment">Коктейльная вечеринка Regeneron продолжается</td><td class="leftalignment">Russian</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Alexander Kovalev</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Vital Signs - Charts of the Day: CLF, CMC, NUE, RYI, AA, ACH, IR, RXN, XYL, AGFY, ABB, ETN, JCI, CSL, PNR, MXL, MPWR, SITM, SYNA, GRMN, MSI, TXT, ZBRA, FTNT, SD, AMR, ARCH, CEIX, BTU, METC, LTHM, SQM, EYPT, GSK, PFE, INVA, ALKS, DVAX, REGN, and PCVX.</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">REGN.OQ / AA.N / AGFY.OQ / ALKS.OQ / CEIX.N / CLF.N / DVAX.OQ / ETN.N / EYPT.OQ / GSK.L / LTHM.N / MXL.N / NUE.N / PCVX.OQ / PFE.N / RXN.N / RYI.N / SITM.OQ / SQMa.SN / SYNA.OQ / TXT.N / XYL.N / ZBRA.OQ / AMR.N / IR.N / ABB.NS / JCI.N / CMC.N / MPWR.OQ / SD.N / FTNT.OQ / MSI.N / ARCH.V</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alcoa Corp / Agrify Corp / Alkermes Plc / CONSOL Energy Inc / Cleveland-Cliffs Inc / Dynavax Technologies Corp / Eaton Corporation PLC / EyePoint Pharmaceuticals Inc / GlaxoSmithKline PLC / Livent Corp / Maxlinear Inc / Nucor Corp / Vaxcyte Inc / Pfizer Inc / Zurn Water Solutions Corp / Ryerson Holding Corp / SiTime Corp / Sociedad Quimica y Minera de Chile SA / Synaptics Inc / Textron Inc / Xylem Inc / Zebra Technologies Corp / Alpha Metallurgical Resources Inc / Ingersoll Rand Inc / ABB India Ltd / Johnson Controls International PLC / Commercial Metals Co / Monolithic Power Systems Inc / SandRidge Energy Inc / Fortinet Inc / Motorola Solutions Inc / Arch Biopartners Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Chile / United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">08/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">As We Expected, Q2 Beats and Raises for Biopharma and Stocks Now Repricing</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 00287Y10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">OPK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPK.O / ABT / BMY / JNJ / LH / REGN.O / ALNY.O / ARDX.O / TEVA.K</td><td class="leftalignment">OPKO Health Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ardelyx Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 6, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / 87166L100 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Synlogic Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: BLUE Drops EU; PFE/BNTX & MRNA 3rd Dose</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2Q21 Results; Late Stage Trial Top-Line Data on Track for 4Q21; Pipeline Expansion Expected in 2H21</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ALLK.OQ / REGN.OQ</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Lebrikizumab P3 studies positive at week 16 in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / SASY.PA / REGN.OQ / ALM.MC / ABBV.N</td><td class="leftalignment">Pfizer Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Almirall SA / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Spain / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Healthcare Co Ltd: 2Q21 review: Profitability hit despite ongoing US biosimilar share gains; all about Regkirona sales in 2H21. Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">091990.KQ / LLY.N / PFE.N / ROG.S / GSK.L / REGN.OQ / 068270.KS</td><td class="leftalignment">Celltrion Healthcare Co Ltd / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Celltrion Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/14/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Our own biotech delta wave</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075 / NL0010696654 / US4380831077 / US04965G1094 / US20451W1018 / US12529R1077 / US81181C1045 / US31773D1019</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Uniqure NV / Homology Medicines Inc / Atreca Inc / Compass Pathways PLC / C4 Therapeutics Inc / Seagen Inc / Finch Therapeutics Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Liisa A. Bayko / Ms. Maneka Mirchandaney / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">08/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2Q21 Results; SBT6050 Update Coming at ESMO 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">SBTX.OQ / REGN.OQ</td><td class="leftalignment">Silverback Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Edward P. White, II</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2Q21 Results; ADI-001 Phase 1 Data Expected by Year End</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACET.OQ / REGN.OQ</td><td class="leftalignment">Adicet Bio Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Edward P. White, II</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">P5x25 Strategy on Track; Transition to Top Five Biotech Underway; Upping Price Target to $250; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">02043Q107 / REGN.OQ / 04280A100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AEP.N / AES.N / BAC.N / BK.N / BOX.N / C.N / CMS.N / CNA.L / COF.N / ED.N / EIX.N / EL.N / EOG.N / FITB.O / JPM.N / KEY.N / KMB.N / NTRS.O / PEG.N / PNC.N / PNW.N / SGEF.PA / SO.N / USB.N / WFC.N / CMA.N / PXD.N / WLL.N / AMGN.O / ETR.N / DUK.N / DIS.N / HBAN.O / D.N / FE.N / PNM.N / K.N / GS.N / MRO.N / PCG.N / PPL.N / DVN.N / RKT.N / STT.N / HCA.N / CYH.N / XEL.N / SRE.N / EXC.N / RRC.N / EQT.N / NLY.N / AWK.N / NWN.N / MTB.N / REGN.O / SWIR.O / SM.N / GFI.N / RF.N / COP.N / CNP.N / CPE.N / BKH.N / CPK.N / FRC.N / SWN.N / SR.N / CRC.N / SEM.N / SIVB.O / AMED.O / TFC.N / BAM.N / SJW.N / BKD.N / MS.N / CLR.N / BIP.N / NOG.A / UTL.N / ADUS.OQ / SPB.N / NEE.N / PEY.TO / TWO.N / MTDR.N / ACHC.O / FANG.O / COTY.N / BEP.N / ARES.N / NEP.N / SAGE.OQ / CFG.N / SGRY.O / BBU.N / AQN.N / PVAC.O / CDEV.O / ESTE.N / VST.N / WPM.N / ORSTED.CO / AY.O / CWEN.N / NWL.O / FIXX.O / APRE.OQ / PNTG.OQ / ETNB.O / OAS.OQ / AZEK.N / WTRG.N / SBSW.N / IGIC.OQ / APA.OQ / PLTR.N / GDRX.O / TLMD.OQ / SHC.OQ / ABNB.OQ / DASH.N / CHK.OQ / OTLY.O / FA.OQ / XMTR.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Bank of America Corp / Bank of New York Mellon Corp / Box Inc / Citigroup Inc / CMS Energy Corp / Centrica PLC / Capital One Financial Corp / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Northern Trust Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Vinci SA / Southern Co / US Bancorp / Wells Fargo & Co / Comerica Inc / Pioneer Natural Resources Co / Whiting Petroleum Corp / Amgen Inc / Entergy Corp / Duke Energy Corp / Walt Disney Co / Huntington Bancshares Inc / Dominion Energy Inc / FirstEnergy Corp / PNM Resources Inc / Kellogg Co / Goldman Sachs Group Inc / Marathon Oil Corp / PG&E Corp / PPL Corp / Devon Energy Corp / Rocket Companies Inc / State Street Corp / HCA Healthcare Inc / Community Health Systems Inc / Xcel Energy Inc / Sempra Energy / Exelon Corp / Range Resources Corp / EQT Corp / Annaly Capital Management Inc / American Water Works Company Inc / Northwest Natural Holding Co / M&T Bank Corp / Regeneron Pharmaceuticals Inc / Sierra Wireless Inc / SM Energy Co / Gold Fields Ltd / Regions Financial Corp / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / Black Hills Corp / Chesapeake Utilities Corp / First Republic Bank / Southwestern Energy Co / Spire Inc / California Resources Corp / Select Medical Holdings Corp / SVB Financial Group / Amedisys Inc / Truist Financial Corp / Brookfield Asset Management Inc / SJW Group / Brookdale Senior Living Inc / Morgan Stanley / Continental Resources Inc / Brookfield Infrastructure Partners LP / Northern Oil and Gas Inc / Unitil Corp / Addus Homecare Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Peyto Exploration & Development Corp / Two Harbors Investment Corp / Matador Resources Co / Acadia Healthcare Company Inc / Diamondback Energy Inc / Coty Inc / Brookfield Renewable Partners LP / Ares Management Corp / Nextera Energy Partners LP / SAGE Therapeutics Inc / Citizens Financial Group Inc / Surgery Partners Inc / Brookfield Business Partners LP / Algonquin Power & Utilities Corp / Ranger Oil Corp / Centennial Resource Development Inc / Earthstone Energy Inc / Vistra Corp / Wheaton Precious Metals Corp / Orsted A/S / Atlantica Sustainable Infrastructure PLC / Clearway Energy Inc / Newell Brands Inc / Homology Medicines Inc / Aprea Therapeutics Inc / Pennant Group Inc / 89Bio Inc / Oasis Petroleum Inc / Azek Company Inc / Essential Utilities Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / APA Corp (US) / Palantir Technologies Inc / Goodrx Holdings Inc / Soc Telemed Inc / Sotera Health Co / Airbnb Inc / DoorDash Inc / Chesapeake Energy Corp / Oatly Group AB / First Advantage Corp / Xometry Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / France / United Kingdom / Sweden / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Brief (We Hope) Pause in the Action – Fund Flow Turns Negative This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Short Interest in Biotechnology Stocks</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US75886F1075 / US92532F1003 / US7665596034 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US09627Y1091 / US4622221004 / US5588681057 / US03753U1060 / US2997341035 / US80706P1030 / US76029N1063 / US04335A1051 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US61775R1059 / US30205M1018 / US80810D1037 / US12529R1077 / CA00288U1066 / US67080N1019 / US24343R1068</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Blueprint Medicines Corp / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Replimune Group Inc / Arvinas Inc / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Exicure Inc / Schrodinger Inc / C4 Therapeutics Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee / Nick Lenard</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Food for Thought : US healthcare in FY22 Budget Resolution bill & latest touted FDA Commissioner candidate tough views on pricing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / UCB.BR / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Regeneron EPS soars 179%</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron up 7.6% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0453271035 / 86816810 / 75886F107 / 640268108 / 68213N109 / US8110544025 / 81619Q105 / 05278C107 / M20598104 / 530307107 / 531229409 / 00108J109 / 873379101 / G0084W10 / 65343E108 / 51818V106 / 53838L100</td><td class="leftalignment">Aspen Technology Inc / Superior Industries International Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Omnicell Inc / E W Scripps Co / Select Medical Holdings Corp / Autohome Inc / Caesarstone Ltd / Liberty Broadband Corp / Liberty Media Corp / ACM Research Inc / Tabula Rasa HealthCare Inc / Adient PLC / NextCure Inc / Latch Inc / LiveVox Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Matthew Harrigan / Ms. Fawne Jiang / Long Lin / Mr. Bill Sutherland / Mr. Michael P. Ward, CFA / Mr. Daniel L. Kurnos, CFA / Mr. Nathan Martin / Mr. Reuben Garner / Mr. Mark Miller / Mr. Mark W. Schappel / Benchmark Research</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">2Q21 Model Update: Cocktail Is The Driver But Other Blockbusters Outperform As Well</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / DDDD.L / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 81750R102 / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / 87166L100 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / 4D Pharma PLC / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Synlogic Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 2516152 / 2496113 / 2486813 / 2640147 / 2973821 / 2050832 / 2113393 / 2216850 / 2270726 / 2542049 / 2328915 / 2342034 / 2100920 / 2369174 / 2471950 / 2630513 / 2657802 / 2680905 / 2684703 / 2048804 / 2730190 / 2440637 / 2138158 / 2825933 / 2829601 / 2503529 / B121557 / 2212922 / 2769796 / 2857817 / B0T7YX2 / B570P91 / 2598246 / 2982924 / B4MG4Z6 / B7VD3F2 / B83YYY6 / BBGVT40 / B7577T2 / BCGCR79 / BTN1Y11 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BD8DJ71 / BP7RS48 / BWFKZT2 / BMYML02 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BG31GH0 / BKTNTR9 / BJVR9Y9 / BFWK4R7 / BD6D4Y5 / BMH0MR7 / BMDCDP2 / BMPRZV5 / BD72R64 / BNGJQZ8 / BMHR7K6 / BKPGJQ1 / BMBP1Q0 / BL53KF5</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / Kohls Corp / Kellogg Co / Nike Inc / Alliant Energy Corp / Ameren Corp / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Gilead Sciences Inc / Incyte Corp / New Jersey Resources Corp / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / World Wrestling Entertainment Inc / Mastercard Inc / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / Lear Corp / Neogenomics Inc / Spectrum Pharmaceuticals Inc / AMC Networks Inc / Duke Energy Corp / ICAD Inc / News Corp / Renewable Energy Group Inc / Sprouts Farmers Market Inc / Medtronic PLC / PayPal Holdings Inc / Shopify Inc / Block Inc / Snap Inc / Intersect Ent Inc / Cellectis SA / DraftKings Inc / Evergy Inc / Spire Inc / Vistra Corp / Y-mAbs Therapeutics Inc / ViacomCBS Inc / iHeartMedia Inc / PagSeguro Digital Ltd / Altair Engineering Inc / Zendesk Inc / Bigcommerce Holdings Inc / Kymera Therapeutics Inc / Liberty Media Corp / Porch Group Inc / Impel Neuropharma Inc / Squarespace Inc / Flywire Corp / F45 Training Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Abicipar Rights Returned, as Anticipated; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MOLN.OQ / REGN.OQ / 766559603 / 78667J108 / 221015100</td><td class="leftalignment">Molecular Partners AG / Regeneron Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / SAGE Therapeutics Inc / Corvus Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Robert Burns / Yi Chen, Ph.D. CFA / Raghuram Selvaraju, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AEP.N / AES.N / AIG.N / ALB.N / ALV.N / CL.N / EIX.N / EL.N / F.N / FLS.N / FSR.N / GM.N / KMB.N / KO.N / MO.N / PNW.N / RYN.N / SO.N / SRCL.O / T.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / GILD.O / CPB.N / LPX.N / TEN.N / WLL.N / CMCSA.O / AMGN.O / DUK.N / BWA.N / LEA.N / K.N / DISH.O / CLX.N / CAG.N / MRO.N / GIS.N / PCG.N / HSY.N / EPC.N / ADCT.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / RKT.N / SGMO.O / VZ.N / EXEL.O / XEL.N / ARNA.O / STZ.N / APH.N / FDS.N / FISV.O / CHTR.O / AXL.N / CHD.N / EPAY.O / NWN.N / BC.N / SAM.N / OPTN.O / REGN.O / ENR.N / NCR.N / TEL.N / ENDP.O / CPK.N / HL.N / PII.N / ST.N / SR.N / AMH.N / PLUG.OQ / GPN.N / ONC.TO / MNST.O / CASY.O / JCOM.O / EQIX.O / ATDb.TO / EDV.TO / MNKD.OQ / NVT.N / DLR.N / IAG.N / WEF.TO / SJW.N / BKD.N / FIS.N / CCOI.O / 025676206 / TEVA.N / HOG.N / ATL.MI / BGS.N / PPL.TO / DAN.N / SII.TO / SPB.N / TXG.TO / NEE.N / CIO.N / PCH.O / ERF.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / MDLZ.OQ / GRT_u.TO / TSLA.N / PRGO.N / PRMW.N / ENTA.O / TMUS.N / UKWG.L / VOYA.N / DOO.TO / COTY.N / PRTA.O / BEP.N / ESNT.N / FLXN.O / BTG.N / GLPG.O / SQ.N / RACE.MI / ADVM.OQ / BBU.N / ADNT.N / LGFB.N / PBYI.OQ / SAND.N / UNIT.O / WPM.N / WOW.N / SSRM.O / BHF.O / ATNX.O / SAIL.N / APTV.N / AMRX.N / VNE.N / KDP.N / AQST.O / NWL.O / 269796108 / CTVA.N / APRE.OQ / CRNC.OQ / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / MGNI.OQ / RXT.OQ / JAMF.O / LUMN.N / PTVE.O / BSY.O / RIDE.OQ / VTRS.OQ / LSPD.N / PUBM.O / NAPA.N / OSO.N / TSP.OQ / OTLY.O / FLYW.O / TASK.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American International Group Inc / Albemarle Corp / Autoliv Inc / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / Fisker Inc / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Pinnacle West Capital Corp / Rayonier Inc / Southern Co / Stericycle Inc / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Gilead Sciences Inc / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Whiting Petroleum Corp / Comcast Corp / Amgen Inc / Duke Energy Corp / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / PG&E Corp / Hershey Co / Edgewell Personal Care Co / ADC Therapeutics SA / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Rocket Companies Inc / Sangamo Therapeutics Inc / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Factset Research Systems Inc / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Bottomline Technologies Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / TE Connectivity Ltd / Endo International PLC / Chesapeake Utilities Corp / Hecla Mining Co / Polaris Inc / Sensata Technologies Holding PLC / Spire Inc / American Homes 4 Rent / Plug Power Inc / Global Payments Inc / Oncolytics Biotech Inc / Monster Beverage Corp / Caseys General Stores Inc / Ziff Davis Inc / Equinix Inc / Alimentation Couche-Tard Inc / Endeavour Mining PLC / MannKind Corp / nVent Electric PLC / Digital Realty Trust Inc / IAMGOLD Corp / Western Forest Products Inc / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / American Equity Investment Life Holding Co / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Dana Inc / Sprott Inc / Spectrum Brands Holdings Inc / Torex Gold Resources Inc / Nextera Energy Inc / City Office REIT Inc / Potlatchdeltic Corp / Enerplus Corp / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Mondelez International Inc / Granite Real Estate Investment Trust / Tesla Inc / Perrigo Company PLC / Primo Water Corp / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Greencoat UK Wind PLC / Voya Financial Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Pacira Biosciences Inc / B2Gold Corp / Galapagos NV / Block Inc / Ferrari NV / Adverum Biotechnologies Inc / Brookfield Business Partners LP / Adient PLC / Lions Gate Entertainment Corp / Puma Biotechnology Inc / Sandstorm Gold Ltd / Uniti Group Inc / Wheaton Precious Metals Corp / WideOpenWest Inc / SSR Mining Inc / Brighthouse Financial Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Newell Brands Inc / Eagle Pharmaceuticals Inc / Corteva Inc / Aprea Therapeutics Inc / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Rackspace Technology Inc / Jamf Holding Corp / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Lordstown Motors Corp / Viatris Inc / Lightspeed Commerce Inc / PubMatic Inc / Duckhorn Portfolio Inc / Olo Inc / TuSimple Holdings Inc / Oatly Group AB / Flywire Corp / Taskus Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Ireland / Israel / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 30</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: mRNA M&A; NVS Hold Lifted 2 Years Later</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/07/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Skinny Labels and Earnings Overload</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US00287Y1091 / US09061G1013 / US09058V1035 / US45337C1027 / US64125C1099 / US75886F1075 / US02043Q1076 / US8036071004 / US4576693075 / US88322Q1085 / US90400D1081 / KYG8807B1068 / US37890U1088 / US4622221004 / US28106W1036 / US00773J1034 / US45826J1051 / US5588681057 / CH0334081137 / US24823R1059 / US5011471027 / US84833T1034 / BMG5269C1010 / US6047491013 / CA07987C2040 / US12674W1099 / US68236R1032 / US89422G1076</td><td class="leftalignment">Abbvie Inc / Biomarin Pharmaceutical Inc / BioCryst Pharmaceuticals Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / TG Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Denali Therapeutics Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Mirum Pharmaceuticals Inc / BELLUS Health Inc / Cabaletta Bio Inc / Oncorus Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen / Chanie Howard</td></tr>
<tr class="odd"><td class="leftalignment">08/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / REGN.O / PRTA.O / PBYI.OQ / ATNX.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Puma Biotechnology Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - July 30 to August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">CA4509131088 / US0010841023 / US0079031078 / US0126531013 / US0341641035 / US0383361039 / US0536111091 / US0584981064 / US1258961002 / US1266501006 / US1270971039 / US1491231015 / US1564311082 / US1844961078 / US22160K1051 / US2546871060 / US2855121099 / US29364G1031 / US30161N1019 / US30231G1022 / US3024913036 / US3666511072 / US4062161017 / US4227041062 / US4282911084 / US4523081093 / US4878361082 / US5463471053 / US5719032022 / US5950171042 / US6153691059 / US65473P1057 / US6821891057 / US6988131024 / US7445731067 / US75281A1097 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / AN8068571086 / US81211K1007 / US8168511090 / US8454671095 / US8740541094 / US87612E1064 / US89531P1057 / US9311421039 / US9621661043 / CA7819036046 / CA3180714048 / CA29250N1050 / CA0977512007 / CA8029121057 / CA85472N1096 / CA4530384086 / CA5649051078 / CA78460T1057 / CA8787422044 / CA5592224011 / CA1363851017 / CA87971M1032 / CA6837151068 / CA3759161035 / US1667641005 / CA7481932084 / CA8765111064 / US0017441017 / US37940X1028 / US87157D1090 / US15189T1079 / US2274831047 / CA67072Q1046 / CA2265331074 / US9604131022 / CA56501R1064 / CA5503721063 / CA8667961053 / CA39138C1068 / US3546131018 / US12008R1077 / CA6993202069 / US7376301039 / CA4495861060 / US42809H1077 / CA21037X1006 / CA05534B7604 / CA1375761048 / CA01626P4033 / BMG383271050 / US30225T1025 / US5021751020 / GB00B1XZS820 / US05508R1068 / CA82835P1036 / BMG3922B1072 / CA45790B1040 / US3932221043 / US2567461080 / US00507V1098 / US38500T1016 / GB00B2QPKJ12 / US38526M1062 / US26884L1098 / DE000BAY0017 / US92345Y1064 / US2566771059 / CA69946Q1046 / CA14042M1023 / US78454L1008 / NL0009538784 / NL0009434992 / CA2927661025 / US61945C1036 / US7512121010 / US2296631094 / US98986T1088 / US4571871023 / CA7063271034 / CA4932711001 / US00287Y1091 / CA04315L1058 / US09739D1000 / US1091941005 / JE00B5TT1872 / BMG162581083 / CA1348082035 / CA69338U1012 / CA74061A1084 / CA77519R1029 / CA96145A2002 / CA09202D2077 / IE00B4Q5ZN47 / CA80013R2063 / US76131N1019 / CA11777Q2099 / CA89531J1093 / US6951271005 / CA29269R1055 / CA3748252069 / US5764852050 / US75902K1060 / US1716041017 / US0942351083 / CA87262K1057 / US08579W1036 / CA5054401073 / CA4882951060 / US65540B1052 / US31189P1021 / US03674X1063 / US2267181046 / US02005N1000 / US33938J1060 / US78667J1088 / IE00BQPVQZ61 / US4435731009 / CA0089118776 / US64829B1008 / US42225P5017 / CA76131D1033 / US74736K1016 / US30040W1080 / CA8310211005 / CA1946931070 / US1638511089 / US4278255009 / US96145D1054 / US5007541064 / CA83125J1049 / US95040Q1040 / US0130911037 / US8522341036 / GB00BYT5JK65 / CA49410M1023 / US45688C1071 / CA94106B1013 / CA8910546032 / US5588681057 / US13462K1097 / US43300A2033 / GB00BDSFG982 / US75134P3038 / US23355L1061 / US93627C1018 / CA46016U1084 / US05722G1004 / GB00BF3ZNS54 / CA7847301032 / US87105L1044 / US12653C1080 / LU1701428291 / CA4707481046 / CA2960061091 / US3610081057 / CA89679A2092 / IL0011417206 / US15677J1088 / US48251W1045 / CA0717341071 / US02607T1097 / US03843E1047 / US34417P1003 / US46005L1017 / US04335A1051 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / CA8849037095 / CA86084H1001 / US1255231003 / CA2849025093 / US57778K1051 / VGG1890L1076 / US85789A1051 / CA53227R1064 / US35137L1052 / US62921N1054 / CA14179V5036 / US73757R1023 / US26614N1028 / US61775R1059 / US30205M1018 / CA29446Y5020 / US03768E1055 / US91734M1036 / US92556H2067 / US67098H1041 / US69047Q1022 / MHY0436Q1098 / CA4220961078 / US44862P1093 / US26484T1060 / US46121Y2019 / US35953D1046 / US03750L1098 / US0412421085 / US62955J1034 / US78440X8048 / CA87975H1001 / CA64016L1013 / GB00BL6K5J42 / US9264001028</td><td class="leftalignment">IAMGOLD Corp / AGCO Corp / Advanced Micro Devices Inc / Albemarle Corp / Andersons Inc / Aptargroup Inc / Avery Dennison Corp / Ball Corp / CMS Energy Corp / CVS Health Corp / Coterra Energy Inc / Caterpillar Inc / Century Aluminum Co / Clean Harbors Inc / Costco Wholesale Corp / Walt Disney Co / Electronic Arts Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / FMC Corp / Gartner Inc / Halliburton Co / Hecla Mining Co / Hexcel Corp / Illinois Tool Works Inc / Kellogg Co / Louisiana-Pacific Corp / Marriott International Inc / Microchip Technology Inc / Moody's Corp / NiSource Inc / ON Semiconductor Corp / Papa John's International Inc / Public Service Enterprise Group Inc / Range Resources Corp / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Schlumberger NV / Sealed Air Corp / Sempra Energy / Southwestern Energy Co / Take-Two Interactive Software Inc / Target Corp / Trex Company Inc / Walmart Inc / Weyerhaeuser Co / Russel Metals Inc / Finning International Inc / Enbridge Inc / Bombardier Inc / Saputo Inc / Stantec Inc / Imperial Oil Ltd / Maple Leaf Foods Inc / SNC-Lavalin Group Inc / Teck Resources Ltd / Magna International Inc / Canadian Natural Resources Ltd / Telus Corp / Open Text Corp / Gildan Activewear Inc / Chevron Corp / Quebecor Inc / Taseko Mines Ltd / AMN Healthcare Services Inc / Global Payments Inc / Synaptics Inc / CenterPoint Energy Inc / Cross Country Healthcare Inc / Nuvista Energy Ltd / Crew Energy Inc / Westlake Chemical Corp / Manulife Financial Corp / Lundin Mining Corp / Sun Life Financial Inc / Great-West Lifeco Inc / Franklin Resources Inc / Builders FirstSource Inc / Paramount Resources Ltd / Potlatchdeltic Corp / IGM Financial Inc / Hess Corp / Constellation Software Inc / BCE Inc / Canfor Corp / Alimentation Couche-Tard Inc / GeoPark Ltd / Extra Space Storage Inc / LTC Properties Inc / Anglo American PLC / B&G Foods Inc / Silvercorp Metals Inc / Genpact Ltd / Innergex Renewable Energy Inc / Green Plains Inc / Dollar Tree Inc / Activision Blizzard Inc / Gran Tierra Energy Inc / Fresnillo PLC / Grand Canyon Education Inc / EQT Corp / Bayer AG / Verisk Analytics Inc / Dollar General Corp / Parex Resources Inc / Capital Power Corp / SM Energy Co / NXP Semiconductors NV / LyondellBasell Industries NV / Enerplus Corp / Mosaic Co / Ralph Lauren Corp / CubeSmart / Zynga Inc / Ingredion Inc / Pembina Pipeline Corp / Keyera Corp / Abbvie Inc / Artis Real Estate Investment Trust / Boise Cascade Co / Bright Horizons Family Solutions Inc / Centamin PLC / Brookfield Renewable Partners LP / Canacol Energy Ltd / PHX Energy Services Corp / Premium Brands Holdings Corp / Rogers Sugar Inc / Westshore Terminals Investment Corp / Black Diamond Group Ltd / Jazz Pharmaceuticals PLC / Sandstorm Gold Ltd / Retail Opportunity Investments Corp / B2Gold Corp / Trevali Mining Corp / Pacira Biosciences Inc / Enerflex Ltd / Gibson Energy Inc / Matador Resources Co / Regional Management Corp / Chuy's Holdings Inc / Bloomin' Brands Inc / TMX Group Ltd / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / Kelt Exploration Ltd / Noodles & Co / Fate Therapeutics Inc / Antero Resources Corp / Criteo SA / Ally Financial Inc / Pacira Biosciences Inc / SAGE Therapeutics Inc / Horizon Therapeutics PLC / HubSpot Inc / Air Canada / New Relic Inc / Healthcare Trust Of America Inc / Restaurant Brands International Inc / Qorvo Inc / Eversource Energy / Slate Office REIT / Colliers International Group Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / Kraft Heinz Co / Sleep Country Canada Holdings Inc / Welltower Inc / Albertsons Companies Inc / Block Inc / Mimecast Ltd / Killam Apartment REIT / Ingevity Corp / Waste Connections Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Camping World Holdings Inc / Hilton Worldwide Holdings Inc / TechnipFMC PLC / Ramaco Resources Inc / DXC Technology Co / Warrior Met Coal Inc / International Petroleum Corp / Baker Hughes Co / Venator Materials PLC / SSR Mining Inc / Switch Inc / CNX Resources Corp / Nexa Resources SA / Jamieson Wellness Inc / Ero Copper Corp / Funko Inc / Trisura Group Ltd / Sol Gel Technologies Ltd / Ceridian HCM Holding Inc / KKR & Co Inc / Bausch Health Companies Inc / American Finance Trust Inc / Aquestive Therapeutics Inc / Focus Financial Partners Inc / International Money Express Inc / Arvinas Inc / Livent Corp / Linde PLC / Calibre Mining Corp / Thomson Reuters Corp / Stingray Group Inc / Cigna Corp / Eldorado Gold Corp / Maxar Technologies Inc / Capri Holdings Ltd / Stealth BioTherapeutics Corp / Lightspeed Commerce Inc / Fox Corp / NGM Biopharmaceuticals Inc / Cargojet Inc / Postal Realty Trust Inc / Dupont De Nemours Inc / Morphic Holding Inc / Exicure Inc / Equinox Gold Corp / Apollo Global Management Inc / US Ecology Inc / ViacomCBS Inc / O-I Glass Inc / Ovintiv Inc / Atlas Corp / Headwater Exploration Inc / Hycroft Mining Holding Corporation / Dun & Bradstreet Holdings Inc / Intrepid Potash Inc / Fubotv Inc / Apartment Income REIT Corp / Arko Corp. / Nov Inc / SL Green Realty Corp / Telus International Cda Inc / Neighbourly Pharmacy Inc / Endeavour Mining PLC / Victoria's Secret & Co</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British / Marshall Islands / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What’s Next in Biotech? ZEB1 Calling the Shots for CD47 and PD-L1</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 2730190 / BGCYWN8</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US03662Q1058 / US2545431015 / CA6837151068 / 75886F107 / 389375106 / 12008R107 / 404251100 / 600544100 / 858155203 / 81619Q105 / 192005106 / 53220K504 / US30212P3038 / 21676P10 / M7516K103 / 98954M101 / 45780R101 / 021369103 / 141788109 / 89785L107 / US65487K1007 / 054540208 / 683344105 / 92556H206 / G6095L10 / 65343E108 / 79400X107 / 683373104</td><td class="leftalignment">ANSYS Inc / Diodes Inc / Open Text Corp / Regeneron Pharmaceuticals Inc / Gray Television Inc / Builders FirstSource Inc / HNI Corp / MillerKnoll Inc / Steelcase Inc / Select Medical Holdings Corp / Codexis Inc / Ligand Pharmaceuticals Inc / Expedia Group Inc / Cooper-Standard Holdings Inc / Nova Ltd / Zillow Group Inc / Installed Building Products Inc / Altair Engineering Inc / CarGurus Inc / TrueCar Inc / nLIGHT Inc / Axcelis Technologies Inc / Onto Innovation Inc / ViacomCBS Inc / Aptiv PLC / NextCure Inc / Salarius Pharmaceuticals Inc / Ontrak Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Israel / Jordan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Michael P. Ward, CFA / Mr. Mark W. Schappel / Mr. Daniel L. Kurnos, CFA / Mr. Reuben Garner / David Williams / Mr. Robert M. Wasserman / Mr. Bill Sutherland / Mr. Aydin Huseynov, MD / Mr. Mark Miller</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">2Q: REGN Is Probably In The Strongest Ever Position</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 06 2021</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">US00738A1060 / US00971T1016 / US01988P1084 / US0366421065 / US0758871091 / US1005571070 / US16411R2085 / US1924221039 / US2545431015 / US30161Q1040 / US34354P1057 / US3695501086 / US4234521015 / US4523271090 / US4657411066 / US5763231090 / US6821891057 / US7475251036 / US75886F1075 / US8006771062 / US8835561023 / US91347P1057 / CA0977512007 / US87157D1090 / LU0156801721 / US6402681083 / US88031M1099 / US6866881021 / US19239V3024 / US45784P1012 / US03152W1099 / BMG3922B1072 / US88076W1036 / US00922R1059 / US1920051067 / DE000A1EWWW0 / US6200763075 / JE00B783TY65 / US03027X1000 / US30212P3038 / US98986T1088 / LU0914713705 / US2908462037 / US4576693075 / US72919P2020 / US00912X3026 / US74587V1070 / US41068X1000 / US38046C1099 / US60468T1051 / US03823U1025 / CA05156V1022 / US7613301099 / US90137F1030 / US70438V1061 / US70432V1026 / US69888T2078 / US94419L1017 / US19249H1032 / US8190471016 / US6323071042 / US23284F1057 / US50127T1097 / US07725L1026 / US00773U1088 / US45073V1089 / US87266J1043 / US36165L1089 / US01345P1066 / US45782B1044 / LGFb / US2067871036 / LGFa / US91325V1089 / US23355L1061 / US1468691027 / US03782L1017 / US03236M2008 / US05722G1004 / US87105L1044 / US74766Q1013 / US4622601007 / US84833T1034 / US05351X1019 / CH0371153492 / US09354A1007 / US15677J1088 / US92336X1090 / US05455M1009 / US55910K1088 / US68373M1071 / US39868T1051 / US40131M1099 / US53814L1089 / US98585X1046 / US35137L1052 / US89377M1099 / US18915M1071 / US85205L1070 / US92764N1028 / US92766K1060 / US69242L1061 / US4833791035 / US03969K1088 / US92537N1081 / US39813G1094 / US14147L1089 / US6833731044 / US07373B1098 / US33813J1060 / US5533681012 / US74767V1098 / US7761531083 / US15961R1059 / US90089L1089 / US44891N2080 / US25401T1088 / US20717M1036 / US87427V1035 / US35909D1090</td><td class="leftalignment">ADTRAN Inc / Akamai Technologies Inc / Allscripts Healthcare Solutions Inc / Antares Pharma Inc / Becton Dickinson and Co / Boston Beer Company Inc / Cheniere Energy Inc / Cognex Corp / Diodes Inc / Exelixis Inc / Flowserve Corp / General Dynamics Corp / Helmerich and Payne Inc / Illumina Inc / Itron Inc / MasTec Inc / ON Semiconductor Corp / Qualcomm Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Thermo Fisher Scientific Inc / Universal Display Corp / Bombardier Inc / Synaptics Inc / Tenaris SA / Nektar Therapeutics / Tenaris SA / Ormat Technologies Inc / Cogent Communications Holdings Inc / Insulet Corp / Amicus Therapeutics Inc / Genpact Ltd / Teradata Corp / Air Transport Services Group Inc / Codexis Inc / Adidas AG / Motorola Solutions Inc / Aptiv PLC / American Tower Corp / Expedia Group Inc / Zynga Inc / Intelsat SA / EMCORE Corp / Insmed Inc / Plug Power Inc / Air Lease Corp / Puma Biotechnology Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Gogo Inc / Mirati Therapeutics Inc / Applied Optoelectronics Inc / Aurinia Pharmaceuticals Inc / Revance Therapeutics Inc / 22nd Century Group Inc / Paylocity Holding Corp / Paycom Software Inc / Par Pacific Holdings Inc / Wayfair Inc / Coherus BioSciences Inc / Shake Shack Inc / Natera Inc / CytomX Therapeutics Inc / Kura Oncology Inc / Beigene Ltd / Adverum Biotechnologies Inc / ITT Inc / TPI Composites Inc / GDS Holdings Ltd / Albireo Pharma Inc / Inseego Corp / Lions Gate Entertainment Corp / Conduent Inc / Lions Gate Entertainment Corp / Uniti Group Inc / DXC Technology Co / Carvana Co / Appian Corp / Amyris Inc / Baker Hughes Co / Switch Inc / Quanterix Corp / Iovance Biotherapeutics Inc / Spero Therapeutics Inc / Avaya Holdings Corp / Landis+Gyr Group AG / Blink Charging Co / Ceridian HCM Holding Inc / Veoneer Inc / AVROBIO Inc / Magenta Therapeutics Inc / Opera Ltd / Gritstone bio Inc / Guardant Health Inc / Livent Corp / Yeti Holdings Inc / Fox Corp / Transmedics Group Inc / Cloudflare Inc / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Virgin Galactic Holdings Inc / Oyster Point Pharma Inc / Kaleyra Inc / Arcutis Biotherapeutics Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / Cardiff Oncology Inc / Ontrak Inc / Beam Global / Fisker Inc / Mp Materials Corp / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc / TuSimple Holdings Inc / IAC/Interactivecorp / DigitalBridge Group Inc / Confluent Inc / Talkspace Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">A Significant Q2, Flood of Catalysts Coming, Rally Should Continue, PT to $725</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">DNB / PFE=US / T=US / TXN=US / RUN=US / CMA=US / GILD=US / EOG=US / PLUG=US / WLL=US / PB=US / DIOD=US / MUR=US / EWBC=US / TRMK=US / UMPQ=US / MRO=US / EXPE=US / VMC=US / PENN=US / BKI=US / CI=US / W=US / WTFC=US / ARCC=US / AMED=US / AMN=US / SWIM=US / ARW=US / AVT=US / KIDS=US / CHH=US / CSTR=US / COLL=US / CSGP=US / DRH=US / EXEL=US / IBP=US / MAIN=US / MCHP=US / NTST=US / ORCC=US / PACW=US / PCTY=US / REGN=US / ROLL=US / STOR=US / TRGP=US / TRIP=US / WAL=US / GOLF=US / FOUR=US / HTH=US / BXS=US / NET=US / FNF=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / ADC=US / BOKF=US / BDN=US / FB=US / FBK=US / MKL=US / ASB=US / SSB=US / SRC=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / REG=US / APPN=US / AUTL=US / UCBI=US / DIN=US / MGNI=US / PNFP=US / ATRS=US / SBCF=US / PRAA=US / MNST=US / BCO=US / JRVR=US / NOMD=US / TCBI=US / FNB=US / CRD.B=US / FHN=US / AINV=US / RNST=US / DENN=US / LHCG=US / THS=US / BLDR=US / AAWW=US / CMG=US / FIS=US / CCOI=US / CADE=US / PNNT=US / SEAS=US / NOG=US / ATSG=US / IAC=US / EPRT=US / AGS=US / RCUS=US / RLJ=US / ANGI=US / ZNGA=US / PDCE=US / HCI=US / IBTX=US / FOXF=US / FEYE=US / CNCE=US / QTWO=US / TSLX=US / 70806A106 / LOCO=US / SHAK=US / ON=US / GSBD=US / LOB=US / ZG=US / ACBI=US / SQ=US / NTLA=US / VVV=US / CDEV=US / IRTC=US / PK=US / CVNA=US / VRNA=US / RDFN=US / SWCH=US / MBIN=US / FNKO=US / COLD=US / LAZY=US / HWC=US / OZK=US / FOCS=US / EB=US / AXNX=US / FSK=US / AMTB=US / TCRR=US / LSPD=US / PLMR=US / DDOG=US / AHCO=US / BIGC=US / 96758W101 / VMEO=US / MNTV=US / DBRG=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Pfizer Inc / AT&T Inc / Texas Instruments Inc / Sunrun Inc / Comerica Inc / Gilead Sciences Inc / EOG Resources Inc / Plug Power Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Diodes Inc / Murphy Oil Corp / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / Vulcan Materials Co / Penn National Gaming Inc / Black Knight Inc / Cigna Corp / Wayfair Inc / Wintrust Financial Corp / Ares Capital Corp / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Arrow Electronics Inc / Avnet Inc / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / CoStar Group Inc / Diamondrock Hospitality Co / Exelixis Inc / Installed Building Products Inc / Main Street Capital Corp / Microchip Technology Inc / Netstreit Corp / Owl Rock Capital Corp / PacWest Bancorp / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / STORE Capital Corp / Targa Resources Corp / Tripadvisor Inc / Western Alliance Bancorp / Acushnet Holdings Corp / Shift4 Payments Inc / Hilltop Holdings Inc / Cadence Bank / Cloudflare Inc / Fidelity National Financial Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / Brandywine Realty Trust / Meta Platforms Inc / FB Financial Corp / Markel Corp / Associated Banc-Corp / SouthState Corp / Spirit Realty Capital Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Regency Centers Corp / Appian Corp / Autolus Therapeutics PLC / United Community Banks Inc / Dine Brands Global Inc / Magnite Inc / Pinnacle Financial Partners Inc / Antares Pharma Inc / Seacoast Banking Corporation of Florida / PRA Group Inc / Monster Beverage Corp / Brinks Co / James River Group Holdings Ltd / Nomad Foods Ltd / Texas Capital Bancshares Inc / FNB Corp / Crawford & Co / First Horizon Corp / Apollo Investment Corp / Renasant Corp / Denny's Corp / LHC Group Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Atlas Air Worldwide Holdings Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Cadence Bank / Pennantpark Investment Corp / SeaWorld Entertainment Inc / Northern Oil and Gas Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / PlayAGS Inc / Arcus Biosciences Inc / RLJ Lodging Trust / Angi Inc / Zynga Inc / PDC Energy Inc / Hci Group Inc / Independent Bank Group Inc / Fox Factory Holding Corp / Mandiant Inc / Concert Pharmaceuticals Inc / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Goldman Sachs BDC Inc / Live Oak Bancshares Inc / Zillow Group Inc / Atlantic Capital Bancshares Inc / Block Inc / Intellia Therapeutics Inc / Valvoline Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Park Hotels & Resorts Inc / Carvana Co / Verona Pharma PLC / Redfin Corp / Switch Inc / Merchants Bancorp / Funko Inc / Americold Realty Trust / Lazydays Holdings Inc / Hancock Whitney Corp / Bank Ozk / Focus Financial Partners Inc / Eventbrite Inc / Axonics Inc / FS KKR Capital Corp / Amerant Bancorp Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Palomar Holdings Inc / Datadog Inc / Adapthealth Corp / Bigcommerce Holdings Inc / WideOpenWest Inc / Vimeo Inc / Momentive Global Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">191</td><td class="leftalignment">US0126531013 / US0383361039 / US0584981064 / US1491231015 / US22160K1051 / US2855121099 / US30161N1019 / US4227041062 / US4601461035 / US4878361082 / US5745991068 / US6153691059 / US6951561090 / US6988131024 / US7549071030 / US75886F1075 / US7703231032 / US81211K1007 / US8168511090 / US87612E1064 / US89531P1057 / US9311421039 / CA7819036046 / CA0977512007 / CA8029121057 / CA5649051078 / CA1363851017 / CA6837151068 / CA3759161035 / CA7481932084 / US37940X1028 / US87157D1090 / US15189T1079 / US2274831047 / CA56501R1064 / US0736851090 / CA8667961053 / US12008R1077 / CA4495861060 / CA21037X1006 / CA05534B7604 / US05508R1068 / CA82835P1036 / BMG3922B1072 / US2567461080 / DE000BAY0017 / US2566771059 / CA2927661025 / CA7063271034 / CA4932711001 / CA04315L1058 / US1091941005 / BMG162581083 / CA1348082035 / CA74061A1084 / CA09202D2077 / CA80013R2063 / CA11777Q2099 / CA89531J1093 / US6951271005 / CA29269R1055 / US34964C1062 / US1716041017 / CA87262K1057 / US08579W1036 / CA5054401073 / CA4882951060 / US78667J1088 / US96145D1054 / CA49410M1023 / CA94106B1013 / CA8910546032 / US5588681057 / US87105L1044 / CA4707481046 / CA89679A2092 / IL0011417206 / US46005L1017 / US04335A1051 / US53814L1089 / CA13000C2058 / CA8849037095 / US1255231003 / US85789A1051 / CA53227R1064 / US03768E1055 / US92556H2067 / CA4220961078 / US05478C1053 / US9264001028</td><td class="leftalignment">Albemarle Corp / Aptargroup Inc / Ball Corp / Caterpillar Inc / Costco Wholesale Corp / Electronic Arts Inc / Exelon Corp / Hecla Mining Co / International Paper Co / Kellogg Co / Masco Corp / Moody's Corp / Packaging Corp of America / Papa John's International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Sealed Air Corp / Sempra Energy / Target Corp / Trex Company Inc / Walmart Inc / Russel Metals Inc / Bombardier Inc / Saputo Inc / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Open Text Corp / Gildan Activewear Inc / Quebecor Inc / Global Payments Inc / Synaptics Inc / CenterPoint Energy Inc / Cross Country Healthcare Inc / Manulife Financial Corp / Beacon Roofing Supply Inc / Sun Life Financial Inc / Builders FirstSource Inc / IGM Financial Inc / Constellation Software Inc / BCE Inc / B&G Foods Inc / Silvercorp Metals Inc / Genpact Ltd / Dollar Tree Inc / Bayer AG / Dollar General Corp / Enerplus Corp / Pembina Pipeline Corp / Keyera Corp / Artis Real Estate Investment Trust / Bright Horizons Family Solutions Inc / Brookfield Renewable Partners LP / Canacol Energy Ltd / Premium Brands Holdings Corp / Black Diamond Group Ltd / Sandstorm Gold Ltd / B2Gold Corp / Trevali Mining Corp / Pacira Biosciences Inc / Enerflex Ltd / Fortune Brands Home & Security Inc / Chuy's Holdings Inc / TMX Group Ltd / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / Kelt Exploration Ltd / SAGE Therapeutics Inc / Westrock Co / Killam Apartment REIT / Waste Connections Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Switch Inc / Jamieson Wellness Inc / Trisura Group Ltd / Sol Gel Technologies Ltd / International Money Express Inc / Arvinas Inc / Livent Corp / Calibre Mining Corp / Thomson Reuters Corp / Cigna Corp / Stealth BioTherapeutics Corp / Lightspeed Commerce Inc / Apollo Global Management Inc / ViacomCBS Inc / Headwater Exploration Inc / Azek Company Inc / Victoria's Secret & Co</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Regeneron Walks the Walk on Delivering Superb 2Q2021 Top and Bottom Line Performance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.OQ / 02043Q107 / NTLA.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intellia Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">US01988P1084 / US75886F1075 / US8036071004 / US23282W6057 / CA05156V1022 / US68906L1052 / US8733791011 / CA39342L1085 / CA22587M1068 / US15117B2025 / US85789A1051 / CA89788C1041 / US6700024010 / CA23126M1023 / US42225T1079 / US39813G1094 / CA00489Y6001 / CA00249N2095</td><td class="leftalignment">Allscripts Healthcare Solutions Inc / Regeneron Pharmaceuticals Inc / Sarepta Therapeutics Inc / Cytokinetics Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Tabula Rasa HealthCare Inc / Green Thumb Industries Inc / Cresco Labs Inc / Celldex Therapeutics Inc / Stealth BioTherapeutics Corp / Trulieve Cannabis Corp / Novavax Inc / Curaleaf Holdings Inc / Health Catalyst Inc / Grid Dynamics Holdings Inc / Acreage Holdings Inc / Ayr Wellness Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US4657411066 / US75886F1075 / NBIX.OQ / 577933104 / US45784P1012 / 004498101 / ACAD.N / US74736L1098 / 72919P202 / US8982021060 / 94419L101 / US98954M1018 / 632307104 / 13173L107 / 05988J103 / 89853L104 / 450056106 / 65487K100 / QTRX.N / 40131M109 / 89377M109 / 05338G106 / 73931J109 / 42225T107 / 683373104 / 08862E109 / 92766K106 / 00653Q102 / 08975P108 / 39813G109 / 25402D102 / 74275K108</td><td class="leftalignment">Itron Inc / Regeneron Pharmaceuticals Inc / Neurocrine Biosciences Inc / Maximus Inc / Insulet Corp / ACI Worldwide Inc / ACADIA Pharmaceuticals Inc / Q2 Holdings Inc / Plug Power Inc / Trupanion Inc / Wayfair Inc / Zillow Group Inc / Natera Inc / Calyxt Inc / Bandwidth Inc / T2 Biosystems Inc / iRhythm Technologies Inc / nLIGHT Inc / Quanterix Corp / Guardant Health Inc / Transmedics Group Inc / Avalara Inc / PowerFleet Inc / Health Catalyst Inc / Ontrak Inc / Beyond Meat Inc / Virgin Galactic Holdings Inc / Adapthealth Corp / Bigcommerce Holdings Inc / Grid Dynamics Holdings Inc / DigitalOcean Holdings Inc / Procore Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">China / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">AXP / V / 4031976 / 5671735 / 2023607 / 2486813 / 2640147 / 2778844 / 2002305 / 2003698 / 2050832 / 2045623 / 2942605 / 2544960 / 2219224 / 2206657 / 2216850 / 2037170 / 2317087 / 2576941 / 2670519 / 2328915 / 2342034 / 2613990 / 2471950 / 2630513 / 2645409 / 2657802 / 2689560 / 2680905 / 2684703 / 2048804 / 2730190 / 2440637 / 2138158 / 2825933 / 2829601 / 2928683 / 2503529 / B1F76F9 / 2212922 / B19FQ48 / B0T7YX2 / B02R1L6 / 2390817 / B7TL820 / B4MG4Z6 / B783TY6 / B7VD3F2 / BBPK0J0 / BBGVT40 / B7577T2 / BDZCRX3 / B95WG16 / BZ07BW4 / BYZLV46 / BYNZGK1 / BZBY005 / BD8DJ71 / BJ1FD74 / BKTHM05 / BR4T3B3 / BMYML02 / BFMXGR0 / BJJMGL2 / BFNR303 / BYXJQG9 / BZ8VJQ8 / BJFSR99 / BFXC911 / BKTNTR9 / BJVR9Y9 / BYWMQJ2 / BYYWPW6 / BHZSB82 / BP3YM85 / BD6D4Y5 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BF3W461 / BYSGPK2 / BKX9VD3 / BJDX8Y8 / BYWVTY5 / BMVWYW8 / BDZ30Q0 / BJMLSD2 / BYTJZL1 / BJTJGC4 / BG0Q4Y1 / BF3N4P3 / BQXZP64 / BMDCDP2 / BYXB1Y8 / BGDQ8B3 / BD72R64 / BNTB3N8 / BMGGJK8 / BKPGJQ1 / BJLV8T9</td><td class="leftalignment">American Express Co / Visa Inc / Adidas AG / Sanofi SA / Amgen Inc / Kellogg Co / Nike Inc / Merck & Co Inc / Abbott Laboratories / ABIOMED Inc / Ameren Corp / ANSYS Inc / Avista Corp / Beasley Broadcast Group Inc / CMS Energy Corp / Coca-Cola Co / Consolidated Edison Inc / 8x8 Inc / Entergy Corp / Exelixis Inc / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Illumina Inc / Incyte Corp / New Jersey Resources Corp / NiSource Inc / OGE Energy Corp / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / VF Corp / World Wrestling Entertainment Inc / Western Union Co / NRG Energy Inc / Amicus Therapeutics Inc / Live Nation Entertainment Inc / ALLETE Inc / Gray Television Inc / Meta Platforms Inc / AMC Networks Inc / Aptiv PLC / Duke Energy Corp / Mirati Therapeutics Inc / News Corp / Renewable Energy Group Inc / RingCentral Inc / Zoetis Inc / Monster Beverage Corp / InflaRx NV / Block Inc / Merus NV / Snap Inc / Revolve Group Inc / Passage Bio Inc / HubSpot Inc / DraftKings Inc / Evergy Inc / Fox Corp / Northwest Natural Holding Co / Spire Inc / Vistra Corp / Revance Therapeutics Inc / Guardant Health Inc / ViacomCBS Inc / iHeartMedia Inc / Alteryx Inc / Beigene Ltd / Covetrus Inc / Trupanion Inc / Altair Engineering Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / ViewRay Inc / Arcutis Biotherapeutics Inc / Mirum Pharmaceuticals Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Arvinas Inc / Karuna Therapeutics Inc / Zogenix Inc / Kontoor Brands Inc / Exicure Inc / Arena Pharmaceuticals Inc / Wayfair Inc / Bigcommerce Holdings Inc / Sunrun Inc / Axonics Inc / Liberty Media Corp / Vizio Holding Corp / Valneva SE / Squarespace Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / France / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2Q21 Results; Positive Regulatory Outlook for Assets; Cosibelimab Approaching First Endgame</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">162828107 / REGN.OQ</td><td class="leftalignment">Checkpoint Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2Q Take: Strong Quarter for Base Business and COVID Franchise</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Eylea shows strong growth; Libtayo doublet trial stopped early as significant improvement displayed</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : 2Q Snapshot & Model Update</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">2Q21 results and mgmt color: REGEN-COV, core biz and growing pipeline</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">REGN - REGN: 2Q21 Postview:  REGEN-COV beat and solid performance in the base business</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2Q - Slam Dunk - Updating Model, PT to $690</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Another Beat For Eylea/Dupi-Libtayo Light Again-Ph3 High-Dose Eylea Data In ‘22</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Glitter in the Sky, Glitter in my Eyes - 6th Straight Week of Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">The Big Beat We Were Waiting for...Not Just COVID but All Franchises Firing</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Post-2Q21 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Tearing it Up in Tarrytown</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2Q21: REGEN-COV Drives the Beat</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">REGN - REGN 2Q21 - They said what?! Highlights from the conf call...and our perspective</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : First Look at 2Q Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2Q21 Results; Strong Financials Bolstered by Growing and Maturing Portfolio; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">98419J206 / REGN.OQ / RZLT.OQ / VIRX.OQ</td><td class="leftalignment">XOMA Corp / Regeneron Pharmaceuticals Inc / Rezolute Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GBP: Libtayo Meets the Bar to Compete w/ MRK's Keytruda in Lung Cancer; Similar Results Suggest an Uphill Battle, but Opens Biggest PD1 Market</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / 5671735 / 2778844 / 2730190</td><td class="leftalignment">Merck & Co Inc / Sanofi SA / Merck & Co Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Mr. Yatin Suneja</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - 2Q21; Another Solid Quarter, All Key Products Performed Well; Libtayo Chemo-Combo Lung Data Positive; Pipeline Making Swift Progress</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Brief of Regeneron Pharmaceuticals Inc conference call, Aug. 05, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Aug. 05, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Q2:21 at first blush: REGEN-COV drives $1B+ Rev beat & Libtayo gets ph3 NSCLC chemo combo win</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">2Q21 Quick Take: 2Q21 driven by Eylea beat and FY2021 driven by higher Dupi sales</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q221 First Look: Biggest Beat We Think We Can Remember</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: August 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A.N / AAP.N / AIG.N / APD.N / BDX.N / BR.N / CF.N / CI.N / CVS.N / ED.N / GM.N / STE.N / WMT.N / DUK.N / DIS.N / D.N / TSN.N / SYY.N / IFF.N / HD.N / LOW.N / RMD.N / TGT.N / BLL.N / TJX.N / VTR.N / CSCO.OQ / JKHY.OQ / REGN.OQ / DISH.OQ / EBAY.OQ / NVDA.OQ / ILMN.OQ / MNST.OQ / VIAC.OQ / TDG.N / MSI.N / ADI.OQ / ZTS.N / PRGO.N / NCLH.N / KEYS.N / APTV.N / BKNG.OQ / CTVA.N / VTRS.OQ / BBWI.N</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Consolidated Edison Inc / General Motors Co / STERIS plc / Walmart Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Lowe's Companies Inc / Resmed Inc / Target Corp / Ball Corp / TJX Companies Inc / Ventas Inc / Cisco Systems Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / DISH Network Corp / eBay Inc / NVIDIA Corp / Illumina Inc / Monster Beverage Corp / ViacomCBS Inc / TransDigm Group Inc / Motorola Solutions Inc / Analog Devices Inc / Zoetis Inc / Perrigo Company PLC / Norwegian Cruise Line Holdings Ltd / Keysight Technologies Inc / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Viatris Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for REGN</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2Q21 Results; Strategic Partnerships and Strong Financials Solidify Rich Pipeline Development</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">720795103 / REGN.OQ / FGEN.OQ</td><td class="leftalignment">Pieris Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / FibroGen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Our Outlook for Regeneron’s Upcoming 2Q21 Earnings Report</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ / 02043Q107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">0989529 / 0925288 / 2434209 / 2516152 / 2681511 / 2000019 / 2023607 / 2486813 / 2778844 / 2229126 / 2208073 / 2270726 / 2829515 / 2670519 / 2328915 / 2100920 / 2471950 / 2623911 / 2657802 / 2689560 / 2684703 / 2048804 / 2707677 / 2730190 / 2829601 / 2853688 / 7103065 / 2783815 / 2712013 / B00FWN1 / B0PZN11 / B121557 / 2769796 / 2857817 / B0T7YX2 / B2R3PV1 / B3D7K31 / B4Y1MH7 / 2390817 / B44C366 / B3SWPT2 / B4V9661 / BJ0KXV4 / BDZCRX3 / BFLR866 / BFZCHN7 / BYY8XK8 / BYVY8G0 / BTF8CF0 / BP4GNK9 / BYW36M8 / BYNZGK1 / BJT1RW7 / BD9GVY0 / BJF8Q81 / BZ1LFB2 / BR4T3B3 / BJ2Z0H2 / BLGJ610 / BJJMGL2 / BZ05388 / BDT5KT5 / BKC9SX3 / BFWGXQ7 / BP84RX0 / 021513106 / BNTB3N8</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Columbia Sportswear Co / Copart Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Incyte Corp / Neurocrine Biosciences Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Southern Co / Stryker Corp / Novartis AG / Zimmer Biomet Holdings Inc / Global Payments Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Discovery Inc / KAR Auction Services Inc / Gray Television Inc / Heska Corp / Ameresco Inc / Ralph Lauren Corp / ONE Gas Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / WEC Energy Group Inc / Alphabet Inc / Restaurant Brands International Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Block Inc / Lyft Inc / Zai Lab Ltd / IAA Inc / Deciphera Pharmaceuticals Inc / HubSpot Inc / Pinterest Inc / Warner Music Group Corp / Fox Corp / Global Blood Therapeutics Inc / Inspire Medical Systems Inc / Arcturus Therapeutics Holdings Inc / Container Store Group Inc / Townsquare Media Inc / Alto Ingredients Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: August 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A.N / AIG.N / APD.N / BDX.N / BR.N / CF.N / CI.N / CVS.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / STE.N / WMT.N / MET.N / DUK.N / DIS.N / D.N / TSN.N / SYY.N / IFF.N / HD.N / EMR.N / RMD.N / BLL.N / VTR.N / AMGN.OQ / REGN.OQ / TT.N / DISH.OQ / ANSS.OQ / EBAY.OQ / ILMN.OQ / MNST.OQ / VIAC.OQ / TDG.N / MSI.N / MPC.N / EA.OQ / ZTS.N / PRGO.N / CDW.OQ / NCLH.N / ETSY.OQ / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Agilent Technologies Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / STERIS plc / Walmart Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Emerson Electric Co / Resmed Inc / Ball Corp / Ventas Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / DISH Network Corp / ANSYS Inc / eBay Inc / Illumina Inc / Monster Beverage Corp / ViacomCBS Inc / TransDigm Group Inc / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / CDW Corp / Norwegian Cruise Line Holdings Ltd / ETSY Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2Q Earnings Preview:  Playin' Basketball</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: August 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AIRP.PA / ALB.N / ALK.N / AXP.N / BA.N / BAC.N / BAX.N / BDX.N / C.N / CCL.N / CI.N / COF.N / CRM.N / DAL.N / FCX.N / GM.N / GPS.N / JNJ.N / JPM.N / KMB.N / LLY.N / LSI.N / LUV.N / MDT.N / MO.N / NEM.N / PFE.N / PM.N / SC.N / T.N / TMO.N / U.N / WAT.N / WFC.N / PG.N / NUE.N / CPB.N / W.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / D.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / DVN.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / PKI.N / VZ.N / WST.N / MUR.N / KSS.N / ORCL.N / PWR.N / COG.N / EFX.N / V.N / EW.N / CPT.N / HWM.N / ACN.N / PLD.N / CHD.N / AIV.N / HAE.N / MKC.N / MAA.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / MHK.N / GME.N / INTC.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / ATVI.OQ / MSFT.OQ / PBCT.OQ / TEAM.OQ / REGN.OQ / SIVB.OQ / QDEL.OQ / CACC.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / GILD.OQ / DFS.N / COST.OQ / CPRT.OQ / INCY.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / TPR.N / NBIX.OQ / CTXS.OQ / AMZN.OQ / MANH.OQ / NVDA.OQ / BMRN.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / EXAS.OQ / ALGN.OQ / VRTX.OQ / JBLU.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / TFC.N / ACAD.OQ / CG.TO / DPZ.N / MOS.N / DLR.N / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / STX.AX / MA.N / IVZ.N / TDC.N / MRNA.OQ / MSCI.N / AVGO.OQ / FTNT.OQ / MU.OQ / GNRC.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / EPAM.N / SPLK.OQ / PSX.N / SRPT.OQ / GMED.N / ALLY.N / PRGO.N / COTY.N / COMM.OQ / NCLH.N / GOOGL.OQ / SAGE.OQ / HUBS.N / WBA.OQ / TDOC.N / PYPL.OQ / GBT.OQ / IONS.OQ / RETA.OQ / COUP.OQ / LW.N / AYX.N / DXC.N / CVNA.N / IOVA.OQ / AXON.OQ / WDAY.OQ / ROKU.OQ / BKNG.OQ / CBRE.N / FB.PS / CPRI.N / NFE.OQ / PINS.N / FSLY.N / CRWD.OQ / RTX.N / LMND.N / GOCO.OQ / CVAC.OQ / AMWL.N / PLTR.N / VTRS.OQ / TSP.OQ / HON.OQ</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Citigroup Inc / Carnival Corp / Cigna Corp / Capital One Financial Corp / Salesforce.Com Inc / Delta Air Lines Inc / Freeport-McMoRan Inc / General Motors Co / Gap Inc / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Life Storage Inc / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Wayfair Inc / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Dominion Energy Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / PerkinElmer Inc / Verizon Communications Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Kohls Corp / Oracle Corp / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Camden Property Trust / Howmet Aerospace Inc / Accenture PLC / Prologis Inc / Church & Dwight Co Inc / Apartment Investment and Management Co / Haemonetics Corp / McCormick & Company Inc / Mid-America Apartment Communities Inc / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Mohawk Industries Inc / GameStop Corp / Intel Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Activision Blizzard Inc / Microsoft Corp / People's United Financial Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / SVB Financial Group / Quidel Corp / Credit Acceptance Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Costco Wholesale Corp / Copart Inc / Incyte Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Tapestry Inc / Neurocrine Biosciences Inc / Citrix Systems Inc / Amazon.com Inc / Manhattan Associates Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Exact Sciences Corp / Align Technology Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Mosaic Co / Digital Realty Trust Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Invesco Ltd / Teradata Corp / Moderna Inc / MSCI Inc / Broadcom Inc / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Epam Systems Inc / Splunk Inc / Phillips 66 / Sarepta Therapeutics Inc / Globus Medical Inc / Ally Financial Inc / Perrigo Company PLC / Coty Inc / CommScope Holding Company Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Iovance Biotherapeutics Inc / Axon Enterprise Inc / Workday Inc / Roku Inc / Booking Holdings Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Fastly Inc / CrowdStrike Holdings Inc / Raytheon Technologies Corp / Lemonade Inc / Gohealth Inc / CureVac NV / American Well Corp / Palantir Technologies Inc / Viatris Inc / TuSimple Holdings Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / France / United Kingdom / Ireland / Luxembourg / Netherlands / Panama / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: August 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / STE.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / TSN.N / SYY.N / IFF.N / EMR.N / RMD.N / BLL.N / PSA.N / AME.N / VTR.N / PRU.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / MCHP.OQ / DISH.OQ / ANSS.OQ / EBAY.OQ / SBAC.OQ / EXPE.OQ / ILMN.OQ / MNST.OQ / VIAC.OQ / FIS.N / TDG.N / NXPI.OQ / MSI.N / MPC.N / EA.OQ / PSX.N / ZTS.N / PRGO.N / CDW.OQ / MAR.OQ / NCLH.N / ETSY.OQ / ZBH.N / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / STERIS plc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Resmed Inc / Ball Corp / Public Storage / AMETEK Inc / Ventas Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Microchip Technology Inc / DISH Network Corp / ANSYS Inc / eBay Inc / SBA Communications Corp / Expedia Group Inc / Illumina Inc / Monster Beverage Corp / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Zoetis Inc / Perrigo Company PLC / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / ETSY Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Regeneron Pharmaceuticals Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / OCX / NVAX.O / ICPT.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / KMDA.TA / 266605104 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 503459604 / 199800.KN / VKTX.O / ADMA.O / CFRX.O / ALSEN.PA / CLBS.O / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / MDGL.O / LYS.PA / IVAA.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / NGM.O / FIXX.O / MBIO.O / 46583P102 / AKRO.O / NBSE.O / LCTX.K / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / ETNB.O / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / 19249J109 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / OncoCyte Corp / Novavax Inc / Intercept Pharmaceuticals Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Kamada Ltd / DURECT Corp / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / La Jolla Pharmaceutical Co / ToolGen Inc / Viking Therapeutics Inc / ADMA Biologics Inc / ContraFect Corp / Sensorion SA / Caladrius Biosciences Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Madrigal Pharmaceuticals Inc / Lysogene SA / Inventiva SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / NGM Biopharmaceuticals Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / Lineage Cell Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / 89Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / CohBar Inc / Novo Nordisk A/S</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">AAP.N / AEP.N / AES.N / ALV.N / BARC.L / BBY.N / CL.N / COST.O / DFDS.CO / EIX.N / EL.N / F.N / FLS.N / FLT.N / FMS.N / GE.N / GM.N / GPS.N / HTG.L / KMB.N / KO.N / L.TO / MO.N / MSFT.O / PEG.N / RL.N / SO.N / T.N / VC.N / WMT.N / PEP.N / CERN.O / ACI.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / TEN.N / CMCSA.O / AMGN.O / UHS.N / DHR.N / BWA.N / LEA.N / WCC.N / DOV.N / IEX.N / ROP.N / ENB.TO / K.N / DT.N / DISH.O / CLX.N / CAG.N / HON.N / HD.N / LOW.N / MMM.N / GIS.N / EMR.N / HSY.N / EPC.N / AMT.N / NKE.N / CONE.O / MRU.TO / GWW.N / VZ.N / JCI.N / ARNA.O / STZ.N / VFC.N / APH.N / TJX.N / AZO.N / KMX.N / FISV.O / V.N / CPT.N / ROST.O / CHTR.O / AXL.N / DLTR.O / DG.N / CHD.N / ESS.N / NWN.N / AME.N / ANF.N / BC.N / GPC.N / PVH.N / SAM.N / CTSH.O / FRAG.DE / BMRN.O / REGN.O / ENR.N / VRTX.O / FTT.TO / MHK.N / SM.N / NCR.N / TEL.N / URBN.O / SSNC.O / WG.L / TSCO.O / CPK.N / CHE.N / GGG.N / PNR.N / PII.N / ST.N / SWN.N / TT.N / SEM.N / SGEN.OQ / GPN.N / DKS.N / PFS.N / MNST.O / IMGN.O / CASY.O / ORLY.O / AMED.O / EQIX.O / ATDb.TO / TIH.TO / NVT.N / DLR.N / LHCG.O / PFC.L / SJW.N / FIS.N / MA.N / MWA.N / HOG.N / MERC.O / PRTS.OQ / AEO.N / 3IN.L / AON.N / BGS.N / LULU.O / GETP.PA / ENSG.O / DAN.N / PBF.N / SWI.N / ADUS.OQ / SPB.N / ENV.N / NEE.N / NXT.AX / CFX.TO / SUBC.OL / CTT.N / MTOR.N / GLEN.L / IFP.TO / ACHC.O / SPLK.OQ / RFP.N / FIVE.OQ / FFHu.TO / MDLZ.OQ / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / AGIO.O / 81762P102 / BURL.N / LB.N / PLC.TO / COUP.N / VRNS.O / QTWO.N / NEP.N / SHLX.N / AENA.MC / EVA.N / PYPL.OQ / OLLI.OQ / AROC.N / SQ.N / MIME.OQ / MESO.O / RACE.MI / SRENH.S / FTV.N / TWLO.N / ATKR.N / TTD.O / ADNT.N / UAA.N / PBYI.OQ / RCM.OQ / GOOS.TO / DXC.N / VST.N / ATUS.N / AQUA.N / APTV.N / EHC.N / GTES.N / BSIG.N / SMAR.N / DBX.O / VNE.N / NTGY.MC / KDP.N / BHC.N / FOCS.O / ESTC.N / NWL.O / AVTR.N / NOVA.N / PING.N / DDOG.O / CRNC.OQ / EPAC.N / PNTG.OQ / REYN.O / CARR.N / NKLA.OQ / FOUR.N / MGNI.OQ / AKES.OL / RXT.OQ / IBEX.O / ACC-ME.OL / LUMN.N / ASAN.N / 900435207 / LSPD.N / WFG.N / TIXT.TO / AFRM.O / TE.PA / NAPA.N / OTLY.O / EVCM.O / 120681711</td><td class="leftalignment">Advance Auto Parts Inc / American Electric Power Company Inc / AES Corp / Autoliv Inc / Barclays PLC / Best Buy Co Inc / Colgate-Palmolive Co / Costco Wholesale Corp / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / Fleetcor Technologies Inc / Fresenius Medical Care AG & Co KGaA / General Electric Co / General Motors Co / Gap Inc / Hunting PLC / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Altria Group Inc / Microsoft Corp / Public Service Enterprise Group Inc / Ralph Lauren Corp / Southern Co / AT&T Inc / Visteon Corp / Walmart Inc / PepsiCo Inc / Cerner Corp / Albertsons Companies Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Amgen Inc / Universal Health Services Inc / Danaher Corp / Borgwarner Inc / Lear Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Enbridge Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / 3M Co / General Mills Inc / Emerson Electric Co / Hershey Co / Edgewell Personal Care Co / American Tower Corp / Nike Inc / CyrusOne Inc / Metro Inc / W W Grainger Inc / Verizon Communications Inc / Johnson Controls International PLC / Arena Pharmaceuticals Inc / Constellation Brands Inc / VF Corp / Amphenol Corp / TJX Companies Inc / Autozone Inc / Carmax Inc / Fiserv Inc / Visa Inc / Camden Property Trust / Ross Stores Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Dollar General Corp / Church & Dwight Co Inc / Essex Property Trust Inc / Northwest Natural Holding Co / AMETEK Inc / Abercrombie & Fitch Co / Brunswick Corp / Genuine Parts Co / PVH Corp / Boston Beer Company Inc / Cognizant Technology Solutions Corp / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / Finning International Inc / Mohawk Industries Inc / SM Energy Co / NCR Corp / TE Connectivity Ltd / Urban Outfitters Inc / SS&C Technologies Holdings Inc / John Wood Group PLC / Tractor Supply Co / Chesapeake Utilities Corp / Chemed Corp / Graco Inc / Pentair PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / DICK'S Sporting Goods Inc / Provident Financial Services Inc / Monster Beverage Corp / ImmunoGen Inc / Caseys General Stores Inc / O'Reilly Automotive Inc / Amedisys Inc / Equinix Inc / Alimentation Couche-Tard Inc / Toromont Industries Ltd / nVent Electric PLC / Digital Realty Trust Inc / LHC Group Inc / Petrofac Ltd / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Mercer International Inc / Carparts.Com Inc / American Eagle Outfitters Inc / 3I Infrastructure PLC / Aon PLC / B&G Foods Inc / Lululemon Athletica Inc / Getlink SE / Ensign Group Inc / Dana Inc / PBF Energy Inc / SolarWinds Corp / Addus Homecare Corp / Spectrum Brands Holdings Inc / Envestnet Inc / Nextera Energy Inc / NEXTDC Ltd / Canfor Pulp Products Inc / Subsea 7 SA / CatchMark Timber Trust Inc / Meritor Inc / Glencore PLC / Interfor Corp / Acadia Healthcare Company Inc / Splunk Inc / Resolute Forest Products Inc / Five Below Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / ServiceNow Inc / Burlington Stores Inc / Bath & Body Works Inc / Park Lawn Corp / Coupa Software Inc / Varonis Systems Inc / Q2 Holdings Inc / Nextera Energy Partners LP / Shell Midstream Partners LP / Aena SME SA / Enviva Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Archrock Inc / Block Inc / Mimecast Ltd / Mesoblast Ltd / Ferrari NV / Swiss Re AG / Fortive Corp / Twilio Inc / Atkore Inc / Trade Desk Inc / Adient PLC / Under Armour Inc / Puma Biotechnology Inc / R1 RCM Inc / Canada Goose Holdings Inc / DXC Technology Co / Vistra Corp / Altice USA Inc / Evoqua Water Technologies Corp / Aptiv PLC / Encompass Health Corp / Gates Industrial Corporation PLC / Brightsphere Investment Group Inc / Smartsheet Inc / Dropbox Inc / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Bausch Health Companies Inc / Focus Financial Partners Inc / Elastic NV / Newell Brands Inc / Avantor Inc / Sunnova Energy International Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Enerpac Tool Group Corp / Pennant Group Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Nikola Corp / Shift4 Payments Inc / Magnite Inc / Aker Solutions ASA / Rackspace Technology Inc / Ibex Ltd / Aker Carbon Capture ASA / Lumen Technologies Inc / Asana Inc / Turquoise Hill Resources Ltd / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Technip Energies NV / Duckhorn Portfolio Inc / Oatly Group AB / EverCommerce Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Luxembourg / Netherlands / Norway / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">FDA Expands Emergency Use Authorization for REGEN-COV to Include Post-COVID Exposure; Raising PT to $741</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: August 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AEE.N / AES.N / AIG.N / APD.N / BDX.N / BR.N / CAH.N / CF.N / CI.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GM.N / LLY.N / MCK.N / PEG.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / TSN.N / SYY.N / IFF.N / VNO.N / EMR.N / VMC.N / WEC.N / XOM.N / RMD.N / BLL.N / PSA.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / MCHP.OQ / O.N / DISH.OQ / ANSS.OQ / TTWO.OQ / EBAY.OQ / ZBRA.OQ / SBAC.OQ / EXPE.OQ / ILMN.OQ / GPN.N / MNST.OQ / MOS.N / VIAC.OQ / FIS.N / TDG.N / PPL.TO / VRSK.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / FANG.OQ / ZTS.N / PRGO.N / CDW.OQ / MAR.OQ / NCLH.N / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / KHC.OQ / WLTW.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / Cardinal Health Inc / CF Industries Holdings Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Public Service Enterprise Group Inc / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / Resmed Inc / Ball Corp / Public Storage / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Take-Two Interactive Software Inc / eBay Inc / Zebra Technologies Corp / SBA Communications Corp / Expedia Group Inc / Illumina Inc / Global Payments Inc / Monster Beverage Corp / Mosaic Co / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Pembina Pipeline Corp / Verisk Analytics Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / Diamondback Energy Inc / Zoetis Inc / Perrigo Company PLC / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Willis Towers Watson PLC / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: DRNA Cleared in AUD; ALNY Collab w/ PeptiDream</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ALNY.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD / Daniil Gataulin, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 79 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMZN.OQ / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / PNC.N / SLB.N / TMO.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / THS.N / KOP.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O / CTVA.N</td><td class="leftalignment">Amazon.com Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / PNC Financial Services Group Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / TreeHouse Foods Inc / Koppers Holdings Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/31/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Weekend Updates: Biotech Galore, Interchangeable Insulin, Week Ahead etc</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US02043Q1076 / US09061G1013 / US75886F1075 / US09609G1004 / US90400D1081 / US4622221004 / US28106W1036 / BMG637AM1024 / US84833T1034 / US6047491013</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Ultragenyx Pharmaceutical Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Myovant Sciences Ltd / Spero Therapeutics Inc / Mirum Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen / Chanie Howard</td></tr>
<tr class="even"><td class="leftalignment">07/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / PRTA.O / AGIO.O / MESO.O / PBYI.OQ</td><td class="leftalignment">Amgen Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Puma Biotechnology Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron climbs 14.5% from 7 week low</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">IN 2 HOURS: Join Our Healthcare Small/Mid Cap 2Q21 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AN=US / HD=US / AVB=US / AMZN=US / T=US / GILD=US / AMT=US / PEB=US / BC=US / CONE=US / V=US / LOW=US / SWN=US / BYD=US / SPOT=US / EXPE=US / ADS=US / TNL=US / ESS=US / MGM=US / HLT=US / AFL=US / HUM=US / CMCSA=US / BKI=US / EQR=US / MLM=US / DV=US / AIZ=US / CHH=US / CYH=US / CNX=US / EQT=US / EXPO=US / FCN=US / AJG=US / LH=US / TREE=US / MAS=US / MHK=US / MCRI=US / TEAM=US / NTST=US / REGN=US / TRIP=US / VSEC=US / VRTX=US / WEX=US / CGEN=US / PYPL=US / BKNG=US / CFR=US / FMBI=US / AVTR=US / CPT=US / OFC=US / CUZ=US / KIM=US / MAA=US / WRE=US / SBSI=US / NLS=US / ENSG=US / AMSF=US / VICI=US / RRR=US / IGMS=US / MMP=US / PRG=US / MOH=US / TPX=US / CZR=US / TXRH=US / HURN=US / DLR=US / XM=US / MPW=US / KBR=US / MA=US / SAIA=US / PAG=US / EHTH=US / WH=US / NXGN=US / IAC=US / RCUS=US / KNSL=US / AR=US / HGV=US / CUBE=US / ANGI=US / TMUS=US / VCYT=US / CMPR=US / ARGX=US / NVCR=US / WLTW=US / CRSP=US / TRVG=US / PK=US / CVNA=US / CARG=US / KDP=US / FTDR=US / SITC=US / ONEW=US / ABNB=US</td><td class="leftalignment">AutoNation Inc / Home Depot Inc / Avalonbay Communities Inc / Amazon.com Inc / AT&T Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / CyrusOne Inc / Visa Inc / Lowe's Companies Inc / Southwestern Energy Co / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / Alliance Data Systems Corp / Travel + Leisure Co / Essex Property Trust Inc / MGM Resorts International / Hilton Worldwide Holdings Inc / Aflac Inc / Humana Inc / Comcast Corp / Black Knight Inc / Equity Residential / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Assurant Inc / Choice Hotels International Inc / Community Health Systems Inc / CNX Resources Corp / EQT Corp / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Laboratory Corporation of America Holdings / Lendingtree Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Atlassian Corporation PLC / Netstreit Corp / Regeneron Pharmaceuticals Inc / Tripadvisor Inc / VSE Corp / Vertex Pharmaceuticals Inc / WEX Inc / Compugen Ltd / PayPal Holdings Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Avantor Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Kimco Realty Corp / Mid-America Apartment Communities Inc / Washington Real Estate Investment Trust / Southside Bancshares Inc / Nautilus Inc / Ensign Group Inc / Amerisafe Inc / VICI Properties Inc / Red Rock Resorts Inc / IGM Biosciences Inc / Magellan Midstream Partners LP / PROG Holdings Inc / Molina Healthcare Inc / Tempur Sealy International Inc / Caesars Entertainment Inc / Texas Roadhouse Inc / Huron Consulting Group Inc / Digital Realty Trust Inc / Qualtrics International Inc / Medical Properties Trust Inc / KBR Inc / Mastercard Inc / Saia Inc / Penske Automotive Group Inc / eHealth Inc / Wyndham Hotels & Resorts Inc / NextGen Healthcare Inc / IAC/Interactivecorp / Arcus Biosciences Inc / Kinsale Capital Group Inc / Antero Resources Corp / Hilton Grand Vacations Inc / CubeSmart / Angi Inc / T-Mobile US Inc / Veracyte Inc / Cimpress PLC / argenx SE / Novocure Ltd / Willis Towers Watson PLC / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Carvana Co / CarGurus Inc / Keurig Dr Pepper Inc / Frontdoor Inc / Site Centers Corp / OneWater Marine Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">V / 5671735 / 0989529 / 2000019 / 2778844 / 2045623 / 2219224 / 2216850 / 2270726 / 2829515 / 2567116 / 2670519 / 2328915 / 2100920 / 2369174 / 2689560 / 2730190 / 2829601 / 2098876 / 2931034 / 2503529 / 5531000 / 7123870 / 2971029 / B121557 / B067BM3 / B1Y9TB3 / 2216991 / B3P93Y7 / B5B2106 / B6197Q2 / B03PGL4 / B0796X4 / B65LWX6 / B4N0JJ6 / B7TL820 / BCBVTX1 / BFDV8K0 / B95N910 / BFLR866 / BYW36M8 / BD3W133 / BXDZ9Z0 / BJLT387 / BDHF4K6 / BNFWR44 / BJ2Z0H2 / BFZ1K46 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYYWPW6 / BWY52P3 / BYNQ369 / BMH0MR7 / BDVLM39 / BFY7DC4 / BJ9N563 / BMBP1Q0 / BJLV8T9</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Amazon.com Inc / Merck & Co Inc / ANSYS Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Edison International / Edwards Lifesciences Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / PG&E Corp / Regeneron Pharmaceuticals Inc / Southern Co / Yum! Brands Inc / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / MorphoSys AG / Nestle SA / LKQ Corp / Mastercard Inc / Molson Coors Beverage Co / Danone SA / Tempur Sealy International Inc / Anheuser Busch Inbev SA / Fortinet Inc / Generac Holdings Inc / NorthWestern Corp / Dexcom Inc / O'Reilly Automotive Inc / Visteon Corp / Meta Platforms Inc / Agios Pharmaceuticals Inc / MacroGenics Inc / PTC Inc / Twitter Inc / PayPal Holdings Inc / Keurig Dr Pepper Inc / Shopify Inc / Avantor Inc / CRISPR Therapeutics AG / Worldline SA / Pinterest Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Beigene Ltd / Blueprint Medicines Corp / Albertsons Companies Inc / Zendesk Inc / argenx SE / Altimmune Inc / Sunnova Energy International Inc / Flywire Corp / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AIG.N / APD.N / BDX.N / BR.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MRK.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / CAT.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / MNST.OQ / CMCSA.OQ / MOS.N / VIAC.OQ / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / KHC.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Broadridge Financial Solutions Inc / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 2Q21 Results Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">SASY.PA / AZN.L / ROG.S / NOVOB.CO / NOVN.S / GSK.L / REGN.OQ / BAYGN.DE</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Trend is Your Friend – Fifth Straight Week of Biotech Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Dupixent Shows Comparable Responses in CSU to Xolair; Limited Readthrough to CLDX as the Bar in CSU Stays the Same</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">REGN Reports Positive Ph3 Results for Dupixent for Chronic Spontanous Urticaria; Reiterate Buy and Raising PT to $729.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Color from SNY EPS call - bullish on Dupi; positive Phase 3 CSU data could add ~$25/sh</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ABEO, CLDX, EVLO, PHGE - Broad Dermatology Breakfast Discussion | 7/30 @ 8-9:30am ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US00289Y1073 / US15117B2025 / US0311621009 / US45337C1027 / US75886F1075 / ABEO.OQ / US0400476075 / US75382E1091</td><td class="leftalignment">Abeona Therapeutics Inc / Celldex Therapeutics Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Sanofi Read-Through: Big Q221 Dupixent Beat</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Dupixent's positive ph3 CSU readout adds clinical excitement to Dupi's strong Q2 commercial beats</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O / 80105N105</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Readthrough from Sanofi 2Q21 Results; Dupixent Continues to Beat High Expectations</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190 / SASY.PA / 5671735</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sanofi SA / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Dupi Sales Solidly Beat; Kevzara Light; Dupi Checks All The Boxes In CSU Ph3</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US75886F1075 / US80105N1054</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / V / 0989529 / 2126335 / 2550707 / 2437071 / 2280220 / 2270726 / 2542049 / 2829515 / 2328915 / 2342034 / 2369174 / 2600088 / 2689560 / 2684703 / 2730190 / 2829601 / 2943523 / 2931034 / 2769796 / B28TS42 / B5B2106 / B03PGL4 / B65LWX6 / B7TL820 / B95N910 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BNFWR44 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BFXC911 / BYY88Y7 / BKS3RS7 / BMG75B4 / BMDCDP2 / BZ4CHH2 / BMZ9Z11</td><td class="leftalignment">American Express Co / Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / McDonald's Corp / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / Monro Inc / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Southern Co / Penske Automotive Group Inc / Vertex Pharmaceuticals Inc / Fidelity National Information Services Inc / Ulta Beauty Inc / Fortinet Inc / NorthWestern Corp / O'Reilly Automotive Inc / Meta Platforms Inc / PTC Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / Block Inc / Worldline SA / Spotify Technology SA / Fox Corp / Spire Inc / Guardant Health Inc / Alphabet Inc / 10X Genomics Inc / Inventiva SA / Bigcommerce Holdings Inc / Soleno Therapeutics Inc / Prometheus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Disrupting Drug Delivery to the Eye; Initiating at Buy and $10 PT</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">CLSD.OQ / REGN.OQ / BIIB / 00771V108 / 67576A100 / 483119103 / 19249H103 / 98419J206 / 67577C105 / 69012T107</td><td class="leftalignment">Clearside Biomedical Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Aerie Pharmaceuticals Inc / Ocular Therapeutix Inc / Kala Pharmaceuticals Inc / Coherus BioSciences Inc / XOMA Corp / Ocugen Inc / Outlook Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Yi Chen, Ph.D. CFA / Raghuram Selvaraju, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CAS.TO / CB.N / CCO.TO / CL.N / F.N / IP.N / NSC.N / PB.N / PFE.N / RYN.N / EQR.N / WY.N / HUM.N / CFP.TO / LPX.N / AGI.N / IEX.N / DT.N / DBKGn.DE / MCD.N / AEM.N / KGC.N / GIBa.TO / CONE.O / OLN.N / CYH.N / CINF.O / APH.N / EPD.N / CTSH.O / BMRN.O / REGN.O / PFG.N / TEL.N / SSNC.O / MEOH.O / CHE.N / PEGA.OQ / SIGI.O / ACGL.O / TCW.TO / FM.TO / 878742204 / DRX.L / ISBC.O / TEVA.N / OC.N / 550372106 / ATL.MI / ENSG.O / CLW.N / 80105N105 / ADN.TO / NXT.AX / PCH.O / SUBC.OL / CTT.N / IFP.TO / FBHS.N / RFP.N / NYCB.N / UKWG.L / 81762P102 / CEQP.N / CFF.TO / PTC.O / CFG.N / SHOP.N / PYPL.OQ / WRK.N / ZG.O / GDS.O / ATUS.N / RDFN.O / KL.N / EHC.N / GSHD.O / OVV.N / PTVE.O / WFG.N / WING.N / MTCH,OQ</td><td class="leftalignment">Cascades Inc / Chubb Ltd / Cameco Corp / Colgate-Palmolive Co / Ford Motor Co / International Paper Co / Norfolk Southern Corp / Prosperity Bancshares Inc / Pfizer Inc / Rayonier Inc / Equity Residential / Weyerhaeuser Co / Humana Inc / Canfor Corp / Louisiana-Pacific Corp / Alamos Gold Inc / IDEX Corp / Dynatrace Inc / Deutsche Bank AG / McDonald's Corp / Agnico Eagle Mines Ltd / Kinross Gold Corp / CGI Inc / CyrusOne Inc / Olin Corp / Community Health Systems Inc / Cincinnati Financial Corp / Amphenol Corp / Enterprise Products Partners LP / Cognizant Technology Solutions Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Principal Financial Group Inc / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Methanex Corp / Chemed Corp / Pegasystems Inc / Selective Insurance Group Inc / Arch Capital Group Ltd / Trican Well Service Ltd / First Quantum Minerals Ltd / Teck Resources Ltd / Drax Group PLC / Investors Bancorp Inc / Teva Pharmaceutical Industries Ltd / Owens Corning / Lundin Mining Corp / Atlantia SpA / Ensign Group Inc / Clearwater Paper Corp / Sanofi SA / Acadian Timber Corp / NEXTDC Ltd / Potlatchdeltic Corp / Subsea 7 SA / CatchMark Timber Trust Inc / Interfor Corp / Fortune Brands Home & Security Inc / Resolute Forest Products Inc / New York Community Bancorp Inc / Greencoat UK Wind PLC / ServiceNow Inc / Crestwood Equity Partners LP / Conifex Timber Inc / PTC Inc / Citizens Financial Group Inc / Shopify Inc / PayPal Holdings Inc / Westrock Co / Zillow Group Inc / GDS Holdings Ltd / Altice USA Inc / Redfin Corp / Kirkland Lake Gold Ltd / Encompass Health Corp / Goosehead Insurance Inc / Ovintiv Inc / Pactiv Evergreen Inc / West Fraser Timber Co Ltd / Wingstop Inc / Match Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Israel / Italy / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / PFE.N / SO.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / KLAC.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Pfizer Inc / Southern Co / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / KLA Corp / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 2Q21 - Initial Diagnosis</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">SASY.PA / REGN.OQ</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">OPK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPK.O / ABT / BMY / JNJ / LH / REGN.O / ALNY.O / ARDX.O / TEVA.K</td><td class="leftalignment">OPKO Health Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ardelyx Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Double the Good News; Positive Regulatory Updates From Two Partners</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">98419J206 / REGN.OQ / RZLT.OQ / VIRX.OQ</td><td class="leftalignment">XOMA Corp / Regeneron Pharmaceuticals Inc / Rezolute Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Small/Mid Cap 2Q Preview Call on 7/30 @ 10 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - New Partnership With AZN to Develop Small Molecule Therapies Targeting "Genetic Superpower" Associated With Protection From Obesity</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / STE.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / MCD.N / TSN.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / AON.N / ES.N / CME.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / STERIS plc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / CME Group Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Breakfast to Discuss Topics in Dermatology on Friday, July 30, at 8:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS / JNJ / LLY / US0311621009 / US45337C1027 / US75886F1075 / US00289Y1073 / US0400476075 / US15117B2025 / US75382E1091 / ARQT / VYNE</td><td class="leftalignment">Aclaris Therapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc / Arcutis Biotherapeutics Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.O / BIIB.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Regeneron and AstraZeneca Bet Big on Obesity and Forge a New Deal to Commercialize Novel Drugs for Novel Targets</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GE.N / GM.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / MCD.N / TSN.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / BLL.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Ball Corp / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 2Q21 Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">SASY.PA / ROG.S / REGN.OQ</td><td class="leftalignment">Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 16: Focus on Almirall's US TRx trends</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ALM.MC / 4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Almirall SA / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US3741631036 / US45337C1027 / US64125C1099 / US75886F1075 / US0042251084 / US40637H1095 / US23282W6057 / US1407551092 / US46116X1019 / CA31447P1009 / US00289Y1073 / US05464T1043 / US0327973006 / US75615P1030 / US0400476075 / US24823R1059 / US22663K1079 / US15117B2025 / US85789A1051 / US6700024010 / US75382E1091</td><td class="leftalignment">Amgen Inc / Geron Corp / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Cytokinetics Inc / Cara Therapeutics Inc / Intra-Cellular Therapies Inc / Fennec Pharmaceuticals Inc / Abeona Therapeutics Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Reata Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Denali Therapeutics Inc / Crinetics Pharmaceuticals Inc / Celldex Therapeutics Inc / Stealth BioTherapeutics Corp / Novavax Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Friday 7/30: Join Our Broad Dermatology In-Person Breakfast</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US0400476075 / US45337C1027 / US75886F1075 / US00289Y1073 / US15117B2025 / US75382E1091</td><td class="leftalignment">Amgen Inc / Arena Pharmaceuticals Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AXP.N / BAC.N / BK.N / BOX.N / C.N / CAS.TO / CCI.N / CL.N / CNA.L / COF.N / DFDS.CO / EIX.N / EL.N / F.N / FITB.O / GM.N / IP.N / JPM.N / KEY.N / KMB.N / KO.N / MO.N / NA / NEM.N / NTRS.O / PEG.N / PNC.N / RYN.N / SO.N / T.N / USB.N / WFC.N / SSE.L / PEP.N / BFb.N / PG.N / CFP.TO / GILD.O / FNV.N / CPB.N / CMCSA.O / CHKP.O / INCY.O / FER.MC / DIS.N / ROP.N / K.N / DT.N / DISH.O / GS.N / CLX.N / MCD.N / CAG.N / YUM.N / HON.N / DV.N / GIS.N / HSY.N / EPC.N / VZ.N / STT.N / SBUX.O / XEL.N / STZ.N / FISV.O / V.N / CHTR.O / NBIX.O / CHD.N / NWN.N / MTB.N / SAM.N / BMRN.O / REGN.O / ENR.N / NCR.N / RF.N / CPK.N / HL.N / TYL.N / NRZ.N / GPN.N / MNST.O / FFBC.O / RGLD.O / PCTY.O / BIIB.O / TFC.N / DPM.TO / DPZ.N / DLR.N / TXRH.O / VIAC.O / IAG.N / WEF.TO / DISCA.O / SJW.N / MS.N / CMG.N / FIS.N / MA.N / MERC.O / BGS.N / GETP.PA / CLW.N / FICO.N / EGO.N / SPB.N / NEE.N / TWO.N / MDLZ.OQ / ALLY.N / KPT.TO / PRMW.N / TMUS.N / COTY.N / FOXA.OQ / PTCT.O / BEP.N / 81762P102 / PTC.O / ITCI.O / 922475108 / PAYC.N / NEP.N / CFG.N / QSR.N / CRBP.OQ / GLPG.O / PYPL.OQ / GDS.O / LGFB.N / VST.N / WPM.N / WOW.N / ATUS.N / ORSTED.CO / COLD.N / VNE.N / KDP.N / NWL.O / KRTX.OQ / GMAB.O / NLOK.O / WTRG.N / REYN.O / FOUR.N / RXT.OQ / LUMN.N / LSPD.N / WFG.N / NAPA.N / WING.N / DBM.TO / OTLY.O / XMTR.OQ / 9VC.F / EVCM.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Box Inc / Citigroup Inc / Cascades Inc / Crown Castle International Corp / Colgate-Palmolive Co / Centrica PLC / Capital One Financial Corp / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fifth Third Bancorp / General Motors Co / International Paper Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / National Bank of Canada / Newmont Corporation / Northern Trust Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Rayonier Inc / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Incyte Corp / Ferrovial SA / Walt Disney Co / Roper Technologies Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Conagra Brands Inc / Yum! Brands Inc / Honeywell International Inc / DoubleVerify Holdings Inc / General Mills Inc / Hershey Co / Edgewell Personal Care Co / Verizon Communications Inc / State Street Corp / Starbucks Corp / Xcel Energy Inc / Constellation Brands Inc / Fiserv Inc / Visa Inc / Charter Communications Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / Regions Financial Corp / Chesapeake Utilities Corp / Hecla Mining Co / Tyler Technologies Inc / New Residential Investment Corp / Global Payments Inc / Monster Beverage Corp / First Financial Bancorp / Royal Gold Inc / Paylocity Holding Corp / Biogen Inc / Truist Financial Corp / Dundee Precious Metals Inc / Domino's Pizza Inc / Digital Realty Trust Inc / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Western Forest Products Inc / Discovery Inc / SJW Group / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Mastercard Inc / Mercer International Inc / B&G Foods Inc / Getlink SE / Clearwater Paper Corp / Fair Isaac Corp / Eldorado Gold Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Two Harbors Investment Corp / Mondelez International Inc / Ally Financial Inc / KP Tissue Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Fox Corp / PTC Therapeutics Inc / Brookfield Renewable Partners LP / ServiceNow Inc / PTC Inc / Intra-Cellular Therapies Inc / Veeva Systems Inc / Paycom Software Inc / Nextera Energy Partners LP / Citizens Financial Group Inc / Restaurant Brands International Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / GDS Holdings Ltd / Lions Gate Entertainment Corp / Vistra Corp / Wheaton Precious Metals Corp / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Americold Realty Trust / Veoneer Inc / Keurig Dr Pepper Inc / Newell Brands Inc / Karuna Therapeutics Inc / Genmab A/S / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Duckhorn Portfolio Inc / Wingstop Inc / Doman Building Materials Group Ltd / Oatly Group AB / Xometry Inc / ATAI Life Sciences NV / EverCommerce Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / Spain / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AES.N / AIG.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CB.N / CI.N / CL.N / CNC.N / CVS.N / DD.N / ECL.N / ED.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / OXY.N / PEG.N / PFE.N / SO.N / TEL.PS / TMO.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / K.N / CAT.N / MCD.N / IFF.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / CHD.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / CNP.N / HAYS.L / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / ZBRA.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / NOW.N / FANG.OQ / ABBV.N / ZTS.N / CDW.OQ / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / IQV.N / APTV.N / XEL.OQ / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Consolidated Edison Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Pfizer Inc / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Kellogg Co / Caterpillar Inc / McDonald's Corp / International Flavors & Fragrances Inc / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Church & Dwight Co Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / CenterPoint Energy Inc / Hays PLC / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Zebra Technologies Corp / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / IQVIA Holdings Inc / Aptiv PLC / Xcel Energy Inc / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: ADVM abandons DME; (+) EMA opinion for MRNA</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADVM.OQ / MRNA.OQ / EBS / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Adverum Biotechnologies Inc / Moderna Inc / Emergent BioSolutions Inc / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/24/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2Q Earnings Underway, Gene Therapy Troubles, DNLI Data Tomorrow, etc</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US09061G1013 / US45337C1027 / US75886F1075 / US92532F1003 / US88322Q1085 / US4277461020 / US90400D1081 / US37890U1088 / US4622221004 / US6047491013 / US35104E1001</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / TG Therapeutics Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / 4D Molecular Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen / Chanie Howard</td></tr>
<tr class="even"><td class="leftalignment">07/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMRN.O / REGN.O / GMAB.O</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Breakfast to Discuss Topics in Dermatology on Friday, July 30, at 8:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / JNJ / LLY / ACRS / US0311621009 / US45337C1027 / US75886F1075 / US00289Y1073 / US0400476075 / US15117B2025 / US75382E1091 / VYNE</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Eli Lilly and Co / Aclaris Therapeutics Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ABEO, CLDX, EVLO, PHGE - Broad Dermatology Breakfast Discussion | 7/30 @ 8-9:30am ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US00289Y1073 / US15117B2025 / US0311621009 / US45337C1027 / US75886F1075 / ABEO.OQ / US0400476075 / US75382E1091</td><td class="leftalignment">Abeona Therapeutics Inc / Celldex Therapeutics Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for REGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What’s Next in Biotech? Proving Your METTL in AML</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 2730190 / BGCYWN8</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">ADVM (Neutral): Safety Signals End ADVM-022 Path in DME, PT to $3</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">00773U108 / 66987V10 / 75886F107 / 75901B107 / 50015M109</td><td class="leftalignment">Adverum Biotechnologies Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Regenxbio Inc / Kodiak Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Matthew Barcus, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BB.N / COF.N / FITB.O / IP.N / MMC.N / PD.TO / RWEG.DE / SGEF.PA / T.N / CFP.TO / LPX.N / FN.TO / POW.TO / CHKP.O / AMGN.O / THC.N / FER.MC / CLS.N / DHR.N / DT.N / DISH.O / UNP.N / DV.N / MRO.N / WHR.N / JAZZ.O / GIBa.TO / VLY.N / EXEL.O / DHI.N / DSGX.O / RRC.N / FDS.N / EFX.N / EQT.N / CHTR.O / DNB.N / OTEX.O / BMRN.O / STL.N / REGN.O / SWIR.O / JHX.AX / AIF.TO / MCO.N / CIX.TO / GGG.N / RLI.N / SWN.N / WBS.N / DFS.N / TRU.N / SGEN.OQ / X.TO / SIVB.O / BPOP.O / BIIB.O / HCG.TO / DPZ.N / IGM.TO / WEF.TO / DISCA.O / BAM.N / 35671D857 / CSU.TO / MERC.O / EXPN.L / CLR.N / CBRO.L / WRB.N / SII.TO / MSCI.N / IFC.TO / FICO.N / VRSK.O / FSZ.TO / CHW.TO / NLSN.N / IFP.TO / MTDR.N / SLM.OQ / EFN.TO / RFP.N / ADT.N / FANG.O / TPH.N / TMUS.N / PTCT.O / ISV.TO / EQB.TO / KXS.TO / ASB.N / SHOP.N / OMF.N / UBSG.S / MTRO.L / SPGI.N / ADVM.OQ / BBU.N / ECN.TO / ENGH.TO / ONEX.TO / CADE.N / FOOD.TO / APTV.N / 05971J102 / VNE.N / GMAB.O / 260557103 / PAGPA.L / AD_u.TO / NVEIu.TO / LSPD.N / WFG.N / TIXT.TO / MAGT.TO / DBM.TO</td><td class="leftalignment">BlackBerry Ltd / Capital One Financial Corp / Fifth Third Bancorp / International Paper Co / Marsh & McLennan Companies Inc / Precision Drilling Corp / Rwe AG / Vinci SA / AT&T Inc / Canfor Corp / Louisiana-Pacific Corp / First National Financial Corp / Power Corporation of Canada / Check Point Software Technologies Ltd / Amgen Inc / Tenet Healthcare Corp / Ferrovial SA / Celestica Inc / Danaher Corp / Dynatrace Inc / DISH Network Corp / Union Pacific Corp / DoubleVerify Holdings Inc / Marathon Oil Corp / Whirlpool Corp / Jazz Pharmaceuticals PLC / CGI Inc / Valley National Bancorp / Exelixis Inc / D R Horton Inc / Descartes Systems Group Inc / Range Resources Corp / Factset Research Systems Inc / Equifax Inc / EQT Corp / Charter Communications Inc / Dun & Bradstreet Holdings Inc / Open Text Corp / Biomarin Pharmaceutical Inc / Sterling Bancorp / Regeneron Pharmaceuticals Inc / Sierra Wireless Inc / James Hardie Industries PLC / Altus Group Ltd / Moody's Corp / CI Financial Corp / Graco Inc / Rli Corp / Southwestern Energy Co / Webster Financial Corp / Discover Financial Services / TransUnion / Seagen Inc / TMX Group Ltd / SVB Financial Group / Popular Inc / Biogen Inc / Home Capital Group Inc / Domino's Pizza Inc / IGM Financial Inc / Western Forest Products Inc / Discovery Inc / Brookfield Asset Management Inc / Freeport-McMoRan Inc / Constellation Software Inc / Mercer International Inc / Experian PLC / Continental Resources Inc / Close Brothers Group PLC / W R Berkley Corp / Sprott Inc / MSCI Inc / Intact Financial Corp / Fair Isaac Corp / Verisk Analytics Inc / Fiera Capital Corp / Chesswood Group Ltd / Nielsen Holdings PLC / Interfor Corp / Matador Resources Co / SLM Corp / Element Fleet Management Corp / Resolute Forest Products Inc / ADT Inc / Diamondback Energy Inc / Tri Pointe Homes Inc (Delaware) / T-Mobile US Inc / PTC Therapeutics Inc / Information Services Corp / Equitable Group Inc / Kinaxis Inc / Associated Banc-Corp / Shopify Inc / OneMain Holdings Inc / UBS Group AG / Metro Bank PLC / S&P Global Inc / Adverum Biotechnologies Inc / Brookfield Business Partners LP / ECN Capital Corp / Enghouse Systems Ltd / Onex Corp / Cadence Bank / Goodfood Market Corp / Aptiv PLC / Cadence Bank / Veoneer Inc / Genmab A/S / Dow Inc / Paragon Banking Group PLC / Alaris Equity Partners Income Trust / Nuvei Corp / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Magnet Forensics Inc / Doman Building Materials Group Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Puerto Rico / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Increase PT to $679/sh as we add potential from REGN3500 in COPD & NTLA-2001 to our model</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">REGEN-COV Can Neutralize the Delta Variant of COVID-19, Which is Rapidly Becoming the Dominant COVID-19 Strain Globally.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ / 09075V102</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Biotech Q2:21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Jackie Yan</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AEE.N / AES.N / AIG.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CVS.N / DD.N / EOG.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / EOG Resources Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">INFINITY Saga—Half of Pipeline Snaps Out of Existence. PT to $2</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">00773U10 / 75886F10</td><td class="leftalignment">Adverum Biotechnologies Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Geoffrey Porges, MBBS / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Mo’ Money, Mo’ Problems? Big Time Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">FR0000054470 / 64110L106 / 75886F107 / 136375102 / 000361105 / 29667K306 / 233278100</td><td class="leftalignment">Ubisoft Entertainment SA / Netflix Inc / Regeneron Pharmaceuticals Inc / Canadian National Railway Co / AAR Corp / Esports Entertainment Group Inc / IONQ Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Matthew Harrigan / Mr. Nathan Martin / Mr. Aydin Huseynov, MD / Mike Hickey / Mr. Mark W. Schappel / Mr. Josh W. Sullivan</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">REGEN-COV May Reach Unexpectedly High Sales If It Captures A Small Portion Of The Prevention Market</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">FR0000054470 / US09061G1013 / US8816242098 / US00971T1016 / US02553E1064 / US0311621009 / US0366421065 / US09058V1035 / US30161Q1040 / US3755581036 / US4062161017 / US45337C1027 / US64125C1099 / US66987V1098 / US75886F1075 / US8305661055 / US91307C1027 / US92532F1003 / CA1363751027 / US64110L1061 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US1696561059 / US29089Q1058 / US2521311074 / US45784P1012 / US53261M1045 / US03152W1099 / US0231112063 / US7181721090 / US46333X1081 / US9100471096 / US4464131063 / NL0010273215 / US5017971046 / US8036071004 / US4576693075 / US88338N1072 / IE00B4Q5ZN47 / US6951271005 / US74587V1070 / US8684591089 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US00771V1089 / US4277461020 / US5034596040 / US90400D1081 / US7613301099 / IE00BJ3V9050 / KYG8807B1068 / US78667J1088 / IE00BQPVQZ61 / US19249H1032 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / US87184Q1076 / US36165L1089 / NL0012169213 / IL0011407140 / VGG111961055 / US04016X1019 / US87105L1044 / US8753722037 / US76243J1051 / US68404V1008 / US05455M1009 / CA0717341071 / KY30744W1070 / US8740602052 / US61775R1059 / US85205L1070 / US65487U1088 / US69353Y1038 / US81181C1045 / US55406W1036 / US92941V2097 / US25401T1088 / US35909D1090</td><td class="leftalignment">Ubisoft Entertainment SA / Biomarin Pharmaceutical Inc / Teva Pharmaceutical Industries Ltd / Akamai Technologies Inc / American Eagle Outfitters Inc / Amgen Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Skechers USA Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Chipotle Mexican Grill Inc / Emergent BioSolutions Inc / Dexcom Inc / Insulet Corp / Limelight Networks Inc / Amicus Therapeutics Inc / Amarin Corporation PLC / Philip Morris International Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Huntington Ingalls Industries Inc / ASML Holding NV / Bath & Body Works Inc / Sarepta Therapeutics Inc / Insmed Inc / TherapeuticsMD Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Puma Biotechnology Inc / Supernus Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Revance Therapeutics Inc / Endo International PLC / Theravance Biopharma Inc / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Coherus BioSciences Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Syros Pharmaceuticals Inc / GDS Holdings Ltd / Qiagen NV / Urogen Pharma Ltd / Biohaven Pharmaceutical Holding Company Ltd / argenx SE / Switch Inc / Tandem Diabetes Care Inc / Rhythm Pharmaceuticals Inc / OptiNose Inc / AVROBIO Inc / Bausch Health Companies Inc / Farfetch Ltd / Takeda Pharmaceutical Co Ltd / Morphic Holding Inc / SpringWorks Therapeutics Inc / Nkarta Inc / PMV Pharmaceuticals Inc / Seagen Inc / MYT Netherlands Parent BV / Vyne Therapeutics Inc / DigitalBridge Group Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Japan / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Earnings Preview: Hoping That Solid Financials Are What The Doctor Ordered</td><td class="leftalignment">English</td><td class="rightalignment">238</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">2Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Japan first to approve REGEN-COV antibody cocktail; awaiting FDA decision</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">EDP.LS / EOG.N / NA / OXB.L / RIO.L / SGEF.PA / ZION.O / GILD.O / AMGN.O / INCY.O / UNH.N / EVTG.DE / SGMO.O / VZ.N / EXEL.O / ARNA.O / AMP.N / DPH.L / NBIX.O / WSP.TO / BMRN.O / REGN.O / ABC.N / VRTX.O / ENAG.MC / BLU.N / HCC.N / AMH.N / SGEN.OQ / IMGN.O / HOOK.O / BLUE.O / BCRX.O / ICPT.O / STN.TO / BIIB.O / IGO.AX / FMG.AX / SNC.TO / FM.TO / 878742204 / SPI.L / ACAD.O / ALNY.O / 35671D857 / ARWR.O / CS.TO / 443628102 / AUY.N / 550372106 / IVZ.N / CVSG.L / INO.OQ / OZL.AX / TCN.TO / SLS.TO / FHI.N / SRPT.O / CLINC.L / 505440107 / APAM.N / ENTA.O / PTCT.O / PRTA.O / AGIO.O / 46579R104 / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / CIA.TO / ARES.N / SAGE.OQ / MOLN.S / 03835T200 / AENA.MC / CRBP.OQ / GLPG.O / GBT.OQ / RPD.O / RGNX.O / WVE.OQ / MESO.O / RMR.OQ / IONS.O / EDIT.O / ADVM.OQ / NTLA.O / CRSP.OQ / CTEC.L / PBYI.OQ / INVH.N / OVID.O / ATNX.O / VCTR.N / BSIG.N / ITRM.O / PRVB.O / MGTX.O / GMDA.OQ / HNSA.ST / NBSE.OQ / ZM.O / FIXX.O / KRTX.OQ / MORF.OQ / NOVA.N / GMAB.O / APRE.OQ / IGMS.O / ETNB.O / BEAM.O / APA.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GATO.N / GDRX.O / ALOO.O / 900435207 / NUVB.N / BHG.N / 9VC.F</td><td class="leftalignment">EDP Energias de Portugal SA / EOG Resources Inc / National Bank of Canada / Oxford BioMedica PLC / Rio Tinto PLC / Vinci SA / Zions Bancorporation NA / Gilead Sciences Inc / Amgen Inc / Incyte Corp / UnitedHealth Group Inc / Evotec SE / Sangamo Therapeutics Inc / Verizon Communications Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Dechra Pharmaceuticals PLC / Neurocrine Biosciences Inc / WSP Global Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amerisourcebergen Corp / Vertex Pharmaceuticals Inc / Enagas SA / BELLUS Health Inc / Warrior Met Coal Inc / American Homes 4 Rent / Seagen Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Stantec Inc / Biogen Inc / IGO Ltd / Fortescue Metals Group Ltd / SNC-Lavalin Group Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Spire Healthcare Group PLC / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Hudbay Minerals Inc / Yamana Gold Inc / Lundin Mining Corp / Invesco Ltd / CVS Group PLC / Inovio Pharmaceuticals Inc / OZ Minerals Ltd / Tricon Residential Inc / Solaris Resources Inc / Federated Hermes Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Labrador Iron Ore Royalty Corp / Artisan Partners Asset Management Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Ivanhoe Mines Ltd / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Champion Iron Ltd / Ares Management Corp / SAGE Therapeutics Inc / Molecular Partners AG / Aptose Biosciences Inc / Aena SME SA / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Rapid7 Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / RMR Group Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ConvaTec Group PLC / Puma Biotechnology Inc / Invitation Homes Inc / Ovid Therapeutics Inc / Athenex Inc / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Iterum Therapeutics PLC / Provention Bio Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Hansa Biopharma AB / NeuBase Therapeutics Inc / Zoom Video Communications Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Sunnova Energy International Inc / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Beam Therapeutics Inc / APA Corp (US) / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Gatos Silver Inc / Goodrx Holdings Inc / Allogene Therapeutics Inc / Turquoise Hill Resources Ltd / Nuvation Bio Inc / Bright Health Group Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / Portugal / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Biotech Halftime Report: Negativity May Create Long-Term Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">105</td><td class="leftalignment">NA / OXB.L / GILD.O / AMGN.O / INCY.O / EVTG.DE / SGMO.O / EXEL.O / ARNA.O / DPH.L / NBIX.O / BMRN.O / REGN.O / ABC.N / VRTX.O / BLU.N / SGEN.OQ / IMGN.O / HOOK.O / BLUE.O / BCRX.O / ICPT.O / BIIB.O / SPI.L / ACAD.O / ALNY.O / ARWR.O / CVSG.L / INO.OQ / SRPT.O / CLINC.L / ENTA.O / PTCT.O / PRTA.O / AGIO.O / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / SAGE.OQ / MOLN.S / 03835T200 / CRBP.OQ / GLPG.O / GBT.OQ / RGNX.O / WVE.OQ / MESO.O / IONS.O / EDIT.O / ADVM.OQ / NTLA.O / CRSP.OQ / CTEC.L / PBYI.OQ / OVID.O / ATNX.O / ITRM.O / PRVB.O / MGTX.O / GMDA.OQ / HNSA.ST / NBSE.OQ / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / IGMS.O / ETNB.O / BEAM.O / NRIX.OQ / SPRB.OQ / MTCR.O / ALOO.O / NUVB.N / 9VC.F</td><td class="leftalignment">National Bank of Canada / Oxford BioMedica PLC / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Evotec SE / Sangamo Therapeutics Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amerisourcebergen Corp / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Seagen Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Spire Healthcare Group PLC / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / CVS Group PLC / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / SAGE Therapeutics Inc / Molecular Partners AG / Aptose Biosciences Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ConvaTec Group PLC / Puma Biotechnology Inc / Ovid Therapeutics Inc / Athenex Inc / Iterum Therapeutics PLC / Provention Bio Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Hansa Biopharma AB / NeuBase Therapeutics Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Beam Therapeutics Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Allogene Therapeutics Inc / Nuvation Bio Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Jack Reynolds-Clark / Yinglu Zhang / Jackie Yan / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Mr. Charles Weston / Stephen Mallon / Leonid Timashev / David Szeto / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 2Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">BioInsights KOL Day: The Past, the Present, and the Future of Viral Vectors</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">09061G101 / 75886F107 / 00973J101 / 83422E105</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Akouos Inc / Solid Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Mr. Swapnil Malekar, Ph.D. / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 09, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2002305 / 2026242 / 2216850 / 2270726 / 2829515 / 2670519 / 2328915 / 2459020 / 2730190 / 2440637 / 2829601 / B067BM3 / 2857817 / B1XGNW4 / B0796X4 / B7TL820 / BTN1Y11 / BS7K7C9 / BYW36M8 / BZBY005 / BJ5FZ74 / BLGJ610 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BF3W461 / BDZ30Q0 / BMPRZV5 / BMC8SQ7 / BP7KZP7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Abbott Laboratories / American Electric Power Company Inc / Consolidated Edison Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / Intuit Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Molson Coors Beverage Co / Netflix Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / Medtronic PLC / Nevro Corp / PayPal Holdings Inc / Merus NV / Adaptive Biotechnologies Corp / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Tandem Diabetes Care Inc / Arvinas Inc / Kymera Therapeutics Inc / BTRS Holdings Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Gene editing tech investments in Prime & Shape</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1266501006 / US1567821046 / US3755581036 / US4448591028 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US15135B1017 / US0367521038 / US1255231003</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Cerner Corp / Gilead Sciences Inc / Humana Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Centene Corp / Anthem Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Small/Mid Cap 2Q Preview Call on 7/30 @ 10 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING IN 1 HOUR (11 AM ET): Cantor Healthcare Large Cap 2Q2021 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma / IQVIA Script Trends for the Week Ended July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US7665596034 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - 1H21 results preview</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ROG.S / REGN.OQ</td><td class="leftalignment">Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Roxa Dinged by AdCom; PT to $63</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">04635310 / 75886F10 / 31572Q80</td><td class="leftalignment">AstraZeneca PLC / Regeneron Pharmaceuticals Inc / FibroGen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2Q21 Large Cap Earnings Preview: We Expect Fewer Surprises and a Recovery in Earnings from COVID</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075 / US0311621009 / US3755581036 / US45337C1027 / US92532F1003 / US09062X1037</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US0400476075 / US03969F1093 / US75382E1091</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Arcus Biosciences Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Don’t Look Now, But Last Week Saw Biggest Biotech Inflows of the Year</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Portfolio Continues to Expand With Checkmate Asset Acquisition</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">98419J206 / REGN.OQ / RZLT.OQ / VIRX.OQ</td><td class="leftalignment">XOMA Corp / Regeneron Pharmaceuticals Inc / Rezolute Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Conference Call to Discuss Current and Developing Treatments in Atopic Dermatitis and Psoriasis TODAY at 12 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0311621009 / US45337C1027 / US75886F1075 / US0400476075 / US75382E1091</td><td class="leftalignment">Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways From Our Therapeutics Panel on Bispecific Antibodies</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRUS / 75886F10 / 478160104 / 98401F10 / GMAB / 41358P10 / FSTX / 09075V10 / K3967W10 / N5749R10</td><td class="leftalignment">Merus NV / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Xencor Inc / Genmab A/S / Harpoon Therapeutics Inc / F-Star Therapeutics Inc / BioNTech SE / Genmab A/S / Merus NV</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United Kingdom / Hong Kong / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA / Andrew Berens, M.D. / Christopher Liu, Pharm.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the Therapeutics Forum Retinal Disease Panel</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">OPT / 71708110 / 75886F10 / 36870G10</td><td class="leftalignment">Opthea Ltd / Pfizer Inc / Regeneron Pharmaceuticals Inc / Gemini Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Marc Goodman / Geoffrey Porges, MBBS / Na Sun / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">7/16 @ 11am ET: Cantor Healthcare Large Cap 2Q21 Preview Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Lung Cancer Survey Takeaways : Perspectives on KRAS G12C Class, TTF and PD1 Market Dynamics</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.O / AMGN.O / NVCR.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Amgen Inc / Novocure Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">2021 Lung Cancer Survey Takeaways : Perspectives on KRAS G12C Class, TTF and PD1 Market Dynamics</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">AMGN.O / NVCR.O / REGN.O</td><td class="leftalignment">Amgen Inc / Novocure Ltd / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NTES.O / 20030N101 / 874054109 / 958102105 / 75886F107 / 30063P105 / 655844108 / 056752108 / 44980X109 / 70959W10 / 12008R107 / 29089Q105 / G5480U120 / 45773H201 / 02156K103 / 76674Q107 / 92556H206 / 34960P10 / 78472F101 / 733245104 / 18563410 / 51476H100 / 51818V106 / 00216W109 / 120438074</td><td class="leftalignment">NetEase Inc / Comcast Corp / Take-Two Interactive Software Inc / Western Digital Corp / Regeneron Pharmaceuticals Inc / Exact Sciences Corp / Norfolk Southern Corp / Baidu Inc / IPG Photonics Corp / Penske Automotive Group Inc / Builders FirstSource Inc / Emergent BioSolutions Inc / Liberty Global PLC / Inovio Pharmaceuticals Inc / Altice USA Inc / Rimini Street Inc / ViacomCBS Inc / Fortress Transportation and Infrastructure Investors LLC / Soc Telemed Inc / Porch Group Inc / Clene Inc. / Hillman Solutions Corp / Latch Inc / ATI Physical Therapy Inc / Holley Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Matthew Harrigan / Mr. Aydin Huseynov, MD / Mr. Mark W. Schappel / Benchmark Research</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Benchmark's Best Ideas for 2H21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NTES.O / 874054109 / 958102105 / 75886F107 / 30063P105 / 655844108 / 056752108 / 44980X109 / 70959W10 / 12008R107 / 29089Q105 / G5480U120 / 02156K103 / 76674Q107 / 92556H206 / 34960P10 / 78472F101 / 733245104 / 18563410 / 51476H100 / 51818V106 / 00216W109 / 120438074</td><td class="leftalignment">NetEase Inc / Take-Two Interactive Software Inc / Western Digital Corp / Regeneron Pharmaceuticals Inc / Exact Sciences Corp / Norfolk Southern Corp / Baidu Inc / IPG Photonics Corp / Penske Automotive Group Inc / Builders FirstSource Inc / Emergent BioSolutions Inc / Liberty Global PLC / Altice USA Inc / Rimini Street Inc / ViacomCBS Inc / Fortress Transportation and Infrastructure Investors LLC / Soc Telemed Inc / Porch Group Inc / Clene Inc. / Hillman Solutions Corp / Latch Inc / ATI Physical Therapy Inc / Holley Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Mark W. Schappel</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: MRNA initiates in influenza; ABUS is greenlit</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ABUS.OQ / MRNA.OQ / EBS / 66987V10 / NVAX.O / G3910J112 / G0593M107 / 92532F100 / F5548N101 / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 46185L103 / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / 05370A108 / IMTX.O / N90064101 / 76029N106 / 83422E105 / 877619106 / 829399104 / N71542109 / 03820J100 / 14888D208 / 75915K200 / 92731L106 / 372446104 / K72807132</td><td class="leftalignment">Arbutus Biopharma Corp / Moderna Inc / Emergent BioSolutions Inc / Novartis AG / Novavax Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Vertex Pharmaceuticals Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Invitae Corp / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Avidity Biosciences Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc / Regulus Therapeutics Inc / Vincerx Pharma Inc / Genprex Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA / Matthew Barcus, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2000019 / 2026242 / 2270726 / 2328915 / 2455965 / 2459202 / 2689560 / 2707677 / 2730190 / 2440637 / 2138158 / 2829601 / 2900335 / 2980906 / 2783815 / B00FWN1 / B121557 / 2857817 / 2983563 / B7TL820 / B7VD3F2 / BYVY8G0 / BYW36M8 / BK7Y2V9 / BD8DJ71 / BLGJ610 / BJJMGL2 / BKTNTR9 / BFWK4R7 / BNKGXX2</td><td class="leftalignment">American Express Co / Amazon.com Inc / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / Biogen Inc / IDEXX Laboratories Inc / PG&E Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / Southern Co / Tractor Supply Co / Foot Locker Inc / Zimmer Biomet Holdings Inc / Alnylam Pharmaceuticals Inc / Mastercard Inc / Netflix Inc / Carmax Inc / Meta Platforms Inc / Duke Energy Corp / Alphabet Inc / PayPal Holdings Inc / Akero Therapeutics Inc / Snap Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / PagSeguro Digital Ltd / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 02, 2021: Focus on Shingrix trends</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare policy: new and updated democrat proposals: Biden drug proposals via EO; Pelosi & Wyden seek legislative approach</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/10/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">More Cancer I/O Noise, Hemophilia A Stumble, ICER's AD Review & More</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075 / US09609G1004 / CA89620X5064 / US04351P1012 / BMG637AM1024 / US38341P1021 / US45781K1051 / US81181C1045 / US92765F1084</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Pfizer Inc / Ascendis Pharma A/S / Myovant Sciences Ltd / Gossamer Bio Inc / Innate Pharma SA / Seagen Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen / Chanie Howard</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Weekend Reading: REGN - RGC Discovers a CNS-Enriched "Genetic Superpower" Target Associated With Protection From Obesity</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What’s Next in Biotech? Close Encounters of the Thermogenic Kind: Autocrine Role of FGF21 in Adipose Tissue</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 2730190 / BGCYWN8</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Big Wheel Keep On Turnin': Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">7/16 @ 11am ET: Cantor Healthcare Large Cap 2Q21 Preview Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">097023105 / 75886F107 / 655844108 / 126408103 / 404251100 / 600544100 / 858155203 / 422806208 / 34960P10 / 78472F101 / 233278100</td><td class="leftalignment">Boeing Co / Regeneron Pharmaceuticals Inc / Norfolk Southern Corp / CSX Corp / HNI Corp / MillerKnoll Inc / Steelcase Inc / HEICO Corp / Fortress Transportation and Infrastructure Investors LLC / Soc Telemed Inc / IONQ Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Nathan Martin / Mr. Aydin Huseynov, MD / Mr. Mark W. Schappel / Mr. Bill Sutherland / Mr. Josh W. Sullivan / Mr. Reuben Garner</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Still Room For Growth; Raising PT To $636</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Biotech 'Strikes Again,' Identifies Gene Mutation that Protects Against Obesity</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Supply Agreement for Libtayo With Regeneron Announced</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SBTX.OQ / REGN.OQ</td><td class="leftalignment">Silverback Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Edward P. White, II</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HD=US / MCD=US / WEN=US / T=US / BLD=US / PEB=US / H=US / LOW=US / BRO=US / EXPE=US / LEG=US / VMC=US / HUM=US / CVS=US / CI=US / W=US / MLM=US / UNH=US / AMED=US / SWIM=US / CBRL=US / DRI=US / DRH=US / AJG=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / REGI=US / TRIP=US / WIX=US / OPT=US / BKNG=US / CNC=US / FB=US / MKL=US / NFLX=US / DIN=US / JRVR=US / MOH=US / TPX=US / EXP=US / BECN=US / SHO=US / PLAY=US / DENN=US / LHCG=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / WH=US / JACK=US / TREX=US / KNSL=US / RLJ=US / FBHS=US / RHP=US / TILE=US / NDLS=US / GOOGL=US / 00770K202 / LOCO=US / OSH=US / ANTM=US / SHAK=US / WING=US / WLTW=US / 82982L103 / TRVG=US / PK=US / JELD=US / ATNX=US / DCPH=US / ARVN=US / FERG=US / PNTG=US / AZEK=US / ABNB=US</td><td class="leftalignment">Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Lowe's Companies Inc / Brown & Brown Inc / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Humana Inc / CVS Health Corp / Cigna Corp / Wayfair Inc / Martin Marietta Materials Inc / UnitedHealth Group Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Arthur J Gallagher & Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Tripadvisor Inc / Wix.Com Ltd / Opthea Ltd / Booking Holdings Inc / Centene Corp / Meta Platforms Inc / Markel Corp / Netflix Inc / Dine Brands Global Inc / James River Group Holdings Ltd / Molina Healthcare Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Kinsale Capital Group Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / Alphabet Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Anthem Inc / Shake Shack Inc / Wingstop Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Trivago NV / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / Arvinas Inc / Ferguson PLC / Pennant Group Inc / Azek Company Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 25, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: REGN - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">REGN</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Libtayo competition but there's more to REGN's pipeline that remains underappreciated</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Guggenheim Biotech 2Q 2021 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4595739 / 2471950 / 2023607 / 2437071 / 2576941 / 2369174 / 2455965 / 2623911 / 2730190 / 2931034 / 5531000 / B00FWN1 / B19FQ48 / 2713317 / BCBVTX1 / BBFL7S1 / BFDV8K0 / B8DPDT7 / BZ1LFB2 / B0SDJB4 / BG31GH0 / BZ05388 / BYYWPW6 / BWY52P3 / BYTJZL1</td><td class="leftalignment">Genmab A/S / Incyte Corp / Amgen Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / MorphoSys AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / MacroGenics Inc / Sarepta Therapeutics Inc / Deciphera Pharmaceuticals Inc / Zealand Pharma A/S / Y-mAbs Therapeutics Inc / Global Blood Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Zogenix Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Guggenheim Biot Research / Mr. Eddie Hickman, Ph.D. / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Yatin Suneja / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / LLY=US / OXY=US / RRC=US / T=US / DVN=US / TXN=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / VZ=US / XOM=US / CRK=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / BYD=US / MRO=US / MGM=US / MANH=US / PENN=US / W=US / STZ=US / AMED=US / ENV=US / COLL=US / CNX=US / DRH=US / EQT=US / HZO=US / MCRI=US / ASGN=US / PLAN=US / PCTY=US / REGN=US / SGMO=US / TRIP=US / VRTX=US / WAL=US / WIX=US / CVX=US / CGEN=US / SGMS=US / SIVB=US / FRT=US / COP=US / MGNI=US / BDSI=US / PTON=US / BIIB=US / CZR=US / TXRH=US / SHO=US / XM=US / BLDR=US / SCPL=US / HST=US / CLR=US / PRPL=US / NOG=US / JACK=US / AR=US / OAS=US / RLJ=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / GTT=US / GOOGL=US / VNOM=US / HUBS=US / VCEL=US / UPLD=US / PRAH=US / WBA=US / SHAK=US / BWXT=US / WING=US / NVCR=US / TTD=US / CDEV=US / PK=US / PVAC=US / SBOW=US / IOVA=US / BTAI=US / UBER=US / CRWD=US / OVV=US / SPCE=US / ZI=US / TSHA / 96758W101 / BALY=US / REPX=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Occidental Petroleum Corp / Range Resources Corp / AT&T Inc / Devon Energy Corp / Texas Instruments Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Boyd Gaming Corp / Marathon Oil Corp / MGM Resorts International / Manhattan Associates Inc / Penn National Gaming Inc / Wayfair Inc / Constellation Brands Inc / Amedisys Inc / Envestnet Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / MarineMax Inc / Monarch Casino & Resort Inc / ASGN Inc / Anaplan Inc / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Compugen Ltd / Scientific Games Corp / SVB Financial Group / Federal Realty Investment Trust / Conocophillips / Magnite Inc / BioDelivery Sciences International Inc / Peloton Interactive Inc / Biogen Inc / Caesars Entertainment Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Qualtrics International Inc / Builders FirstSource Inc / Sciplay Corp / Host Hotels & Resorts Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Antero Resources Corp / Oasis Petroleum Inc / RLJ Lodging Trust / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / GTT Communications Inc / Alphabet Inc / Viper Energy Partners LP / HubSpot Inc / Vericel Corp / Upland Software Inc / Prahova Estival 2002 SA / Walgreens Boots Alliance Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Novocure Ltd / Trade Desk Inc / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / SilverBow Resources Inc / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Ovintiv Inc / Virgin Galactic Holdings Inc / ZoomInfo Technologies Inc / Taysha Gene Therapies Inc / WideOpenWest Inc / Bally's Corp / Riley Exploration Permian Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Israel / Romania / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Immunotherapy Player With a Game-Changing T-Cell Engager Platform; Initiate With Buy and a $35 PT</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">JANX.OQ / REGN.OQ / 23284F105 / 41358P106</td><td class="leftalignment">Janux Therapeutics Inc / Regeneron Pharmaceuticals Inc / CytomX Therapeutics Inc / Harpoon Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Swayampakula Ramakanth, Ph.D. / Arthur He, Ph.D. / Sean Lee</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / BARC.L / CCI.N / CMS.N / CNA.L / EIX.N / HSBA.L / LLOY.L / MRK.N / PD.N / PEG.N / PFE.N / PNN.L / SO.N / STO.AX / T.N / SSE.L / CNQ.TO / CMCSA.O / SJRb.TO / RCIb.TO / DUK.N / FE.N / PCG.N / PPL.N / JAZZ.O / GIBa.TO / CONE.O / NG.L / VZ.N / EXEL.O / ALA.TO / EXC.N / RRC.N / EQT.N / ADSK.O / EPD.N / AWK.N / NWN.N / FTS.TO / FRAG.DE / BMRN.O / OPTN.O / REGN.O / EMA.TO / ENAG.MC / CU.TO / COP.N / ENDP.O / CPK.N / CRC.N / LNG.A / NWG.L / RGLD.O / EQIX.O / DPM.TO / MNKD.OQ / DLR.N / SCL.TO / RDSb.L / DISCA.O / SJW.N / DRX.L / TEVA.N / H.TO / PPL.TO / CBRO.L / ARX.TO / CVE.TO / NEE.N / TOU.TO / CFX.TO / FRU.TO / PCRX.O / CTT.N / TVE.TO / ABBV.N / PRGO.N / TMUS.N / BEP.N / AGIO.O / AGRX.O / EVA.N / WRK.N / MESO.O / MTRO.L / TWLO.N / AZRE.N / AKERBP.OL / SAND.N / AQN.N / OKTA.OQ / AMRX.N / AQST.O / 269796108 / ZM.O / FSLY.N / DOCU.N / VMUK.L / PAGPA.L / WTRG.N / AKES.OL / ASAN.N / COUR.N / TASK.O</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Barclays PLC / Crown Castle International Corp / CMS Energy Corp / Centrica PLC / Edison International / HSBC Holdings PLC / Lloyds Banking Group PLC / Merck & Co Inc / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Pennon Group PLC / Southern Co / Santos Ltd / AT&T Inc / SSE PLC / Canadian Natural Resources Ltd / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Duke Energy Corp / FirstEnergy Corp / PG&E Corp / PPL Corp / Jazz Pharmaceuticals PLC / CGI Inc / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / AltaGas Ltd / Exelon Corp / Range Resources Corp / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / American Water Works Company Inc / Northwest Natural Holding Co / Fortis Inc / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Emera Inc / Enagas SA / Canadian Utilities Ltd / Conocophillips / Endo International PLC / Chesapeake Utilities Corp / California Resources Corp / Cheniere Energy Inc / Natwest Group PLC / Royal Gold Inc / Equinix Inc / Dundee Precious Metals Inc / MannKind Corp / Digital Realty Trust Inc / Shawcor Ltd / Royal Dutch Shell PLC / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Hydro One Ltd / Pembina Pipeline Corp / Close Brothers Group PLC / ARC Resources Ltd / Cenovus Energy Inc / Nextera Energy Inc / Tourmaline Oil Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Tamarack Valley Energy Ltd / Abbvie Inc / Perrigo Company PLC / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Agile Therapeutics Inc / Enviva Inc / Westrock Co / Mesoblast Ltd / Metro Bank PLC / Twilio Inc / Azure Power Global Ltd / Aker BP ASA / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / DocuSign Inc / Virgin Money UK PLC / Paragon Banking Group PLC / Essential Utilities Inc / Aker Solutions ASA / Asana Inc / Coursera Inc / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Germany / Spain / United Kingdom / Ireland / Israel / Mauritius / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - CDE guidance on cancer drug development: Not overtightening regulation but long-term nudge for industry</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / REGN.OQ / INCY.OQ / BAYGN.DE / 2269.HK</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Regeneron Pharmaceuticals Inc / Incyte Corp / Bayer AG / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">07/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: SIGHT in both eyes; ARWR pause in CF</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 829399104 / N71542109 / 03820J100 / 14888D208</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">07/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">W/E Updates: KRYS' 105 Looks Good; NVAX/myocarditis; SPRO Gain, VRTX Unlocks Fra</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00287Y1091 / KRYS.OQ / SPRO.OQ / VRTX.OQ / US75886F1075 / US92532F1003 / US02043Q1076 / ABBV.N / US8036071004 / US4277461020 / CA89620X5064 / US4622221004 / US5588681057 / US8051111016 / US24823R1059 / US5011471027 / US84833T1034 / US35655L1070 / US12529R1077 / US2300311063</td><td class="leftalignment">Abbvie Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Abbvie Inc / Sarepta Therapeutics Inc / Heron Therapeutics Inc / Pfizer Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Savara Inc / Denali Therapeutics Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Freeline Therapeutics Holdings PLC / C4 Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">07/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">EXEL.O / BMRN.O / REGN.O / AGIO.O / MESO.O</td><td class="leftalignment">Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Mesoblast Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Jul-2021 Watch List: 82 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">AMZN.OQ / T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / PNC.N / SLB.N / BEN.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / HBAN.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O</td><td class="leftalignment">Amazon.com Inc / AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / Huntington Bancshares Inc / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Defense / Electronics / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Regeneron Genetics Center Strikes Again; Novel Target for Protection Against Obesity Identified</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / 02043Q107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Don’t Call it a Comeback; Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Lots to Write Home About – 2H21 Shaping Up as a Catalyst Rich Period</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">CBIO.OQ / 031162100 / 64125C109 / 766559603 / 09062X103 / 881624209 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G30401106 / 023111206 / G50871105 / 45773H201 / 189464100 / 78667J108 / 03209R103 / 16383L106 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 00771V108 / 01345P106 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 805111101 / 98401F105 / 23284F105 / 03168L105 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 483347100 / 37890U108 / 269796108 / 87166L100 / 088786108 / 29668H708 / 68906L105 / 04016X101 / 62921N105 / 87184Q107 / 481116101 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 729139105 / 00972D105 / 760273102 / 282559103 / 02083G100 / 02155H200 / 03969T109 / 24344T101 / 604749101 / 92243A200 / 74366E102 / 00166B105 / 576810105 / 45790W108 / 04335A105 / 23257D103 / 4525EP101 / 46565G104 / 75382E109 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 50107A104 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 03890D108 / 55028X109 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 38406L103 / 81728A108 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 09077A106 / 75082Q105</td><td class="leftalignment">Catalyst Biosciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Endo International PLC / Amarin Corporation PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Aerie Pharmaceuticals Inc / Albireo Pharma Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / Savara Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / Eagle Pharmaceuticals Inc / Synlogic Inc / Bicycle Therapeutics PLC / ESSA Pharma Inc / Otonomy Inc / argenx SE / NGM Biopharmaceuticals Inc / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / 89Bio Inc / Alpine Immune Sciences Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Matinas BioPharma Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Immunic Inc / Iteos Therapeutics Inc / Rapt Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Kronos Bio Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Aravive Inc / Lumos Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Biomea Fusion Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Biotechnology Monthly: Gene editing arrives</td><td class="leftalignment">English</td><td class="rightalignment">168</td><td class="leftalignment">US75886F1075 / 019770106 / H17182108 / 438083107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Homology Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Canaccord Genui Research / Michelle Gilson / Sumant Kulkarni / Ms. Arlinda A. Lee, PHD / Mr. John L. Newman, Ph.D., CFA, PHD / Mr. Edward H. Nash / Benedict Shim</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Regeneron shares post best quarter in a year</td><td class="leftalignment">English</td><td class="rightalignment">78</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron advances 19% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">FR0000054470 / 75886F107 / 44980X109 / 12008R107 / 600544100 / 606710200 / 89531P105 / US8110544025 / 92763W103 / 09739D100 / 09624H208</td><td class="leftalignment">Ubisoft Entertainment SA / Regeneron Pharmaceuticals Inc / IPG Photonics Corp / Builders FirstSource Inc / MillerKnoll Inc / Mitek Systems Inc / Trex Company Inc / E W Scripps Co / Vipshop Holdings Ltd / Boise Cascade Co / Bluelinx Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Ms. Fawne Jiang / Long Lin / Mike Hickey / Mr. Reuben Garner / Mr. Daniel L. Kurnos, CFA / Mr. Mark W. Schappel / Mr. Mark Miller</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Booster Shots - Charts highlighted: K, ASPS, BMRN, MASI, REGN, RETA, TNDM, APLT, AXSM, CHMA, EDIT, LGND, LXRX, PCVX, RGNX, VERO, SPLK, U, APPN, MAXN, NOVA, PI, RUN, SAIL, XONE, MGNI, NRG, and RGCO.</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">REGN.OQ / APLT.OQ / APPN.OQ / ASPS.OQ / BMRN.OQ / EDIT.OQ / K.N / LGND.OQ / LXRX.OQ / MASI.OQ / MAXN.OQ / MGNI.OQ / NOVA.N / PCVX.OQ / RETA.OQ / RGCO.OQ / RGNX.OQ / RUN.OQ / SPLK.OQ / TNDM.OQ / VERO.OQ / NRG.N / AXSM.OQ / PI.OQ / SAIL.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Applied Therapeutics Inc / Appian Corp / Altisource Portfolio Solutions SA / Biomarin Pharmaceutical Inc / Editas Medicine Inc / Kellogg Co / Ligand Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Masimo Corp / Maxeon Solar Technologies Ltd / Magnite Inc / Sunnova Energy International Inc / Vaxcyte Inc / Reata Pharmaceuticals Inc / RGC Resources Inc / Regenxbio Inc / Sunrun Inc / Splunk Inc / Tandem Diabetes Care Inc / Venus Concept Inc / NRG Energy Inc / Axsome Therapeutics Inc / Impinj Inc / SailPoint Technologies Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Luxembourg / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Regeneron Genetic Center - Driver of Long-Term Performance</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways from MEDACorp KOL Call on NTLA-2001 and Evolving ATTR Landscape</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F10 / 02043Q10 / 46222210 / 10806X10 / 45826J10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / Germany / Spain / France / United Kingdom / Israel / Japan / Netherlands / New Zealand / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Geoffrey Porges, MBBS / Greco Song, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">SYK=US / IGT=US / ENV=US / PCTY=US / REGN=US / SGMO=US / TRIP=US / SGMS=US / TPX=US / NUVA=US / TXRH=US / BLDR=US / SIBN=US / SCPL=US / PRPL=US / TIL=US / JACK=US / OAS=US / RLJ=US / SPLK=US / GMED=US / VCEL=US / NVRO=US / SHAK=US / ZBH=US / WING=US / SPNE=US / NTLA=US / IOVA=US / BTAI=US / CRWD=US / TSHA / NGMS=US</td><td class="leftalignment">Stryker Corp / International Game Technology PLC / Envestnet Inc / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Scientific Games Corp / Tempur Sealy International Inc / NuVasive Inc / Texas Roadhouse Inc / Builders FirstSource Inc / SI-BONE Inc / Sciplay Corp / Purple Innovation Inc / Instil Bio Inc / Jack in the Box Inc / Oasis Petroleum Inc / RLJ Lodging Trust / Splunk Inc / Globus Medical Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Zimmer Biomet Holdings Inc / Wingstop Inc / SeaSpine Holdings Corp / Intellia Therapeutics Inc / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / CrowdStrike Holdings Inc / Taysha Gene Therapies Inc / NeoGames SA</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2367026 / 2516152 / 2000019 / 2496113 / 2486813 / 2973821 / 2216850 / 2280220 / 2270726 / 2542049 / 2317087 / 2328915 / 2369174 / 2707677 / 2730190 / 2138158 / 2829601 / 7123870 / B121557 / B1Y9TB3 / 2857817 / 2951452 / B7TL820 / B7VD3F2 / B8CKK03 / B3V9F12 / BDZCRX3 / BYRY499 / BYY8XK8 / BYVY8G0 / BYW36M8 / BYQHP96 / BXDZ9Z0 / BYNZGK1 / BK7Y2V9 / BJ1N1M9 / BD8DJ71 / BJJMGL2 / BGSP7M9 / BJDX8Y8 / BJMLSD2 / BMG75B4 / BGT0PL8 / BD8QGD5 / BD72R64 / BFY7DC4 / BMCC9R7 / BMC8SQ7</td><td class="leftalignment">General Mills Inc / Eli Lilly and Co / Amazon.com Inc / Kohls Corp / Kellogg Co / Alliant Energy Corp / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Gilead Sciences Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Nestle SA / Mastercard Inc / Danone SA / Netflix Inc / J M Smucker Co / Meta Platforms Inc / Duke Energy Corp / Mondelez International Inc / PVH Corp / RingCentral Inc / Kraft Heinz Co / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Shopify Inc / Block Inc / Akero Therapeutics Inc / Capri Holdings Ltd / Snap Inc / Fox Corp / Zoom Video Communications Inc / Mirum Pharmaceuticals Inc / Karuna Therapeutics Inc / Inventiva SA / DiaMedica Therapeutics Inc / Liberty Media Corp / Liberty Media Corp / Altimmune Inc / SCYNEXIS Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Highlights from Guggenheim's BioPharma Strategy Series Discussion with Management</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Regeneron Pharmaceuticals, Inc. JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US92532F1003 / US68554V1089 / US6402681083 / US09060J1060 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US48576U1060 / CA4990531069 / US71742Q1067 / US0453961080 / CA68620P1018 / US5165441032 / US98978L2043 / US53222K2050 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / Nektar Therapeutics / BioDelivery Sciences International Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Karyopharm Therapeutics Inc / Knight Therapeutics Inc / Phibro Animal Health Corp / Assembly Biosciences Inc / OrganiGram Holdings Inc / Lantheus Holdings Inc / Zogenix Inc / LifeVantage Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Beyond oncology franchise, we could see more genetics medicines from REGN's pipeline</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron climbs 14.1% from 8 week low</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Jun. 29, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Overblown Competitive Concerns Create Attractive Entry Point for Mega-Cap Leader; Initiate at Buy and $703 PT</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">REGN.OQ / BIIB / 92532F100 / 02043Q107 / NTLA.OQ / ALT.OQ / 75382E109</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intellia Therapeutics Inc / Altimmune Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">Multiple Modalities Still Needed After NTLA/REGN's Landmark CRISPR Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.OQ / 75886F107 / 501147102 / 68570P101 / 77313F106 / G5966510</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Krystal Biotech Inc / Orchard Therapeutics PLC / Rocket Pharmaceuticals Inc / MeiraGTx Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD / Tong Liu, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BP.L / CMS.N / DFDS.CO / HSX.L / NA / SGEF.PA / FER.MC / TV.TO / XOM.N / KGC.N / IG.MI / REGN.O / VRTX.O / CVX.N / MEOH.O / HCC.N / AMED.O / FM.TO / 878742204 / RDSb.L / LHCG.O / 35671D857 / LRE.L / ARWR.O / CS.TO / 443628102 / 550372106 / BEZG.L / CVE.TO / SLS.TO / 505440107 / TSLA.N / 46579R104 / CIA.TO / AENA.MC / NTLA.O / SAND.N / NEXA.TO</td><td class="leftalignment">BP PLC / CMS Energy Corp / DFDS AS / Hiscox Ltd / National Bank of Canada / Vinci SA / Ferrovial SA / Trevali Mining Corp / Exxon Mobil Corp / Kinross Gold Corp / Italgas SpA / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Methanex Corp / Warrior Met Coal Inc / Amedisys Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Royal Dutch Shell PLC / LHC Group Inc / Freeport-McMoRan Inc / Lancashire Holdings Ltd / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Hudbay Minerals Inc / Lundin Mining Corp / Beazley PLC / Cenovus Energy Inc / Solaris Resources Inc / Labrador Iron Ore Royalty Corp / Tesla Inc / Ivanhoe Mines Ltd / Champion Iron Ltd / Aena SME SA / Intellia Therapeutics Inc / Sandstorm Gold Ltd / Nexa Resources SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Denmark / Spain / France / United Kingdom / Italy / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.O / VRTX.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 18, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Intellia Shares Rise 49% on 'Landmark' Interim Results in Phase 1 ATTR Amyloidosis Trial</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">NTLA.OQ / REGN.OQ</td><td class="leftalignment">Intellia Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / COMMODITIES / OVERVIEW / PORTFOLIO STRATEGY / SECTOR / EQUITY</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CRISPR toolbox expands pipeline potential with positive early ATTR data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US75886F1075 / US02043Q1076</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Competitive ATTR data look encouraging though we still think near-term franchise risk is minimal</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US02043Q1076 / US75886F1075</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What’s Next in Biotech? The Masque of the Cell Death (and Cancer Metabolism)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 2730190 / BGCYWN8</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 829399104 / N71542109 / 03820J100 / 14888D208</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: NTLA publishes landmark CRISPR data in NEJM</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">CRSP.BN / NTLA.OQ / EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 829399104 / N71542109 / 03820J100 / 14888D208</td><td class="leftalignment">CRISPR Therapeutics AG / Intellia Therapeutics Inc / Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US1101221083 / US1924221039 / US3695501086 / US37733W1053 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US87612E1064 / US8832031012 / CA0977512007 / US4771431016 / US4198791018 / US80105N1054 / US31620M1062 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US29082A1079 / US00287Y1091 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US70450Y1038 / US5588681057 / US8760301072 / US5904791358 / US28414H1032 / US76156B1070 / US88339P1012 / US26142R1041 / US12769G1004 / CA67079A1021 / US05875B1061 / US73739W1045 / BMG6964L1072</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cognex Corp / General Dynamics Corp / GlaxoSmithKline PLC / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Target Corp / Textron Inc / Bombardier Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Embraer SA / Abbvie Inc / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / PayPal Holdings Inc / Madrigal Pharmaceuticals Inc / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Revolve Group Inc / RealReal Inc / DraftKings Inc / Caesars Entertainment Inc / Nuvei Corp / Bally's Corp / Poshmark Inc / Paysafe Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / FISV=US / PEP=US / CAG=US / KO=US / CL=US / PG=US / EBAY=US / RUN=US / CRM=US / V=US / ENR=US / PB=US / VMC=US / PENN=US / NWL=US / MLM=US / FLO=US / STZ=US / AIR=US / ATRO=US / B=US / CHD=US / COLL=US / CW=US / DCO=US / EPC=US / HAIN=US / HEI=US / HXL=US / REGN=US / REGI=US / ROLL=US / SGMO=US / SMG=US / TGI=US / VSEC=US / POST=US / GPN=US / PYPL=US / SPR=US / EVOP=US / MGPI=US / BDSI=US / MNST=US / JRVR=US / NOMD=US / BIIB=US / FLT=US / MOG.A=US / EXP=US / FRPT=US / THS=US / GMS=US / REX=US / FIS=US / TDG=US / MA=US / GPRE=US / ELF=US / CENTA=US / UTZ=US / WWD=US / QTWO=US / 00770K202 / NVRO=US / SQ=US / NTLA=US / PETQ=US / CARG=US / SMAR=US / KDP=US / OSMT=US / LSPD=US / RPAY=US / BRBR=US / REYN=US / SPCE=US / NCNO=US / PAYA=US / HYFM=US / 67421J108</td><td class="leftalignment">Albany International Corp / Fiserv Inc / PepsiCo Inc / Conagra Brands Inc / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / eBay Inc / Sunrun Inc / Salesforce.Com Inc / Visa Inc / Energizer Holdings Inc / Prosperity Bancshares Inc / Vulcan Materials Co / Penn National Gaming Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Constellation Brands Inc / AAR Corp / Astronics Corp / Barnes Group Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Curtiss-Wright Corp / Ducommun Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / RBC Bearings Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / VSE Corp / Post Holdings Inc / Global Payments Inc / PayPal Holdings Inc / Spirit AeroSystems Holdings Inc / EVO Payments Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / James River Group Holdings Ltd / Nomad Foods Ltd / Biogen Inc / Fleetcor Technologies Inc / Moog Inc / Eagle Materials Inc / Freshpet Inc / TreeHouse Foods Inc / GMS Inc / REX American Resources Corp / Fidelity National Information Services Inc / TransDigm Group Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Central Garden & Pet Co / UTZ Brands Inc / Woodward Inc / Q2 Holdings Inc / Aemetis Inc / Nevro Corp / Block Inc / Intellia Therapeutics Inc / PetIQ Inc / CarGurus Inc / Smartsheet Inc / Keurig Dr Pepper Inc / Osmotica Pharmaceuticals PLC / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / nCino Inc / Paya Holdings Inc / Hydrofarm Holdings Group Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Luxembourg / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Platform-Validating Interim Data Readout Reinforces Our Enthusiasm for the Stock; Reiterate Buy and Raising PT to $171</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">NTLA.OQ / 75886F107 / 02043Q107</td><td class="leftalignment">Intellia Therapeutics Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2126335 / 2516152 / 2000019 / 2973821 / 2065159 / 2437071 / 2280220 / 2270726 / 2829515 / 2455965 / 2459020 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 2895163 / B00FWN1 / B125XQ6 / 2983563 / B6197Q2 / B87ZMX0 / B95N910 / B424494 / BFZCHN7 / BYVY8G0 / BS7K7C9 / BF4VBS8 / BXDZ9Z0 / BK0VHF6 / BD8DJ71 / BLGJ610 / BGSP7M9 / BZ1LFG7 / BMDCDP2 / BMC8SQ7 / BNTB3N8 / BN2RM92 / BLF0CW7</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Alliant Energy Corp / Autodesk Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Edison International / Biogen Inc / Intuit Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / United Natural Foods Inc / Alnylam Pharmaceuticals Inc / Portland General Electric Co / Carmax Inc / Generac Holdings Inc / Palo Alto Networks Inc / PTC Inc / Splunk Inc / Wix.Com Ltd / Alphabet Inc / Nevro Corp / BioXcel Therapeutics Inc / Shopify Inc / IDEAYA Biosciences Inc / Snap Inc / Warner Music Group Corp / Zoom Video Communications Inc / Roku Inc / Bigcommerce Holdings Inc / BTRS Holdings Inc / Vizio Holding Corp / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / CCI.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / PD.N / PFE.N / PNN.L / RWEG.DE / SO.N / T.N / SSE.L / DRE.N / TRI.N / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / REE.MC / GIS.N / JAZZ.O / CONE.O / NG.L / VZ.N / EXEL.O / KMX.N / AWK.N / NWN.N / BMRN.O / REGN.O / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / SEM.N / CASY.O / EQIX.O / ATDb.TO / BIIB.O / DLR.N / WEF.TO / ALNY.O / DISCA.O / SJW.N / DRX.L / TEVA.N / SLRS.MC / EONGn.DE / BHPB.L / NEE.N / CIO.N / SPLK.OQ / ABBV.N / TMUS.N / PRTA.O / BEP.N / ESNT.N / NEP.N / DEA.N / 78667J108 / EDIT.O / NTLA.O / TWLO.N / UN01.DE / NTNX.O / CRSP.OQ / GREG.MC / VST.N / ORSTED.CO / EHC.N / SMAR.N / DBX.O / CWEN.N / OSMT.O / 269796108 / ZM.O / FSLY.N / GMAB.O / DOCU.N / WTRG.N / BEAM.O / IGIC.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Crown Castle International Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Rwe AG / Southern Co / AT&T Inc / SSE PLC / Duke Realty Corp / Thomson Reuters Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Red Electrica Corporacion SA / General Mills Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Carmax Inc / American Water Works Company Inc / Northwest Natural Holding Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Select Medical Holdings Corp / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Digital Realty Trust Inc / Western Forest Products Inc / Alnylam Pharmaceuticals Inc / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Solaria Energia y Medio Ambiente SA / E.ON SE / BHP Group PLC / Nextera Energy Inc / City Office REIT Inc / Splunk Inc / Abbvie Inc / T-Mobile US Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Nextera Energy Partners LP / Easterly Government Properties Inc / SAGE Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Twilio Inc / Uniper SE / Nutanix Inc / CRISPR Therapeutics AG / Grenergy Renovables SA / Vistra Corp / Orsted A/S / Encompass Health Corp / Smartsheet Inc / Dropbox Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Genmab A/S / DocuSign Inc / Essential Utilities Inc / Beam Therapeutics Inc / International General Insurance Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jun 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Innovent's weight loss drug Ph1 data promising; Junshi's COVID antibody US distribution paused</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1801.HK / 1877.HK / REGN.OQ / 6160.HK / 688180.SS</td><td class="leftalignment">Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Regeneron Pharmaceuticals Inc / Beigene Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Shirley Chen / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Promising Initial Ph1 TTR Data Shows First Clinical Evidence Of CRISPR Efficacy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Partner NTLA Announces Groundbreaking ATTR Data; Potentially Gives REGN a Leading Position in the New Era of Genomic Medicine</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">REGN first foray into gene editing in ATTR bodes well for pipeline</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/26/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates - 4 Webinars Last Week; 4 Again This Week</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US00287Y1091 / US09061G1013 / US45337C1027 / US75886F1075 / US92532F1003 / US02043Q1076 / US29251M1062 / US28106W1036 / US00773J1034 / US45826J1051 / US45781K1051 / US35655L1070 / US45720L1070 / US12529R1077 / US68236R1032</td><td class="leftalignment">Abbvie Inc / Biomarin Pharmaceutical Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / Innate Pharma SA / Freeline Therapeutics Holdings PLC / Inhibrx Inc / C4 Therapeutics Inc / Oncorus Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">06/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Far more than proof of concept: first in human gene-editing data are surprisingly impressive</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Introducing PRS-220; New Initiative in IPF Gets a Cash Jump Start</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">720795103 / 75886F107 / FGEN.OQ</td><td class="leftalignment">Pieris Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / FibroGen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Six In a Row - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss Current and Developing Treatments in Atopic Dermatitis and Psoriasis on Thursday, July 15 at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARQT.O / JNJ / LLY / PFE / AMGN.O / INCY.O / ARNA.O / REGN.O / ACRS.O / EVLO.O / RAPT.O / PHGE.K / VYNE.O</td><td class="leftalignment">Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Incyte Corp / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Aclaris Therapeutics Inc / Evelo Biosciences Inc / Rapt Therapeutics Inc / Biomx Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - June 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">GB0007188757 / US0231351067 / US1258961002 / US2546871060 / US3755581036 / US75886F1075 / US9746371007 / CA8029121057 / CA4530384086 / CA2918434077 / CA1363851017 / US1667641005 / US7665596034 / US49446R1095 / US3546131018 / US74144T1088 / US1011211018 / US09247X1019 / BMG491BT1088 / CA8672241079 / CA15135U1093 / CA5527041084 / CA9237251058 / CA00208D4084 / CA2927661025 / US30303M1027 / CA0158571053 / CA04682R1073 / US2921041065 / US03674X1063 / US90184L1026 / US2267181046 / IE00BQPVQZ61 / US29444U7000 / GB00BWFY5505 / US02079K3059 / US4622221004 / BMG475671050 / CA53680Q2071 / US03753U1060 / US92645B1035 / US80706P1030 / US48251W1045 / US03843E1047 / US50015M1099 / US03990B1017 / US35137L1052 / US09260D1072 / US30205M1018 / US03768E1055 / US14316J1088 / US78440X8048 / US24343R1068 / CA00791P1071</td><td class="leftalignment">Rio Tinto PLC / Amazon.com Inc / CMS Energy Corp / Walt Disney Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Winnebago Industries Inc / Saputo Inc / Imperial Oil Ltd / Empire Company Ltd / Canadian Natural Resources Ltd / Chevron Corp / Rigel Pharmaceuticals Inc / Kimco Realty Corp / Franklin Resources Inc / T Rowe Price Group Inc / Boston Properties Inc / BlackRock Inc / Invesco Ltd / Suncor Energy Inc / Cenovus Energy Inc / MEG Energy Corp / Vermilion Energy Inc / ARC Resources Ltd / Enerplus Corp / Meta Platforms Inc / Algonquin Power & Utilities Corp / Athabasca Oil Corp / Empire State Realty Trust Inc / Antero Resources Corp / Twitter Inc / Criteo SA / Horizon Therapeutics PLC / Equinix Inc / Nielsen Holdings PLC / Alphabet Inc / Ionis Pharmaceuticals Inc / IHS Markit Ltd / Lithium Americas Corp / Apellis Pharmaceuticals Inc / Victory Capital Holdings Inc / Scholar Rock Holding Corp / KKR & Co Inc / Aquestive Therapeutics Inc / Kodiak Sciences Inc / Ares Management Corp / Fox Corp / Blackstone Inc / Exicure Inc / Apollo Global Management Inc / Carlyle Group Inc / SL Green Realty Corp / Decibel Therapeutics Inc / Advantage Energy Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">Top Biotech Picks and Catalysts from Our Coverage Universe Heading into 2H21</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">004225108 / 01671P100 / 75886F107 / 04744L106 / 040047607 / 98420N105 / 501147102 / 68570P101 / 77313F106 / 05464T104 / 74374N102 / 757468103 / G5966510 / 38341P102</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Allakos Inc / Regeneron Pharmaceuticals Inc / Athersys Inc / Arena Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Krystal Biotech Inc / Orchard Therapeutics PLC / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Provention Bio Inc / Redhill Biopharma Ltd / MeiraGTx Holdings PLC / Gossamer Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David T. Hoang, PHD / Tong Liu, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Spotlight Conference on Rare Disease and Ophtho: BioPharma/Biotech Wrap-Up</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US75886F1075 / US7665596034 / IE00BQPVQZ61 / US4622221004 / US03753U1060 / US80706P1030 / US03843E1047 / US50015M1099 / US30205M1018 / US24343R1068</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Horizon Therapeutics PLC / Ionis Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Scholar Rock Holding Corp / Aquestive Therapeutics Inc / Kodiak Sciences Inc / Exicure Inc / Decibel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Production Sites Approved; COVID-19 Vaccine Landscape Updates; Reit Neutral</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09075V102 / 75886F107</td><td class="leftalignment">BioNTech SE / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MUTUAL FUNDS / TRUSTS RESEARCH</td><td class="leftalignment">Mr. Robert Burns / Raghuram Selvaraju, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US92532F1003 / US68554V1089 / US6402681083 / US09060J1060 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US48576U1060 / CA4990531069 / US71742Q1067 / US0453961080 / CA68620P1018 / US5165441032 / US98978L2043 / US53222K2050 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / Nektar Therapeutics / BioDelivery Sciences International Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Karyopharm Therapeutics Inc / Knight Therapeutics Inc / Phibro Animal Health Corp / Assembly Biosciences Inc / OrganiGram Holdings Inc / Lantheus Holdings Inc / Zogenix Inc / LifeVantage Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc. (REGN) - Continued to grow through its largest brands</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Jun. 22, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 11, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">346</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: DHR to buy Aldevron; CVAC C19 vaccine misses</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 462260100 / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / 46583P102 / NBSE.O / 77313F106 / OCGN.O / XCUR.O / 12674W109 / PASG.O / IMTX.O / N90064101 / 76029N106 / 83422E105 / 829399104 / N71542109 / 03820J100 / 14888D208</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / Iveric Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Cabaletta Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Solid Biosciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp / Catalyst Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">A Multi-Specific Platform for Oncology and Infectious Disease; Assume Coverage at Buy</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">MOLN.OQ / 766559603 / 75886F107 / 78667J108 / 221015100</td><td class="leftalignment">Molecular Partners AG / Rigel Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / SAGE Therapeutics Inc / Corvus Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Robert Burns / Yi Chen, Ph.D. CFA / Raghuram Selvaraju, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/19/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech Updates- ADC Deep Dive, 3 Webinars This Week  More</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US09058V1035 / US75886F1075 / US8036071004 / US88322Q1085 / US37890U1088 / US4622221004 / CH0334081137 / US84833T1034 / US6047491013 / US35655L1070 / US59101E1038 / US12529R1077 / US68236R1032</td><td class="leftalignment">BioCryst Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Spero Therapeutics Inc / Mirum Pharmaceuticals Inc / Freeline Therapeutics Holdings PLC / Metacrine Inc / C4 Therapeutics Inc / Oncorus Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 6.18.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 00282410 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 58949210 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710 / 00288U10 / 90184D10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Abbott Laboratories / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc / Abcellera Biologics Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Mgmt. Mtgs Highlight Confidence In PYLARIFY Market Oppty & Commercial Launch</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">51654410 / 75886F10</td><td class="leftalignment">Lantheus Holdings Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Richard Newitter / Jaime Morgan / Erin Fahey</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let It Go, Let It Go - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US5627501092 / 75886F107 / G5480U120</td><td class="leftalignment">Manhattan Associates Inc / Regeneron Pharmaceuticals Inc / Liberty Global PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Matthew Harrigan / Mr. Mark W. Schappel</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">REGEN-COV Is Alive And Well; Expect New Government Contracts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">OXY=US / BXP=US / BLD=US / DVN=US / RUN=US / AMT=US / PEB=US / CPE=US / EOG=US / BC=US / H=US / CONE=US / MTN=US / MUR=US / MAR=US / MRO=US / TNL=US / VMC=US / HLT=US / MLM=US / CHH=US / DRH=US / IBP=US / HZO=US / PDM=US / PII=US / REGN=US / TRIP=US / WGO=US / CNC=US / VNO=US / COP=US / BIIB=US / SHO=US / BLDR=US / SPWR=US / HST=US / XPO=US / WH=US / HGV=US / RLJ=US / VAC=US / MTDR=US / ENPH=US / PDCE=US / RHP=US / FATE=US / MBUU=US / 00770K202 / SEDG=US / MCFT=US / ZS=US / AXSM=US / WLTW=US / CDEV=US / PK=US / PLYA=US / LYFT=US / UBER=US / ONEW=US</td><td class="leftalignment">Occidental Petroleum Corp / Boston Properties Inc / TopBuild Corp / Devon Energy Corp / Sunrun Inc / American Tower Corp / Pebblebrook Hotel Trust / Callon Petroleum Co / EOG Resources Inc / Brunswick Corp / Hyatt Hotels Corp / CyrusOne Inc / Vail Resorts Inc / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Installed Building Products Inc / MarineMax Inc / Piedmont Office Realty Trust Inc / Polaris Inc / Regeneron Pharmaceuticals Inc / Tripadvisor Inc / Winnebago Industries Inc / Centene Corp / Vornado Realty Trust / Conocophillips / Biogen Inc / Sunstone Hotel Investors Inc / Builders FirstSource Inc / SunPower Corp / Host Hotels & Resorts Inc / XPO Logistics Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Matador Resources Co / Enphase Energy Inc / PDC Energy Inc / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Malibu Boats Inc / Aemetis Inc / Solaredge Technologies Inc / Mastercraft Boat Holdings Inc / Zscaler Inc / Axsome Therapeutics Inc / Willis Towers Watson PLC / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Lyft Inc / Uber Technologies Inc / OneWater Marine Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Phase 3 RECOVERY trial of antibody cocktail improved survival in hospitalized COVID-19 pts</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Regeneron Pharmaceuticals Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Compass: Yields Testing Support Ahead Of FOMC Meeting. Charts Highlighted: SGMS, AGS, NTAP, DBX, NTNX, VRNS, BOX, CVLT, REGN, FATE, RHHBY, BEAM, NTLA, DRNA, ZTS, FRPT, HSKA, and PAHC</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">REGN.OQ / BEAM.OQ / CVLT.OQ / DBX.OQ / FATE.OQ / FRPT.OQ / HSKA.OQ / NTAP.OQ / NTLA.OQ / NTNX.OQ / PAHC.OQ / SGMS.OQ / VRNS.OQ / ZTS.N / BOX.N / ROG.S / AGS.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Beam Therapeutics Inc / Commvault Systems Inc / Dropbox Inc / Fate Therapeutics Inc / Freshpet Inc / Heska Corp / NetApp Inc / Intellia Therapeutics Inc / Nutanix Inc / Phibro Animal Health Corp / Scientific Games Corp / Varonis Systems Inc / Zoetis Inc / Box Inc / Roche Holding AG / PlayAGS Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INTERNAL REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GSK Licensing Deal Hugely Validating for EOS-448 and TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">11012210 / 45337C10 / 71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / M2572210 / 09062X10 / 478160104 / 640268108 / 771195104 / 58933Y10 / 92337C10 / 04651310 / 75046920 / 00287Y10 / 98401F10 / ITOS.OQ / 58949210 / 09627Y10 / 07725L10 / G3910J11 / 81181C10 / K3967W10 / 46565G10 / 61776010 / 03969F10 / F5548N10 / 48111610</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Compugen Ltd / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Verastem Inc / Atara Biotherapeutics Inc / Radius Health Inc / Abbvie Inc / Xencor Inc / Iteos Therapeutics Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Genmab A/S / Iteos Therapeutics Inc / MorphoSys AG / Arcus Biosciences Inc / Sanofi SA / Jounce Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Jeffrey La Rosa / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US92532F1003 / US68554V1089 / US6402681083 / US09060J1060 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US6951271005 / US48576U1060 / CA4990531069 / US03209R1032 / US0453961080 / CA68620P1018 / US98978L2043 / US53222K2050 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US92556V1061 / US0547548745 / US92941V2097 / US04546C2052</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / Nektar Therapeutics / BioDelivery Sciences International Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Pacira Biosciences Inc / Karyopharm Therapeutics Inc / Knight Therapeutics Inc / Amphastar Pharmaceuticals Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / LifeVantage Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc / Assertio Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 04, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, REGN</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">To RSV or Not to RSV? Prevention Could Generate $10bn in Vaccine Sales 2030</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">G3910J11 / F5548N10 / 71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / 60770K10</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Biologics Sector - Regkirona Ph-3 topline data read; key findings from the confirmatory trial and read-through to share price direction - Initial take</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">068270.KS / 091990.KQ / LLY.N / GSK.L / REGN.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Eli Lilly and Co / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) NBSE platform data; BLUE resuming trials</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US75886F1075 / US92532F1003 / US00847X1046 / US37890U1088 / US88870R1023 / US03753U1060 / US2312692005</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Global Blood Therapeutics Inc / Tivity Health Inc / Apellis Pharmaceuticals Inc / Curis Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MONDAY 6/14 at 11 AM ET: Virtual KOL Conference Call to Discuss EHA Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US00847X1046 / US2312692005 / US75886F1075 / US92532F1003 / APS.TO / US37890U1088 / US03753U1060</td><td class="leftalignment">Agios Pharmaceuticals Inc / Curis Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Initiating Coverage of Intellia; Poised For Success With “One and Done” CRISPR/Cas9 Cures for Genetic Diseases</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">NTLA.OQ / 92532F100 / 75886F107 / 02043Q107 / 09058V103 / 800677106 / PRTA.OQ / AGIO.OQ / 15117K103 / 04280A100 / 483497103 / 019770106 / 37890U108 / 10806X102 / 74019P108 / 34633R104 / 14875P206</td><td class="leftalignment">Intellia Therapeutics Inc / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Sangamo Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Cellectis SA / Arrowhead Pharmaceuticals Inc / Kalvista Pharmaceuticals Inc / Allogene Therapeutics Inc / Global Blood Therapeutics Inc / BridgeBio Pharma Inc / Precision BioSciences Inc / Forma Therapeutics Holdings Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HGEN: Bringing Calm to the (Cytokine) Storm; Initiate with an Outperform Rating and $28 TP</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">HGEN.OQ / BMY.N / SASY.PA / ROG.S / NOVN.S / GSK.L / REGN.OQ / GILD.OQ / IMAB.OQ</td><td class="leftalignment">Humanigen Inc / Bristol-Myers Squibb Co / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Tiago Fauth / Matthew Terwelp / Mr. Thomas Deal / Roger Xu / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Outflows Lessen, but Continue to Drag On</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MONDAY 6/14 at 11 AM ET: Join Our Virtual KOL Conference Call to Discuss EHA Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US00847X1046 / US03753U1060 / US75886F1075 / US92532F1003 / APS.TO / US37890U1088 / US2312692005</td><td class="leftalignment">Agios Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Curis Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / BMY=US / GBT=US / BLD=US / INCY=US / GL=US / GILD=US / PAA=US / CHRS=US / LEG=US / VMC=US / MLM=US / PATH=US / BNL=US / DRI=US / ENDP=US / IBP=US / MHK=US / NTST=US / REGN=US / THO=US / VRTX=US / HIW=US / BDN=US / PRI=US / EGP=US / KIM=US / MAA=US / UDR=US / DRE=US / AUTL=US / DIN=US / OGN / BCO=US / TPX=US / EXP=US / BECN=US / TXRH=US / BLDR=US / PGTI=US / OC=US / KTOS=US / TREX=US / OLO=US / APTS=US / MEIP=US / ABBV=US / TILE=US / HTRG=US / DEA=US / 82982L103 / CRSP=US / YEXT=US / COLD=US / EOLS=US / UBER=US / GMAB=US / AZEK=US / VTRS=US / DASH=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Globe Life Inc / Gilead Sciences Inc / Plains All American Pipeline LP / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / UiPath Inc / Bunzl plc / Darden Restaurants Inc / Endo International PLC / Installed Building Products Inc / Mohawk Industries Inc / Netstreit Corp / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Vertex Pharmaceuticals Inc / Highwoods Properties Inc / Brandywine Realty Trust / Primerica Inc / Eastgroup Properties Inc / Kimco Realty Corp / Mid-America Apartment Communities Inc / UDR Inc / Duke Realty Corp / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Brinks Co / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / PGT Innovations Inc / Owens Corning / Kratos Defense and Security Solutions Inc / Trex Company Inc / Olo Inc / Preferred Apartment Communities Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / Heritage Insurance Holdings Inc / Easterly Government Properties Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Yext Inc / Americold Realty Trust / Evolus Inc / Uber Technologies Inc / Genmab A/S / Azek Company Inc / Viatris Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v2.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Animal Tracks: Howl in Pain: Assessing the Expanding Companion Animal Pain Market Opportunity; Disruptive Innovation Drivers at ZTS</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ZTS.N / DPH.L / REGN.OQ / CEVA.OQ / BAYGN.DE / ELAN.N</td><td class="leftalignment">Zoetis Inc / Dechra Pharmaceuticals PLC / Regeneron Pharmaceuticals Inc / CEVA Inc / Bayer AG / Elanco Animal Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Delayed But Not Deterred; Derms Remain Enthusiastic For Rinvoq</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">00287Y109 / 75886F107</td><td class="leftalignment">Abbvie Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US1101221083 / US1266501006 / US4448591028 / US75886F1075 / US09062X1037 / US0042251084 / US15135B1017 / US42226A1079 / US0367521038 / US05464T1043 / US0327973006 / US24823R1059 / US1255231003</td><td class="leftalignment">Bristol-Myers Squibb Co / CVS Health Corp / Humana Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Centene Corp / Healthequity Inc / Anthem Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Jun. 08, 2021 / 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US9022521051 / 75886F107 / 640268108 / 690742101 / 53220K504 / 09075G105 / 17143G106</td><td class="leftalignment">Tyler Technologies Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Owens Corning / Ligand Pharmaceuticals Inc / Biofrontera AG / Skillsoft Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Mark W. Schappel / Mr. Reuben Garner / Mr. Robert M. Wasserman / Mr. Bruce D. Jackson</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">ASCO Updates Are Encouraging</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107 / 640268108</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Nektar Therapeutics</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / INCY=US / TEVA=US / MTN=US / LOW=US / PB=US / CHRS=US / LEG=US / VMC=US / MLM=US / AIR=US / SWIM=US / CBRL=US / CSTR=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / REGN=US / REGI=US / FOUR=US / CGEN=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / FBK=US / SSB=US / RF=US / FFIN=US / GBCI=US / DIN=US / PNFP=US / SBCF=US / BIIB=US / TPX=US / EXP=US / BDC=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / IBTX=US / NDLS=US / FATE=US / 00770K202 / COUP=US / LOCO=US / HQY=US / SHAK=US / WING=US / ARGX=US / ACBI=US / SQ=US / 82982L103 / TVTY=US / JELD=US / SFIX=US / HWC=US / BTAI=US / LSPD=US / FERG=US / OPCH=US / ARQT=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / AAR Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Shift4 Payments Inc / Compugen Ltd / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / SouthState Corp / Regions Financial Corp / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Wingstop Inc / argenx SE / Atlantic Capital Bancshares Inc / Block Inc / SiteOne Landscape Supply Inc / Tivity Health Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Lightspeed Commerce Inc / Ferguson PLC / Option Care Health Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - June 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">US1096411004 / US1475281036 / US2017231034 / US5010441013 / US6703461052 / US75886F1075 / US8425871071 / US8581191009 / US8851601018 / US9746371007 / CA0679011084 / US9129091081 / CA1349211054 / US9604131022 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / US91912E1055 / CA22576C1014 / NL0009434992 / CA0194561027 / CA04315L1058 / CA3874371147 / CA16141A1030 / CA8661201167 / CA6674951059 / CA0266951064 / CA58546R1091 / CA17039A1066 / CA72820F1036 / CA45868C1095 / CA26153P1045 / CA1264621006 / LU1057788488 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / CA49410M1023 / US13462K1097 / US8608971078 / CA8585221051 / CA46136U1030 / CA05585D1033 / US48251W1045 / CA60448E1034 / CA4039254079 / US03990B1017 / US2605571031 / CA7426943006 / US09260D1072 / US03768E1055 / CA31890B1031 / US14316J1088 / US12529R1077 / CA33843T1084</td><td class="leftalignment">Brinker International Inc / Caseys General Stores Inc / Commercial Metals Co / Kroger Co / Nucor Corp / Regeneron Pharmaceuticals Inc / Southern Co / Steel Dynamics Inc / Thor Industries Inc / Winnebago Industries Inc / Barrick Gold Corp / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Westlake Chemical Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Vale SA / Crescent Point Energy Corp / LyondellBasell Industries NV / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Summit Industrial Income REIT / NorthWest Healthcare Properties REIT / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Plaza Retail REIT / Interfor Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Trinseo PLC / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Killam Apartment REIT / Camping World Holdings Inc / Stitch Fix Inc / Stelco Holdings Inc / Invesque Inc / BSR Real Estate Investment Trust / KKR & Co Inc / Minto Apartment Real Estate Investment Trust / H&R Real Estate Investment Trust / Ares Management Corp / Dow Inc / PRO Real Estate Investment Trust / Blackstone Inc / Apollo Global Management Inc / First Capital Real Estate Investment Trust / Carlyle Group Inc / C4 Therapeutics Inc / Flagship Communities Real Estate Investment Trust</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Cayman Islands / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Lagging on LAG, Waiting for Co-Stims; New ADC and METxMET Potentially Met-erial</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2065159 / 2216850 / 2270726 / 2542049 / 2829515 / 2576941 / 2328915 / 2455965 / 2457864 / 2689560 / 2684703 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / BBGVT40 / BYVY8G0 / BP4GNK9 / BYNZGK1 / BJ2Z0H2 / BMQ5T49 / BFMXGR0 / BFNR303 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BDVLM39 / BP8XZL1 / BMG5660</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Autodesk Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / News Corp / Alphabet Inc / SAGE Therapeutics Inc / Block Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Northwest Natural Holding Co / ViacomCBS Inc / Roku Inc / Alphabet Inc / argenx SE / Healthequity Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Initial Costim Data Checks Box On Safety-Novel METxMET Bispecific Is Promising</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Post-ASCO Updates Highlights Breadth of Oncology Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">METxMET could be bigger than the Met Ball; novel onc approaches combined with CPI are key to upside</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Incremental Updates from REGN's Oncology Portfolio; LAG3+PD-1 Combo Offers a Competitive Alternative to CTLA4+PD-1</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BAYRY-US -  Dividend Quality Analysis, for the period ended May 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BAYRY.PK / JNJ / LLY / MRK / NVS / PFE / GSK / REGN.O / NKTR.O / TEVA.K / SNY.O</td><td class="leftalignment">Bayer AG / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 28, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Jun. 07, 2021 / 4:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING SOON @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: KOL Video Call To Discuss ASCO Highlights at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM / JNJ / LLY / MRK / PFE / GILD.O / US75886F1075 / BSLN.S / HTBX.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Basilea Pharmaceutica AG / Heat Biologics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">75886F107 / 404251100 / 600544100 / 858155203 / 747619104 / 09075G105 / 02156K103 / 18978H10 / 375036100</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / HNI Corp / MillerKnoll Inc / Steelcase Inc / Quanex Building Products Corp / Biofrontera AG / Altice USA Inc / CNS Pharmaceuticals Inc / Uphealth Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Matthew Harrigan / Mr. Reuben Garner / Mr. Bruce D. Jackson / Mr. Bill Sutherland / Mr. Michael P. Ward, CFA / Mr. Mark W. Schappel</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">REGEN-COV Sales Are Harder To Predict</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: REPL results; LOGC & ALNY clinical progress</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">REPL.OQ / EBS / ISEE / ARCT / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / RGLS / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / CBIO / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / IOVA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / SIOX / N71542109 / 03820J100</td><td class="leftalignment">Replimune Group Inc / Emergent BioSolutions Inc / Iveric Bio Inc / Arcturus Therapeutics Holdings Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FISV=US / MRK=US / LLY=US / PEP=US / AMGN=US / CAG=US / KO=US / CL=US / PG=US / T=US / INCY=US / GILD=US / ENR=US / MANH=US / NWL=US / FLO=US / STZ=US / PATH=US / ENV=US / CENT=US / CHD=US / COLL=US / EPC=US / HAIN=US / REGN=US / SMG=US / FOUR=US / POST=US / GPN=US / SNV=US / AUTL=US / MGNI=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / BIIB=US / FRPT=US / DENN=US / THS=US / FIS=US / ELF=US / TIL=US / AAN=US / UTZ=US / OLO=US / MEIP=US / ABBV=US / FATE=US / COUP=US / SQ=US / NTLA=US / IOVA=US / PETQ=US / EQH=US / KDP=US / BTAI=US / HARP=US / LSPD=US / RPAY=US / BRBR=US / GMAB=US / REYN=US / ZI=US / BIGC=US / HYFM=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Energizer Holdings Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / UiPath Inc / Envestnet Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Shift4 Payments Inc / Post Holdings Inc / Global Payments Inc / Synovus Financial Corp / Autolus Therapeutics PLC / Magnite Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Fidelity National Information Services Inc / elf Beauty Inc / Instil Bio Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / Coupa Software Inc / Block Inc / Intellia Therapeutics Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Equitable Holdings Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Harpoon Therapeutics Inc / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Genmab A/S / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Senolytics Platform Offers Novel Targets Within Retinopathies; Initiating With Buy Rating and $12 PT</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">UBX.OQ / BIIB / 75886F107 / 00771V108 / 67576A100 / RZLT.OQ / 00810B105 / 67577C105 / CGEM.OQ</td><td class="leftalignment">UNITY Biotechnology Inc / Biogen Inc / Regeneron Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Ocular Therapeutix Inc / Rezolute Inc / Aadi Bioscience Inc / Ocugen Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">China / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew S. Fein / Matthew Caufield / Andres Y. Maldonado, PhD / Ananda Ghosh, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/06/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Updates/Upcoming; Week Ahead & Week in Review</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US00287Y1091 / US09058V1035 / US45337C1027 / US75886F1075 / US02043Q1076 / US88322Q1085 / US29251M1062 / US45826J1051 / KYG108301006 / US6047491013 / US65487U1088 / US59101E1038 / US81181C1045 / US89422G1076 / US2300311063</td><td class="leftalignment">Abbvie Inc / BioCryst Pharmaceuticals Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / TG Therapeutics Inc / Enanta Pharmaceuticals Inc / Intellia Therapeutics Inc / Beyondspring Inc / Mirum Pharmaceuticals Inc / Nkarta Inc / Metacrine Inc / Seagen Inc / Travere Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ASCO 2021 Generally Incremental for Our Covered Names</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">031162100 / 75886F107 / 24344T101 / 46565G104</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Iteos Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MONDAY 6/7 @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Updated EUA for REGEN-COV for prevention includes lower dose & subcu; could increase use</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009 / US1266501006 / US3755581036 / US4448591028 / US75886F1075 / US15135B1017 / US74587V1070 / US31189P1021 / US0367521038 / US03969F1093 / US1255231003 / US71944F1066</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Gilead Sciences Inc / Humana Inc / Regeneron Pharmaceuticals Inc / Centene Corp / Puma Biotechnology Inc / Fate Therapeutics Inc / Anthem Inc / Arcus Biosciences Inc / Cigna Corp / Phreesia Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row: The Bleeding Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">MONDAY 6/7 @ 12 PM ET: Join Our Virtual KOL Conference Call to Discuss ASCO Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US0311621009 / US31189P1021 / US3755581036 / US75886F1075 / US74587V1070 / US03969F1093</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IGMS (BUY) - Mgmt Discussion Highlights Potential COVID-19 Prophylaxis Opportunity with IGM-6268, a New Pipeline Agent</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKS3SM8 / 0925288 / 2516152 / 2730190</td><td class="leftalignment">IGM Biosciences Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss EHA Highlights on 6/14 at 11 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US00847X1046 / US03753U1060 / US75886F1075 / US92532F1003 / US37890U1088 / US2312692005</td><td class="leftalignment">Agios Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Global Blood Therapeutics Inc / Curis Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Jun. 02, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: May 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CAH.N / CC.N / CL.N / COF.N / CRM.N / ECL.N / EIX.N / EOG.N / F.N / FCX.N / FDX.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KMB.N / LLY.N / LMT.N / MRK.N / SC.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / AAL.L / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / NKE.N / LIN.N / OLN.N / IT.N / TGT.N / AVY.N / RKT.N / BLL.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / VFC.N / NRG.N / PWR.N / NEU.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / HAE.N / PVH.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / INTC.OQ / CTSH.OQ / ABMD.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / JKHY.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / SIVB.OQ / QDEL.OQ / QCOM.OQ / INTU.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / STLD.OQ / AMZN.OQ / LNG.A / MRCY.OQ / NVDA.OQ / SBAC.OQ / BMRN.OQ / PACW.OQ / TREE.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / TXN.OQ / CMCSA.OQ / BIIB.OQ / TPX.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / WAL.N / MS.N / FIS.N / STX.AX / RPRX.OQ / HES.N / MA.N / AWI.N / FSLR.OQ / CNK.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / NEE.N / TSLA.OQ / LPLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / LDOS.N / RNG.N / COMM.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / SQ.N / IONS.OQ / IAC.OQ / TTD.OQ / COUP.OQ / UAA.N / AYX.N / DXC.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / QRTEA.OQ / FB.PS / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / LMND.N / AMWL.N / VTRS.OQ / HON.OQ</td><td class="leftalignment">Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Cardinal Health Inc / Chemours Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Linde PLC / Olin Corp / Gartner Inc / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / VF Corp / NRG Energy Inc / Quanta Services Inc / NewMarket Corp / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Haemonetics Corp / PVH Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Jack Henry & Associates Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Quidel Corp / Qualcomm Inc / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Lendingtree Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Western Alliance Bancorp / Morgan Stanley / Fidelity National Information Services Inc / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Cinemark Holdings Inc / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / LPL Financial Holdings Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / Leidos Holdings Inc / RingCentral Inc / CommScope Holding Company Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Block Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Trade Desk Inc / Coupa Software Inc / Under Armour Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Lemonade Inc / American Well Corp / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / United Kingdom / Ireland / Luxembourg / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 21, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Sanofi - Read across from Kyowa Kirin/Amgen collaboration for OX-40 in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SASY.PA / LLY.N / AZN.L / 4151.T / REGN.OQ / ALM.MC</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / AstraZeneca PLC / Kyowa Kirin Co Ltd / Regeneron Pharmaceuticals Inc / Almirall SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Spain / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Promising efficacy signals from SIGHT and MRNA</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / ISEE / ARCT / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / RGLS / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / CBIO / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / IOVA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / SIOX / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Iveric Bio Inc / Arcturus Therapeutics Holdings Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/29/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Updates/Upcoming; Week Ahead & Week In Review</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US00287Y1091 / US75886F1075 / US09609G1004 / US4576693075 / US88322Q1085 / US4277461020 / US23257D1037 / BMG637AM1024 / KYG108301006 / US84833T1034 / US6047491013 / US69353Y1038 / US12529R1077 / US68236R1032</td><td class="leftalignment">Abbvie Inc / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Insmed Inc / TG Therapeutics Inc / Heron Therapeutics Inc / Cymabay Therapeutics Inc / Myovant Sciences Ltd / Beyondspring Inc / Spero Therapeutics Inc / Mirum Pharmaceuticals Inc / PMV Pharmaceuticals Inc / C4 Therapeutics Inc / Oncorus Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">05/29/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 82 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / XOM.N / NKE.N / SNN.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / TDY.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PYPL.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / IQV.N / WELL.N / TLRY.OQ / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / Nike Inc / Smith & Nephew PLC / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Teledyne Technologies Inc / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PayPal Holdings Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / IQVIA Holdings Inc / Welltower Inc / Tilray Brands Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Defense / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Regeneron (REGN: $502.43) rises for a third consecutive month, a three-month rise of 12%</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.28.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What’s Next in Biotech? Deal or No DLL - A Pre-Memorial Day Weekend Oncology Read</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 2730190 / BGCYWN8</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN=US / DIS=US / MCD=US / AGL=US / AMZN=US / T=US / GILD=US / NVDA=US / PEB=US / H=US / MTN=US / VRM=US / SCOR=US / EWBC=US / BRO=US / MAR=US / UMPQ=US / TNL=US / HLT=US / WTFC=US / CHH=US / CW=US / DRH=US / DCO=US / AJG=US / MCRI=US / PACW=US / HOOK=US / REGN=US / WAL=US / HTH=US / SNOW=US / CGEN=US / BXS=US / FNF=US / CFB=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / WRE=US / CATY=US / GBCI=US / REG=US / NFLX=US / ECPG=US / PNFP=US / SBCF=US / PRAA=US / STRO=US / BIIB=US / FNB=US / FHN=US / SHO=US / RNST=US / REX=US / HST=US / ELF=US / CADE=US / TAST=US / QSR=US / NMTR=US / WH=US / RCUS=US / HGV=US / NLSN=US / PCRX=US / RLJ=US / VAC=US / MEIP=US / RHP=US / ABBV=US / IBTX=US / FATE=US / NMIH=US / EVH=US / ACBI=US / PK=US / LGF.B=US / PLYA=US / OKTA=US / CVNA=US / ROKU=US / HWC=US / BTAI=US / OZK=US / ALLO=US / HARP=US / PLMR=US / HCAT=US / AVAH=US</td><td class="leftalignment">Amgen Inc / Walt Disney Co / McDonald's Corp / agilon health Inc / Amazon.com Inc / AT&T Inc / Gilead Sciences Inc / NVIDIA Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Vroom Inc / Comscore Inc / East West Bancorp Inc / Brown & Brown Inc / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / Choice Hotels International Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Snowflake Inc. / Compugen Ltd / Cadence Bank / Fidelity National Financial Inc / Crossfirst Bankshares Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Washington Real Estate Investment Trust / Cathay General Bancorp / Glacier Bancorp Inc / Regency Centers Corp / Netflix Inc / Encore Capital Group Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / PRA Group Inc / Sutro Biopharma Inc / Biogen Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / REX American Resources Corp / Host Hotels & Resorts Inc / elf Beauty Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / MEI Pharma Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Fate Therapeutics Inc / NMI Holdings Inc / Evolent Health Inc / Atlantic Capital Bancshares Inc / Park Hotels & Resorts Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Okta Inc / Carvana Co / Roku Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Bank Ozk / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Palomar Holdings Inc / Health Catalyst Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Regeneron Pharmaceuticals Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US5627501092 / 75886F107 / 01609W102 / 47215P106 / 44332N106 / KYG596691041 / 722304102 / 22564L105 / 120438074</td><td class="leftalignment">Manhattan Associates Inc / Regeneron Pharmaceuticals Inc / Alibaba Group Holding Ltd / JD.Com Inc / Huazhu Group Ltd / Meituan / Pinduoduo Inc / LiveVox Holdings Inc / Holley Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Ms. Fawne Jiang / Long Lin / Mr. Mark W. Schappel / Mr. John Lawrence / Mr. Michael P. Ward, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Why is the Low-dose EUA Taking So Long?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / AMZN=US / T=US / INCY=US / GILD=US / VZ=US / CHRS=US / EWBC=US / MANH=US / MLM=US / DV=US / WTFC=US / AIZ=US / CBRL=US / ELY=US / EXEL=US / HEI=US / MAIN=US / OKE=US / HOOK=US / REGN=US / GOLF=US / CGEN=US / CFB=US / SNV=US / SIVB=US / ABCB=US / FB=US / FBK=US / SSB=US / GBCI=US / NLS=US / PNFP=US / SBCF=US / JRVR=US / STRO=US / RNG=US / IAC=US / RCUS=US / CLNY=US / KNSL=US / MEIP=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / ACBI=US / ZS=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / OZK=US / FTDR=US / ALLO=US / HARP=US / UBER=US / GMAB=US / AVAH=US / VMEO=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Amazon.com Inc / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / Coherus BioSciences Inc / East West Bancorp Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Wintrust Financial Corp / Assurant Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Exelixis Inc / HEICO Corp / Main Street Capital Corp / ONEOK Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Acushnet Holdings Corp / Compugen Ltd / Crossfirst Bankshares Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / Meta Platforms Inc / FB Financial Corp / SouthState Corp / Glacier Bancorp Inc / Nautilus Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Sutro Biopharma Inc / RingCentral Inc / IAC/Interactivecorp / Arcus Biosciences Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / MEI Pharma Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / Genmab A/S / Aveanna Healthcare Holdings Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ASCO Planner v2.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Regeneron lifts 9.9% in past quarter; Institutional Ownership up 1%</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Initiating Coverage of Werewolf Therapeutics; Cancer’s Worst Nightmare</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">HOWL.OQ / BIIB / 75886F107 / 00847G705 / M25722105 / ALPN.OQ / 23284F105 / 98985W102 / 41358P106 / 869367102 / 64049K104 / ALXO.OQ / ITOS.OQ / 449585108 / 58490H107</td><td class="leftalignment">Werewolf Therapeutics Inc / Biogen Inc / Regeneron Pharmaceuticals Inc / Agenus Inc / Compugen Ltd / Alpine Immune Sciences Inc / CytomX Therapeutics Inc / Zymeworks Inc / Harpoon Therapeutics Inc / Sutro Biopharma Inc / Neoleukin Therapeutics Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / IGM Biosciences Inc / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">A Story Coming Into Full Rezolution; Initiate With Buy and a $21 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">RZLT.OQ / 75886F107 / 98920Y304 / 483497103 / 98419J206 / 22663K107 / 69012T107</td><td class="leftalignment">Rezolute Inc / Regeneron Pharmaceuticals Inc / Zealand Pharma A/S / Kalvista Pharmaceuticals Inc / XOMA Corp / Crinetics Pharmaceuticals Inc / Outlook Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Douglas D. Tsao</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 14, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING NOW: KOL Call to Discuss Emerging Therapies in IgAN and LN (KDNY, VRTX, REGN, ALNY, AUPH, OMER)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KDNY.OQ / US75886F1075 / US92532F1003 / US02043Q1076 / CA05156V1022</td><td class="leftalignment">Chinook Therapeutics Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Aurinia Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Emma K. Nealon, III / Ms. Alethia R. Young</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US92532F1003 / US68554V1089 / US09060J1060 / US02043Q1076 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US48576U1060 / US2697961082 / CA4990531069 / US03209R1032 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US53222K2050 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Knight Therapeutics Inc / Amphastar Pharmaceuticals Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / LifeVantage Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TODAY @ 1pm ET: KOL Call to Discuss Emerging Therapies in IgAN and LN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KDNY.OQ / US75886F1075 / US92532F1003 / US02043Q1076 / CA05156V1022</td><td class="leftalignment">Chinook Therapeutics Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Aurinia Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Emma K. Nealon, III / Ms. Alethia R. Young</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TODAY @ 1pm ET: KOL Call to Discuss Emerging Therapies in IgAN and LN - KDNY, VRTX, AUPH, REGN, and ALNY</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075 / US92532F1003 / US02043Q1076 / CA05156V1022</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Aurinia Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: NeuBase is a Chardan Top Pick for 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">NBSE.OQ / EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">NeuBase Therapeutics Inc / Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Highlights in Melanoma and Early Phase IO from our ASCO KOL Preview Day</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">75886F10 / 640268108 / 58933Y10 / G0176710 / 76029N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Merck & Co Inc / Alkermes Plc / Replimune Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">RSV Could Be the Next $10bn Vaccine Market. Who’s Best Positioned?</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">71708110 / 04635310 / 75886F10 / 478160104 / 58933Y10 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Merck & Co Inc / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AEP.N / AES.N / ANTO.L / BAC.N / BK.N / C.N / CL.N / CMS.N / COF.N / CRM.N / EIX.N / EL.N / FGP.L / FITB.O / JPM.N / KEY.N / KMB.N / KO.N / MRK.N / NTRS.O / PEG.N / PFE.N / PNC.N / RWEG.DE / SO.N / T.N / USB.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / CMCSA.O / CHKP.O / AAL.L / DUK.N / HBAN.O / D.N / K.N / DT.N / DISH.O / ADBE.O / CLX.N / CAG.N / SUN.N / GIS.N / PAA.N / EPC.N / AMT.N / VZ.N / STT.N / HCA.N / EXEL.O / XEL.N / ARNA.O / STZ.N / VFC.N / GEL.N / EXC.N / FISV.O / ADSK.O / V.N / EPD.N / CHTR.O / AWK.N / ARE.N / CHD.N / NWN.N / MTB.N / VTR.N / SAM.N / BMRN.O / REGN.O / ENR.N / NCR.N / GFI.N / VRNT.O / RF.N / CNP.N / APF.L / BKH.N / CPK.N / FRC.N / SR.N / WES.N / LTC.N / AMH.N / LNG.A / NTCT.OQ / SGEN.OQ / GPN.N / MNST.O / SIVB.O / CASY.O / MMP.N / ATDb.TO / TFC.N / DCP.N / 02209S103 / CWX.TO / EDR.N / 427866108 / WEF.TO / MPW.N / RDSb.L / DISCA.O / SJW.N / BKD.N / FIS.N / MA.N / BGS.N / EDPR.LS / UTL.N / VALE.N / SPB.N / NEE.N / PCH.O / TRGP.N / IFP.TO / ACHC.O / RFP.N / PANW.N / MDLZ.OQ / SMLP.N / WDAY.N / MPLX.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / DOC.N / BEP.N / 81762P102 / CEQP.N / COUP.N / ENLC.N / RYAM.N / CFG.N / CAPL.N / SHLX.N / CTRE.O / PYPL.OQ / SGRY.O / SQ.N / MESO.O / NTNX.O / GDS.O / INVH.N / UNIT.O / OKTA.OQ / ATNX.O / WELL.N / ZS.OQ / KDP.N / ETRN.N / NWL.O / ZM.O / GMAB.O / PEAK.N / DHC.O / WTRG.N / REYN.O / IGIC.OQ / FOUR.N / NRIX.OQ / LUMN.N / WFG.N / NUVB.N / NAPA.N / OSO.N / AVAH.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Antofagasta PLC / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Salesforce.Com Inc / Edison International / Estee Lauder Companies Inc / FirstGroup PLC / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Public Service Enterprise Group Inc / Pfizer Inc / PNC Financial Services Group Inc / Rwe AG / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Anglo American PLC / Duke Energy Corp / Huntington Bancshares Inc / Dominion Energy Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Adobe Inc / Clorox Co / Conagra Brands Inc / Sunoco LP / General Mills Inc / Plains All American Pipeline LP / Edgewell Personal Care Co / American Tower Corp / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / VF Corp / Genesis Energy LP / Exelon Corp / Fiserv Inc / Autodesk Inc / Visa Inc / Enterprise Products Partners LP / Charter Communications Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Ventas Inc / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / Gold Fields Ltd / Verint Systems Inc / Regions Financial Corp / CenterPoint Energy Inc / Anglo Pacific Group PLC / Black Hills Corp / Chesapeake Utilities Corp / First Republic Bank / Spire Inc / Western Midstream Partners LP / LTC Properties Inc / American Homes 4 Rent / Cheniere Energy Inc / Netscout Systems Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Magellan Midstream Partners LP / Alimentation Couche-Tard Inc / Truist Financial Corp / DCP Midstream LP / Altria Group Inc / Doman Building Materials Group Ltd / Endeavor Group Holdings Inc / Hershey Co / Western Forest Products Inc / Medical Properties Trust Inc / Royal Dutch Shell PLC / Discovery Inc / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Mastercard Inc / B&G Foods Inc / EDP Renovaveis SA / Unitil Corp / Vale SA / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / Targa Resources Corp / Interfor Corp / Acadia Healthcare Company Inc / Resolute Forest Products Inc / Palo Alto Networks Inc / Mondelez International Inc / Summit Midstream Partners LP / Workday Inc / MPLX LP / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Physicians Realty Trust / Brookfield Renewable Partners LP / ServiceNow Inc / Crestwood Equity Partners LP / Coupa Software Inc / EnLink Midstream LLC / Rayonier Advanced Materials Inc / Citizens Financial Group Inc / Crossamerica Partners LP / Shell Midstream Partners LP / CareTrust REIT Inc / PayPal Holdings Inc / Surgery Partners Inc / Block Inc / Mesoblast Ltd / Nutanix Inc / GDS Holdings Ltd / Invitation Homes Inc / Uniti Group Inc / Okta Inc / Athenex Inc / Welltower Inc / Zscaler Inc / Keurig Dr Pepper Inc / Equitrans Midstream Corp / Newell Brands Inc / Zoom Video Communications Inc / Genmab A/S / Healthpeak Properties Inc / Diversified Healthcare Trust / Essential Utilities Inc / Reynolds Consumer Products Inc / International General Insurance Holdings Ltd / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Duckhorn Portfolio Inc / Olo Inc / Aveanna Healthcare Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Innovating Next-Gen Therapeutic and Prophylactic Immunotherapies; Initiating at Buy and $25 PT</td><td class="leftalignment">English</td><td class="rightalignment">85</td><td class="leftalignment">VACC.OQ / 75886F107 / 30161Q104 / 556099109 / 60468T105 / 04280A100 / 09627Y109 / 91822J103 / 92511W108 / 19249H103 / 09075V102 / 43906K100 / G10830100 / 70465T107 / 66988N106 / BWBSJ10</td><td class="leftalignment">Vaccitech PLC / Regeneron Pharmaceuticals Inc / Exelixis Inc / MacroGenics Inc / Mirati Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / VBI Vaccines Inc / Verrica Pharmaceuticals Inc / Coherus BioSciences Inc / BioNTech SE / HOOKIPA Pharma Inc / Beyondspring Inc / PDS Biotechnology Corp / Novan Inc / OSE Immunotherapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Yi Chen, Ph.D. CFA / Raghuram Selvaraju, Ph.D. / Boobalan Pachaiyappan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/22/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Biospiracy, Updates & Upcoming</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09061G1013 / US45337C1027 / US75886F1075 / US6402681083 / US09609G1004 / US8036071004 / US88322Q1085 / US1894641000 / US90400D1081 / CA89620X5064 / US4622221004 / BMG637AM1024 / US84833T1034 / US65487U1088 / US59101E1038 / US81181C1045 / US2300311063 / US92765F1084</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / bluebird bio Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Clovis Oncology Inc / Ultragenyx Pharmaceutical Inc / Pfizer Inc / Ionis Pharmaceuticals Inc / Myovant Sciences Ltd / Spero Therapeutics Inc / Nkarta Inc / Metacrine Inc / Seagen Inc / Cullinan Oncology Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">05/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / PRTA.O / MESO.O / ATNX.O / GMAB.O / NRIX.OQ / NUVB.N</td><td class="leftalignment">Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Mesoblast Ltd / Athenex Inc / Genmab A/S / Nurix Therapeutics Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">2434209 / 2936921 / 2496113 / 2973821 / 2050832 / 2942605 / 2219224 / 2190750 / 2208073 / 2280220 / 2270726 / 2317087 / 2455965 / 2459020 / 2600088 / 2630513 / 2657802 / 2048804 / 2730190 / 2746711 / 2829601 / B1F76F9 / 2857817 / B02R1L6 / B3D7K31 / 2598246 / B03PGL4 / B7TL820 / B4V9661 / BJ0KXV4 / B87ZMX0 / BFH3N85 / BP4GNK9 / BZ1HM42 / BJ5FZ74 / BJ2Z0H2 / BFZ1K46 / BMYML02 / BFMXGR0 / BYXJQG9 / BFXC911 / BKTNTR9 / BFWK4R7 / BGKG6M3 / BNRQM83 / BMDJ085</td><td class="leftalignment">Home Depot Inc / Walmart Inc / Kohls Corp / Alliant Energy Corp / Ameren Corp / Avista Corp / CMS Energy Corp / Chesapeake Utilities Corp / Copart Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Biogen Inc / Intuit Inc / Monro Inc / New Jersey Resources Corp / OGE Energy Corp / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Southern Co / Western Union Co / Netflix Inc / ALLETE Inc / Discovery Inc / Neogenomics Inc / NorthWestern Corp / Meta Platforms Inc / Ralph Lauren Corp / ONE Gas Inc / Palo Alto Networks Inc / Veeva Systems Inc / SAGE Therapeutics Inc / Adyen NV / Adaptive Biotechnologies Corp / Pinterest Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Spire Inc / Guardant Health Inc / ViacomCBS Inc / PagSeguro Digital Ltd / StoneCo Ltd / Petco Health and Wellness Company Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Luxembourg / Mexico / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US4228061093 / US45253H1014 / US75886F1075 / US8968181011 / 44842L103 / 89377M109 / 86150R107 / 09203E105 / 22788C105 / 82657L107</td><td class="leftalignment">HEICO Corp / ImmunoGen Inc / Regeneron Pharmaceuticals Inc / Triumph Group Inc / HUTCHMED (China) Ltd / Transmedics Group Inc / Stoke Therapeutics Inc / Black Diamond Therapeutics Inc / CrowdStrike Holdings Inc / Sigilon Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Libtayo improves OS, PFS measures in NSCLC vs Keytruda; favorable in brain metastases</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00846U1016 / US0311621009 / US2666051048 / US3755581036 / US75886F1075 / US02043Q1076 / US74587V1070 / IL0011313900 / CA68620P1018 / CA1380351009 / US03969F1093 / US88688T1007 / US15117B2025 / CA05156X8843 / US56854Q2003 / US40434H2031 / CA4283043079</td><td class="leftalignment">Agilent Technologies Inc / Amgen Inc / DURECT Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Puma Biotechnology Inc / Galmed Pharmaceuticals Ltd / OrganiGram Holdings Inc / Canopy Growth Corp / Arcus Biosciences Inc / Tilray Brands Inc / Celldex Therapeutics Inc / Aurora Cannabis Inc / Marinus Pharmaceuticals Inc / HTG Molecular Diagnostics Inc / Hexo Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">All Good Things Must Come to an End - Biotech Outflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">NA / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - First Positive Clinical Data for Fianlimab/Libtayo Combo in Advanced Melanoma to Be Presented at ASCO; Investor Webcast on June 7th</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss ASCO Highlights on 6/7 at 12 PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN.O / FATE.O / GILD.O / REGN.O / PBYI.O / RCUS.K</td><td class="leftalignment">Amgen Inc / Fate Therapeutics Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000077919 / US0126531013 / US0311621009 / US0530151036 / US1264081035 / US17275R1023 / US22284P1057 / US2310211063 / US30161Q1040 / US3614481030 / US3755581036 / US3936571013 / US4456581077 / US45253H1014 / US45337C1027 / US6558441084 / US66987V1098 / US6795801009 / US6937181088 / US7043261079 / US75886F1075 / US7782961038 / US8447411088 / US8725401090 / US87612E1064 / US8965221091 / US9029251066 / US9078181081 / US9297401088 / US9507551086 / CA1363751027 / CA13645T1003 / US3570231007 / US9043111072 / US78709Y1055 / US29089Q1058 / US9837931008 / US74587V1070 / US16934W1062 / US29428V1044 / US1220171060 / US5560991094 / US70438V1061 / US70432V1026 / US03937C1053 / US09627Y1091 / US00653A1079 / US07725L1026 / CA87241L1094 / US23753F1075 / US80689H1023 / US3621LQ1099 / US4990491049 / US8760301072 / CA53680Q2071 / US02083G1004 / US1010441053 / US67022C1062 / US4622601007 / VGG273581030 / US05351X1019 / SE0009414576 / US15677J1088 / US86877M2098 / US55910K1088 / US29260V1052 / US9842411095 / KY30744W1070 / US8693671021 / US40131M1099 / US0197701065 / US53814L1089 / US18453H1068 / CA16106R1091 / US09203E1055 / US92537N1081 / CH0499880968 / US05370A1088 / US81181C1045 / US74767V1098 / US55406W1036 / US15961R1059 / US49926T1043 / US83089J1088</td><td class="leftalignment">JCDecaux SA / Albemarle Corp / Amgen Inc / Automatic Data Processing Inc / CSX Corp / Cisco Systems Inc / Covenant Logistics Group Inc / Cummins Inc / Exelixis Inc / GATX Corp / Gilead Sciences Inc / Greenbrier Companies Inc / J B Hunt Transport Services Inc / ImmunoGen Inc / Incyte Corp / Norfolk Southern Corp / Novartis AG / Old Dominion Freight Line Inc / Paccar Inc / Paychex Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Southwest Airlines Co / TJX Companies Inc / Target Corp / Trinity Industries Inc / USA Truck Inc / Union Pacific Corp / Westinghouse Air Brake Technologies Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / FreightCar America Inc / Under Armour Inc / Saia Inc / Emergent BioSolutions Inc / XPO Logistics Inc / Puma Biotechnology Inc / Chimerix Inc / Epizyme Inc / Burlington Stores Inc / MacroGenics Inc / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Blueprint Medicines Corp / Adaptimmune Therapeutics PLC / Beigene Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / G1 Therapeutics Inc / Knight-Swift Transportation Holdings Inc / Tapestry Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Boston Omaha Corp / NuCana PLC / Iovance Biotherapeutics Inc / Despegar.com Corp / Avaya Holdings Corp / Oncopeptides AB / Ceridian HCM Holding Inc / Surface Oncology Inc / Magenta Therapeutics Inc / Endava PLC / Y-mAbs Therapeutics Inc / Farfetch Ltd / Sutro Biopharma Inc / Guardant Health Inc / Allogene Therapeutics Inc / Livent Corp / Clear Channel Outdoor Holdings Inc / Charlotte's Web Holdings Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / ADC Therapeutics SA / Avidity Biosciences Inc / Seagen Inc / Quantumscape Corp / MYT Netherlands Parent BV / ChargePoint Holdings Inc / Knowbe4 Inc / Skywater Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN=US / BMY=US / HD=US / ADI=US / T=US / GILD=US / AMT=US / PEB=US / H=US / MTN=US / VZ=US / LOW=US / MAR=US / ADS=US / TTWO=US / TNL=US / HLT=US / BMRN=US / CHH=US / CPRT=US / DRH=US / RARE=US / REGN=US / STRO=US / EXP=US / AWH / SHO=US / NSP=US / HST=US / WH=US / TIL=US / JACK=US / RCUS=US / HGV=US / RLJ=US / VAC=US / MEIP=US / RHP=US / FATE=US / 00770K202 / UPLD=US / VVV=US / PK=US / GDS=US / PLYA=US / IOVA=US / BTAI=US / ALLO=US / FERG=US / SPCE=US / KNBE=US</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / Analog Devices Inc / AT&T Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Lowe's Companies Inc / Marriott International Inc / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Copart Inc / Diamondrock Hospitality Co / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sutro Biopharma Inc / Eagle Materials Inc / Aspira Women's Health Inc / Sunstone Hotel Investors Inc / Insperity Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / Jack in the Box Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / MEI Pharma Inc / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Aemetis Inc / Upland Software Inc / Valvoline Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Ferguson PLC / Virgin Galactic Holdings Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - May 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US8336351056 / IL0002810146 / US0326541051 / US0536111091 / US1270971039 / US25179M1036 / US26875P1012 / US3024913036 / US31428X1063 / US4062161017 / US4433201062 / US4456581077 / US6267171022 / US6516391066 / US6745991058 / US7237871071 / US75281A1097 / US75886F1075 / AN8068571086 / US8454671095 / US9113121068 / AU000000NCM7 / CA8787422044 / CA1247651088 / CA0679011084 / US5658491064 / CA3359341052 / US20825C1045 / US35671D8570 / CA2052491057 / US20451N1019 / US25754A2015 / CA98462Y1007 / US1252691001 / US12541W2098 / US42809H1077 / US16115Q3083 / US2120151012 / US26884L1098 / CA9838911027 / DE000BAY0017 / US78454L1008 / US6742151086 / US61945C1036 / DE000KSAG888 / US71922G2093 / US5017971046 / US69327R1014 / CA04364G1063 / CA74139C1023 / US5764852050 / US25278X1090 / US65540B1052 / US03674X1063 / US2057683029 / US15136A1025 / CA87241L1094 / GB00BDSFG982 / US74347M1080 / US05722G1004 / US12653C1080 / CA67077M1086 / US87484T1088 / US08579X1019 / CA14179V5036 / US22052L1044 / CA04302L1004 / US71722W1071 / US69047Q1022 / US5168062058 / US13123X5086 / US46121Y2019 / US62955J1034 / US03743Q1085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Icl Group Ltd / Analog Devices Inc / Avery Dennison Corp / Coterra Energy Inc / Devon Energy Corp / EOG Resources Inc / FMC Corp / FedEx Corp / Halliburton Co / Hub Group Inc / J B Hunt Transport Services Inc / Murphy Oil Corp / Newmont Corporation / Occidental Petroleum Corp / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Schlumberger NV / Southwestern Energy Co / United Parcel Service Inc / Newcrest Mining Ltd / Teck Resources Ltd / CAE Inc / Barrick Gold Corp / Marathon Oil Corp / First Quantum Minerals Ltd / Conocophillips / Freeport-McMoRan Inc / Computer Modelling Group Ltd / Compass Minerals International Inc / Domino's Pizza Inc / Yamana Gold Inc / CF Industries Holdings Inc / CH Robinson Worldwide Inc / Hess Corp / Chart Industries Inc / Continental Resources Inc / EQT Corp / Xebec Adsorption Inc / Bayer AG / SM Energy Co / Oasis Petroleum Inc / Mosaic Co / K&S AG / PhosAgro PAO / Bath & Body Works Inc / PDC Energy Inc / Ascot Resources Ltd / Pretium Resources Inc / Matador Resources Co / Diamondback Energy Inc / Noodles & Co / Antero Resources Corp / Comstock Resources Inc / Centennial Resource Development Inc / TFI International Inc / TechnipFMC PLC / ProPetro Holding Corp / Baker Hughes Co / CNX Resources Corp / Nutrien Ltd / Talos Energy Inc / Berry Corporation (Bry) / Cargojet Inc / Corteva Inc / Artemis Gold Inc / Phathom Pharmaceuticals Inc / Ovintiv Inc / Laredo Petroleum Inc / Callon Petroleum Co / Intrepid Potash Inc / Nov Inc / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Germany / United Kingdom / Israel / Russian Federation / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Four Highlights and Insights from ASCO Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">11012210 / 37555810 / 75886F10 / 03969F10 / F5548N10</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Arcus Biosciences Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Biotech Highlights From ASCO Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0311621009 / US30161Q1040 / US3755581036 / US45253H1014 / US45337C1027 / US66987V1098 / US75886F1075 / US74587V1070 / US16934W1062 / US29428V1044 / US5560991094 / US09627Y1091 / US00653A1079 / US3621LQ1099 / US02083G1004 / US4622601007 / SE0009414576 / US86877M2098 / US55910K1088 / US9842411095 / US8693671021 / CH0499880968 / US81181C1045</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Novartis AG / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Chimerix Inc / Epizyme Inc / MacroGenics Inc / Blueprint Medicines Corp / Adaptimmune Therapeutics PLC / G1 Therapeutics Inc / Alpine Immune Sciences Inc / Iovance Biotherapeutics Inc / Oncopeptides AB / Surface Oncology Inc / Magenta Therapeutics Inc / Y-mAbs Therapeutics Inc / Sutro Biopharma Inc / ADC Therapeutics SA / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - May 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NA / WY.N / CFP.TO / GILD.O / LPX.N / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / NBIX.O / WSP.TO / VTR.N / BMRN.O / OPTN.O / REGN.O / ARE.TO / JHX.AX / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / STN.TO / SNC.TO / CWX.TO / MNKD.OQ / ACAD.O / WEF.TO / MPW.N / LHCG.O / BKD.N / ARWR.O / CRR_u.TO / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / TOU.TO / PCH.O / PCRX.O / IFP.TO / ACHC.O / OPS.TO / VCRA.N / RFP.N / SRPT.O / CLINC.L / DLGD.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / CFF.TO / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / SRU_u.TO / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / VTRS.OQ / SHC.OQ / WFG.N / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Neurocrine Biosciences Inc / WSP Global Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Aecon Group Inc / James Hardie Industries PLC / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Stantec Inc / SNC-Lavalin Group Inc / Doman Building Materials Group Ltd / MannKind Corp / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / Crombie Real Estate Investment Trust / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Tourmaline Oil Corp / Potlatchdeltic Corp / Pacira Biosciences Inc / Interfor Corp / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Direct Line Insurance Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Conifex Timber Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / SmartCentres Real Estate Investment Trust / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Viatris Inc / Sotera Health Co / West Fraser Timber Co Ltd / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NA / SVT.L / TOL.N / GILD.O / DRI.N / EAT.N / MCD.N / YUM.N / HD.N / LOW.N / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / SBUX.O / CYH.N / ARNA.O / TJX.N / FISV.O / V.N / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / SRG.MI / ENDP.O / BLU.N / CHE.N / SGEN.OQ / GPN.N / ONC.TO / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / DPZ.N / TXRH.O / ACAD.O / MPW.N / LHCG.O / BKD.N / CMG.N / FIS.N / ARWR.O / MA.N / EHTH.O / ATL.MI / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / WEN.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / DLGD.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / QSR.N / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / SGRY.O / RGNX.O / SQ.N / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / FTV.N / RCM.OQ / OVID.O / ORSTED.CO / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / NTGY.MC / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / FOUR.N / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / ALOO.O / VTRS.OQ / SHC.OQ / DHT_u.TO / WING.N</td><td class="leftalignment">National Bank of Canada / Severn Trent PLC / Toll Brothers Inc / Gilead Sciences Inc / Darden Restaurants Inc / Brinker International Inc / McDonald's Corp / Yum! Brands Inc / Home Depot Inc / Lowe's Companies Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Starbucks Corp / Community Health Systems Inc / Arena Pharmaceuticals Inc / TJX Companies Inc / Fiserv Inc / Visa Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Snam SpA / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Global Payments Inc / Oncolytics Biotech Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / Domino's Pizza Inc / Texas Roadhouse Inc / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / eHealth Inc / Atlantia SpA / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Wendys Co / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Direct Line Insurance Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Restaurant Brands International Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / Block Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / Fortive Corp / R1 RCM Inc / Ovid Therapeutics Inc / Orsted A/S / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Naturgy Energy Group SA / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Shift4 Payments Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Allogene Therapeutics Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust / Wingstop Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">ASCO 2021 Virtual Annual Meeting Abstracts Review</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">031162100 / 75886F107 / 30161Q104 / 45253H101 / 189464100 / 31189P102 / 09627Y109 / 81750R102 / 462260100 / 41358P106 / 869367102 / 44975P103 / 02083G100 / 24344T101 / 46565G104 / 38406L103 / 81728A108 / 45256X103</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / ImmunoGen Inc / Clovis Oncology Inc / Fate Therapeutics Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / Sutro Biopharma Inc / I-Mab / Alpine Immune Sciences Inc / Deciphera Pharmaceuticals Inc / Iteos Therapeutics Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Capital Markets Global Healthcare Virtual Conference</td><td class="leftalignment">English</td><td class="rightalignment">81</td><td class="leftalignment">NA / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Financial Services / Healthcare / Insurance / Manufacturing / Pharmaceuticals / Real Estate / Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">RBCCM Australia Research / Mr. Gregory J. Renza, MD / Douglas M. Miehm / Mr. Charles Weston / Brian Abrahams, MD / Daniel Busby / Michael W. Carroll, CFA / Mr. Sean W. Dodge, CFA / Mr. Anton Hie / Mr. Luca Issi, PHD / Kennen MacKay, PHD / Frank G. Morgan</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">US00461U1051 / US5288723027 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US91307C1027 / US92532F1003 / US68554V1089 / US09060J1060 / US02043Q1076 / CA87402A1084 / US58933Y1055 / US92345Y1064 / US42805E3062 / US48576U1060 / US2697961082 / US03209R1032 / US14167L1035 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US53222K2050 / BSP733981026 / US4622221004 / US44842L1035 / US1710774076 / US64049K1043 / US04537Y1091 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Taiga Building Products Ltd / Merck & Co Inc / Verisk Analytics Inc / Heska Corp / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / LifeVantage Corp / Nymox Pharmaceutical Corp / Ionis Pharmaceuticals Inc / HUTCHMED (China) Ltd / Chromadex Corp / Neoleukin Therapeutics Inc / Aspira Women's Health Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bahamas / Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">MEIP/RCUS have stellar data, stock could be up; but given the market condition -?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD=US / MEIP.OQ / RCUS=US / AMGN=US / REGN=US / GILD.OQ / MEIP=US / FATE=US / BTAI=US</td><td class="leftalignment">Gilead Sciences Inc / MEI Pharma Inc / Arcus Biosciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / MEI Pharma Inc / Fate Therapeutics Inc / BioXcel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">ASCO 2021 Abstracts: First Look at LAG-3 in Melanoma + EMPOWER-Lung 1 Sub-Group</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ASCO: What's new and what we're paying attention to</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / AMGN.O / REGN.O / PBYI.O / RCUS.K</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Puma Biotechnology Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - May 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">EML.AX / NA / TV.TO / JAZZ.O / SGMO.O / NBIX.O / VTR.N / OPTN.O / REGN.O / HCC.N / HOOK.O / AMED.O / WEB.AX / FM.TO / 878742204 / MNKD.OQ / ACAD.O / LHCG.O / 35671D857 / ARWR.O / CS.TO / 443628102 / NCU.TO / INO.OQ / ENSG.O / GEM.AX / ADUS.OQ / PCRX.O / SRPT.O / 505440107 / ABBV.N / ENTA.O / PTCT.O / DOC.N / 46579R104 / ITCI.O / QURE.O / CIA.TO / HQY.OQ / GUD.TO / APX.AX / 78667J108 / CRBP.OQ / GLPG.O / SGRY.O / RGNX.O / MESO.O / RCM.OQ / NEXA.TO / AMRX.N / PRVB.O / NXGN.O / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / APRE.OQ / PNTG.OQ / SLQT.N / AHCO.O / OTRK.OQ / NRIX.OQ / MTCR.O / 900435207 / VTRS.OQ / SHC.OQ</td><td class="leftalignment">EML Payments Ltd / National Bank of Canada / Trevali Mining Corp / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / Neurocrine Biosciences Inc / Ventas Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Warrior Met Coal Inc / HOOKIPA Pharma Inc / Amedisys Inc / Webjet Ltd / First Quantum Minerals Ltd / Teck Resources Ltd / MannKind Corp / ACADIA Pharmaceuticals Inc / LHC Group Inc / Freeport-McMoRan Inc / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Hudbay Minerals Inc / Nevada Copper Corp / Inovio Pharmaceuticals Inc / Ensign Group Inc / G8 Education Ltd / Addus Homecare Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Physicians Realty Trust / Ivanhoe Mines Ltd / Intra-Cellular Therapies Inc / Uniqure NV / Champion Iron Ltd / Healthequity Inc / Knight Therapeutics Inc / Appen Ltd / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Surgery Partners Inc / Regenxbio Inc / Mesoblast Ltd / R1 RCM Inc / Nexa Resources SA / Amneal Pharmaceuticals Inc / Provention Bio Inc / NextGen Healthcare Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Pennant Group Inc / SelectQuote Inc / Adapthealth Corp / Ontrak Inc / Nurix Therapeutics Inc / Metacrine Inc / Turquoise Hill Resources Ltd / Viatris Inc / Sotera Health Co</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Mon 5/24 @ 1pm ET: KOL Call to Discuss Emerging Therapies in IgAN and LN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KDNY.O / REGN.O / VRTX.O / ALNY.O / AUP.TO</td><td class="leftalignment">Chinook Therapeutics Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Aurinia Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Emma K. Nealon, III / Ms. Alethia R. Young</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - May 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CM.TO / BBDb.TO / BMO.TO / BNS.TO / IP.N / L.TO / NA / NA.TO / PD.TO / TD.TO / ITP.TO / TV.TO / JAZZ.O / MRU.TO / SGMO.O / NBIX.O / WSP.TO / LB.TO / VTR.N / CWB.TO / OPTN.O / REGN.O / FTT.TO / WCN.N / DOL.TO / HCC.N / EFX.TO / HOOK.O / AMED.O / TCLa.TO / STN.TO / ATDb.TO / EMPA.TO / TIH.TO / SNC.TO / MDI.TO / HLF.TO / FM.TO / 878742204 / HCG.TO / MNKD.OQ / ACAD.O / WEF.TO / LHCG.O / 35671D857 / ARWR.O / CTCa.TO / CS.TO / 443628102 / MERC.O / NCU.TO / INO.OQ / ENSG.O / ARX.TO / ADUS.OQ / TOU.TO / CJT.TO / CFX.TO / FRU.TO / PCRX.O / IFP.TO / WTE.TO / RFP.N / SRPT.O / 505440107 / ABBV.N / ENTA.O / PTCT.O / DOC.N / 46579R104 / ITCI.O / PLC.TO / QURE.O / CIA.TO / PSK.TO / RYAM.N / HQY.OQ / GUD.TO / 78667J108 / CRBP.OQ / SIA.TO / GLPG.O / FIHu.TO / SGRY.O / RGNX.O / TWM.TO / MESO.O / APR_U.TO / ATZ.TO / ECN.TO / RCM.OQ / JWEL.TO / NEXA.TO / AMRX.N / MI_U.TO / HOMU.TO / PRVB.O / NXGN.O / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / APRE.OQ / PNTG.OQ / GFL.N / SLQT.N / AHCO.O / OTRK.OQ / ERE_u.TO / NRIX.OQ / AD_u.TO / MTCR.O / 900435207 / VTRS.OQ / SHC.OQ / WFG.N</td><td class="leftalignment">Canadian Imperial Bank of Commerce / Bombardier Inc / Bank of Montreal / Bank of Nova Scotia / International Paper Co / Loblaw Companies Ltd / National Bank of Canada / National Bank of Canada / Precision Drilling Corp / Toronto-Dominion Bank / Intertape Polymer Group Inc / Trevali Mining Corp / Jazz Pharmaceuticals PLC / Metro Inc / Sangamo Therapeutics Inc / Neurocrine Biosciences Inc / WSP Global Inc / Laurentian Bank of Canada / Ventas Inc / Canadian Western Bank / OptiNose Inc / Regeneron Pharmaceuticals Inc / Finning International Inc / Waste Connections Inc / Dollarama Inc / Warrior Met Coal Inc / Enerflex Ltd / HOOKIPA Pharma Inc / Amedisys Inc / Transcontinental Inc / Stantec Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / Toromont Industries Ltd / SNC-Lavalin Group Inc / Major Drilling Group International Inc / High Liner Foods Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Home Capital Group Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / LHC Group Inc / Freeport-McMoRan Inc / Arrowhead Pharmaceuticals Inc / Canadian Tire Corporation Ltd / Capstone Mining Corp / Hudbay Minerals Inc / Mercer International Inc / Nevada Copper Corp / Inovio Pharmaceuticals Inc / Ensign Group Inc / ARC Resources Ltd / Addus Homecare Corp / Tourmaline Oil Corp / Cargojet Inc / Canfor Pulp Products Inc / Freehold Royalties Ltd / Pacira Biosciences Inc / Interfor Corp / Westshore Terminals Investment Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Physicians Realty Trust / Ivanhoe Mines Ltd / Intra-Cellular Therapies Inc / Park Lawn Corp / Uniqure NV / Champion Iron Ltd / Prairiesky Royalty Ltd / Rayonier Advanced Materials Inc / Healthequity Inc / Knight Therapeutics Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Sienna Senior Living Inc / Galapagos NV / Fairfax India Holdings Corp / Surgery Partners Inc / Regenxbio Inc / Tidewater Midstream and Infrastructure Ltd / Mesoblast Ltd / Automotive Properties Real Estate Investment Trust / Aritzia Inc / ECN Capital Corp / R1 RCM Inc / Jamieson Wellness Inc / Nexa Resources SA / Amneal Pharmaceuticals Inc / Minto Apartment Real Estate Investment Trust / BSR Real Estate Investment Trust / Provention Bio Inc / NextGen Healthcare Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Pennant Group Inc / GFL Environmental Inc / SelectQuote Inc / Adapthealth Corp / Ontrak Inc / European Residential REIT / Nurix Therapeutics Inc / Alaris Equity Partners Income Trust / Metacrine Inc / Turquoise Hill Resources Ltd / Viatris Inc / Sotera Health Co / West Fraser Timber Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BP.L / ENI.MI / FLS.N / GE.N / IP.N / NA / PNN.L / REP.MC / RWEG.DE / SVT.L / TOTF.PA / WMB.N / WMT.N / ETN.N / DHR.N / WCC.N / DOV.N / IEX.N / ROP.N / TV.TO / HON.N / HD.N / LOW.N / EMR.N / XOM.N / JAZZ.O / SGMO.O / JCI.N / NBIX.O / AME.N / VTR.N / OPTN.O / REGN.O / CVX.N / GGG.N / PNR.N / TT.N / HCC.N / MFA.N / ADS.N / HOOK.O / AMED.O / FM.TO / 878742204 / MNKD.OQ / NVT.N / ACAD.O / NESTE.HE / RDSb.L / LHCG.O / 35671D857 / ARWR.O / MWA.N / CS.TO / 443628102 / MERC.O / GALP.LS / NCU.TO / RENE.LS / GETP.PA / INO.OQ / ENSG.O / EONGn.DE / ADUS.OQ / CFX.TO / PCRX.O / XYL.N / RFP.N / SRPT.O / 505440107 / ABBV.N / FLOW.N / ENTA.O / PTCT.O / DOC.N / 46579R104 / ITCI.O / QURE.O / CIA.TO / RYAM.N / HQY.OQ / GUD.TO / 78667J108 / CRBP.OQ / GLPG.O / FIHu.TO / SGRY.O / RGNX.O / MESO.O / ATKR.N / RCM.OQ / ORSTED.CO / AQUA.N / NEXA.TO / GTES.N / AMRX.N / NTGY.MC / PRVB.O / NXGN.O / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / APRE.OQ / EPAC.N / PNTG.OQ / CARR.N / SLQT.N / AHCO.O / OTRK.OQ / NRIX.OQ / IBEX.O / MTCR.O / 900435207 / VTRS.OQ / SHC.OQ / WFG.N / DSEY.O</td><td class="leftalignment">BP PLC / Eni SpA / Flowserve Corp / General Electric Co / International Paper Co / National Bank of Canada / Pennon Group PLC / Repsol SA / Rwe AG / Severn Trent PLC / TotalEnergies SE / Williams Companies Inc / Walmart Inc / Eaton Corporation PLC / Danaher Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Trevali Mining Corp / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / Emerson Electric Co / Exxon Mobil Corp / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / Johnson Controls International PLC / Neurocrine Biosciences Inc / AMETEK Inc / Ventas Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Chevron Corp / Graco Inc / Pentair PLC / Trane Technologies PLC / Warrior Met Coal Inc / MFA Financial Inc / Alliance Data Systems Corp / HOOKIPA Pharma Inc / Amedisys Inc / First Quantum Minerals Ltd / Teck Resources Ltd / MannKind Corp / nVent Electric PLC / ACADIA Pharmaceuticals Inc / Neste Oyj / Royal Dutch Shell PLC / LHC Group Inc / Freeport-McMoRan Inc / Arrowhead Pharmaceuticals Inc / Mueller Water Products Inc / Capstone Mining Corp / Hudbay Minerals Inc / Mercer International Inc / Galp Energia SGPS SA / Nevada Copper Corp / Ren Redes Energeticas Nacionais SGPS SA / Getlink SE / Inovio Pharmaceuticals Inc / Ensign Group Inc / E.ON SE / Addus Homecare Corp / Canfor Pulp Products Inc / Pacira Biosciences Inc / Xylem Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / Abbvie Inc / SPX FLOW Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Physicians Realty Trust / Ivanhoe Mines Ltd / Intra-Cellular Therapies Inc / Uniqure NV / Champion Iron Ltd / Rayonier Advanced Materials Inc / Healthequity Inc / Knight Therapeutics Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Fairfax India Holdings Corp / Surgery Partners Inc / Regenxbio Inc / Mesoblast Ltd / Atkore Inc / R1 RCM Inc / Orsted A/S / Evoqua Water Technologies Corp / Nexa Resources SA / Gates Industrial Corporation PLC / Amneal Pharmaceuticals Inc / Naturgy Energy Group SA / Provention Bio Inc / NextGen Healthcare Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Enerpac Tool Group Corp / Pennant Group Inc / Carrier Global Corp / SelectQuote Inc / Adapthealth Corp / Ontrak Inc / Nurix Therapeutics Inc / Ibex Ltd / Metacrine Inc / Turquoise Hill Resources Ltd / Viatris Inc / Sotera Health Co / West Fraser Timber Co Ltd / Diversey Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / India / Ireland / Italy / Luxembourg / Netherlands / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Regeneron Pharmaceuticals Incorporated</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - May 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BP.L / CWK.L / ENI.MI / NA / REP.MC / TOTF.PA / AAL.L / TV.TO / XOM.N / JAZZ.O / SGMO.O / NBIX.O / IGG.L / VTR.N / OPTN.O / REGN.O / CVX.N / HCC.N / HOOK.O / AMED.O / FM.TO / 878742204 / MNKD.OQ / ACAD.O / NESTE.HE / RDSb.L / LHCG.O / 35671D857 / ARWR.O / CS.TO / 443628102 / GALP.LS / NCU.TO / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / SRPT.O / 505440107 / ABBV.N / ENTA.O / PTCT.O / DOC.N / 46579R104 / ITCI.O / QURE.O / CIA.TO / HQY.OQ / GUD.TO / S32.AX / 78667J108 / CRBP.OQ / GLPG.O / SGRY.O / RGNX.O / MESO.O / IMB.L / CMCX.L / RCM.OQ / NEXA.TO / AMRX.N / PRVB.O / NXGN.O / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / APRE.OQ / PNTG.OQ / SLQT.N / AHCO.O / OTRK.OQ / NRIX.OQ / MTCR.O / 900435207 / VTRS.OQ / SHC.OQ</td><td class="leftalignment">BP PLC / Cranswick PLC / Eni SpA / National Bank of Canada / Repsol SA / TotalEnergies SE / Anglo American PLC / Trevali Mining Corp / Exxon Mobil Corp / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / Neurocrine Biosciences Inc / IG Group Holdings PLC / Ventas Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Chevron Corp / Warrior Met Coal Inc / HOOKIPA Pharma Inc / Amedisys Inc / First Quantum Minerals Ltd / Teck Resources Ltd / MannKind Corp / ACADIA Pharmaceuticals Inc / Neste Oyj / Royal Dutch Shell PLC / LHC Group Inc / Freeport-McMoRan Inc / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Hudbay Minerals Inc / Galp Energia SGPS SA / Nevada Copper Corp / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Physicians Realty Trust / Ivanhoe Mines Ltd / Intra-Cellular Therapies Inc / Uniqure NV / Champion Iron Ltd / Healthequity Inc / Knight Therapeutics Inc / South32 Ltd / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Surgery Partners Inc / Regenxbio Inc / Mesoblast Ltd / Imperial Brands PLC / CMC Markets PLC / R1 RCM Inc / Nexa Resources SA / Amneal Pharmaceuticals Inc / Provention Bio Inc / NextGen Healthcare Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Pennant Group Inc / SelectQuote Inc / Adapthealth Corp / Ontrak Inc / Nurix Therapeutics Inc / Metacrine Inc / Turquoise Hill Resources Ltd / Viatris Inc / Sotera Health Co</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Spain / Finland / France / United Kingdom / Ireland / Italy / Luxembourg / Netherlands / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Capital Markets Global Healthcare Virtual Conference</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">NA / JAZZ.O / SGMO.O / NBIX.O / VTR.N / OPTN.O / REGN.O / HOOK.O / AMED.O / MNKD.OQ / ACAD.O / LHCG.O / ARWR.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / SRPT.O / ABBV.N / ENTA.O / PTCT.O / DOC.N / ITCI.O / QURE.O / HQY.OQ / GUD.TO / 78667J108 / CRBP.OQ / GLPG.O / SGRY.O / RGNX.O / MESO.O / RCM.OQ / AMRX.N / PRVB.O / NXGN.O / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / APRE.OQ / PNTG.OQ / SLQT.N / AHCO.O / OTRK.OQ / NRIX.OQ / MTCR.O / VTRS.OQ / SHC.OQ</td><td class="leftalignment">National Bank of Canada / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / Neurocrine Biosciences Inc / Ventas Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / HOOKIPA Pharma Inc / Amedisys Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / LHC Group Inc / Arrowhead Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Physicians Realty Trust / Intra-Cellular Therapies Inc / Uniqure NV / Healthequity Inc / Knight Therapeutics Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Surgery Partners Inc / Regenxbio Inc / Mesoblast Ltd / R1 RCM Inc / Amneal Pharmaceuticals Inc / Provention Bio Inc / NextGen Healthcare Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Pennant Group Inc / SelectQuote Inc / Adapthealth Corp / Ontrak Inc / Nurix Therapeutics Inc / Metacrine Inc / Viatris Inc / Sotera Health Co</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">RBCCM Australia Research / Mr. Gregory J. Renza, MD / Douglas M. Miehm / Mr. Charles Weston / Brian Abrahams, MD / Daniel Busby / Michael W. Carroll, CFA / Mr. Sean W. Dodge, CFA / Mr. Anton Hie / Mr. Luca Issi, PHD / Kennen MacKay, PHD / Frank G. Morgan</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) - Highlights from the virtual RBC Global Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, May 18, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">VOYAGE to the Esophagus Could Open $2B-Plus Revenue Opportunity; Establishing EoE Market Model; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">040047607 / 75886F107 / 91307C102 / ALLK.OQ</td><td class="leftalignment">Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Allakos Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Many Billion Dollar Birds, One Stone; Initiating With a Buy and $230 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">ALLK.OQ / 75886F107 / 040047607</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 07, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: AUTL's next-gen CD19 CAR-T; CTX001 follow-up</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / TWTR=US / GBT=US / CL=US / AMZN=US / T=US / EBAY=US / INCY=US / GILD=US / VZ=US / IGT=US / VRM=US / BYD=US / SPOT=US / EXPE=US / MGM=US / AKR=US / PENN=US / W=US / DV=US / AMK=US / PATH=US / COLL=US / TREE=US / NOW=US / MCRI=US / REGN=US / SNAP=US / TRIP=US / TRUE=US / VRTX=US / WIX=US / PSA=US / SNOW=US / SGMS=US / NET=US / HIW=US / PYPL=US / BKNG=US / EGP=US / FB=US / MTCH=US / AUTL=US / BDSI=US / RRR=US / PTON=US / BIIB=US / RNG=US / CZR=US / EXR=US / GMS=US / PGTI=US / WH=US / TIL=US / IAC=US / 45665G303 / OLO=US / NLSN=US / ANGI=US / MEIP=US / SSTK=US / ABBV=US / VOYA=US / PTCT=US / FATE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / VCEL=US / GDDY=US / ETSY=US / ARGX=US / ZG=US / SQ=US / WVE=US / MIME=US / TTD=US / CRSP=US / TRVG=US / GDS=US / CVNA=US / YEXT=US / IOVA=US / RDFN=US / ROKU=US / CARG=US / SFIX=US / ROOT=US / COLD=US / FTDR=US / SVMK=US / EB=US / SITC=US / AMTB=US / LYFT=US / UBER=US / GMAB=US / DKNG=US / CRMD.US / BALY=US / ABNB=US / DASH=US / NGMS=US / COUR-US / KNBE=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Twitter Inc / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / AT&T Inc / eBay Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / MGM Resorts International / Acadia Realty Trust / Penn National Gaming Inc / Wayfair Inc / DoubleVerify Holdings Inc / AssetMark Financial Holdings Inc / UiPath Inc / Collegium Pharmaceutical Inc / Lendingtree Inc / ServiceNow Inc / Monarch Casino & Resort Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Public Storage / Snowflake Inc. / Scientific Games Corp / Cloudflare Inc / Highwoods Properties Inc / PayPal Holdings Inc / Booking Holdings Inc / Eastgroup Properties Inc / Meta Platforms Inc / Match Group Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / Extra Space Storage Inc / GMS Inc / PGT Innovations Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Olo Inc / Nielsen Holdings PLC / Angi Inc / MEI Pharma Inc / Shutterstock Inc / Abbvie Inc / Voya Financial Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / Vericel Corp / GoDaddy Inc / ETSY Inc / argenx SE / Zillow Group Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / GDS Holdings Ltd / Carvana Co / Yext Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / CarGurus Inc / Stitch Fix Inc / Root Inc / Americold Realty Trust / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Site Centers Corp / Amerant Bancorp Inc / Lyft Inc / Uber Technologies Inc / Genmab A/S / DraftKings Inc / CorMedix Inc / Bally's Corp / Airbnb Inc / DoorDash Inc / NeoGames SA / Coursera Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for REGN</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 5.16.21</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABT / ACAD / 00365410 / 28176E10 / 62855J10 / 01988P10 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 45253H10 / 12665010 / 07181310 / 10113710 / 92532F10 / 88355610 / 35802910 / 94184810 / 04635310 / 43644010 / 76115210 / 64125C10 / 87936910 / 37555810 / 15678210 / 03116210 / 66987V10 / 75886F10 / 46120E60 / M2572210 / 45232710 / 09062X10 / 01625510 / 30063P10 / 478160104 / 98956P10 / 159864107 / 640268108 / 075887109 / 02043Q10 / 67070410 / 207410101 / 205306103 / 45784P10 / 25213110 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 92337F10 / 05463X10 / 45780L10 / 92247510 / 09073M104 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 75046920 / 74587V10 / 00287Y10 / 92346J10 / 98401F10 / 46071F10 / G5960L10 / 46222210 / 18946410 / 04004760 / 04280A10 / 92686J10 / 05337M104 / 23283X20 / 40131M10 / 63230710 / 89853L10 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 90041T10 / 09627Y10 / 68071010 / Y9530810 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 87337910 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 98978L20 / 92857F10 / 04685N10 / 13089P10 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 98887Q10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 80405P10 / N4482110 / 92765F10 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 23306J10 / 34385P10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / H9060V101</td><td class="leftalignment">Abbott Laboratories / ACADIA Pharmaceuticals Inc / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / ImmunoGen Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Fresenius Medical Care AG & Co KGaA / Waters Corp / AstraZeneca PLC / Hologic Inc / Resmed Inc / Neurocrine Biosciences Inc / Teleflex Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Compugen Ltd / Illumina Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Zimmer Biomet Holdings Inc / Charles River Laboratories International Inc / Nektar Therapeutics / Becton Dickinson and Co / Alnylam Pharmaceuticals Inc / NuVasive Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / Veracyte Inc / AxoGen Inc / Inogen Inc / Veeva Systems Inc / Bio-Techne Corp / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Radius Health Inc / Puma Biotechnology Inc / Abbvie Inc / Vericel Corp / Xencor Inc / Intersect Ent Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Viking Therapeutics Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Natera Inc / T2 Biosystems Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Olink Holding AB (publ) / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Tabula Rasa HealthCare Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / Vocera Communications Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Zai Lab Ltd / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Satsuma Pharmaceuticals Inc / InflaRx NV / Viracta Therapeutics Inc / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / DBV Technologies SA / Fluidigm Corp / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / VectivBio Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Australian Research at a Glance - May 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NA / OXB.L / APH.L / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / ARE.N / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / TLMD.OQ / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Oxford BioMedica PLC / Alliance Pharma PLC / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/15/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Busy Week In Biotech - Updates & Upcoming</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US35104E1001 / US09058V1035 / US45337C1027 / US75886F1075 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US88322Q1085 / US90400D1081 / US37890U1088 / US5011471027 / US77313F1066 / CA07987C2040 / US20451W1018 / US1920101060</td><td class="leftalignment">4D Molecular Therapeutics Inc / BioCryst Pharmaceuticals Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / TG Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Global Blood Therapeutics Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / BELLUS Health Inc / Compass Pathways PLC / Codiak BioSciences, Inc.</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.14.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v1.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What’s Next in Biotech? Doing More With Less – Partial Agonism of GLP-1R/GCGR to Improve Glycemic Activity</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 2730190 / BGCYWN8</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">CI.N / EOG.N / NA / OXB.L / PPG.N / PXD.N / APH.L / GILD.O / TA.TO / DIS.N / NICE.O / MRO.N / PAA.N / DVN.N / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / RRC.N / EQT.N / ARE.N / RPM.N / NBIX.O / VTR.N / AJG.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / SWIR.O / SM.N / COP.N / CPE.N / ENDP.O / BLU.N / CHE.N / SWN.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / BIIB.O / TCW.TO / MNKD.OQ / ACAD.O / MPW.N / BLDR.O / LHCG.O / BAM.N / BKD.N / ARWR.O / EHTH.O / 3IN.L / CLR.N / INO.OQ / ENSG.O / NOG.A / AGNC.O / ADUS.OQ / TRGP.N / PCRX.O / MTDR.N / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / FANG.O / ABBV.N / ENTA.O / PTCT.O / PRTA.O / BPY.N / DOC.N / 81762P102 / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / CAPL.N / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / GOOS.TO / CDEV.O / ESTE.N / OVID.O / ORSTED.CO / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / OAS.OQ / AZEK.N / SLQT.N / AHCO.O / VMD.OQ / APA.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / MAX.N / TLMD.OQ / VTRS.OQ / SHC.OQ / PUBM.O / DHT_u.TO / CHK.OQ</td><td class="leftalignment">Cigna Corp / EOG Resources Inc / National Bank of Canada / Oxford BioMedica PLC / PPG Industries Inc / Pioneer Natural Resources Co / Alliance Pharma PLC / Gilead Sciences Inc / TransAlta Corp / Walt Disney Co / Nice Ltd / Marathon Oil Corp / Plains All American Pipeline LP / Devon Energy Corp / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Range Resources Corp / EQT Corp / Alexandria Real Estate Equities Inc / RPM International Inc / Neurocrine Biosciences Inc / Ventas Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / SM Energy Co / Conocophillips / Callon Petroleum Co / Endo International PLC / BELLUS Health Inc / Chemed Corp / Southwestern Energy Co / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Trican Well Service Ltd / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / Builders FirstSource Inc / LHC Group Inc / Brookfield Asset Management Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / 3I Infrastructure PLC / Continental Resources Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Northern Oil and Gas Inc / AGNC Investment Corp / Addus Homecare Corp / Targa Resources Corp / Pacira Biosciences Inc / Matador Resources Co / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Diamondback Energy Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Brookfield Property Partners LP / Physicians Realty Trust / ServiceNow Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Crossamerica Partners LP / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Canada Goose Holdings Inc / Centennial Resource Development Inc / Earthstone Energy Inc / Ovid Therapeutics Inc / Orsted A/S / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / Oasis Petroleum Inc / Azek Company Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / APA Corp (US) / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Mediaalpha Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / PubMatic Inc / Dri Healthcare Trust / Chesapeake Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AC.TO / NA / OXB.L / APH.L / GILD.O / TA.TO / QBRb.TO / TV.TO / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / ARE.N / NBIX.O / WSP.TO / VTR.N / BMRN.O / EXE.TO / OPTN.O / REGN.O / VRTX.O / SWIR.O / CIX.TO / CAR_u.TO / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / CCLb.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / TCW.TO / HR_u.TO / CHR.TO / BEI_u.TO / HCG.TO / MNKD.OQ / SCL.TO / ACAD.O / MPW.N / LHCG.O / BAM.N / BKD.N / ARWR.O / CTCa.TO / EHTH.O / IIP_u.TO / INO.OQ / ENSG.O / SPB.TO / ADUS.OQ / EIF.TO / NWH_u.TO / TCN.TO / NPI.TO / PCRX.O / LGO.TO / DR.TO / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / Y.TO / ENTA.O / PTCT.O / PRTA.O / BPY.N / DOC.N / KPTI.O / XNCR.OQ / CJ.TO / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / TWM.TO / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / GOOS.TO / STEP.TO / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / TLMD.OQ / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">Air Canada / National Bank of Canada / Oxford BioMedica PLC / Alliance Pharma PLC / Gilead Sciences Inc / TransAlta Corp / Quebecor Inc / Trevali Mining Corp / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / WSP Global Inc / Ventas Inc / Biomarin Pharmaceutical Inc / Extendicare Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / CI Financial Corp / Canadian Apartment Properties Real Estate Investment Trust / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / CCL Industries Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Trican Well Service Ltd / H&R Real Estate Investment Trust / Chorus Aviation Inc / Boardwalk Real Estate Investment Trust / Home Capital Group Inc / MannKind Corp / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookfield Asset Management Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / Canadian Tire Corporation Ltd / eHealth Inc / InterRent Real Estate Investment Trust / Inovio Pharmaceuticals Inc / Ensign Group Inc / Superior Plus Corp / Addus Homecare Corp / Exchange Income Corp / NorthWest Healthcare Properties REIT / Tricon Residential Inc / Northland Power Inc / Pacira Biosciences Inc / Largo Inc / Medical Facilities Corp / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Yellow Pages Ltd / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Brookfield Property Partners LP / Physicians Realty Trust / Karyopharm Therapeutics Inc / Xencor Inc / Cardinal Energy Ltd (Alberta) / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / Tidewater Midstream and Infrastructure Ltd / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Canada Goose Holdings Inc / Step Energy Services Ltd / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LVMH.PA / NA / OXB.L / PRTP.PA / APH.L / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / ARE.N / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / WG.L / BRBY.L / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / LEGD.PA / CFR.S / EHTH.O / HRGV.L / BEZG.L / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / URW.AS / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / TLMD.OQ / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / National Bank of Canada / Oxford BioMedica PLC / Kering SA / Alliance Pharma PLC / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / John Wood Group PLC / Burberry Group PLC / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / Legrand SA / Compagnie Financiere Richemont SA / eHealth Inc / Hargreaves Lansdown PLC / Beazley PLC / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Unibail-Rodamco-Westfield SE / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Capital Markets Global Healthcare Virtual Conference Preview</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">NA / OXB.L / APH.L / GILD.O / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / ARE.N / NBIX.O / VTR.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / ENDP.O / BLU.N / CHE.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / MNKD.OQ / ACAD.O / MPW.N / LHCG.O / BKD.N / ARWR.O / EHTH.O / INO.OQ / ENSG.O / ADUS.OQ / PCRX.O / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / ABBV.N / ENTA.O / PTCT.O / PRTA.O / DOC.N / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / OVID.O / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / SLQT.N / AHCO.O / VMD.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / TLMD.OQ / VTRS.OQ / SHC.OQ / DHT_u.TO</td><td class="leftalignment">National Bank of Canada / Oxford BioMedica PLC / Alliance Pharma PLC / Gilead Sciences Inc / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Endo International PLC / BELLUS Health Inc / Chemed Corp / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / LHC Group Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Addus Homecare Corp / Pacira Biosciences Inc / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Physicians Realty Trust / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Ovid Therapeutics Inc / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">RBCCM Australia Research / Kennen MacKay, PHD / Frank G. Morgan / Mr. Gregory J. Renza, MD / Douglas M. Miehm / Mr. Charles Weston / Ms. Lori Calvasina / Sara Mahaffy / Brian Abrahams, MD / Daniel Busby / Michael W. Carroll, CFA / Mr. Sean W. Dodge, CFA / Mr. Anton Hie / Mr. Luca Issi, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Never Mind The Tape - Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ALB.N / CC.N / CCK.N / CE.N / DD.N / EMN.N / F.N / FMC.N / IBE.MC / NA / PPG.N / RWEG.DE / SEE.N / SSE.L / GILD.O / INCY.O / WLK.N / DT.N / EPR.N / OLN.N / SHW.N / OI.N / BLL.N / PCOM.O / NLY.N / RPM.N / SLGN.O / REGN.O / VRTX.O / GPK.N / WES.N / HCC.N / HOOK.O / ICPT.O / BIIB.O / HUN.N / 3IN.L / VMW.N / LYB.N / MSP.N / AMCX.O / WEN.O / SRPT.O / BERY.N / 505440107 / VRNS.O / FLXN.O / AXTA.N / 78667J108 / CRBP.OQ / GLPG.O / RMR.OQ / VNTR.N / ORSTED.CO / STLC.TO / EAF.N / NBSE.OQ / CTVA.N / KRTX.OQ / 260557103 / IGMS.O / ETNB.O / GOCO.O / PTVE.O / 900435207 / ATC.N / CHK.OQ / DSEY.O</td><td class="leftalignment">Albemarle Corp / Chemours Co / Crown Holdings Inc / Celanese Corp / Dupont De Nemours Inc / Eastman Chemical Co / Ford Motor Co / FMC Corp / Iberdrola SA / National Bank of Canada / PPG Industries Inc / Rwe AG / Sealed Air Corp / SSE PLC / Gilead Sciences Inc / Incyte Corp / Westlake Chemical Corp / Dynatrace Inc / EPR Properties / Olin Corp / Sherwin-Williams Co / O-I Glass Inc / Ball Corp / Points International Ltd / Annaly Capital Management Inc / RPM International Inc / Silgan Holdings Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Graphic Packaging Holding Co / Western Midstream Partners LP / Warrior Met Coal Inc / HOOKIPA Pharma Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Huntsman Corp / 3I Infrastructure PLC / VMware Inc / LyondellBasell Industries NV / Datto Holding Corp / AMC Networks Inc / Wendys Co / Sarepta Therapeutics Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / Varonis Systems Inc / Pacira Biosciences Inc / Axalta Coating Systems Ltd / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / RMR Group Inc / Venator Materials PLC / Orsted A/S / Stelco Holdings Inc / GrafTech International Ltd / NeuBase Therapeutics Inc / Corteva Inc / Karuna Therapeutics Inc / Dow Inc / IGM Biosciences Inc / 89Bio Inc / Gohealth Inc / Pactiv Evergreen Inc / Turquoise Hill Resources Ltd / Atotech Ltd / Chesapeake Energy Corp / Diversey Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GB0009252882 / CH0012005267 / US75886F1075 / US92532F1003 / US02043Q1076 / CA05156V1022 / US03820J1007 / US68906L1052 / 928661107 / US6700024010 / US86150R1077 / US30068X1037 / US8163073005 / IL0011681371</td><td class="leftalignment">GlaxoSmithKline PLC / Novartis AG / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Aurinia Pharmaceuticals Inc / Applied Genetic Technologies Corp / Otonomy Inc / VolitionRX Ltd / Novavax Inc / Stoke Therapeutics Inc / Exagen Inc / SelectQuote Inc / Nano-X Imaging Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GILD.O / REGN.O</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Call to Discuss Emerging Therapies in IgA Nephropathy and LN: 5/24 at 1pm ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">KDNY.OQ / US75886F1075 / US92532F1003 / US02043Q1076 / CA05156V1022</td><td class="leftalignment">Chinook Therapeutics Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Aurinia Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Emma K. Nealon, III / Ms. Alethia R. Young</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, May 11, 2021 / 1:15PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">1Q21: Racking Up New and Unexpected Phase 3 Trials at an Impressive Rate</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">01671P100 / 75886F107</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD / Tong Liu, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US64125C1099 / US75886F1075 / US0042251084 / US40637H1095 / US88322Q1085 / US46116X1019 / US78667J1088 / US05464T1043 / CA23126M1023</td><td class="leftalignment">Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / TG Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Axsome Therapeutics Inc / Curaleaf Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Zai Lab: Watch 3rd product to generate revenue and multiple important catalysts in 2021. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZLAB.OQ / REGN.OQ / 600276.SS / TPTX.OQ / BGNE.OQ / ARGX.OQ</td><td class="leftalignment">Zai Lab Ltd / Regeneron Pharmaceuticals Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Turning Point Therapeutics Inc / Beigene Ltd / argenx SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">90389910 / 75886F107 / 640268108 / 17243V102 / 12008R107 / 40637H109 / US8110544025 / 192005106 / 52186520 / 00165C104 / 21676P10 / 09062W204 / 89620X506 / 09739D100 / 45780R101 / 00183L102 / 00108J109 / 930752100 / 640671400 / 65343E108 / 26142R104 / 34960Q10 / 17143G106</td><td class="leftalignment">Ultralife Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Cinemark Holdings Inc / Builders FirstSource Inc / Halozyme Therapeutics Inc / E W Scripps Co / Codexis Inc / Lear Corp / AMC Entertainment Holdings Inc / Cooper-Standard Holdings Inc / BioLife Solutions Inc / Pfizer Inc / Boise Cascade Co / Installed Building Products Inc / Angi Inc / ACM Research Inc / Waitr Holdings Inc / Nephros Inc / NextCure Inc / DraftKings Inc / Fortress Biotech Inc / Skillsoft Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Daniel L. Kurnos, CFA / Mike Hickey / Mr. Michael P. Ward, CFA / Mr. Reuben Garner / Mr. Robert M. Wasserman / Mr. Josh W. Sullivan / Mr. Mark Miller / Mr. Mark W. Schappel</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">1Q21 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / ICPT.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / VKTX.O / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / MDGL.O / LYS.PA / IVAA.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / NGM.O / 87166L100 / FIXX.O / MBIO.O / AXLA.O / AKRO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / ETNB.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Viking Therapeutics Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Madrigal Pharmaceuticals Inc / Lysogene SA / Inventiva SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / NGM Biopharmaceuticals Inc / Synlogic Inc / Homology Medicines Inc / Mustang Bio Inc / Axcella Health Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / 89Bio Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: MRNA booster results; AVRO regulatory hurdles</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">MRNA.OQ / EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Moderna Inc / Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">All Eyes on COVAXIN EUA; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">67577C105 / 75886F107</td><td class="leftalignment">Ocugen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Swayampakula Ramakanth, Ph.D. / Arthur He, Ph.D. / Sean Lee / Sean Kang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Virtual BioInsights Northeast Bus Tour Roundup</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">75886F107 / 02043Q107 / 023111206 / 868459108 / G11196105 / 558868105 / 67576A100 / 60770K107 / 492327101 / 760273102 / 24344T101</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amarin Corporation PLC / Supernus Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / Madrigal Pharmaceuticals Inc / Ocular Therapeutix Inc / Moderna Inc / Keros Therapeutics Inc / Repare Therapeutics Inc / Deciphera Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.7.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US03662Q1058 / US0017441017 / US2274831047 / 75886F107 / 404251100 / 416906105 / 483007704 / 600544100 / 858155203 / 902104108 / 81619Q105 / US30212P3038 / 743713109 / US1635722093 / 21676P10 / M7516K103 / 09073M104 / 89055F103 / 14575E105 / 021369103 / 141788109 / 89785L107 / US65487K1007 / 873379101 / 92556H206 / 14686910 / G0084W10 / 77543R102</td><td class="leftalignment">ANSYS Inc / AMN Healthcare Services Inc / Cross Country Healthcare Inc / Regeneron Pharmaceuticals Inc / HNI Corp / Harvard Bioscience Inc / Kaiser Aluminum Corp / MillerKnoll Inc / Steelcase Inc / II-VI Inc / Select Medical Holdings Corp / Expedia Group Inc / Proto Labs Inc / Chembio Diagnostics Inc / Cooper-Standard Holdings Inc / Nova Ltd / Bio-Techne Corp / TopBuild Corp / Cars.com Inc / Altair Engineering Inc / CarGurus Inc / TrueCar Inc / nLIGHT Inc / Tabula Rasa HealthCare Inc / ViacomCBS Inc / Carvana Co / Adient PLC / Roku Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Daniel L. Kurnos, CFA / Mr. Mark W. Schappel / Ms. Fawne Jiang / Long Lin / Mr. Robert M. Wasserman / Mr. Reuben Garner / Mr. Michael P. Ward, CFA / Mr. Bill Sutherland / Mr. Josh W. Sullivan / Mr. Bruce D. Jackson / Mr. Mark Miller / Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">1Q Earnings: Momentum Is Strong</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">1Q21: Model Update; Plenty of Catalysts in 2H21; PT $641</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">75886F10 / 11012210 / F5548N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Bristol-Myers Squibb Co / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">DNB / AMGN=US / TWTR=US / BLD=US / DVN=US / RUN=US / GILD=US / EOG=US / WLL=US / PAA=US / DIOD=US / CHRS=US / EXPE=US / CLI=US / PENN=US / BKI=US / W=US / AMED=US / AMN=US / ARW=US / ATRO=US / AVT=US / ENV=US / KIDS=US / CW=US / DRH=US / EPC=US / EQT=US / HAIN=US / DOC=US / MCHP=US / ORCC=US / REGN=US / STOR=US / TRIP=US / GOLF=US / FOUR=US / NET=US / PYPL=US / LCI=US / EVOP=US / REG=US / AUTL=US / BDSI=US / PRAA=US / MNST=US / PTON=US / JRVR=US / NOMD=US / RPD=US / BECN=US / LHCG=US / THS=US / BLDR=US / FIS=US / HST=US / OC=US / PAGP=US / SEAS=US / ATSG=US / IAC=US / PSN=US / AGS=US / CLNY=US / HTA=US / KNSL=US / GDOT=US / NLSN=US / ESTE=US / ANGI=US / PDCE=US / NCLH=US / FOXF=US / FATE=US / QTWO=US / LOCO=US / SHAK=US / CHCT=US / CABO=US / SQ=US / NTLA=US / ADVM=US / CDEV=US / IRTC=US / CRSP=US / PK=US / CVNA=US / ROKU=US / CARG=US / FNKO=US / COLD=US / FOCS=US / SVMK=US / EB=US / AXNX=US / UBER=US / DDOG=US / BRBR=US / AHCO=US / PNTG=US / OPCH=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Amgen Inc / Twitter Inc / TopBuild Corp / Devon Energy Corp / Sunrun Inc / Gilead Sciences Inc / EOG Resources Inc / Whiting Petroleum Corp / Plains All American Pipeline LP / Diodes Inc / Coherus BioSciences Inc / Expedia Group Inc / Veris Residential Inc / Penn National Gaming Inc / Black Knight Inc / Wayfair Inc / Amedisys Inc / AMN Healthcare Services Inc / Arrow Electronics Inc / Astronics Corp / Avnet Inc / Envestnet Inc / OrthoPediatrics Corp / Curtiss-Wright Corp / Diamondrock Hospitality Co / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / Physicians Realty Trust / Microchip Technology Inc / Owl Rock Capital Corp / Regeneron Pharmaceuticals Inc / STORE Capital Corp / Tripadvisor Inc / Acushnet Holdings Corp / Shift4 Payments Inc / Cloudflare Inc / PayPal Holdings Inc / Lannett Company Inc / EVO Payments Inc / Regency Centers Corp / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / PRA Group Inc / Monster Beverage Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Nomad Foods Ltd / Rapid7 Inc / Beacon Roofing Supply Inc / LHC Group Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Owens Corning / Plains GP Holdings LP / SeaWorld Entertainment Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Parsons Corp / PlayAGS Inc / DigitalBridge Group Inc / Healthcare Trust Of America Inc / Kinsale Capital Group Inc / Green Dot Corp / Nielsen Holdings PLC / Earthstone Energy Inc / Angi Inc / PDC Energy Inc / Norwegian Cruise Line Holdings Ltd / Fox Factory Holding Corp / Fate Therapeutics Inc / Q2 Holdings Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Community Healthcare Trust Inc / Cable One Inc / Block Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Carvana Co / Roku Inc / CarGurus Inc / Funko Inc / Americold Realty Trust / Focus Financial Partners Inc / Momentive Global Inc / Eventbrite Inc / Axonics Inc / Uber Technologies Inc / Datadog Inc / Bellring Brands Inc / Adapthealth Corp / Pennant Group Inc / Option Care Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">204</td><td class="leftalignment">US0126531013 / US0584981064 / US1844961078 / US3024913036 / US4227041062 / US4878361082 / US5745991068 / US5950171042 / US6988131024 / US7445731067 / US75886F1075 / US7802871084 / US89531P1057 / CA13321L1085 / CA53278L1076 / CA0977512007 / CA85472N1096 / CA5592224011 / CA1363851017 / CA6837151068 / CA0099051009 / US87157D1090 / US15189T1079 / US2274831047 / CA5734591046 / CA2265331074 / CA56501R1064 / US0736851090 / CA8667961053 / CA39138C1068 / US12008R1077 / US1252691001 / CA32076V1031 / US9814191048 / CA2271071094 / US38526M1062 / CA1724541000 / CA2927661025 / CA7063271034 / US1091941005 / CA02215R1073 / CA0158571053 / CA74061A1084 / CA77519R1029 / US0067391062 / CA74139C1023 / US34964C1062 / US1716041017 / CA5054401073 / US45845P1084 / CA4882951060 / CA58546R1091 / US85208M1027 / US2267181046 / US03820J1007 / US03209R1032 / US78667J1088 / US70450Y1038 / CA8485101031 / US72703H1014 / CA49410M1023 / US5588681057 / CA49741E1007 / GB00BF3ZNS54 / CA7847301032 / US68404V1008 / US3610081057 / CA89679A2092 / US34417P1003 / US2936141033 / IE00BZ12WP82 / CA45075E1043 / US63253R2013 / US35137L1052 / US62921N1054 / US70614W1009 / CA36168Q1046 / US05478C1053 / US57667L1070 / US26484T1060 / US69526K1051 / CA89055A2039 / US89422G1076</td><td class="leftalignment">Albemarle Corp / Ball Corp / Clean Harbors Inc / FMC Corp / Hecla Mining Co / Kellogg Co / Masco Corp / Microchip Technology Inc / Papa John's International Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Trex Company Inc / Cameco Corp / Linamar Corp / Bombardier Inc / Stantec Inc / Magna International Inc / Canadian Natural Resources Ltd / Open Text Corp / AKITA Drilling Ltd / Synaptics Inc / CenterPoint Energy Inc / Cross Country Healthcare Inc / Martinrea International Inc / Crew Energy Inc / Manulife Financial Corp / Beacon Roofing Supply Inc / Sun Life Financial Inc / Great-West Lifeco Inc / Builders FirstSource Inc / CF Industries Holdings Inc / First Majestic Silver Corp / World Acceptance Corp / Crombie Real Estate Investment Trust / Grand Canyon Education Inc / Cineplex Inc / Enerplus Corp / Pembina Pipeline Corp / Bright Horizons Family Solutions Inc / Altus Group Ltd / Algonquin Power & Utilities Corp / Premium Brands Holdings Corp / Rogers Sugar Inc / Addus Homecare Corp / Pretium Resources Inc / Fortune Brands Home & Security Inc / Chuy's Holdings Inc / Labrador Iron Ore Royalty Corp / Intercept Pharmaceuticals Inc / Kelt Exploration Ltd / Melcor Real Estate Investment Trust / Sprouts Farmers Market Inc / Criteo SA / Applied Genetic Technologies Corp / Amphastar Pharmaceuticals Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Spin Master Corp / Planet Fitness Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / Kirkland Lake Gold Ltd / Venator Materials PLC / SSR Mining Inc / OptiNose Inc / Funko Inc / Trisura Group Ltd / Focus Financial Partners Inc / Entasis Therapeutics Holdings Inc / Linde PLC / iA Financial Corporation Inc / NAK Kazatomprom AO / Fox Corp / NGM Biopharmaceuticals Inc / Peloton Interactive Inc / GFL Environmental Inc / Azek Company Inc / Match Group Inc / Dun & Bradstreet Holdings Inc / Pactiv Evergreen Inc / Topaz Energy Corp / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Ireland / Kazakhstan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">US0464331083 / US75886F1075 / US9021041085 / 913915104 / 577933104 / ATEC.OQ / US45784P1012 / US09609G1004 / US74736L1098 / 94419L101 / 16383L106 / 852234103 / 632307104 / APRN.N / 30050B101 / 89853L104 / 450056106 / 98986X109 / 26210C104 / 65487K100 / 019770106 / 37890U108 / 40131M109 / 05338G106 / 70614W100 / 090043100 / 683373104 / 00653Q102 / 34380C102 / 25401G106 / 39813G109 / 58450V104 / 009066101 / 62011B102 / 92557A101 / 702141102 / 00091G104 / 25402D102 / Y4600W108</td><td class="leftalignment">Astronics Corp / Regeneron Pharmaceuticals Inc / II-VI Inc / Universal Technical Institute Inc / Maximus Inc / Alphatec Holdings Inc / Insulet Corp / bluebird bio Inc / Q2 Holdings Inc / Wayfair Inc / ChemoCentryx Inc / Block Inc / Natera Inc / Blue Apron Holdings Inc / Evolent Health Inc / T2 Biosystems Inc / iRhythm Technologies Inc / Zynerba Pharmaceuticals Inc / Dropbox Inc / nLIGHT Inc / Allogene Therapeutics Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Avalara Inc / Peloton Interactive Inc / Bill.com Holdings Inc / Ontrak Inc / Adapthealth Corp / Fluent Inc / Digital Media Solutions Inc / Grid Dynamics Holdings Inc / Mediaalpha Inc / Airbnb Inc / Motorsport Games Inc / Viant Technology Inc / PARTS iD Inc / ACV Auctions Inc / DigitalOcean Holdings Inc / Karooooo Ltd</td><td class="leftalignment"></td><td class="leftalignment">Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">AXP / 2516152 / 2486813 / 2778844 / 2973821 / 2045623 / 2219224 / 2175672 / 2216850 / 2576941 / 2670519 / 2345022 / 2459202 / 2459020 / 2378534 / 2630513 / 2645409 / 2657802 / 2680905 / 2684703 / 2048804 / 2707677 / 2730190 / 2440637 / 2416962 / 2138158 / 2799351 / 2825933 / 5531000 / 7103065 / 2212922 / 2769796 / 2857817 / B125XQ6 / B0T7YX2 / B02R1L6 / B3P93Y7 / B44C366 / B7TL820 / B783TY6 / BBPK0J0 / BBGVT40 / B95N910 / BDZCRX3 / B8DPDT7 / BFLR866 / B6WXT12 / B95WG16 / BZ07BW4 / BYVY8G0 / BYW36M8 / BF09HX3 / BYNZGK1 / BJT1RW7 / BZBY005 / BKS3SM8 / BQT3XY6 / BJ1FD74 / BJFSR88 / BKDS4H5 / BR4T3B3 / BWFKZT2 / BKVDFF7 / BFMXGR0 / BJJMGL2 / BFXC911 / BKTNTR9 / BK6N347 / BJVR9Y9 / BYWMQJ2 / BHZSB82 / BL95N25 / BD6D4Y5 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BJDX8Y8 / BYWVTY5 / BMVWYW8 / BJMLSD2 / BYQBFS7 / BYSFJV8 / BKWD3M9 / BYTJZL1 / BX7RSN3 / BYNPPC6 / BWY4XV3 / BJTJGC4 / BKLCX50 / BYQCZ35 / BQXZP64 / BGDW0N7 / BMPRZV5 / BGT0PL8 / BLBLMD5 / BNTB3N8</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / ANSYS Inc / CMS Energy Corp / Cardinal Health Inc / Consolidated Edison Inc / Exelixis Inc / Exelon Corp / Macy's Inc / IDEXX Laboratories Inc / Intuit Inc / Mckesson Corp / New Jersey Resources Corp / NiSource Inc / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Henry Schein Inc / Sempra Energy / Sinclair Broadcast Group Inc / South Jersey Industries Inc / MorphoSys AG / Novartis AG / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Anheuser Busch Inbev SA / Heska Corp / Meta Platforms Inc / Aptiv PLC / Mirati Therapeutics Inc / News Corp / PTC Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / TherapeuticsMD Inc / Zoetis Inc / Monster Beverage Corp / Alphabet Inc / PayPal Holdings Inc / Tapestry Inc / Block Inc / Lyft Inc / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Revolve Group Inc / Uniqure NV / Bill.com Holdings Inc / HubSpot Inc / Cellectis SA / Oric Pharmaceuticals Inc / Evergy Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Alteryx Inc / Covetrus Inc / Phibro Animal Health Corp / Altair Engineering Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Mirum Pharmaceuticals Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Karuna Therapeutics Inc / Tabula Rasa HealthCare Inc / Planet Fitness Inc / Progyny Inc / Zogenix Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Adaptimmune Therapeutics PLC / Kontoor Brands Inc / Health Catalyst Inc / Madison Square Garden Sports Corp / Wayfair Inc / Trevena Inc / Kymera Therapeutics Inc / DiaMedica Therapeutics Inc / Array Technologies Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">F2Q21 Results; On the Cusp of Validating RNAi Therapeutics Outside the Liver</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">04280A100 / 92532F100 / 75886F107 / 02043Q107</td><td class="leftalignment">Arrowhead Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEE.N / APD.N / BDX.N / CI.N / SPG.N / DUK.N / DIS.N / IFF.N / VTR.N / REGN.OQ / VIAC.OQ / FIS.N / TDG.N / HBI.N / EA.OQ / ZTS.N / PRGO.N / MAR.OQ</td><td class="leftalignment">Ameren Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cigna Corp / Simon Property Group Inc / Duke Energy Corp / Walt Disney Co / International Flavors & Fragrances Inc / Ventas Inc / Regeneron Pharmaceuticals Inc / ViacomCBS Inc / Fidelity National Information Services Inc / TransDigm Group Inc / HanesBrands Inc / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - POSEIDON: Imfinzi + treme + chemo triplet show survival benefit in 1L lung cancer</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AZN.L / BMY.N / MRK.N / SASY.PA / ROG.S / REGN.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">REGN - REGN 1Q21 Postview:  Quiet, decent quarter</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Eylea steady; REGN-COV seeking to expand EUA; await Libtayo + anti-LAG3 data at ASCO</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Eylea holding steady, but key to long-term growth is pipeline</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Didn’t See That Coming – Positive Fund Flow Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : 1Q Snapshot & Model Update</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Post-1Q21 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">1Q21: Good Start to the Year</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Strong Q1 Results; BCMA Moves Ahead Despite SNY Snub; Busy 2H21</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F10 / F5548N10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">1Q Results: Eyes On High Dose Eylea & Onc Portfolio (& NTLA)</td><td class="leftalignment">English</td><td class="rightalignment">113</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 Eylea/Dupi Solid, Libtayo Light – Eyes On High-Dose Eylea Data By YE</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Strong Quarter, Strong Outlook; Remains a Top Large Cap Pick</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : First Look at 1Q Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on May 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">K.N / AES.N / AIG.N / BDX.N / CAH.N / ED.N / EOG.N / MCK.N / PPL.N / MTD.N / LIN.N / BLL.N / NRG.N / PWR.N / ARW.N / HWM.N / IRM.N / CNP.N / REGN.OQ / PENN.OQ / TPR.N / EXPE.OQ / MNST.OQ / VIAC.OQ / LYV.N / FIS.N / ABI.BR / NWSA.OQ / MSI.N / NLSN.N / HII.N / ZTS.N / NCLH.N / APTV.N / DBX.OQ / EVRG.N / REG.OQ / LNT.OQ / BYND.OQ</td><td class="leftalignment">Kellogg Co / AES Corp / American International Group Inc / Becton Dickinson and Co / Cardinal Health Inc / Consolidated Edison Inc / EOG Resources Inc / Mckesson Corp / PPL Corp / Mettler-Toledo International Inc / Linde PLC / Ball Corp / NRG Energy Inc / Quanta Services Inc / Arrow Electronics Inc / Howmet Aerospace Inc / Iron Mountain Inc / CenterPoint Energy Inc / Regeneron Pharmaceuticals Inc / Penn National Gaming Inc / Tapestry Inc / Expedia Group Inc / Monster Beverage Corp / ViacomCBS Inc / Live Nation Entertainment Inc / Fidelity National Information Services Inc / Anheuser Busch Inbev SA / News Corp / Motorola Solutions Inc / Nielsen Holdings PLC / Huntington Ingalls Industries Inc / Zoetis Inc / Norwegian Cruise Line Holdings Ltd / Aptiv PLC / Dropbox Inc / Evergy Inc / Regency Centers Corp / Alliant Energy Corp / Beyond Meat Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - 1Q21; Eylea Delivers Another Good Performance, As The Overall Business Continues To Diversify</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Brief of Regeneron Pharmaceuticals Inc conference call, May 06, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, May 06, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q121 First Look: Strong Quarter for Eylea & Dupi</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">1Q21 Quick Take: 1Q21 driven by Eylea beat and FY2021 driven by higher Dupi sales</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: May 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEE.N / APD.N / BDX.N / CI.N / ED.N / GM.N / SPG.N / MET.N / DUK.N / DIS.N / IFF.N / EMR.N / LIN.N / VTR.N / REGN.OQ / FIS.N / TDG.N / HBI.N / EA.OQ / ZTS.N / PRGO.N / MAR.OQ / PYPL.OQ / BKNG.OQ</td><td class="leftalignment">Ameren Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cigna Corp / Consolidated Edison Inc / General Motors Co / Simon Property Group Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / International Flavors & Fragrances Inc / Emerson Electric Co / Linde PLC / Ventas Inc / Regeneron Pharmaceuticals Inc / Fidelity National Information Services Inc / TransDigm Group Inc / HanesBrands Inc / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / PayPal Holdings Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GMAB.CO / JNJ.N / PFE.N / RECI.MI / ROG.S / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / REGN.OQ / SGEN.OQ / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / HZNP.OQ / ABBV.N / VIFN.S</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Regeneron Pharmaceuticals Inc / Seagen Inc / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Horizon Therapeutics PLC / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Ireland / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Positive Regulatory Update; 6/3 Next</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">76029N10 / 75886F10</td><td class="leftalignment">Replimune Group Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: May 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEE.N / AES.N / APD.N / BDX.N / CI.N / CVS.N / ED.N / GM.N / PFE.N / SPG.N / MET.N / DUK.N / IFF.N / EMR.N / LIN.N / VTR.N / COP.N / ATVI.OQ / REGN.OQ / FIS.N / TDG.N / HBI.N / EA.OQ / ZTS.N / PRGO.N / MAR.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cigna Corp / CVS Health Corp / Consolidated Edison Inc / General Motors Co / Pfizer Inc / Simon Property Group Inc / MetLife Inc / Duke Energy Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Linde PLC / Ventas Inc / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Fidelity National Information Services Inc / TransDigm Group Inc / HanesBrands Inc / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">REGN - REGN 1Q21 earnings preview</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALXN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIOb / JNJ / GILD.O / REGN.O / VRTX.O / RARE.O / BIIB.O / SRPT.O / AGIO.O / QGEN.K</td><td class="leftalignment">Bio Rad Laboratories Inc / Johnson & Johnson / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Qiagen NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">1Q21 Preview & 2021 Outlook - Key Moving Pieces</td><td class="leftalignment">English</td><td class="rightalignment">137</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">US00461U1051 / US5288723027 / US4525253062 / US5160121019 / US62855J1043 / US6388423021 / US74838J1016 / US75886F1075 / US91307C1027 / US92532F1003 / US68554V1089 / US09060J1060 / US02043Q1076 / CA87402A1084 / US58933Y1055 / US42805E3062 / US88322Q1085 / US1635722093 / US63009R1095 / US48576U1060 / US00847L1008 / US03209R1032 / US14167L1035 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US53222K2050 / US4622221004 / US45781M1018 / CA0717341071 / US04537Y1091 / US92556V1061 / US0547548745 / US92941V2097</td><td class="leftalignment">Aclaris Therapeutics Inc / Lexicon Pharmaceuticals Inc / ImmuCell Corp / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Quidel Corp / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / OraSure Technologies Inc / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Taiga Building Products Ltd / Merck & Co Inc / Heska Corp / TG Therapeutics Inc / Chembio Diagnostics Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Agile Therapeutics Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / LifeVantage Corp / Ionis Pharmaceuticals Inc / Innoviva Inc / Bausch Health Companies Inc / Aspira Women's Health Inc / Viatris Inc / Aytu Biopharma Inc / Vyne Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / MDT=US / BLD=US / DVN=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / CHRS=US / MRO=US / LEG=US / KFRC=US / VMC=US / MLM=US / CBRL=US / CNX=US / DRI=US / EQT=US / EXEL=US / GFF=US / IBP=US / HZO=US / MAS=US / MHK=US / HOOK=US / REGN=US / REGI=US / RHI=US / WIX=US / CVX=US / SAGE=US / PSA=US / EPD=US / CGEN=US / BXS=US / SNV=US / ADC=US / CUZ=US / OHI=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / STRO=US / TPX=US / EXP=US / FHN=US / CDLX=US / BECN=US / SHO=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / KBR=US / CMG=US / REX=US / CCOI=US / XPO=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / EPRT=US / JACK=US / RCUS=US / CLNY=US / TREX=US / AR=US / NLSN=US / WWD=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / TILE=US / NDLS=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / SEDG=US / BWXT=US / WING=US / SPNE=US / CABO=US / ACBI=US / AXSM=US / 82982L103 / CDEV=US / CRSP=US / PVAC=US / JELD=US / CVNA=US / SBOW=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / DCPH=US / MAXR=US / BTAI=US / FTDR=US / SVMK=US / ALLO=US / KOD=US / HARP=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / ZI=US / AZEK=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Coherus BioSciences Inc / Marathon Oil Corp / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Griffon Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / Wix.Com Ltd / Chevron Corp / SAGE Therapeutics Inc / Public Storage / Enterprise Products Partners LP / Compugen Ltd / Cadence Bank / Synovus Financial Corp / Agree Realty Corp / Cousins Properties Inc / Omega Healthcare Investors Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Sutro Biopharma Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Cardlytics Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / XPO Logistics Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / DigitalBridge Group Inc / Trex Company Inc / Antero Resources Corp / Nielsen Holdings PLC / Woodward Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Solaredge Technologies Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Carvana Co / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Kodiak Sciences Inc / Harpoon Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: May 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEE.N / AES.N / APD.N / BDX.N / CI.N / CVS.N / ED.N / EL.N / GM.N / PFE.N / WMB.N / SPG.N / MET.N / DUK.N / IFF.N / EMR.N / WEC.N / LIN.N / AWK.N / VTR.N / COP.N / ATVI.OQ / REGN.OQ / O.N / FIS.N / TDG.N / HBI.N / EA.OQ / ZTS.N / PRGO.N / MAR.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cigna Corp / CVS Health Corp / Consolidated Edison Inc / Estee Lauder Companies Inc / General Motors Co / Pfizer Inc / Williams Companies Inc / Simon Property Group Inc / MetLife Inc / Duke Energy Corp / International Flavors & Fragrances Inc / Emerson Electric Co / WEC Energy Group Inc / Linde PLC / American Water Works Company Inc / Ventas Inc / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Realty Income Corp / Fidelity National Information Services Inc / TransDigm Group Inc / HanesBrands Inc / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: April 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ALB.N / AN.N / AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CL.N / CNC.N / COF.N / CRM.N / ED.N / EIX.N / EOG.N / FCX.N / GE.N / GM.N / GPS.N / IBM.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / MRK.N / OXY.N / TXT.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / DHR.N / DIS.N / UNH.N / FE.N / URI.N / DE.N / CAT.N / SPOT.N / AMG.N / GS.N / CLX.N / HON.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / LIN.N / OLN.N / TGT.N / AVY.N / PKI.N / VZ.N / NYT.N / KSS.N / HRB.N / ORCL.N / KMX.N / PWR.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / AIV.N / HAE.N / LB.TO / BLK.N / CVX.N / MHK.N / NWS.AX / IRM.N / NCR.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / COHR.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / PII.N / REGN.OQ / SIVB.OQ / XLNX.OQ / QDEL.OQ / QCOM.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / VSAT.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / NVDA.OQ / BMRN.OQ / PACW.OQ / EXPE.OQ / TREE.OQ / MRVL.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / SGEN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / BIIB.OQ / SNX.N / TPX.N / SBNY.OQ / AGO.N / ACAD.OQ / MOS.N / MKTX.OQ / DXCM.OQ / WAL.N / MS.N / STX.AX / MA.N / AWI.N / FSLR.OQ / IVZ.N / CLR.N / QGEN.N / TDC.N / SATS.OQ / MRNA.OQ / NWSA.OQ / AGCO.N / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / NXPI.OQ / ADSGN.F / LPLA.OQ / AMD.OQ / XYL.N / SLM.OQ / ENPH.OQ / TRIP.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / RNG.N / MAR.OQ / PTC.OQ / GOOGL.OQ / PAYC.N / EQC.N / HUBS.N / ETSY.OQ / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / IONS.OQ / RETA.OQ / TWLO.N / COUP.OQ / CDEV.OQ / AYX.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / PEP.OQ / ZS.OQ / FB.PS / STNE.OQ / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / RTX.N / CARR.N / LMND.N / AMWL.N / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / AutoNation Inc / Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / Consolidated Edison Inc / Edison International / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Occidental Petroleum Corp / Textron Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Affiliated Managers Group Inc / Goldman Sachs Group Inc / Clorox Co / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Linde PLC / Olin Corp / Target Corp / Avery Dennison Corp / PerkinElmer Inc / Verizon Communications Inc / New York Times Co / Kohls Corp / H & R Block Inc / Oracle Corp / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Haemonetics Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Mohawk Industries Inc / News Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / Coherent Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / SVB Financial Group / Xilinx Inc / Quidel Corp / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / ViaSat Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Expedia Group Inc / Lendingtree Inc / Marvell Technology Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Seagen Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Biogen Inc / TD Synnex Corp / Tempur Sealy International Inc / Signature Bank / Assured Guaranty Ltd / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Dexcom Inc / Western Alliance Bancorp / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Invesco Ltd / Continental Resources Inc / Qiagen NV / Teradata Corp / EchoStar Corp / Moderna Inc / News Corp / AGCO Corp / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / NXP Semiconductors NV / Adidas AG / LPL Financial Holdings Inc / Advanced Micro Devices Inc / Xylem Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / RingCentral Inc / Marriott International Inc / PTC Inc / Alphabet Inc / Paycom Software Inc / Equity Commonwealth / HubSpot Inc / ETSY Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Centennial Resource Development Inc / Alteryx Inc / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / PepsiCo Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / American Well Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Germany / Ireland / Luxembourg / Netherlands / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Our due diligence suggests injection debulking some segments could be favorable</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">KOD=US / REGN=US</td><td class="leftalignment">Kodiak Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Sandoz Phase 3 Plans for Eylea Biosimilar is a Win for REGN</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F10</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist ASCO Planner v1.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 5671735 / 0989529 / 2701271 / 2000019 / 2045623 / 2065159 / 2219224 / 2175672 / 2270726 / 2317087 / 2670519 / 2459020 / 2378534 / 2630513 / 2689560 / 2048804 / 2730190 / 2440637 / 2829601 / 2883878 / 7123870 / 2795393 / B121557 / B125XQ6 / B3D7K31 / B5B2106 / B7TL820 / B95N910 / BH65L93 / BFLR866 / BFZCHN7 / BQPVQZ6 / BYVY8G0 / BYW36M8 / BFNF1D6 / BXDZ9Z0 / BJLFHW7 / BFM2GV1 / BR4T3B3 / BGCYWN8 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BZ8VJQ8 / BD6D4Y5 / BMH0MR7 / BMG75B4 / BMDCDP2 / BLBLMD5</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Costco Wholesale Corp / Amazon.com Inc / ANSYS Inc / Autodesk Inc / CMS Energy Corp / Cardinal Health Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Intuit Inc / Mckesson Corp / New Jersey Resources Corp / PG&E Corp / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Teva Pharmaceutical Industries Ltd / Nestle SA / Amerisourcebergen Corp / Mastercard Inc / Portland General Electric Co / Discovery Inc / Fortinet Inc / Meta Platforms Inc / PTC Inc / Seacoast Banking Corporation of Florida / Twitter Inc / Wix.Com Ltd / Horizon Therapeutics PLC / Alphabet Inc / PayPal Holdings Inc / Amneal Pharmaceuticals Inc / Shopify Inc / Chewy Inc / GreenSky Inc / HubSpot Inc / Xencor Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / Vistra Corp / Altair Engineering Inc / Zendesk Inc / Inventiva SA / Bigcommerce Holdings Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / ALV.N / CL.N / ED.N / EL.N / ENI.MI / F.N / FLS.N / GM.N / KMB.N / KO.N / MRK.N / MSFT.O / NA / PFE.N / REP.MC / SO.N / STO.AX / T.N / TRV.N / VC.N / PEP.N / AVB.N / TRI.N / BFb.N / PG.N / WY.N / CNQ.TO / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / ETN.N / BWA.N / LEA.N / WCC.N / K.N / DT.N / DISH.O / SU.TO / CTXS.O / CLX.N / CAG.N / GIS.N / EMR.N / PCG.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / GWW.N / VZ.N / EXEL.O / JCI.N / STZ.N / APH.N / FISV.O / EQT.N / EPD.N / CPT.N / CHTR.O / AXL.N / AWK.N / CHD.N / AME.N / BC.N / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / MHK.N / SM.N / NCR.N / NET.N / TEL.N / COP.N / ENDP.O / PII.N / ST.N / SWN.N / TT.N / LNG.A / SGEN.OQ / GPN.N / PFS.N / MNST.O / EFX.TO / WSBC.O / CASY.O / PCTY.O / FFIV.O / EQIX.O / ATDb.TO / 02209S103 / NVT.N / DLR.N / SCL.TO / 427866108 / MPW.N / RDSb.L / DRX.L / FIS.N / CCOI.O / MWA.N / HOG.N / MERC.O / BGS.N / PPL.TO / TDC.N / ENSG.O / DAN.N / ARX.TO / FTNT.O / SPB.N / NEE.N / LYB.N / TOU.TO / FRU.TO / PCRX.O / MTOR.N / PXT.TO / XYL.N / PSX.N / HTGC.N / FFHu.TO / MDLZ.OQ / APAM.N / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / PTCT.O / AGIO.O / PAYC.N / AGRX.O / SHLX.N / QSR.N / EVA.N / PYPL.OQ / AROC.N / SQ.N / WVE.OQ / MIME.OQ / OMF.N / MESO.O / IONS.O / RACE.MI / ADVM.OQ / TWLO.N / KNSL.OQ / ADNT.N / JELD.N / VST.N / ATUS.N / AQUA.N / APTV.N / GTES.N / WELL.N / BSIG.N / AMRX.N / VNE.N / KDP.N / AQST.O / CWEN.N / NWL.O / NBSE.OQ / PING.N / DDOG.O / CRNC.OQ / EPAC.N / 2222.SE / REYN.O / NKLA.OQ / FOUR.N / AKES.OL / NRIX.OQ / NAPA.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Autoliv Inc / Colgate-Palmolive Co / Consolidated Edison Inc / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / Flowserve Corp / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Microsoft Corp / National Bank of Canada / Pfizer Inc / Repsol SA / Southern Co / Santos Ltd / AT&T Inc / Travelers Companies Inc / Visteon Corp / PepsiCo Inc / Avalonbay Communities Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Eaton Corporation PLC / Borgwarner Inc / Lear Corp / Wesco International Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Suncor Energy Inc / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Emerson Electric Co / PG&E Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Exelixis Inc / Johnson Controls International PLC / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / EQT Corp / Enterprise Products Partners LP / Camden Property Trust / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / AMETEK Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Mohawk Industries Inc / SM Energy Co / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Conocophillips / Endo International PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / Cheniere Energy Inc / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / Monster Beverage Corp / Enerflex Ltd / WesBanco Inc / Caseys General Stores Inc / Paylocity Holding Corp / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / nVent Electric PLC / Digital Realty Trust Inc / Shawcor Ltd / Hershey Co / Medical Properties Trust Inc / Royal Dutch Shell PLC / Drax Group PLC / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mueller Water Products Inc / Harley-Davidson Inc / Mercer International Inc / B&G Foods Inc / Pembina Pipeline Corp / Teradata Corp / Ensign Group Inc / Dana Inc / ARC Resources Ltd / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / LyondellBasell Industries NV / Tourmaline Oil Corp / Freehold Royalties Ltd / Pacira Biosciences Inc / Meritor Inc / Parex Resources Inc / Xylem Inc / Phillips 66 / Hercules Capital Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Artisan Partners Asset Management Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / PTC Therapeutics Inc / Agios Pharmaceuticals Inc / Paycom Software Inc / Agile Therapeutics Inc / Shell Midstream Partners LP / Restaurant Brands International Inc / Enviva Inc / PayPal Holdings Inc / Archrock Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / OneMain Holdings Inc / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Kinsale Capital Group Inc / Adient PLC / JELD-WEN Holding Inc / Vistra Corp / Altice USA Inc / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Welltower Inc / Brightsphere Investment Group Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Clearway Energy Inc / Newell Brands Inc / NeuBase Therapeutics Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Enerpac Tool Group Corp / Saudi Arabian Oil Co / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Aker Solutions ASA / Nurix Therapeutics Inc / Duckhorn Portfolio Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / Saudi Arabia / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: May 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AES.N / APD.N / BDX.N / CI.N / CL.N / CVS.N / ED.N / EL.N / GM.N / PFE.N / WMB.N / SPG.N / MET.N / DUK.N / IFF.N / EMR.N / WEC.N / LIN.N / AWK.N / VTR.N / COP.N / ATVI.OQ / REGN.OQ / O.N / CHTR.OQ / FIS.N / ZTS.N / MAR.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">AES Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Consolidated Edison Inc / Estee Lauder Companies Inc / General Motors Co / Pfizer Inc / Williams Companies Inc / Simon Property Group Inc / MetLife Inc / Duke Energy Corp / International Flavors & Fragrances Inc / Emerson Electric Co / WEC Energy Group Inc / Linde PLC / American Water Works Company Inc / Ventas Inc / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Realty Income Corp / Charter Communications Inc / Fidelity National Information Services Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: QURE hold cleared as ADVM sees SUSAR</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ADVM.OQ / UQ1.F / EBS / ISEE / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / RGLS / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / CBIO / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / IOVA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Adverum Biotechnologies Inc / Uniqure NV / Emergent BioSolutions Inc / Iveric Bio Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Peer Group Analytics - Q4 FY2020</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Around the Horn- Updates and Upcoming</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US35104E1001 / US09061G1013 / US09058V1035 / US64125C1099 / US75886F1075 / US92532F1003 / US09609G1004 / US29251M1062 / NL0010696654 / US37890U1088 / US4622221004 / US24823R1059 / US5011471027 / US84833T1034 / US77313F1066 / US38341P1021 / US6047491013 / US65487U1088 / US45720L1070 / US92765F1084</td><td class="leftalignment">4D Molecular Therapeutics Inc / Biomarin Pharmaceutical Inc / BioCryst Pharmaceuticals Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / bluebird bio Inc / Enanta Pharmaceuticals Inc / Uniqure NV / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Denali Therapeutics Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Rocket Pharmaceuticals Inc / Gossamer Bio Inc / Mirum Pharmaceuticals Inc / Nkarta Inc / Inhibrx Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 85 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / KR.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / RUSHA.OQ / NDAQ.OQ / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Kroger Co / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Rush Enterprises Inc / Nasdaq Inc / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose:</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / AGIO.O / NRIX.OQ</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Agios Pharmaceuticals Inc / Nurix Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Regeneron (REGN:$481.30) rises for a second consecutive month, a two-month rise of 7%</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What’s Next in Biotech? "Holy T Cell Co-stimulation Batman!" - Dynamic Duos with CD28?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 2730190 / BGCYWN8</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">RAPT: Dermatitis Data Expected in 1H21 - KOL Call on May 6th to Discuss Hurdle</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">RAPT.OQ / REGN</td><td class="leftalignment">Rapt Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">EBS / ISEE / 66987V10 / 75886F107 / 02043Q107 / 339 / 03152W109 / ALSEN.PA / 75901B107 / SIGHT.PA / 45826J105 / SLDB / 00773U108 / MGTX.O / 501147102 / PASG.O / N90064101 / 50015M109 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Iveric Bio Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sensorion SA / Regenxbio Inc / Gensight Biologics SA / Intellia Therapeutics Inc / Solid Biosciences Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / Krystal Biotech Inc / Passage Bio Inc / Uniqure NV / Kodiak Sciences Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 Virtual ASCO Planner</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">45337C10 / 75991610 / 71708110 / 45253H10 / 04635310 / 37555810 / 03116210 / 75886F10 / M2572210 / 45232710 / 30063P10 / 478160104 / 640268108 / 30161Q104 / 64049M20 / 58933Y10 / G0176710 / 53220K50 / 92337F10 / 46185L10 / 00653A107 / 74587V10 / 00287Y10 / 98401F10 / 18946410 / 40131M10 / 58490H10 / 63230710 / 05358830 / 76029N10 / 41358P10 / 09627Y10 / 09075V10 / 09609G10 / 55609910 / N0104510 / 31189P10 / 07725L10 / G3910J11 / 24344T10 / 29428V10 / 81181C10 / 04685N10 / 13089P10 / 22101510 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 89620X50 / 98887Q10 / 98943L10 / 98985W10</td><td class="leftalignment">Incyte Corp / Repligen Corp / Pfizer Inc / ImmunoGen Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Illumina Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Exelixis Inc / Neogenomics Inc / Merck & Co Inc / Alkermes Plc / Ligand Pharmaceuticals Inc / Veracyte Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Puma Biotechnology Inc / Abbvie Inc / Xencor Inc / Clovis Oncology Inc / Guardant Health Inc / Medicenna Therapeutics Corp / Natera Inc / Aveo Pharmaceuticals Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Blueprint Medicines Corp / BioNTech SE / bluebird bio Inc / MacroGenics Inc / Affimed NV / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Deciphera Pharmaceuticals Inc / Epizyme Inc / Seagen Inc / Athenex Inc / Calithera Biosciences Inc / Corvus Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Pfizer Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Andrew Berens, M.D. / Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Mr. Puneet Souda</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AES.N / BDX.N / CI.N / CL.N / CVS.N / ED.N / EL.N / GM.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / EMR.N / WEC.N / XOM.N / LIN.N / AWK.N / VTR.N / CVX.N / COP.N / ATVI.OQ / REGN.OQ / O.N / AMZN.OQ / CHTR.OQ / CMCSA.OQ / FIS.N / ABBV.N / ZTS.N / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">AES Corp / Becton Dickinson and Co / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Consolidated Edison Inc / Estee Lauder Companies Inc / General Motors Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Linde PLC / American Water Works Company Inc / Ventas Inc / Chevron Corp / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Comcast Corp / Fidelity National Information Services Inc / Abbvie Inc / Zoetis Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row - Biotech Fund Flows Stay Positive</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q Earnings Season: Read-Through from MRK's Results</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / GILD.O / AMGN.O / REGN.O / SGEN.O / CLVS.O</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Clovis Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">ADVM: Downgrade to Neutral—Too many options exist amid ADVM-022 questions</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">00773U108 / ISEE / 66987V10 / 75886F107 / 339 / 03152W109 / ALSEN.PA / 75901B107 / SIGHT.PA / SLDB / MGTX.O / 501147102 / PASG.O / N90064101 / 50015M109 / SIOX / N71542109 / 03820J100</td><td class="leftalignment">Adverum Biotechnologies Inc / Iveric Bio Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sensorion SA / Regenxbio Inc / Gensight Biologics SA / Solid Biosciences Inc / MeiraGTx Holdings PLC / Krystal Biotech Inc / Passage Bio Inc / Uniqure NV / Kodiak Sciences Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / France / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Regeneron Pharmaceuticals Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">V / 5671735 / 0925288 / 2434209 / 2293819 / 2486813 / 2113434 / 2219224 / 2115902 / 2280220 / 2270726 / 2829515 / 2317087 / 2670519 / 2328915 / 2342034 / 2689560 / 2684703 / 2048804 / 2707677 / 2730190 / 2440637 / 2883878 / 2943523 / 2503529 / B125XQ6 / B02R1L6 / B3D7K31 / 2679204 / B5B2106 / B65LWX6 / B7TL820 / B7VD3F2 / B83YYY6 / B95N910 / BDZCRX3 / BYW36M8 / BZ19F50 / BXDZ9Z0 / BF5L3T2 / BJLT387 / BD8DJ71 / BJFSR88 / BJ2Z0H2 / BFZ1K46 / BMYML02 / BKTNTR9 / BFWK4R7 / BZ1LFG7 / BYY88Y7 / BMVWYW8 / BYQRFY1 / BLBLMD5</td><td class="leftalignment">Visa Inc / Sanofi SA / GlaxoSmithKline PLC / Home Depot Inc / eBay Inc / Kellogg Co / Boston Scientific Corp / CMS Energy Corp / OPKO Health Inc / DTE Energy Co / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / Nextera Energy Inc / Fiserv Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Teva Pharmaceutical Industries Ltd / Penske Automotive Group Inc / World Wrestling Entertainment Inc / Portland General Electric Co / ALLETE Inc / Discovery Inc / Align Technology Inc / Fortinet Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / ICAD Inc / PTC Inc / RingCentral Inc / PayPal Holdings Inc / Veoneer Inc / Shopify Inc / Elanco Animal Health Inc / Avantor Inc / Snap Inc / Uniqure NV / Pinterest Inc / Spotify Technology SA / DraftKings Inc / ViacomCBS Inc / PagSeguro Digital Ltd / Roku Inc / Alphabet Inc / Protara Therapeutics Inc / Teladoc Health Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BDX.N / CL.N / CVS.N / EL.N / GM.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / YUM.N / EMR.N / WEC.N / XOM.N / LIN.N / AWK.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / REGN.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / CMCSA.OQ / FIS.N / ABBV.N / ZTS.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / FB.PS</td><td class="leftalignment">Boeing Co / Becton Dickinson and Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / General Motors Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Yum! Brands Inc / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Linde PLC / American Water Works Company Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Regeneron Pharmaceuticals Inc / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Comcast Corp / Fidelity National Information Services Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 1Q21 Results Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">SASY.PA / AZN.L / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / REGN.OQ / MRNA.OQ / BAYGN.DE</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Moderna Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc. (REGN) - INITIATING COVERAGE - Expect growth from antibody REGEN-COV and key products</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Dupixent ahead of St. expectations, still below our high estimates</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Readthrough from Sanofi 1Q21 Results</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2730190 / SASY.PA / 5671735</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sanofi SA / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Sanofi Read-Through: Strong Quarter for Dupixent</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 Dupi Strong; Kevzara Light – SNY Did Not Opt In To BCMA Or MUC16 Bispecifics</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ANTO.L / BP.L / COF.N / GE.N / MMC.N / MSFT.O / PFE.N / PHM.N / RIO.L / HUM.N / GILD.O / AMGN.O / UHS.N / FER.MC / AAL.L / ROP.N / UNP.N / CLX.N / WM.N / MMM.N / BOL.ST / SBUX.O / AMP.N / RRC.N / FISV.O / V.N / SUI.N / BMRN.O / REGN.O / NCR.N / BLU.N / CHE.N / BRO.N / PII.N / ST.N / SGEN.OQ / BCRX.O / ACGL.O / FFIV.O / FM.TO / ACAD.O / ALNY.O / ARWR.O / CLR.N / INO.OQ / VALE.N / BHPB.L / GLEN.L / SMSS.L / MDLZ.OQ / ABBV.N / SYF.N / 03835T200 / FSV.O / GBT.OQ / UBSG.S / ADVM.OQ / CRSP.OQ / ORSTED.CO / EHC.N / ITRM.O / NTGY.MC / PRVB.O / KRTX.OQ / MORF.OQ / APRE.OQ / ETNB.O / SPRB.OQ</td><td class="leftalignment">Antofagasta PLC / BP PLC / Capital One Financial Corp / General Electric Co / Marsh & McLennan Companies Inc / Microsoft Corp / Pfizer Inc / Pultegroup Inc / Rio Tinto PLC / Humana Inc / Gilead Sciences Inc / Amgen Inc / Universal Health Services Inc / Ferrovial SA / Anglo American PLC / Roper Technologies Inc / Union Pacific Corp / Clorox Co / Waste Management Inc / 3M Co / Boliden AB / Starbucks Corp / Ameriprise Financial Inc / Range Resources Corp / Fiserv Inc / Visa Inc / Sun Communities Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / NCR Corp / BELLUS Health Inc / Chemed Corp / Brown & Brown Inc / Polaris Inc / Sensata Technologies Holding PLC / Seagen Inc / BioCryst Pharmaceuticals Inc / Arch Capital Group Ltd / F5 Inc / First Quantum Minerals Ltd / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Continental Resources Inc / Inovio Pharmaceuticals Inc / Vale SA / BHP Group PLC / Glencore PLC / Smart Metering Systems PLC / Mondelez International Inc / Abbvie Inc / Synchrony Financial / Aptose Biosciences Inc / FirstService Corp / Global Blood Therapeutics Inc / UBS Group AG / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Orsted A/S / Encompass Health Corp / Iterum Therapeutics PLC / Naturgy Energy Group SA / Provention Bio Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / 89Bio Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biopharma: Our Top 15 Most Interesting/Surprising Takeaways From RBC's Doctor Days</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / GILD.O / BMRN.O / REGN.O / BLU.N / SGEN.OQ / BCRX.O / ALNY.O / ARWR.O / ABBV.N / ADVM.OQ / PRVB.O / KRTX.OQ / ETNB.O / SPRB.OQ</td><td class="leftalignment">Pfizer Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BELLUS Health Inc / Seagen Inc / BioCryst Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Abbvie Inc / Adverum Biotechnologies Inc / Provention Bio Inc / Karuna Therapeutics Inc / 89Bio Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Steve Daddeo / Michael Murray / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Daniel Busby / Leonid Timashev / David Szeto / Yinglu Zhang / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - Primary focus remains on Covid-19 partnership</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MOLN.S / LLY.N / ROG.S / NOVN.S / AMGN.OQ / REGN.OQ / ABBV.N</td><td class="leftalignment">Molecular Partners AG / Eli Lilly and Co / Roche Holding AG / Novartis AG / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Fr. Barbora Blaha / Herr. Christoph Gretler / Ms Jo Walton</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Dermatologist Survey: Skyrizi, Dupixent, Oral/Topical JAK Implications</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">INCY.O / REGN.O</td><td class="leftalignment">Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / CL=US / WEN=US / PLD=US / AMZN=US / BLD=US / DVN=US / INCY=US / KMI=US / APA=US / CPE=US / EOG=US / DGX=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / CHKP=US / PXD=US / ENR=US / HSII=US / MGY=US / SWN=US / MUR=US / BRO=US / BYD=US / MRO=US / LEG=US / HCA=US / VMC=US / MGM=US / PENN=US / NWL=US / MLM=US / FLO=US / KFY=US / ARCC=US / CBRL=US / CENT=US / CHD=US / CNX=US / DRI=US / EPC=US / EQT=US / GFF=US / HAIN=US / IBP=US / SAFE=US / TREE=US / MAIN=US / MAS=US / MEDP=US / MHK=US / MCRI=US / ORCC=US / PACW=US / REGN=US / REGI=US / SBAC=US / SMG=US / SSNC=US / SNAP=US / VRTX=US / CVX=US / POST=US / BXS=US / BKNG=US / FBK=US / FR=US / FFIN=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / MNST=US / RRR=US / NOMD=US / TPX=US / FNB=US / EXP=US / CZR=US / NUVA=US / AINV=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / NOG=US / JACK=US / AAN=US / TREX=US / AR=US / NXPI=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / NDLS=US / GLPI=US / TSLX=US / 00770K202 / VNOM=US / 70806A106 / LOCO=US / ANTM=US / SHAK=US / AJRD=US / GSBD=US / WING=US / ARGX=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / PETQ=US / ROKU=US / CARG=US / COLD=US / EOLS=US / KDP=US / OZK=US / FSK=US / LYFT=US / RTLR=US / FERG=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DKNG=US / FSKR=US / AZEK=US / BALY=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Colgate-Palmolive Co / Wendys Co / Prologis Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Kinder Morgan Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Pioneer Natural Resources Co / Energizer Holdings Inc / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Brown & Brown Inc / Boyd Gaming Corp / Marathon Oil Corp / Leggett & Platt Inc / HCA Healthcare Inc / Vulcan Materials Co / MGM Resorts International / Penn National Gaming Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Korn Ferry / Ares Capital Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Hain Celestial Group Inc / Installed Building Products Inc / Safehold Inc / Lendingtree Inc / Main Street Capital Corp / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / Scotts Miracle-Gro Co / SS&C Technologies Holdings Inc / Snap Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Post Holdings Inc / Cadence Bank / Booking Holdings Inc / FB Financial Corp / First Industrial Realty Trust Inc / First Financial Bankshares Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Red Rock Resorts Inc / Nomad Foods Ltd / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / Caesars Entertainment Inc / NuVasive Inc / Apollo Investment Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Aaron's Company Inc / Trex Company Inc / Antero Resources Corp / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Gaming and Leisure Properties Inc / Sixth Street Specialty Lending Inc / Aemetis Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Anthem Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / PetIQ Inc / Roku Inc / CarGurus Inc / Americold Realty Trust / Evolus Inc / Keurig Dr Pepper Inc / Bank Ozk / FS KKR Capital Corp / Lyft Inc / Rattler Midstream LP / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DraftKings Inc / FS KKR Capital Corp / Azek Company Inc / Bally's Corp / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 1Q21 Preview</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">SASY.PA / PFE.N / REGN.OQ</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Mr. Trung Huynh / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Regeneron increases 3.7% in 2021, but lagging Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">75</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">From Good To Great, Takeaways From R&D Day Support Our Positive Investment Thesis</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IMAB.OQ / US75886F1075 / HGEN.OQ</td><td class="leftalignment">I-Mab / Regeneron Pharmaceuticals Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Transcript from Expert call on LAG-3 inhibitors and BMY’s relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY=US / MRK=US / AMGN=US / INCY=US / REGN=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / ISEE / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / RGLS / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / CBIO / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / IOVA / 45826J105 / SLDB / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / SIOX / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Iveric Bio Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Catalyst Biosciences Inc / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / Sio Gene Therapies Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">Etrasimod 3 mg Dose Likely Needed to Remain Competitive in Atopic Dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">040047607 / 75886F107</td><td class="leftalignment">Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD / Tong Liu, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Chardan's 5th GMs Manufacturing Summit is here</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">EBS / 66987V10 / NVAX.O / 75886F107 / 02043Q107 / 339 / 03152W109 / 800677106 / MRNA.O / ARCT.O / 045396108 / 199800.KN / ALSEN.PA / 00289Y107 / 03879J100 / 75901B107 / M96883109 / 04280A100 / SIGHT.PA / 00653A107 / LYS.PA / 45826J105 / 28106W103 / 00773U108 / MGTX.O / 54142F102 / H17182108 / 501147102 / FIXX.O / MBIO.O / NBSE.O / 77313F106 / OCGN.O / XCUR.O / PASG.O / IMTX.O / N90064101 / 76029N106 / N71542109 / 03820J100</td><td class="leftalignment">Emergent BioSolutions Inc / Novartis AG / Novavax Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Core Economy Investment Group Ltd / Amicus Therapeutics Inc / Sangamo Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Assembly Biosciences Inc / ToolGen Inc / Sensorion SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Regenxbio Inc / Vascular Biogenics Ltd / Arrowhead Pharmaceuticals Inc / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Lysogene SA / Intellia Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / MeiraGTx Holdings PLC / LogicBio Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Homology Medicines Inc / Mustang Bio Inc / NeuBase Therapeutics Inc / Rocket Pharmaceuticals Inc / Ocugen Inc / Exicure Inc / Passage Bio Inc / Immatics NV / Uniqure NV / Replimune Group Inc / ProQR Therapeutics NV / Applied Genetic Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Large-Cap Biotechnology: Termination of Coverage</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ACRX.OQ / BIIB.OQ / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Biogen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">- Credit Suisse U Eq. Res.</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global ESG Research: Sustainable Investing: is it 'Dot.com' in disguise?</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">0257.HK / 0551.HK / 0895.HK / 1038.HK / 1093.HK / ABT.N / ACC.BO / AES.N / AHT.L / AIRP.PA / ALSO.PA / ALVG.DE / ANA.MC / APD.N / ARDS.AS / ASMI.AS / ASML.AS / BH.BK / BMWG.DE / BMY.N / BOUY.PA / CCK.N / CRH.I / DSMN.AS / ECL.N / ED.N / EL.N / ELUXB.ST / EMG.L / ERICB.ST / FLS.N / HEXAB.ST / IMI.L / IP.N / KPJH.KL / LLY.N / NIBEB.ST / PNW.N / PSON.L / ROR.L / SCC.BK / SCHN.PA / SGEF.PA / SMDS.L / SN.L / T.TO / TOM.OL / TOTF.PA / UU.L / VERB.VI / VLOF.PA / VNT.N / WPL.AX / 0371.HK / CONG.DE / OHL.MC / ETN.N / AMAR.BO / BWA.N / URI.N / WCC.N / PH.N / REE.MC / TRP.TO / CAT.N / ABBN.S / SIEGN.DE / ACE.MI / ROCKB.CO / HON.N / MFC.TO / VOPA.AS / EMR.N / ENEI.MI / MGA.N / DTEGN.F / IFXGN.DE / LIN.N / BLL.N / EXID.BO / GBFG.DE / VIE.PA / APA.AX / NZYMB.CO / KMI.N / PWR.N / MTZ.N / EPD.N / AXL.N / PCAR3.SA / FLR.N / KRC.N / NDXG.DE / DOW.AX / BLDP.TO / AMS.S / 600690.SS / NLS.N / BSL.AX / WG.L / 1211.HK / CNP.N / 600008.SS / 600009.SS / 000651.SZ / CGNX.OQ / FAST.OQ / TROW.OQ / REGN.OQ / TRMB.OQ / YORW.OQ / TTEK.OQ / SCHL.OQ / AZPN.OQ / BRKS.OQ / GRMN.OQ / MNST.OQ / UMI.BR / 012330.KS / 012630.KS / STMN.S / 0451.HK / 2628.HK / TRQ.TO / 600170.SS / 0981.HK / YAR.OL / 2338.HK / 2318.HK / 2331.HK / CPFE3.SA / 600820.SS / 600884.SS / 002008.SZ / 3311.HK / EDF.PA / 600491.SS / PFC.L / SGM.AX / SPWR.OQ / 600835.SS / 600845.SS / CSMG3.SA / ZUMV.VI / CPX.TO / 3899.HK / ERIC.OQ / ASHM.L / 1800.HK / 2006.HK / 3898.HK / 601628.SS / 601318.SS / SKG.I / 000338.SZ / ACM.N / DAIGN.DE / PGRD.BO / GL9.I / APEI.OQ / 3800.HK / FLUI.MC / 601390.SS / 0806.HK / 0390.HK / 601601.SS / 601186.SS / BIP.N / WRT1V.HE / LABB.MX / ERII.OQ / SEVI.PA / HOLI.OQ / AIPJ.J / 2009.HK / LOPE.OQ / 601727.SS / 1313.HK / 601888.SS / 002294.SZ / AQN.TO / 2601.HK / GNRC.N / 002431.SZ / 300073.SZ / 300024.SZ / LHCJ.J / TSLA.OQ / BASFN.DE / 002527.SZ / 1590.TW / KEY.TO / APAM.AS / WWD.OQ / FHI.N / 601992.SS / 002594.SZ / QUAL3.SA / UNFI.N / REGI.OQ / WETF.OQ / VAC.N / ENPH.OQ / 601800.SS / 002672.SZ / TAEE11.SA / SIIC.SI / BFAM.N / WSKT.JK / COTY.N / CAV1V.HE / CORB.AS / CHGG.N / ARMK.N / LNTAQ.L / APPS.MC / 2186.HK / MDLY.N / XXLA.OL / 1317.HK / SEDG.OQ / CLNX.MC / WRK.N / PLNT.N / IEL.AX / 1565.HK / MDCM.L / LHN.S / BFIT.AS / BEDU.N / SGREN.MC / REDU.OQ / ORSTED.CO / 0807.HK / DWSG.DE / EQNR.OL / 300750.SZ / ARCE.OQ / LTHM.N / 1797.HK / COGN3.SA / BRBR.N / DQ.ZY / J.N / 688339.SS / ENR1N.DE / ALGM.OQ / 6690.HK</td><td class="leftalignment">China Everbright Environment Group Ltd / Yue Yuen Industrial (Holdings) Ltd / Dongjiang Environmental Co Ltd / CK Infrastructure Holdings Ltd / CSPC Pharmaceutical Group Ltd / Abbott Laboratories / ACC Ltd / AES Corp / Ashtead Group PLC / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Alstom SA / Allianz SE / Acciona SA / Air Products and Chemicals Inc / Arcadis NV / ASM International NV / ASML Holding NV / Bumrungrad Hospital PCL / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Bouygues SA / Crown Holdings Inc / CRH PLC / Koninklijke DSM NV / Ecolab Inc / Consolidated Edison Inc / Estee Lauder Companies Inc / Electrolux AB / Man Group PLC / Telefonaktiebolaget LM Ericsson / Flowserve Corp / Hexagon AB / IMI PLC / International Paper Co / KPJ Healthcare Bhd / Eli Lilly and Co / Nibe Industrier AB / Pinnacle West Capital Corp / Pearson PLC / Rotork PLC / Siam Cement PCL / Schneider Electric SE / Vinci SA / DS Smith PLC / Smith & Nephew PLC / Telus Corp / Tomra Systems ASA / TotalEnergies SE / United Utilities Group PLC / Verbund AG / Valeo SE / Vontier Corp / Woodside Petroleum Ltd / Beijing Enterprises Water Group Ltd / Continental AG / Obrascon Huarte Lain SA / Eaton Corporation PLC / Amara Raja Batteries Ltd / Borgwarner Inc / United Rentals Inc / Wesco International Inc / Parker-Hannifin Corp / Red Electrica Corporacion SA / TC Energy Corp / Caterpillar Inc / Abb Ltd / Siemens AG / Acea SpA / Rockwool International A/S / Honeywell International Inc / Manulife Financial Corp / Koninklijke Vopak NV / Emerson Electric Co / Enel SpA / Magna International Inc / Deutsche Telekom AG / Infineon Technologies AG / Linde PLC / Ball Corp / Exide Industries Ltd / Bilfinger SE / Veolia Environnement SA / APA Group / Novozymes A/S / Kinder Morgan Inc / Quanta Services Inc / MasTec Inc / Enterprise Products Partners LP / American Axle & Manufacturing Holdings Inc / Companhia Brasileira de Distribuicao / Fluor Corp / Kilroy Realty Corp / Nordex SE / Downer EDI Ltd / Ballard Power Systems Inc / ams AG / Haier Smart Home Co Ltd / Nautilus Inc / BlueScope Steel Ltd / John Wood Group PLC / BYD Co Ltd / CenterPoint Energy Inc / Beijing Capital Eco-Environment Protection Group Co Ltd / Shanghai International Airport Co Ltd / Gree Electric Appliances Inc of Zhuhai / Cognex Corp / Fastenal Co / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trimble Inc / York Water Co / Tetra Tech Inc / Scholastic Corp / Aspen Technology Inc / Azenta Inc / Garmin Ltd / Monster Beverage Corp / Umicore SA / Hyundai Mobis Co Ltd / HDC Holdings Co Ltd / Straumann Holding AG / GCL New Energy Holdings Ltd / China Life Insurance Co Ltd / Turquoise Hill Resources Ltd / Shanghai Construction Group Co Ltd / Semiconductor Manufacturing International Corp / Yara International ASA / Weichai Power Co Ltd / Ping An Insurance Group Co of China Ltd / Li Ning Co Ltd / CPFL Energia SA / Shanghai Tunnel Engineering Co Ltd / Ningbo Shanshan Co Ltd / Han's Laser Technology Industry Group Co Ltd / China State Construction International Holdings Ltd / Electricite de France SA / Long Yuan Construction Group Co Ltd / Petrofac Ltd / Sims Ltd / SunPower Corp / Shanghai Mechanical & Electrical Industry Co Ltd / Shanghai Baosight Software Co Ltd / Companhia de Saneamento de Minas Gerais Copasa MG / Zumtobel Group AG / Capital Power Corp / CIMC Enric Holdings Ltd / Telefonaktiebolaget LM Ericsson / Ashmore Group PLC / China Communications Construction Co Ltd / Shanghai Jin Jiang Capital Co Ltd / Zhuzhou CRRC Times Electric Co Ltd / China Life Insurance Co Ltd / Ping An Insurance Group Co of China Ltd / Smurfit Kappa Group PLC / Weichai Power Co Ltd / AECOM / Daimler AG / Power Grid Corporation of India Ltd / Glanbia PLC / American Public Education Inc / GCL-Poly Energy Holdings Ltd / Fluidra SA / China Railway Group Ltd / Value Partners Group Ltd / China Railway Group Ltd / China Pacific Insurance Group Co Ltd / China Railway Construction Corp Ltd / Brookfield Infrastructure Partners LP / Wartsila Oyj Abp / Genomma Lab Internacional SAB de CV / Energy Recovery Inc / Suez SA / Hollysys Automation Technologies Ltd / Adcock Ingram Holdings Ltd / BBMG Corp / Grand Canyon Education Inc / Shanghai Electric Group Co Ltd / China Resources Cement Holdings Ltd / China Tourism Group Duty Free Corp Ltd / Shenzhen Salubris Pharmaceuticals Co Ltd / Algonquin Power & Utilities Corp / China Pacific Insurance Group Co Ltd / Generac Holdings Inc / Palm Eco-Town Development Co Ltd / Beijing Easpring Material Technology CO LTD / SIASUN Robot & Automation Co Ltd / Life Healthcare Group Holdings Ltd / Tesla Inc / BASF SE / Shanghai STEP Electric Corp / Airtac International Group / Keyera Corp / Aperam SA / Woodward Inc / Federated Hermes Inc / BBMG Corp / BYD Co Ltd / Qualicorp Consultoria e Corretora de Seguros SA / United Natural Foods Inc / Renewable Energy Group Inc / Wisdom Tree Investments Inc / Marriott Vacations Worldwide Corp / Enphase Energy Inc / China Communications Construction Co Ltd / Dongjiang Environmental Co Ltd / Transmissora Alianca de Energia Eletrica SA / SIIC Environment Holdings Ltd / Bright Horizons Family Solutions Inc / Waskita Karya (Persero) Tbk PT / Coty Inc / Caverion Oyj / Corbion NV / Chegg Inc / Aramark / Lenta Plc / Applus Services SA / Luye Pharma Group Ltd / Medley Management Inc / XXL ASA / China Maple Leaf Educational Systems Ltd / Solaredge Technologies Inc / Cellnex Telecom SA / Westrock Co / Planet Fitness Inc / IDP Education Ltd / Virscend Education Company Ltd / Mediclinic International PLC / Holcim AG / Basic Fit NV / Bright Scholar Education Holdings Ltd / Siemens Gamesa Renewable Energy SA / Rise Education Cayman Ltd / Orsted A/S / SIIC Environment Holdings Ltd / DWS Group GmbH & Co KgaA / Equinor ASA / Contemporary Amperex Technology Co Ltd / Arco Platform Ltd / Livent Corp / Koolearn Technology Holding Ltd / Cogna Educacao SA / Bellring Brands Inc / Daqo New Energy Corp / Jacobs Engineering Group Inc / Beijing SinoHytec Co Ltd / Siemens Energy AG / Allegro Microsystems Inc / Haier Smart Home Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Brazil / Canada / Switzerland / China / Cayman Islands / Cyprus / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / Indonesia / India / Ireland / Italy / Korea, Republic of / Luxembourg / Mexico / Malaysia / Netherlands / Norway / New Zealand / Singapore / Sweden / Thailand / United States / Virgin Islands, British / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Environmental, Social, Governance</td><td class="leftalignment">Global ESG Team / Eugene Klerk / Bahar Sezer Longworth / Ms. Betty Jiang / Phineas Glover</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Here Comes the Sun – Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">05329W10 / 75886F107 / 136375102 / 13645T100 / 421906108</td><td class="leftalignment">AutoNation Inc / Regeneron Pharmaceuticals Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Healthcare Services Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Nathan Martin / Mr. Michael P. Ward, CFA / Mr. Reuben Garner / Mr. Bill Sutherland</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Cocktail Sales In EU Ramping Up</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AN=US / AMGN=US / BMY=US / DIS=US / PG=US / T=US / INCY=US / GILD=US / AMT=US / PEB=US / AKAM=US / CHTR=US / H=US / CONE=US / MTN=US / VZ=US / CCI=US / MGY=US / THC=US / MAR=US / SPOT=US / MRO=US / LEG=US / TNL=US / HLT=US / CMCSA=US / UNH=US / DISH=US / WTFC=US / BMRN=US / CHH=US / DRH=US / EQIX=US / HXL=US / MAN=US / PRGO=US / REGN=US / SBAC=US / VRTX=US / SNV=US / JAZZ=US / NFLX=US / PNFP=US / BIIB=US / TPX=US / EXP=US / SHO=US / DLR=US / PLAY=US / GMS=US / CCOI=US / HST=US / RPRX=US / LLNW=US / PRPL=US / LUMN=US / WH=US / CLNY=US / HGV=US / PCRX=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / TMUS=US / SPNE=US / CABO=US / CRSP=US / PK=US / GDS=US / PLYA=US / SBOW=US / ROKU=US / SWCH=US / BHC=US / ARVN=US / AXNX=US / GMAB=US / 96758W101 / HIMS=US</td><td class="leftalignment">AutoNation Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Akamai Technologies Inc / Charter Communications Inc / Hyatt Hotels Corp / CyrusOne Inc / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Magnolia Oil & Gas Corp / Tenet Healthcare Corp / Marriott International Inc / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Wintrust Financial Corp / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Equinix Inc / Hexcel Corp / ManpowerGroup Inc / Perrigo Company PLC / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Synovus Financial Corp / Jazz Pharmaceuticals PLC / Netflix Inc / Pinnacle Financial Partners Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / GMS Inc / Cogent Communications Holdings Inc / Host Hotels & Resorts Inc / Royalty Pharma PLC / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / DigitalBridge Group Inc / Hilton Grand Vacations Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / T-Mobile US Inc / SeaSpine Holdings Corp / Cable One Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / SilverBow Resources Inc / Roku Inc / Switch Inc / Bausch Health Companies Inc / Arvinas Inc / Axonics Inc / Genmab A/S / WideOpenWest Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Read-Throughs from Roche's 1Q21 Results: Our Thoughts on REGN, BIIB, AMGN, and MRTX</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ / AMGN.OQ / BIIB.OQ / MRTX.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Amgen Inc / Biogen Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">N=54 prescriber poll on JAK inhibitors in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Bringing investors back to Biotech -- What's on tap for 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN=US / BIIB=US / INCY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / CRSP=US</td><td class="leftalignment">Amgen Inc / Biogen Inc / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LBPS=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / DDDD=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">4D Pharma PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / 4D Pharma PLC / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / ALV.N / ANTO.L / BAC.N / BK.N / BP.L / C.N / CCI.N / CL.N / EIX.N / EL.N / ENI.MI / F.N / GM.N / JNJ.N / JPM.N / KMB.N / KO.N / MRK.N / NA / PFE.N / PNC.N / REP.MC / RIO.L / SO.N / T.N / TOTF.PA / VC.N / PEP.N / BFb.N / PG.N / CFP.TO / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / INCY.O / THC.N / UHS.N / AAL.L / DUK.N / UNH.N / BWA.N / LEA.N / K.N / DISH.O / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / BOL.ST / CONE.O / VZ.N / STT.N / HCA.N / CYH.N / ARNA.O / STZ.N / APH.N / FISV.O / V.N / CHTR.O / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / REGN.O / ENR.N / CVX.N / NCR.N / TEL.N / CNP.N / APF.L / ENDP.O / BLU.N / CPK.N / PII.N / ST.N / GPN.N / MNST.O / CASY.O / ICPT.O / EQIX.O / ATDb.TO / 02209S103 / DLR.N / NESTE.HE / 416515104 / 427866108 / WEF.TO / WAL.N / RDSb.L / SJW.N / MS.N / FIS.N / MA.N / HOG.N / GALP.LS / 3IN.L / ATL.MI / BGS.N / PPL.TO / SLRS.MC / DAN.N / VALE.N / SPB.N / BHPB.L / NEE.N / CAML.L / PCRX.O / MTOR.N / GLEN.L / IFP.TO / MDLZ.OQ / ALLY.N / FANG.O / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / 81762P102 / CFF.TO / PTC.O / BTG.N / CFG.N / GLPG.O / TDOC.N / RACE.MI / TWLO.N / ADNT.N / VST.N / APTV.N / VNE.N / KDP.N / CWEN.N / OSMT.O / NWL.O / MORF.OQ / CRNC.OQ / 2222.SE / ETNB.O / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / MTCR.O / TLMD.OQ / WFG.N / AFRM.O / NAPA.N / CARE.TO / OSO.N / DSEY.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Antofagasta PLC / Bank of America Corp / Bank of New York Mellon Corp / BP PLC / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / General Motors Co / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / Pfizer Inc / PNC Financial Services Group Inc / Repsol SA / Rio Tinto PLC / Southern Co / AT&T Inc / TotalEnergies SE / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Universal Health Services Inc / Anglo American PLC / Duke Energy Corp / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / Boliden AB / CyrusOne Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / BELLUS Health Inc / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Global Payments Inc / Monster Beverage Corp / Caseys General Stores Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / Digital Realty Trust Inc / Neste Oyj / Hartford Financial Services Group Inc / Hershey Co / Western Forest Products Inc / Western Alliance Bancorp / Royal Dutch Shell PLC / SJW Group / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Harley-Davidson Inc / Galp Energia SGPS SA / 3I Infrastructure PLC / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Solaria Energia y Medio Ambiente SA / Dana Inc / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Nextera Energy Inc / Central Asia Metals PLC / Pacira Biosciences Inc / Meritor Inc / Glencore PLC / Interfor Corp / Mondelez International Inc / Ally Financial Inc / Diamondback Energy Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / ServiceNow Inc / Conifex Timber Inc / PTC Inc / B2Gold Corp / Citizens Financial Group Inc / Galapagos NV / Teladoc Health Inc / Ferrari NV / Twilio Inc / Adient PLC / Vistra Corp / Aptiv PLC / Veoneer Inc / Keurig Dr Pepper Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Morphic Holding Inc / Cerence Inc / Saudi Arabian Oil Co / 89Bio Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Metacrine Inc / Soc Telemed Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Dialogue Health Technologies Inc / Olo Inc / Diversey Holdings Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Saudi Arabia / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09061G1013 / US0028241000 / US0079731008 / US0116591092 / US0311621009 / US0382221051 / US0463531089 / US0556221044 / US1101221083 / US1924461023 / US1925761066 / US30161Q1040 / US30231G1022 / US3755581036 / US37733W1053 / US45337C1027 / US4567881085 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US64125C1099 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91307C1027 / US91347P1057 / US92532F1003 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / RDSa.AS / PAP310761054 / US16115Q3083 / US3020811044 / US29089Q1058 / US92932M1018 / US01748X1028 / US2473617023 / US87874R1005 / US03152W1099 / BMG3922B1072 / CH0102993182 / IE00B4BNMY34 / US58933Y1055 / US46333X1081 / US9100471096 / US03027X1000 / US29414B1044 / US00287Y1091 / NL0010273215 / US98978V1035 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / CA0089118776 / US2681582019 / US31572Q8087 / US22822V1017 / IE00BTN1Y115 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / KYG4740B1059 / US2067871036 / US78410G1040 / US23355L1061 / IL0011407140 / US76243J1051 / US89854H1023 / US05351X1019 / US05455M1009 / US29260V1052 / US5904791358 / CA39342L1085 / US28414H1032 / US61775R1059 / US92537N1081 / US39813G1094 / US44891N1090 / US12769G1004 / US81181C1045 / US05875B1061</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Cognizant Technology Solutions Corp / Cohu Inc / Exelixis Inc / Exxon Mobil Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Infosys Ltd / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Neurocrine Biosciences Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / United Therapeutics Corp / Universal Display Corp / Vertex Pharmaceuticals Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Copa Holdings SA / Chart Industries Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / TechTarget Inc / Amicus Therapeutics Inc / Genpact Ltd / TE Connectivity Ltd / Accenture PLC / Merck & Co Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / American Tower Corp / Epam Systems Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Air Canada / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Medtronic PLC / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Conduent Inc / SBA Communications Corp / DXC Technology Co / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / TTEC Holdings Inc / Avaya Holdings Corp / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Morphic Holding Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / IAC/Interactivecorp / Caesars Entertainment Inc / Seagen Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">PD-(L)1 Market Model: Potential Price Erosion Offset By Adjuvant Visibility</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US80105N1054 / US58933Y1055 / US07725L1026</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BioPharma: RBC’s Rheum/Inflamm/Derm Day – Asthma/Allergy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Lisa Walter / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Daniel Busby / Mr. Luca Issi, PHD / Leonid Timashev / Steve Daddeo / David Szeto / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BioPharma: RBC’s Rheum/Inflamm/Derm Day – Atopic Dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N / INCY.O / ARNA.O / REGN.O / ABBV.N</td><td class="leftalignment">Pfizer Inc / Incyte Corp / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Lisa Walter / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Daniel Busby / Mr. Luca Issi, PHD / Leonid Timashev / Steve Daddeo / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 1Q21 EPS Preview: Biotech Headwinds Led to Underperformance in Q1, but M&A Could Provide Catalysts to Lift Sentiment</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / LLY.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / EXEL.OQ / SGEN.OQ / VRTX.OQ / GLPG.AS / EPZM.OQ / MRTX.OQ / BPMC.OQ / DCPH.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Exelixis Inc / Seagen Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Epizyme Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Deciphera Pharmaceuticals Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park / Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: TSHA now pivotal-stage; JNJ C19 safety pause</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/17/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Weekend Updates - Around the Horn For Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US02043Q1076 / US09061G1013 / US09058V1035 / US75886F1075 / US4622221004 / BMG637AM1024 / US77313F1066 / BMG5269C1010 / US6047491013 / US45720L1070 / US12529R1077 / US1920101060</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / BioCryst Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Myovant Sciences Ltd / Rocket Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Mirum Pharmaceuticals Inc / Inhibrx Inc / C4 Therapeutics Inc / Codiak BioSciences, Inc.</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US1266501006 / US3755581036 / US4448591028 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US15135B1017 / US69366J2006 / US0367521038 / US1255231003</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Gilead Sciences Inc / Humana Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Centene Corp / PTC Therapeutics Inc / Anthem Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">1Q21 Large Cap Preview: We see mostly solid prints across the board in spite of COVID</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0311621009 / US09062X1037 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003</td><td class="leftalignment">Amgen Inc / Biogen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.16.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for REGN. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">FSTX=US / GANX=US / MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / NVS=US / AZN=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / UCB=BE / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CHE=US / CYH=US / EW=US / ISEE=US / GEN=US / ISRG=US / PHG=US / LH=US / PRVL=US / REGN=US / USPH=US / UHS=US / VRTX=US / SGEN=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / IGMS=US / BIIB=US / ISR=US / SLP=US / MRNA=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / OSCR=US / FOLD=US / EHC=US / TMDI=US / ADXN=US / SWAV=US / ADUS=US / SRNE=US / RGNX=US / ANVS=US / ACHC=US / PRTA=US / MRTX=US / MGNX=US / AERI=US / XNCR=US / TRVN=US / FLXN=US / CTRE=US / VBIV=US / WBA=US / NVTA=US / EVH=US / TDOC=US / NVCR=US / VYGR=US / MRUS=US / APVO=US / IRTC=US / CRSP=US / IOVA=US / MTEM=US / SYBX=US / NCNA=US / MDNA=US / ALLO=US / IDYA=US / BCYC=US / PSNL=US / ONCT=US / NBSE=US / DMTK=US / BNTX=US / PNTG=US / PASG=US / LYS=US / ORIC=US / INBX=US / TSHA=US / KDNY=US / SIOX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Gain Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Ucb SA / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Iveric Bio Inc / General Electric Co / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Porvair PLC / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / IGM Biosciences Inc / Biogen Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Oscar Health Inc / Amicus Therapeutics Inc / Encompass Health Corp / Titan Medical Inc / Addex Therapeutics Ltd / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Regenxbio Inc / Annovis Bio Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Xencor Inc / Trevena Inc / Pacira Biosciences Inc / CareTrust REIT Inc / VBI Vaccines Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Merus NV / Aptevo Therapeutics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Molecular Templates Inc / Synlogic Inc / NuCana PLC / Medicenna Therapeutics Corp / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Personalis Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / DermTech Inc / BioNTech SE / Pennant Group Inc / Passage Bio Inc / Lysogene SA / Oric Pharmaceuticals Inc / Inhibrx Inc / Taysha Gene Therapies Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Updating model regarding REGEN-COV sales</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">April 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">171</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACI=US / FSTX=US / AAPL=US / IBM=US / MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / INTC=US / MSFT=US / C=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / INCY=US / BAC=US / USB=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / NVS=US / VZ=US / URI=US / TSM=US / CCI=US / UPS=US / AZN=US / GSK=US / JNJ=US / TTWO=US / ATVI=US / PNC=US / CMCSA=US / UNH=US / DISH=US / INTU=US / NUAN=US / APPS=US / HRB=US / CTL=US / CME=US / EGAN=US / EGHT=US / EQIX=US / HEAR=US / QUIK=US / REGN=US / SBAC=US / VG=US / WSC=US / RDWR=US / SNOW=US / NET=US / CRNT=US / RHHBY=US / GME=US / FB=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / IGMS=US / RNG=US / CEVA=US / MRNA=US / GOOG=US / DLR=US / VIAC=US / INO=US / HSBC=US / DISCA=US / PDD=US / CCOI=US / LLNW=US / LUMN=US / BBVA=US / 700-HK=US / UBI-PAR=US / TSLA=US / ZNGA=US / EA=US / TMUS=US / MGNX=US / GTT=US / XNCR=US / AVYA=US / GOOGL=US / TSLX=US / FIVN=US / BABA=US / NVTA=US / MRUS=US / APVO=US / DZSI=US / TEUM=US / ATUS=US / BILI=US / HUYA=US / ZM=US / FSLY=US / ONCT=US / CMBM=US / DMTK=US / BNTX=US / DKNG=US / INBX=US / KDNY=US / CRSR=US / RXT=US / ONDS=US / PLTK=US / DOCN=US</td><td class="leftalignment">Albertsons Companies Inc / F-Star Therapeutics Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Microsoft Corp / Citigroup Inc / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Incyte Corp / Bank of America Corp / US Bancorp / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / Novartis AG / Verizon Communications Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / PNC Financial Services Group Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Digital Turbine Inc / H & R Block Inc / Lumen Technologies Inc / CME Group Inc / eGain Corp / 8x8 Inc / Equinix Inc / Turtle Beach Corp / QuickLogic Corp / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vonage Holdings Corp / Willscot Mobile Mini Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Roche Holding AG / GameStop Corp / Meta Platforms Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / IGM Biosciences Inc / RingCentral Inc / CEVA Inc / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Inovio Pharmaceuticals Inc / HSBC Holdings PLC / Discovery Inc / Pinduoduo Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Lumen Technologies Inc / Banco Bilbao Vizcaya Argentaria SA / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tesla Inc / Zynga Inc / Electronic Arts Inc / T-Mobile US Inc / MacroGenics Inc / GTT Communications Inc / Xencor Inc / Avaya Holdings Corp / Alphabet Inc / Sixth Street Specialty Lending Inc / Five9 Inc / Alibaba Group Holding Ltd / Invitae Corp / Merus NV / Aptevo Therapeutics Inc / DZS Inc / Pareteum Corp / Altice USA Inc / Bilibili Inc / HUYA Inc / Zoom Video Communications Inc / Fastly Inc / Oncternal Therapeutics Inc / Cambium Networks Corp / DermTech Inc / BioNTech SE / DraftKings Inc / Inhibrx Inc / Chinook Therapeutics Inc / Corsair Gaming Inc / Rackspace Technology Inc / Ondas Holdings Inc / Playtika Holding Corp / DigitalOcean Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Germany / Spain / United Kingdom / Israel / Netherlands / Sweden / Taiwan / United States / Guernsey</td><td class="leftalignment">Banks / Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / PEP=US / AMGN=US / BMY=US / DIS=US / PLD=US / AMZN=US / CPE=US / VRM=US / BRO=US / EXPE=US / UNH=US / KIDS=US / AJG=US / MAN=US / REGN=US / SNAP=US / TRIP=US / WIX=US / BKNG=US / FB=US / KIM=US / PTON=US / STRO=US / BIIB=US / AAWW=US / CLNY=US / GDOT=US / PCRX=US / ANGI=US / SPLK=US / PTCT=US / VCYT=US / QURE=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / WLTW=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / HARP=US / LYFT=US / UBER=US / TCRR=US / GMAB=US / CRMD.US</td><td class="leftalignment">Merck & Co Inc / PepsiCo Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Prologis Inc / Amazon.com Inc / Callon Petroleum Co / Vroom Inc / Brown & Brown Inc / Expedia Group Inc / UnitedHealth Group Inc / OrthoPediatrics Corp / Arthur J Gallagher & Co / ManpowerGroup Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Booking Holdings Inc / Meta Platforms Inc / Kimco Realty Corp / Peloton Interactive Inc / Sutro Biopharma Inc / Biogen Inc / Atlas Air Worldwide Holdings Inc / DigitalBridge Group Inc / Green Dot Corp / Pacira Biosciences Inc / Angi Inc / Splunk Inc / PTC Therapeutics Inc / Veracyte Inc / Uniqure NV / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Willis Towers Watson PLC / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Genmab A/S / CorMedix Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Strong Volume Trends in Q1, but Currency and COVID Therapies Both Major Factors</td><td class="leftalignment">English</td><td class="rightalignment">101</td><td class="leftalignment">ABBV=US / PFE=US / AMGN=US / GILD=US / SAN=FR / GSK=GB / GSK=US / REGN=US / VRTX=US / SNY=US / RDUS=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sanofi SA / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AACR Takeaways: Rise Of The Immune-Cell Engagers (Biotech) (Updated)</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / AMGN=US / REGN=US / HARP=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">AACR Takeaways: Rise Of The Immune-Cell Engagers</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / AMGN=US / REGN=US / HARP=US / TCRR=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small Biotech Inflows Break Up the Bleeding</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A Potential North Star of Bispecific Antibody Engineering; Initiate at Outperform & $30 PT</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">FSTX=US / MRK=US / AMGN=US / BMY=US / INCY=US / NVS=US / GSK=US / REGN=US / RHHBY=US / IGMS=US / MGNX=US / XNCR=US / MRUS=US / APVO=US / INBX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Merck & Co Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Roche Holding AG / IGM Biosciences Inc / MacroGenics Inc / Xencor Inc / Merus NV / Aptevo Therapeutics Inc / Inhibrx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AFL.N / AIG.N / BMWG.DE / CB.N / CNA.L / EPED.PA / JPM.N / MICP.PA / MMC.N / RENA.PA / TRV.N / VIEV.VI / VLOF.PA / VOLVb.ST / WFC.N / VOWG_p.DE / CONG.DE / SJRb.TO / AMGN.O / MET.N / AAL.L / GS.N / UNM.N / MTG.N / RDN.N / CINF.O / LNC.N / FRAG.DE / AJG.N / REGN.O / PFG.N / PRU.N / FRC.N / MKL.N / BRO.N / RLI.N / HCC.N / SIGI.O / ACGL.O / SJ.TO / MTL.TO / 416515104 / 025676206 / AEO.N / AON.N / ATL.MI / CLR.N / VMW.N / DAIGn.DE / WRB.N / 759351604 / AND.TO / SWI.N / CJT.TO / WTE.TO / FFHu.TO / FANG.O / VOYA.N / ESNT.N / NMIH.O / RACE.MI / KNSL.OQ / UN01.DE / BHF.O / EQH.N / GSHD.O / TFII.N / IGIC.OQ</td><td class="leftalignment">Aflac Inc / American International Group Inc / Bayerische Motoren Werke AG / Chubb Ltd / Centrica PLC / Faurecia SE / JPMorgan Chase & Co / Compagnie Generale des Etablissements Michelin SCA / Marsh & McLennan Companies Inc / Renault SA / Travelers Companies Inc / Flughafen Wien AG / Valeo SE / Volvo AB / Wells Fargo & Co / Volkswagen AG / Continental AG / Shaw Communications Inc / Amgen Inc / MetLife Inc / Anglo American PLC / Goldman Sachs Group Inc / Unum Group / MGIC Investment Corp / Radian Group Inc / Cincinnati Financial Corp / Lincoln National Corp / Fraport AG Frankfurt Airport Services Worldwide / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Principal Financial Group Inc / Prudential Financial Inc / First Republic Bank / Markel Corp / Brown & Brown Inc / Rli Corp / Warrior Met Coal Inc / Selective Insurance Group Inc / Arch Capital Group Ltd / Stella-Jones Inc / Mullen Group Ltd / Hartford Financial Services Group Inc / American Equity Investment Life Holding Co / American Eagle Outfitters Inc / Aon PLC / Atlantia SpA / Continental Resources Inc / VMware Inc / Daimler AG / W R Berkley Corp / Reinsurance Group of America Inc / Andlauer Healthcare Group Inc / SolarWinds Corp / Cargojet Inc / Westshore Terminals Investment Corp / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / Voya Financial Inc / Essent Group Ltd / NMI Holdings Inc / Ferrari NV / Kinsale Capital Group Inc / Uniper SE / Brighthouse Financial Inc / Equitable Holdings Inc / Goosehead Insurance Inc / TFI International Inc / International General Insurance Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Austria / Bermuda / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Elliott Advisors takes stake in GSK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GSK.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BAYGN.DE</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 02, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - April 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">US0079031078 / US0383361039 / US0584981064 / US1924461023 / US2017231034 / US4567881085 / US4581401001 / US5949181045 / US6703461052 / US67066G1040 / US75886F1075 / US81211K1007 / US8270481091 / US8354951027 / US8581191009 / US9129091081 / US2283681060 / CA3499151080 / US38500T1016 / US91912E1055 / CA87505Y4094 / US08579W1036 / US25278X1090 / CA68827L1013 / US78667J1088 / CA0089118776 / 100507888 / CA31730E1016 / CA49741E1007 / CA86816U1066 / CY0103562118 / CA35905B1076 / CA8585221051 / US22052L1044 / JE00BJ1F3079 / US61775R1059 / US67098H1041 / CA89055A2039</td><td class="leftalignment">Advanced Micro Devices Inc / Aptargroup Inc / Ball Corp / Cognizant Technology Solutions Corp / Commercial Metals Co / Infosys Ltd / Intel Corp / Microsoft Corp / Nucor Corp / NVIDIA Corp / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / United States Steel Corp / Crown Holdings Inc / Fortuna Silver Mines Inc / Gran Tierra Energy Inc / Vale SA / Tamarack Valley Energy Ltd / Berry Global Group Inc / Diamondback Energy Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Air Canada / SandRidge Energy Inc / Filo Mining Corp / Kirkland Lake Gold Ltd / Superior Gold Inc / Tharisa PLC / Frontera Energy Corp / Stelco Holdings Inc / Corteva Inc / Amcor PLC / Morphic Holding Inc / O-I Glass Inc / Topaz Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cyprus / India / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, April 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US75886F1075 / CA8676EP1086 / 450056106 / 98983V106 / 04351P101 / 682310875 / M5425M103</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sunopta Inc / iRhythm Technologies Inc / Zuora Inc / Ascendis Pharma A/S / Oncolytics Biotech Inc / Inmode Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Encouraging Data From Injectable REGEN-COV</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">REGN-COV in asymptomatic patients reduces progression to symptomatic COVID-19</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">75886F107 / 690742101 / 12008R107 / 404251100 / 747619104 / 575385109 / 01609W102 / M20598104 / 09739D100 / 09075G105 / 16842Q100 / 93627C101 / G9001E102 / 77543R102 / 09624H208 / US82452T1079 / 37519D10 / 51476H100 / 34988510</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Owens Corning / Builders FirstSource Inc / HNI Corp / Quanex Building Products Corp / Masonite International Corp / Alibaba Group Holding Ltd / Caesarstone Ltd / Boise Cascade Co / Biofrontera AG / Chicken Soup for The Soul Entertainment Inc / Warrior Met Coal Inc / Liberty Latin America Ltd / Roku Inc / Bluelinx Holdings Inc / Shift Technologies Inc / Lightning eMotors Inc / Hillman Solutions Corp / Electric Last Mile Solutions Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Daniel L. Kurnos, CFA / Ms. Fawne Jiang / Long Lin / Mr. Aydin Huseynov, MD / Mr. Matthew Harrigan / Mr. Bruce D. Jackson / Mr. Nathan Martin / Mr. Michael P. Ward, CFA / Mr. Reuben Garner</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Full Approval Or EUA For REGEN-COV Low Dose Likely Coming</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: 6-mo MRNA C19 data; DRNA sells ALNY royalties</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ALNY.OQ / MRNA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / CACI=US / AMGN=US / CAG=US / DIS=US / DVN=US / INCY=US / GILD=US / BC=US / CRM=US / IGT=US / BYD=US / SPOT=US / MGM=US / PENN=US / BL=US / COLL=US / EXEL=US / HZO=US / MCRI=US / NTST=US / PII=US / HOOK=US / REGN=US / THO=US / WGO=US / CGEN=US / SGMS=US / MANT=US / CRTO=US / NFLX=US / AUTL=US / BDSI=US / RRR=US / IGMS=US / STRO=US / PRG=US / CZR=US / BAH=US / NSP=US / KBR=US / PGTI=US / ICFI=US / SAIC=US / CWH=US / PSN=US / RCUS=US / TREX=US / OLO=US / FBHS=US / ZNGA=US / MEIP=US / LDOS=US / FATE=US / MBUU=US / COUP=US / BABA=US / HUBS=US / MCFT=US / IRTC=US / CRSP=US / LGF.B=US / ROKU=US / NCNA=US / ALLO=US / TCRR=US / NXTC=US / GMAB=US / ONEW=US / DKNG=US / AZEK=US / NCNO=US / BALY=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Amgen Inc / Conagra Brands Inc / Walt Disney Co / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / Brunswick Corp / Salesforce.Com Inc / International Game Technology PLC / Boyd Gaming Corp / Spotify Technology SA / MGM Resorts International / Penn National Gaming Inc / Blackline Inc / Collegium Pharmaceutical Inc / Exelixis Inc / MarineMax Inc / Monarch Casino & Resort Inc / Netstreit Corp / Polaris Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Winnebago Industries Inc / Compugen Ltd / Scientific Games Corp / ManTech International Corp / Criteo SA / Netflix Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / IGM Biosciences Inc / Sutro Biopharma Inc / PROG Holdings Inc / Caesars Entertainment Inc / Booz Allen Hamilton Holding Corp / Insperity Inc / KBR Inc / PGT Innovations Inc / ICF International Inc / Science Applications International Corp / Camping World Holdings Inc / Parsons Corp / Arcus Biosciences Inc / Trex Company Inc / Olo Inc / Fortune Brands Home & Security Inc / Zynga Inc / MEI Pharma Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Malibu Boats Inc / Coupa Software Inc / Alibaba Group Holding Ltd / HubSpot Inc / Mastercraft Boat Holdings Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Lions Gate Entertainment Corp / Roku Inc / NuCana PLC / Allogene Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / OneWater Marine Inc / DraftKings Inc / Azek Company Inc / nCino Inc / Bally's Corp / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / AMAT.O / AMD.N / ANA.MC / CB.N / CCI.N / CRM.N / EIX.N / F.N / GM.N / LRCX.O / MMC.N / MRK.N / PB.N / PFE.N / SO.N / T.N / TRV.N / VC.N / ZION.O / CMA.N / CFP.TO / ASML.O / LPX.N / TEN.N / CMCSA.O / AMGN.O / MET.N / DUK.N / HBAN.O / BWA.N / LEA.N / NVDA.O / DISH.O / UNM.N / PCG.N / SBAC.O / AMT.N / CONE.O / ADI.O / VZ.N / VLY.N / SNV.N / EXEL.O / PACW.O / STZ.N / CINF.O / LNC.N / APH.N / FISV.O / SNPS.O / ADSK.O / V.N / AXL.N / AWK.N / NWN.N / BC.N / DB1Gn.DE / AJG.N / BMRN.O / STL.N / REGN.O / PFG.N / MU.O / PRU.N / NCR.N / TEL.N / CNP.N / ENDP.O / CFR.N / CPK.N / FRC.N / MKL.N / BRO.N / PII.N / RLI.N / ST.N / WBS.N / FCF.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIGI.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / COLB.O / ACGL.O / WTFC.O / TCBI.O / ATDb.TO / FHN.N / DLR.N / 416515104 / WEF.TO / WAL.N / ALNY.O / DISCA.O / CDNS.O / FIS.N / 025676206 / ISBC.O / MA.N / HOG.N / AON.N / DAN.N / WRB.N / 759351604 / HOMB.O / NEE.N / BKU.N / PCRX.O / MTOR.N / IFP.TO / SPLK.OQ / PANW.N / FFHu.TO / NYCB.N / ABBV.N / TSLA.N / TMUS.N / VOYA.N / PRTA.O / ONB.OQ / 81762P102 / CFF.TO / XNCR.OQ / COUP.N / QURE.O / GWB.N / ASB.N / AENA.MC / RGNX.O / MESO.O / RACE.MI / ADVM.OQ / TWLO.N / KNSL.OQ / ADNT.N / UNIT.O / OKTA.OQ / CADE.N / ATUS.N / BHF.O / AY.O / APTV.N / 05971J102 / AMRX.N / EQH.N / GSHD.O / VNE.N / ESTC.N / FIXX.O / CRWD.O / GMAB.O / CRNC.OQ / IGIC.OQ / NKLA.OQ / FOUR.N / DCT.O / LUMN.N / WFG.N / NUVB.N / NAPA.N / OSO.N</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Acciona SA / Chubb Ltd / Crown Castle International Corp / Salesforce.Com Inc / Edison International / Ford Motor Co / General Motors Co / Lam Research Corp / Marsh & McLennan Companies Inc / Merck & Co Inc / Prosperity Bancshares Inc / Pfizer Inc / Southern Co / AT&T Inc / Travelers Companies Inc / Visteon Corp / Zions Bancorporation NA / Comerica Inc / Canfor Corp / ASML Holding NV / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / MetLife Inc / Duke Energy Corp / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / NVIDIA Corp / DISH Network Corp / Unum Group / PG&E Corp / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / Exelixis Inc / PacWest Bancorp / Constellation Brands Inc / Cincinnati Financial Corp / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Synopsys Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Northwest Natural Holding Co / Brunswick Corp / Deutsche Boerse AG / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Sterling Bancorp / Regeneron Pharmaceuticals Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Cullen/Frost Bankers Inc / Chesapeake Utilities Corp / First Republic Bank / Markel Corp / Brown & Brown Inc / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Webster Financial Corp / First Commonwealth Financial Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / Selective Insurance Group Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / Columbia Banking System Inc / Arch Capital Group Ltd / Wintrust Financial Corp / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / First Horizon Corp / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Western Forest Products Inc / Western Alliance Bancorp / Alnylam Pharmaceuticals Inc / Discovery Inc / Cadence Design Systems Inc / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / Dana Inc / W R Berkley Corp / Reinsurance Group of America Inc / Home BancShares Inc / Nextera Energy Inc / BankUnited Inc / Pacira Biosciences Inc / Meritor Inc / Interfor Corp / Splunk Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / New York Community Bancorp Inc / Abbvie Inc / Tesla Inc / T-Mobile US Inc / Voya Financial Inc / Prothena Corporation PLC / Old National Bancorp / ServiceNow Inc / Conifex Timber Inc / Xencor Inc / Coupa Software Inc / Uniqure NV / Great Western Bancorp Inc / Associated Banc-Corp / Aena SME SA / Regenxbio Inc / Mesoblast Ltd / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Kinsale Capital Group Inc / Adient PLC / Uniti Group Inc / Okta Inc / Cadence Bank / Altice USA Inc / Brighthouse Financial Inc / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Cadence Bank / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Elastic NV / Homology Medicines Inc / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Duck Creek Technologies Inc / Lumen Technologies Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Duckhorn Portfolio Inc / Olo Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Gene Therapy Day – Ophthalmology</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.O / RGNX.O / ADVM.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Regenxbio Inc / Adverum Biotechnologies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Luca Issi, PHD / Kennen MacKay, PHD / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Lisa Walter / Edwin Delfin / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biopharma: Latest Short Interest for US Biopharma: Large Caps Stable; ACRX and NBIX See Moderate Increases Among SMid Caps</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2021 Outlook Compendia: Get Your Biotech Motors Running</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US35104E1001 / US09061G1013 / US09058V1035 / US45337C1027 / US64125C1099 / US75886F1075 / US92532F1003 / US02043Q1076 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US88322Q1085 / US29251M1062 / US4277461020 / US90400D1081 / NL0010696654 / KYG8807B1068 / US23257D1037 / CA89620X5064 / US04351P1012 / US37890U1088 / US4622221004 / US00773J1034 / US5588681057 / BMG637AM1024 / KYG108301006 / US24823R1059 / US5011471027 / US84833T1034 / US77313F1066 / BMG5269C1010 / KYG596651029 / US02155H2004 / US04335A1051 / US38341P1021 / US04965G1094 / US00973Y1082 / US6047491013 / CA07987C2040 / US12674W1099 / US65487U1088 / US35655L1070 / US45720L1070 / US20451W1018 / US59101E1038 / US69353Y1038 / US12529R1077 / US68236R1032 / US16961L1061 / US1920101060 / US89422G1076 / US2300311063 / US92765F1084 / US54300N1037</td><td class="leftalignment">4D Molecular Therapeutics Inc / Biomarin Pharmaceutical Inc / BioCryst Pharmaceuticals Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / TG Therapeutics Inc / Enanta Pharmaceuticals Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Theravance Biopharma Inc / Cymabay Therapeutics Inc / Pfizer Inc / Ascendis Pharma A/S / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Aeglea Bio Therapeutics Inc / Madrigal Pharmaceuticals Inc / Myovant Sciences Ltd / Beyondspring Inc / Denali Therapeutics Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Rocket Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / MeiraGTx Holdings PLC / Altimmune Inc / Arvinas Inc / Gossamer Bio Inc / Atreca Inc / Akero Therapeutics Inc / Mirum Pharmaceuticals Inc / BELLUS Health Inc / Cabaletta Bio Inc / Nkarta Inc / Freeline Therapeutics Holdings PLC / Inhibrx Inc / Compass Pathways PLC / Metacrine Inc / PMV Pharmaceuticals Inc / C4 Therapeutics Inc / Oncorus Inc / Chinook Therapeutics Inc / Codiak BioSciences, Inc. / Travere Therapeutics Inc / Cullinan Oncology Inc / Viracta Therapeutics Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Liisa A. Bayko / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Weekend Updates - Around the Horn in Our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075 / US4277461020 / US37890U1088 / US4622221004 / US84833T1034 / US65487U1088 / US69353Y1038 / US16961L1061 / US1920101060 / US2300311063</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Heron Therapeutics Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Spero Therapeutics Inc / Nkarta Inc / PMV Pharmaceuticals Inc / Chinook Therapeutics Inc / Codiak BioSciences, Inc. / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">New Zealand / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="even"><td class="leftalignment">04/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Mackay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O / SGEN.OQ / PRTA.O / MESO.O / GMAB.O / NUVB.N</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Mesoblast Ltd / Genmab A/S / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Michael Murray</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.9.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">When It Rains, It Pours - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - Revisiting our Outperform and addressing investor pushbacks</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">AZN.L / 1093.HK / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / FGEN.PS / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / First Gen Corp / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Hong Kong / Philippines / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: March 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / AAL.L / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Anglo American PLC / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AFL.N / AIG.N / AMAT.O / AMD.N / CB.N / CCO.TO / CRM.N / EIX.N / F.N / GM.N / INTC.O / LRCX.O / MMC.N / QCOM.O / RYN.N / SO.N / T.N / TRV.N / WY.N / PXD.N / GILD.O / ASML.O / CMCSA.O / AMGN.O / AAPL.O / MET.N / AAL.L / DIS.N / D.N / NVDA.O / DT.N / DISH.O / UNM.N / AMT.N / KGC.N / GIBa.TO / CONE.O / ADI.O / VZ.N / HCA.N / EXEL.O / XEL.N / PACW.O / CINF.O / LNC.N / KMX.N / FISV.O / SNPS.O / ADSK.O / CHTR.O / AWK.N / NBIX.O / NWN.N / TXN.O / AJG.N / REGN.O / VRTX.O / PFG.N / MU.O / PRU.N / NCR.N / NET.N / CNP.N / CPK.N / MKL.N / BRO.N / RLI.N / GPN.N / SIGI.O / CASY.O / ACGL.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / FM.TO / NST.AX / 878742204 / NTR.N / MOS.N / DLR.N / ACAD.O / 416515104 / CDNS.O / SJW.N / FIS.N / 025676206 / CS.TO / 443628102 / AON.N / SLR.AX / WRB.N / 759351604 / CLW.N / VALE.N / FTNT.O / SPB.N / NEE.N / PCH.O / CTT.N / GLEN.L / ACHC.O / SPLK.OQ / WDC.O / PANW.N / QLYS.O / FFHu.TO / 505440107 / TSLA.N / ENTA.O / TMUS.N / VOYA.N / PRTA.O / AGIO.O / 81762P102 / 46579R104 / PTC.O / ITCI.O / COUP.N / VRNS.O / CIA.TO / BTG.N / NEP.N / S32.AX / PYPL.OQ / RPD.O / MESO.O / TWLO.N / OR.N / KNSL.OQ / GDS.O / ICHR.O / PBYI.OQ / OKTA.OQ / WPM.N / BHF.O / KL.N / SAIL.N / APTV.N / EHC.N / ZS.OQ / EQH.N / GSHD.O / VNE.N / ESTC.N / CRWD.O / GMAB.O / PING.N / DDOG.O / SBSW.N / IGIC.OQ / FOUR.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / American International Group Inc / Applied Materials Inc / Advanced Micro Devices Inc / Chubb Ltd / Cameco Corp / Salesforce.Com Inc / Edison International / Ford Motor Co / General Motors Co / Intel Corp / Lam Research Corp / Marsh & McLennan Companies Inc / Qualcomm Inc / Rayonier Inc / Southern Co / AT&T Inc / Travelers Companies Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Gilead Sciences Inc / ASML Holding NV / Comcast Corp / Amgen Inc / Apple Inc / MetLife Inc / Anglo American PLC / Walt Disney Co / Dominion Energy Inc / NVIDIA Corp / Dynatrace Inc / DISH Network Corp / Unum Group / American Tower Corp / Kinross Gold Corp / CGI Inc / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Xcel Energy Inc / PacWest Bancorp / Cincinnati Financial Corp / Lincoln National Corp / Carmax Inc / Fiserv Inc / Synopsys Inc / Autodesk Inc / Charter Communications Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Texas Instruments Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / NCR Corp / Cloudflare Inc / CenterPoint Energy Inc / Chesapeake Utilities Corp / Markel Corp / Brown & Brown Inc / Rli Corp / Global Payments Inc / Selective Insurance Group Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Nutrien Ltd / Mosaic Co / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Cadence Design Systems Inc / SJW Group / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Capstone Mining Corp / Hudbay Minerals Inc / Aon PLC / Silver Lake Resources Ltd / W R Berkley Corp / Reinsurance Group of America Inc / Clearwater Paper Corp / Vale SA / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / CatchMark Timber Trust Inc / Glencore PLC / Acadia Healthcare Company Inc / Splunk Inc / Western Digital Corp / Palo Alto Networks Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Labrador Iron Ore Royalty Corp / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Voya Financial Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Ivanhoe Mines Ltd / PTC Inc / Intra-Cellular Therapies Inc / Coupa Software Inc / Varonis Systems Inc / Champion Iron Ltd / B2Gold Corp / Nextera Energy Partners LP / South32 Ltd / PayPal Holdings Inc / Rapid7 Inc / Mesoblast Ltd / Twilio Inc / Osisko Gold Royalties Ltd / Kinsale Capital Group Inc / GDS Holdings Ltd / Ichor Holdings Ltd / Puma Biotechnology Inc / Okta Inc / Wheaton Precious Metals Corp / Brighthouse Financial Inc / Kirkland Lake Gold Ltd / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Zscaler Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Elastic NV / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Datadog Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Shift4 Payments Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) update for QURE in hemB; new tech for DRNA</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">UQ1.F / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Uniqure NV / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O / PRTA.O / AGIO.O / MESO.O / PBYI.OQ / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Puma Biotechnology Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 86 US Companies with Undisclosed SEC Probes</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">T.N / AEP.N / BAC.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / THC.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / MGPI.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / GRPN.OQ / FB.OQ / XPO.N / COTY.N / CTG.OQ / ANTM.N / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / American Electric Power Company Inc / Bank of America Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Tenet Healthcare Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / MGP Ingredients Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Groupon Inc / Meta Platforms Inc / XPO Logistics Inc / Coty Inc / Computer Task Group Inc / Anthem Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Consumer / Education / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Canaccord Genuity (QUEST)</td><td class="leftalignment">QUEST | Global Large Cap: Oversold Quality Stocks</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MMC.N / ROG.S / UNH.N / EFX.N / ACN.N / REL.L / REGN.OQ / CHRW.OQ / NST.AX / RMV.L / MFG.AX / POLYP.L / ABBV.N / ENX.PA / AUTOA.L</td><td class="leftalignment">Marsh & McLennan Companies Inc / Roche Holding AG / UnitedHealth Group Inc / Equifax Inc / Accenture PLC / Relx PLC / Regeneron Pharmaceuticals Inc / CH Robinson Worldwide Inc / Northern Star Resources Ltd / Rightmove PLC / Magellan Financial Group Ltd / Polymetal International PLC / Abbvie Inc / Euronext NV / Auto Trader Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Cosmetics & Personal Care / Defense / Education / Electrical / Electronics / Engineering & Construction / Environmental Services / Financial Services / Food / Government / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Miscellaneous / Photography / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Technology / Tire & Rubber / Transportation / Internet / Marketing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">Graham Simpson</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Biotechnology Monthly</td><td class="leftalignment">English</td><td class="rightalignment">170</td><td class="leftalignment">US45253H1014 / US75886F1075 / ONC.TO / 44842L103 / 48576U106 / 09627Y109 / 046513107 / 98401F105 / 019770106 / H17182108 / 41358P106 / 90041T108 / 088786108 / 04965G109 / 64049K104 / 68062P106</td><td class="leftalignment">ImmunoGen Inc / Regeneron Pharmaceuticals Inc / Oncolytics Biotech Inc / HUTCHMED (China) Ltd / Karyopharm Therapeutics Inc / Blueprint Medicines Corp / Atara Biotherapeutics Inc / Xencor Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Harpoon Therapeutics Inc / Turning Point Therapeutics Inc / Bicycle Therapeutics PLC / Atreca Inc / Neoleukin Therapeutics Inc / Olema Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Canaccord Genui Research / Sumant Kulkarni / Michelle Gilson / Ms. Arlinda A. Lee, PHD / Mr. Edward H. Nash / Mr. John L. Newman, Ph.D., CFA, PHD / Jia Min, CFA / Benedict Shim</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ / ABCL.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron dips 2.1% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Regeneron Pharmaceuticals, Inc. MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Regeneron Pharmaceuticals, Inc. - Confirmatory Eylea Trial Results Supports Potential Q16W Dosing for Patients with Diabetic Retinopathy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / ROG.S</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EPZM: Margin of Safety (for Drug and Stock); Initiate with an Outperform Rating, $13 TP</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">EPZM.OQ / BMY.N / ROG.S / NOVN.S / REGN.OQ / GILD.OQ / INCY.OQ / EXEL.OQ / SGEN.OQ / BAYGN.DE / ABBV.N / TGTX.OQ / MGNX.OQ / BPMC.OQ / PBYI.OQ / ZLAB.OQ / DCPH.OQ / GMAB.CO</td><td class="leftalignment">Epizyme Inc / Bristol-Myers Squibb Co / Roche Holding AG / Novartis AG / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Exelixis Inc / Seagen Inc / Bayer AG / Abbvie Inc / TG Therapeutics Inc / MacroGenics Inc / Blueprint Medicines Corp / Puma Biotechnology Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Regeneron Pharmaceuticals Incorporated</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">US5288723027 / CA87402A1084 / US5160121019 / US62855J1043 / US6388423021 / US75886F1075 / US92532F1003 / US6402681083 / US09060J1060 / US02043Q1076 / US45665G3039 / US58933Y1055 / US42805E3062 / US88322Q1085 / US74345W1080 / US14888U1016 / US63009R1095 / US92337F1075 / US48576U1060 / US2697961082 / CA4990531069 / US00847L1008 / US03209R1032 / US14167L1035 / US0453961080 / CA68620P1018 / US98978L2043 / CA1380351009 / US00461U1051 / US53222K2050 / US4622221004 / US45781M1018 / US05368M1062 / US23725P2092 / US14147L1089 / US04537Y1091 / US92556V1061 / US0547548745</td><td class="leftalignment">Lexicon Pharmaceuticals Inc / Taiga Building Products Ltd / Lannett Company Inc / Myriad Genetics Inc / Natural Alternatives International Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / BioDelivery Sciences International Inc / Alnylam Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Merck & Co Inc / Heska Corp / TG Therapeutics Inc / Prophase Labs Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Knight Therapeutics Inc / Agile Therapeutics Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Assembly Biosciences Inc / OrganiGram Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / LifeVantage Corp / Ionis Pharmaceuticals Inc / Innoviva Inc / Avid Bioservices Inc / DarioHealth Corp / Cardiff Oncology Inc / Aspira Women's Health Inc / Viatris Inc / Aytu Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Herd Immunity Update: Vaccination Pace Encouraging, But Offset So Far By Variants/Re-Openings</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N / INCY.O / REGN.O</td><td class="leftalignment">Pfizer Inc / Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AEP.N / AES.N / ALV.N / BAC.N / BK.N / CL.N / CP.TO / EIX.N / EL.N / EOG.N / FMS.N / KMB.N / KO.N / MRK.N / NTRS.O / PFE.N / SO.N / T.N / USB.N / WFC.N / PEP.N / BFb.N / PG.N / CPB.N / TEN.N / CMCSA.O / INCY.O / DUK.N / K.N / DT.N / ADBE.O / CLX.N / CAG.N / GIS.N / PCG.N / EPC.N / AMT.N / JAZZ.O / CONE.O / VZ.N / STT.N / STZ.N / APH.N / ADSK.O / AXL.N / AWK.N / NBIX.O / CHD.N / NWN.N / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / NET.N / TEL.N / CNP.N / ENDP.O / CPK.N / ST.N / SGEN.OQ / MNST.O / BLUE.O / BIIB.O / 02209S103 / DLR.N / ACAD.O / 427866108 / MS.N / TEVA.N / ATL.MI / BGS.N / SPB.N / NEE.N / ERF.TO / ACHC.O / SPLK.OQ / PANW.N / MDLZ.OQ / ABBV.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / PTCT.O / PRTA.O / AGIO.O / 81762P102 / LB.N / KPTI.O / ITCI.O / QURE.O / VRNS.O / AGRX.O / ANTM.N / 78667J108 / RGNX.O / WVE.OQ / IONS.O / TWLO.N / OKTA.OQ / VST.N / ATNX.O / SAIL.N / APTV.N / ZS.OQ / AMRX.N / KDP.N / XERS.O / AQST.O / MGTX.O / ESTC.N / NWL.O / NBSE.OQ / KRTX.OQ / CRWD.O / GMAB.O / PING.N / CRNC.OQ / WTRG.N / REYN.O / NKLA.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Bank of America Corp / Bank of New York Mellon Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Fresenius Medical Care AG & Co KGaA / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Pfizer Inc / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Campbell Soup Co / Tenneco Inc / Comcast Corp / Incyte Corp / Duke Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Edgewell Personal Care Co / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Constellation Brands Inc / Amphenol Corp / Autodesk Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Cloudflare Inc / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Seagen Inc / Monster Beverage Corp / bluebird bio Inc / Biogen Inc / Altria Group Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hershey Co / Morgan Stanley / Teva Pharmaceutical Industries Ltd / Atlantia SpA / B&G Foods Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Enerplus Corp / Acadia Healthcare Company Inc / Splunk Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Varonis Systems Inc / Agile Therapeutics Inc / Anthem Inc / SAGE Therapeutics Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Ionis Pharmaceuticals Inc / Twilio Inc / Okta Inc / Vistra Corp / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / MeiraGTx Holdings PLC / Elastic NV / Newell Brands Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Italy / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMRN.O / REGN.O / SGEN.OQ / AGIO.O / ATNX.O</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Agios Pharmaceuticals Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">03/28/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Weekend Updates - Key Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US04351P1012 / US45337C1027 / US75886F1075 / US09609G1004 / BMG637AM1024 / KYG108301006 / US77313F1066 / US20451W1018 / US35104E1001</td><td class="leftalignment">Ascendis Pharma A/S / Incyte Corp / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Myovant Sciences Ltd / Beyondspring Inc / Rocket Pharmaceuticals Inc / Compass Pathways PLC / 4D Molecular Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Denmark / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="odd"><td class="leftalignment">03/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) results from PRQR & KRYS; ide-cel approved</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.26.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">OPK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPK.O / ABT / BMY / JNJ / LH / REGN.O / ALNY.O / ARDX.O / TEVA.K</td><td class="leftalignment">OPKO Health Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ardelyx Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AdComm's Near-Unanimous "No" Delays NGFs' Timing, Lowers Probability of Success</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">REGN=US / PFE=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2113393 / 2216850 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2632003 / 2680905 / 2684703 / 2730190 / 2829601 / 2883878 / B121557 / B7TL820 / BFDV8K0 / BBGVT40 / BYVY8G0 / BYVYD43 / BYZLV46 / BMQ5T49 / BGCYWN8 / BFZ1K46 / BZ8VJQ8 / BJ9NFQ3 / BN2R582 / BN7K304</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / New York Times Co / PPL Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Southern Co / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Meta Platforms Inc / MacroGenics Inc / News Corp / Alphabet Inc / Performance Food Group Co / InflaRx NV / Zentalis Pharmaceuticals Inc / Xencor Inc / Spotify Technology SA / Vistra Corp / Neoleukin Therapeutics Inc / Relay Therapeutics Inc / Academy Sports and Outdoors Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAC.N / BAER.S / BARC.L / BB.N / BK.N / BNPP.PA / C.N / CBKG.DE / CSGN.S / FITB.O / HSBA.L / JPM.N / LLOY.L / RWEG.DE / SAN.MC / SGC.L / SOGN.PA / WFC.N / HUM.N / CPB.N / TA.TO / AMGN.O / DRI.N / GS.N / DBKGn.DE / BBVA.MC / OLN.N / MTG.N / RDN.N / STT.N / CYH.N / REGN.O / CVX.N / CAGR.PA / NWG.L / ACGL.O / INGA.AS / MS.N / 443628102 / CBRO.L / GTE.TO / EONGn.DE / PXT.TO / ACHC.O / TSLA.N / ESNT.N / NMIH.O / ABNd.AS / UBSG.S / MTRO.L / VMUK.L / PAGPA.L</td><td class="leftalignment">Bank of America Corp / Julius Baer Gruppe AG / Barclays PLC / BlackBerry Ltd / Bank of New York Mellon Corp / BNP Paribas SA / Citigroup Inc / Commerzbank AG / Credit Suisse Group AG / Fifth Third Bancorp / HSBC Holdings PLC / JPMorgan Chase & Co / Lloyds Banking Group PLC / Rwe AG / Banco Santander SA / Stagecoach Group PLC / Societe Generale SA / Wells Fargo & Co / Humana Inc / Campbell Soup Co / TransAlta Corp / Amgen Inc / Darden Restaurants Inc / Goldman Sachs Group Inc / Deutsche Bank AG / Banco Bilbao Vizcaya Argentaria SA / Olin Corp / MGIC Investment Corp / Radian Group Inc / State Street Corp / Community Health Systems Inc / Regeneron Pharmaceuticals Inc / Chevron Corp / Credit Agricole SA / Natwest Group PLC / Arch Capital Group Ltd / ING Groep NV / Morgan Stanley / Hudbay Minerals Inc / Close Brothers Group PLC / Gran Tierra Energy Inc / E.ON SE / Parex Resources Inc / Acadia Healthcare Company Inc / Tesla Inc / Essent Group Ltd / NMI Holdings Inc / ABN Amro Bank NV / UBS Group AG / Metro Bank PLC / Virgin Money UK PLC / Paragon Banking Group PLC</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Spain / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / BMY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: AstraZeneca BioPharma Meet Management event, March 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AZN.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / AMGN.OQ / REGN.OQ</td><td class="leftalignment">AstraZeneca PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">AACR Annual Meeting 2021 Congress Planner</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">375558103 / 031162100 / 75886F107 / 45337C102 / 45253H101 / 29667D104 / 00287Y109 / 189464100 / 31189P102 / 60468T105 / 09627Y109 / 52187K101 / 07725L102 / 462260100 / 67022C106 / 98401F105 / 23284F105 / 019770106 / H17182108 / 41358P106 / 87808K106 / 481116101 / 44975P103 / 02083G100 / 24344T101 / 04335A105 / 46565G104 / 14147L108 / 81181C104 / 03835L108 / 38406L103</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Incyte Corp / ImmunoGen Inc / ESSA Bancorp Inc / Abbvie Inc / Clovis Oncology Inc / Fate Therapeutics Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Leap Therapeutics Inc / Beigene Ltd / Iovance Biotherapeutics Inc / NuCana PLC / Xencor Inc / CytomX Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Jounce Therapeutics Inc / I-Mab / Alpine Immune Sciences Inc / Deciphera Pharmaceuticals Inc / Arvinas Inc / Iteos Therapeutics Inc / Cardiff Oncology Inc / Seagen Inc / Aptevo Therapeutics Inc / Gracell Biotechnologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Eleanor Maughan, Ph.D. / Joseph Catanzaro, PhD / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Tyler M. Van Buren, M.SC</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Green Shoots or Eye of the Hurricane? Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">458140100 / 75886F107 / 000361105 / 928661107 / 23130Q10 / 17143G106</td><td class="leftalignment">Intel Corp / Regeneron Pharmaceuticals Inc / AAR Corp / VolitionRX Ltd / Curiositystream Inc. / Skillsoft Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Daniel L. Kurnos, CFA / Mr. Ruben Roy / Mr. Aydin Huseynov, MD / Mr. Josh W. Sullivan / Mike Hickey / Mr. Mark W. Schappel / Mr. Bruce D. Jackson</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">REGEN-COV Sales Will Be A Significant Addition To REGN Revenue In 2021/2022</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FR0000120073 / NL0000226223 / FR0000054470 / DE0006231004 / DE0006969603 / US00724F1012 / US0079031078 / US0079731008 / US0231351067 / US0378331005 / US0382221051 / US0463531089 / US0997241064 / US1311931042 / US1727551004 / US1925761066 / US1985161066 / US2435371073 / US2546871060 / US2855121099 / US4581401001 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US55306N1046 / US5951121038 / US6541061031 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US75886F1075 / US7782961038 / US8305661055 / US8610121027 / US8636671013 / US8725401090 / US8740541094 / US8807701029 / US91347P1057 / US9182041080 / US9282981086 / US9297401088 / US9581021055 / US98956P1021 / US3448491049 / US83088M1027 / US2533931026 / US1572101053 / US90385V1070 / US6098391054 / US9043111072 / US82706C1080 / US4103451021 / US5500211090 / US00507V1098 / US25470F1049 / US25470F3029 / IE00B58JVZ52 / DE000A1EWWW0 / US6936561009 / US7512121010 / US98986T1088 / NL0010273215 / US6951271005 / US55405Y1001 / KYG037AX1015 / US1220171060 / US4277461020 / US74736K1016 / US34959J1088 / KYG4740B1059 / US11135F1012 / US98585X1046 / US35137L1052 / US03828A1016 / CA16106R1091 / US50107A1043 / US72815L1070</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / STMicroelectronics NV / Ubisoft Entertainment SA / Infineon Technologies AG / Puma SE / Adobe Inc / Advanced Micro Devices Inc / Advanced Energy Industries Inc / Amazon.com Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Callaway Golf Co / Cirrus Logic Inc / Cohu Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Walt Disney Co / Electronic Arts Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / MKS Instruments Inc / Micron Technology Inc / Nike Inc / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Skechers USA Inc / STMicroelectronics NV / Stryker Corp / TJX Companies Inc / Take-Two Interactive Software Inc / Teradyne Inc / Universal Display Corp / VF Corp / Vishay Intertechnology Inc / Westinghouse Air Brake Technologies Corp / Western Digital Corp / Zimmer Biomet Holdings Inc / Foot Locker Inc / Skyworks Solutions Inc / DICK'S Sporting Goods Inc / CEVA Inc / Ultra Clean Holdings Inc / Monolithic Power Systems Inc / Under Armour Inc / Silicon Motion Technology Corp / HanesBrands Inc / Lululemon Athletica Inc / Activision Blizzard Inc / Discovery Inc / Discovery Inc / Seagate Technology Holdings PLC / Adidas AG / PVH Corp / Ralph Lauren Corp / Zynga Inc / ASML Holding NV / Pacira Biosciences Inc / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Burlington Stores Inc / Heron Therapeutics Inc / Qorvo Inc / Fortive Corp / Ichor Holdings Ltd / Broadcom Inc / Yeti Holdings Inc / Fox Corp / Applied Therapeutics Inc / Charlotte's Web Holdings Inc / Kronos Bio Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, March 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0464331083 / US75886F1075 / 000361105 / 759910102 / US81762P1021 / 57165B106 / 85209W109 / 81255T108 / 11778X104</td><td class="leftalignment">Astronics Corp / Regeneron Pharmaceuticals Inc / AAR Corp / Repro Med Systems Inc / ServiceNow Inc / Marrone Bio Innovations Inc / Sprout Social Inc / SeaSpine Holdings Corp / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMAT.O / AMD.N / AXAF.PA / EDP.LS / F.N / GM.N / INTC.O / SVT.L / FER.MC / BWA.N / NVDA.O / ADBE.O / SNPS.O / NLY.N / FRAG.DE / REGN.O / MU.O / CDNS.O / GETP.PA / EONGn.DE / FHI.N / TWO.N / ARES.N / 03835T200 / AENA.MC / VCTR.N</td><td class="leftalignment">Applied Materials Inc / Advanced Micro Devices Inc / AXA SA / EDP Energias de Portugal SA / Ford Motor Co / General Motors Co / Intel Corp / Severn Trent PLC / Ferrovial SA / Borgwarner Inc / NVIDIA Corp / Adobe Inc / Synopsys Inc / Annaly Capital Management Inc / Fraport AG Frankfurt Airport Services Worldwide / Regeneron Pharmaceuticals Inc / Micron Technology Inc / Cadence Design Systems Inc / Getlink SE / E.ON SE / Federated Hermes Inc / Two Harbors Investment Corp / Ares Management Corp / Aptose Biosciences Inc / Aena SME SA / Victory Capital Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Spain / France / United Kingdom / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Large Cap Modestly Higher / STSA With Greatest Sequential Change Among SMid Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">COVID-19 UPDATE: Low Dose REGN-COV2 Solid; AZN Faces Scrutiny; PFE Antiviral</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">REGN.OQ / AZN.L / PFE.N / US0463531089 / US7170811035 / US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / AstraZeneca PLC / Pfizer Inc / AstraZeneca PLC / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Updated REGN Model to Reflect New 1Q21 REGN-COV2 Guidance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">REGEN-COV ph3 wins in non-hospitalized COVID-19 but preliminary Q1 sales lag vs Street</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">REGN-COV2 Looks Better and Better, Giving Insurance Against Vaccine Failure</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">REGEN-COV shows positive topline results in non-hospitalized patients; retains potency against new variants</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">P3 REGEN-COV Data Shows Efficacy of Low Dose; Raising FY21 Numbers</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Regeneron Pharmaceuticals, Inc. - REGN-COV effective at lower 1,200 mg dose: We expect full realization of the $2.6B BARDA contract</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ / LLY.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Biologics Sector - Quick take: Looking ahead to EMA CHMP opinion this week</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">068270.KS / 091990.KQ / LLY.N / REGN.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Mar 12, 2021: Focus on 1Q21 trends for EU Majors</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Quick Thoughts On Fasinumab Given Availability Of Tanezumab Briefing Docs</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">881624209 / 717081103 / 532457108 / 75886F107</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Pfizer Inc / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALV.N / ANTO.L / BAC.N / BHP.AX / BK.N / C.N / CL.N / CP.TO / EDP.LS / EL.N / F.N / GM.N / JPM.N / KMB.N / KO.N / MRK.N / NCM.AX / NEM.N / NSC.N / PFE.N / RIO.AX / RIO.L / RSG.AX / T.N / VC.N / WFC.N / PEP.N / BFb.N / PG.N / GILD.O / FNV.N / CPB.N / TEN.N / AAL.L / CNR.TO / BWA.N / LEA.N / K.N / DT.N / DISH.O / CSX.N / TV.TO / UNP.N / GS.N / CLX.N / CAG.N / GIS.N / EPC.N / SBM.AX / AMT.N / BOL.ST / NG.L / VZ.N / STT.N / EXEL.O / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / ACN.N / NBIX.O / CHD.N / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / VRTX.O / NCR.N / NET.N / TEL.N / APF.L / PII.N / ST.N / HCC.N / GPN.N / MNST.O / BLUE.O / CASY.O / BCRX.O / EQIX.O / ATDb.TO / IGO.AX / FMG.AX / GOLD.N / FM.TO / RMS.AX / NST.AX / 02209S103 / 878742204 / RRL.AX / DLR.N / WSA.AX / 427866108 / ALNY.O / 35671D857 / MS.N / FIS.N / ARWR.O / MA.N / CS.TO / HOG.N / 443628102 / 550372106 / BGS.N / NCU.TO / SLR.AX / DAN.N / EDPR.LS / OZL.AX / SFR.AX / NGD.A / OGC.TO / VALE.N / SPB.N / BHPB.L / GOR.AX / CAML.L / PCRX.O / MTOR.N / GLEN.L / EVN.AX / SPLK.OQ / PANW.N / MDLZ.OQ / 505440107 / TSLA.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / AGIO.O / 81762P102 / 46579R104 / VRNS.O / CIA.TO / S32.AX / PYPL.OQ / GBT.OQ / IONS.O / RACE.MI / ADVM.OQ / TWLO.N / ADNT.N / CRSP.OQ / PBYI.OQ / OKTA.OQ / SAIL.N / APTV.N / NEXA.TO / ZS.OQ / VNE.N / KDP.N / XERS.O / AQST.O / PRVB.O / ESTC.N / OSMT.O / NWL.O / CRWD.O / PING.N / CRNC.OQ / REYN.O / SBSW.N / NKLA.OQ / FOUR.N / SPRB.OQ / 900435207 / AFRM.O / TEEC.L / 120681711</td><td class="leftalignment">Autoliv Inc / Antofagasta PLC / Bank of America Corp / BHP Group Ltd / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Rio Tinto Ltd / Rio Tinto PLC / Resolute Mining Ltd / AT&T Inc / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Tenneco Inc / Anglo American PLC / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Boliden AB / National Grid PLC / Verizon Communications Inc / State Street Corp / Exelixis Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Anglo Pacific Group PLC / Polaris Inc / Sensata Technologies Holding PLC / Warrior Met Coal Inc / Global Payments Inc / Monster Beverage Corp / bluebird bio Inc / Caseys General Stores Inc / BioCryst Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / IGO Ltd / Fortescue Metals Group Ltd / Barrick Gold Corp / First Quantum Minerals Ltd / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Teck Resources Ltd / Regis Resources Ltd / Digital Realty Trust Inc / Western Areas Ltd / Hershey Co / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Morgan Stanley / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / Capstone Mining Corp / Harley-Davidson Inc / Hudbay Minerals Inc / Lundin Mining Corp / B&G Foods Inc / Nevada Copper Corp / Silver Lake Resources Ltd / Dana Inc / EDP Renovaveis SA / OZ Minerals Ltd / Sandfire Resources Ltd / New Gold Inc / OceanaGold Corp / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Gold Road Resources Ltd / Central Asia Metals PLC / Pacira Biosciences Inc / Meritor Inc / Glencore PLC / Evolution Mining Ltd / Splunk Inc / Palo Alto Networks Inc / Mondelez International Inc / Labrador Iron Ore Royalty Corp / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Ivanhoe Mines Ltd / Varonis Systems Inc / Champion Iron Ltd / South32 Ltd / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Adient PLC / CRISPR Therapeutics AG / Puma Biotechnology Inc / Okta Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Nexa Resources SA / Zscaler Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / Elastic NV / Osmotica Pharmaceuticals PLC / Newell Brands Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / Nikola Corp / Shift4 Payments Inc / Spruce Biosciences Inc / Turquoise Hill Resources Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Cayman Islands / Spain / United Kingdom / Ireland / Luxembourg / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: SLDB makes progress in DMD</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">SLDB.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Solid Biosciences Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Weekend Updates</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US00973Y1082 / US09061G1013 / US45337C1027 / US75886F1075 / US09609G1004 / US4622221004 / KYG108301006 / US02155H2004 / US65487U1088</td><td class="leftalignment">Akero Therapeutics Inc / Biomarin Pharmaceutical Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Ionis Pharmaceuticals Inc / Beyondspring Inc / Altimmune Inc / Nkarta Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="odd"><td class="leftalignment">03/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">EXEL.O / REGN.O / PRTA.O / AGIO.O / PBYI.OQ</td><td class="leftalignment">Exelixis Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Puma Biotechnology Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q4 2020: Regeneron reports Net Profit of $1.1b</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">334</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ / INCY.OQ / LLY.N / MRK.N / AZN.L / SASY.PA / AMGN.OQ / REGN.OQ / ALKS.OQ / STSA.OQ / GILD.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / TEVA.N / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / SAGE.OQ / ZBH.N / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Incyte Corp / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / SAGE Therapeutics Inc / Zimmer Biomet Holdings Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">You’re Going the Wrong Way! Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">OXUR.BR: FY20 Update - Don't Lose Sight of THR-149 Data in DME During Mid-2021</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">OXUR.BR / REGN / CLSD.OQ / KOD.OQ</td><td class="leftalignment">Oxurion NV / Regeneron Pharmaceuticals Inc / Clearside Biomedical Inc / Kodiak Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">IMTX=US / AXLA=US / ADAP=US / DRRX=US / ICPT=US / REGN=US / SNY=US / EVLO=US / KLDO=US / VKTX=US / MCRB=US / MDGL=US / IVA=FR / SYBX=US / CWBR=US / NGM=US / IBTB=SE / AKRO=US / ETNB=US / FBRX=US</td><td class="leftalignment">Immatics NV / Axcella Health Inc / Adaptimmune Therapeutics PLC / DURECT Corp / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / Evelo Biosciences Inc / Kaleido Biosciences Inc / Viking Therapeutics Inc / Seres Therapeutics Inc / Madrigal Pharmaceuticals Inc / Inventiva SA / Synlogic Inc / CohBar Inc / NGM Biopharmaceuticals Inc / Infant Bacterial Therapeutics AB / Akero Therapeutics Inc / 89Bio Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">FBRX (Buy, $105): A blue skies FB-401 success in AD implies ~$192-$839/share</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FBRX=US / REGN=US / SNY=US / EVLO=US / KLDO=US / MCRB=US / SYBX=US / IBTB=SE</td><td class="leftalignment">Forte Biosciences Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / Evelo Biosciences Inc / Kaleido Biosciences Inc / Seres Therapeutics Inc / Synlogic Inc / Infant Bacterial Therapeutics AB</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Revisiting the Current Situation at the FDA and Potential Implications for Biogen's Aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / MRK.N / REGN.OQ / FGEN.PS / ACHC.OQ</td><td class="leftalignment">Biogen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / First Gen Corp / Acadia Healthcare Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Regeneron Pharmaceuticals Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">007903107 / 75886F107 / 45245E109 / 25058X10 / 17143G106</td><td class="leftalignment">Advanced Micro Devices Inc / Regeneron Pharmaceuticals Inc / Imax Corp / Desktop Metal Inc / Skillsoft Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Ruben Roy / Mr. Aydin Huseynov, MD / Mr. Josh W. Sullivan / Mr. Mark W. Schappel / Mike Hickey / Mr. Michael P. Ward, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Libtayo Could Beat Keytruda in Cervical Cancer?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AACR 2021 Virtual Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">PFE=US / AMGN=US / INCY=US / GILD=US / SAN=FR / AZN=US / GSK=US / JNJ=US / IMGN=US / EXAS=US / ILMN=US / HOOK=US / REGN=US / NTRA=US / TPTX=US / BOLT=US / NEO=US / RCUS=US / VSTM=US / ABBV=US / MRTX=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AFMD=US / BPMC=US / BGNE=US / MRUS=US / MRSN=US / GH=US / BHC=US / REPL=US / RUBY=US / SBTX=US / TWST=US / HARP=US / TCRR=US / BNTX=US / GMAB=US / RVMD=US / ZNTL=US / ITOS=US / MOLN=DE</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / ImmunoGen Inc / Exact Sciences Corp / Illumina Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Natera Inc / Turning Point Therapeutics Inc / Bolt Biotherapeutics Inc / Neogenomics Inc / Arcus Biosciences Inc / Verastem Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Affimed NV / Blueprint Medicines Corp / Beigene Ltd / Merus NV / Mersana Therapeutics Inc / Guardant Health Inc / Bausch Health Companies Inc / Replimune Group Inc / Rubius Therapeutics Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / BioNTech SE / Genmab A/S / Revolution Medicines Inc / Zentalis Pharmaceuticals Inc / Iteos Therapeutics Inc / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges / Dr. Andrew S. Berens, MD / Mr. Jonathan W. Chang, PHD / Mr. Puneet Souda</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Mar. 16, 2021 / 7:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / GILD=US / AMT=US / VZ=US / LOW=US / PB=US / CHRS=US / LEG=US / DISH=US / BNL=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / REGI=US / SBAC=US / STOR=US / ABCB=US / ADC=US / BOKF=US / FFIN=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / EPRT=US / JACK=US / TREX=US / CUBE=US / FBHS=US / TILE=US / TMUS=US / NDLS=US / CNCE=US / LOCO=US / HQY=US / SHAK=US / RLMD=US / WING=US / ZG=US / 82982L103 / ANAB=US / JELD=US / RDFN=US / BTAI=US / OPCH=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / American Tower Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / DISH Network Corp / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / STORE Capital Corp / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / First Financial Bankshares Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Trex Company Inc / CubeSmart / Fortune Brands Home & Security Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Relmada Therapeutics Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / AnaptysBio Inc / JELD-WEN Holding Inc / Redfin Corp / BioXcel Therapeutics Inc / Option Care Health Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - March 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">US2017231034 / US3755581036 / US5463471053 / US6703461052 / US7549071030 / US75886F1075 / US8581191009 / US9621661043 / CA8787422044 / CA1247651088 / CA7751092007 / CA9528451052 / CA82028K2002 / CA0099051009 / US9129091081 / AU000000FMG4 / US7376301039 / CA32076V1031 / US5021751020 / US63633D1046 / CA3518581051 / US91912E1055 / CA8672241079 / IE00B4BNMY34 / DE000BAY0017 / US09739D1000 / US03209R1032 / US9840171030 / US1638511089 / US00856G1094 / GB00BF3ZNS54 / CA8585221051 / GB00BJT16S69 / CA59124U6051 / US90278Q1085 / CA67079A1021</td><td class="leftalignment">Commercial Metals Co / Gilead Sciences Inc / Louisiana-Pacific Corp / Nucor Corp / Rayonier Inc / Regeneron Pharmaceuticals Inc / Steel Dynamics Inc / Weyerhaeuser Co / Teck Resources Ltd / CAE Inc / Rogers Communications Inc / West Fraser Timber Co Ltd / Shaw Communications Inc / AKITA Drilling Ltd / United States Steel Corp / Fortescue Metals Group Ltd / Potlatchdeltic Corp / First Majestic Silver Corp / LTC Properties Inc / National Health Investors Inc / Franco-Nevada Corp / Vale SA / Suncor Energy Inc / Accenture PLC / Bayer AG / Boise Cascade Co / Amphastar Pharmaceuticals Inc / Xenia Hotels & Resorts Inc / Chemours Co / AgroFresh Solutions Inc / Venator Materials PLC / Stelco Holdings Inc / Tronox Holdings PLC / Metalla Royalty & Streaming Ltd / Ufp Industries Inc / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009 / US75886F1075 / US7665596034 / US09062X1037</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Deep Dive: Highlighting the Knee Pain OA Market Ahead of TLC599 Phase 3 Results in 2H21E</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">PFE / US0311621009 / US75886F1075</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Libtayo Shows Survival Benefit in Cervical Cancer</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Libtayo Now First PD1 To Show OS Benefit In Cervical Cancer – Ph3 Stopped Early</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Libtayo Advances with Positive Phase 3 Cervical Cancer Data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Positive cervical OS data could add another feather in the cap for Libtayo</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">EVLO=US / ADAP=US / MRK=US / LLY=US / PFE=US / BMY=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / JNJ=US / BMRN=US / BLUE=US / ISEE=US / EXAS=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NESN=US / KLDO=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / DDDD=GB / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / MCRB=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PHGE=US / PASG=US / SIGHT:FP=FR / FBRX=US / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Evelo Biosciences Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Exact Sciences Corp / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Nestle SA / Kaleido Biosciences Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / 4D Pharma PLC / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Seres Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Biomx Inc / Passage Bio Inc / Gensight Biologics SA / Forte Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Covering When You Cough...New Drugs/Trials in Asthma & COPD - Good for REGN/SNY</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">REGN=US / AMGN=US / SAN=FR / AZN=US / SNY=US / AMGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Amgen Inc / Sanofi SA / AstraZeneca PLC / Sanofi SA / Amgen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABF.L / AEP.N / ALV.N / AU.N / CAS.TO / CI.N / CL.N / CMS.N / EDP.LS / EIX.N / EL.N / F.N / FGP.L / GM.N / GOG.L / HMb.ST / IBE.MC / IP.N / JD.L / KBH.N / KMB.N / KO.N / MKS.L / MRK.N / NCM.AX / NEM.N / NXT.L / PD.N / PFE.N / PHM.N / RSG.AX / RYN.N / SO.N / T.N / TOL.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / GILD.O / FNV.N / CPB.N / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / DUK.N / AGI.N / BWA.N / LEA.N / PNM.N / K.N / DT.N / DISH.O / LEN.N / CLX.N / CAG.N / GIS.N / AEM.N / EPC.N / SBM.AX / AMT.N / KGC.N / NKE.N / JAZZ.O / CONE.O / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / ITX.MC / BMRN.O / OPTN.O / REGN.O / ENR.N / JHX.AX / CEY.L / NCR.N / NET.N / TEL.N / GFI.N / ASC.L / CNP.N / ENDP.O / CPK.N / PII.N / ST.N / SEM.N / SGEN.OQ / GPN.N / MNST.O / RGLD.O / BLUE.O / CASY.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / RMS.AX / NST.AX / 02209S103 / CWX.TO / RRL.AX / DLR.N / IAG.N / 427866108 / WEF.TO / FIS.N / ARWR.O / TEVA.N / MA.N / HOG.N / MERC.O / AUY.N / ATL.MI / BGS.N / HOCM.L / SLR.AX / ENSG.O / DAN.N / NOG.A / FRES.L / NGD.A / CLW.N / OGC.TO / ADUS.OQ / EGO.N / ADN.TO / SPB.N / NEE.N / GOR.AX / PCH.O / CFX.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / POLYP.L / EVN.AX / SPLK.OQ / RFP.N / BOSSn.DE / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / COTY.N / PRTA.O / 81762P102 / CFF.TO / LB.N / KPTI.O / XNCR.OQ / VRNS.O / BOOH.L / BTG.N / AGRX.O / RYAM.N / ZALG.DE / 03835T200 / SHOP.N / WRK.N / SGRY.O / RACE.MI / TWLO.N / OR.N / ADNT.N / CRSP.OQ / GDS.O / SAND.N / AQN.N / OKTA.OQ / VST.N / WPM.N / KL.N / ATNX.O / SAIL.N / APTV.N / EHC.N / SDRY.L / ZS.OQ / AMRX.N / ITRM.O / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / FOCS.O / ESTC.N / GMDA.OQ / OSMT.O / NWL.O / OPI.OQ / CRWD.O / GMAB.O / PING.N / APRE.OQ / CRNC.OQ / IGMS.O / FRAS.L / REYN.O / SBSW.N / IGIC.OQ / NKLA.OQ / FOUR.N / GOCO.O / ALOO.O / MAX.N / WFG.N / AG1G.DE / 120291281 / 120681711</td><td class="leftalignment">Associated British Foods PLC / American Electric Power Company Inc / Autoliv Inc / AngloGold Ashanti Ltd / Cascades Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / H & M Hennes & Mauritz AB / Iberdrola SA / International Paper Co / JD Sports Fashion PLC / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Marks and Spencer Group PLC / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Next PLC / PagerDuty Inc / Pfizer Inc / Pultegroup Inc / Resolute Mining Ltd / Rayonier Inc / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Alamos Gold Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Lennar Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Agnico Eagle Mines Ltd / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Kinross Gold Corp / Nike Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Industria de Diseno Textil SA / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Gold Fields Ltd / ASOS PLC / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Royal Gold Inc / bluebird bio Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Doman Building Materials Group Ltd / Regis Resources Ltd / Digital Realty Trust Inc / IAMGOLD Corp / Hershey Co / Western Forest Products Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Mercer International Inc / Yamana Gold Inc / Atlantia SpA / B&G Foods Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Ensign Group Inc / Dana Inc / Northern Oil and Gas Inc / Fresnillo PLC / New Gold Inc / Clearwater Paper Corp / OceanaGold Corp / Addus Homecare Corp / Eldorado Gold Corp / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Gold Road Resources Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Polymetal International PLC / Evolution Mining Ltd / Splunk Inc / Resolute Forest Products Inc / Hugo Boss AG / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / Coty Inc / Prothena Corporation PLC / ServiceNow Inc / Conifex Timber Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Xencor Inc / Varonis Systems Inc / boohoo group plc / B2Gold Corp / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Zalando SE / Aptose Biosciences Inc / Shopify Inc / Westrock Co / Surgery Partners Inc / Ferrari NV / Twilio Inc / Osisko Gold Royalties Ltd / Adient PLC / CRISPR Therapeutics AG / GDS Holdings Ltd / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Vistra Corp / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Superdry PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Iterum Therapeutics PLC / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Office Properties Income Trust / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Frasers Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Gohealth Inc / Allogene Therapeutics Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / AUTO1 Group SE / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: BNTX/PFE efficacy in C19; (+) LentiGlobin news</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE.N / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Pfizer Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / REGN.O / PRTA.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC</td><td class="leftalignment"></td><td class="leftalignment">China / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">OPT=US / VBIV=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / BMY=US / MDT=US / AMZN=US / WMT=US / INSP=US / CMS=US / GILD=US / DGX=US / BBI=US / RMD=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ISRG=US / LH=US / PHAR=US / REGN=US / USPH=US / UHS=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MRNS=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / EHC=US / NMTR=US / TMDI=US / SPRO=US / ASND=US / ADUS=US / ACHC=US / PRTA=US / OM=US / FLXN=US / CTRE=US / ALDX=US / XENT=US / WBA=US / EVH=US / ZBH=US / CATB=US / LIVN=US / CERC=US / AVDL=US / SRRA=US / SLNO=US / SYNH=US / FIXX=US / MRKR=US / GMDA=US / PDSB=US / TMDX=US / BCYC=US / KRTX=US / BNTX=US / PNTG=US</td><td class="leftalignment">Opthea Ltd / VBI Vaccines Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Amazon.com Inc / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Brickell Biotech Inc / Resmed Inc / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / Pharming Group NV / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Titan Medical Inc / Spero Therapeutics Inc / Ascendis Pharma A/S / Addus Homecare Corp / Acadia Healthcare Company Inc / Prothena Corporation PLC / Outset Medical Inc / Pacira Biosciences Inc / CareTrust REIT Inc / Aldeyra Therapeutics Inc / Intersect Ent Inc / Walgreens Boots Alliance Inc / Evolent Health Inc / Zimmer Biomet Holdings Inc / Astria Therapeutics Inc / LivaNova PLC / Avalo Therapeutics Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Soleno Therapeutics Inc / Syneos Health Inc / Homology Medicines Inc / Marker Therapeutics Inc / Gamida Cell Ltd / PDS Biotechnology Corp / Transmedics Group Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / BioNTech SE / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.12.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / ALDX=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FR0000121014 / US0028241000 / US00738A1060 / US00846U1016 / US0126531013 / US02553E1064 / US0311621009 / US0463531089 / US1101221083 / US17275R1023 / US22160K1051 / US2358511028 / US30226D1063 / US3156161024 / US3377381088 / US3647601083 / US3755581036 / US37733W1053 / US4364401012 / US4523271090 / US4781601046 / US48203R1041 / US5002551043 / US5324571083 / US6245801062 / US62855J1043 / US6549022043 / US6556641008 / US66987V1098 / US6701002056 / US7140461093 / US7170811035 / US75886F1075 / US87612E1064 / US8835561023 / US9021041085 / US91307C1027 / US9311421039 / US9418481035 / US30063P1057 / US37940X1028 / AU000000LYC6 / US2948216088 / US1167941087 / US31620M1062 / US57636Q1040 / US1717793095 / US79546E1047 / US55616P1049 / US90384S3031 / US92826C8394 / US58933Y1055 / US13100M5094 / US1920051067 / US9100471096 / US69404D1081 / US92335C1062 / US98978V1035 / US5017971046 / US64051T1007 / US45845P1084 / US69366J2006 / US63009R1095 / US03823U1025 / CH0210483332 / US09062W2044 / US0404131064 / US78667J1088 / US0994061002 / IE00BTN1Y115 / US46185L1035 / US6323071042 / US70450Y1038 / US72703H1014 / US8522341036 / US26856L1035 / US74967X1037 / NL0012169213 / CA1350861060 / US03236M2008 / US8760301072 / CA53680Q2071 / US74766Q1013 / US7625441040 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / KY30744W1070 / US40131M1099 / US53814L1089 / US90184D1000 / VGG1890L1076 / US05352A1007 / US76156B1070 / US71535D1063 / US39874R1014 / US00650F1093 / US88339P1012 / US24984K1051 / US88025U1097 / US30068X1037 / US92766K1060 / US14448C1045 / US12233L1070 / US57667L1070 / US0843101017 / US07373B1098 / CA67079A1021 / US5533681012 / US74767V1098 / US81578P1066 / US65443P1021 / US7761531083 / US73739W1045 / US55406W1036 / US12047B1052 / US15961R1059</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abbott Laboratories / ADTRAN Inc / Agilent Technologies Inc / Albemarle Corp / American Eagle Outfitters Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cisco Systems Inc / Costco Wholesale Corp / Danaher Corp / Extreme Networks Inc / F5 Inc / Fiserv Inc / Gap Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Hologic Inc / Illumina Inc / Johnson & Johnson / Juniper Networks Inc / Kohls Corp / Eli Lilly and Co / Movado Group Inc / Myriad Genetics Inc / Nokia Oyj / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PerkinElmer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / Thermo Fisher Scientific Inc / II-VI Inc / United Therapeutics Corp / Walmart Inc / Waters Corp / Exact Sciences Corp / Global Payments Inc / Lynas Rare Earths Ltd / Telefonaktiebolaget LM Ericsson / Bruker Corp / Fidelity National Information Services Inc / Mastercard Inc / Ciena Corp / Sally Beauty Holdings Inc / Macy's Inc / Ulta Beauty Inc / Visa Inc / Merck & Co Inc / Calix Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Vera Bradley Inc / Zoetis Inc / Bath & Body Works Inc / NeoPhotonics Corp / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Applied Optoelectronics Inc / Compagnie Financiere Richemont SA / BioLife Solutions Inc / Arista Networks Inc / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Medtronic PLC / Invitae Corp / Natera Inc / PayPal Holdings Inc / Planet Fitness Inc / Block Inc / elf Beauty Inc / RH / Qiagen NV / Canada Goose Holdings Inc / Amyris Inc / Tapestry Inc / Lithium Americas Corp / Quanterix Corp / Ribbon Communications Inc / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Farfetch Ltd / Guardant Health Inc / Livent Corp / Twist Bioscience Corp / Capri Holdings Ltd / Avantor Inc / Revolve Group Inc / Personalis Inc / Grocery Outlet Holding Corp / Adaptive Biotechnologies Corp / RealReal Inc / DermTech Inc / 10X Genomics Inc / Exagen Inc / Virgin Galactic Holdings Inc / Carrier Global Corp / Burning Rock Biotech Ltd / Match Group Inc / Berkeley Lights Inc / Beam Global / Nuvei Corp / Mp Materials Corp / Quantumscape Corp / Seer Inc / 908 Devices Inc. / Romeo Power Inc / Poshmark Inc / MYT Netherlands Parent BV / Bumble Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 0925288 / 2516152 / 2000019 / 2050832 / 2026242 / 2270726 / 2542049 / 2317087 / 2345022 / 2100920 / 2415204 / 2459020 / 2638625 / 2657802 / 2730190 / 2799351 / 2895163 / 2795393 / B121557 / 2769796 / B125XQ6 / B7TL820 / BFLR866 / BYVY8G0 / BYW36M8 / BF4VBS8 / BFM2GV1 / BQT3XY6 / B0SDJB4 / BFZ1K46 / BZ8VJQ8 / BKTNTR9 / BMVWYW8 / BG0Q4Y1 / BGKG6M3 / BMPRZV5 / BGT0PL8 / BMTVQT8 / 021513106</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Amazon.com Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Macy's Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Intuit Inc / National Beverage Corp / OGE Energy Corp / Regeneron Pharmaceuticals Inc / Sinclair Broadcast Group Inc / United Natural Foods Inc / Amerisourcebergen Corp / Mastercard Inc / Fidelity National Information Services Inc / Portland General Electric Co / Meta Platforms Inc / Twitter Inc / Alphabet Inc / PayPal Holdings Inc / BioXcel Therapeutics Inc / GreenSky Inc / Cyberark Software Ltd / Zealand Pharma A/S / Spotify Technology SA / Vistra Corp / ViacomCBS Inc / Protara Therapeutics Inc / Exicure Inc / StoneCo Ltd / Kymera Therapeutics Inc / DiaMedica Therapeutics Inc / Goodrx Holdings Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / JNJ.N / LLY.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Johnson & Johnson / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EU Pharma Feedback. Bayer CMD Day Two : Innovation and notes from breakout sessions</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BAYGn.DE / JNJ.N / MRK.N / TMO.N / ROG.S / LONN.S / REGN.OQ / ORNBV.HE / ATRA.OQ / CTVA.N</td><td class="leftalignment">Bayer AG / Johnson & Johnson / Merck & Co Inc / Thermo Fisher Scientific Inc / Roche Holding AG / Lonza Group AG / Regeneron Pharmaceuticals Inc / Orion Oyj / Atara Biotherapeutics Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Finland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New AD Survey Indicates Continued Dupi Dominance; Sheds Light on New Therapies</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">75886F107 / 00287Y109</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Bleeding Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Deep Dive - Why Eylea Is Less Vulnerable Than You May Think</td><td class="leftalignment">English</td><td class="rightalignment">104</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US1924791031 / 878742204 / 75886F107 / 416906105 / 00165C104 / US86881A1007 / 33938J106 / 93627C101 / AU0000026122 / 502431109</td><td class="leftalignment">Coherent Inc / Teck Resources Ltd / Regeneron Pharmaceuticals Inc / Harvard Bioscience Inc / AMC Entertainment Holdings Inc / Surgery Partners Inc / Pacira Biosciences Inc / Warrior Met Coal Inc / Coronado Global Resources Inc / L3harris Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Josh W. Sullivan / Mr. Mark Miller / Mike Hickey / Mr. Bill Sutherland / Mr. Bruce D. Jackson / Mr. Nathan Martin</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">REGEN-COV Low-Dose Data As Major Catalyst This Month</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">VIR-7831 Really Is a Good (Single) Antibody, as It Reduces COVID Severity</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GSK=GB / REGN=US</td><td class="leftalignment">GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Synthetic Lethality Primer - A Prelude to Innovative IDEAYAs in DNA Damage Repare and Next-Generation Targeted Oncology</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2576941 / 2369174 / 2457864 / 2471950 / 2730190 / 5531000 / 7103065 / 2982924 / BCBVTX1 / BBFL7S1 / B6RS2B3 / BCZS820 / BFDV8K0 / BBPK0J0 / B7F2TY6 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BWFKZT2 / BKVDFF7 / BG31GH0 / BJXBP30 / BYQHPK7 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BL71K91 / BYWVTY5 / BDZ30Q0 / BWY4XV3 / BN2R582 / BDD1B07 / BMPRZV5 / BF3NP05 / BMDJ397</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / MorphoSys AG / Novartis AG / Spectrum Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Clovis Oncology Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / Puma Biotechnology Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Cellectis SA / Oric Pharmaceuticals Inc / Y-mAbs Therapeutics Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Revolution Medicines Inc / CytomX Therapeutics Inc / Arvinas Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Mersana Therapeutics Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mali / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron up 5% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AMGN.O / REGN.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Mar. 10, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DNB / HD=US / MCD=US / WEN=US / PD=US / AMZN=US / T=US / CMA=US / BC=US / VZ=US / LOW=US / PB=US / EWBC=US / TRMK=US / UMPQ=US / EXPE=US / LEG=US / KFRC=US / BKI=US / WTFC=US / KFY=US / AIZ=US / AMN=US / BMRN=US / CBRL=US / CSTR=US / DRI=US / EXPO=US / FCN=US / HAIN=US / MAN=US / MHK=US / PACW=US / REGN=US / STRA=US / THO=US / TRIP=US / WAL=US / HTH=US / CVX=US / POST=US / SNOW=US / BXS=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / ADC=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / DIN=US / PNFP=US / SBCF=US / BCO=US / MRNS=US / BIIB=US / TCBI=US / TPX=US / FNB=US / FHN=US / PLAY=US / RNST=US / DENN=US / XM=US / THS=US / CMG=US / CCOI=US / EHTH=US / CADE=US / TAST=US / PRPL=US / IAC=US / JACK=US / CLNY=US / VRSK=US / FBHS=US / ANGI=US / SPLK=US / IBTX=US / TMUS=US / NDLS=US / FEYE=US / GOOGL=US / LOCO=US / OSH=US / SHAK=US / WING=US / LOB=US / EVRI=US / ACBI=US / ZS=US / IBEX=US / TRVG=US / PVAC=US / OKTA=US / RDFN=US / ATNX=US / MBIN=US / HWC=US / OZK=US / FTDR=US / ESTC=US / AMTB=US / GOCO=US / DKNG=US / CRMD.US / ABNB=US / AFRM=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Home Depot Inc / McDonald's Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / AT&T Inc / Comerica Inc / Brunswick Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Expedia Group Inc / Leggett & Platt Inc / Kforce Inc / Black Knight Inc / Wintrust Financial Corp / Korn Ferry / Assurant Inc / AMN Healthcare Services Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Exponent Inc / FTI Consulting Inc / Hain Celestial Group Inc / ManpowerGroup Inc / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Strategic Education Inc / Thor Industries Inc / Tripadvisor Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Chevron Corp / Post Holdings Inc / Snowflake Inc. / Cadence Bank / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Brinks Co / Marinus Pharmaceuticals Inc / Biogen Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / First Horizon Corp / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Qualtrics International Inc / TreeHouse Foods Inc / Chipotle Mexican Grill Inc / Cogent Communications Holdings Inc / eHealth Inc / Cadence Bank / Carrols Restaurant Group Inc / Purple Innovation Inc / IAC/Interactivecorp / Jack in the Box Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Fortune Brands Home & Security Inc / Angi Inc / Splunk Inc / Independent Bank Group Inc / T-Mobile US Inc / Noodles & Co / Mandiant Inc / Alphabet Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / Ibex Ltd / Trivago NV / Ranger Oil Corp / Okta Inc / Redfin Corp / Athenex Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Elastic NV / Amerant Bancorp Inc / Gohealth Inc / DraftKings Inc / CorMedix Inc / Airbnb Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Add'l color from competitor mgmt on data; key takeaways below</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Preliminary top-line data from Ph2b study of potential Eylea competitor</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0028241000 / US0231351067 / US0311621009 / US0463531089 / US1101221083 / US2358511028 / US3377381088 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US87612E1064 / US9021041085 / US91307C1027 / US9311421039 / US37940X1028 / US0042251084 / US0491642056 / US31620M1062 / US57636Q1040 / US92826C8394 / US00922R1059 / US58933Y1055 / US69404D1081 / US30303M1027 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US90184L1026 / US0396971071 / US78667J1088 / IE00BTN1Y115 / US81750R1023 / US6323071042 / US70450Y1038 / US8522341036 / US87164F1057 / US03236M2008 / US8760301072 / US05351X1019 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / US68373M1071 / US90184D1000 / US1255231003 / US62921N1054 / US05352A1007 / US92537N1081 / US68902V1070 / US07373B1098 / US56854Q2003 / CA67079A1021 / US74767V1098 / US21077C1071 / US7761531083 / US73739W1045 / US15961R1059</td><td class="leftalignment">Abbott Laboratories / Amazon.com Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Danaher Corp / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / II-VI Inc / United Therapeutics Corp / Walmart Inc / Global Payments Inc / ACADIA Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Fidelity National Information Services Inc / Mastercard Inc / Visa Inc / Air Transport Services Group Inc / Merck & Co Inc / Pacific Biosciences of California Inc / Meta Platforms Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Twitter Inc / Ardelyx Inc / SAGE Therapeutics Inc / Medtronic PLC / Seres Therapeutics Inc / Natera Inc / PayPal Holdings Inc / Block Inc / Syndax Pharmaceuticals Inc / Amyris Inc / Tapestry Inc / Avaya Holdings Corp / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Opera Ltd / Twist Bioscience Corp / Cigna Corp / NGM Biopharmaceuticals Inc / Avantor Inc / Vertiv Holdings Co / Otis Worldwide Corp / Beam Global / Marinus Pharmaceuticals Inc / Nuvei Corp / Quantumscape Corp / ContextLogic Inc / Romeo Power Inc / Poshmark Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - March 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">US00724F1012 / US02553E1064 / US3647601083 / US5949181045 / US5962781010 / US6541061031 / US6556641008 / US68389X1054 / US75886F1075 / US7782961038 / US8030542042 / US8725401090 / US9170471026 / US9182041080 / CA1249003098 / IL0010824113 / US79466L3024 / US0534841012 / US7588491032 / US2971781057 / US1331311027 / US2644115055 / US9290421091 / US9043111072 / US59522J1034 / US49427F1084 / US9285634021 / US5500211090 / US02913V1035 / US90384S3031 / US38526M1062 / US34959E1091 / CA9237251058 / US6936561009 / US7512121010 / US1091941005 / US5017971046 / US81762P1021 / US98138H1014 / US92936U1097 / US70509V1008 / US8486371045 / US6974351057 / US31816Q1013 / US1220171060 / US11120U1051 / US1630921096 / US44157R1095 / US90214J1016 / US14174T1079 / US4435731009 / US64829B1008 / US29444U7000 / US72703H1014 / US95040Q1040 / GB00BYT5JK65 / GB00BZ09BD16 / US5186132032 / US6792951054 / US00737L1035 / US8760301072 / US8608971078 / US63845R1077 / US98980G1022 / US15677J1088 / US83200N1037 / US86272C1036 / US1255231003 / VGG1890L1076 / US26614N1028 / US76156B1070 / US88339P1012 / US2681501092 / US03768E1055 / US70614W1009 / US42250P1030 / US69526K1051 / US23821D1000 / CA9004352071 / US87969B1017 / US86333M1080 / US7476012015 / JE00BMVMZ478 / US24343R1068</td><td class="leftalignment">Adobe Inc / American Eagle Outfitters Inc / Gap Inc / Microsoft Corp / Middleby Corp / Nike Inc / Nordstrom Inc / Oracle Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / SAP SE / TJX Companies Inc / Urban Outfitters Inc / VF Corp / CCL Industries Inc / Check Point Software Technologies Ltd / Salesforce.Com Inc / Avalonbay Communities Inc / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Duke Realty Corp / Vornado Realty Trust / Under Armour Inc / Mid-America Apartment Communities Inc / Kilroy Realty Corp / VMware Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Grand Canyon Education Inc / Fortinet Inc / Vermilion Energy Inc / PVH Corp / Ralph Lauren Corp / Bright Horizons Family Solutions Inc / Bath & Body Works Inc / ServiceNow Inc / Workday Inc / WP Carey Inc / Pebblebrook Hotel Trust / Splunk Inc / Palo Alto Networks Inc / Mandiant Inc / Burlington Stores Inc / Brixmor Property Group Inc / Chegg Inc / Houghton Mifflin Harcourt Co / 2U Inc / CareTrust REIT Inc / HubSpot Inc / New Relic Inc / Equinix Inc / Planet Fitness Inc / Welltower Inc / Mimecast Ltd / Atlassian Corporation PLC / Laureate Education Inc / Okta Inc / Adtalem Global Education Inc / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Zscaler Inc / Ceridian HCM Holding Inc / Smartsheet Inc / Strategic Education Inc / Cigna Corp / Capri Holdings Ltd / Dupont De Nemours Inc / Revolve Group Inc / RealReal Inc / Dynatrace Inc / Apollo Global Management Inc / Peloton Interactive Inc / Healthpeak Properties Inc / Pactiv Evergreen Inc / Datto Holding Corp / Turquoise Hill Resources Ltd / Telos Corp / Stride Inc / Qualtrics International Inc / Atotech Ltd / Decibel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Germany / United Kingdom / Israel / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Relatively Stable for Large Cap and SMid Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Topical Panel Wrap-Up</td><td class="leftalignment">English</td><td class="rightalignment">217</td><td class="leftalignment">US0028241000 / US0311621009 / US0463531089 / US1101221083 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US91307C1027 / US58933Y1055 / US69404D1081 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US78667J1088 / IE00BTN1Y115 / US03236M2008 / VGG312491084 / US90184D1000</td><td class="leftalignment">Abbott Laboratories / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Merck & Co Inc / Pacific Biosciences of California Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / SAGE Therapeutics Inc / Medtronic PLC / Amyris Inc / Establishment Labs Holdings Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Health Care Team / Cowen Washington Research</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Initiating at OP: Targeting the Inner Ear to Treat Hearing & Balance Disorders</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">US24343R1068 / US75886F1075</td><td class="leftalignment">Decibel Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss Hot Topics and Key 2021 Focus Areas in Eye Diseases TODAY @ 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / REGN.OQ / BIIB.OQ / AERI.OQ / AGTC.OQ / ALDX.OQ / ADVM.OQ / EYPT.OQ / UBX.OQ / GRAY.OQ</td><td class="leftalignment">Johnson & Johnson / Regeneron Pharmaceuticals Inc / Biogen Inc / Aerie Pharmaceuticals Inc / Applied Genetic Technologies Corp / Aldeyra Therapeutics Inc / Adverum Biotechnologies Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Graybug Vision Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IVA=FR / PASG=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / PRVL=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / LYS=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Inventiva SA / Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Porvair PLC / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Lysogene SA / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / REGN.OQ / AMRN.OQ / BIIB.OQ / AERI.OQ / AGTC.OQ / AKBA.OQ / ALDX.OQ / ADVM.OQ / TVTY.OQ / EYPT.OQ / UBX.OQ / HGEN.OQ / GRAY.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Regeneron Pharmaceuticals Inc / Amarin Corporation PLC / Biogen Inc / Aerie Pharmaceuticals Inc / Applied Genetic Technologies Corp / Akebia Therapeutics Inc / Aldeyra Therapeutics Inc / Adverum Biotechnologies Inc / Tivity Health Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Humanigen Inc / Graybug Vision Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">F1H21 Review: P3 Trials on-Track for 1H21 Initiation</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">OPT=US / REGN=US / RHHBY=US</td><td class="leftalignment">Opthea Ltd / Regeneron Pharmaceuticals Inc / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AEP.N / AES.N / ALV.N / BAC.N / BBDb.TO / BK.N / C.N / CL.N / CMS.N / COF.N / CP.TO / DFDS.CO / ED.N / EIX.N / EL.N / ELE.MC / F.N / FITB.O / GM.N / JPM.N / KEY.N / KMB.N / KO.N / MRK.N / NTRS.O / PEG.N / PNC.N / PNW.N / RWEG.DE / SO.N / T.N / USB.N / VC.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / TEN.N / AMGN.O / ETR.N / CNR.TO / DUK.N / HBAN.O / BWA.N / LEA.N / D.N / FE.N / PNM.N / NVDA.O / K.N / DT.N / DISH.O / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / PPL.N / EPC.N / MGA.N / AMT.N / JAZZ.O / CONE.O / VZ.N / STT.N / EXEL.O / XEL.N / ARNA.O / STZ.N / APH.N / SRE.N / EXC.N / FISV.O / ADSK.O / CHTR.O / AXL.N / AWK.N / CHD.N / NWN.N / WSP.TO / MTB.N / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / FTT.TO / NCR.N / NET.N / TEL.N / RF.N / CNP.N / WCN.N / BKH.N / CPK.N / FRC.N / PII.N / ST.N / SR.N / GPN.N / MNST.O / SIVB.O / CASY.O / EQIX.O / STN.TO / ATDb.TO / WPK.TO / SNC.TO / TFC.N / 02209S103 / DLR.N / 427866108 / WEF.TO / SJW.N / MS.N / FIS.N / TEVA.N / HOG.N / BGS.N / GETP.PA / DAN.N / UTL.N / SPB.N / NEE.N / PCH.O / CJT.TO / CFX.TO / MSP.N / MTOR.N / IFP.TO / SPLK.OQ / RFP.N / PANW.N / MDLZ.OQ / GRT_u.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / PRTA.O / AGIO.O / 81762P102 / VRNS.O / FLXN.O / NEP.N / CFG.N / PYPL.OQ / MESO.O / RACE.MI / MP1.AX / TWLO.N / ADNT.N / PBYI.OQ / AQN.N / UNIT.O / OKTA.OQ / VST.N / ATUS.N / ATNX.O / AY.O / SAIL.N / APTV.N / ILPT.O / ZS.OQ / SMAR.N / VNE.N / KDP.N / XERS.O / AQST.O / CWEN.N / ESTC.N / NWL.O / CRWD.O / PING.N / CRNC.OQ / WTRG.N / REYN.O / GFL.N / NKLA.OQ / FOUR.N / 77311W101 / LUMN.N / ASAN.N / SUMO.O / WFG.N / TIXT.TO / AFRM.O / ATC.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Bank of America Corp / Bombardier Inc / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Canadian Pacific Railway Ltd / DFDS AS / Consolidated Edison Inc / Edison International / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fifth Third Bancorp / General Motors Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Rwe AG / Southern Co / AT&T Inc / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Amgen Inc / Entergy Corp / Canadian National Railway Co / Duke Energy Corp / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / Dominion Energy Inc / FirstEnergy Corp / PNM Resources Inc / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / PPL Corp / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Sempra Energy / Exelon Corp / Fiserv Inc / Autodesk Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / WSP Global Inc / M&T Bank Corp / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Finning International Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Regions Financial Corp / CenterPoint Energy Inc / Waste Connections Inc / Black Hills Corp / Chesapeake Utilities Corp / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Spire Inc / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Equinix Inc / Stantec Inc / Alimentation Couche-Tard Inc / Winpak Ltd / SNC-Lavalin Group Inc / Truist Financial Corp / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Western Forest Products Inc / SJW Group / Morgan Stanley / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / B&G Foods Inc / Getlink SE / Dana Inc / Unitil Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / Datto Holding Corp / Meritor Inc / Interfor Corp / Splunk Inc / Resolute Forest Products Inc / Palo Alto Networks Inc / Mondelez International Inc / Granite Real Estate Investment Trust / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Varonis Systems Inc / Pacira Biosciences Inc / Nextera Energy Partners LP / Citizens Financial Group Inc / PayPal Holdings Inc / Mesoblast Ltd / Ferrari NV / Megaport Ltd / Twilio Inc / Adient PLC / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Uniti Group Inc / Okta Inc / Vistra Corp / Altice USA Inc / Athenex Inc / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Industrial Logistics Properties Trust / Zscaler Inc / Smartsheet Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Clearway Energy Inc / Elastic NV / Newell Brands Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / GFL Environmental Inc / Nikola Corp / Shift4 Payments Inc / Rocket Companies Inc / Lumen Technologies Inc / Asana Inc / Sumo Logic Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Atotech Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 26, 2021: Focus on Novo GLP-1s</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Deep Dive On Wet AMD And Beyond; Opportunities For GRAY and EYPT Remain Underappreciated Ahead Of Key Near-Term Readouts</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">EYPT.OQ / GRAY.OQ / REGN.OQ</td><td class="leftalignment">EyePoint Pharmaceuticals Inc / Graybug Vision Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Jennifer M. Kim / Louise Chen / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/07/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Game On (& Other Updates)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US04335A1051 / US45337C1027 / US75886F1075 / US88322Q1085 / US4380831077 / BMG5269C1010 / US89422G1076 / US2300311063</td><td class="leftalignment">Arvinas Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / TG Therapeutics Inc / Homology Medicines Inc / Kiniksa Pharmaceuticals Ltd / Travere Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="even"><td class="leftalignment">03/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 booster developments; 4Q20 & FY20 earnings</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / BMRN.O / REGN.O / PRTA.O / AGIO.O / MESO.O / PBYI.OQ / ATNX.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Mesoblast Ltd / Puma Biotechnology Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.5.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / A=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / 4502.T / JNJ.N / LLY.N / MRK.N / AZN.L / SASY.PA / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Know the Ledge – Biggest Biotech Outflows So Far This Year</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">China-sourced PD1s coming to a market near you!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Dupixent Asthma Outlook Following AAAAI -- A Specialist's View</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">ADVM=US / NVS=US / ROG=CH / ISEE=US / REGN=US / FOLD=US / RGNX=US / QURE=US / AGTC=US / PRQR=US / VYGR=US / ALSEN=FR / KRYS=US / SLDB=US / MGTX=US / KOD=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US</td><td class="leftalignment">Adverum Biotechnologies Inc / Novartis AG / Roche Holding AG / Iveric Bio Inc / Regeneron Pharmaceuticals Inc / Amicus Therapeutics Inc / Regenxbio Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Voyager Therapeutics Inc / Sensorion SA / Krystal Biotech Inc / Solid Biosciences Inc / MeiraGTx Holdings PLC / Kodiak Sciences Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / France / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 3 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00846U1016 / US0311621009 / US1985161066 / US2435371073 / US28176E1082 / US4448591028 / US5002551043 / US6752321025 / US75886F1075 / US7782961038 / US8636671013 / US2533931026 / US0043971052 / US58733R1023 / CH0048265513 / US8036071004 / US85916J4094 / KYG037AX1015 / US60468T1051 / US1220171060 / IL0011316309 / IE00BQPVQZ61 / US31572Q8087 / IE00BTN1Y115 / US87918A1051 / US07725L1026 / US81141R1005 / US74766Q1013 / VGG312491084 / US55087P1049 / US89377M1099 / US03828A1016 / US00650F1093 / CA74319B5027 / US68902V1070</td><td class="leftalignment">Agilent Technologies Inc / Amgen Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Edwards Lifesciences Corp / Humana Inc / Kohls Corp / Oceaneering International Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Stryker Corp / DICK'S Sporting Goods Inc / Accuray Inc / Mercadolibre Inc / Transocean Ltd / Sarepta Therapeutics Inc / Stereotaxis Inc / Ambarella Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Mediwound Ltd / Horizon Therapeutics PLC / FibroGen Inc / Medtronic PLC / Teladoc Health Inc / Beigene Ltd / Sea Ltd / Quanterix Corp / Establishment Labs Holdings Inc / Lyft Inc / Transmedics Group Inc / Applied Therapeutics Inc / Adaptive Biotechnologies Corp / Profound Medical Corp / Otis Worldwide Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Ireland / Israel / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">ADVM (Buy, PT$20): Time (durability, safety) may work in Adverum's favor</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ADVM=US / NVS=US / ROG=CH / ISEE=US / REGN=US / FOLD=US / RGNX=US / QURE=US / AGTC=US / PRQR=US / VYGR=US / ALSEN=FR / KRYS=US / SLDB=US / MGTX=US / KOD=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US</td><td class="leftalignment">Adverum Biotechnologies Inc / Novartis AG / Roche Holding AG / Iveric Bio Inc / Regeneron Pharmaceuticals Inc / Amicus Therapeutics Inc / Regenxbio Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Voyager Therapeutics Inc / Sensorion SA / Krystal Biotech Inc / Solid Biosciences Inc / MeiraGTx Holdings PLC / Kodiak Sciences Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / France / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">FORECASTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Conf Highlights: REGN Bispecifics, FGEN AdCom, KRAS Update, Sitravatinib Solid</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ / FGEN.OQ / US0311621009 / US75886F1075 / US60468T1051 / US31572Q8087 / US07725L1026</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / FibroGen Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Mirati Therapeutics Inc / FibroGen Inc / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Regeneron Net Profit up 66%; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">FY20: Lirentelimab Requires Another Phase 2/3 Trial for SC Formulation Approval</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">01671P100 / 75886F107 / 004225108 / 040047607 / 77313F106</td><td class="leftalignment">Allakos Inc / Regeneron Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Rocket Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD / Tong Liu, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Mar. 02, 2021 / 9:10AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: February 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / AAL.OQ / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AWK / C / CNI / CP / DVN / EOG / JNJ / MGY / NSC / OLN / PVH / PXD / RKT / UNP / WLK / ASND.O / GILD.O / AMGN.O / SGMO.O / ARNA.O / ISRG.O / REGN.O / TSCO.O / CALA.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ZIOP.O / ARCT.O / RGLS.O / FANG.O / MEIP.O / RNA.O / FATE.O / QURE.O / AGTC.O / AFMD.O / BLCM.O / TCON.O / ZBH / CYAD.O / GBT.O / VYGR.O / CSX.O / IONS.O / ADAP.O / EDIT.O / AGLE.O / NTLA.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / IOVA.O / CDLX.O / AVRO.O / AUTL.O / KZR.O / STRO.O / CPRI.K / TPTX.O / RTLR.O / MORF.O / BCSF.K / IMV.O / PGEN.O / GHLD.K / GRCL.O / 87975H100</td><td class="leftalignment">American Water Works Company Inc / Citigroup Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Devon Energy Corp / EOG Resources Inc / Johnson & Johnson / Magnolia Oil & Gas Corp / Norfolk Southern Corp / Olin Corp / PVH Corp / Pioneer Natural Resources Co / Rocket Companies Inc / Union Pacific Corp / Westlake Chemical Corp / Ascendis Pharma A/S / Gilead Sciences Inc / Amgen Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / Calithera Biosciences Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / ZIOPHARM Oncology Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Diamondback Energy Inc / MEI Pharma Inc / Avidity Biosciences Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Affimed NV / Bellicum Pharmaceuticals Inc / TRACON Pharmaceuticals Inc / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / CSX Corp / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Iovance Biotherapeutics Inc / Cardlytics Inc / AVROBIO Inc / Autolus Therapeutics PLC / Kezar Life Sciences Inc / Sutro Biopharma Inc / Capri Holdings Ltd / Turning Point Therapeutics Inc / Rattler Midstream LP / Morphic Holding Inc / Bain Capital Specialty Finance Inc / IMV Inc / Precigen Inc / Guild Holdings Co / Gracell Biotechnologies Inc / Telus International Cda Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">KOD: 4Q20- Busy 2021 Will Set the Stage for Multiple Topline Readouts in 2022</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">KOD.OQ / REGN</td><td class="leftalignment">Kodiak Sciences Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2H20 Recap - Clarity on Zejula NRDL Pricing; Multiple 2021 Catalysts Ahead</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ZLAB=US / BMY=US / A=US / INCY=US / GSK=GB / GSK=US / PRTK=US / REGN=US / TPTX=US / MGNX=US / DCPH=US</td><td class="leftalignment">Zai Lab Ltd / Bristol-Myers Squibb Co / Agilent Technologies Inc / Incyte Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Paratek Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Turning Point Therapeutics Inc / MacroGenics Inc / Deciphera Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jonathan W. Chang, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EDIT=US / MRNA=US / ADAP=US / MRK=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / DRRX=US / ISEE=US / GRTS=US / ICPT=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NK=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / VKTX=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / NTLA=US / ADVM=US / MDGL=US / CRSP=US / ALSEN=FR / 199800=KR / IVA=FR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / CWBR=US / NGM=US / KOD=US / AXLA=US / STOK=US / AKRO=US / NBSE=US / ETNB=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Editas Medicine Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / DURECT Corp / Iveric Bio Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Immunitybio Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Inventiva SA / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / CohBar Inc / NGM Biopharmaceuticals Inc / Kodiak Sciences Inc / Axcella Health Inc / Stoke Therapeutics Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Suspending Coverage: Biotechnology</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BLCM.O / GILD.O / REGN.O / ICPT.O / BIIB.O / IMV.O</td><td class="leftalignment">Amgen Inc / Bellicum Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / IMV Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / ANTO.L / BAC.N / BARC.L / BCE.TO / BK.N / BNPP.PA / C.N / CCI.N / CL.N / CMS.N / COF.N / CSGN.S / DGE.L / EIX.N / EL.N / EOG.N / F.N / FITB.O / GM.N / HSBA.L / JPM.N / KEY.N / KMB.N / KO.N / L.TO / MRK.N / NEM.N / NTRS.O / PFE.N / PNC.N / RIO.L / SO.N / SOGN.PA / T.N / T.TO / USB.N / VC.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CNQ.TO / GILD.O / FNV.N / ASML.O / CPB.N / TEN.N / CMCSA.O / SJRb.TO / TA.TO / RCIb.TO / AMGN.O / FER.MC / AAL.L / CNR.TO / DUK.N / QBRb.TO / HBAN.O / BWA.N / LEA.N / PNM.N / ENB.TO / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / IMO.TO / GS.N / DBKGn.DE / CLX.N / CAG.N / HON.N / MFC.TO / GIS.N / PCG.N / AEM.N / XOM.N / EPC.N / MGA.N / SBAC.O / AMT.N / BOL.ST / CONE.O / ADI.O / VZ.N / STT.N / EXEL.O / MDRX.O / ALA.TO / ARNA.O / STZ.N / APH.N / SRE.N / EXC.N / DSGX.O / FISV.O / SNPS.O / V.N / AXL.N / AWK.N / ARE.N / PLD.N / CHD.N / MTB.N / BC.N / FTS.TO / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / CVX.N / EMA.TO / MU.O / CAGR.PA / NCR.N / NET.N / TEL.N / RF.N / FLS.CO / CNP.N / APF.L / ENDP.O / MEOH.O / CPK.N / DOL.TO / FRC.N / PII.N / ST.N / SWN.N / WES.N / SEM.N / ADS.N / GPN.N / MNST.O / SIVB.O / CASY.O / EQIX.O / ATDb.TO / TFC.N / INGA.AS / 02209S103 / DLR.N / 427866108 / RDSb.L / BLDR.O / DISCA.O / CDNS.O / MS.N / FIS.N / CCOI.O / HICL.L / CTCa.TO / BLX.TO / MA.N / MWA.N / HOG.N / ATL.MI / BGS.N / PPL.TO / DAN.N / BIP.N / SII.TO / CLW.N / VALE.N / SPB.N / ENV.N / BHPB.L / NEE.N / NXT.AX / CAML.L / MTOR.N / GLEN.L / GEI.TO / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / PRTA.O / BEP.N / AGIO.O / VRNS.O / AGRX.O / CFG.N / DEA.N / SHOP.N / PYPL.OQ / SQ.N / RACE.MI / UBSG.S / ADNT.N / FRTA.OQ / GDS.O / PBYI.OQ / AQN.N / VST.N / WOW.N / ATUS.N / GRPG.I / ATNX.O / AQUA.N / AY.O / SAIL.N / APTV.N / AMRX.N / VNE.N / KDP.N / ESTC.N / NWL.O / 269796108 / ZM.O / CRWD.O / GMAB.O / PING.N / CRNC.OQ / REYN.O / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / 77311W101 / LUMN.N / PTVE.O / BSY.O / MAX.N / WFG.N / TIXT.TO / AFRM.O / ATC.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Antofagasta PLC / Bank of America Corp / Barclays PLC / BCE Inc / Bank of New York Mellon Corp / BNP Paribas SA / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Credit Suisse Group AG / Diageo PLC / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fifth Third Bancorp / General Motors Co / HSBC Holdings PLC / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Merck & Co Inc / Newmont Corporation / Northern Trust Corp / Pfizer Inc / PNC Financial Services Group Inc / Rio Tinto PLC / Southern Co / Societe Generale SA / AT&T Inc / Telus Corp / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Franco-Nevada Corp / ASML Holding NV / Campbell Soup Co / Tenneco Inc / Comcast Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Amgen Inc / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Duke Energy Corp / Quebecor Inc / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Enbridge Inc / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / Imperial Oil Ltd / Goldman Sachs Group Inc / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Manulife Financial Corp / General Mills Inc / PG&E Corp / Agnico Eagle Mines Ltd / Exxon Mobil Corp / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / American Tower Corp / Boliden AB / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Allscripts Healthcare Solutions Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Sempra Energy / Exelon Corp / Descartes Systems Group Inc / Fiserv Inc / Synopsys Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / M&T Bank Corp / Brunswick Corp / Fortis Inc / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Emera Inc / Micron Technology Inc / Credit Agricole SA / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Regions Financial Corp / FLSmidth & Co A/S / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / Methanex Corp / Chesapeake Utilities Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Western Midstream Partners LP / Select Medical Holdings Corp / Alliance Data Systems Corp / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / ING Groep NV / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Royal Dutch Shell PLC / Builders FirstSource Inc / Discovery Inc / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / HICL Infrastructure PLC / Canadian Tire Corporation Ltd / Boralex Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Dana Inc / Brookfield Infrastructure Partners LP / Sprott Inc / Clearwater Paper Corp / Vale SA / Spectrum Brands Holdings Inc / Envestnet Inc / BHP Group PLC / Nextera Energy Inc / NEXTDC Ltd / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Gibson Energy Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Varonis Systems Inc / Agile Therapeutics Inc / Citizens Financial Group Inc / Easterly Government Properties Inc / Shopify Inc / PayPal Holdings Inc / Block Inc / Ferrari NV / UBS Group AG / Adient PLC / Forterra Inc / GDS Holdings Ltd / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Vistra Corp / WideOpenWest Inc / Altice USA Inc / Greencoat Renewables PLC / Athenex Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rocket Companies Inc / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Atotech Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: Positive news flow: PD-1 co-promotion by AZ and COVID-19 NAb US government order. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1877.HK / LLY.N / AZN.L / REGN.OQ</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 81 US Companies with Undisclosed SEC Probes - March 01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">T.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / BEN.N / TRI.N / PG.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / NKE.N / AMP.N / MTZ.N / ARW.N / ATO.N / TWTR.N / TUP.N / OMI.N / CVX.N / AMGN.OQ / CSCO.OQ / GNTX.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / CVGI.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / INO.OQ / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / FB.OQ / XPO.N / CTG.OQ / NTRA.OQ / PFX.N / 100088979 / MFIN.OQ / DXC.N / CVNA.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / US29350E1047 / LYFT.O</td><td class="leftalignment">AT&T Inc / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / Franklin Resources Inc / Thomson Reuters Corp / Procter & Gamble Co / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Atmos Energy Corp / Twitter Inc / Tupperware Brands Corp / Owens & Minor Inc / Chevron Corp / Amgen Inc / Cisco Systems Inc / Gentex Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Commercial Vehicle Group Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / Inovio Pharmaceuticals Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Meta Platforms Inc / XPO Logistics Inc / Computer Task Group Inc / Natera Inc / PhenixFIN Corp / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Carvana Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Enochian Biosciences Inc / Lyft Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / Greece / Ireland / United States / Curaçao</td><td class="leftalignment">Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Biotechnology / Broadcasting & Cable / Consumer / Education / Electronics / Engineering & Construction / Financial Services / Healthcare / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/28/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Weekend Update - REGN, BLUE, CGEM, SRPT, NKTR & More</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ / US00973Y1082 / SRPT.OQ / US75886F1075 / US6402681083 / US8036071004 / US1894641000 / US92915B1061 / AKRO.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Akero Therapeutics Inc / Sarepta Therapeutics Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Sarepta Therapeutics Inc / Clovis Oncology Inc / Voyager Therapeutics Inc / Akero Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="even"><td class="leftalignment">02/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine boosters; BEAM acquires GuideTx</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / BMRN.O / REGN.O / PRTA.O / AGIO.O / PBYI.OQ / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Puma Biotechnology Inc / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.26.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ICAD=US / LHCG=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / INCY=US / INSP=US / CMS=US / DGX=US / NVS=US / BWAY=US / SNN=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ARNA=US / ATRC=US / BDX=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / LH=US / NBIX=US / PHAR=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / SAGE=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / MD=US / NKTR=US / SLF=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / GOOG=US / DXCM=US / SNSS=US / CHNG=US / PODD=US / EHC=US / TNDM=US / ADUS=US / BLRX=US / ACHC=US / ALSN=US / ABBV=US / AGIO=US / FATE=US / AERI=US / MDWD=US / CTRE=US / AUPH=US / OTIC=US / EKTAY=US / VBLT=US / VCEL=US / NVRO=US / WBA=US / EVH=US / GKOS=US / TDOC=US / NVCR=US / VYGR=US / IONS=US / EDIT=US / NTLA=US / SRTS=US / TCMD=US / IRTC=US / IOVA=US / KALA=US / ATNX=US / RCKT=US / ALLO=US / TMDX=US / PSNL=US / KRTX=US / PNTG=US / ARQT=US / FBRX=US / FMTX=US / CZMWY=US / BIOVF=US / VPAHF=US</td><td class="leftalignment">ICAD Inc / LHC Group Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / Brainsway Ltd / Smith & Nephew PLC / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / SAGE Therapeutics Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Alphabet Inc / Dexcom Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Insulet Corp / Encompass Health Corp / Tandem Diabetes Care Inc / Addus Homecare Corp / BioLine RX Ltd / Acadia Healthcare Company Inc / Allison Transmission Holdings Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Elekta AB (publ) / Vascular Biogenics Ltd / Vericel Corp / Nevro Corp / Walgreens Boots Alliance Inc / Evolent Health Inc / Glaukos Corp / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Personalis Inc / Karuna Therapeutics Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Forma Therapeutics Holdings Inc / Carl Zeiss Meditec AG / Swedish Orphan Biovitrum AB (publ) / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / New Zealand / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">HD=US / TWTR=US / ICLR=US / T=US / BLD=US / RUN=US / CMA=US / AMT=US / CPE=US / EOG=US / PLUG=US / CRM=US / VZ=US / LOW=US / WLL=US / PB=US / SWN=US / CHRS=US / EWBC=US / TRMK=US / UMPQ=US / MGM=US / CLI=US / DISH=US / WTFC=US / CSTR=US / CW=US / FCN=US / IBP=US / TREE=US / DOC=US / OKE=US / ORCC=US / PLAN=US / PACW=US / REGN=US / REGI=US / STOR=US / WAL=US / WW=US / GOLF=US / HTH=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / EVOP=US / NTRA=US / AMSF=US / UCBI=US / PNFP=US / MGPI=US / SBCF=US / MNST=US / NOMD=US / TCBI=US / FNB=US / CZR=US / FHN=US / NUVA=US / PLAY=US / RNST=US / CCOI=US / PGTI=US / ICFI=US / AWI=US / CADE=US / KTOS=US / SEAS=US / CWH=US / ATSG=US / SWI=US / CLNY=US / PCRX=US / RLJ=US / CUBE=US / TILE=US / NCLH=US / IBTX=US / TMUS=US / NDLS=US / PTCT=US / FOXF=US / FATE=US / AERI=US / CNCE=US / SHAK=US / ETSY=US / LOB=US / NVCR=US / ACBI=US / ZS=US / EDIT=US / NTLA=US / CDEV=US / IRTC=US / CRSP=US / PK=US / CVNA=US / VRNA=US / MBIN=US / SAIL=US / ROOT=US / HWC=US / KDP=US / OZK=US / EB=US / AXNX=US / AMTB=US / UBER=US / PLMR=US / PNTG=US / ONEM=US / ABNB=US / DASH=US</td><td class="leftalignment">Home Depot Inc / Twitter Inc / ICON PLC / AT&T Inc / TopBuild Corp / Sunrun Inc / Comerica Inc / American Tower Corp / Callon Petroleum Co / EOG Resources Inc / Plug Power Inc / Salesforce.Com Inc / Verizon Communications Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Southwestern Energy Co / Coherus BioSciences Inc / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / MGM Resorts International / Veris Residential Inc / DISH Network Corp / Wintrust Financial Corp / CapStar Financial Holdings Inc / Curtiss-Wright Corp / FTI Consulting Inc / Installed Building Products Inc / Lendingtree Inc / Physicians Realty Trust / ONEOK Inc / Owl Rock Capital Corp / Anaplan Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / STORE Capital Corp / Western Alliance Bancorp / WW International Inc / Acushnet Holdings Corp / Hilltop Holdings Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / EVO Payments Inc / Natera Inc / Amerisafe Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / MGP Ingredients Inc / Seacoast Banking Corporation of Florida / Monster Beverage Corp / Nomad Foods Ltd / Texas Capital Bancshares Inc / FNB Corp / Caesars Entertainment Inc / First Horizon Corp / NuVasive Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Cogent Communications Holdings Inc / PGT Innovations Inc / ICF International Inc / Armstrong World Industries Inc / Cadence Bank / Kratos Defense and Security Solutions Inc / SeaWorld Entertainment Inc / Camping World Holdings Inc / Air Transport Services Group Inc / SolarWinds Corp / DigitalBridge Group Inc / Pacira Biosciences Inc / RLJ Lodging Trust / CubeSmart / Interface Inc / Norwegian Cruise Line Holdings Ltd / Independent Bank Group Inc / T-Mobile US Inc / Noodles & Co / PTC Therapeutics Inc / Fox Factory Holding Corp / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Shake Shack Inc / ETSY Inc / Live Oak Bancshares Inc / Novocure Ltd / Atlantic Capital Bancshares Inc / Zscaler Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Carvana Co / Verona Pharma PLC / Merchants Bancorp / SailPoint Technologies Holdings Inc / Root Inc / Hancock Whitney Corp / Keurig Dr Pepper Inc / Bank Ozk / Eventbrite Inc / Axonics Inc / Amerant Bancorp Inc / Uber Technologies Inc / Palomar Holdings Inc / Pennant Group Inc / 1Life Healthcare Inc / Airbnb Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / United Kingdom / Ireland / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AMGN: Amgen, Inc. - Q&A Our Way: Highlights from Amgen's Tezepelumab Presentation and Q&A from AAAAI 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / AZN.L / REGN.OQ</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / European Pharma Team / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: AZN/Amgen: tezepelumab NAVIGATOR P3 data at AAAAI in line with abstract</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN.OQ / AZN.L / SASY.PA / NOVN.S / GSK.L / REGN.OQ</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. Evan D. Seigerman / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Continue – At Least For Now</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Encouraging signals from ongoing Phase 3 of REGEN-COV antibody cocktail</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Short Shots - Charts highlighted: AGI, GOLD, KL, MAS, MRCY, ROP, APD, FMC, ATR, RPM, GSK, GRFS, PFE, PRGO, CHRS, CGEN, DCPH, INCY, REGN, SGEN, GMAB, SILK, STE, MKC, PEP, CHD, UL, FDS, CERN, LDOS, PDFS, SPLK, CVMK, AYX, BKI, JOBS, AKAM, CHKP, DGX, WMT, DG,</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">SBAC.OQ / APD.N / CMS.N / ED.N / FMC.N / MAS.N / PFE.N / STE.N / ULVR.L / WMT.N / DGX.N / ROP.N / HD.N / AGI.PS / FDS.N / GSK.L / RPM.N / DG.N / CHD.N / ATR.N / MKC.N / CERN.OQ / CHRS.OQ / REGN.OQ / COST.OQ / INCY.OQ / DLTR.OQ / CHKP.OQ / MRCY.OQ / AKAM.OQ / PDFS.OQ / SGEN.OQ / BSRR.OQ / JOBS.OQ / LULU.OQ / GRLS.MC / ES.N / AEE.AX / CGEN.TA / VRSK.OQ / SPLK.OQ / CONE.OQ / PRGO.N / LDOS.N / KNSL.OQ / KL.TO / AYX.N / DCPH.OQ / PEP.OQ / XEL.OQ / GOLD.TO / LNT.OQ / SILK.OQ / GMAB.CO</td><td class="leftalignment">SBA Communications Corp / Air Products and Chemicals Inc / CMS Energy Corp / Consolidated Edison Inc / FMC Corp / Masco Corp / Pfizer Inc / STERIS plc / Unilever PLC / Walmart Inc / Quest Diagnostics Inc / Roper Technologies Inc / Home Depot Inc / Alliance Global Group Inc / Factset Research Systems Inc / GlaxoSmithKline PLC / RPM International Inc / Dollar General Corp / Church & Dwight Co Inc / Aptargroup Inc / McCormick & Company Inc / Cerner Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Costco Wholesale Corp / Incyte Corp / Dollar Tree Inc / Check Point Software Technologies Ltd / Mercury Systems Inc / Akamai Technologies Inc / PDF Solutions Inc / Seagen Inc / Sierra Bancorp / 51job Inc / Lululemon Athletica Inc / Grifols SA / Eversource Energy / Aura Energy Ltd / Compugen Ltd / Verisk Analytics Inc / Splunk Inc / CyrusOne Inc / Perrigo Company PLC / Leidos Holdings Inc / Kinsale Capital Group Inc / Kirkland Lake Gold Ltd / Alteryx Inc / Deciphera Pharmaceuticals Inc / PepsiCo Inc / Xcel Energy Inc / GoldMining Inc / Alliant Energy Corp / Silk Road Medical Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / Denmark / Spain / United Kingdom / Ireland / Israel / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the SVB Leerink Global Healthcare Conference - 2.24.21</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MDT=US / A=US / ABMD=US / ALKS=US / ATRC=US / BDX=US / CSTL=US / MYGN=US / RARE=US / REGN=US / TECH=US / OPT=US / JAZZ=US / RNA=US / NUVA=US / GRAY=US / AXGN=US / PINC=US / VCYT=US / KPTI=US / XNCR=US / HRTX=US / TBPH=US / ARDX=US / HQY=US / GNFT=US / DBVT=US / VCEL=US / XENE=US / NVTA=US / ABEO=US / AXSM=US / PTGX=US / ACIU=US / ZYME=US / AVDL=US / OBSV=US / BHVN=US / MRSN=US / SCPH=US / SLDB=US / EOLS=US / REPL=US / SBTX=US / AXNX=US / OSMT=US / ORGO=US / HARP=US / TCRR=US / BNTX=US / IPHA=US / CNTG=US / ZNTL=US / KROS=US / FMTX=US / ACCD=US / ITOS=US / KDNY=US / SPRB=US / SIOX=US / GLTO=US / TVTX=US / KNTE=US / ELDN=US</td><td class="leftalignment">Medtronic PLC / Agilent Technologies Inc / ABIOMED Inc / Alkermes Plc / AtriCure Inc / Becton Dickinson and Co / Castle Biosciences Inc / Myriad Genetics Inc / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Bio-Techne Corp / Opthea Ltd / Jazz Pharmaceuticals PLC / Avidity Biosciences Inc / NuVasive Inc / Graybug Vision Inc / AxoGen Inc / Premier Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Xencor Inc / Heron Therapeutics Inc / Theravance Biopharma Inc / Ardelyx Inc / Healthequity Inc / Genfit SA / DBV Technologies SA / Vericel Corp / Xenon Pharmaceuticals Inc / Invitae Corp / Abeona Therapeutics Inc / Axsome Therapeutics Inc / Protagonist Therapeutics Inc / AC Immune SA / Zymeworks Inc / Avadel Pharmaceuticals PLC / Obseva SA / Biohaven Pharmaceutical Holding Company Ltd / Mersana Therapeutics Inc / scPharmaceuticals Inc / Solid Biosciences Inc / Evolus Inc / Replimune Group Inc / Silverback Therapeutics Inc / Axonics Inc / Osmotica Pharmaceuticals PLC / Organogenesis Holdings Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / BioNTech SE / Innate Pharma SA / Centogene NV / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Accolade Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Spruce Biosciences Inc / Sio Gene Therapies Inc / Galecto Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / Eledon Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / France / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4502.T / JNJ.N / PFE.N / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Super-Cyclicals Revisited</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">A.N / AEE.N / AES.N / BAX.N / BG.N / BMY.N / BSX.N / CCI.N / CI.N / CL.N / EL.N / FLT.N / KMB.N / KO.N / LLY.N / LSI.N / MDT.N / PM.N / PNW.N / PPCJ.J / SO.N / TAP.N / TMO.N / WMT.N / DRE.N / EQR.N / FLO.N / PG.N / WY.N / DELL.N / CPB.N / W.N / ETR.N / ADML.L / DHR.N / DIS.N / UNH.N / TFX.N / D.N / OGE.N / IPG.N / CLX.N / CAG.N / VNO.N / GLW.N / LH.N / KR.N / GIS.N / XRX.N / NI.N / PCG.N / AMT.N / RMD.N / TDS.N / DTEGN.F / MTD.N / IT.N / PKI.N / WST.N / COO.N / STZ.N / APH.N / NNN.N / PSA.N / ARW.N / EW.N / CPT.N / BXP.N / ACN.N / ARE.N / CHD.N / NUS.N / TWTR.N / ESS.N / HAE.N / FRT.N / UGI.N / OFC.N / CUZ.N / HRL.N / BDN.N / SAM.N / ABC.N / JNPR.N / IRM.N / CNP.N / INTC.OQ / CTSH.OQ / ABMD.OQ / AMGN.OQ / AMAT.OQ / ADSK.OQ / CERN.OQ / CHE.N / CRUS.OQ / FISV.OQ / JKHY.OQ / LRCX.OQ / ATVI.OQ / PAYX.OQ / TEAM.OQ / REGN.OQ / SJM.N / TECH.OQ / TYL.N / QDEL.OQ / SNPS.OQ / ICUI.OQ / IDXX.OQ / QCOM.OQ / INTU.OQ / LFUS.OQ / COST.OQ / XRAY.OQ / NKTR.OQ / DISH.OQ / NTAP.OQ / AMED.OQ / PCTY.OQ / ANSS.OQ / LAMR.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / LITE.OQ / TTWO.OQ / VRSN.OQ / MANH.OQ / ZBRA.OQ / NVDA.OQ / MKSI.OQ / UTHR.OQ / SBAC.OQ / BMRN.OQ / HAIN.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / NXST.OQ / ACAD.OQ / MPWR.OQ / ELS.N / HLF.N / OLED.OQ / SRC.N / CDNS.OQ / LYV.N / FIS.N / ADP.PA / MA.N / WU.N / DEI.N / FSLR.OQ / IPGP.OQ / QGEN.N / PODD.OQ / VMW.N / TDC.N / SATS.OQ / NWSA.OQ / CACI.N / FICO.N / FTNT.OQ / HPP.N / BAH.N / ADSGN.F / HHC.N / MSI.N / HZNP.OQ / ACHC.OQ / ENPH.OQ / EPAM.N / GWRE.N / ADI.OQ / SRPT.OQ / GMED.N / HTA.N / ABBV.N / PRGO.N / WEX.N / CDW.OQ / FOXA.O / SFM.OQ / REXR.N / LDOS.N / PINC.OQ / AGIO.OQ / RNG.N / GLPI.OQ / BRX.N / PTC.OQ / FIVN.OQ / GLOB.N / CTLT.N / CDK.OQ / KEYS.N / PGRE.N / OUT.N / STOR.N / ANTM.N / NEWR.N / QRVO.OQ / SEDG.OQ / ON.OQ / ETSY.OQ / LBRDK.OQ / TDOC.N / CABO.N / ZBH.N / KHC.OQ / GBT.OQ / PEN.N / NVCR.OQ / PSTG.N / SQ.N / IONS.OQ / RETA.OQ / EVBG.OQ / TTD.OQ / LW.N / PK.N / FWONA.OQ / ROKU.OQ / EHC.N / XEL.OQ / SYNH.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / CBRE.N / CDAY.N / AVT.OQ / EVRG.N / ELAN.N / TER.OQ / LNT.OQ / EXC.OQ / MSGS.N / AEP.OQ / 120175706</td><td class="leftalignment">Agilent Technologies Inc / Ameren Corp / AES Corp / Baxter International Inc / Bunge Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Estee Lauder Companies Inc / Fleetcor Technologies Inc / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Life Storage Inc / Medtronic PLC / Philip Morris International Inc / Pinnacle West Capital Corp / PPC Ltd / Southern Co / Molson Coors Beverage Co / Thermo Fisher Scientific Inc / Walmart Inc / Duke Realty Corp / Equity Residential / Flowers Foods Inc / Procter & Gamble Co / Weyerhaeuser Co / Dell Technologies Inc / Campbell Soup Co / Wayfair Inc / Entergy Corp / Admiral Group PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Dominion Energy Inc / OGE Energy Corp / Interpublic Group of Companies Inc / Clorox Co / Conagra Brands Inc / Vornado Realty Trust / Corning Inc / Laboratory Corporation of America Holdings / Kroger Co / General Mills Inc / Xerox Holdings Corp / NiSource Inc / PG&E Corp / American Tower Corp / Resmed Inc / Telephone and Data Systems Inc / Deutsche Telekom AG / Mettler-Toledo International Inc / Gartner Inc / PerkinElmer Inc / West Pharmaceutical Services Inc / Cooper Companies Inc / Constellation Brands Inc / Amphenol Corp / National Retail Properties Inc / Public Storage / Arrow Electronics Inc / Edwards Lifesciences Corp / Camden Property Trust / Boston Properties Inc / Accenture PLC / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / NU Skin Enterprises Inc / Twitter Inc / Essex Property Trust Inc / Haemonetics Corp / Federal Realty Investment Trust / UGI Corp / Corporate Office Properties Trust / Cousins Properties Inc / Hormel Foods Corp / Brandywine Realty Trust / Boston Beer Company Inc / Amerisourcebergen Corp / Juniper Networks Inc / Iron Mountain Inc / CenterPoint Energy Inc / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Amgen Inc / Applied Materials Inc / Autodesk Inc / Cerner Corp / Chemed Corp / Cirrus Logic Inc / Fiserv Inc / Jack Henry & Associates Inc / Lam Research Corp / Activision Blizzard Inc / Paychex Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / J M Smucker Co / Bio-Techne Corp / Tyler Technologies Inc / Quidel Corp / Synopsys Inc / ICU Medical Inc / IDEXX Laboratories Inc / Qualcomm Inc / Intuit Inc / Littelfuse Inc / Costco Wholesale Corp / DENTSPLY SIRONA Inc / Nektar Therapeutics / DISH Network Corp / NetApp Inc / Amedisys Inc / Paylocity Holding Corp / ANSYS Inc / Lamar Advertising Co / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Lumentum Holdings Inc / Take-Two Interactive Software Inc / Verisign Inc / Manhattan Associates Inc / Zebra Technologies Corp / NVIDIA Corp / MKS Instruments Inc / United Therapeutics Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / Hain Celestial Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Nexstar Media Group Inc / ACADIA Pharmaceuticals Inc / Monolithic Power Systems Inc / Equity LifeStyle Properties Inc / Herbalife Nutrition Ltd / Universal Display Corp / Spirit Realty Capital Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Mastercard Inc / Western Union Co / Douglas Emmett Inc / First Solar Inc / IPG Photonics Corp / Qiagen NV / Insulet Corp / VMware Inc / Teradata Corp / EchoStar Corp / News Corp / CACI International Inc / Fair Isaac Corp / Fortinet Inc / Hudson Pacific Properties Inc / Booz Allen Hamilton Holding Corp / Adidas AG / Howard Hughes Corp / Motorola Solutions Inc / Horizon Therapeutics PLC / Acadia Healthcare Company Inc / Enphase Energy Inc / Epam Systems Inc / Guidewire Software Inc / Analog Devices Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Healthcare Trust Of America Inc / Abbvie Inc / Perrigo Company PLC / WEX Inc / CDW Corp / Fox Corp / Sprouts Farmers Market Inc / Rexford Industrial Realty Inc / Leidos Holdings Inc / Premier Inc / Agios Pharmaceuticals Inc / RingCentral Inc / Gaming and Leisure Properties Inc / Brixmor Property Group Inc / PTC Inc / Five9 Inc / Globant SA / Catalent Inc / CDK Global Inc / Keysight Technologies Inc / Paramount Group Inc / OUTFRONT Media Inc / STORE Capital Corp / Anthem Inc / New Relic Inc / Qorvo Inc / Solaredge Technologies Inc / ON Semiconductor Corp / ETSY Inc / Liberty Broadband Corp / Teladoc Health Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Kraft Heinz Co / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Pure Storage Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Everbridge Inc / Trade Desk Inc / Lamb Weston Holdings Inc / Park Hotels & Resorts Inc / Liberty Media Corp / Roku Inc / Encompass Health Corp / Xcel Energy Inc / Syneos Health Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / CBRE Group Inc / Ceridian HCM Holding Inc / Avnet Inc / Evergy Inc / Elanco Animal Health Inc / Teradyne Inc / Alliant Energy Corp / Exelon Corp / Madison Square Garden Sports Corp / American Electric Power Company Inc / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: AZN/Amgen: Framing expectations ahead of the tezepelumab NAVIGATOR P3 data at AAAAI</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / AZN.L / SASY.PA / NOVN.S / GSK.L / REGN.OQ</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. Evan D. Seigerman / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">REGN - Key Takeaways from the SVB Leerink Global Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Feb. 24, 2021 / 10:40AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Continued stability for Large Cap, Some SMid sequentially lower</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / REGN.OQ / NVAX.OQ / HSTM.OQ / BIIB.OQ / CLDX.OQ / AXGN.OQ / PRQR.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novavax Inc / HealthStream Inc / Biogen Inc / Celldex Therapeutics Inc / AxoGen Inc / ProQR Therapeutics NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NTES.O / 127387108 / 75886F107 / 056752108 / 40637H109 / 89531P105 / 00507V109 / 81619Q105 / 192005106 / KYG875721634 / US86881A1007 / 172406209</td><td class="leftalignment">NetEase Inc / Cadence Design Systems Inc / Regeneron Pharmaceuticals Inc / Baidu Inc / Halozyme Therapeutics Inc / Trex Company Inc / Activision Blizzard Inc / Select Medical Holdings Corp / Codexis Inc / Tencent Holdings Ltd / Surgery Partners Inc / Cinedigm Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mike Hickey / Mr. Ruben Roy / Mr. Bill Sutherland / Mr. Reuben Garner / Mr. Daniel L. Kurnos, CFA / Mr. Aydin Huseynov, MD / Mr. Robert M. Wasserman / Ms. Fawne Jiang / Long Lin</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">What Market Cares About for REGN?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">February 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PANW=US / XM=US / BSX=US / LLY=US / PFE=US / ABT=US / HD=US / MDT=US / AMZN=US / QCOM=US / ORCL=US / ADBE=US / INCY=US / U=US / NVDA=US / EVER=US / CRM=US / NVS=US / EL=US / LOW=US / SAP=US / ZEN=US / RSG=US / ARNA=US / ADSK=US / BL=US / CHD=US / DOCU=US / LPSN=US / NOW=US / NDSN=US / PCTY=US / REGN=US / SHOP=US / TWOU=US / FB=US / RNG=US / SPSC=US / GOOG=US / FRPT=US / SNSS=US / PUBM=US / UTZ=US / 2454-TW=US / ALSN=US / WDAY=US / GOOGL=US / PAYC=US / COUP=US / HUBS=US / NVRO=US / BILL=US / TTD=US / YEXT=US / CNNE=US / SVMK=US / ARQT=US / FBRX=US</td><td class="leftalignment">Palo Alto Networks Inc / Qualtrics International Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Home Depot Inc / Medtronic PLC / Amazon.com Inc / Qualcomm Inc / Oracle Corp / Adobe Inc / Incyte Corp / Unity Software Inc / NVIDIA Corp / EverQuote Inc / Salesforce.Com Inc / Novartis AG / Estee Lauder Companies Inc / Lowe's Companies Inc / SAP SE / Zendesk Inc / Republic Services Inc / Arena Pharmaceuticals Inc / Autodesk Inc / Blackline Inc / Church & Dwight Co Inc / DocuSign Inc / LivePerson Inc / ServiceNow Inc / Nordson Corp / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Shopify Inc / 2U Inc / Meta Platforms Inc / RingCentral Inc / SPS Commerce Inc / Alphabet Inc / Freshpet Inc / Viracta Therapeutics Inc / PubMatic Inc / UTZ Brands Inc / MediaTek Inc / Allison Transmission Holdings Inc / Workday Inc / Alphabet Inc / Paycom Software Inc / Coupa Software Inc / HubSpot Inc / Nevro Corp / Bill.com Holdings Inc / Trade Desk Inc / Yext Inc / Cannae Holdings Inc / Momentive Global Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Ireland / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Retailing / Semiconductors</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Libtayo Joins the NSCLC Scrum With PD-L1 High Approval but Can It Compete?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2973821 / 2050832 / 2026242 / 2270726 / 2542049 / 2345022 / 2100920 / 2367480 / 2638625 / 2645409 / 2680905 / 2684703 / 2048804 / 2730190 / 7103065 / 2971029 / B125XQ6 / B2R3PV1 / B3D7K31 / B3WNNP3 / B7254K9 / B7VD3F2 / B87ZMX0 / BFLR866 / BVVN4Q8 / BYW36M8 / BYNZGK1 / BJ5FZ74 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BMDCDP2 / BMDJ085</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Macy's Inc / FirstEnergy Corp / Genuine Parts Co / National Beverage Corp / NiSource Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / LKQ Corp / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Green Dot Corp / AxoGen Inc / Duke Energy Corp / Palo Alto Networks Inc / Twitter Inc / Eversource Energy / PayPal Holdings Inc / Block Inc / Adaptive Biotechnologies Corp / Evergy Inc / Fox Corp / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Bigcommerce Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, February 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">US75886F1075 / 39304D102 / US74736L1098 / US3383071012 / 05463X106 / L8681T102 / EVER.OQ / 14843C105 / 04530L203 / 37186H100 / 08975P108 / 09075X108 / 747601201</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Green Dot Corp / Q2 Holdings Inc / Five9 Inc / AxoGen Inc / Spotify Technology SA / EverQuote Inc / Castle Biosciences Inc / Aspen Group Inc / Genetron Holdings Ltd / Bigcommerce Holdings Inc / Biodesix Inc / Qualtrics International Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Takeaways from SVB Leerink's GHC DLBCL Panel</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">INCY=US / MOR=DE / REGN=US</td><td class="leftalignment">Incyte Corp / MorphoSys AG / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Dr. Andrew S. Berens, MD / Mr. Geoffrey Porges / Mr. Jonathan W. Chang, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3621</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BAYGn.DE: Bayer - 4Q20 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BAYGN.DE / REGN.OQ / CTVA.N</td><td class="leftalignment">Bayer AG / Regeneron Pharmaceuticals Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Call Takeaways: Atopic Dermatitis (Eczema)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / PFE=US / INCY=US / NVS=US / ARNA=US / REGN=US / ALSN=US / ARQT=US / FBRX=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Incyte Corp / Novartis AG / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Allison Transmission Holdings Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Regeneron Net Profit up 66%; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AJG / AON / BAC / CMG / CNI / CP / DFS / DRI / DVN / EAT / EOG / GS / H / HLT.N / MCD / MGY / MMC / MTB / NSC / PXD / RKT / RPM / UNP / WMT / YUM / BRO / SBUX.O / ILMN.O / REGN.O / CAKE.O / PBCT.O / RRGB.O / DPZ / PLAY.O / BJRI.O / SLM.O / BLMN.O / FANG.O / PFSI.K / MAR.O / SHLX.K / OMF / CSX.O / WLTW.O / GOOS.TO / BRP.O / PGEN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Aon PLC / Bank of America Corp / Chipotle Mexican Grill Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Discover Financial Services / Darden Restaurants Inc / Devon Energy Corp / Brinker International Inc / EOG Resources Inc / Goldman Sachs Group Inc / Hyatt Hotels Corp / Hilton Worldwide Holdings Inc / McDonald's Corp / Magnolia Oil & Gas Corp / Marsh & McLennan Companies Inc / M&T Bank Corp / Norfolk Southern Corp / Pioneer Natural Resources Co / Rocket Companies Inc / RPM International Inc / Union Pacific Corp / Walmart Inc / Yum! Brands Inc / Brown & Brown Inc / Starbucks Corp / Illumina Inc / Regeneron Pharmaceuticals Inc / Cheesecake Factory Inc / People's United Financial Inc / Red Robin Gourmet Burgers Inc / Domino's Pizza Inc / Dave & Buster's Entertainment Inc / BJ's Restaurants Inc / SLM Corp / Bloomin' Brands Inc / Diamondback Energy Inc / PennyMac Financial Services Inc / Marriott International Inc / Shell Midstream Partners LP / OneMain Holdings Inc / CSX Corp / Willis Towers Watson PLC / Canada Goose Holdings Inc / BRP Group Inc / Precigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Libtayo Approved for NSCLC With ≥50% TPS; Label In-Line With Expectations</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">FDA approves Libtayo in NSCLC; focus on launch next</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Libtayo's label in 1L NSCLC looks strong and we think approval will be a near-term positive revenue driver</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights - February 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / AON / BAC / CMG / DRI / MCD / MTB / RPM / WMT / YUM / SBUX.O / ILMN.O / REGN.O / PBCT.O / MAR.O / WLTW.O / GOOS.TO / PGEN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Aon PLC / Bank of America Corp / Chipotle Mexican Grill Inc / Darden Restaurants Inc / McDonald's Corp / M&T Bank Corp / RPM International Inc / Walmart Inc / Yum! Brands Inc / Starbucks Corp / Illumina Inc / Regeneron Pharmaceuticals Inc / People's United Financial Inc / Marriott International Inc / Willis Towers Watson PLC / Canada Goose Holdings Inc / Precigen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Adam Muro / Alexandra Green / Anne Bode</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">V / 0989529 / 2000019 / 2496113 / 2293819 / 2008154 / 2973821 / 2050832 / 2026242 / 2045623 / 2219224 / 2206657 / 2216850 / 2208073 / 2280220 / 2270726 / 2542049 / 2100920 / 2455965 / 2459202 / 2613990 / 2471950 / 2680905 / 2730190 / 2829601 / 7123870 / B00FWN1 / B121557 / B1Y9TB3 / B125XQ6 / B2R3PV1 / 2679204 / 2949758 / B7TL820 / B87ZMX0 / BFZCHN7 / B95WG16 / BVVN4Q8 / BYVY8G0 / BF4VBS8 / BXDZ9Z0 / BYNZGK1 / BJLT387 / BJ2Z0H2 / BZ8VJQ8 / BP3YM85 / BL95N25 / BZ1LFG7 / BKS3RS7 / BKT6B38 / BMDCDP2 / BMDJ085</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Amazon.com Inc / Kohls Corp / eBay Inc / Adobe Inc / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / ANSYS Inc / CMS Energy Corp / Coca-Cola Co / Consolidated Edison Inc / Copart Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Biogen Inc / IDEXX Laboratories Inc / Illumina Inc / Incyte Corp / PPL Corp / Regeneron Pharmaceuticals Inc / Southern Co / Nestle SA / Alnylam Pharmaceuticals Inc / Mastercard Inc / Danone SA / Portland General Electric Co / American Water Works Company Inc / Align Technology Inc / Nexstar Media Group Inc / Meta Platforms Inc / Palo Alto Networks Inc / Wix.Com Ltd / Zoetis Inc / Eversource Energy / Alphabet Inc / BioXcel Therapeutics Inc / Shopify Inc / Block Inc / Avantor Inc / Pinterest Inc / Vistra Corp / Trupanion Inc / Phibro Animal Health Corp / Roku Inc / 10X Genomics Inc / SmileDirectClub Inc / Bigcommerce Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ALTR.O / ALV.N / AU.N / BP.L / CCI.N / CF.N / CL.N / CNA.L / CNE.L / EL.N / ENI.MI / EOG.N / F.N / FLS.N / FOUG.PA / GE.N / GM.N / KMB.N / KO.N / MRK.N / NA / NVA.TO / OXY.N / PD.TO / PFE.N / REP.MC / SGC.L / STO.AX / T.N / TLW.L / TOTF.PA / VC.N / WPL.AX / PEP.N / TRI.N / BFb.N / PG.N / PXD.N / CNQ.TO / CPB.N / TEN.N / CMCSA.O / AMGN.O / ETN.N / BWA.N / LEA.N / WCC.N / K.N / DISH.O / IMO.TO / SU.TO / BTE.TO / CLX.N / CAG.N / VLO.N / MRO.N / INTU.O / GIS.N / EMR.N / XOM.N / DVN.N / EPC.N / MGA.N / JAZZ.O / ORG.AX / CONE.O / GWW.N / VZ.N / EXEL.O / JCI.N / ARNA.O / STZ.N / APH.N / RRC.N / FISV.O / EQT.N / ADSK.O / CHTR.O / AXL.N / CHD.N / BC.N / DK.N / POU.TO / ESI.TO / SAM.N / FOG.L / BMRN.O / REGN.O / ENR.N / CVX.N / BPT.AX / SM.N / NCR.N / PSI.TO / TEL.N / COP.N / CPE.N / ENDP.O / PII.N / ST.N / SWN.N / TT.N / FCF.N / O.N / SGEN.OQ / GPN.N / MNST.O / EFX.TO / IMGN.O / CASY.O / ANSS.O / EQIX.O / ATDb.TO / FAR.AX / COE.AX / CVN.AX / TCW.TO / CFW.TO / 02209S103 / NTR.N / NVT.N / CR.TO / DLR.N / SCL.TO / NESTE.HE / 427866108 / WEF.TO / RDSb.L / KOS.N / DISCA.O / KAR.AX / FIS.N / SES.TO / ALD.AX / MWA.N / HOG.N / GALP.LS / BIR.TO / CLR.N / BGS.N / VMW.N / COI.AX / DAN.N / GTE.TO / NOG.A / PBF.N / EDPR.LS / WGO.AX / CPG.TO / AAV.TO / CEU.TO / SPB.N / ATH.TO / OAS.N / MEG.TO / VET.TO / TOU.TO / NXT.AX / ERF.TO / FRU.TO / PEY.TO / PCRX.O / MTOR.N / MPC.N / HFC.N / PXT.TO / MTDR.N / XYL.N / TVE.TO / PSX.N / PANW.N / MDLZ.OQ / FANG.O / KEL.TO / TSLA.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / CJ.TO / QTWO.N / TSLX.N / PSK.TO / LXE.V / AXTA.N / SHOP.N / GLPG.O / SQ.N / MESO.O / RACE.MI / TWLO.N / ATKR.N / PARR.N / KNSL.OQ / ATS.AX / AKERBP.OL / NTNX.O / ADNT.N / GDS.O / CDEV.O / STEP.TO / ESTE.N / ATNX.O / APTV.N / ZS.OQ / ENOG.L / DBX.O / AMRX.N / VNE.N / KDP.N / FOCS.O / VEN.AX / ESTC.N / NWL.O / PIPE.V / LSPD.TO / 269796108 / CRWD.O / GMAB.O / PING.N / CRNC.OQ / EPAC.N / 2222.SE / OVV.N / REYN.O / CARR.N / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / RXT.OQ / IBEX.O / LUMN.N / PLTR.N / MCFE.OQ / TPZ.TO / AFRM.O / 120291281 / 120681711</td><td class="leftalignment">Altair Engineering Inc / Autoliv Inc / AngloGold Ashanti Ltd / BP PLC / Crown Castle International Corp / CF Industries Holdings Inc / Colgate-Palmolive Co / Centrica PLC / Capricorn Energy PLC / Estee Lauder Companies Inc / Eni SpA / EOG Resources Inc / Ford Motor Co / Flowserve Corp / Eiffage SA / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / Nuvista Energy Ltd / Occidental Petroleum Corp / Precision Drilling Corp / Pfizer Inc / Repsol SA / Stagecoach Group PLC / Santos Ltd / AT&T Inc / Tullow Oil PLC / TotalEnergies SE / Visteon Corp / Woodside Petroleum Ltd / PepsiCo Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Campbell Soup Co / Tenneco Inc / Comcast Corp / Amgen Inc / Eaton Corporation PLC / Borgwarner Inc / Lear Corp / Wesco International Inc / Kellogg Co / DISH Network Corp / Imperial Oil Ltd / Suncor Energy Inc / Baytex Energy Corp / Clorox Co / Conagra Brands Inc / Valero Energy Corp / Marathon Oil Corp / Intuit Inc / General Mills Inc / Emerson Electric Co / Exxon Mobil Corp / Devon Energy Corp / Edgewell Personal Care Co / Magna International Inc / Jazz Pharmaceuticals PLC / Origin Energy Ltd / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Exelixis Inc / Johnson Controls International PLC / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Range Resources Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Brunswick Corp / Delek US Holdings Inc / Paramount Resources Ltd / Ensign Energy Services Inc / Boston Beer Company Inc / Falcon Oil & Gas Ltd / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Beach Energy Ltd / SM Energy Co / NCR Corp / Pason Systems Inc / TE Connectivity Ltd / Conocophillips / Callon Petroleum Co / Endo International PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / First Commonwealth Financial Corp / Realty Income Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / ImmunoGen Inc / Caseys General Stores Inc / ANSYS Inc / Equinix Inc / Alimentation Couche-Tard Inc / FAR Ltd / Cooper Energy Ltd / Carnarvon Energy Ltd / Trican Well Service Ltd / Calfrac Well Services Ltd / Altria Group Inc / Nutrien Ltd / nVent Electric PLC / Crew Energy Inc / Digital Realty Trust Inc / Shawcor Ltd / Neste Oyj / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Kosmos Energy Ltd / Discovery Inc / Karoon Energy Ltd / Fidelity National Information Services Inc / Secure Energy Services Inc / Ampol Ltd / Mueller Water Products Inc / Harley-Davidson Inc / Galp Energia SGPS SA / Birchcliff Energy Ltd / Continental Resources Inc / B&G Foods Inc / VMware Inc / Comet Ridge Ltd / Dana Inc / Gran Tierra Energy Inc / Northern Oil and Gas Inc / PBF Energy Inc / EDP Renovaveis SA / Warrego Energy Ltd / Crescent Point Energy Corp / Advantage Energy Ltd / CES Energy Solutions Corp / Spectrum Brands Holdings Inc / Athabasca Oil Corp / Oasis Petroleum Inc / MEG Energy Corp / Vermilion Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Enerplus Corp / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Pacira Biosciences Inc / Meritor Inc / Marathon Petroleum Corp / HollyFrontier Corp / Parex Resources Inc / Matador Resources Co / Xylem Inc / Tamarack Valley Energy Ltd / Phillips 66 / Palo Alto Networks Inc / Mondelez International Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Tesla Inc / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Cardinal Energy Ltd (Alberta) / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / Prairiesky Royalty Ltd / Leucrotta Exploration Inc / Axalta Coating Systems Ltd / Shopify Inc / Galapagos NV / Block Inc / Mesoblast Ltd / Ferrari NV / Twilio Inc / Atkore Inc / Par Pacific Holdings Inc / Kinsale Capital Group Inc / Australis Oil & Gas Ltd / Aker BP ASA / Nutanix Inc / Adient PLC / GDS Holdings Ltd / Centennial Resource Development Inc / Step Energy Services Ltd / Earthstone Energy Inc / Athenex Inc / Aptiv PLC / Zscaler Inc / Energean PLC / Dropbox Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Focus Financial Partners Inc / Vintage Energy Ltd / Elastic NV / Newell Brands Inc / Pipestone Energy Corp / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Enerpac Tool Group Corp / Saudi Arabian Oil Co / Ovintiv Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Palantir Technologies Inc / Mcafee Corp / Topaz Energy Corp / Affirm Holdings Inc / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Netherlands / Norway / Papua New Guinea / Portugal / Saudi Arabia / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Three for Three: Increasing our TP on three successful FDA approvals in Feb 2021, helping to diversify beyond Eylea and Dupixent</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">REGN.OQ / MRK.N / SASY.PA</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Merck & Co Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 12, 2021: Focus on Jan 2021 Rx volumes for branded and generic drugs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CTP2021-ALSEN, MGTX, SIGHT; LentiGlobin BLUEs</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MGTX.OQ / SIGHT.PA / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">MeiraGTx Holdings PLC / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 2.21.21</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">ADAP=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / TMO=US / MDT=US / A=US / INCY=US / INSP=US / TEVA=US / GILD=US / MOR=DE / SAN=FR / GSK=GB / SYK=US / BAX=US / AZN=US / WAT=US / JNJ=US / MDRX=US / IMGN=US / NUAN=US / ABMD=US / ALKS=US / ALC=US / AMRN=US / ARNA=US / ATRC=US / BDX=US / BMRN=US / BLUE=US / CSTL=US / CALA=US / CERN=US / CNMD=US / EW=US / ENDP=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / INGN=US / ISRG=US / MYGN=US / NBIX=US / PRGO=US / PRTK=US / RARE=US / HOOK=US / REGN=US / RGEN=US / SENS=US / SIEN=US / SILK=US / TECH=US / TFX=US / VRTX=US / ALGN=US / SGEN=US / SAGE=US / OPT=US / PRVB=US / CGEN=US / ALVR=US / JAZZ=US / PHR=US / STSA=US / RNA=US / IMTX=US / MREO=US / NTRA=US / CPSI=US / NKTR=US / MRNS=US / AMTI=US / BIIB=US / ACRS=US / ARWR=US / APTX=US / NUVA=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / COGT=US / DXCM=US / CYRX=US / CBAY=US / GRAY=US / EQ=US / QTRX=US / AVRO=US / TPTX=US / AMRX=US / FOLD=US / PODD=US / TNDM=US / IFRX=US / ITRM=US / NXGN=US / FULC=US / LUN=US / ASND=US / AVEO=US / NEO=US / RCUS=US / MOLN / CTSO=US / ZGNX=US / PCRX=US / RGNX=US / CLVS=US / PBYI=US / AXGN=US / VCRA=US / CCXI=US / FGEN=US / SRPT=US / GMED=US / ABBV=US / EPZM=US / MRTX=US / AGIO=US / PINC=US / FATE=US / MGNX=US / VEEV=US / VCYT=US / KPTI=US / OM=US / ITCI=US / XNCR=US / HRTX=US / QURE=US / GNCA=US / TBPH=US / ARDX=US / RDUS=US / MASS=US / XENT=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / AFMD=US / GNFT=US / DBVT=US / VCEL=US / XENE=US / NVRO=US / NVTA=US / RLMD=US / VKTX=US / BPMC=US / HTGM=US / ZBH=US / ABEO=US / TDOC=US / KURA=US / WVE=US / AXSM=US / IONS=US / BGNE=US / NTLA=US / ADVM=US / RETA=US / MDGL=US / PTGX=US / ACIU=US / TRHC=US / MYOV=US / ZYME=US / AVDL=US / OBSV=US / RCM=US / BHVN=US / MRSN=US / KALV=US / ATNX=US / SYBX=US / ZLAB=US / DCPH=US / SCPH=US / SLDB=US / GH=US / RCKT=US / EOLS=US / XERS=US / REPL=US / RUBY=US / CRNX=US / ALLK=US / SBTX=US / TWST=US / AXNX=US / MLND=US / OSMT=US / ORGO=US / HARP=US / GOSS=US / TCRR=US / IMUX=US / AXLA=US / BBIO=US / HCAT=US / BNTX=US / GMAB=US / IPHA=US / ETNB=US / PGNY=US / CNTG=US / IMVT=US / ONEM=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ACCD=US / ITOS=US / KDNY=US / GDRX=US / SPRB=US / SIOX=US / VTRS=US / ABCM=US / GLTO=US / TVTX=US / ABCL=US / KNTE=US / ELDN=US / PRTC=US / CGEM=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Incyte Corp / Inspire Medical Systems Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / MorphoSys AG / Sanofi SA / GlaxoSmithKline PLC / Stryker Corp / Baxter International Inc / AstraZeneca PLC / Waters Corp / Johnson & Johnson / Allscripts Healthcare Solutions Inc / ImmunoGen Inc / Nuance Communications Inc / ABIOMED Inc / Alkermes Plc / Alcon AG / Amarin Corporation PLC / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / Biomarin Pharmaceutical Inc / bluebird bio Inc / Castle Biosciences Inc / Calithera Biosciences Inc / Cerner Corp / Conmed Corp / Edwards Lifesciences Corp / Endo International PLC / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Inogen Inc / Intuitive Surgical Inc / Myriad Genetics Inc / Neurocrine Biosciences Inc / Perrigo Company PLC / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Senseonics Holdings Inc / Sientra Inc / Silk Road Medical Inc / Bio-Techne Corp / Teleflex Inc / Vertex Pharmaceuticals Inc / Align Technology Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Allovir Inc / Jazz Pharmaceuticals PLC / Phreesia Inc / Satsuma Pharmaceuticals Inc / Avidity Biosciences Inc / Immatics NV / Mereo Biopharma Group PLC / Natera Inc / Computer Programs and Systems Inc / Nektar Therapeutics / Marinus Pharmaceuticals Inc / Applied Molecular Transport Inc. / Biogen Inc / Aclaris Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Aptinyx Inc / NuVasive Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cogent Biosciences Inc / Dexcom Inc / Cryoport Inc / Cymabay Therapeutics Inc / Graybug Vision Inc / Equillium Inc / Quanterix Corp / AVROBIO Inc / Turning Point Therapeutics Inc / Amneal Pharmaceuticals Inc / Amicus Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Iterum Therapeutics PLC / NextGen Healthcare Inc / Fulcrum Therapeutics Inc / H Lundbeck A/S / Ascendis Pharma A/S / Aveo Pharmaceuticals Inc / Neogenomics Inc / Arcus Biosciences Inc / Molecular Partners AG / Cytosorbents Corp / Zogenix Inc / Pacira Biosciences Inc / Regenxbio Inc / Clovis Oncology Inc / Puma Biotechnology Inc / AxoGen Inc / Vocera Communications Inc / ChemoCentryx Inc / FibroGen Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Abbvie Inc / Epizyme Inc / Mirati Therapeutics Inc / Agios Pharmaceuticals Inc / Premier Inc / Fate Therapeutics Inc / MacroGenics Inc / Veeva Systems Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Intra-Cellular Therapies Inc / Xencor Inc / Heron Therapeutics Inc / Uniqure NV / Genocea Biosciences Inc / Theravance Biopharma Inc / Ardelyx Inc / Radius Health Inc / 908 Devices Inc. / Intersect Ent Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Affimed NV / Genfit SA / DBV Technologies SA / Vericel Corp / Xenon Pharmaceuticals Inc / Nevro Corp / Invitae Corp / Relmada Therapeutics Inc / Viking Therapeutics Inc / Blueprint Medicines Corp / HTG Molecular Diagnostics Inc / Zimmer Biomet Holdings Inc / Abeona Therapeutics Inc / Teladoc Health Inc / Kura Oncology Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Reata Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Protagonist Therapeutics Inc / AC Immune SA / Tabula Rasa HealthCare Inc / Myovant Sciences Ltd / Zymeworks Inc / Avadel Pharmaceuticals PLC / Obseva SA / R1 RCM Inc / Biohaven Pharmaceutical Holding Company Ltd / Mersana Therapeutics Inc / Kalvista Pharmaceuticals Inc / Athenex Inc / Synlogic Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / scPharmaceuticals Inc / Solid Biosciences Inc / Guardant Health Inc / Rocket Pharmaceuticals Inc / Evolus Inc / Xeris Biopharma Holdings Inc / Replimune Group Inc / Rubius Therapeutics Inc / Crinetics Pharmaceuticals Inc / Allakos Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Axonics Inc / Tempest Therapeutics Inc / Osmotica Pharmaceuticals PLC / Organogenesis Holdings Inc / Harpoon Therapeutics Inc / Gossamer Bio Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / BridgeBio Pharma Inc / Health Catalyst Inc / BioNTech SE / Genmab A/S / Innate Pharma SA / 89Bio Inc / Progyny Inc / Centogene NV / Immunovant Inc / 1Life Healthcare Inc / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Accolade Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Sio Gene Therapies Inc / Viatris Inc / Abcam PLC / Galecto Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc / Eledon Pharmaceuticals Inc / PureTech Health PLC / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / MESO.O / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Mesoblast Ltd / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Regeneron Net Profit up 66%; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.19.21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Post-4Q20 Model Sweep: ALXN, BIIB, REGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2455965 / 2730190</td><td class="leftalignment">Biogen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">UTHR=US / XAIR=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / TEVA=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BWAY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / BLUE=US / CHE=US / CYH=US / EW=US / EXAS=US / EXEL=US / GEN=US / ICPT=US / PHG=US / LH=US / REGN=US / USPH=US / UHS=US / VRTX=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / MASI=US / EHC=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / SRPT=US / AGIO=US / CTRE=US / OTIC=US / VBLT=US / WBA=US / NVTA=US / CLLS=US / VKTX=US / EVH=US / CFMS=US / CERC=US / EDIT=US / MDGL=US / IRTC=US / CRSP=US / VERU=US / MBIO=US / MDNA=US / SESN=US / ARVN=US / FREQ=US / BXRX=US / PNTG=US / TARA=US / AYLA=US / FMTX=US / MNKKQ=US / CHGCY=US</td><td class="leftalignment">United Therapeutics Corp / Beyond Air Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Teva Pharmaceutical Industries Ltd / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Brainsway Ltd / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Masimo Corp / Encompass Health Corp / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Walgreens Boots Alliance Inc / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Evolent Health Inc / Conformis Inc / Avalo Therapeutics Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Sesen Bio Inc / Arvinas Inc / Frequency Therapeutics Inc / Baudax Bio Inc / Pennant Group Inc / Protara Therapeutics Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Mallinckrodt PLC / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">In The Relentless Pursuit Of Innovation</td><td class="leftalignment">English</td><td class="rightalignment">99</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NBIX.OQ / VRTX.OQ / PFE.N / AZN.L / ROG.S / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues - Website Introduction Slides</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back in Black; Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Roth Capital Partners, Inc.</td><td class="leftalignment">KOD: Data Update Keeps Us Bullish, but Moving to Neutral on Valuation - $155 PT.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">KOD.OQ / REGN / CLSD.OQ</td><td class="leftalignment">Kodiak Sciences Inc / Regeneron Pharmaceuticals Inc / Clearside Biomedical Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zegbeh Jallah, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALSEN=FR / MGTX=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / REPL=US / KOD=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Sensorion SA / MeiraGTx Holdings PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / Replimune Group Inc / Kodiak Sciences Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AIMC=US / MCO=US / AAPL=US / BSX=US / CSII=US / LLY=US / PFE=US / SBUX=US / ABT=US / CAT=US / COST=US / INTC=US / AMD=US / WM=US / BWA=US / MSFT=US / MDT=US / JNPR=US / AMZN=US / QCOM=US / WMT=US / TXN=US / TEVA=US / RUN=US / NVDA=US / MPWR=US / FCEL=US / PLUG=US / CRM=US / SCI=US / EL=US / SMTC=US / BJ=US / DAL=US / TSM=US / HELE=US / CTAS=US / JCI=US / JNJ=US / TTWO=US / LSTR=US / DE=US / HUM=US / LECO=US / UNH=US / INTU=US / RSG=US / ALB=US / AMSC=US / ARRY=US / AVNT=US / AVGO=US / CMI=US / CHE=US / CREE=US / DHI=US / DG=US / EW=US / EGAN=US / EXEL=US / ITRI=US / PHG=US / MS=US / TEAM=US / PZZA=US / REGN=US / ROK=US / SNAP=US / TRMB=US / TYL=US / UTHR=US / VG=US / WIX=US / RDWR=US / NET=US / ACA=US / FB=US / NEP=US / JBLU=US / NFLX=US / VRNT=US / BE=US / CLH=US / WCN=US / NDAQ=US / RNG=US / MRNA=US / MNKD=US / ENS=US / GOOG=US / TWIN=US / ORA=US / OLED=US / FRPT=US / LHCG=US / AMRS=US / SPWR=US / AXON=US / XPO=US / ELF=US / TEL=US / CSIQ=US / FSLR=US / LULU=US / MASI=US / ULTA=US / TNDM=US / DAN=US / SPGI=US / WPRT=US / KKR=US / AGCO=US / ADUS=US / TCEHY=US / TSLA=US / AMRC=US / ENPH=US / WDAY=US / HASI=US / CNHI=US / COUP=US / OTIC=US / VBLT=US / QRVO=US / NVTA=US / ETSY=US / SEDG=US / AQMS=US / WKHS=US / TTD=US / EVBG=US / IRTC=US / CRSP=US / OKTA=US / IOVA=US / ROKU=US / MDB=US / APTV=US / VOW3-DE=US / FOCS=US / CWEN=US / FTDR=US / ESTC=US / UBER=US / CRWD=US / DKNG=US / VLDR=US</td><td class="leftalignment">Altra Industrial Motion Corp / Moody's Corp / Apple Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Starbucks Corp / Abbott Laboratories / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Advanced Micro Devices Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Medtronic PLC / Juniper Networks Inc / Amazon.com Inc / Qualcomm Inc / Walmart Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Sunrun Inc / NVIDIA Corp / Monolithic Power Systems Inc / Fuelcell Energy Inc / Plug Power Inc / Salesforce.Com Inc / Service Corporation International / Estee Lauder Companies Inc / Semtech Corp / BJ's Wholesale Club Holdings Inc / Delta Air Lines Inc / Taiwan Semiconductor Manufacturing Co Ltd / Helen of Troy Ltd / Cintas Corp / Johnson Controls International PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Landstar System Inc / Deere & Co / Humana Inc / Lincoln Electric Holdings Inc / UnitedHealth Group Inc / Intuit Inc / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / Avient Corp / Broadcom Inc / Cummins Inc / Chemed Corp / Wolfspeed Inc / D R Horton Inc / Dollar General Corp / Edwards Lifesciences Corp / eGain Corp / Exelixis Inc / Itron Inc / Koninklijke Philips NV / Morgan Stanley / Atlassian Corporation PLC / Papa John's International Inc / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / Snap Inc / Trimble Inc / Tyler Technologies Inc / United Therapeutics Corp / Vonage Holdings Corp / Wix.Com Ltd / Radware Ltd / Cloudflare Inc / Arcosa Inc / Meta Platforms Inc / Nextera Energy Partners LP / JetBlue Airways Corp / Netflix Inc / Verint Systems Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / RingCentral Inc / Moderna Inc / MannKind Corp / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Universal Display Corp / Freshpet Inc / LHC Group Inc / Amyris Inc / SunPower Corp / Axon Enterprise Inc / XPO Logistics Inc / elf Beauty Inc / TE Connectivity Ltd / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Masimo Corp / Ulta Beauty Inc / Tandem Diabetes Care Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / KKR & Co Inc / AGCO Corp / Addus Homecare Corp / Tencent Holdings Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / Workday Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Coupa Software Inc / Otonomy Inc / Vascular Biogenics Ltd / Qorvo Inc / Invitae Corp / ETSY Inc / Solaredge Technologies Inc / Aqua Metals Inc / Workhorse Group Inc / Trade Desk Inc / Everbridge Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Okta Inc / Iovance Biotherapeutics Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Volkswagen AG / Focus Financial Partners Inc / Clearway Energy Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / CrowdStrike Holdings Inc / DraftKings Inc / Velodyne Lidar Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Pharmaceuticals / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0382221051 / US0463531089 / US0530151036 / US0997241064 / US1101221083 / US1311931042 / US30161Q1040 / US3614481030 / US3647601083 / US37733W1053 / US4234521015 / US4663671091 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US87612E1064 / US9311421039 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US2533931026 / US25754A2015 / US0491642056 / US1696561059 / PAP310761054 / US79546E1047 / US01748X1028 / US2473617023 / US90384S3031 / US00922R1059 / US58933Y1055 / US9100471096 / US92335C1062 / US00287Y1091 / US5017971046 / IE00B4Q5ZN47 / US55345K1034 / US8485771021 / US21240E1055 / US1220171060 / CA05156V1022 / US02376R1023 / US70438V1061 / US70432V1026 / US0404131064 / US67576A1007 / IE00BQPVQZ61 / US0994061002 / CA0089118776 / US12685J1051 / US26856L1035 / US01345P1066 / CA1350861060 / US8760301072 / US15677J1088 / US5904791358 / CA39342L1085 / CA23126M1023 / US81181C1045 / US55406W1036</td><td class="leftalignment">Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Borgwarner Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Exelixis Inc / GATX Corp / Gap Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Jack in the Box Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / Target Corp / Walmart Inc / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / DICK'S Sporting Goods Inc / Domino's Pizza Inc / Atlas Air Worldwide Holdings Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Sally Beauty Holdings Inc / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Air Transport Services Group Inc / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / Abbvie Inc / Bath & Body Works Inc / Jazz Pharmaceuticals PLC / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Paylocity Holding Corp / Paycom Software Inc / Arista Networks Inc / Ocular Therapeutix Inc / Horizon Therapeutics PLC / Boot Barn Holdings Inc / Air Canada / Cable One Inc / elf Beauty Inc / Albireo Pharma Inc / Canada Goose Holdings Inc / Tapestry Inc / Ceridian HCM Holding Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Curaleaf Holdings Inc / Seagen Inc / MYT Netherlands Parent BV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Faricimab's Full Data Doesn't Make It a Category Killer - On Par with Eylea</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - February 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US0231351067 / US0326541051 / US1264081035 / US2546871060 / US25746U1097 / US2786421030 / US30161N1019 / US4606901001 / US4878361082 / US5719032022 / US5770811025 / US6153691059 / US6558441084 / US6819191064 / US7237871071 / US75886F1075 / US9078181081 / CA1363751027 / CA29250N1050 / CA1247651088 / CA0084741085 / CA9528451052 / CA3495531079 / CA13645T1003 / US64110L1061 / US49446R1095 / CA67072Q1046 / CA2265331074 / US6293775085 / CA98462Y1007 / US29476L1070 / US1331311027 / CA6993202069 / US8288061091 / CA0906971035 / CA4495861060 / CA21037X1006 / US02208R1068 / CA7669101031 / CA00765F1018 / CA00208D4084 / CA7170461064 / US9858171054 / US30303M1027 / CA89156V1067 / JE00B8KF9B49 / CA4882951060 / US90184L1026 / US2267181046 / US90214J1016 / US14174T1079 / CA68827L1013 / US1638511089 / CA83179X1087 / US70450Y1038 / US72703H1014 / GB00BWFY5505 / US02079K3059 / CA6882811046 / US43300A2033 / US92840M1027 / US00183L1026 / LU1701428291 / US15677J1088 / CA4039254079 / US50015M1099 / US53815P1084 / CA7241121077 / US35137L1052 / US26614N1028 / US04546L1061 / US92556H2067 / MHY0436Q1098 / US57667L1070 / US44891N1090 / US35953D1046</td><td class="leftalignment">Amazon.com Inc / Analog Devices Inc / CSX Corp / Walt Disney Co / Dominion Energy Inc / eBay Inc / Exelon Corp / Interpublic Group of Companies Inc / Kellogg Co / Marriott International Inc / Mattel Inc / Moody's Corp / Norfolk Southern Corp / Omnicom Group Inc / Pioneer Natural Resources Co / Regeneron Pharmaceuticals Inc / Union Pacific Corp / Canadian National Railway Co / Enbridge Inc / CAE Inc / Agnico Eagle Mines Ltd / West Fraser Timber Co Ltd / Fortis Inc / Canadian Pacific Railway Ltd / Netflix Inc / Kimco Realty Corp / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Yamana Gold Inc / Equity Residential / Camden Property Trust / Paramount Resources Ltd / Simon Property Group Inc / Birchcliff Energy Ltd / IGM Financial Inc / Constellation Software Inc / Altra Industrial Motion Corp / RioCan Real Estate Investment Trust / Advantage Energy Ltd / ARC Resources Ltd / Peyto Exploration & Development Corp / Yelp Inc / Meta Platforms Inc / Tourmaline Oil Corp / WPP PLC / Kelt Exploration Ltd / Twitter Inc / Criteo SA / 2U Inc / CareTrust REIT Inc / Osisko Gold Royalties Ltd / Chemours Co / SmartCentres Real Estate Investment Trust / PayPal Holdings Inc / Planet Fitness Inc / Nielsen Holdings PLC / Alphabet Inc / Osisko Mining Inc / Hilton Worldwide Holdings Inc / Vistra Corp / Angi Inc / Nexa Resources SA / Ceridian HCM Holding Inc / H&R Real Estate Investment Trust / Kodiak Sciences Inc / Liveramp Holdings Inc / Pipestone Energy Corp / Fox Corp / Dupont De Nemours Inc / AssetMark Financial Holdings Inc / ViacomCBS Inc / Atlas Corp / Match Group Inc / IAC/Interactivecorp / Fubotv Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights - Feb 15 2021 9:33PM</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / NCOX.PA / REGN.OQ / 3040.T / AERI.OQ / ALDX.OQ / EYPT.OQ / UBX.OQ / HGEN.OQ / GRAY.OQ</td><td class="leftalignment">Johnson & Johnson / Nicox SA / Regeneron Pharmaceuticals Inc / Soliton Systems KK / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Humanigen Inc / Graybug Vision Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Reports 4Q; Litigation Uncertainty Remains Key Overhang</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">TEVA=US / LLY=US / PFE=US / REGN=US</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">2126335 / 2516152 / 2023607 / 2778844 / 2026242 / 2111955 / 2280220 / 2270726 / 2542049 / 2576941 / 2100920 / 2455965 / 2457864 / 2459020 / 2048804 / 2730190 / 2402121 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / B76LYJ2 / BFH3N85 / BYY8XK8 / BP4GNK9 / BYW36M8 / BFZNYB7 / BD9GVY0 / BDHF4K6 / BZBY005 / BKS3SM8 / BQT3XY6 / BZ1HM42 / BR4T3B3 / BMQ5T49 / BWFKZT2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJXBP30 / BYQHPK7 / BJ9NFQ3 / BK71LY6 / BM8MM05 / BP8XZL1</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Borgwarner Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / FirstEnergy Corp / Biogen Inc / ImmunoGen Inc / Intuit Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Nuance Communications Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Veeva Systems Inc / WEC Energy Group Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Adyen NV / HubSpot Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Neoleukin Therapeutics Inc / WW International Inc / Madison Square Garden Entertainment Corp / Healthequity Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AC.TO / ALV.N / ANTO.L / BAER.S / BARC.L / BBDb.TO / BCE.TO / BHP.AX / BNPP.PA / CC.N / CI.N / CL.N / CP.TO / CSGN.S / EDP.LS / EL.N / ELE.MC / F.N / GM.N / HSBA.L / IBE.MC / IP.N / KBH.N / KMB.N / KO.N / LLOY.L / MRK.N / PFE.N / PHM.N / RIO.AX / RIO.L / RWEG.DE / SAN.MC / SOGN.PA / T.N / T.TO / TOL.N / VC.N / SSE.L / PEP.N / BFb.N / PG.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CAE.TO / SJRb.TO / RCIb.TO / AMGN.O / THC.N / FER.MC / AAL.L / CNR.TO / QBRb.TO / UNH.N / BWA.N / LEA.N / CCA.TO / REE.MC / ENB.TO / K.N / DISH.O / LEN.N / TV.TO / DBKGn.DE / CLX.N / CAG.N / GIS.N / EPC.N / MGA.N / SBAC.O / BBVA.MC / JAZZ.O / ADI.O / NG.L / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / DVA.N / FISV.O / SNPS.O / CHTR.O / AXL.N / PLD.N / CHD.N / ATA.TO / BC.N / ARCC.O / SAM.N / FRAG.DE / REGN.O / ENR.N / VRTX.O / SWIR.O / FTT.TO / CAGR.PA / MHK.N / NCR.N / NET.N / TEL.N / APF.L / PII.N / ST.N / TYL.N / HCC.N / SGEN.OQ / GPN.N / MNST.O / NWG.L / CCLb.TO / IMGN.O / CASY.O / STN.TO / ATDb.TO / IGO.AX / TIH.TO / SNC.TO / FM.TO / INGA.AS / 02209S103 / 878742204 / DLR.N / HUN.N / 427866108 / 35671D857 / FIS.N / TEVA.N / CS.TO / HOG.N / 443628102 / 550372106 / ATL.MI / BGS.N / CBRO.L / DAN.N / EDPR.LS / OZL.AX / ABI.BR / SFR.AX / VALE.N / SPB.N / BHPB.L / CAML.L / MTOR.N / GLEN.L / TRL.TO / QLYS.O / FFHu.TO / MDLZ.OQ / 505440107 / TPH.N / TSLA.N / PRMW.N / TMUS.N / TMHC.N / DOO.TO / COTY.N / PRTA.O / 46579R104 / VRNS.O / CIA.TO / PAYC.N / RYAM.N / HUBS.N / ANTM.N / CIGI.O / PYPL.OQ / WRK.N / RPD.O / ABNd.AS / MESO.O / RACE.MI / UBSG.S / MTRO.L / MP1.AX / ADNT.N / GRPG.I / ATNX.O / ORSTED.CO / APTV.N / NEXA.TO / VNE.N / NTGY.MC / KDP.N / XERS.O / NWL.O / GMAB.O / DDOG.O / CRNC.OQ / VMUK.L / PEAK.N / PAGPA.L / REYN.O / SBSW.N / TFII.N / SLQT.N / NKLA.OQ / FOUR.N / LUMN.N / 900435207 / AFRM.O / 120681711</td><td class="leftalignment">Air Canada / Autoliv Inc / Antofagasta PLC / Julius Baer Gruppe AG / Barclays PLC / Bombardier Inc / BCE Inc / BHP Group Ltd / BNP Paribas SA / Chemours Co / Cigna Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Credit Suisse Group AG / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / General Motors Co / HSBC Holdings PLC / Iberdrola SA / International Paper Co / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Lloyds Banking Group PLC / Merck & Co Inc / Pfizer Inc / Pultegroup Inc / Rio Tinto Ltd / Rio Tinto PLC / Rwe AG / Banco Santander SA / Societe Generale SA / AT&T Inc / Telus Corp / Toll Brothers Inc / Visteon Corp / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / CAE Inc / Shaw Communications Inc / Rogers Communications Inc / Amgen Inc / Tenet Healthcare Corp / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Quebecor Inc / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / Cogeco Communications Inc / Red Electrica Corporacion SA / Enbridge Inc / Kellogg Co / DISH Network Corp / Lennar Corp / Trevali Mining Corp / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / Banco Bilbao Vizcaya Argentaria SA / Jazz Pharmaceuticals PLC / Analog Devices Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / DaVita Inc / Fiserv Inc / Synopsys Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Prologis Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Brunswick Corp / Ares Capital Corp / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / Finning International Inc / Credit Agricole SA / Mohawk Industries Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Anglo Pacific Group PLC / Polaris Inc / Sensata Technologies Holding PLC / Tyler Technologies Inc / Warrior Met Coal Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Natwest Group PLC / CCL Industries Inc / ImmunoGen Inc / Caseys General Stores Inc / Stantec Inc / Alimentation Couche-Tard Inc / IGO Ltd / Toromont Industries Ltd / SNC-Lavalin Group Inc / First Quantum Minerals Ltd / ING Groep NV / Altria Group Inc / Teck Resources Ltd / Digital Realty Trust Inc / Huntsman Corp / Hershey Co / Freeport-McMoRan Inc / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Harley-Davidson Inc / Hudbay Minerals Inc / Lundin Mining Corp / Atlantia SpA / B&G Foods Inc / Close Brothers Group PLC / Dana Inc / EDP Renovaveis SA / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Trilogy International Partners Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Labrador Iron Ore Royalty Corp / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / BRP Inc / Coty Inc / Prothena Corporation PLC / Ivanhoe Mines Ltd / Varonis Systems Inc / Champion Iron Ltd / Paycom Software Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Anthem Inc / Colliers International Group Inc / PayPal Holdings Inc / Westrock Co / Rapid7 Inc / ABN Amro Bank NV / Mesoblast Ltd / Ferrari NV / UBS Group AG / Metro Bank PLC / Megaport Ltd / Adient PLC / Greencoat Renewables PLC / Athenex Inc / Orsted A/S / Aptiv PLC / Nexa Resources SA / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Newell Brands Inc / Genmab A/S / Datadog Inc / Cerence Inc / Virgin Money UK PLC / Healthpeak Properties Inc / Paragon Banking Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / TFI International Inc / SelectQuote Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Turquoise Hill Resources Ltd / Affirm Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Brazil / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">REGN Still has Unappreciated Base Business and Potential Pipeline Growth Ahead</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - Key takeaways from Roche Angiogenesis call</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ROG.S / NOVN.S / REGN.OQ / BAYGN.DE</td><td class="leftalignment">Roche Holding AG / Novartis AG / Regeneron Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">SMBC Nikko Securities America, Inc.</td><td class="leftalignment">All-In on COVID-19 Therapeutics, With Rest of Pipeline Shaping Up Well for 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">757468103 / 75886F107</td><td class="leftalignment">Redhill Biopharma Ltd / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David T. Hoang, PHD / Tong Liu, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Full Faricimab Data: Eylea Competition Coming but Higher IOI a Potential Oppty</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Faricimab Update a Sweet Valentine Treat For Eylea – Eylea Dominance Will Continue</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Opthalmology: Updates on faricimab, Port Delivery and Beovu: Updates on faricimab, Port Delivery and Beovu</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ROG.S / NOVN.S / 4768.T / REGN.OQ / BAYGN.DE / ABBV.N / MOLN.S</td><td class="leftalignment">Roche Holding AG / Novartis AG / Otsuka Corp / Regeneron Pharmaceuticals Inc / Bayer AG / Abbvie Inc / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. Evan D. Seigerman / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 05, 2021: Focus on Dupixent's resilience</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Long-Term KSI-301 + Full Faricimab Ph3 Data Highly Competitive In AMD & DME</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/13/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Weekend Update: Inflation Watch, DNLI, REGN, MIRM, QURE, FIXX, BYSI, etc</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">REGN.OQ / KYG108301006 / FIXX.OQ / MIRM.OQ / UQ1.F / US09058V1035 / US75886F1075 / US4576693075 / US29251M1062 / US90400D1081 / NL0010696654 / US23257D1037 / US75901B1070 / US4380831077 / US6047491013 / US68236R1032 / US16961L1061 / US1920101060 / US89422G1076</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Beyondspring Inc / Homology Medicines Inc / Mirum Pharmaceuticals Inc / Uniqure NV / BioCryst Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Insmed Inc / Enanta Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Cymabay Therapeutics Inc / Regenxbio Inc / Homology Medicines Inc / Mirum Pharmaceuticals Inc / Oncorus Inc / Chinook Therapeutics Inc / Codiak BioSciences, Inc. / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="odd"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Ex vivo GT sees positive readouts</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O / SGEN.OQ / IMGN.O / PRTA.O / MESO.O / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Prothena Corporation PLC / Mesoblast Ltd / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Australia / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Regeneron sinks 13.1% from 2 week high</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.12.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Faricimab Emerges As A Real Competitor To Eylea – Safety Will Be Key</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">ABBV/REGN/INCY - Rheum/Derm Feedback On Xeljanz Safety Update & Readthroughs</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BNGO=US / INO=US / AAPL=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / BMY=US / MDT=US / WMT=US / INCY=US / EPIX=US / CMS=US / DGX=US / NVS=US / AZN=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXEL=US / GEN=US / LH=US / NVAX=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / VRTX=US / SGEN=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / SNY=US / MD=US / SLF=US / BIIB=US / ISR=US / MRNA=US / ALNY=US / GOOG=US / DXCM=US / LHCG=US / CHNG=US / INFI=US / ORTX=US / EHC=US / BAYRY=US / SPRO=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / ARCT=US / ABBV=US / PRTA=US / ENTA=US / CTRE=US / WBA=US / NVTA=US / EVH=US / ZBH=US / IONS=US / EDIT=US / AVDL=US / MTEM=US / VERU=US / GMDA=US / NBSE=US / FREQ=US / RCEL=US / PNTG=US / TSHA=US / SIOX=US</td><td class="leftalignment">Bionano Genomics Inc / Inovio Pharmaceuticals Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / Novavax Inc / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / Sanofi SA / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / IsoRay Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Dexcom Inc / LHC Group Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Orchard Therapeutics PLC / Encompass Health Corp / Bayer AG / Spero Therapeutics Inc / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Arcturus Therapeutics Holdings Inc / Abbvie Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Zimmer Biomet Holdings Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Avadel Pharmaceuticals PLC / Molecular Templates Inc / Veru Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Frequency Therapeutics Inc / AVITA Medical Inc / Pennant Group Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, REGN</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">INO=US / TWOU=US / AAPL=US / MRK=US / WSM=US / NKE=US / PFE=US / BMY=US / HD=US / INTC=US / ADI=US / AMD=US / BWA=US / MSFT=US / AMZN=US / QCOM=US / BBY=US / TXN=US / EPIX=US / MPWR=US / NVS=US / SMTC=US / LOW=US / TSM=US / AZN=US / CRY=US / XLNX=US / EXPE=US / JNJ=US / UNH=US / ARCC=US / AVGO=US / BL=US / CRUS=US / IFX=US / FROG=US / MCHP=US / NVAX=US / REGN=US / TSCO=US / UTHR=US / VCTR=US / WTS=US / SGEN=US / RHHBY=US / PYPL=US / SWKS=US / ARES=US / DKS=US / BIIB=US / MRNA=US / ALNY=US / ENS=US / GOOG=US / BJRI=US / PBH=US / DXCM=US / XPO=US / LULU=US / GNRC=US / MXL=US / NXPI=US / ARCT=US / PRTA=US / VRNS=US / GDDY=US / UAA=US / CARG=US / DDOG=US / RCEL=US / SIOX=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / 2U Inc / Apple Inc / Merck & Co Inc / Williams-Sonoma Inc / Nike Inc / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Borgwarner Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Best Buy Co Inc / Texas Instruments Inc / ESSA Pharma Inc / Monolithic Power Systems Inc / Novartis AG / Semtech Corp / Lowe's Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / CryoLife Inc / Xilinx Inc / Expedia Group Inc / Johnson & Johnson / UnitedHealth Group Inc / Ares Capital Corp / Broadcom Inc / Blackline Inc / Cirrus Logic Inc / Infineon Technologies AG / Jfrog Ltd / Microchip Technology Inc / Novavax Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / United Therapeutics Corp / Victory Capital Holdings Inc / Watts Water Technologies Inc / Seagen Inc / Roche Holding AG / PayPal Holdings Inc / Skyworks Solutions Inc / Ares Management Corp / DICK'S Sporting Goods Inc / Biogen Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / EnerSys / Alphabet Inc / BJ's Restaurants Inc / Prestige Consumer Healthcare Inc / Dexcom Inc / XPO Logistics Inc / Lululemon Athletica Inc / Generac Holdings Inc / Maxlinear Inc / NXP Semiconductors NV / Arcturus Therapeutics Holdings Inc / Prothena Corporation PLC / Varonis Systems Inc / GoDaddy Inc / Under Armour Inc / CarGurus Inc / Datadog Inc / AVITA Medical Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- Happy Lunar New Year!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small Biotech Outflows End the Four-Week Inflow Streak</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A DNA Medicines Disruptor Gaining Steam; Initiate at Outperform with $35 PT</td><td class="leftalignment">English</td><td class="rightalignment">93</td><td class="leftalignment">INO=US / MRK=US / PFE=US / AZN=US / JNJ=US / NVAX=US / REGN=US / UTHR=US / MRNA=US / ALNY=US / ARCT=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Novavax Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Moderna Inc / Alnylam Pharmaceuticals Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Regeneron Pharmaceuticals</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Short Shots - Charts highlighted: BTG, GOLD, HYLN, ROP, APD, FMC, AZN, BMY, MRK, PFE, BLUE, IMVT, REGN, VRTX, MDLZ, KO, PEP, CLX, PG, UL, WCN, FDS, DNB, CHKP, HUM, FMS, CHTR, LNT, AEP, PNW, XEL, UWMC, CNNE, PGR, SBAC, T, and VZ.</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">VZ.N / APD.N / BMY.N / FMC.N / KO.N / MRK.N / PFE.N / ULVR.L / PG.N / HUM.N / ROP.N / CLX.N / FDS.N / DNB.N / REGN.OQ / CHKP.OQ / CHTR.OQ / BLUE.OQ / VRTX.OQ / WCN.AX / BLHI.PK / AZN.V / MDLZ.OQ / CNNE.N / PEP.OQ / XEL.OQ / LNT.OQ / IMVT.OQ / HYLN.N / UWMC.N</td><td class="leftalignment">Verizon Communications Inc / Air Products and Chemicals Inc / Bristol-Myers Squibb Co / FMC Corp / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Unilever PLC / Procter & Gamble Co / Humana Inc / Roper Technologies Inc / Clorox Co / Factset Research Systems Inc / Dun & Bradstreet Holdings Inc / Regeneron Pharmaceuticals Inc / Check Point Software Technologies Ltd / Charter Communications Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / White Cliff Minerals Ltd / Blue Holdings Inc / AZN Capital Corp / Mondelez International Inc / Cannae Holdings Inc / PepsiCo Inc / Xcel Energy Inc / Alliant Energy Corp / Immunovant Inc / Hyliion Holdings Corp / UWM Holdings Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">KMDA=US / MESO=US / NVS=US / BLUE=US / LOGC=US / REGN=US / SGMO=US / SNY=US / NK=US / RGNX=US / IONS=US / EDIT=US / NTLA=US / CRSP=US / 199800=KR / FIXX=US / DTIL=US</td><td class="leftalignment">Kamada Ltd / Mesoblast Ltd / Novartis AG / bluebird bio Inc / LogicBio Therapeutics Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Sanofi SA / Immunitybio Inc / Regenxbio Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ToolGen Inc / Homology Medicines Inc / Precision BioSciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / France / Israel / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">CCO.TO / GM.N / KO.N / NA / PD.TO / RWEG.DE / SGEF.PA / CERN.O / THC.N / REE.MC / IMO.TO / MFC.TO / PAA.N / KGC.N / OI.N / EXEL.O / CINF.O / REGN.O / SSNC.O / SLF.TO / TYL.N / HCSG.O / ACGL.O / ADP.PA / TEVA.N / WU.N / BIP.N / EONGn.DE / VALE.N / SMSS.L / QLYS.O / FLOW.N / TMHC.N / VOYA.N / COTY.N / PAYC.N / UAA.N / ATUS.N / ORSTED.CO / NWL.O / REYN.O</td><td class="leftalignment">Cameco Corp / General Motors Co / Coca-Cola Co / National Bank of Canada / Precision Drilling Corp / Rwe AG / Vinci SA / Cerner Corp / Tenet Healthcare Corp / Red Electrica Corporacion SA / Imperial Oil Ltd / Manulife Financial Corp / Plains All American Pipeline LP / Kinross Gold Corp / O-I Glass Inc / Exelixis Inc / Cincinnati Financial Corp / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Sun Life Financial Inc / Tyler Technologies Inc / Healthcare Services Group Inc / Arch Capital Group Ltd / Aeroports de Paris SA / Teva Pharmaceutical Industries Ltd / Western Union Co / Brookfield Infrastructure Partners LP / E.ON SE / Vale SA / Smart Metering Systems PLC / Qualys Inc / SPX FLOW Inc / Taylor Morrison Home Corp / Voya Financial Inc / Coty Inc / Paycom Software Inc / Under Armour Inc / Altice USA Inc / Orsted A/S / Newell Brands Inc / Reynolds Consumer Products Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Germany / Denmark / Spain / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2021 Outlook - Updated For 10K (Yes, We Read It)</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">NTLA (Buy): PT to $85 on anticipated 2021 pipeline momentum</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">NTLA=US / NVS=US / LOGC=US / REGN=US / SGMO=US / RGNX=US / IONS=US / EDIT=US / CRSP=US / 199800=KR / FIXX=US / DTIL=US</td><td class="leftalignment">Intellia Therapeutics Inc / Novartis AG / LogicBio Therapeutics Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Regenxbio Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / CRISPR Therapeutics AG / ToolGen Inc / Homology Medicines Inc / Precision BioSciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geulah Livshits, PhD, PHD / DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - February 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">71</td><td class="leftalignment">US3666511072 / US38059T1060 / US4523081093 / US6703461052 / US75886F1075 / US81211K1007 / CA1366812024 / NO0010208051 / US15135B1017 / CA00386B1094 / BMG3922B1072 / US56117J1007 / CA1264621006 / US68268W1036 / AU000000NST8 / US78409V1044 / CA46016U1084 / US15677J1088 / CA05585D1033 / US48251W1045 / CA33767E2024 / US26614N1028 / CA29446Y5020 / FR0013467479 / CA31890B1031 / CA36352H1001 / US03940R1077 / 120291281</td><td class="leftalignment">Gartner Inc / Gold Fields Ltd / Illinois Tool Works Inc / Nucor Corp / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Canadian Tire Corporation Ltd / Yara International ASA / Centene Corp / Absolute Software Corp / Genpact Ltd / Malibu Boats Inc / CT Real Estate Investment Trust / OneMain Holdings Inc / Northern Star Resources Ltd / S&P Global Inc / International Petroleum Corp / Ceridian HCM Holding Inc / BSR Real Estate Investment Trust / KKR & Co Inc / FirstService Corp / Dupont De Nemours Inc / Equinox Gold Corp / Constellium SE / First Capital Real Estate Investment Trust / Galiano Gold Inc / Arch Resources Inc / Cenovus Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / France / Norway / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Libtayo Approved for BCC; NSCLC on Deck</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">20030N101 / 874054109 / 285512109 / 75886F107 / 09227Q100 / 421906108 / 922280102</td><td class="leftalignment">Comcast Corp / Take-Two Interactive Software Inc / Electronic Arts Inc / Regeneron Pharmaceuticals Inc / Blackbaud Inc / Healthcare Services Group Inc / Varonis Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Matthew Harrigan / Mr. Aydin Huseynov, MD / Mike Hickey / Mr. Mark W. Schappel / Mr. Bill Sutherland</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Model Update: It All Boils Down To REGEN-COV</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Some SMid incrementally higher, but stable for Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Regeneron Pharmaceuticals, Inc.(REGN) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Regeneron Pharmaceuticals Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Road to Reopening: The Evolution of COVID-19 Event Recap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">375558103 / 75886F107 / 452327109 / 74838J101 / 359664109 / 64049K104 / 60770K107 / 729139105 / 02155H200 / 01626L105</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Illumina Inc / Quidel Corp / Fulgent Genetics Inc / Neoleukin Therapeutics Inc / Moderna Inc / Pliant Therapeutics Inc / Altimmune Inc / Aligos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Yasmeen Rahimi, Ph.D. / Steven Mah, Ph.D. / Mr. Tyler M. Van Buren, M.SC / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Regeneron Pharmaceuticals Inc: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">64125C109 / 874054109 / 75886F107 / 98156Q108 / 53220K504 / 86722A103 / G9001E102 / G6095L10 / G0084W10</td><td class="leftalignment">Neurocrine Biosciences Inc / Take-Two Interactive Software Inc / Regeneron Pharmaceuticals Inc / World Wrestling Entertainment Inc / Ligand Pharmaceuticals Inc / SunCoke Energy Inc / Liberty Latin America Ltd / Aptiv PLC / Adient PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / China / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Michael P. Ward, CFA / Mike Hickey / Mr. Aydin Huseynov, MD / Mr. Matthew Harrigan / Mr. Nathan Martin / Mr. Robert M. Wasserman</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Impressed by 4Q; Optimistic About 1H21 Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: VYGR deal termination; big pharma engages GRTS</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GRTS.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">IEX=US / XYL=US / AAPL=US / BSX=US / CIEN=US / CSII=US / ABT=US / AIT=US / KLIC=US / TJX=US / WM=US / MDT=US / MEOH=US / EXTR=US / GS=US / PSMT=US / FLEX=US / NTAP=US / VC=US / SYK=US / WAT=US / EMR=US / HON=US / EXPE=US / FWRD=US / ADS=US / HCA=US / DLTR=US / NCR=US / MGM=US / AMKR=US / NWL=US / KEYS=US / RSG=US / AZZ=US / AEIS=US / ALG=US / APLS=US / ACI=US / ATRC=US / AVNT=US / CTS=US / CGC=US / CHH=US / COHU=US / CYH=US / CYBR=US / DFS=US / EBIX=US / EW=US / EGHT=US / ENDP=US / ENDO=US / ESE=US / FORD=US / GNTX=US / ITT=US / NSIT=US / ITRI=US / TREE=US / LNN=US / LFUS=US / OLN=US / REGN=US / ROG=US / SILK=US / TRV=US / TPR=US / VCTR=US / RHHBY=US / BKNG=US / RLI=US / PRA=US / SF=US / CRTO=US / VRNT=US / NPO=US / VMI=US / CLH=US / WCN=US / SNY=US / NDAQ=US / OPEN=US / INFN=US / ENS=US / ORA=US / ZUMZ=US / AMRS=US / BNGO=US / ADR=US / BCPC=US / ANET=US / IVZ=US / ACIW=US / BAYRY=US / DAN=US / BEST=US / SPRO=US / TBK=US / SWAV=US / CDXS=US / CBOE=US / WWD=US / TROX=US / RXN=US / GMED=US / AMBA=US / FEYE=US / CNHI=US / SYF=US / NVTA=US / ZBH=US / PSTG=US / 113875965 / UAA=US / AVDL=US / HLNE=US / CPRI=US / HLIO=US</td><td class="leftalignment">IDEX Corp / Xylem Inc / Apple Inc / Boston Scientific Corp / Ciena Corp / Cardiovascular Systems Inc / Abbott Laboratories / Applied Industrial Technologies Inc / Kulicke and Soffa Industries Inc / TJX Companies Inc / Waste Management Inc / Medtronic PLC / Methanex Corp / Extreme Networks Inc / Goldman Sachs Group Inc / PriceSmart Inc / Flex Ltd / NetApp Inc / Visteon Corp / Stryker Corp / Waters Corp / Emerson Electric Co / Honeywell International Inc / Expedia Group Inc / Forward Air Corp / Alliance Data Systems Corp / HCA Healthcare Inc / Dollar Tree Inc / NCR Corp / MGM Resorts International / Amkor Technology Inc / Newell Brands Inc / Keysight Technologies Inc / Republic Services Inc / AZZ Inc / Advanced Energy Industries Inc / Alamo Group Inc / Apellis Pharmaceuticals Inc / Albertsons Companies Inc / AtriCure Inc / Avient Corp / CTS Corp / Canopy Growth Corp / Choice Hotels International Inc / Cohu Inc / Community Health Systems Inc / Cyberark Software Ltd / Discover Financial Services / Ebix Inc / Edwards Lifesciences Corp / 8x8 Inc / Endo International PLC / Thermic Science International Corp / ESCO Technologies Inc / Forward Industries Inc / Gentex Corp / ITT Inc / Insight Enterprises Inc / Itron Inc / Lendingtree Inc / Lindsay Corp / Littelfuse Inc / Olin Corp / Regeneron Pharmaceuticals Inc / Rogers Corp / Silk Road Medical Inc / Travelers Companies Inc / Tapestry Inc / Victory Capital Holdings Inc / Roche Holding AG / Booking Holdings Inc / Rli Corp / ProAssurance Corp / Stifel Financial Corp / Criteo SA / Verint Systems Inc / EnPro Industries Inc / Valmont Industries Inc / Clean Harbors Inc / Waste Connections Inc / Sanofi SA / Nasdaq Inc / Opendoor Technologies Inc / Infinera Corp / EnerSys / Ormat Technologies Inc / Zumiez Inc / Amyris Inc / Bionano Genomics Inc / Adcorp Holdings Ltd / Balchem Corp / Arista Networks Inc / Invesco Ltd / ACI Worldwide Inc / Bayer AG / Dana Inc / BEST Inc / Spero Therapeutics Inc / Triumph Bancorp Inc / Shockwave Medical Inc / Codexis Inc / Cboe Global Markets Inc / Woodward Inc / Tronox Holdings PLC / Zurn Water Solutions Corp / Globus Medical Inc / Ambarella Inc / Mandiant Inc / CNH Industrial NV / Synchrony Financial / Invitae Corp / Zimmer Biomet Holdings Inc / Pure Storage Inc / CNH Industrial NV / Under Armour Inc / Avadel Pharmaceuticals PLC / Hamilton Lane Inc / Capri Holdings Ltd / Helios Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Virgin Islands, British / South Africa</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Machinery / Retailing / Semiconductors</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 Growth Still Depends on Flu; Immunology Opportunities Expanding, PT EUR106</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">SAN=FR / REGN=US / SNY=US</td><td class="leftalignment">Sanofi SA / Regeneron Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 8 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1156372096 / US1266501006 / US14149Y1082 / US1912161007 / US1925761066 / US2546871060 / US37733W1053 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US9021041085 / US9029251066 / US91347P1057 / US03073E1055 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US3463751087 / US60855R1005 / US90385V1070 / US60871R2094 / US15135B1017 / RDSa.AS / PAP310761054 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US25470F3029 / US9100471096 / US00164V1035 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US61174X1090 / US87918A1051 / KYG4740B1059 / LGFb / LGFa / US53115L1044 / US05351X1019 / US49271V1008 / US5904791358 / US28414H1032 / US1255231003 / US35137L1052 / US92556H2067 / US92537N1081 / US6833731044 / US03044L1052 / US62955J1034 / US73739W1045 / 120175706 / 120404208</td><td class="leftalignment">STMicroelectronics NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Brown-Forman Corp / CVS Health Corp / Cardinal Health Inc / Coca-Cola Co / Cohu Inc / Walt Disney Co / GlaxoSmithKline PLC / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / II-VI Inc / USA Truck Inc / Universal Display Corp / Amerisourcebergen Corp / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / FormFactor Inc / Molina Healthcare Inc / Ultra Clean Holdings Inc / Molson Coors Beverage Co / Centene Corp / Royal Dutch Shell PLC / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / Discovery Inc / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Monster Beverage Corp / Teladoc Health Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Lions Gate Entertainment Corp / Liberty Oilfield Services Inc / Avaya Holdings Corp / Keurig Dr Pepper Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Fox Corp / ViacomCBS Inc / Vertiv Holdings Co / Ontrak Inc / American Well Corp / Nov Inc / Poshmark Inc / Cisco Systems Inc / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PEP=US / CAG=US / DIS=US / KO=US / OXY=US / TWTR=US / RRC=US / CL=US / PG=US / AMZN=US / DVN=US / EBAY=US / APA=US / CPE=US / EOG=US / DGX=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / MUR=US / MRO=US / EXPE=US / LEG=US / AFL=US / HUM=US / NWL=US / UNM=US / CI=US / W=US / FLO=US / STZ=US / CBRL=US / CENT=US / CHD=US / CSTR=US / COLL=US / CNX=US / DRI=US / EPC=US / EQT=US / HAIN=US / TREE=US / MAS=US / MHK=US / REGN=US / SMG=US / SHOP=US / SNAP=US / TRIP=US / TRUE=US / WIX=US / CVX=US / POST=US / BKNG=US / FB=US / MTCH=US / ENSG=US / COP=US / MGNI=US / MGPI=US / BDSI=US / MNST=US / PTON=US / NOMD=US / TPX=US / EXP=US / CDLX=US / AINV=US / BECN=US / TXRH=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / SCPL=US / ELF=US / AWI=US / OC=US / CLR=US / NMTR=US / NOG=US / IAC=US / AAN=US / AR=US / ESTE=US / FBHS=US / ANGI=US / ZNGA=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / SSTK=US / TILE=US / GOOGL=US / FIVN=US / HTRG=US / VNOM=US / LOCO=US / BABA=US / CMPR=US / GDDY=US / ETSY=US / ZBH=US / ZG=US / WVE=US / TTD=US / CDEV=US / TRVG=US / LGF.B=US / PVAC=US / YEXT=US / SBOW=US / RDFN=US / PETQ=US / CARG=US / MBIN=US / SFIX=US / ROOT=US / KDP=US / FTDR=US / SVMK=US / EB=US / KOD=US / LYFT=US / UBER=US / RTLR=US / BRBR=US / OVV=US / REYN=US / ZI=US / BIGC=US / ABNB=US / DASH=US / HYFM=US / AFRM=US / 100087548</td><td class="leftalignment">PepsiCo Inc / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Colgate-Palmolive Co / Procter & Gamble Co / Amazon.com Inc / Devon Energy Corp / eBay Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / Aflac Inc / Humana Inc / Newell Brands Inc / Unum Group / Cigna Corp / Wayfair Inc / Flowers Foods Inc / Constellation Brands Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / Lendingtree Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Shopify Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Wix.Com Ltd / Chevron Corp / Post Holdings Inc / Booking Holdings Inc / Meta Platforms Inc / Match Group Inc / Ensign Group Inc / Conocophillips / Magnite Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Peloton Interactive Inc / Nomad Foods Ltd / Tempur Sealy International Inc / Eagle Materials Inc / Cardlytics Inc / Apollo Investment Corp / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Sciplay Corp / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Aaron's Company Inc / Antero Resources Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Zynga Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Shutterstock Inc / Interface Inc / Alphabet Inc / Five9 Inc / Heritage Insurance Holdings Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / ETSY Inc / Zimmer Biomet Holdings Inc / Zillow Group Inc / WAVE Life Sciences Ltd / Trade Desk Inc / Centennial Resource Development Inc / Trivago NV / Lions Gate Entertainment Corp / Ranger Oil Corp / Yext Inc / SilverBow Resources Inc / Redfin Corp / PetIQ Inc / CarGurus Inc / Merchants Bancorp / Stitch Fix Inc / Root Inc / Keurig Dr Pepper Inc / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Kodiak Sciences Inc / Lyft Inc / Uber Technologies Inc / Rattler Midstream LP / Bellring Brands Inc / Ovintiv Inc / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Airbnb Inc / DoorDash Inc / Hydrofarm Holdings Group Inc / Affirm Holdings Inc / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Ireland / Israel / Luxembourg / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - February 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">CA4509131088 / US0010841023 / US0351282068 / US0383361039 / US3703341046 / US38059T1060 / US4227041062 / US4278661081 / US4404521001 / US4878361082 / US5770811025 / US6516391066 / US6951561090 / US75886F1075 / US7802871084 / US81211K1007 / US8740541094 / US9024941034 / US92276F1003 / AU000000NCM7 / CA6979001089 / CA0084741085 / CA0679011084 / CA09950M3003 / CA98462Y1007 / CA4969024047 / US9290421091 / CA6445351068 / CA95083R1001 / CA32076V1031 / GB00B1FW5029 / US4219461047 / US5021751020 / US63633D1046 / CA29258Y1034 / CA3499151080 / US05508R1068 / CA82835P1036 / CA3518581051 / GB00B2QPKJ12 / US1921085049 / US7374461041 / AU000000EVN4 / US6092071058 / JE00B5TT1872 / CA0805581091 / CA96145A2002 / IE00B4Q5ZN47 / CA6752221037 / CA80013R2063 / CA11777Q2099 / CA38045Y1025 / US78573L1061 / CA74139C1023 / US08579W1036 / US71943U1043 / US56117J1007 / CA45868C1095 / US14174T1079 / CA5503711080 / US42225P5017 / US96145D1054 / US5007541064 / CA0115321089 / US95040Q1040 / AU000000NST8 / CA4991131083 / CA8910546032 / BMG162341090 / CA49741E1007 / CA86816U1066 / CA9628791027 / CA7847301032 / US3843135084 / IE00BZ12WP82 / CA38119T8077 / CA13000C2058 / CA2849025093 / US73757R1023 / CA57776F4050 / CA5625684025 / CA29446Y5020 / US70614W1009 / US0798231009 / US42250P1030 / CA92625W5072 / US82575P1075 / CA65532M2004 / US44862P1093 / CA2674881040 / CA67079A1021 / US3680361090</td><td class="leftalignment">IAMGOLD Corp / AGCO Corp / AngloGold Ashanti Ltd / Aptargroup Inc / General Mills Inc / Gold Fields Ltd / Hecla Mining Co / Hershey Co / Hormel Foods Corp / Kellogg Co / Mattel Inc / Newmont Corporation / Packaging Corp of America / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Sealed Air Corp / Take-Two Interactive Software Inc / Tyson Foods Inc / Ventas Inc / Newcrest Mining Ltd / Pan American Silver Corp / Agnico Eagle Mines Ltd / Barrick Gold Corp / Boralex Inc / Yamana Gold Inc / Kinross Gold Corp / Vornado Realty Trust / New Gold Inc / Wesdome Gold Mines Ltd / First Majestic Silver Corp / Hochschild Mining PLC / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Endeavour Silver Corp / Fortuna Silver Mines Inc / B&G Foods Inc / Silvercorp Metals Inc / Franco-Nevada Corp / Fresnillo PLC / Coeur Mining Inc / Post Holdings Inc / Evolution Mining Ltd / Mondelez International Inc / Centamin PLC / Belo Sun Mining Corp / Westshore Terminals Investment Corp / Jazz Pharmaceuticals PLC / OceanaGold Corp / Sandstorm Gold Ltd / B2Gold Corp / GoGold Resources Inc / Sabra Health Care REIT Inc / Pretium Resources Inc / Berry Global Group Inc / Physicians Realty Trust / Malibu Boats Inc / Interfor Corp / CareTrust REIT Inc / Lundin Gold Inc / Healthcare Trust Of America Inc / Westrock Co / Kraft Heinz Co / Alamos Gold Inc / Welltower Inc / Northern Star Resources Ltd / K92 Mining Inc / Torex Gold Resources Inc / Brookfield Business Partners LP / Kirkland Lake Gold Ltd / Superior Gold Inc / Wheaton Precious Metals Corp / SSR Mining Inc / GrafTech International Ltd / Linde PLC / Golden Star Resources Ltd / Calibre Mining Corp / Eldorado Gold Corp / Postal Realty Trust Inc / Maverix Metals Inc / Mandalay Resources Corp / Equinox Gold Corp / Peloton Interactive Inc / Bellring Brands Inc / Healthpeak Properties Inc / Victoria Gold Corp / Sibanye Stillwater Ltd / Nomad Royalty Company Ltd / Hycroft Mining Holding Corporation / Dye & Durham Ltd / Nuvei Corp / Gatos Silver Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID Cash Flattens Growth Outlook-Can Bispecifics, IL33 & Allergy Restore It?</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 2000019 / 2094670 / 2113393 / 2219224 / 2175672 / 2542049 / 2630513 / 2730190 / 2503529 / 2783815 / B121557 / 2857817 / B2R3PV1 / B5B2106 / B7VD3F2 / BBGVT40 / BFLR866 / BYY8XK8 / BYVY8G0 / BF09HX3 / BZ19F50 / BD8DJ71 / BKDS4H5 / BJ2Z0H2 / BFMXGR0 / BYXJQG9 / BGT3960 / BMH0MR7 / BDVLM39 / BF3N4P3 / BJRFSB7 / 021513106 / BNRQM83</td><td class="leftalignment">Sanofi SA / Amazon.com Inc / Best Buy Co Inc / Boston Beer Company Inc / CMS Energy Corp / Cardinal Health Inc / Dominion Energy Inc / New Jersey Resources Corp / Regeneron Pharmaceuticals Inc / World Wrestling Entertainment Inc / Zimmer Biomet Holdings Inc / Mastercard Inc / Netflix Inc / American Water Works Company Inc / Fortinet Inc / Duke Energy Corp / News Corp / Twitter Inc / WEC Energy Group Inc / Alphabet Inc / Tapestry Inc / Veoneer Inc / Snap Inc / Bill.com Holdings Inc / Pinterest Inc / Evergy Inc / Spire Inc / Orchard Therapeutics PLC / Zendesk Inc / argenx SE / Arena Pharmaceuticals Inc / Immunovant Inc / Alto Ingredients Inc / Petco Health and Wellness Company Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Profile of COVID DARPins Rises as Variants Muzzle Some Competing mAbs</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MOLN=DE / A=US / REGN=US</td><td class="leftalignment">Molecular Partners AG / Agilent Technologies Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALXN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIOb / JNJ / GILD.O / REGN.O / VRTX.O / RARE.O / BIIB.O / SRPT.O / AGIO.O / QGEN.K</td><td class="leftalignment">Bio Rad Laboratories Inc / Johnson & Johnson / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Qiagen NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, February 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US75886F1075 / US98956P1021 / TDG.N / 918284100 / ACAD.N / US8982021060 / US98954M1018 / PLTH.CD / 55087P104 / 90353T100 / 62011B102</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Zimmer Biomet Holdings Inc / TransDigm Group Inc / VSE Corp / ACADIA Pharmaceuticals Inc / Trupanion Inc / Zillow Group Inc / Planet 13 Holdings Inc / Lyft Inc / Uber Technologies Inc / Motorsport Games Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">AEP.N / AES.N / AFL.N / ALV.N / CB.N / CI.N / CL.N / CMS.N / CP.TO / EIX.N / EL.N / EMN.N / EOG.N / F.N / GM.N / IBE.MC / IP.N / JNJ.N / KMB.N / KO.N / MRK.N / NSC.N / PEG.N / PFE.N / RWEG.DE / SO.N / T.N / VC.N / PEP.N / BFb.N / PG.N / PXD.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CAE.TO / CHKP.O / AMGN.O / AAPL.O / MET.N / FLEX.O / CNR.TO / DUK.N / DIS.N / BWA.N / LEA.N / K.N / DT.N / DISH.O / CSX.N / UNP.N / CLX.N / CAG.N / UNM.N / GIS.N / EPC.N / MGA.N / SBAC.O / JAZZ.O / NG.L / VZ.N / HCA.N / EXEL.O / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / CHTR.O / AXL.N / AWK.N / CHD.N / ATA.TO / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / PRU.N / NCR.N / TEL.N / CNP.N / CPK.N / MKL.N / PII.N / RLI.N / ST.N / SR.N / TT.N / SGEN.OQ / GPN.N / MNST.O / CCLb.TO / CASY.O / ORLY.O / ACGL.O / PCTY.O / ATDb.TO / 02209S103 / AINV.O / DLR.N / VIAC.O / 416515104 / 427866108 / DISCA.O / SJW.N / FIS.N / TEVA.N / HOG.N / AON.N / BGS.N / TDC.N / ENSG.O / DAN.N / VALE.N / FTNT.O / SPB.N / CHNG.O / CJT.TO / PCRX.O / MTOR.N / IFP.TO / AMCX.O / MDLZ.OQ / FANG.O / ABBV.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / FOXA.OQ / PRTA.O / RYAM.N / SHOP.N / PYPL.OQ / WRK.N / MIME.OQ / RACE.MI / MP1.AX / BBU.N / ADNT.N / LGFB.N / TFII.TO / WOW.N / ATUS.N / ORSTED.CO / APTV.N / EAF.N / VNE.N / NTGY.MC / KDP.N / NWL.O / GMAB.O / DDOG.O / CRNC.OQ / NLOK.O / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / LUMN.N / AFRM.O / TEEC.L / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / Autoliv Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / Canadian Pacific Railway Ltd / Edison International / Estee Lauder Companies Inc / Eastman Chemical Co / EOG Resources Inc / Ford Motor Co / General Motors Co / Iberdrola SA / International Paper Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Rwe AG / Southern Co / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / CAE Inc / Check Point Software Technologies Ltd / Amgen Inc / Apple Inc / MetLife Inc / Flex Ltd / Canadian National Railway Co / Duke Energy Corp / Walt Disney Co / Borgwarner Inc / Lear Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Unum Group / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / Jazz Pharmaceuticals PLC / National Grid PLC / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Chesapeake Utilities Corp / Markel Corp / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Spire Inc / Trane Technologies PLC / Seagen Inc / Global Payments Inc / Monster Beverage Corp / CCL Industries Inc / Caseys General Stores Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Paylocity Holding Corp / Alimentation Couche-Tard Inc / Altria Group Inc / Apollo Investment Corp / Digital Realty Trust Inc / ViacomCBS Inc / Hartford Financial Services Group Inc / Hershey Co / Discovery Inc / SJW Group / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Teradata Corp / Ensign Group Inc / Dana Inc / Vale SA / Fortinet Inc / Spectrum Brands Holdings Inc / Change Healthcare Inc / Cargojet Inc / Pacira Biosciences Inc / Meritor Inc / Interfor Corp / AMC Networks Inc / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Fox Corp / Prothena Corporation PLC / Rayonier Advanced Materials Inc / Shopify Inc / PayPal Holdings Inc / Westrock Co / Mimecast Ltd / Ferrari NV / Megaport Ltd / Brookfield Business Partners LP / Adient PLC / Lions Gate Entertainment Corp / TFI International Inc / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Aptiv PLC / GrafTech International Ltd / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Newell Brands Inc / Genmab A/S / Datadog Inc / Cerence Inc / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ABT / AIG / AJG / ALC / ALL / AMT / AON / BAX / BDX / BEP / BIP / BLL / BSX / CB / CCI / CCO / CLX / COO / CPB / DANO.PA / DIS / DLR / DY / EL / ETM / GIS / HIG / HSY / IPG / JNJ / K / LIN / LNC / MDT / MET / MMC / OMC / PEN / PGR / PRU / RE / RNR / SJM / SON / SPB / SYK / T / TFX / THS / TRV / USM / BYND.O / EW / WWE / IRM / BRO / SBGI.O / GTN / SBAC.O / SIRI.O / CONE.O / IART.O / VZ / AXS / ISRG.O / GEF / REGN.O / PROG.O / MMSI.O / ACGL.O / HAIN.O / EQIX.O / WOOF.O / NFLX.O / NXST.O / NUVA.O / VIAC.O / DXCM.O / DISCA.O / CCOI.O / PODD.O / TNDM.OQ / NOG.A / LUNG.O / AMCX.O / GMED.K / MDLZ.O / BERY.K / SMPL.O / UIHC.O / MEIP.O / POST.K / VOYA.K / FOXA.O / HMTV.O / NVRO.K / GKOS.K / ZBH / TGNA.K / KHC.O / SPNE.O / NVCR.O / TMUS.O / OMF / WLTW.O / LGFb.N / UNIT.O / BHF.O / BOMN.O / ROKU.O / SWCH.K / EQH / INSP.K / SPOT.K / SSP.O / NOMD.K / AXNX.O / SWAV.O / IHRT.O / BRP.O / BRBR.K / BIPC.K / NARI.O / BEPC.K / LUMN.K / EAR.O / ROOT.O</td><td class="leftalignment">Abbott Laboratories / American International Group Inc / Arthur J Gallagher & Co / Alcon AG / Allstate Corp / American Tower Corp / Aon PLC / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Brookfield Infrastructure Partners LP / Ball Corp / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Clear Channel Outdoor Holdings Inc / Clorox Co / Cooper Companies Inc / Campbell Soup Co / Danone SA / Walt Disney Co / Digital Realty Trust Inc / Dycom Industries Inc / Estee Lauder Companies Inc / Audacy Inc / General Mills Inc / Hartford Financial Services Group Inc / Hershey Co / Interpublic Group of Companies Inc / Johnson & Johnson / Kellogg Co / Linde PLC / Lincoln National Corp / Medtronic PLC / MetLife Inc / Marsh & McLennan Companies Inc / Omnicom Group Inc / Penumbra Inc / Progressive Corp / Prudential Financial Inc / Everest Re Group Ltd / Renaissancere Holdings Ltd / J M Smucker Co / Sonoco Products Co / Spectrum Brands Holdings Inc / Stryker Corp / AT&T Inc / Teleflex Inc / TreeHouse Foods Inc / Travelers Companies Inc / United States Cellular Corp / Beyond Meat Inc / Edwards Lifesciences Corp / World Wrestling Entertainment Inc / Iron Mountain Inc / Brown & Brown Inc / Sinclair Broadcast Group Inc / Gray Television Inc / SBA Communications Corp / Sirius XM Holdings Inc / CyrusOne Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / AXIS Capital Holdings Ltd / Intuitive Surgical Inc / Greif Inc / Regeneron Pharmaceuticals Inc / Progenity Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / Hain Celestial Group Inc / Equinix Inc / Petco Health and Wellness Company Inc / Netflix Inc / Nexstar Media Group Inc / NuVasive Inc / ViacomCBS Inc / Dexcom Inc / Discovery Inc / Cogent Communications Holdings Inc / Insulet Corp / Tandem Diabetes Care Inc / Northern Oil and Gas Inc / Pulmonx Corp / AMC Networks Inc / Globus Medical Inc / Mondelez International Inc / Berry Global Group Inc / Simply Good Foods Co / United Insurance Holdings Corp / MEI Pharma Inc / Post Holdings Inc / Voya Financial Inc / Fox Corp / Hemisphere Media Group Inc / Nevro Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Tegna Inc / Kraft Heinz Co / SeaSpine Holdings Corp / Novocure Ltd / T-Mobile US Inc / OneMain Holdings Inc / Willis Towers Watson PLC / Lions Gate Entertainment Corp / Uniti Group Inc / Brighthouse Financial Inc / Boston Omaha Corp / Roku Inc / Switch Inc / Equitable Holdings Inc / Inspire Medical Systems Inc / Spotify Technology SA / E W Scripps Co / Nomad Foods Ltd / Axonics Inc / Shockwave Medical Inc / iHeartMedia Inc / BRP Group Inc / Bellring Brands Inc / Brookfield Infrastructure Corp / Inari Medical Inc / Brookfield Renewable Corp / Lumen Technologies Inc / Eargo Inc / Root Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Luxembourg / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">A.N / AIG.N / CNC.N / CVS.N / ECL.N / EL.N / GM.N / KO.N / DUK.N / DIS.N / D.N / FE.N / ITW.N / LIN.N / TWTR.N / MCO.N / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / TTWO.OQ / ILMN.OQ / EQIX.OQ / GPN.N / DLR.N / FIS.N / TDG.N / CME.OQ / ZTS.N / SPG.NZ / IQV.N / PEP.OQ / NWL.OQ</td><td class="leftalignment">Agilent Technologies Inc / American International Group Inc / Centene Corp / CVS Health Corp / Ecolab Inc / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Illinois Tool Works Inc / Linde PLC / Twitter Inc / Moody's Corp / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Take-Two Interactive Software Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Digital Realty Trust Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Zoetis Inc / Stride Property Ltd / IQVIA Holdings Inc / PepsiCo Inc / Newell Brands Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Eyes on Libtayo priority review dates; REGN CoV against COVID-19 progressing</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John L. Newman, Ph.D., CFA, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">REGN: 4Q20 Earnings and Outlook Highlights Multiple Growth Drivers</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="even"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Robust pipeline remains undervalued; PT goes to $756 from $770, maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN=US / KOD=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Kodiak Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">02/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Trimming NT Royalty Revs to Reflect Bamlanivimab Outlook; LT Trajectory Strong</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ABCL=US / REGN=US</td><td class="leftalignment">Abcellera Biologics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Puneet Souda</td></tr>
<tr class="even"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 Solid-Eylea Competition + Dupi/REGN-COV2 Key Focus In ‘21-New PT $565(-$119)</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Q4:20 post-call: We focus on Libtayo launch as interest shifts to 2021 pipeline</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">02/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / ARNA.O / BMRN.O / REGN.O / SGEN.OQ / PRTA.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / Prothena Corporation PLC / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">REGN - REGN 4Q20 Postview:  Quiet quarter, focus turns to growth opportunities beyond Eylea</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : 4Q Snapshot - Solid EPS Beat on Low Expenses; REGEN-COV Key Factor in 2021 Growth Outlook</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q20 Review: Another Stellar Commercial/Pipeline Quarter</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN=US / RHHBY=US / SNY=US / BAYRY=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Roche Holding AG / Sanofi SA / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">4Q20: A Good Quarter Overall</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.5.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">4Q Highlights: Strong Fundamentals + Recent Pullback = Compelling Entry Point</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Solid Q420, We See Meaningful Upside to Consensus '21 EPS</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Regeneron Pharmaceuticals : First Look at 4Q Results - EPS Beat Driven by OpEx</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Products (Dupi, Eylea) Fully Recovered Plus Strong Bottom-Line Beat</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Good 4Q; Eylea Sales In Line With Pre-Announcement; Dupixent Continues To Outperform; Pipeline Progressing Well</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">REGN.OQ - Event Transcript of Regeneron Pharmaceuticals Inc conference call, Feb. 05, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">4Q20 First Look</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q420 First Look: In-Line Top-Line; Bottom-Line Beat</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">4Q20 Quick Take: 4Q20 driven by Eylea beat and FY2020 driven by higher Dupi sales</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Our thoughts post the 4Q20 call: Strong base business bolstered by REGN-COV (near-term) and oncology (long-term)</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">REGN.OQ / BMY.N / SASY.PA / TEVA.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Bristol-Myers Squibb Co / Sanofi SA / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">REGN: Regeneron Pharmaceuticals, Inc. - 4Q20 First Take: Strong set up for 2021: Eylea & Dupixent anchor upside potential from the Covid-19 Ab program and oncology updates</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / PM.N / DUK.N / DIS.N / D.N / FE.N / ITW.N / LIN.N / TWTR.N / MCO.N / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / TTWO.OQ / ILMN.OQ / EQIX.OQ / GPN.N / DLR.N / FIS.N / TDG.N / CME.OQ / TMUS.OQ / SPG.NZ / IQV.N / PEP.OQ / NWL.OQ</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / Philip Morris International Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Illinois Tool Works Inc / Linde PLC / Twitter Inc / Moody's Corp / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Take-Two Interactive Software Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Digital Realty Trust Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / T-Mobile US Inc / Stride Property Ltd / IQVIA Holdings Inc / PepsiCo Inc / Newell Brands Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for REGN</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Mo Money, Mo Problems? 4th Consecutive Week of Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / MET.N / DUK.N / DIS.N / FE.N / ITW.N / HSY.N / LIN.N / TWTR.N / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / TTWO.OQ / ILMN.OQ / EQIX.OQ / GPN.N / DLR.N / FIS.N / TDG.N / CME.OQ / ABBV.N / PYPL.OQ / SPG.NZ / IQV.N / PEP.OQ / CTVA.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / FirstEnergy Corp / Illinois Tool Works Inc / Hershey Co / Linde PLC / Twitter Inc / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Take-Two Interactive Software Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Digital Realty Trust Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Abbvie Inc / PayPal Holdings Inc / Stride Property Ltd / IQVIA Holdings Inc / PepsiCo Inc / Corteva Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">The Life Sciences Division Ltd</td><td class="leftalignment">Executive Summary of 141 page Covid-19 Multilateralism Agility and Innovation TLSD Industry Update Equities Research 1 February 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">22UAy.DE / GSK.L / 4507.T / JNJ / LLY / PFE / AZN.L / BAVA.CO / REGN.O / 4563.T / IMM.L / CADI.NS / NVAX.O / SYNG.L / MRNA.O / 1099.HK / SVA.O / 4142.TW / ARCT.O / VBIV.O / ALT.O / VXRT.O / POLX.L / BNTX.O / VIR.O / 688185.SS</td><td class="leftalignment">BioNTech SE / GlaxoSmithKline PLC / Shionogi & Co Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Bavarian Nordic A/S / Regeneron Pharmaceuticals Inc / AnGes Inc / ImmuPharma PLC / Cadila Healthcare Ltd / Novavax Inc / Synairgen PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd / Adimmune Corp / Arcturus Therapeutics Holdings Inc / VBI Vaccines Inc / Altimmune Inc / Vaxart Inc / Polarean Imaging PLC / BioNTech SE / Vir Biotechnology Inc / CanSino Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Canada / China / Germany / Denmark / United Kingdom / India / Japan / Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / CORPORATE SUMMARY / STRATEGY / STRATEGIC ANALYSIS / EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Navid Malik, Ph.D. / Ms. Alia Minhas, MBA</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / PFE.N / PM.N / HUM.N / FE.N / ITW.N / XOM.N / LIN.N / TWTR.N / AMGN.OQ / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / EQIX.OQ / GPN.N / FIS.N / TDG.N / CME.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / IQV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Humana Inc / FirstEnergy Corp / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Twitter Inc / Amgen Inc / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Equinix Inc / Global Payments Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2021 Prep Pack - Attractive Value Entry, But Technicals Less Bullish</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / EBAY=US / TXN=US / TEVA=US / GILD=US / PEB=US / CONE=US / LOW=US / FMS=US / HSII=US / DIOD=US / CHRS=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / MAC=US / KFY=US / AMN=US / CBRL=US / CSTR=US / DRI=US / DRH=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MHK=US / ASGN=US / REGN=US / REGI=US / RHI=US / ROLL=US / SKY=US / THO=US / CCRN=US / MTCH=US / VNO=US / FFIN=US / GBCI=US / DIN=US / PTON=US / RPD=US / TPX=US / EXP=US / BECN=US / SHO=US / DLR=US / PLAY=US / BAH=US / WMG=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / EHC=US / NMTR=US / IAC=US / JACK=US / RCUS=US / TREX=US / NXPI=US / WWD=US / RLJ=US / FBHS=US / ANGI=US / EA=US / RHP=US / TILE=US / IBTX=US / NDLS=US / PINC=US / CNCE=US / MTNB=US / LOCO=US / ANTM=US / WBA=US / SHAK=US / ON=US / WING=US / ARGX=US / 82982L103 / PK=US / GDS=US / JELD=US / SWCH=US / FERGY=US / ARQT=US / AZEK=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / eBay Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Pebblebrook Hotel Trust / CyrusOne Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Heidrick & Struggles International Inc / Diodes Inc / Coherus BioSciences Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Macerich Co / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / RBC Bearings Inc / Skyline Champion Corp / Thor Industries Inc / Cross Country Healthcare Inc / Match Group Inc / Vornado Realty Trust / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Peloton Interactive Inc / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Warner Music Group Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / 9 Meters Biopharma Inc / IAC/Interactivecorp / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Premier Inc / Concert Pharmaceuticals Inc / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Switch Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / Germany / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Libtayo WAC price increases +1.5% since launch in 2018</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 4Q20 and CMD Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">SASY.PA / PFE.N / REGN.OQ</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BDX.N / BMY.N / BSX.N / CI.N / EL.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / HD.N / ITW.N / XOM.N / LIN.N / ARE.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / QCOM.OQ / GILD.OQ / AMZN.OQ / TTWO.OQ / GPN.N / VRTX.OQ / ICE.N / TDG.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Home Depot Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Intercontinental Exchange Inc / TransDigm Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: January 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / ALB.N / AXP.N / BA.N / BAC.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CRM.N / CVS.N / DAL.N / DD.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / GM.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MDT.N / MO.N / MRK.N / OXY.N / SLB.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / CMA.N / PG.N / W.N / RIG.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / MGM.N / RCL.N / SYY.N / HON.N / VLO.N / HD.N / LOW.N / MRO.N / SYK.N / JWN.N / XOM.N / NKE.N / LIN.N / TGT.N / VZ.N / SNV.N / KSS.N / ORCL.N / VFC.N / HP.N / MAC.N / KMI.N / KMX.N / PWR.N / EQT.N / V.N / OKE.N / HWM.N / ACN.N / WSM.N / AIV.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / COHR.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / PII.N / REGN.OQ / ROL.N / SIVB.OQ / THO.N / QDEL.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / CREE.OQ / GILD.OQ / COST.OQ / CPRT.OQ / TRU.N / ACGL.OQ / SSNC.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / MRCY.OQ / EBAY.OQ / NVDA.OQ / MFA.N / CHTR.OQ / NUAN.OQ / ISRG.OQ / ILMN.OQ / ALGN.OQ / GPN.N / PTEN.OQ / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / SBNY.OQ / OSH.N / MOS.N / LVS.N / VIAC.OQ / DISCA.OQ / KOS.N / CDNS.OQ / MS.N / FIS.N / MA.N / SIX.N / SPR.N / CNK.N / IVZ.N / M.N / BGCP.OQ / PBF.N / MRNA.OQ / MSCI.N / CHNG.OQ / AVGO.OQ / FICO.N / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / NEE.N / TSLA.OQ / ADSGN.F / HHC.N / TWO.N / SABR.OQ / MPC.N / HFC.N / HZNP.OQ / AMD.OQ / ENPH.OQ / PSX.N / NOW.N / SRPT.OQ / BERY.N / FANG.OQ / ABBV.N / BFAM.N / COTY.N / FEYE.OQ / MAR.OQ / AAL.OQ / NCLH.N / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / WBA.OQ / SEDG.OQ / ETSY.OQ / TDOC.N / PYPL.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / RETA.OQ / TWLO.N / SPG.NZ / TTD.OQ / CDEV.OQ / UAA.N / FTI.PA / CVNA.N / AXON.OQ / ROKU.OQ / PEP.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / FB.PS / CDAY.N / UAL.OQ / STNE.OQ / ETRN.N / NWL.OQ / CPRI.N / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / CRWD.OQ / PTON.OQ / SVC.OQ / SPCE.N / RTX.N / CARR.N / LMND.N / CHK.N^F20 / AMWL.N / LUMN.N / CHX.OQ</td><td class="leftalignment">Abbott Laboratories / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / General Motors Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Merck & Co Inc / Occidental Petroleum Corp / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Comerica Inc / Procter & Gamble Co / Wayfair Inc / Transocean Ltd / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Royal Caribbean Cruises Ltd / Sysco Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Stryker Corp / Nordstrom Inc / Exxon Mobil Corp / Nike Inc / Linde PLC / Target Corp / Verizon Communications Inc / Synovus Financial Corp / Kohls Corp / Oracle Corp / VF Corp / Helmerich and Payne Inc / Macerich Co / Kinder Morgan Inc / Carmax Inc / Quanta Services Inc / EQT Corp / Visa Inc / ONEOK Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Coherent Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Thor Industries Inc / Quidel Corp / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Wolfspeed Inc / Gilead Sciences Inc / Costco Wholesale Corp / Copart Inc / TransUnion / Arch Capital Group Ltd / SS&C Technologies Holdings Inc / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Mercury Systems Inc / eBay Inc / NVIDIA Corp / MFA Financial Inc / Charter Communications Inc / Nuance Communications Inc / Intuitive Surgical Inc / Illumina Inc / Align Technology Inc / Global Payments Inc / Patterson-UTI Energy Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Signature Bank / Oak Street Health Inc / Mosaic Co / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Kosmos Energy Ltd / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Six Flags Entertainment Corp / Spirit AeroSystems Holdings Inc / Cinemark Holdings Inc / Invesco Ltd / Macy's Inc / BGC Partners Inc / PBF Energy Inc / Moderna Inc / MSCI Inc / Change Healthcare Inc / Broadcom Inc / Fair Isaac Corp / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Nextera Energy Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / Two Harbors Investment Corp / Sabre Corp / Marathon Petroleum Corp / HollyFrontier Corp / Horizon Therapeutics PLC / Advanced Micro Devices Inc / Enphase Energy Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Diamondback Energy Inc / Abbvie Inc / Bright Horizons Family Solutions Inc / Coty Inc / Mandiant Inc / Marriott International Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Solaredge Technologies Inc / ETSY Inc / Teladoc Health Inc / PayPal Holdings Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Reata Pharmaceuticals Inc / Twilio Inc / Stride Property Ltd / Trade Desk Inc / Centennial Resource Development Inc / Under Armour Inc / TechnipFMC PLC / Carvana Co / Axon Enterprise Inc / Roku Inc / PepsiCo Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Ceridian HCM Holding Inc / United Airlines Holdings Inc / StoneCo Ltd / Equitrans Midstream Corp / Newell Brands Inc / Capri Holdings Ltd / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Service Properties Trust / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / Chesapeake Energy Corp / American Well Corp / Lumen Technologies Inc / ChampionX Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Liberia / New Zealand / Panama / Philippines / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">AstraZeneca : Teze NAVIGATOR Phase III abstract: Competitive in high eosinophil, best in class, in low eosinophil patients</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.L / AMGN.O / SASY.PA / GSK.L / REGN.O</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Sanofi SA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">James D. Gordon / Mr. Richard B. Vosser / Sarita Kapila / Ms. Laerke Engkilde</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">The Life Sciences Division Ltd</td><td class="leftalignment">Executive Summary Covid-19 Multilateralism Agility and Innovation The Life Sciences Division Industry Update Equities Research 1 February 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.L / NVAX.OQ / JNJ.N / LLY.N / PFE.N / GSK.L / IMM.L / REGN.OQ / SYNG.L / MRNA.OQ / 1099.HK / SVA.OQ / ARCT.OQ / POLX.L / 6185.HK / VIR.OQ</td><td class="leftalignment">AstraZeneca PLC / Novavax Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / GlaxoSmithKline PLC / ImmuPharma PLC / Regeneron Pharmaceuticals Inc / Synairgen PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd / Arcturus Therapeutics Holdings Inc / Polarean Imaging PLC / CanSino Biologics Inc / Vir Biotechnology Inc</td><td class="leftalignment">RESEARCH OVERVIEW - INVESTMENT STRATEGY</td><td class="leftalignment">Antigua and Barbuda / China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / CORPORATE SUMMARY / COMPANY REPORT</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Navid Malik, Ph.D. / Ms. Alia Minhas, MBA</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Probes Reporter</td><td class="leftalignment">Watch List: 77 US Companies with Undisclosed SEC Probes - February 01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN.OQ / PG.N / CL.N / COF.N / CRM.N / F.N / HLT.N / MDT.N / PNC.N / SLB.N / T.N / BEN.N / TRI.N / REV.N / ADM.N / VLO.N / UPS.N / NWL.N / RMD.N / NKE.N / AMP.N / MTZ.N / ARW.N / TWTR.N / OMI.N / CVX.N / GNTX.OQ / REGN.OQ / ROL.N / SEIC.OQ / RARE.OQ / MNRO.OQ / CAKE.OQ / GILD.OQ / COST.OQ / NKTR.OQ / AZPN.OQ / MYGN.OQ / SSNC.OQ / CTXS.OQ / AMZN.OQ / MSTR.OQ / NVDA.OQ / CHTR.OQ / TNP.N / NFLX.OQ / EGBN.OQ / NDAQ.OQ / TAL.N / MA.N / SIX.N / AON.N / BX.N / BGCP.OQ / UTL.N / SCHW.N / MSI.N / MPC.N / FB.OQ / XPO.N / CTG.OQ / NTRA.OQ / 100088979 / MFIN.OQ / DXC.N / CVNA.N / RYTM.OQ / SWCH.N / IQV.N / WELL.N / LYFT.O / US71742W1036 / 120175706</td><td class="leftalignment">Amgen Inc / Procter & Gamble Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ford Motor Co / Hilton Worldwide Holdings Inc / Medtronic PLC / PNC Financial Services Group Inc / Schlumberger NV / AT&T Inc / Franklin Resources Inc / Thomson Reuters Corp / Revlon Inc / Archer-Daniels-Midland Co / Valero Energy Corp / United Parcel Service Inc / Newell Brands Inc / Resmed Inc / Nike Inc / Ameriprise Financial Inc / MasTec Inc / Arrow Electronics Inc / Twitter Inc / Owens & Minor Inc / Chevron Corp / Gentex Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SEI Investments Co / Ultragenyx Pharmaceutical Inc / Monro Inc / Cheesecake Factory Inc / Gilead Sciences Inc / Costco Wholesale Corp / Nektar Therapeutics / Aspen Technology Inc / Myriad Genetics Inc / SS&C Technologies Holdings Inc / Citrix Systems Inc / Amazon.com Inc / Microstrategy Inc / NVIDIA Corp / Charter Communications Inc / Tsakos Energy Navigation Ltd / Netflix Inc / Eagle Bancorp Inc / Nasdaq Inc / TAL Education Group / Mastercard Inc / Six Flags Entertainment Corp / Aon PLC / Blackstone Inc / BGC Partners Inc / Unitil Corp / Charles Schwab Corp / Motorola Solutions Inc / Marathon Petroleum Corp / Meta Platforms Inc / XPO Logistics Inc / Computer Task Group Inc / Natera Inc / Huntington Bancshares Inc / Medallion Financial Corp / DXC Technology Co / Carvana Co / Rhythm Pharmaceuticals Inc / Switch Inc / IQVIA Holdings Inc / Welltower Inc / Lyft Inc / PhenixFIN Corp / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Monthly Highlights--February 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FISV=US / AAPL=US / VECO=US / WSM=US / NKE=US / CSII=US / FDX=US / CAT=US / INTC=US / MCD=US / CHRW=US / BWA=US / AMZN=US / T=US / ADBE=US / INCY=US / CG=US / D=US / USB=US / WFC=US / GILD=US / NVDA=US / EVER=US / TMX=US / JPM=US / FCEL=US / PLUG=US / BBI=US / NICE=US / SBH=US / CRM=US / GE=US / VZ=US / SYK=US / RMD=US / BAX=US / EMR=US / HON=US / HELE=US / CTAS=US / EXPE=US / TTWO=US / LSTR=US / ATVI=US / HCA=US / HUM=US / LECO=US / DOV=US / RSG=US / ALB=US / AMED=US / APPS=US / ACI=US / ATRC=US / ADSK=US / BOX=US / B=US / BL=US / BLUE=US / CHD=US / KMX=US / CRUS=US / COO=US / CYBR=US / DRI=US / DFS=US / DOCU=US / E=US / ECL=US / EGHT=US / EQIX=US / EXEL=US / HEAR=US / HRL=US / ITT=US / ICPT=US / IDCC=US / ITRI=US / TREE=US / LIFE=US / MNRO=US / TEAM=US / NR=US / NDSN=US / OSIS=US / ORLY=US / PZZA=US / PCTY=US / PHAR=US / REGN=US / ROK=US / SHOP=US / SUNS=US / SCM=US / SNAP=US / TWOU=US / UNFI=US / UTHR=US / URBN=US / Z=US / VRTX=US / VG=US / SAGE=US / PRVB=US / AAP=US / CRNT=US / CCRN=US / PYPL=US / JEF=US / AOS=US / FB=US / SWKS=US / ENSG=US / BE=US / ALPN=US / TWLO=US / CLH=US / MIST=US / WCN=US / DKS=US / MD=US / CASI=US / BIIB=US / ISR=US / SFM=US / ALNY=US / MBRX=US / DPZ=US / GOOG=US / BJRI=US / TXRH=US / ORA=US / FRPT=US / AMRS=US / PERI=US / SNSS=US / ICE=US / AXON=US / TH=US / CMG=US / MWA=US / SIX=US / XPO=US / FSLR=US / AIMC=US / NM=US / QSR=US / TRIT=US / M=US / PODD=US / VMW=US / TNDM=US / WH=US / DAN=US / SPRO=US / WYND=US / KLR=US / SPGI=US / AGCO=US / SLRC=US / CBOE=US / BLRX=US / MSCI=US / NXPI=US / WWD=US / ANGI=US / ZNGA=US / ENPH=US / TCPC=US / RXN=US / PANW=US / GMED=US / AMBA=US / HASI=US / MRTX=US / CNHI=US / ARMK=US / MDWD=US / VBIV=US / LOVE=US / VCEL=US / NVRO=US / NEWR=US / RLMD=US / GKOS=US / WING=US / PSTG=US / SPXC=US / AQMS=US / SQ=US / CERC=US / 113875965 / IONS=US / NTNX=US / 100502968 / WKHS=US / TCMD=US / FLGT=US / IRTC=US / UAA=US / AVDL=US / SRRA=US / OKTA=US / YEXT=US / VREX=US / NCNA=US / RCKT=US / CAAP=US / MOTS=US / SMAR=US / FOCS=US / CWEN=US / FTDR=US / MRKR=US / GMDA=US / CPRI=US / XFOR=US / ZM=US / TMDX=US / IDYA=US / CRWD=US / MWK=US / CMBM=US / FVRR=US / KRTX=US / DDOG=US / FREQ=US / ETNB=US / BXRX=US / MSGS=US / ORIC=US / AYLA=US / NNOX=US / TSHA=US / VLDR=US / ASAN=US / ABNB=US / ONDS=US</td><td class="leftalignment">Fiserv Inc / Apple Inc / Veeco Instruments Inc / Williams-Sonoma Inc / Nike Inc / Cardiovascular Systems Inc / FedEx Corp / Caterpillar Inc / Intel Corp / McDonald's Corp / CH Robinson Worldwide Inc / Borgwarner Inc / Amazon.com Inc / AT&T Inc / Adobe Inc / Incyte Corp / Carlyle Group Inc / Dominion Energy Inc / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / NVIDIA Corp / EverQuote Inc / Terminix Global Holdings Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Brickell Biotech Inc / Nice Ltd / Sally Beauty Holdings Inc / Salesforce.Com Inc / General Electric Co / Verizon Communications Inc / Stryker Corp / Resmed Inc / Baxter International Inc / Emerson Electric Co / Honeywell International Inc / Helen of Troy Ltd / Cintas Corp / Expedia Group Inc / Take-Two Interactive Software Inc / Landstar System Inc / Activision Blizzard Inc / HCA Healthcare Inc / Humana Inc / Lincoln Electric Holdings Inc / Dover Corp / Republic Services Inc / Albemarle Corp / Amedisys Inc / Digital Turbine Inc / Albertsons Companies Inc / AtriCure Inc / Autodesk Inc / Box Inc / Barnes Group Inc / Blackline Inc / bluebird bio Inc / Church & Dwight Co Inc / Carmax Inc / Cirrus Logic Inc / Cooper Companies Inc / Cyberark Software Ltd / Darden Restaurants Inc / Discover Financial Services / DocuSign Inc / Eni SpA / Ecolab Inc / 8x8 Inc / Equinix Inc / Exelixis Inc / Turtle Beach Corp / Hormel Foods Corp / ITT Inc / Intercept Pharmaceuticals Inc / InterDigital Inc / Itron Inc / Lendingtree Inc / aTyr Pharma Inc / Monro Inc / Atlassian Corporation PLC / Newpark Resources Inc / Nordson Corp / OSI Systems Inc / O'Reilly Automotive Inc / Papa John's International Inc / Paylocity Holding Corp / Pharming Group NV / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / Shopify Inc / SLR Senior Investment Corp / Stellus Capital Investment Corp / Snap Inc / 2U Inc / United Natural Foods Inc / United Therapeutics Corp / Urban Outfitters Inc / Zillow Group Inc / Vertex Pharmaceuticals Inc / Vonage Holdings Corp / SAGE Therapeutics Inc / Provention Bio Inc / Advance Auto Parts Inc / Ceragon Networks Ltd / Cross Country Healthcare Inc / PayPal Holdings Inc / Jefferies Financial Group Inc / A O Smith Corp / Meta Platforms Inc / Skyworks Solutions Inc / Ensign Group Inc / Bloom Energy Corp / Alpine Immune Sciences Inc / Twilio Inc / Clean Harbors Inc / Milestone Pharmaceuticals Inc / Waste Connections Inc / DICK'S Sporting Goods Inc / MEDNAX Inc / CASI Pharmaceuticals Inc / Biogen Inc / IsoRay Inc / Sprouts Farmers Market Inc / Alnylam Pharmaceuticals Inc / Moleculin Biotech Inc / Domino's Pizza Inc / Alphabet Inc / BJ's Restaurants Inc / Texas Roadhouse Inc / Ormat Technologies Inc / Freshpet Inc / Amyris Inc / Perion Network Ltd / Viracta Therapeutics Inc / Intercontinental Exchange Inc / Axon Enterprise Inc / Target Hospitality Corp / Chipotle Mexican Grill Inc / Mueller Water Products Inc / Six Flags Entertainment Corp / XPO Logistics Inc / First Solar Inc / Altra Industrial Motion Corp / Navios Maritime Holdings Inc / Restaurant Brands International Inc / Triterras Inc / Macy's Inc / Insulet Corp / VMware Inc / Tandem Diabetes Care Inc / Wyndham Hotels & Resorts Inc / Dana Inc / Spero Therapeutics Inc / Travel + Leisure Co / Kaleyra Inc / S&P Global Inc / AGCO Corp / SLR Investment Corp / Cboe Global Markets Inc / BioLine RX Ltd / MSCI Inc / NXP Semiconductors NV / Woodward Inc / Angi Inc / Zynga Inc / Enphase Energy Inc / BlackRock TCP Capital Corp / Zurn Water Solutions Corp / Palo Alto Networks Inc / Globus Medical Inc / Ambarella Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Mirati Therapeutics Inc / CNH Industrial NV / Aramark / Mediwound Ltd / VBI Vaccines Inc / Lovesac Co / Vericel Corp / Nevro Corp / New Relic Inc / Relmada Therapeutics Inc / Glaukos Corp / Wingstop Inc / Pure Storage Inc / SPX Corp / Aqua Metals Inc / Block Inc / Avalo Therapeutics Inc / CNH Industrial NV / Ionis Pharmaceuticals Inc / Nutanix Inc / Precision Drilling Corp / Workhorse Group Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Okta Inc / Yext Inc / Varex Imaging Corp / NuCana PLC / Rocket Pharmaceuticals Inc / Corporacion America Airports SA / Motus GI Holdings Inc / Smartsheet Inc / Focus Financial Partners Inc / Clearway Energy Inc / Frontdoor Inc / Marker Therapeutics Inc / Gamida Cell Ltd / Capri Holdings Ltd / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / CrowdStrike Holdings Inc / Aterian Inc / Cambium Networks Corp / Fiverr International Ltd / Karuna Therapeutics Inc / Datadog Inc / Frequency Therapeutics Inc / 89Bio Inc / Baudax Bio Inc / Madison Square Garden Sports Corp / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Velodyne Lidar Inc / Asana Inc / Airbnb Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / United States / Virgin Islands, British / Marshall Islands</td><td class="leftalignment">Services</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">AEP.N / AFL.N / AIG.N / ALV.N / AMAT.O / AMD.N / ANA.MC / AU.N / BBDb.TO / BCE.TO / CB.N / CCI.N / CE.N / CL.N / CMS.N / CNA.L / CP.TO / DFDS.CO / EIX.N / EL.N / ELE.MC / F.N / FLT.N / GM.N / INTC.O / KMB.N / KO.N / MMC.N / MSFT.O / MUVGn.DE / NSC.N / PEG.N / PFE.N / SCOR.PA / SO.N / STO.AX / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / CNQ.TO / ASML.O / CPB.N / CMCSA.O / SJRb.TO / RCIb.TO / CHKP.O / AMGN.O / MET.N / CNR.TO / DUK.N / QBRb.TO / DIS.N / BWA.N / LEA.N / ROP.N / DRI.N / NVDA.O / K.N / DT.N / DISH.O / CSX.N / LNR.TO / SU.TO / NICE.O / CLX.N / EAT.N / MCD.N / CAG.N / HON.N / GIS.N / EPC.N / MGA.N / AMT.N / JAZZ.O / BOL.ST / CONE.O / OLN.N / ADI.O / VLY.N / EXEL.O / SBUX.O / JCI.N / STZ.N / CINF.O / LNC.N / HNRGn.DE / APH.N / FISV.O / EQT.N / SNPS.O / ADSK.O / EPD.N / CHTR.O / AXL.N / AWK.N / CHD.N / ATA.TO / EPAY.O / BC.N / SAM.N / CTSH.O / AJG.N / BMRN.O / OPTN.O / REGN.O / ENR.N / PFG.N / MU.O / PRU.N / CEY.L / SM.N / NCR.N / NET.N / GFI.N / COP.N / CNP.N / ENDP.O / CPK.N / MKL.N / BRO.N / PII.N / RLI.N / ST.N / SR.N / LNG.A / NTCT.OQ / ADS.N / SGEN.OQ / GPN.N / PFS.N / MNST.O / EFX.TO / FFBC.O / IMGN.O / SIGI.O / CASY.O / ACGL.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / MRE.TO / 02209S103 / DPZ.N / DLR.N / SCL.TO / 416515104 / 427866108 / RDSb.L / DISCA.O / CDNS.O / SJW.N / DRX.L / CMG.N / FIS.N / 025676206 / ISBC.O / MA.N / MWA.N / HOG.N / CVLT.O / EHTH.O / AON.N / BGS.N / PPL.TO / HOCM.L / GETP.PA / DAN.N / FRES.L / 759351604 / ACQ.TO / SPB.N / LYB.N / CFX.TO / FRU.TO / FHI.N / MTOR.N / NGL.N / PXT.TO / BKR.N / AMCX.O / POLYP.L / SPLK.OQ / PSX.N / PANW.N / FFHu.TO / MDLZ.OQ / ABBV.N / PRGO.N / PRMW.N / DOO.TO / COTY.N / FOXA.OQ / PSXP.N / AGIO.O / 81762P102 / PTC.O / QTWO.N / AGRX.O / SYF.N / QSR.N / EVA.N / PYPL.OQ / BYD.TO / RPD.O / MIME.OQ / RACE.MI / SRENH.S / KNSL.OQ / AKERBP.OL / NTNX.O / ADNT.N / LGFB.N / PBYI.OQ / DXC.N / ATUS.N / BHF.O / ATNX.O / SAIL.N / APTV.N / AMRX.N / EQH.N / GSHD.O / NTGY.MC / KDP.N / AQST.O / ESTC.N / NWL.O / RTLR.O / CRWD.O / GMAB.O / CRNC.OQ / ETNB.O / REYN.O / SBSW.N / IGIC.OQ / GFL.N / NKLA.OQ / FOUR.N / LUMN.N / MTCR.O / SUMO.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / Aflac Inc / American International Group Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Acciona SA / AngloGold Ashanti Ltd / Bombardier Inc / BCE Inc / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Colgate-Palmolive Co / CMS Energy Corp / Centrica PLC / Canadian Pacific Railway Ltd / DFDS AS / Edison International / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fleetcor Technologies Inc / General Motors Co / Intel Corp / Kimberly-Clark Corp / Coca-Cola Co / Marsh & McLennan Companies Inc / Microsoft Corp / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Scor SE / Southern Co / Santos Ltd / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / ASML Holding NV / Campbell Soup Co / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Check Point Software Technologies Ltd / Amgen Inc / MetLife Inc / Canadian National Railway Co / Duke Energy Corp / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Roper Technologies Inc / Darden Restaurants Inc / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Linamar Corp / Suncor Energy Inc / Nice Ltd / Clorox Co / Brinker International Inc / McDonald's Corp / Conagra Brands Inc / Honeywell International Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Boliden AB / CyrusOne Inc / Olin Corp / Analog Devices Inc / Valley National Bancorp / Exelixis Inc / Starbucks Corp / Johnson Controls International PLC / Constellation Brands Inc / Cincinnati Financial Corp / Lincoln National Corp / Hannover Rueck SE / Amphenol Corp / Fiserv Inc / EQT Corp / Synopsys Inc / Autodesk Inc / Enterprise Products Partners LP / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Bottomline Technologies Inc / Brunswick Corp / Boston Beer Company Inc / Cognizant Technology Solutions Corp / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / Centamin PLC / SM Energy Co / NCR Corp / Cloudflare Inc / Gold Fields Ltd / Conocophillips / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Markel Corp / Brown & Brown Inc / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Spire Inc / Cheniere Energy Inc / Netscout Systems Inc / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / Monster Beverage Corp / Enerflex Ltd / First Financial Bancorp / ImmunoGen Inc / Selective Insurance Group Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Martinrea International Inc / Altria Group Inc / Domino's Pizza Inc / Digital Realty Trust Inc / Shawcor Ltd / Hartford Financial Services Group Inc / Hershey Co / Royal Dutch Shell PLC / Discovery Inc / Cadence Design Systems Inc / SJW Group / Drax Group PLC / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Commvault Systems Inc / eHealth Inc / Aon PLC / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / Getlink SE / Dana Inc / Fresnillo PLC / Reinsurance Group of America Inc / AutoCanada Inc / Spectrum Brands Holdings Inc / LyondellBasell Industries NV / Canfor Pulp Products Inc / Freehold Royalties Ltd / Federated Hermes Inc / Meritor Inc / NGL Energy Partners LP / Parex Resources Inc / Baker Hughes Co / AMC Networks Inc / Polymetal International PLC / Splunk Inc / Phillips 66 / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Abbvie Inc / Perrigo Company PLC / Primo Water Corp / BRP Inc / Coty Inc / Fox Corp / Phillips 66 Partners LP / Agios Pharmaceuticals Inc / ServiceNow Inc / PTC Inc / Q2 Holdings Inc / Agile Therapeutics Inc / Synchrony Financial / Restaurant Brands International Inc / Enviva Inc / PayPal Holdings Inc / Boyd Group Services Inc / Rapid7 Inc / Mimecast Ltd / Ferrari NV / Swiss Re AG / Kinsale Capital Group Inc / Aker BP ASA / Nutanix Inc / Adient PLC / Lions Gate Entertainment Corp / Puma Biotechnology Inc / DXC Technology Co / Altice USA Inc / Brighthouse Financial Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Elastic NV / Newell Brands Inc / Rattler Midstream LP / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / 89Bio Inc / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / GFL Environmental Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Metacrine Inc / Sumo Logic Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / Norway / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Biotech Q4:20 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">AMGN.O / EXEL.O / BMRN.O / REGN.O / SGEN.OQ / IMGN.O / AGIO.O / PBYI.OQ / ATNX.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Seagen Inc / ImmunoGen Inc / Agios Pharmaceuticals Inc / Puma Biotechnology Inc / Athenex Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / CAT.N / HON.N / ITW.N / XOM.N / LIN.N / ARE.N / CVX.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / CHTR.OQ / GPN.N / VRTX.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Caterpillar Inc / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Charter Communications Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 4Q20 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Weekend Updates - ABBV, INCY, REGN, IONS, TVTX, Noubar & Much More</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.OQ / US00287Y1091 / INCY.OQ / IONS.OQ / TVTX.OQ / US45337C1027 / US75886F1075 / US37890U1088 / US4622221004 / BMG637AM1024 / US84833T1034 / US77313F1066 / US89422G1076</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Abbvie Inc / Incyte Corp / Ionis Pharmaceuticals Inc / Travere Therapeutics Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Myovant Sciences Ltd / Spero Therapeutics Inc / Rocket Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Liisa A. Bayko / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccines vs variants; IND cleared for PASG</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PASG.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AMGN.O / REGN.O / AGIO.O / GMAB.O</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 1.29.21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">BAER.S / BNPP.PA / ENI.MI / EOG.N / FGP.L / MMC.N / PHM.N / TOTF.PA / PXD.N / RCIb.TO / AMGN.O / INCY.O / FER.MC / DHR.N / DOV.N / DT.N / EAT.N / MCD.N / VLO.N / WHR.N / SHW.N / AMP.N / V.N / BC.N / AJG.N / REGN.O / TSCO.O / CFR.N / MEOH.O / BLU.N / PNR.N / RLI.N / FCF.N / HCC.N / NTCT.OQ / ADS.N / SIGI.O / BPOP.O / COLB.O / 02209S103 / 878742204 / TEVA.N / MA.N / GALP.LS / AEO.N / NOG.A / SLM.OQ / WDC.O / FANG.O / ABBV.N / PRGO.N / UKWG.L / WRK.N / UBSG.S / GRPG.I / ORSTED.CO / NTGY.MC / 260557103 / IGMS.O / 120291281</td><td class="leftalignment">Julius Baer Gruppe AG / BNP Paribas SA / Eni SpA / EOG Resources Inc / FirstGroup PLC / Marsh & McLennan Companies Inc / Pultegroup Inc / TotalEnergies SE / Pioneer Natural Resources Co / Rogers Communications Inc / Amgen Inc / Incyte Corp / Ferrovial SA / Danaher Corp / Dover Corp / Dynatrace Inc / Brinker International Inc / McDonald's Corp / Valero Energy Corp / Whirlpool Corp / Sherwin-Williams Co / Ameriprise Financial Inc / Visa Inc / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Tractor Supply Co / Cullen/Frost Bankers Inc / Methanex Corp / BELLUS Health Inc / Pentair PLC / Rli Corp / First Commonwealth Financial Corp / Warrior Met Coal Inc / Netscout Systems Inc / Alliance Data Systems Corp / Selective Insurance Group Inc / Popular Inc / Columbia Banking System Inc / Altria Group Inc / Teck Resources Ltd / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Galp Energia SGPS SA / American Eagle Outfitters Inc / Northern Oil and Gas Inc / SLM Corp / Western Digital Corp / Diamondback Energy Inc / Abbvie Inc / Perrigo Company PLC / Greencoat UK Wind PLC / Westrock Co / UBS Group AG / Greencoat Renewables PLC / Orsted A/S / Naturgy Energy Group SA / Dow Inc / IGM Biosciences Inc / Cenovus Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Puerto Rico / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Preview Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / BAYGN.DE / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Bayer AG / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / ITW.N / XOM.N / LIN.N / V.N / ARE.N / CVX.N / AMGN.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / CHTR.OQ / EXPE.OQ / VRTX.OQ / CMCSA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / OTIS.N</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Expedia Group Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">INCY.O / REGN.O</td><td class="leftalignment">Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row: Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US0453271035 / 75886F107 / 13645T100 / 655844108</td><td class="leftalignment">Aspen Technology Inc / Regeneron Pharmaceuticals Inc / Canadian Pacific Railway Ltd / Norfolk Southern Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Nathan Martin / Mr. Aydin Huseynov, MD / Mr. Mark W. Schappel</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">REGN Cocktail is Becoming a Multi-Year Repetitive Business for Years to Come</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GB0004544929 / US09061G1013 / US0028241000 / US0079031078 / US0231351067 / US0311621009 / US0378331005 / US0382221051 / US0530151036 / US0970231058 / US1271903049 / US2254471012 / US28176E1082 / US30161Q1040 / US30226D1063 / US3696041033 / US3755581036 / US4364401012 / US45253H1014 / US45337C1027 / US4824801009 / US5128071082 / US55306N1046 / US5951121038 / US64125C1099 / US6558441084 / US75886F1075 / US8168501018 / US8636671013 / US8793601050 / US8807701029 / US8832031012 / US91307C1027 / US9138371003 / US9182041080 / US92532F1003 / US9581021055 / US9839191015 / NL0000200384 / US5658491064 / US83088M1027 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / US12541W2098 / US00206R1023 / ACOR.OQ / US42809H1077 / US82706C1080 / US6247581084 / US29089Q1058 / US0043971052 / US03152W1099 / US64110D1046 / US2120151012 / US46333X1081 / US13100M5094 / IE00B58JVZ52 / US88160R1014 / US4361061082 / US56585A1025 / US7185461040 / US30303M1027 / NL0010273215 / US81762P1021 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US69888T2078 / US2681582019 / US31572Q8087 / US22822V1017 / US74736K1016 / US09627Y1091 / US37890U1088 / US74624M1027 / US4622221004 / US07725L1026 / KYG4740B1059 / IL0011407140 / US4990491049 / US8760301072 / US76243J1051 / CH0371153492 / SE0009414576 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Imperial Brands PLC / Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Micro Devices Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Automatic Data Processing Inc / Boeing Co / CACI International Inc / Wolfspeed Inc / Edwards Lifesciences Corp / Exelixis Inc / Extreme Networks Inc / General Electric Co / Gilead Sciences Inc / Hologic Inc / ImmunoGen Inc / Incyte Corp / KLA Corp / Lam Research Corp / MKS Instruments Inc / Micron Technology Inc / Neurocrine Biosciences Inc / Norfolk Southern Corp / Regeneron Pharmaceuticals Inc / Semtech Corp / Stryker Corp / Teledyne Technologies Inc / Teradyne Inc / Textron Inc / United Therapeutics Corp / Universal Stainless & Alloy Products Inc / VF Corp / Vertex Pharmaceuticals Inc / Western Digital Corp / Xilinx Inc / Core Laboratories NV / Marathon Oil Corp / Skyworks Solutions Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Hess Corp / Silicon Motion Technology Corp / Mueller Water Products Inc / Emergent BioSolutions Inc / Accuray Inc / Amicus Therapeutics Inc / NetApp Inc / Continental Resources Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Seagate Technology Holdings PLC / Tesla Inc / HollyFrontier Corp / Marathon Petroleum Corp / Phillips 66 / Meta Platforms Inc / ASML Holding NV / ServiceNow Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Par Pacific Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Qorvo Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Pure Storage Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Urogen Pharma Ltd / Knight-Swift Transportation Holdings Inc / Tapestry Inc / Rhythm Pharmaceuticals Inc / Landis+Gyr Group AG / Oncopeptides AB / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / PEP=US / PFE=US / AMGN=US / BMY=US / KO=US / AMD=US / CL=US / T=US / PEB=US / SLG=US / PLUG=US / H=US / MTN=US / VZ=US / SYK=US / CCI=US / ENR=US / PB=US / SWN=US / XLNX=US / BRO=US / MAR=US / LSTR=US / HLT=US / NWL=US / RCL=US / FLO=US / APH=US / ARW=US / AVT=US / CCL=US / CENT=US / CHH=US / CHD=US / DRH=US / EPC=US / EXAS=US / AJG=US / HAIN=US / NOW=US / MNRO=US / REGN=US / SMG=US / POST=US / R=US / FB=US / FBK=US / MKL=US / DRE=US / SBSI=US / NTRA=US / MGPI=US / MNST=US / JRVR=US / NOMD=US / STRO=US / SHO=US / FRPT=US / THS=US / HST=US / XPO=US / ELF=US / SAIA=US / TEL=US / NMTR=US / WH=US / NXGN=US / WYND=US / ATSG=US / NEO=US / AAN=US / KNSL=US / HGV=US / NXPI=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / NCLH=US / VCYT=US / ARCB=US / LOB=US / WLTW=US / PK=US / PLYA=US / PETQ=US / KDP=US / HARP=US / PLMR=US / PSNL=US / BRBR=US / REYN=US / HYFM=US</td><td class="leftalignment">CACI International Inc / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / Advanced Micro Devices Inc / Colgate-Palmolive Co / AT&T Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Plug Power Inc / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Stryker Corp / Crown Castle International Corp / Energizer Holdings Inc / Prosperity Bancshares Inc / Southwestern Energy Co / Xilinx Inc / Brown & Brown Inc / Marriott International Inc / Landstar System Inc / Hilton Worldwide Holdings Inc / Newell Brands Inc / Royal Caribbean Cruises Ltd / Flowers Foods Inc / Amphenol Corp / Arrow Electronics Inc / Avnet Inc / Carnival Corp / Central Garden & Pet Co / Choice Hotels International Inc / Church & Dwight Co Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Exact Sciences Corp / Arthur J Gallagher & Co / Hain Celestial Group Inc / ServiceNow Inc / Monro Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Post Holdings Inc / Ryder System Inc / Meta Platforms Inc / FB Financial Corp / Markel Corp / Duke Realty Corp / Southside Bancshares Inc / Natera Inc / MGP Ingredients Inc / Monster Beverage Corp / James River Group Holdings Ltd / Nomad Foods Ltd / Sutro Biopharma Inc / Sunstone Hotel Investors Inc / Freshpet Inc / TreeHouse Foods Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / elf Beauty Inc / Saia Inc / TE Connectivity Ltd / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / NextGen Healthcare Inc / Travel + Leisure Co / Air Transport Services Group Inc / Neogenomics Inc / Aaron's Company Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Norwegian Cruise Line Holdings Ltd / Veracyte Inc / ArcBest Corp / Live Oak Bancshares Inc / Willis Towers Watson PLC / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / PetIQ Inc / Keurig Dr Pepper Inc / Harpoon Therapeutics Inc / Palomar Holdings Inc / Personalis Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Ireland / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Pulse Call: 10 Insights from REGN Infectious Diseases Guru About COVID Variants</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN=US / PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4+2021 Preview: Fundamentals Remain Strong, Should Provide Investment Oppy's</td><td class="leftalignment">English</td><td class="rightalignment">226</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: Lilly's Ph 3 trial of COVID-19 neutralising antibody cocktail met primary endpoints. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">1877.HK / LLY.N / REGN.OQ / BGNE.OQ / 6160.HK</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Beigene Ltd / Beigene Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Taking on B.1.351: REGN Abs Active Vs. Variant; LLY Testing 3rd Ab w/ VIR & GSK</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INTERNAL REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">REGN's antibody cocktail showed potency for UK variant, reduced potency for SA variant</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Regeneron Pharmaceuticals Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">FISV=US / PFE=US / AMGN=US / INTC=US / ADI=US / AMD=US / BXP=US / PLD=US / T=US / DVN=US / INCY=US / TXN=US / TEVA=US / AMT=US / NVDA=US / EOG=US / BC=US / PLUG=US / H=US / VZ=US / WLL=US / CHKP=US / CCI=US / MGY=US / XLNX=US / BRO=US / MRO=US / DISH=US / DHI=US / ENDP=US / HXL=US / HZO=US / PACW=US / PRGO=US / PII=US / REGN=US / SBAC=US / ST=US / BXS=US / NET=US / GPN=US / FMBI=US / SNV=US / LCI=US / MKL=US / RPD=US / BIIB=US / FIS=US / TEL=US / AMRX=US / CLR=US / EHC=US / NOG=US / SWI=US / NXPI=US / PCRX=US / VAC=US / PANW=US / FANG=US / ABBV=US / TMUS=US / PTCT=US / FEYE=US / MBUU=US / VRNS=US / AJRD=US / MCFT=US / EVRI=US / ZS=US / OKTA=US / SAIL=US / BHC=US / TENB=US / PLMR=US / CRWD=US / ONEW=US / VTRS=US / 100073616</td><td class="leftalignment">Fiserv Inc / Pfizer Inc / Amgen Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Boston Properties Inc / Prologis Inc / AT&T Inc / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / EOG Resources Inc / Brunswick Corp / Plug Power Inc / Hyatt Hotels Corp / Verizon Communications Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Crown Castle International Corp / Magnolia Oil & Gas Corp / Xilinx Inc / Brown & Brown Inc / Marathon Oil Corp / DISH Network Corp / D R Horton Inc / Endo International PLC / Hexcel Corp / MarineMax Inc / PacWest Bancorp / Perrigo Company PLC / Polaris Inc / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Sensata Technologies Holding PLC / Cadence Bank / Cloudflare Inc / Global Payments Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Lannett Company Inc / Markel Corp / Rapid7 Inc / Biogen Inc / Fidelity National Information Services Inc / TE Connectivity Ltd / Amneal Pharmaceuticals Inc / Continental Resources Inc / Encompass Health Corp / Northern Oil and Gas Inc / SolarWinds Corp / NXP Semiconductors NV / Pacira Biosciences Inc / Marriott Vacations Worldwide Corp / Palo Alto Networks Inc / Diamondback Energy Inc / Abbvie Inc / T-Mobile US Inc / PTC Therapeutics Inc / Mandiant Inc / Malibu Boats Inc / Varonis Systems Inc / Aerojet Rocketdyne Holdings Inc / Mastercraft Boat Holdings Inc / Everi Holdings Inc / Zscaler Inc / Okta Inc / SailPoint Technologies Holdings Inc / Bausch Health Companies Inc / Tenable Holdings Inc / Palomar Holdings Inc / CrowdStrike Holdings Inc / OneWater Marine Inc / Viatris Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">LLY Ab Combo Reduced COVID Events by 70%; Prepped for Variants w/ Next-Gen Abs</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2270726 / 2542049 / 2829515 / 2382892 / 2670519 / 2328915 / 2459020 / 2689560 / 2680905 / 2684703 / 2048804 / 2730190 / 2862532 / 2138158 / 2503529 / 4595739 / 5531000 / 7103065 / B121557 / B2R3PV1 / B7TL820 / BCBVTX1 / B7VD3F2 / BFLR866 / B76LYJ2 / BTN1Y44 / BYY8XK8 / BNGY4Q0 / BF5L3T2 / BYNZGK1 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BKLCX50</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Walt Disney Co / Dominion Energy Inc / Edison International / Audacy Inc / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / World Wrestling Entertainment Inc / Genmab A/S / MorphoSys AG / Novartis AG / Mastercard Inc / American Water Works Company Inc / Meta Platforms Inc / Agios Pharmaceuticals Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Walgreens Boots Alliance Inc / WEC Energy Group Inc / Nextera Energy Partners LP / Elanco Animal Health Inc / Block Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Health Catalyst Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AEGN.AS / ALB.N / ALV.N / ALVG.DE / AMD.N / AXAF.PA / AXP.N / CC.N / CCK.N / CE.N / CL.N / COF.N / DD.N / EMN.N / FGP.L / FMC.N / GE.N / GOG.L / HSX.L / LGEN.L / MSFT.O / MUVGn.DE / NEX.L / PPG.N / PRU.L / SCOR.PA / SEE.N / SLA.L / ZURN.S / SJP.L / FER.MC / ADML.L / ETN.N / CNR.TO / WLK.N / WCC.N / IEX.N / HON.N / MMM.N / OLN.N / SHW.N / OI.N / BLL.N / VZ.N / SNV.N / SBUX.O / JCI.N / DHI.N / HNRGn.DE / RPM.N / CHD.N / SLGN.O / AME.N / TXN.O / REGN.O / JNPR.N / GPK.N / AV.L / GGG.N / PNR.N / BRO.N / PII.N / TT.N / NATI.O / FFIV.O / HUN.N / RDSb.L / EDF.PA / 35671D857 / LRE.L / BEZG.L / GETP.PA / WRB.N / PHNX.L / AGES.BR / LYB.N / BERY.N / DLGD.L / AGIO.O / NN.AS / AXTA.N / SGRY.O / SRENH.S / ATKR.N / JUSTJ.L / VNTR.N / SAIL.N / 05971J102 / EHC.N / EAF.N / CTVA.N / 260557103 / MNG.L / OVV.N / CARR.N / PTVE.O</td><td class="leftalignment">Aegon NV / Albemarle Corp / Autoliv Inc / Allianz SE / Advanced Micro Devices Inc / AXA SA / American Express Co / Chemours Co / Crown Holdings Inc / Celanese Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Eastman Chemical Co / FirstGroup PLC / FMC Corp / General Electric Co / Go-Ahead Group PLC / Hiscox Ltd / Legal & General Group PLC / Microsoft Corp / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Express Group PLC / PPG Industries Inc / Prudential PLC / Scor SE / Sealed Air Corp / Abrdn PLC / Zurich Insurance Group AG / St James's Place PLC / Ferrovial SA / Admiral Group PLC / Eaton Corporation PLC / Canadian National Railway Co / Westlake Chemical Corp / Wesco International Inc / IDEX Corp / Honeywell International Inc / 3M Co / Olin Corp / Sherwin-Williams Co / O-I Glass Inc / Ball Corp / Verizon Communications Inc / Synovus Financial Corp / Starbucks Corp / Johnson Controls International PLC / D R Horton Inc / Hannover Rueck SE / RPM International Inc / Church & Dwight Co Inc / Silgan Holdings Inc / AMETEK Inc / Texas Instruments Inc / Regeneron Pharmaceuticals Inc / Juniper Networks Inc / Graphic Packaging Holding Co / Aviva PLC / Graco Inc / Pentair PLC / Brown & Brown Inc / Polaris Inc / Trane Technologies PLC / National Instruments Corp / F5 Inc / Huntsman Corp / Royal Dutch Shell PLC / Electricite de France SA / Freeport-McMoRan Inc / Lancashire Holdings Ltd / Beazley PLC / Getlink SE / W R Berkley Corp / Phoenix Group Holdings PLC / Ageas SA / LyondellBasell Industries NV / Berry Global Group Inc / Direct Line Insurance Group PLC / Agios Pharmaceuticals Inc / NN Group NV / Axalta Coating Systems Ltd / Surgery Partners Inc / Swiss Re AG / Atkore Inc / Just Group PLC / Venator Materials PLC / SailPoint Technologies Holdings Inc / Cadence Bank / Encompass Health Corp / GrafTech International Ltd / Corteva Inc / Dow Inc / M&G PLC / Ovintiv Inc / Carrier Global Corp / Pactiv Evergreen Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Stable for Large Cap Stocks, SMid incrementally higher</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology 4Q20 Preview: More of the same? Large Cap lethargy, SMid-Cap enthusiasm, against the continuing pandemic backdrop</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">AMGN.OQ / GILD.OQ / BMY.N / LLY.N / PFE.N / REGN.OQ / RARE.OQ / INCY.OQ / NBIX.OQ / ICPT.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / ARNA.OQ / ESPR.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / GLPG.AS / IRWD.OQ / SRPT.OQ / ABBV.N / PTCT.OQ / RNA.OQ / QURE.OQ / FLXN.OQ / ASND.OQ / ANAB.OQ / APLS.OQ / KURA.OQ / NTLA.OQ / ARGX.OQ / IFRX.OQ / SRRK.OQ / CYCN.OQ / ISEE.OQ / STOK.OQ / INBX.OQ / IMVT.OQ / FMTX.OQ / ALXO.OQ / CVAC.OQ / SPRB.OQ / GLTO.OQ / BCAB.OQ / ABCL.OQ</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / Galapagos NV / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Avidity Biosciences Inc / Uniqure NV / Pacira Biosciences Inc / Ascendis Pharma A/S / AnaptysBio Inc / Apellis Pharmaceuticals Inc / Kura Oncology Inc / Intellia Therapeutics Inc / argenx SE / InflaRx NV / Scholar Rock Holding Corp / Cyclerion Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Inhibrx Inc / Immunovant Inc / Forma Therapeutics Holdings Inc / ALX Oncology Holdings Inc / CureVac NV / Spruce Biosciences Inc / Galecto Inc / Bioatla Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Denmark / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Dr. Martin Auster, M.D. / Ms. Judah C. Frommer / Mr. Tiago Fauth / Mark Connolly / Jonathan Woo / Yunhee Park / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / INCY=US / REGN=US / BIIB=US / PTCT=US</td><td class="leftalignment">Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">SubQ REGEN-COV passive vaccine data show encouraging results at an interim read; confirmatory data to follow in Q2</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">LLY's Antibody Combo Reduces Deaths and Hospitalizations Due To COVID-19</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / AMGN.O / REGN.O / HGEN.O</td><td class="leftalignment">Eli Lilly and Co / Amgen Inc / Regeneron Pharmaceuticals Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">CoroNation Update: REGN/LLY Antibody Cocktails Are Very Effective, May See Significant Use In Light Of Slow Vaccine Rollout</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / LLY.N / 2516152 / 2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Kushal Patel / Tarun Soni</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Good News on the COVID Roller Coaster: REGN Abs Prevent COVID in Interim Ph. 3</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">75886F107 / 98156Q108 / 62886E108 / 690742101 / 53220K504</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / World Wrestling Entertainment Inc / NCR Corp / Owens Corning / Ligand Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Reuben Garner / Mr. Daniel L. Kurnos, CFA / Mike Hickey / Mr. Robert M. Wasserman / Mr. Michael P. Ward, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Germany Opened the European Gates for the Cocktail; Eylea is too Strong to Be Defeated</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Read-throughs to our large-cap Biotech coverage from NVS' earnings call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / INCY=US / REGN=US / BIIB=US / PTCT=US</td><td class="leftalignment">Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Positive Interim REGEN-COV Phase 3 Data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">REGEN-COV Prevention Utility Adds to Confidence in Our Estimates</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">REGEN-COV early data looks like another weapon in preventing symptomatic COVID-19 in high risk individuals</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Mgmt color: REGEN-COV passive vaccine has data on protection & potency against new variant</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BSX=US / PFE=US / HD=US / MCD=US / WEN=US / BLD=US / RUN=US / GILD=US / BC=US / LOW=US / IART=US / MUR=US / BRO=US / LEG=US / MANH=US / CBRL=US / ELY=US / FUN=US / KIDS=US / DRI=US / GFF=US / HAS=US / HXL=US / IBP=US / HZO=US / MAS=US / MAT=US / MHK=US / PII=US / REGN=US / SGMO=US / STRA=US / THO=US / WW=US / WGO=US / GOLF=US / OPT=US / BXS=US / FBK=US / NLS=US / DIN=US / MGPI=US / BIIB=US / TPX=US / EXP=US / FHN=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / SIX=US / XPO=US / PGTI=US / SAIA=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / NMTR=US / SEAS=US / CWH=US / IAC=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / FOXF=US / MBUU=US / ARCB=US / LOCO=US / VCEL=US / NVRO=US / SHAK=US / WING=US / SPNE=US / TDOC=US / MCFT=US / ACBI=US / 82982L103 / JELD=US / FNKO=US / AXNX=US / KOD=US / FERGY=US / BRBR=US / ONEM=US / ONEW=US / AZEK=US / BALY=US</td><td class="leftalignment">Boston Scientific Corp / Pfizer Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Sunrun Inc / Gilead Sciences Inc / Brunswick Corp / Lowe's Companies Inc / Integra Lifesciences Holdings Corp / Murphy Oil Corp / Brown & Brown Inc / Leggett & Platt Inc / Manhattan Associates Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Cedar Fair LP / OrthoPediatrics Corp / Darden Restaurants Inc / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mattel Inc / Mohawk Industries Inc / Polaris Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Thor Industries Inc / WW International Inc / Winnebago Industries Inc / Acushnet Holdings Corp / Opthea Ltd / Cadence Bank / FB Financial Corp / Nautilus Inc / Dine Brands Global Inc / MGP Ingredients Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Six Flags Entertainment Corp / XPO Logistics Inc / PGT Innovations Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / SeaWorld Entertainment Inc / Camping World Holdings Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Fox Factory Holding Corp / Malibu Boats Inc / ArcBest Corp / El Pollo Loco Holdings Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Teladoc Health Inc / Mastercraft Boat Holdings Inc / Atlantic Capital Bancshares Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Funko Inc / Axonics Inc / Kodiak Sciences Inc / Ferguson PLC / Bellring Brands Inc / 1Life Healthcare Inc / OneWater Marine Inc / Azek Company Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0989529 / 2259101 / 2434209 / 2778844 / 2973821 / 2270726 / 2542049 / 2829515 / 2317087 / 2342034 / 2100920 / 2459020 / 2630513 / 2048804 / 2730190 / 2138158 / 2825933 / 2503529 / B2R3PV1 / 2598246 / B7TL820 / B7VD3F2 / B87ZMX0 / BYY8XK8 / BYVY8G0 / BYVFC94 / BD8DJ71 / BZ00V34 / BJJMGL2 / BFXC911 / BDFZSP1 / BP84RX0 / BQXZP64 / BGDQ8B3 / BN0XTW4</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Target Corp / Home Depot Inc / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Dominion Energy Inc / Edison International / Entergy Corp / Fiserv Inc / FirstEnergy Corp / Intuit Inc / New Jersey Resources Corp / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Sempra Energy / South Jersey Industries Inc / World Wrestling Entertainment Inc / American Water Works Company Inc / Neogenomics Inc / Meta Platforms Inc / Duke Energy Corp / Palo Alto Networks Inc / WEC Energy Group Inc / Alphabet Inc / US Foods Holding Corp / Snap Inc / Zscaler Inc / Fox Corp / Guardant Health Inc / Okta Inc / Townsquare Media Inc / Wayfair Inc / Axonics Inc / Orphazyme A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Covid-19 Antibody Update: REGN-CoV2 shows promising potential as a prophylaxis, while Lilly's combo therapy significantly reduces hospitalizations and risk of death</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">REGN.OQ / LLY.N</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for REGN.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN.OQ</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US / SGMO=US / OPT=US / KOD=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Opthea Ltd / Kodiak Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Faricimab Hits In Ph3 AMD Adding Major Competitive Headwind To Eylea</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Wolfe Pharma & Biotech* 4Q20 EPS Preview - Model Changes and Updated Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ROG's ph3 faricimab data suggests a new competitive threat to Eylea in wet AMD; safety is critical unknown ahead of full data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Eylea Competitor Faricimab Meets Primary Endpoint in Wet AMD</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN=US / RHHBY=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REGN - Roche's Faricimab Non-Inferior to Eylea at Less Frequent Dosing Schedule; Could Put Pressure on Eylea Franchise</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2730190</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ANG2/VEGF-A bispecific could enter wAMD market near-term but Eylea could have staying power</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">KOD=US / OPT=US / REGN=US</td><td class="leftalignment">Kodiak Sciences Inc / Opthea Ltd / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LJPC=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">La Jolla Pharmaceutical Co / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MCD=US / SCI=US / AAPL=US / IBM=US / WMB=US / BSX=US / CSII=US / LLY=US / SBUX=US / ABT=US / CAT=US / COST=US / INTC=US / KO=US / MO=US / AMD=US / WM=US / BWA=US / MSFT=US / WEN=US / MDT=US / GNSS=US / JNPR=US / K=US / AMZN=US / T=US / ORCL=US / WMT=US / RUN=US / D=US / ED=US / SRE=US / WFC=US / NVDA=US / HBI=US / AKAM=US / YUM=US / PCG=US / FCEL=US / PLUG=US / VZ=US / EL=US / GIS=US / SAP=US / URI=US / BAX=US / GSK=US / JCI=US / JNJ=US / TTWO=US / LEG=US / LRCX=US / ATVI=US / KR=US / DE=US / EIX=US / UNH=US / RSG=US / ABMD=US / ALB=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / AVGO=US / HRB=US / CMI=US / CHD=US / CSGP=US / CREE=US / DHI=US / XRAY=US / DG=US / EW=US / EQIX=US / FMC=US / ISRG=US / ITRI=US / MS=US / PCAR=US / PRVL=US / REGN=US / ROK=US / SBAC=US / HSIC=US / SILK=US / SJM=US / TRMB=US / ALGN=US / PFG=US / CINF=US / SIVB=US / FB=US / NEP=US / O=US / SWKS=US / NFLX=US / BE=US / CLH=US / WCN=US / TCOM=US / DPZ=US / ENS=US / TWIN=US / ORA=US / AMRS=US / SPWR=US / ICE=US / CSIQ=US / FSLR=US / QSR=US / BX=US / LULU=US / VMW=US / DAN=US / SPGI=US / WPRT=US / KKR=US / SWAV=US / 700-HK=US / AGCO=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / NXPI=US / AMRC=US / EA=US / ENPH=US / TMUS=US / HASI=US / CNHI=US / SIEGY=US / BABA=US / NVRO=US / SEDG=US / ZBH=US / PEN=US / AQMS=US / HPE=US / SQ=US / WKHS=US / OKTA=US / APTV=US / VOW3-DE=US / CWEN=US / VLDR=US / 120175706 / 120248964</td><td class="leftalignment">McDonald's Corp / Service Corporation International / Apple Inc / International Business Machines Corp / Williams Companies Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Starbucks Corp / Abbott Laboratories / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Coca-Cola Co / Altria Group Inc / Advanced Micro Devices Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Wendys Co / Medtronic PLC / Genasys Inc / Juniper Networks Inc / Kellogg Co / Amazon.com Inc / AT&T Inc / Oracle Corp / Walmart Inc / Sunrun Inc / Dominion Energy Inc / Consolidated Edison Inc / Sempra Energy / Wells Fargo & Co / NVIDIA Corp / HanesBrands Inc / Akamai Technologies Inc / Yum! Brands Inc / PG&E Corp / Fuelcell Energy Inc / Plug Power Inc / Verizon Communications Inc / Estee Lauder Companies Inc / General Mills Inc / SAP SE / United Rentals Inc / Baxter International Inc / GlaxoSmithKline PLC / Johnson Controls International PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Activision Blizzard Inc / Kroger Co / Deere & Co / Edison International / UnitedHealth Group Inc / Republic Services Inc / ABIOMED Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Broadcom Inc / H & R Block Inc / Cummins Inc / Church & Dwight Co Inc / CoStar Group Inc / Wolfspeed Inc / D R Horton Inc / DENTSPLY SIRONA Inc / Dollar General Corp / Edwards Lifesciences Corp / Equinix Inc / FMC Corp / Intuitive Surgical Inc / Itron Inc / Morgan Stanley / Paccar Inc / Porvair PLC / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / SBA Communications Corp / Henry Schein Inc / Silk Road Medical Inc / J M Smucker Co / Trimble Inc / Align Technology Inc / Principal Financial Group Inc / Cincinnati Financial Corp / SVB Financial Group / Meta Platforms Inc / Nextera Energy Partners LP / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Trip.com Group Ltd / Domino's Pizza Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / SunPower Corp / Intercontinental Exchange Inc / Canadian Solar Inc / First Solar Inc / Restaurant Brands International Inc / Blackstone Inc / Lululemon Athletica Inc / VMware Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / KKR & Co Inc / Shockwave Medical Inc / Tencent Holdings Ltd / AGCO Corp / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / NXP Semiconductors NV / Ameresco Inc / Electronic Arts Inc / Enphase Energy Inc / T-Mobile US Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Siemens AG / Alibaba Group Holding Ltd / Nevro Corp / Solaredge Technologies Inc / Zimmer Biomet Holdings Inc / Penumbra Inc / Aqua Metals Inc / Hewlett Packard Enterprise Co / Block Inc / Workhorse Group Inc / Okta Inc / Aptiv PLC / Volkswagen AG / Clearway Energy Inc / Velodyne Lidar Inc / Cisco Systems Inc / Frontier Communications Parent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Leisure & Entertainment / Lodging & Restaurants / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US0374111054 / US0383361039 / US0584981064 / US0936711052 / US1270971039 / US2441991054 / US25179M1036 / US26875P1012 / US3755581036 / US3976241071 / US4062161017 / US4601461035 / US5463471053 / US6267171022 / US6745991058 / US6935061076 / US6951561090 / US7237871071 / US7310681025 / US75281A1097 / US7549071030 / US75886F1075 / AN8068571086 / US81211K1007 / US8270481091 / US8354951027 / US8454671095 / US92276F1003 / US9621661043 / CA29250N1050 / CA1469001053 / CA9528451052 / US5658491064 / US20825C1045 / US2283681060 / US02043Q1076 / US7588491032 / US3137472060 / US7376301039 / US40637H1095 / CA0010921058 / CA4495861060 / US42809H1077 / CA1375761048 / US5021751020 / US63633D1046 / US9814191048 / US88076W1036 / US3886891015 / US2120151012 / CA1254911003 / US26884L1098 / US78454L1008 / US18538R1032 / CA7063271034 / CA4932711001 / US09739D1000 / US81762P1021 / US09609G1004 / US69327R1014 / US78573L1061 / CA3748252069 / US5764852050 / US08579W1036 / US45845P1084 / US25278X1090 / US31189P1021 / US03674X1063 / US02005N1000 / US03820J1007 / CA45868C1095 / US14174T1079 / US92686J1060 / US1638511089 / US96145D1054 / US95040Q1040 / 100507888 / US5588681057 / US2057683029 / US15136A1025 / US12653C1080 / US03753U1060 / US2997341035 / US87484T1088 / US80706P1030 / US08579X1019 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / CA87807B1076 / US22052L1044 / US26614N1028 / JE00BJ1F3079 / US42250P1030 / US67098H1041 / US69047Q1022 / US80810D1037 / US90278Q1085 / US5168062058 / US13123X5086 / US69526K1051 / US3773201062 / CA00288U1066</td><td class="leftalignment">APA Corp (US) / Aptargroup Inc / Ball Corp / H & R Block Inc / Coterra Energy Inc / Deere & Co / Devon Energy Corp / EOG Resources Inc / Gilead Sciences Inc / Greif Inc / Halliburton Co / International Paper Co / Louisiana-Pacific Corp / Murphy Oil Corp / Occidental Petroleum Corp / PPG Industries Inc / Packaging Corp of America / Pioneer Natural Resources Co / Polaris Inc / Range Resources Corp / Rayonier Inc / Regeneron Pharmaceuticals Inc / Schlumberger NV / Sealed Air Corp / Silgan Holdings Inc / Sonoco Products Co / Southwestern Energy Co / Ventas Inc / Weyerhaeuser Co / Enbridge Inc / Cascades Inc / West Fraser Timber Co Ltd / Marathon Oil Corp / Conocophillips / Crown Holdings Inc / Alnylam Pharmaceuticals Inc / Regency Centers Corp / Federal Realty Investment Trust / Potlatchdeltic Corp / Halozyme Therapeutics Inc / AGF Management Ltd / IGM Financial Inc / Hess Corp / Canfor Corp / LTC Properties Inc / National Health Investors Inc / World Acceptance Corp / Teradata Corp / Graphic Packaging Holding Co / Continental Resources Inc / CI Financial Corp / EQT Corp / SM Energy Co / Clearwater Paper Corp / Pembina Pipeline Corp / Keyera Corp / Boise Cascade Co / ServiceNow Inc / bluebird bio Inc / PDC Energy Inc / Sabra Health Care REIT Inc / Gibson Energy Inc / Matador Resources Co / Berry Global Group Inc / Intercept Pharmaceuticals Inc / Diamondback Energy Inc / Fate Therapeutics Inc / Antero Resources Corp / Ally Financial Inc / Applied Genetic Technologies Corp / Interfor Corp / CareTrust REIT Inc / Viking Therapeutics Inc / Chemours Co / Westrock Co / Welltower Inc / SandRidge Energy Inc / Madrigal Pharmaceuticals Inc / Comstock Resources Inc / Centennial Resource Development Inc / CNX Resources Corp / Apellis Pharmaceuticals Inc / Evelo Biosciences Inc / Talos Energy Inc / Scholar Rock Holding Corp / Berry Corporation (Bry) / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / TC Energy Corp / Corteva Inc / Dupont De Nemours Inc / Amcor PLC / Healthpeak Properties Inc / O-I Glass Inc / Ovintiv Inc / Schrodinger Inc / Ufp Industries Inc / Laredo Petroleum Inc / Callon Petroleum Co / Pactiv Evergreen Inc / Glatfelter Corp / Abcellera Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues 2021 Strategic Conclusions. Summary slides</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh / Elizabeth Walton / Mr. Dominic Lunn</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2021 Outlook: Biotech Fundamentals Remain Strong</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">US03753U1060 / US3755581036 / US75886F1075 / US02043Q1076 / US40637H1095 / US09609G1004 / US45845P1084 / US31189P1021 / US03820J1007 / US92686J1060 / US5588681057 / US2997341035 / US80706P1030 / US2936141033 / US50015M1099 / US85789A1051 / US62921N1054 / US80810D1037 / CA00288U1066</td><td class="leftalignment">Apellis Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Fate Therapeutics Inc / Applied Genetic Technologies Corp / Viking Therapeutics Inc / Madrigal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Entasis Therapeutics Holdings Inc / Kodiak Sciences Inc / Stealth BioTherapeutics Corp / NGM Biopharmaceuticals Inc / Schrodinger Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Ikechukwu Oji / Jin Lee</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Upgrade to Outperform; Well Positioned Heading into 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matthew Luchini / Jin Lee</td></tr>
<tr class="even"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine from GRTS; TSHA designations</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GRTS.OQ / TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MacKay's Weekly Dose</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AMGN.O / EXEL.O / REGN.O</td><td class="leftalignment">Amgen Inc / Exelixis Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Kennen MacKay, PHD / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">01/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">IPO Froth Resembles Mid-90s</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">AAPL=US / IBM=US / WMB=US / COST=US / INTC=US / KO=US / MCD=US / MO=US / AMD=US / MSFT=US / JNPR=US / K=US / AMZN=US / T=US / ORCL=US / WMT=US / D=US / ED=US / WFC=US / NVDA=US / HBI=US / AKAM=US / VZ=US / EL=US / GIS=US / SAP=US / URI=US / BAX=US / GSK=US / JNJ=US / TTWO=US / LEG=US / LRCX=US / ATVI=US / KR=US / EIX=US / UNH=US / ABMD=US / AVGO=US / HRB=US / CMI=US / CHD=US / CSGP=US / DHI=US / XRAY=US / DG=US / EW=US / EQIX=US / FMC=US / ISRG=US / MS=US / REGN=US / ROK=US / SBAC=US / HSIC=US / SJM=US / ALGN=US / PFG=US / CINF=US / SIVB=US / FB=US / O=US / SWKS=US / NFLX=US / QSR=US / BX=US / LULU=US / VMW=US / SPGI=US / KKR=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / EA=US / TMUS=US / BABA=US / ZBH=US / SQ=US / OKTA=US / 120175706</td><td class="leftalignment">Apple Inc / International Business Machines Corp / Williams Companies Inc / Costco Wholesale Corp / Intel Corp / Coca-Cola Co / McDonald's Corp / Altria Group Inc / Advanced Micro Devices Inc / Microsoft Corp / Juniper Networks Inc / Kellogg Co / Amazon.com Inc / AT&T Inc / Oracle Corp / Walmart Inc / Dominion Energy Inc / Consolidated Edison Inc / Wells Fargo & Co / NVIDIA Corp / HanesBrands Inc / Akamai Technologies Inc / Verizon Communications Inc / Estee Lauder Companies Inc / General Mills Inc / SAP SE / United Rentals Inc / Baxter International Inc / GlaxoSmithKline PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Activision Blizzard Inc / Kroger Co / Edison International / UnitedHealth Group Inc / ABIOMED Inc / Broadcom Inc / H & R Block Inc / Cummins Inc / Church & Dwight Co Inc / CoStar Group Inc / D R Horton Inc / DENTSPLY SIRONA Inc / Dollar General Corp / Edwards Lifesciences Corp / Equinix Inc / FMC Corp / Intuitive Surgical Inc / Morgan Stanley / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / SBA Communications Corp / Henry Schein Inc / J M Smucker Co / Align Technology Inc / Principal Financial Group Inc / Cincinnati Financial Corp / SVB Financial Group / Meta Platforms Inc / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Restaurant Brands International Inc / Blackstone Inc / Lululemon Athletica Inc / VMware Inc / S&P Global Inc / KKR & Co Inc / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Electronic Arts Inc / T-Mobile US Inc / Alibaba Group Holding Ltd / Zimmer Biomet Holdings Inc / Block Inc / Okta Inc / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ACB.TO / IBIO.A / ZTS.N / WEED.TO / TLRY.OQ / OGI.TO / XGN.OQ / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Aurora Cannabis Inc / Ibio Inc / Zoetis Inc / Canopy Growth Corp / Tilray Brands Inc / OrganiGram Holdings Inc / Exagen Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMTK=US / VERU=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / GBT=US / MDT=US / DYN=US / WMT=US / CMS=US / GILD=US / DGX=US / NVS=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CSTL=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / PHG=US / LH=US / REGN=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / CCRN=US / CNC=US / ACA=US / STSA=US / NTRA=US / ENSG=US / MIST=US / MD=US / NKTR=US / SLF=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / TPTX=US / IVA=US / EHC=US / NEO=US / ADUS=US / BEAM=US / ACHC=US / SRPT=US / AGIO=US / FATE=US / VCYT=US / CTRE=US / WBA=US / NVTA=US / VKTX=US / EVH=US / VRAY=US / MDGL=US / IRTC=US / NCNA=US / GH=US / ARVN=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / APLT=US / IDYA=US / BCYC=US / BCEL=US / KRTX=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PNTG=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">DermTech Inc / Veru Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Dyne Therapeutics Inc / Walmart Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Castle Biosciences Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Satsuma Pharmaceuticals Inc / Natera Inc / Ensign Group Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Inventiva SA / Encompass Health Corp / Neogenomics Inc / Addus Homecare Corp / Beam Therapeutics Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Veracyte Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Viking Therapeutics Inc / Evolent Health Inc / ViewRay Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / NuCana PLC / Guardant Health Inc / Arvinas Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Atreca Inc / Karuna Therapeutics Inc / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Pennant Group Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Biotech Weekly Prescription Report</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IL0006290147 / US0311621009 / US3755581036 / US75886F1075 / US45845P1084</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Do G. Kim / Matthew Luchini / Jameson Kao / Jin Lee / Ikechukwu Oji</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BSX=US / LSI=US / HD=US / INTC=US / OXY=US / TWTR=US / AMD=US / RRC=US / BXP=US / PLD=US / AVB=US / AMZN=US / BLD=US / DVN=US / EBAY=US / INCY=US / AMT=US / NVDA=US / APA=US / CPE=US / EOG=US / AKAM=US / SLG=US / REI=US / CONE=US / XOM=US / CRK=US / WLL=US / PXD=US / CCI=US / MGY=US / SWN=US / MUR=US / UMPQ=US / MRO=US / EXPE=US / TTMI=US / VMC=US / ESS=US / MGM=US / CLI=US / AKR=US / EQR=US / W=US / RCL=US / MLM=US / MAC=US / BNL=US / CCL=US / CHH=US / CNX=US / DRH=US / EQIX=US / EQT=US / IBP=US / SAFE=US / TREE=US / DOC=US / MCHP=US / NTST=US / PDM=US / REGN=US / SBAC=US / STOR=US / SNAP=US / TRIP=US / TRUE=US / WIX=US / CVX=US / PSA=US / SPG=US / NET=US / HIW=US / BKNG=US / SIVB=US / ADC=US / BOKF=US / BDN=US / CPT=US / OFC=US / CUZ=US / EGP=US / EPR=US / FB=US / FRT=US / FR=US / KIM=US / MTCH=US / MAA=US / NHI=US / OHI=US / SRC=US / UDR=US / VNO=US / WRE=US / DRE=US / REG=US / COP=US / VICI=US / BRX=US / MGP=US / BCO=US / PTON=US / TCBI=US / CDLX=US / EXR=US / DLR=US / BLDR=US / MPW=US / CCOI=US / CLR=US / LLNW=US / LUMN=US / WH=US / WYND=US / IAC=US / EPRT=US / HTA=US / AR=US / HGV=US / NXPI=US / SBRA=US / APTS=US / RLJ=US / ESTE=US / VAC=US / CUBE=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / SSTK=US / NCLH=US / GLPI=US / GTT=US / GOOGL=US / BABA=US / CMPR=US / DEA=US / SUM=US / GDDY=US / ETSY=US / NXRT=US / NSA=US / CHCT=US / ZG=US / 82982L103 / TTD=US / CDEV=US / IRTC=US / TRVG=US / PVAC=US / GDS=US / YEXT=US / SBOW=US / RDFN=US / MPWR-US / CARG=US / SFIX=US / ROOT=US / COLD=US / HWC=US / FTDR=US / SVMK=US / EB=US / SITC=US / LYFT=US / UBER=US / OVV=US / FBRX=US / ABNB=US / DASH=US / AIRC=US / 100087548</td><td class="leftalignment">Boston Scientific Corp / Life Storage Inc / Home Depot Inc / Intel Corp / Occidental Petroleum Corp / Twitter Inc / Advanced Micro Devices Inc / Range Resources Corp / Boston Properties Inc / Prologis Inc / Avalonbay Communities Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / eBay Inc / Incyte Corp / American Tower Corp / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Akamai Technologies Inc / SL Green Realty Corp / Ring Energy Inc / CyrusOne Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / TTM Technologies Inc / Vulcan Materials Co / Essex Property Trust Inc / MGM Resorts International / Veris Residential Inc / Acadia Realty Trust / Equity Residential / Wayfair Inc / Royal Caribbean Cruises Ltd / Martin Marietta Materials Inc / Macerich Co / Bunzl plc / Carnival Corp / Choice Hotels International Inc / CNX Resources Corp / Diamondrock Hospitality Co / Equinix Inc / EQT Corp / Installed Building Products Inc / Safehold Inc / Lendingtree Inc / Physicians Realty Trust / Microchip Technology Inc / Netstreit Corp / Piedmont Office Realty Trust Inc / Regeneron Pharmaceuticals Inc / SBA Communications Corp / STORE Capital Corp / Snap Inc / Tripadvisor Inc / TrueCar Inc / Wix.Com Ltd / Chevron Corp / Public Storage / Simon Property Group Inc / Cloudflare Inc / Highwoods Properties Inc / Booking Holdings Inc / SVB Financial Group / Agree Realty Corp / BOK Financial Corp / Brandywine Realty Trust / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Eastgroup Properties Inc / EPR Properties / Meta Platforms Inc / Federal Realty Investment Trust / First Industrial Realty Trust Inc / Kimco Realty Corp / Match Group Inc / Mid-America Apartment Communities Inc / National Health Investors Inc / Omega Healthcare Investors Inc / Spirit Realty Capital Inc / UDR Inc / Vornado Realty Trust / Washington Real Estate Investment Trust / Duke Realty Corp / Regency Centers Corp / Conocophillips / VICI Properties Inc / Brixmor Property Group Inc / MGM Growth Properties LLC / Brinks Co / Peloton Interactive Inc / Texas Capital Bancshares Inc / Cardlytics Inc / Extra Space Storage Inc / Digital Realty Trust Inc / Builders FirstSource Inc / Medical Properties Trust Inc / Cogent Communications Holdings Inc / Continental Resources Inc / Limelight Networks Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Travel + Leisure Co / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Healthcare Trust Of America Inc / Antero Resources Corp / Hilton Grand Vacations Inc / NXP Semiconductors NV / Sabra Health Care REIT Inc / Preferred Apartment Communities Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / CubeSmart / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Shutterstock Inc / Norwegian Cruise Line Holdings Ltd / Gaming and Leisure Properties Inc / GTT Communications Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Easterly Government Properties Inc / Summit Materials Inc / GoDaddy Inc / ETSY Inc / NexPoint Residential Trust Inc / National Storage Affiliates Trust / Community Healthcare Trust Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Trivago NV / Ranger Oil Corp / GDS Holdings Ltd / Yext Inc / SilverBow Resources Inc / Redfin Corp / Monolithic Power Systems Inc / CarGurus Inc / Stitch Fix Inc / Root Inc / Americold Realty Trust / Hancock Whitney Corp / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / Ovintiv Inc / Forte Biosciences Inc / Airbnb Inc / DoorDash Inc / Apartment Income REIT Corp / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Israel / Liberia / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">458140100 / 75886F107 / 655844108 / 907818108 / 126408103 / G7945M107 / 874080104 / 743713109 / 33938J106 / 172406209</td><td class="leftalignment">Intel Corp / Regeneron Pharmaceuticals Inc / Norfolk Southern Corp / Union Pacific Corp / CSX Corp / Seagate Technology Holdings PLC / TAL Education Group / Proto Labs Inc / Pacira Biosciences Inc / Cinedigm Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Ruben Roy / Mr. Nathan Martin / Ms. Fawne Jiang / Long Lin / Mr. Mark Miller / Mr. Robert M. Wasserman / Mr. Bruce D. Jackson / Mr. Daniel L. Kurnos, CFA / Mr. Michael P. Ward, CFA / Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Prophylactic Antibodies Prevent COVID-19; In A Vaccine Age it Does Not Matter</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">75886F107</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">4Q Large Cap Preview:  We are paying most attention to BIIB and GILD outlooks around 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.O / GILD.O / AMGN.O / INCY.O / REGN.O / VRTX.O</td><td class="leftalignment">Biogen Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">INCY=US / REGN=US / FBRX=US</td><td class="leftalignment">Incyte Corp / Regeneron Pharmaceuticals Inc / Forte Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Minh Vong / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BGNE (NEUTRAL) - Model Update Post NOVN Collaboration; Incremental Updates on 2021 Key Milestones; Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BYYWPW6 / 5671735 / 0989529 / 0925288 / 2126335 / 2778844 / 2684703 / 2730190 / 7103065</td><td class="leftalignment">Beigene Ltd / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">I'm Hooked On a Feeling... Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">LLY's COVID Ab Results in Nursing Homes Validates Prophylaxis; REGN Up Next</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">REGN=US / LLY.N / LLY=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Regeneron climbs 10.8% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">REGN.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN=US / HD=US / MCD=US / WEN=US / PD=US / AMZN=US / DT=US / BLD=US / CMA=US / PEB=US / H=US / CRM=US / MTN=US / LOW=US / MAR=US / LEG=US / KFRC=US / HLT=US / AMN=US / CBRL=US / CHH=US / DRI=US / DRH=US / EXPO=US / GFF=US / IBP=US / NOW=US / MAN=US / MAS=US / MHK=US / TEAM=US / REGN=US / SNOW=US / ZION=US / NFLX=US / APPN=US / UCBI=US / DIN=US / PNFP=US / TPX=US / EXP=US / BDC=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / WH=US / WYND=US / JACK=US / TREX=US / HGV=US / RLJ=US / VAC=US / FBHS=US / SPLK=US / RHP=US / TILE=US / NDLS=US / GOOGL=US / LOCO=US / NEWR=US / SHAK=US / WING=US / ZG=US / 82982L103 / PK=US / JELD=US / PLYA=US / AYX=US / RDFN=US / ESTC=US / FERGY=US / DDOG=US / AZEK=US</td><td class="leftalignment">Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / Dynatrace Inc / TopBuild Corp / Comerica Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Lowe's Companies Inc / Marriott International Inc / Leggett & Platt Inc / Kforce Inc / Hilton Worldwide Holdings Inc / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Exponent Inc / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Snowflake Inc. / Zions Bancorporation NA / Netflix Inc / Appian Corp / United Community Banks Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Travel + Leisure Co / Jack in the Box Inc / Trex Company Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Splunk Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / Alphabet Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Alteryx Inc / Redfin Corp / Elastic NV / Ferguson PLC / Datadog Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">PTON=US / VERU=US / INTC=US / AMD=US / AMZN=US / T=US / DYN=US / BAC=US / GILD=US / NVDA=US / GS=US / NICE=US / CHKP=US / TSM=US / SPOT=US / CYBR=US / MS=US / REGN=US / UTHR=US / VRTX=US / WIX=US / RDWR=US / OPT=US / NET=US / MTCH=US / STSA=US / NFLX=US / VRNT=US / MIST=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / VIAC=US / TPTX=US / IVA=US / SWI=US / FTNT=US / TSLA=US / BEAM=US / XYL=US / PANW=US / SRPT=US / FEYE=US / FATE=US / VRNS=US / GDDY=US / OKTA=US / SAIL=US / IQ=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / TUFN=US / APLT=US / IDYA=US / BCYC=US / CRWD=US / BCEL=US / KRTX=US / PING=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">Peloton Interactive Inc / Veru Inc / Intel Corp / Advanced Micro Devices Inc / Amazon.com Inc / AT&T Inc / Dyne Therapeutics Inc / Bank of America Corp / Gilead Sciences Inc / NVIDIA Corp / Goldman Sachs Group Inc / Nice Ltd / Check Point Software Technologies Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Spotify Technology SA / Cyberark Software Ltd / Morgan Stanley / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Radware Ltd / Opthea Ltd / Cloudflare Inc / Match Group Inc / Satsuma Pharmaceuticals Inc / Netflix Inc / Verint Systems Inc / Milestone Pharmaceuticals Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Inventiva SA / SolarWinds Corp / Fortinet Inc / Tesla Inc / Beam Therapeutics Inc / Xylem Inc / Palo Alto Networks Inc / Sarepta Therapeutics Inc / Mandiant Inc / Fate Therapeutics Inc / Varonis Systems Inc / GoDaddy Inc / Okta Inc / SailPoint Technologies Holdings Inc / iQIYI Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Tufin Software Technologies Ltd / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / CrowdStrike Holdings Inc / Atreca Inc / Karuna Therapeutics Inc / Ping Identity Holding Corp / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Info. Tech./Software / Machinery / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: PharmaValues 2021 strategic conclusions</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Ms. Gretel Janu / Mr. Dominic Lunn / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Evan D. Seigerman / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Feedback from Early 2021 Large/Mid-Cap Biotech Presentations</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD=US / REGN=US / UTHR=US / VRTX=US / MRNA=US / SRPT=US</td><td class="leftalignment">Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAC / CCO / CMA / CNI / CP / CPB / DANO.PA / EOG / ETM / FMC / GIS / HSY / IPG / K / MRO / NSC / OMC / SHW / SJM / SM / TFX / THS / UNP / BYND.O / GILD.O / AMGN.O / AAPL.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / AXS / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / HAIN.O / BIIB.O / INFI.O / HALO.O / NOG.A / MRNA.O / ARCT.O / MDLZ.O / FANG.O / SMPL.O / POST.K / FATE.O / AFMD.O / BLCM.O / KHC.O / CYAD.O / OMF / CSX.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / NOMD.K / KZR.O / STRO.O / IHRT.O / IMV.O / BRBR.K / RAPT.O</td><td class="leftalignment">Bank of America Corp / Clear Channel Outdoor Holdings Inc / Comerica Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Campbell Soup Co / Danone SA / EOG Resources Inc / Audacy Inc / FMC Corp / General Mills Inc / Hershey Co / Interpublic Group of Companies Inc / Kellogg Co / Marathon Oil Corp / Norfolk Southern Corp / Omnicom Group Inc / Sherwin-Williams Co / J M Smucker Co / SM Energy Co / Teleflex Inc / TreeHouse Foods Inc / Union Pacific Corp / Beyond Meat Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / AXIS Capital Holdings Ltd / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Hain Celestial Group Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Northern Oil and Gas Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Mondelez International Inc / Diamondback Energy Inc / Simply Good Foods Co / Post Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Kraft Heinz Co / Celyad Oncology SA / OneMain Holdings Inc / CSX Corp / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Nomad Foods Ltd / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Bellring Brands Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / France / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CCO / ETM / IPG / OMC / SHW / TFX / GILD.O / AMGN.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ARCT.O / FATE.O / AFMD.O / BLCM.O / CYAD.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / KZR.O / STRO.O / IHRT.O / IMV.O / RAPT.O</td><td class="leftalignment">Clear Channel Outdoor Holdings Inc / Audacy Inc / Interpublic Group of Companies Inc / Omnicom Group Inc / Sherwin-Williams Co / Teleflex Inc / Gilead Sciences Inc / Amgen Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Celyad Oncology SA / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Anne Bode</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: IQVIA NBRx Trends (AMGN, REGN)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.OQ / AMGN.OQ / AMGN=US / REGN=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Amgen Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Minh Vong / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KRYS=US / ADAP=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / LOGC=US / MGEN=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US</td><td class="leftalignment">Krystal Biotech Inc / Adaptimmune Therapeutics PLC / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / LogicBio Therapeutics Inc / Viridian Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Normally Q4 is Solid, but COVID & Currency Cloud Outlook</td><td class="leftalignment">English</td><td class="rightalignment">118</td><td class="leftalignment">ABBV=US / PFE=US / AMGN=US / GILD=US / SAN=FR / GSK=GB / REGN=US / VRTX=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 0925288 / 2516152 / 2050832 / 2026242 / 2544960 / 2115902 / 2270726 / 2542049 / 2317087 / 2459020 / 2048804 / 2730190 / 2853688 / 2883878 / 7103065 / B067BM3 / 2212922 / B19FQ48 / 2857817 / B125XQ6 / B2R3PV1 / B1HJLW5 / BFRTDG1 / B6RS2B3 / B7VD3F2 / BJ3V905 / BJ0XLZ3 / B3X26D8 / BFLR866 / B6WXT12 / BJ36RM8 / BTN1Y11 / BYY8XK8 / BQPVQZ6 / BYVY8G0 / BS7K7C9 / BYVYD43 / BFNF1D6 / BXDZ9Z0 / BJXBP41 / BKS3SM8 / BNFWR44 / BJJMGL2 / BYXJQG9 / BG31GH0 / BKTNTR9 / BYQHPK7 / BZ1LFG7 / BX7RSN3 / BFFVVC1 / BGKG6M3 / BYXR425</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Beasley Broadcast Group Inc / OPKO Health Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Intuit Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Stryker Corp / Teva Pharmaceutical Industries Ltd / Novartis AG / Molson Coors Beverage Co / NRG Energy Inc / Amicus Therapeutics Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Emergent BioSolutions Inc / Aerie Pharmaceuticals Inc / Clovis Oncology Inc / Duke Energy Corp / Endo International PLC / Heron Therapeutics Inc / Pacira Biosciences Inc / Twitter Inc / TherapeuticsMD Inc / Pacira Biosciences Inc / Medtronic PLC / WEC Energy Group Inc / Horizon Therapeutics PLC / Alphabet Inc / Nevro Corp / Performance Food Group Co / Amneal Pharmaceuticals Inc / Shopify Inc / Alcon AG / IGM Biosciences Inc / Worldline SA / Fox Corp / Spire Inc / Y-mAbs Therapeutics Inc / ViacomCBS Inc / Zymeworks Inc / Roku Inc / Collegium Pharmaceutical Inc / Bausch Health Companies Inc / StoneCo Ltd / RH</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AC.TO / AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / BARC.L / BBDb.TO / C.N / CI.N / CL.N / CMS.N / CNA.L / CP.TO / CVS.N / EDP.LS / EIX.N / EL.N / ELE.MC / EOG.N / F.N / GM.N / HSBA.L / HSX.L / INTC.O / IP.N / JPM.N / KBH.N / KMB.N / KO.N / LLOY.L / PD.N / PEG.N / PFE.N / PHM.N / PNC.N / SAN.MC / SGEF.PA / SO.N / T.N / TOL.N / VC.N / WFC.N / SSE.L / PEP.N / BFb.N / PG.N / PXD.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / INCY.O / THC.N / CNR.TO / DUK.N / UNH.N / BWA.N / LEA.N / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / EPR.N / LEN.N / CTXS.O / CLX.N / CAG.N / MRO.N / GIS.N / DVN.N / EPC.N / MGA.N / AMT.N / JAZZ.O / VZ.N / EXEL.O / CYH.N / DHI.N / STZ.N / APH.N / FISV.O / EQT.N / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / BC.N / SAM.N / FRAG.DE / BMRN.O / OPTN.O / REGN.O / ENR.N / MU.O / SM.N / NCR.N / NET.N / TEL.N / COP.N / CNP.N / CPE.N / ENDP.O / CPK.N / PII.N / ST.N / SWN.N / SR.N / NTCT.OQ / GPN.N / MNST.O / NWG.L / IMGN.O / CASY.O / ANSS.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / BIIB.O / CHR.TO / 02209S103 / DLR.N / ACAD.O / 427866108 / SJW.N / BKD.N / FIS.N / HICL.L / ADP.PA / TEVA.N / MA.N / HOG.N / CVLT.O / ATL.MI / BGS.N / VMW.N / TDC.N / INO.OQ / DAN.N / EDPR.LS / SWI.N / EIF.TO / FTNT.O / SPB.N / FHZN.S / PCRX.O / MSP.N / MTOR.N / MTDR.N / SPLK.OQ / WDC.O / PANW.N / QLYS.O / MDLZ.OQ / FANG.O / ABBV.N / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / DOO.TO / COTY.N / AGIO.O / PTC.O / VRNS.O / AGRX.O / ANTM.N / AENA.MC / SHOP.N / GLPG.O / WRK.N / RPD.O / SGRY.O / MIME.OQ / MESO.O / RACE.MI / MTRO.L / SCWX.O / TWLO.N / ADNT.N / PBYI.OQ / OKTA.OQ / CDEV.O / ESTE.N / SAIL.N / APTV.N / ZS.OQ / AMRX.N / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / PRVB.O / ESTC.N / NWL.O / ZM.O / CRWD.O / GMAB.O / DOCU.N / PING.N / DDOG.O / CRNC.OQ / VMUK.L / NLOK.O / WTRG.N / REYN.O / NKLA.OQ / APA.OQ / FOUR.N / JAMF.O / PLTR.N / ASAN.N / MTCR.O / SUMO.O / BSY.O / MCFE.OQ / 900435207 / 120681711</td><td class="leftalignment">Air Canada / American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Barclays PLC / Bombardier Inc / Citigroup Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / Centrica PLC / Canadian Pacific Railway Ltd / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / EOG Resources Inc / Ford Motor Co / General Motors Co / HSBC Holdings PLC / Hiscox Ltd / Intel Corp / International Paper Co / JPMorgan Chase & Co / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Lloyds Banking Group PLC / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Pultegroup Inc / PNC Financial Services Group Inc / Banco Santander SA / Vinci SA / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Wells Fargo & Co / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Canadian National Railway Co / Duke Energy Corp / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / EPR Properties / Lennar Corp / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / Devon Energy Corp / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Verizon Communications Inc / Exelixis Inc / Community Health Systems Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Brunswick Corp / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Micron Technology Inc / SM Energy Co / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Natwest Group PLC / ImmunoGen Inc / Caseys General Stores Inc / ANSYS Inc / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Chorus Aviation Inc / Altria Group Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hershey Co / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / HICL Infrastructure PLC / Aeroports de Paris SA / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Commvault Systems Inc / Atlantia SpA / B&G Foods Inc / VMware Inc / Teradata Corp / Inovio Pharmaceuticals Inc / Dana Inc / EDP Renovaveis SA / SolarWinds Corp / Exchange Income Corp / Fortinet Inc / Spectrum Brands Holdings Inc / Flughafen Zuerich AG / Pacira Biosciences Inc / Datto Holding Corp / Meritor Inc / Matador Resources Co / Splunk Inc / Western Digital Corp / Palo Alto Networks Inc / Qualys Inc / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / BRP Inc / Coty Inc / Agios Pharmaceuticals Inc / PTC Inc / Varonis Systems Inc / Agile Therapeutics Inc / Anthem Inc / Aena SME SA / Shopify Inc / Galapagos NV / Westrock Co / Rapid7 Inc / Surgery Partners Inc / Mimecast Ltd / Mesoblast Ltd / Ferrari NV / Metro Bank PLC / SecureWorks Corp / Twilio Inc / Adient PLC / Puma Biotechnology Inc / Okta Inc / Centennial Resource Development Inc / Earthstone Energy Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Virgin Money UK PLC / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Jamf Holding Corp / Palantir Technologies Inc / Asana Inc / Metacrine Inc / Sumo Logic Inc / Bentley Systems Inc / Mcafee Corp / Turquoise Hill Resources Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : Putting a Wrap on The 2021 Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CVS.N / JNJ.N / MCK.N / PFE.N / GILD.O / AMGN.O / INCY.O / ALKS.O / BMRN.O / REGN.O / VRTX.O / RARE.O / BLUE.O / NVAX.O / SGEN.O / BIIB.O / ACAD.O / MRNA.O / CLVS.O / SAGE.O / GBT.O / NVCR.O / EDIT.O / PBYI.O / JNCE.O / ALLO.O / BNTX.O / LEGN.O / BCAB.O</td><td class="leftalignment">CVS Health Corp / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Alkermes Plc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Novavax Inc / Seagen Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / Editas Medicine Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc / BioNTech SE / Legend Biotech Corp / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe</td></tr>
</tbody></table>
</body>
</html>